Comments
Description
Transcript
PDFはこちら - 感覚器センター
㻌 㻌 㻌 ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓ㻌 ᮾ ி ་ ⒪ 䝉䞁䝍䞊㻌 ⮫ ᗋ ◊ ✲ 䝉䞁䝍䞊㻌 㻌 㻌 ◊✲ᖺሗ㻌 㻞㻜㻝㻡㻌 㻌 㻌 㻌 㻌 㻌 㻺㼍㼠㼕㼛㼚㼍㼘㻌㻵㼚㼟㼠㼕㼠㼡㼠㼑㻌㼛㼒㻌㻿㼑㼚㼟㼛㼞㼥㻌㻻㼞㼓㼍㼚㼟㻌 㻺㼍㼠㼕㼛㼚㼍㼘㻌㻴㼛㼟㼜㼕㼠㼍㼘㻌㻻㼞㼓㼍㼚㼕㼦㼍㼠㼕㼛㼚㻌㼀㼛㼗㼥㼛㻌㻹㼑㼐㼕㼏㼍㼘㻌㻯㼑㼚㼠㼑㼞 ⮫ᗋ◊✲ࢭࣥࢱ࣮ 2015 ◊✲ᖺሗ ᕳ㢌ゝ ᖹᡂ 27 ᖺᗘࡢ◊✲ᖺಧࢆⓎ⾜ࡍࡿ࠶ࡓࡗ࡚ ᮾி་⒪ࢭࣥࢱ࣮ 㝔㛗 Ṋ⏣⣧୕ 1980 ᖺ㸦 55 ᖺ㸧ࠊᅜ❧ᮾி➨㝔ෆ⮫ᗋ◊✲㒊ࡀタ⨨ࡉࢀࡓࡇጞࡲࡗࡓ ⮫ᗋ◊✲㒊㛛ࡣࠊᅜ❧㝔ࡢ⊂❧⾜ᨻἲேక࠸ࠊ2003 ᖺ㸦ᖹᡂ 15 ᖺ㸧10 ᭶ 1 ᪥ᮾ ி་⒪ࢭࣥࢱ࣮ ⮫ᗋ◊✲㸦ឤぬჾࢭࣥࢱ࣮㸧ࢭࣥࢱ࣮ࡋ࡚Ⓨ㊊ࡋࡓࠋⓎ㊊௨᮶ࠊ㡰ㄪ ᡂᯝࢆୖࡆ࡚ࡁ࡚࠸ࡿࠋ ᅜ࡛ࡣࠊ2015 ᖺ 4 ᭶᪥ᮏ་⒪◊✲㛤Ⓨᶵᵓ(AMED)ࢆタ❧ࡋࠊᇶ♏◊✲ࡽᐇ⏝ ୍㈏ࡋ࡚⧅ࡄࣉࣟࢪ࢙ࢡࢺࡢᐇࠊඹ㏻ᇶ┙ࡢᩚഛ㺃ά⏝ࢆ┠ᣦࡋ࡚ࠊᩥ㒊⛉Ꮫ┬ࠊཌ⏕ ປാ┬ࠊ⤒῭⏘ᴗ┬ࡢ◊✲㈨㔠ࢆࠊ⥲ྜㄪᩚࢆ⾜ࡗ࡚⥲ྜⓗ࡞ㄪᩚ㓄ศࡀ㛤ጞࡉࢀ࡚࠸ࡿࠋ ࡉࡽࠊ་⒪ἲᇶ࡙ࡃ⮫ᗋ◊✲୰᰾㝔ࡢᣦᐃࡀ㛤ጞࡉࢀ࡚࠾ࡾࠊᮏ㑥࠾ࡅࡿ⮫ᗋ◊✲ ࡢ᪂ࡋ࠸⤌ࡳࡀฟ᮶ୖࡀࡾࡘࡘ࠶ࡿࠋ ᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲ࢭࣥࢱ࣮ࡋ࡚ࡶࠊࡇࢀࡽࡢᅜෆ≧ἣࡢኚ༑ศᑐᛂ࡛ࡁ ࡿయไసࡾᐇ⦼ࢆୖࡆ࡚࠸ࡃᚲせࡀ࠶ࡿࠋᖺᮎࡣ ISO 15189 ࢆཷᑂࡋࠊ⌧ᅾ⤖ᯝᚅ ࡕ࡛࠶ࡿࡀࠊ⮫ᗋ᳨ᰝ㒊㛛ࡀ᳨య᳨ᰝࠊ⏕య᳨ᰝࢆྵࡵ࡚ᅜ㝿ㄆドࢆᚓࡿࡇ࡞ࡾࠊᑗ᮶ ணࡉࢀࡿᅜ㝿ඹྠ㦂ࡢタᇶ‽ࡢᑐ⟇ࢆ㐍ࡵ࡚࠸ࡿࠋࡲࡓࠊᩥ㒊⛉Ꮫ┬ཌ⏕ປാ┬ ࡼࡾᖹᡂ 26 ᖺ 12 ᭶ไᐃ࣭࿌♧ࡉࢀࡓࠊ ࠕேࢆᑐ㇟ࡍࡿ་Ꮫ⣔◊✲㛵ࡍࡿ⌮ᣦ㔪ࠖ ᇶ࡙ࡁࠊ㝔ෆࡢ⌮ጤဨつ⛬ࡢᨵಟࢆ⾜ࡗ࡚ࡁࡓࠋ ୍᪉࡛ࠊ㝔ෆࡢ⮫ᗋ◊✲ࡢࣥࣇࣛࢆᩚഛࡍࡿࡓࡵࠊ⮫ᗋ◊✲ᨭ㒊㛛ࡢタ⨨ࡢ᳨ウࢆ ጞࡵ࡚࠸ࡿࠋࢫ࣮࣌ࢫࠊ࣐ࣥࣃ࣮࣡ࡶ㊊ࡋ࡚࠸ࡿ୰࡛ࡢ❧ୖࡆࡔࡅࠊ㞴⏘ࡀணࡉ ࢀࡿࡀࠊ᪂ࡋ࠸௦ࡢ⮫ᗋ◊✲⪏࠼࠺ࡿࡼ࠺࡞యไసࡾࢆᐇ⌧ࡋࡓ࠸⪃࠼࡚࠸ࡿࠋ ẖᖺ㛤ദࡋ࡚࠸ࡿឤぬჾࢩ࣏ࣥࢪ࣒࢘ࡣࠊᮏᖺࡣ 3 ᭶ 4 ᪥㛤ദணᐃ࡛ࠊ➨ 11 ᅇࢆ㏄࠼ ࡿࠋࢸ࣮࣐ࡣࠗ㧗㱋⪅་⒪ ࢧࢡࢭࢫࣇ࣭࢚ࣝࢪࣥࢢࡢᣮᡓ࡛࠘ࠊ⮫ᗋ◊✲ࢭࣥࢱ࣮ ࡢࡍ࡚ࡢ㒊㛛ࡼࡾⓎ⾲ࢆ࠾㢪࠸ࡋ࡚࠸ࡿࠋ͆㧗㱋⪅་⒪͇࠸࠺ࡍ࡚ࡢ㒊㛛ඹ㏻ࡍࡿ ࣮࣮࢟࣡ࢻࡀ࠶ࡗࡓࡇࠊࡑࡢ࣮࣮࢟࣡ࢻࡀ⌧ᅾࡢ᪥ᮏࡢ་⒪ࡢᢪ࠼࡚࠸ࡿၥ㢟୍⮴ࡋ ࡚࠸ࡓࡇࡣࠊ⮫ᗋ◊✲ࢭࣥࢱ࣮ࡢ┠ᣦࡋ࡚࠸ࡿ᪉ྥᛶࡀࠊṇࡋ࠸᪉ྥࢆྥ࠸࡚ࡁ࡚࠸ࡓࡇ ࢆ≀ㄒࡗ࡚࠸ࡿ⪃࠼ࡽࢀࡿࠋᚋࡢⓎᒎࢆᮇᚅࡋ࡚࠸ࡿࡇࢁ࡛࠶ࡿࠋ 㛗ᖺࠊᮏ㝔㈉⊩࠸ࡓࡔ࠸ࡓ⫈ぬ࣭ᖹ⾮ぬ◊✲㒊㛗ࡢ⸨ṇேඛ⏕ࡀࠊᖹᡂ 28 ᖺ 3 ᭶ᮎ ࢆࡶࡗ࡚ᐃᖺ㏥⫋ࡉࢀࡲࡍࠋ㛗ᖺࡢࡈຌ⦼ᩗពࢆ⾲ࡍࡿࡶࠊឤㅰ⏦ࡋୖࡆࡲࡍࠋ ᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲ࢭࣥࢱ࣮ ᖹᡂ 27 ᖺ ◊✲ሗ࿌ ┠ḟ ᕳ㢌ゝ Ṋ⏣⣧୕ ᮾி་⒪ࢭࣥࢱ࣮㝔㛗 Ϩ㸬ྛ◊✲㒊ࡢ◊✲ሗ࿌ i㸯 ᨻ⟇་⒪⏬◊✲㒊 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 1 ࠝ⮫ᗋᏛ◊✲ᐊࠞ Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery. ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 2 Bito S, Miyata S, Migita K, Nakamura M, Shinohara K, Sato T, Tonai T, Shimizu M, Shibata Y, Kishi K, Kubota C, Nakahara S, Mori T, Ikeda K, Ota S, Minamizaki T, Yamada S, Shiota N, KameiM, Motokawa S. ᕷ୰㝔࠾ࡅࡿ⮫ᗋ◊✲άືࡢᨭ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 3 ᑿ⸨ ㄔྖ ᶆ‽ホ౯㡯┠ࢆ⏝࠸ࡓᆅᇦデ⒪ᡤࡢໟᣓⓗホ౯◊✲ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 5 ᯇᮧ┿ྖࠊᑿ⸨ㄔྖ ⬤ᙅ㧗㱋⪅ࡢデ⒪ሗᥦ౪᭩ࣇ࢛࣮࣐ࢵࢺ㛤Ⓨ㛵ࡍࡿ ࣥࢱࣅ࣮ࣗㄪᰝ ‥‥‥‥‥‥‥‥‥‥‥ 11 ᯇᮧ┿ྖࠊᑿ⸨ㄔྖࠊ᪂᳃ຍዉᏊ ࠝ་⒪⤒Ⴀሗ࣭㧗㱋⪅ࢣ◊✲ᐊࠞ 㧗㱋⪅ࢣ◊✲ᐊ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 14 ་⒪⤒Ⴀሗ◊✲ᐊ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 15 ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫ࣭Ꮫ⾡ㅮ₇ 2015.5.23 ༓௦⏣༊ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 19 ຍᡃྩᏕࠊ༡ಟྖ㑻ࠊ᪂ṇ⏤⣖Ꮚ ࠝᡭ⾡ᨭࣟ࣎ࢵࢺᢏ⾡ᛂ⏝◊✲ᐊࠞ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 21 ࠝ⮫ᗋ◊✲࣭㦂᥎㐍ᐊࠞ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 23 Corrective and Preventative Actions (CAPA)ࡼࡿ㐓⬺㜵Ṇࡢྲྀࡾ⤌ࡳ ‥‥‥‥‥‥‥‥‥‥‥‥ 25 ✄ྜྷ⨾⏤⣖ࠊᮏஂ⨾Ꮚࠊᔱᒸ ⥳ࠊ⸨ᕝᏊࠊ㧘ᮌᜨ⨾ࠊ➉ୗᬛᜨࠊ▼㔛ࠊ㔠ග❶Ụࠊ ୰ᕝ⏤⨾ࠊ㏆⸨┤ᶞ First-in-human ➨Ϩ┦་ᖌᑟ㦂ࡢᐇࢆ㏻ࡋ࡚ࡢホ౯⪃ᐹ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 27 㧘ᮌ ᜨ⨾ࠊ⸨ᕝ Ꮚࠊ➉ୗ ᬛᜨࠊඵ௦ ᬛᏊࠊ✄ྜྷ⨾⏤⣖ࠊ㔠ග ❶Ụࠊ୰ᕝ ⏤⨾ࠊ ᮏஂ⨾Ꮚࠊᔱᒸ ⥳ࠊ▼ 㔛ࠊ㏆⸨ ┤ᶞࠊᾏ Ꮫࠊ ༓⏣ ᫀஅࠊஂಖ⏣⠜ྖࠊ㇂ᆅ ㇏ࠊ㕥ᮌ ⩏ᙪࠊᵻᒣ ᖾᙪ Portfolio ᐇ⏝∧ࡢసᡂ ̿ᶆ‽࣒࢝ࣜ࢟ࣗࣛᇶ࡙࠸ࡓホ౯ࢶ࣮ࣝࢆ᳨ウ̿ ‥‥‥‥‥‥‥‥‥ 29 ✄ྜྷ ⨾⏤⣖ࠊᚋ⸨ ⨾✑ࠊ῝ᕝᜨ⨾Ꮚ i㸰 どぬ◊✲㒊 どぬ◊✲㒊 ࠝどぬ⏕⌮Ꮫ◊✲ᐊࠞ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 31 㑇ఏᛶ⥙⬦⤡⭷ᝈࡢⓏ㘓ࢿࢵࢺ࣮࣡ࢡ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 32 ゅ⏣⦾ ࣮ࠝࣟࣅࢪࣙࣥ◊✲ᐊࠞ ᪂ࡓ࡞㧗⢭ᗘ║ෆࣞࣥࢬᗘᩘィ⟬⌮ㄽᘧࡢ㛤Ⓨ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 37 㔝⏣ᚭࠊ୍ᙪ i㸱 ⫈ぬ࣭ᖹ⾮ぬ◊✲㒊 ⫈ぬ࣭ᖹ⾮ぬ◊✲㒊 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 43 ࣮࣡ࣝࢹࣥࣈࣝࢢೃ⩌Ϩᆺࡢ᪂ࡓ࡞㑇ఏⓗཎᅉࡢ᳨ウ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 45 ᯇỌ㐩㞝ࠊົྎⱥᶞࠊ㞴Ἴ୍ᚨ Exome ゎᯒࢆ⏝࠸ࡓೃ⩌ᛶ㞴⫈ᑐࡍࡿཎᅉ㑇ఏᏊྠᐃࡢヨࡳ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 47 ົྎⱥᶞ࣭௰㔝ᩔᏊ࣭᭷ᮏᏘᏊ࣭ᯇỌ㐩㞝 㞴⫈㑇ఏᏊ LOXHD1 ࡢ᪂つኚ␗యࡢศᏊែࡢ᳨ド ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 50 㞴Ἴ୍ᚨ ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤Ⓨ㛵ࡍࡿ◊✲ ‥‥‥‥‥‥‥ 52 ༡ಟྖ㑻 ෆ⪥እഃቨ⥺⥔⣽⬊ࡢ⏕⼗∵ෆ㟁 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 55 Ỉ㊊㑥㞝 㞴ᛶᮎᲈᛶࡵࡲ࠸ࡢ㔜ᗘᙳ㡪ࡍࡿᚰ⌮♫ⓗせᅉࡢ᳨ウ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 57 ᓥྐ⾜ࠊⲨ⨾ᕼࠊ∦ᒸᯞ㔛Ꮚࠊఀ㐩ዉ⨾ࠊ୕ᾆṇ⛱ 㢌㢕㒊ᡥᖹୖ⓶⒴࠾ࡅࡿࣄࢺங㢌⭘࢘ࣝࢫ㸦HPV㸧ࡢ㛵 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 60 ᚨ ⿱ࠊ⸨ṇே 㢌㢕㒊ᡥᖹୖ⓶⒴࠾ࡅࡿࡀࢇᖿ⣽⬊ᵝ⣽⬊࣐࣮࣮࢝ࡢⓎ⌧ࡑࡢ⮫ᗋⓗព⩏㛵ࡍࡿ᳨ウ -StageϨ/ϩ⯉ᡥᖹୖ⓶⒴࠾ࡅࡿᚋⓎ㢕㒊ࣜࣥࣃ⠇㌿⛣࠾࠸࡚- ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 63 ⩚⏕᪼ ⸨ṇே ࢹࢢ࢚ࣜࣥࡣ㢌㢕㒊ᡥᖹୖ⓶⒴⣽⬊ᰴ࠾࠸࡚ EGFR ࣥࣄࣅࢱ࣮ࡢᢠ⭘⒆ຠᯝࢆቑࡉࡏࡿ ‥‥‥ 66 㤿ሙඃ ⸨ṇே ⮬ᐙ㦵⨨ᆺ྾ᛶேᕤ㦵ࡢຠ⋡ⓗ࡞㦵⏕ࡴࡅ࡚ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 68 ⴠྜ༤Ꮚࠊᆏᮏዲ i㸲 ேᕤ⮚ჾ㺃ᶵჾ㛤Ⓨ◊✲㒊 ேᕤ⮚ჾ࣭ᶵჾ㛤Ⓨ◊✲㒊‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 75 Patients' perceptions of vocal problems: results from a survey in the Tokyo area. ‥‥‥‥‥‥‥‥ 77 Tsunoda K, Fujimaki Y, Nito T, Yamasoba T, Tayama N, Makiyama K, Murofushi T, Tsunoda A, Ohshima K, Nishiyama K, Kano S, Niimi S. Sensory deprivation disrupts homeostatic regeneration of newly generated olfactory sensory neurons after injury in adult mice. ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 78 Kikuta S, Sakamoto T, Nagayama S, Kanaya K, Kinoshita M, Kondo K, Tsunoda K, Mori K, Yamasoba T. Prtformance Eveluation of Ad Hoc Network Protocol Implemented in Server Side Java Script ‥‥ 79 Atsushi Ito, Hiroyuki Hatano, Masahiro Fujii, Mie Sato, Yu Watanabe Yuko Hiramatsu, Fumihiro Sato, Akira Sasaki Bluetooth Low Energy ࢆ⏝࠸ࡓࢻ࣍ࢵࢡࢿࢵࢺ࣮࣡ࢡࡢᵓ⠏ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 85 ຍ⸨ᣅஓࠊఀ⸨⠜ࠊ⸨㞞ᘯࠊ⩚ከ㔝⿱அࠊΏ㎶⿱ࠊᏱ㒔ᐑᰤ i㸳 ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊 ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 87 ⁱฟᆺຍ㱋㯤ᩬኚᛶឤཷᛶ㑇ఏᏊ ARMS2-HTRA1 ࡢゎᯒ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 89 ᐙᓥ㍜㸪୰ᒣ┿ኸ㸪㔝⏣ᚭ㸪ᒾ⏣ᓅ 㑇ఏᛶ⥙⭷Ⰽ⣲ኚᛶᝈ⪅㗹యᮞయࢪࢫࢺࣟࣇ࣮ᝈ⪅ࡑࢀࡒࢀࡽぢࡘࡗࡓ &RUI 㑇ఏᏊࡢ᪂ つኚ␗ࡢྠᐃ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 95 ᒸᮏᬗᏊࠊ⁁⏣῟ࠊຍ⸨ගᘯࠊᅧྜྷ୍ᶞࠊྜྷṊᩄࠊWilliam C.Sultanࠊᒣᓮṇᚿࠊゅ⏣⦾ࠊ ᒾ⏣ᓅ 21 ᆺᴟ⣽⬊␗ᖖࢆక࠺㯤ᩬኚᛶᐙ⣔ࡢཎᅉ㑇ఏᏊゎᯒ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 98 ᕝᮧ㞝୍ࠊ⸨ᕳᣅ㑻ࠊྜྷṊᩄࠊゅ⏣⦾ࠊᮧୖ ᬗࠊᒾ⏣ ᓅ ϩ㸬ᴗ⦼㞟㸦ᏛⓎ⾲ࠊㄽᩥࠊദࢩ࣏ࣥࢪ࣒࢘㸧 Ϫ㸬◊✲㈝ ϫ㸬⤌⧊⾲ Ϭ㸬⥘㡿࣭つ⛬࡞ ࣭⮫ᗋ◊✲ࢭࣥࢱ࣮タ⨨㐠Ⴀ⥘㡿 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 235 ࣭⛉Ꮫ◊✲㈝⿵ຓ㔠ࡼࡿ◊✲ᐇつ⛬ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 238 ࣭㑇ఏᏊ⤌࠼ᐇ㦂⟶⌮つ⛬ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 239 ࣭ື≀ᐇ㦂⟶⌮つ⛬ ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 242 ࣭ື≀ᐇ㦂ᣦ㔪 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 251 㻌 ϭ㸬⮫ᗋ◊✲ࢭࣥࢱ࣮ධ㒊࣭㏥㒊ᡭ⥆᭩㢮 ࣭ධ㒊࣭㏥㒊㛵ಀ᭩㢮 ‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 255 ࣭ࢭࣥࢱ࣮ㅮᖌᐟἩタ⏝ᡭ㡰 㻌‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥ 263 ⦅㞟ᚋグ ຍᡃྩᏕ ྡ⮫ᗋ◊✲ࢭࣥࢱ࣮㛗 ⮫ᗋ◊✲䝉䞁䝍䞊㛗 ົྲྀᢅ䚷㻔Ṋ⏣㻌⣧୕㻕 ྡ⮫ᗋ◊✲䝉䞁䝍䞊㛗 㻔Ᏹ䚷ᖾ㶾㻕 ྡ⮫ᗋ◊✲䝉䞁䝍䞊㛗 㻔ຍᡃ㻌ྩᏕ㻕 ⮫ᗋ◊✲䝉䞁䝍䞊⤌⧊ᅗ ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊 㻔ᒾ⏣㻌ᓅ㻕 ேᕤ⮚ჾ䞉ᶵჾ㛤Ⓨ◊✲㒊 㻔ゅ⏣㻌୍㻕 ⫈ぬ䞉ᖹ⾮ぬ◊✲㒊 㻔⸨㻌ṇே㻕 どぬ◊✲㒊 㻔ゅ⏣䚷⦾䠅 ᨻ⟇་⒪⏬◊✲㒊 㻔䝉䞁䝍䞊㛗ే௵㻌㻕 㻌⚄⤒⏕≀Ꮫ◊✲ᐊ䚷㻔ᒾ⏣㻌ᓅ㻕 㻌どぬ⏕≀Ꮫ◊✲ᐊ䚷㻔ᒾ⏣㻌ᓅ㻕 㻌Ⓨ⏕་Ꮫ◊✲ᐊ䚷㻔ゅ⏣㻌୍㻕 㻌㡢ኌ䞉ゝㄒ䝁䝭䝳䝙䜿䞊䝅䝵䞁◊✲ᐊ䚷㻔ゅ⏣㻌୍㻕 㻌௦⏝⮚ჾ㛤Ⓨ◊✲ᐊ䚷㻔ゅ⏣㻌୍㻕 㻌⏕་⒪◊✲ᐊ䚷㻔ⴠྜ㻌༤Ꮚ㻕 㻌ᖹ⾮ぬ㞀ᐖ◊✲ᐊ䚷㻔ᓥ㻌ྐ⾜㻕 㻌⫈ぬ㞀ᐖ◊✲ᐊ䚷㻔ᯇỌ㻌㐩㞝㻕 ║⛉Ꮫ◊✲ᐊ 㻌䝻䞊䝡䝆䝵䞁◊✲ᐊ䚷㻔㔝⏣㻌ᚭ㻕 㻌どぬ⏕⌮Ꮫ◊✲ᐊ䚷㻔ゅ⏣㻌⦾㻕 ⮫ᗋ◊✲䞉㦂᥎㐍ᐊ䚷㻔ᵻᒣ㻌ᖾᙪ㻕 㻌ᡭ⾡ᨭ䝻䝪䝑䝖ᢏ⾡ᛂ⏝◊✲ᐊ䚷㻔ᩧ⸨㻌ྐ㑻㻕 㻌་⒪⤒Ⴀሗ䞉㧗㱋⪅䜿䜰◊✲ᐊ䚷㻔ᮏ⏣㻌⨾Ꮚ㻕 㻌⮫ᗋᏛ◊✲ᐊ䚷㻔ᑿ⸨㻌ㄔྖ㻕 㻌 㻌 㻌 㻌 䊠㻌 ྛ◊✲㒊䛾◊✲ሗ࿌㻌 㻌 㻌 㻌 㻌 㻌 ᨻ⟇་⒪⏬◊✲㒊㻌 㻌 㒊㛗㻌 㻌 㻌 䝉䞁䝍䞊㛗ే௵㻌 㻌 ⮫ᗋᏛ◊✲ᐊ㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 ᑿ⸨㻌 ㄔྖ㻌 ᐊ㛗㻌 ་⒪⤒Ⴀሗ䞉㧗㱋⪅䜿䜰◊✲ᐊ㻌 㻌 㻌 ᮏ⏣㻌 ⨾Ꮚ㻌 ᐊ㛗㻌 ᡭ⾡ᨭ䝻䝪䝑䝖ᢏ⾡ᛂ⏝◊✲ᐊ㻌 㻌 㻌 㻌 ᩧ⸨㻌 ྐ㑻㻌 ᐊ㛗㻌 ⮫ᗋ◊✲䞉㦂᥎㐍ᐊ㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 ᵻᒣ㻌 ᖾᙪ㻌 ᐊ㛗㻌 ᨻ⟇་⒪⏬◊✲㒊 ⮫ᗋᏛ◊✲ᐊ㛗 ᑿ⸨ ㄔྖ ⮫ᗋᏛ◊✲ᐊ ⮫ᗋᏛ◊✲ᐊ࡛ࡣࠊᩥ㒊⛉Ꮫ◊✲㈝ࡸᅜ❧㝔ᶵᵓ㐠Ⴀ㈝㔠◊✲㈝࡛⾜ࢃࢀࡿከ タඹྠ⮫ᗋ◊✲➼ࠊࡉࡲࡊࡲ࡞⮫ᗋ◊✲ࢆ⾜ࡗ࡚࠸ࡲࡍࠋ ࣭ 㹌㹆㹍ከタඹྠ◊✲㸦㹃㹀㹋᥎㐍◊✲ᴗ㸧ࡋ࡚ᐇࡉࢀࡓࠊ ࠕேᕤᰤ㣴㸦୰ᚰ㟼⬦ ᰤ㣴ࡶࡋࡃࡣ⤒⭠ᰤ㣴㸧ࢆ⾜࠺㝿ࡢ་⒪⾜ⅭࡢᏳᛶࠊᝈ⪅ணᚋ㛵ࡍࡿほᐹ◊✲ࠖ 㸦JAPOAN ◊✲㸧⤖ᯝࡀࠊேᕤᰤ㣴㛵ࡍࡿⱥᩥㄅ࡛᭷ྡ࡞ Journal of Parenteral and Enteral Nutrition (JPEN)ཎⴭㄽᩥࡋ࡚ᥖ㍕ࡉࢀࡲࡋࡓࠋBito S et. Al. Prospective cohort study comparing the effects of different artificial nutrition methods on longterm survival in the elderly: Japan Assessment Study on Procedures and Outcomes of Artificial Nutrition (JAPOAN). JPEN J Parenter Enteral Nutr. 2015 May;39(4):456-64. ࣭ 㹌㹆㹍ከタඹྠ◊✲㸦㹃㹀㹋᥎㐍◊✲ᴗ㸧ࡋ࡚ᐇࡉࢀࡓࠊࠕேᕤ㛵⠇⨨⾡ᚋ ࡢ㟼⬦⾑ᰦሰᰦࡢᐇែண㜵㛵ࡍࡿ⮫ᗋ◊✲ࠖ㸦J-PSVT ◊✲㸧ࡢ⤖ᯝࡀࠊBlood ㄅཎⴭㄽᩥࡋ࡚ᥖ㍕ࡉࢀࡲࡋࡓࠋBito S et al. Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery. Blood. 2016 Feb 25;127(8):1036-43. ࣭ ཌ⏕ປാ⛉Ꮫ◊✲㈝⿵ຓ㔠ᴗ ࠕ◊✲࣐ࣥࢻࢆᣢࡘ⮫ᗋ་ᑐࡍࡿᏛᩍ⫱ࣉࣟ ࢢ࣒ࣛࡢ㛤Ⓨᇶ┙ᩚഛ㸦௵◊✲⪅ 㧗ᶫ ⌮㸧ࠖ㸸ᕷ୰㝔ົࡍࡿⱝ࠸་ᖌࡀ ⮫ᗋ◊✲ࡢᢏ⾡ࢆᏛࡧࠊᐇ㝿ᐇࡍࡿࡇࢆᨭࡍࡿࡓࡵࡢ◊✲ᴗ࡛ࡍࠋ ࣭ ⛉◊㈝ᴗ ࠕࡶ⪃࠼ࡿࣥࣇ࢛࣮࣒ࢻ࣭ࢥࣥࢭࣥࢺࠖᐇ㊶ࣔࢹࣝࡢᥦ♧᭷ຠ ᛶࡢ᳨ド (௵◊✲⪅ ᑿ⸨ㄔྖ)㸸ᝈ⪅ࡉࢇࡗ࡚᭱ၿ࡞ࡿデ⒪㑅ᢥࣉࣟࢭࢫࢆ ᳨ドࡋࠊࡑࡢ᭷ຠᛶࢆほᐹࡍࡿࡓࡵࡢ◊✲ᴗ࡛ࡍࠋ3ᖺィ⏬ࡢ࠺ࡕࡢᖺࡢ◊✲ᮇ㛫 ࡀ⤊ࡋࡲࡋࡓࠋ ࣭ ⛉◊㈝ᴗ ࠕ⬤ᙅ㧗㱋⪅ࡢࢣ⛣⾜࠾ࡅࡿデ⒪ሗఏ㐩ࡢࡓࡵࡢᶆ‽ⓗࣇ࢛࣮ ࣐ࢵࢺ㛤Ⓨࠖ 㸦௵◊✲⪅ ᯇᮧ┿ྖ㸧㸸ᝈ⪅ࡉࢇࡀධ㝔ࠊ࠶ࡿ࠸ࡣ㏥㝔ࡍࡿ㝿ࠊ 㝔デ⒪ᡤࡢᝈ⪅ࡉࢇ㛵ࡍࡿሗᥦ౪ࡢෆᐜࢆྫྷࡋࠊࡼࡾᐇࡋࡓෆᐜࢆ⏦ࡋ㏦ ࡿࣇ࢛࣮࣐ࢵࢺࢆ㛤Ⓨࡍࡿࡓࡵࡢ◊✲࡛ࡍࠋ3ᖺィ⏬ࡢ࠺ࡕ୍ᖺࡢ◊✲ᮇ㛫ࡀ⤊ࡋࡲ ࡋࡓࠋ ࣭ ཌ⏕ປാ┬ࣔࢹࣝᴗ ࠕᖹᡂ27ᖺᗘ ே⏕ࡢ᭱⤊ẁ㝵࠾ࡅࡿ་⒪యไᩚഛᴗࠖ ᪥ᮏᅜࡽ5ࡘࡢࣔࢹࣝᴗయタࡀ㑅ᐃࡉࢀࠊᮾி་⒪ࢭࣥࢱ࣮ࡀࡑࡢ୍ࡘ㑅ࡤ ࢀᴗࢆ⾜࠸ࡲࡋࡓࠋᙜ㝔࡛ࡣࠕ㝔ෆ⌮ࢥࣥࢧࣝࢸ࣮ࢩࣙࣥᴗࠖࢆ୰ᚰࠊពᛮ Ỵᐃᑐࡋ࡚⌮ⓗ࡞᳨ウࡀᚲせ࡞ࡿᑐࡋ࡚ࠊࢳ࣮࣒࡛ពᛮỴᐃᨭࢆ⾜࠺ ᴗ࡛ࡍࠋάⓎ࡞άືࢆᖺ㛫ࢆ㏻ࡋ࡚⾜࠺ࡇࡀ࡛ࡁࡲࡋࡓࠋ ―1― [⮫ᗋᏛ◊✲ᐊ] Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery. Published in Blood. 2016 Feb 25;127(8):1036-43. doi: 10.1182/blood-2015-06-651620. Epub 2015 Dec 9. Bito S(1), Miyata S(2), Migita K(3), Nakamura M(4), Shinohara K(3), Sato T(3), Tonai T(3), Shimizu M(3), Shibata Y(3), Kishi K(3), Kubota C(3), Nakahara S(3), Mori T(3), Ikeda K(3), Ota S(3), Minamizaki T(3), Yamada S(3), Shiota N(3), Kamei M(5), Motokawa S(6). Platelet-activating antibodies, which recognize platelet factor 4 (PF4)/heparin complexes, induce spontaneous heparin-induced thrombocytopenia (HIT) syndrome or fondaparinux-associated HIT without exposure to unfractionated heparin (UFH) or lowmolecular-weight heparin (LMWH). This condition mostly occurs after major orthopedic surgery, implying that surgery itself could trigger this immune response, although the mechanism is unclear. To investigate how surgery may do so, we performed a multicenter, prospective study of 2069 patients who underwent total knee arthroplasty (TKA) or hip arthroplasty. patients Approximately half of the received postoperative thromboprophylaxis with UFH, LMWH, or fondaparinux. The other half received only mechanical thromboprophylaxis, including dynamic (intermittent plantar or pneumatic compression device), static (graduated compression stockings [GCSs]), or both. We measured anti-PF4/heparin immunoglobulins G, A, and M before and 10 days after surgery using an immunoassay. Multivariate analysis revealed that dynamic mechanical thromboprophylaxis (DMT) was an independent risk factor for seroconversion (odds ratio [OR], 2.01; 95% confidence interval [CI], 1.34-3.02; P = .001), which was confirmed with propensity-score matching (OR, 1.99; 95% CI, 1.17-3.37; P = .018). For TKA, the seroconversion rates in patients treated with DMT but no anticoagulation and in patients treated with UFH or LMWH without DMT were similar, but significantly higher than in patients treated with only GCSs. The proportion of patients with 1.4 optical density units appeared to be higher among those treated with any anticoagulant plus DMT than among those not treated with DMT. Our study suggests that DMT increases risk of an anti-PF4/heparin immune response, even without heparin exposure. This trial was registered to www.umin.ac.jp/ctr as #UMIN000001366. © 2016 by The American Society of Hematology. ―2― ࠝ⮫ᗋᏛ◊✲ᐊࠞ ᕷ୰㝔࠾ࡅࡿ⮫ᗋ◊✲άືࡢᨭ ◊✲ศᢸ⪅ ᑿ⸨ ㄔྖ ᮾி་⒪ࢭࣥࢱ࣮ ᩍ⫱◊ಟ㒊/⮫ᗋᏛ◊✲ᐊ ᐊ㛗 ◊✲せ᪨ ᕷ୰㝔࡛ࡣࠊᏛ㝔ẚ㍑ࡋ࡚ⱝ࠸་ᖌࡀ⮫ᗋ◊✲ࡢ᪉ἲㄽࢆ┤᥋Ꮫࡪᶵ ゐࢀࡿᶵࡣᑡ࡞࠸ࠋᅇࡢᡃࠎࡢ┠ⓗࡣࠊデ⒪⛉ࡸ⫋✀ࡢᯟࢆ㉸࠼࡚⮫ᗋ ◊✲ࡢ᪉ἲㄽࢆᏛࡪᶵࢆᕷ୰㝔ࡢ୰ࠕࢮ࣑ࠖࡢᙧᘧ࡛❧ࡕୖࡆࠊࡑࡢຠᯝࢆ ほᐹࡍࡿࡇ࠶ࡿࠋᮾி་⒪ࢭࣥࢱ࣮ෆ࡛ࠕ⮫ᗋ◊✲ࢮ࣑ࠖࢆ❧ࡕୖࡆࠊࢮ࣑ཷ ㅮࡍࡿࡶࡢࢆ་ᖌࡸ⸆ᖌࡽເࡗࡓࠋ3 㐌㛫୍ᗘ⛬ᗘࡢࢮ࣑ࢆ⥅⥆ⓗ⾜࠺ ࡇ࡛ࠊ㹃࣮ࣛࢽࣥࢢࢆ㏻ࡋ࡚ࡢ⮬ᕫᏛ⩦ࡢ┦ຠᯝࢆᚓࡿࡇࡀ࡛ࡁࡓࠋᛁ ࡋ࠸ᕷ୰㝔ࡢ་ᖌ࠾࠸࡚ࡣࠊ௨ୗຠ⋡ⓗᏛࡧࢆ⾜࠸ࡘࡘ◊✲ᡂᯝࢆୖࡆ ࡿ࠸࠺ࡇࡀᚋࡢㄢ㢟࡞ࡿࠋ A. ◊✲┠ⓗ ⮫ᗋ◊✲ࢆ⾜࠺ሙࡋ࡚ࠊᏛ࡞ࡢ◊✲ᶵ 㛵ࡼࡾࡶᕷ୰㝔ࡢ࠺ࡀࡍࡄࢀ࡚࠸ࡿ㠃ࡀ ࠸ࡃࡘ࠶ࡿࠋ୍ࡘࡣࠊ⮫ᗋ◊✲࡛ᑐ㇟࡞ࡿ ᝈ⪅ࡢᩘࡸእⓗጇᙜᛶࡀᕷ୰㝔ࡢ࠺ࡀ㧗 ࠸࡛࠶ࢁ࠺⪃࠼ࡽࢀࡿࡇࠊࡉࡽࡣࠊ◊✲ ࢆ⾜࠺ഃࡗ࡚ࡶࠊࣜࢧ࣮ࢳ࣭ࢡ࢚ࢫࢳࣙࣥ ࡲ࡛Ⓨᒎࡉࡏ࡚࠸ࡃࡇࡀ࡛ࡁࡿ᪥ᖖᝎࢇ ࡛࠸ࡿ⮫ᗋⓗ࡞ၥࡀ㉳ࡋࡸࡍ࠸≧ἣ࠶ ࡿࡇ࡞ࡀ࠶ࡆࡽࢀࡿࠋ୍᪉ࠊᐇ㝿ࡣᕷ୰ 㝔࡛ⱝ࠸་ᖌࡀ⮫ᗋ◊✲ࢆ⾜࠺ࡇࡣ㞴ࡋ ࠸ࡋࠊᐇ㝿⮫ᗋ◊✲ࢆάⓎ⾜࠺ᕷ୰㝔ࡢ ་ᖌࡣᑡ࡞࠸ࠋࡇࡢཎᅉࡋ࡚ࡣࠊ◊✲㈝ࡸ ࡍ㛫ࡢ࡞ࡉࡸࠊ◊✲άືᑐࡍࡿホ౯࡞ࡢ ┦ᑐⓗ࡞ᑠࡉࡉ࡞ࠊ࠸ࡃࡘࡢ⌮⏤ࡀ࠶ࡆࡽ ࢀࡿࡀࠊࡑࡢ୰ࡢ୍ࡘࠊ⮫ᗋ◊✲ࢆᐇࡍࡿ ࠺࠼࡛ࡢࢫ࢟ࣝࢆᏛ⩦ࡍࡿᶵࡀ࡞࠸ࡇࡀ ࠶ࡿࠋ ☜ᕷ୰㝔ࡣᏛ㝔➼ࡢᏛ⾡ᶵ㛵 ẚ㍑ࡋ࡚⮫ᗋ◊✲ࡢ᪉ἲㄽࢆᏛࡪ㈨※ࡣᑡ ࡞࠸࡛࠶ࢁ࠺ࠋࡓࡔࠊࡢ㹃࣮ࣛࢽࣥࢢ➼ࡢ ᬑཬࡼࡗ࡚ࠊሗ㈨※ࡘ࠸࡚ࡣඞ᭹ࡀྍ⬟ ࡞≧ែ࡞ࡾࡘࡘ࠶ࡿࠋ࠶ࡣேⓗ㈨※࡛࠶ࡿ ࡀࠊᕷ୰㝔࡛ࡣデ⒪⛉㛫ࡸ⫋✀㛫ࡢᇉ᰿ࡀ┦ ᑐⓗపࡃࠊᑠࡉ࡞ࢢ࣮ࣝࣉࢆゐᡭᶓ᩿ⓗᵓ ᡂࡍࡿࡇ࡛ࠊࣁࣥࢬ࡛࢜ࣥ⮫ᗋ◊✲ࡢ᪉ἲㄽ ࢆᏛࡪሙࢆタࡅࡿࡇࡀ࡛ࡁࡿࠋ ᅇࡢ┠ⓗࡣࠊᮾி་⒪ࢭࣥࢱ࣮ົࡍࡿ ་ᖌࢆ୰ᚰࡋࡓ་⒪ᑓ㛛⫋ࢆᑐ㇟ࠊ㹃࣮ࣛ ࢽࣥࢢࡼࡿᏛ⩦ࢆಶู⾜࠸࡞ࡀࡽࠊಶேಶ ேࡀ❧ࡋࡓ◊✲ィ⏬ࢆࣁࣥࢬ࡛࢜ࣥ㆟ㄽࡍ ࡿࠕࢮ࣑ࠖᘧࡢሙࢆタࡅࡿࡇࡀࠊⱝᡭ་⒪⫋ ࡢ⮫ᗋ◊✲᥎㐍ᐤࡍࡿ࠺ࡘ࠸࡚ ࡢࢡࢩ࣭ࣙࣥࣜࢧ࣮ࢳࢆ⾜࠺ࡇ࡛࠶ࡿࠋ B. ◊✲᪉ἲ ◊✲ࢹࢨࣥ㸸ࢡࢩ࣭ࣙࣥࣜࢧ࣮ࢳ ᑐ㇟⪅㸸ᮾி་⒪ࢭࣥࢱ࣮ົࡍࡿ་⒪⫋ဨ ࢮ࣑⏕ࡢⓏ㘓㸸2014 ᖺ 1 ᭶ᮾி་⒪ࢭࣥ ࢱ࣮་⒪ᑓ㛛⫋⫋ဨࢮ࣑ࡢධ㒊ࢆࡧ ࡅࡓࠋ ࢮ࣑ࡢෆᐜ㸸2014 ᖺ 4 ᭶㹃࣮ࣛࢽࣥࢢࢩࢫ ࢸ࣒ࡀ㛤ጞࡉࢀࡿࡇక࠸ࢮ࣑ࢆ㛤ጞࡋࡓࠋ ࢮ࣑ࡣࠊ㹃࣮ࣛࢽࣥࢢࡀ⾜ࢃࢀ࡚࠸ࡿ 4 ᭶ࡽ 㸵᭶ࡅ࡚ࡣ 3 㐌㛫୍ᗘࡢ㢖ᗘ࡛⾜࠸ࠊ㸶 ᭶ࡽࡣ 5 㐌㛫୍ᗘ⛬ᗘࡢ㢖ᗘ࡛⾜ࡗࡓࠋࢮ ࣑ࡢෆᐜࡣࠊ๓༙ࡘ࠸࡚ࡣ㹃࣮ࣛࢽࣥࢢࢥࣥ ―3― ࢸࣥࢶࡢゎㄝࠊࢮ࣑⏕ࡑࢀࡒࢀࡢ㐍ᤖࡢሗ࿌ࠊ ࠾ࡼࡧ㐍ᤖ≧ែᑐࡍࡿ┦ࡢࣇ࣮ࢻࣂࢵ ࢡࢆ⾜ࡗࡓࠋ ホ౯㡯┠㸸௨ୗࢆࠊࢮ࣑⏕ࡢ◊✲άື㛵ࡍࡿ ᣦᶆࡋࡓࠋ ࣭ ◊✲௬ㄝࢆタᐃࡋࡓࢮ࣑⏕ࡢྜ ࣭ 㹃࣮ࣛࢽࣥࢢࢆ㐙ࡋࡓࢮ࣑⏕ࡢྜ ࣭ ⌮ጤဨ◊✲ィ⏬᭩ࢆᥦฟࡋࡓࢮ࣑ ⏕ࡢྜ ࣭ ࢹ࣮ࢱ㞟ศᯒࢆ⤊ࡋࡓࢮ࣑⏕ࡢ ྜ ࣭ Ꮫᢒ㘓ࢆᥦฟࡋࡓࢮ࣑⏕ࡢྜࠋ 㸦⌮㠃ࡢ㓄៖㸧 ᮏࣉࣟࢪ࢙ࢡࢺࡣࠊ㝔࠾ࡅࡿ⮫ᗋ◊✲ ᇶ┙᥎㐍ࡑࡢࡶࡢࢆ┠ⓗࡋ࡚࠸ࡿࡶࡢ࡛࠶ ࡾࠊࢡࢩࣙࣥ⮬యࡢ┠ⓗࡣ◊✲࡛ࡣ࡞ࡃ ᩍ⫱ࡑࡢࡶࡢ࠶ࡿࡓࡵࠊᮏᴗ⮬యࡘ࠸ ࡚ࡢ⌮ᑂᰝጤဨࡢ⏦ㄳࡣ⾜ࡗ࡚࠸࡞ ࠸ࠋ୍᪉ࠊࡇࡢㄪᰝ࡛グ㏙ࡍࡿࡶࡢࡣ࠶ࡃࡲ ࡛ࡶ㞟ᅋྜࡢࡳ࡛࠶ࡾࠊࢮ࣑⏕୍ே୍ேࡢ ಶ⚊ࢆࢹ࣮ࢱࡍࡿࡇࡣ⾜ࡗ࡚࠸࡞࠸ࠋࡑ ࡢࡓࡵࠊಶேሗ࡞ࡾ࠺ࡿࢹ࣮ࢱࡣ⏕ᡂࡉ ࢀ࡚࠸࡞࠸ࠋ C. ◊✲⤖ᯝ ࢮ࣑⏕ࡢⓏ㘓㸸10 ྡࡢࢮ࣑⏕ 2 ྡࡢ࣓ࣥࢱ ࣮ࢆⓏ㘓ࡋࡓࠋࢮ࣑⏕ࡢ࠺ࡕࠊ8 ྡࡣ་ᖌ࡛࠶ ࡾࠊ㸯ྡࡣ⸆ᖌࠊ㸯ྡࡣ⌮Ꮫ⒪ἲኈ࡛࠶ࡗࡓࠋ ࢮ࣑ࡢ㛤ദ㸸ࢮ࣑ࡣィ⏬‽ࡌ࡚㛤ദࡉࢀࡓࠋ ẖᅇࡢࢮ࣑ࡢฟᖍࡢ୰ኸ್ࡣ㸲ྡ࡛࠶ࡗࡓࠋ ࢮ࣑⏕ࡢάືᛶᣦᶆ㸸ࡑࢀࡒࢀࡢᣦᶆࡣ௨ୗࡢ ࡶࡢ࡛࠶ࡗࡓࠋ ࣭ ◊✲௬ㄝࢆタᐃࡋࡓࢮ࣑⏕ࡢྜ㸸㸵ྡ 㸦70㸣㸧 ࣭ 㹃࣮ࣛࢽࣥࢢࢆ㐙ࡋࡓࢮ࣑⏕ࡢྜ㸸6 ྡ㸦60㸣㸧 ࣭ ⌮ጤဨ◊✲ィ⏬᭩ࢆᥦฟࡋࡓࢮ࣑ ⏕ࡢྜ㸸4 ྡ㸦40㸣㸧 ࣭ ࢹ࣮ࢱ㞟ศᯒࢆ⤊ࡋࡓࢮ࣑⏕ࡢ ྜ㸸2 ྡ㸦20㸣㸧 ࣭ Ꮫᢒ㘓ࢆᥦฟࡋࡓࢮ࣑⏕ࡢྜ㸸0 ྡ 㸦0㸣㸧 D. ⪃ᐹ ᐇᆅ⮫ᗋ࠸ࡑࡋࡴᕷ୰㝔࡛ࡢⱝ࠸་ᖌ ࡗ࡚ࠊ⮫ᗋ◊✲ࢆ㐙ࡍࡿࡣ࠸ࡃࡘࡶࡢ 㧗࠸ࣁ࣮ࢻࣝࡀ࠶ࡿࠋᅇࡢ㹃࣮ࣛࢽࣥࢢࢩࢫ ࢸ࣒ࡢᥦ౪ࡶ㛤ദࡉࢀࡓࢮ࣑ᙧᘧ࡛ࡢ ࣁࣥࢬ࢜ࣥࢺ࣮ࣞࢽࣥࢢࡣࠊᙼዪࡽ࠸ࡃࡘ ࡢຠᯝࢆࡶࡓࡽࡋࡓ⪃࠼ࡽࢀࡿࠋ➨୍ࡣࠊ ᐃᮇⓗྠࡌࡼ࠺ᅔ㞴ࢆឤࡌ࡚࠸ࡿ௰㛫ࡢ 㐍ᤖࡸၥ㢟Ⅼࡘ࠸࡚ඹ᭷ࡍࡿࡇ࡛ࠊࡶ 㞴㢟ࢆࡾ㉺࠼࡚࠸ࡇ࠺࠸࠺ᩥࡀ⏕ࡲࢀ ࡚ࡃࡿ࠸࠺ࡇ࡛࠶ࡿࠋࡶ࠺୍Ⅼࡣࠊࣥࢱ ࣮ࢿࢵࢺࢆ㏻ࡌࡓࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥࡔࡅ࡛ ࡣ࡞࡞ࢽࣗࣥࢫࡀఏࢃࡽ࡞࠸ၥࡸၥ 㢟ࡘ࠸࡚ࠊከேᩘ࡛㆟ㄽࢆࡍࡿࡇ࡛▱㆑ࡸ ⪃࠼᪉ࡢᩚ⌮ࡀ࡛ࡁࡿ࠸࠺ࡇ࡛࠶ࡿࠋᅇ ࡢࢮ࣑࡛ࡣࠊ௨ୖࡢࡼ࠺࡞Ⅼࡘ࠸࡚ࡣ☜ Ⰻ࠸ຠᯝࢆࡶࡓࡽࡋ࡚࠸ࡓ⪃࠼ࡽࢀࡓࠋ ୍᪉࡛ࠊṧᏑࡍࡿၥ㢟Ⅼࡋ࡚ࡣࠊࡸࡣࡾࢱ ࣒࣐ࢿࢪ࣓ࣥࢺࡢၥ㢟࡛࠶ࡿࠋ㹃࣮ࣛࢽࣥࢢ ࢆཷㅮࡋࡓࡾࠊᐟ㢟ࢆᥦฟࡍࡿࡇࢁࡲ࡛ࡣࠊ ఱ㛫ࢆฟࡍࡿࡇࡀ࡛ࡁࡿࡀࠊᐇ㝿 ィ⏬ࡉࢀࡓ◊✲ࢆᐇ⾜⛣ࡋࡓࡾࠊࢹ࣮ࢱࡢ 㞟ࢆ⾜࠺࠸࠺ࡇࡣࠊᛁࡋ࠸୍⯡㝔ࡢ་⒪ ⫋ࡗ࡚ࡣࡸࡣࡾ㞴㢟࡛࠶ࡿࠋࡇࢀࡽࡢㄢ㢟 ࢆゎỴࡍࡿ࠺࠼࡛ࡢᚋࡢᥦࡣࠊ๓ྥࡁࢥ࣍ ࣮ࢺ◊✲ࡢࡼ࠺࡞ከ࡞ປຊࡀࡿ◊✲ࢆ 㑊ࡅࠊ㟁Ꮚ࢝ࣝࢸࡸ㹂㹎㹁ࢹ࣮ࢱ࡞ࠊ᪥ࠎࡢ デ⒪ࢆ㏻ࡌ࡚㝔ሗࢩࢫࢸ࣒᱁⣡ࡉࢀࡿ ⮫ᗋࢹ࣮ࢱࢆ᭷ຠ◊✲┠ⓗḟ⏝ࡍࡿ ࡇ࡛࠶ࢁ࠺ࠋࡑࢀࡼࡗ࡚ࠊ◊✲⪅ࡢ㈇ᢸࡣ ᖜ๐ῶࡉࢀࡿࠋࡓࡔࠊḟ⏝ࡀάⓎ⾜ ࢃࢀࡿࡼ࠺࡞ࡿࡓࡵࡣࠊᑓ௵ࡢࢩࢫࢸ࣒࣭ ࢚ࣥࢪࢽࡸ⤫ィᐙࡀᚲせ࡞ࡗ࡚ࡃࡿࠋ500 ᗋࢆ㉸࠼ࡿつᶍࡢ㝔࠾࠸࡚ࡣࠊᚋ✚ᴟⓗ ࡑࡢࡼ࠺࡞ேဨࡢ㞠⏝ࢆ᳨ウࡋ࡚࠸ࡃࡇ ࡀ᥎ዡࡉࢀࡿࠋ 㹃. ⤖ㄽ ࢮ࣑ᙧᘧ࡛ࡢࣁࣥࢬ࢜ࣥࡼࡿ⮫ᗋ◊✲ࢫ ࢟ࣝࡢᩍ⫱ࣉࣟࢢ࣒ࣛࡣࠊ㝈⏺ࡀ࠶ࡿࡀࠊ㹃 ࣮ࣛࢽࣥࢢࡼࡿ⮬ᕫᏛ⩦ࢆ⿵ࡍࡿྍ⬟ᛶ ࡀ♧၀ࡉࢀࡓࠋ 㹅. ◊✲Ⓨ⾲ 1. ㄽᩥⓎ⾲ ≉グ㡯࡞ࡋ 2. ᏛⓎ⾲ ≉グ㡯࡞ࡋ 㹆. 1. 2. 3. ―4― ▱ⓗ㈈⏘ᶒࡢฟ㢪࣭Ⓩ㘓≧ἣ ≉チྲྀᚓ㸸࡞ࡋ ᐇ⏝᪂Ⓩ㘓㸸࡞ࡋ ࡑࡢ㸸࡞ࡋ ࠝ⮫ᗋᏛ◊✲ᐊࠞ ᶆ‽ホ౯㡯┠ࢆ⏝࠸ࡓᆅᇦデ⒪ᡤࡢໟᣓⓗホ౯◊✲ ᯇᮧ┿ྖࠊᑿ⸨ㄔྖ 㸦⮫ᗋᏛ◊✲ᐊ㸧 せ ⣙ ࢃࡀᅜ࠾࠸࡚ࠊデ⒪ᣦᶆࢆ⏝࠸ࡓデ⒪ࡢ㉁ホ౯ࡣࠊẚ㍑ⓗつᶍࡢࡁ࠸㝔࠾࠸࡚ࡣ ⾜ࢃࢀ࡚࠸ࡿࡀࠊࣉ࣐ࣛࣜࢣࢆᢸ࠺ᆅᇦࡢデ⒪ᡤ࡛ࡣࢇ⾜ࢃࢀ࡚࠸࡞࠸ࠋᅇࡉ ࡲࡊࡲ࡞ഃ㠃࡛␗࡞ࡿᆅᇦࡢ 2 デ⒪ᡤᑐࡋ࡚ࠊࡇࢀࡲ࡛㛤Ⓨࡋ࡚ࡁࡓデ⒪ᣦᶆࢆ⏝࠸࡚ࠊ ᆅᇦデ⒪ᡤ࡛ᥦ౪ࡉࢀ࡚࠸ࡿࣉ࣐ࣛࣜࢣࡘ࠸࡚ࠊໟᣓⓗ࡞ホ౯ࢆ⾜ࡗࡓࠋホ౯⏝࠸ ࡓデ⒪ᣦᶆࡣᡃࠎࡀ㛤Ⓨࡋࠊ2014 ᖺᐇᆅ࡛⏝ࡋࡓ 5 ࢝ࢸࢦ࣮ࣜ㸦ᖜᗈ࠸デ⒪࠾ࡼࡧᶆ ‽ⓗデ⒪ࠊࢡࢭࢫࠊࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥࠊ㐃ᦠࠊᝈ⪅⫼ᬒࡢᑛ㔜㸧 ࠊ42 㡯┠ࡽᵓᡂࡉࢀ ࡚࠸ࡿᣦᶆ࡛࠶ࡿࠋࢹ࣮ࢱ※ࡣ 3 㡯┠ࡀࣞࢭࣉࢺࠊ18 㡯┠ࡀデ⒪㘓ࠊ21 㡯┠ࡀᝈ⪅ㄪᰝ࡛ ࠶ࡿࠋ2014 ᖺ 8 ᭶Ɇ2015 ᖺ 7 ᭶ࡢ 1 ᖺ㛫ࢆㄪᰝᮇ㛫ࡋࠊࡇࡢ㛫ࡢデ⒪㘓࠾ࡼࡧࣞࢭࣉ ࢺࢹ࣮ࢱࢆᑐ㇟⾜ࢃࢀࡓࠋ ᝈ⪅ㄪᰝࡣ 2015 ᖺ 8 ᭶ࡢࡑࢀࡒࢀ 1 㐌㛫ࡢཷデᝈ⪅ࢆᑐ㇟ࡋ࡚⾜ࢃࢀࡓࠋ୧デ⒪ᡤ ࡶ 2-3 ᪥ࡢᐇᆅㄪᰝᮇ㛫࡛デ⒪㘓ㄪᰝࡀ⤊ࡋࡓࡀࠊ㝔እฎ᪉ࢆ᥇⏝ࡋ࡚࠸ࡿ B デ⒪ᡤ ࠾࠸࡚ࡣ⌧ᆅ࡛ฎ᪉ෆᐜࢆ☜ㄆࡍࡿᚲせᛶࡀ⏕ࡌࠊࡍ࡚ࡀデ⒪㘓ㄪᰝ࡞ࡗࡓࠋᝈ⪅ㄪ ᰝࡣ A デ⒪ᡤ 44 ྡࠊB デ⒪ᡤ 126 ྡࡽᅇ⟅ࡀᚓࡽࢀࡓࠋࡇࡢ୰࡛ᑜࡡࡽࢀࡓࠕࡇࡢࡼ࠺ ࡞ࣥࢣ࣮ࢺㄪᰝࢆᐃᮇⓗ⾜࠺ࡇࢆዲࡲࡋࡃᛮ࠺ࠖ࠸࠺㉁ၥᑐࡋ࡚ࠊA デ⒪ᡤ࡛ ࡣ 72.7㸣㸦32 ྡ/ 44 ྡ㸧ࠊB デ⒪ᡤࡣ 67.5㸣㸦83 ྡ/ 123 ྡ㸧ࡀࠕࡑ࠺ᛮ࠺ࠖࠕኚࡑ ࠺ᛮ࠺ࠖከࡃࡢᝈ⪅ࡀ⫯ᐃⓗ࡞ពぢ࡛࠶ࡗࡓࠋࡲࡓࠊࠕᐃᮇⓗእ㒊ホ౯ࢆཷࡅࡿࡇ 㛵ࡋ࡚ዲࡲࡋ࠸ᛮ࠺ࠖࠊࡢၥ࠸ᑐࡋ࡚ࡶࠊA デ⒪ᡤ࡛ࡣ 72.7㸣㸦32 ྡ/ 44 ྡ㸧ࠊB デ⒪ᡤ࡛ࡣ 72.1㸣㸦88 ྡ/ 122 ྡ㸧ࡀࠕࡑ࠺ᛮ࠺ࠖࠕኚࡑ࠺ᛮ࠺ࠖከࡃࡀ⫯ᐃⓗ࡞ព ぢ࡛࠶ࡗࡓࠋᅇࡢ◊✲ࢆ㏻ࡌ࡚ࠊ࠸ࡃࡘᐇ⾜ୖࡢㄢ㢟ࡣ࠶ࡿࡶࡢࡢࠊࡇࡢࡼ࠺࡞デ⒪ᣦ ᶆࢆ⏝࠸ࡓデ⒪ᡤ࠾ࡅࡿࣉ࣐ࣛࣜࢣࡢホ౯㛵ࡋ࡚ࠊ␗࡞ࡿࣉࣛࢵࢺࣇ࢛࣮࣒࠾ ࠸࡚ࡶࡑࡢ᭷ຠᛶ࣭ᐇ⾜ྍ⬟ᛶࡣᚓࡽࢀࡓࡶࡢ⪃࠼ࡽࢀࡓࠋ ┠ ⓗ ࡀᅜ࠾࠸࡚ࠊデ⒪ᣦᶆࢆ⏝࠸ࡓデ⒪ࡢ㉁ホ౯ࡣࠊつᶍࡢࡁ࠸㝔࠾࠸࡚ࡣ୍⯡ࡋ ࡘࡘ࠶ࡿࡀࠊࣉ࣐ࣛࣜࢣࢆᢸ࠺デ⒪ᡤ࡛ࡣࢇ⾜ࢃࢀ࡚࠸࡞࠸ࠋಶࠎࡢデ⒪ᡤࡣࡑ ࡢᆅ⌮ⓗ࡞⨨ࡅࠊࡋ࡚ᥦ౪ࡋ࡚࠸ࡿデ⒪ෆᐜࠊタつᶍࡼࡗ࡚ࡁ࡞ᕪ␗ࡀ࠶ࡿ ࡶࡢࡢࠊࡑࡢ᰾࡞ࡿࣉ࣐ࣛࣜࢣᶵ⬟㛵ࡋ࡚ࡣ༢⨯ᝈࡢ་⒪ࢧ࣮ࣅࢫࡢᥦ ౪ࢆ⾜࠺ࡲࡽࡎࠊ᪥ᖖࡢண㜵άື࣭ᗣቑ㐍ࠊ་⒪࣭ㆤ࣭⚟♴ࢧ࣮ࣅࢫࡢㄪᩚࠊᆅ ᇦࡢேࠎࡢὶࢆ㏻ࡌࡓᆅᇦࡢάᛶ࡞ࠊከᒱࢃࡓࡿᵝࠎ࡞άືࢆྵࡴ୍ᐃࡢඹ㏻ 㒊ศࡀ࠶ࡿ⪃࠼ࡽࢀࡿࠋ ࡇࢀࡲ࡛ᡃࠎࡣࠊࡇࢀࡽࡢඹ㏻㒊ศ㛵ࡋ࡚ᶆ‽ⓗࣉ࣐ࣛࣜࢣ㛵ࡍࡿデ⒪ᣦᶆࢆ 㛤Ⓨࡋࠊࡇࢀࡽࢆ⏝࠸࡚ᐇ⋡ࢆᐇᆅ࡛ ᐃࡋࣇ࣮ࢻࣂࢵࢡࢆࡍࡿᡭἲࢆ⏝࠸࡚ࠊ୍ᆅᇦ ࠾ࡅࡿ」ᩘࡢデ⒪ᡤ࠾࠸࡚ᐇᆅ࡛㐩ᡂ⋡ࡢ ᐃࢆ⾜࠸ࠊࡑࡢ᭷⏝ᛶ࠾ࡼࡧᐇ⾜ྍ⬟ᛶ ―5― ࢆ᳨ドࡋ࡚ࡁࡓࠋࡋࡋタ❧ẕయࠊ⏝ࡍࡿデ⒪㘓ࠊࣞࢭࣉࢺࢥࣥࣆ࣮ࣗࢱ࡞ࡀ␗࡞ࡗ࡚ ࠸ࡓሙྜࡶᐇ㝿ᐇࡀྍ⬟࡛࠶ࡿࡘ࠸࡚ࡢ▱ぢࡣ㝈ᐃⓗ࡛࠶ࡗࡓࠋࡾࢃࡅࠊ㟁Ꮚ ࢝ࣝࢸࢆ⏝࠸ࡓデ⒪㘓ㄪᰝࡣࠊேⓗ࣭㛫ⓗປຊࡀࡿࡇࡀࡇࢀࡲ࡛ࡢ◊✲࡛᫂ࡽ ࡞ࡗ࡚࠾ࡾࠊࣉ࣐ࣛࣜࢣ࠾ࡅࡿデ⒪ᡤࡢከᵝᛶࡽᐇ⾜ྍ⬟ᛶࡀᢸಖࡉࢀࡿࡢ ࠺㛵ࡋ࡚ࡣ࡛᫂࠶ࡗࡓࠋ ᮏ◊✲ࡣࠊ␗࡞ࡿᆅᇦ࣭タ❧ẕయ࣭࢝ࣝࢸ࣭ࣞࢭࣉࢺ࣓࣮࣮࢝ࢆ⏝࠸ࡿᆅᇦࡢ」ᩘࡢデ⒪ ᡤ࠾࠸࡚ᶆ‽ⓗ࡞ࣉ࣐ࣛࣜࢣ㛵ࡍࡿデ⒪ᣦᶆࢆ⏝࠸ࡓࠊデ⒪ホ౯ࢆ⾜࠸ࠊࡑࡢᐇ⾜ ྍ⬟ᛶᚋࡢㄢ㢟ࡘ࠸᳨࡚ウࡍࡿࡇࢆ┠ⓗࡋ࡚࠸ࡿࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ ᅇᡃࠎࡣ༠ຊデ⒪ᡤ 2 タ࠾࠸࡚ホ౯◊✲ࢆ⾜ࡗࡓࠋ୧デ⒪ᡤࡶࠊ㤳㒔ᅪ㏆㑹 ࡢఫᏯᆅ⨨ࡋ࡚࠸ࡿࡀࠊ㸿デ⒪ᡤࡣෆ⛉య࡛࠶ࡾ㧗㱋⪅ࡢẚ⋡ࡶẚ㍑ⓗከ࠸ᆅᇦ࡛ 㛗ᖺ㛤ᴗࡋ࡚࠸ࡿಶே❧ࡢデ⒪ᡤ࡛࠶ࡿࡢᑐࡋࠊ㹀デ⒪ᡤࡣᑠඣ⛉ࡢẚ⋡ࡀከࡃ㥐๓ࡢ ẚ㍑ⓗே㏻ࡾࡢከ࠸ᆅᇦࡢ」ྜࣅࣝෆ⨨ࡋ࡚࠾ࡾࠊྠࣅࣝෆ⸆ᒁ࠾ࡼࡧᑓ㛛⛉ࡢ デ⒪ᡤࡀ㛤タࡋ࡚࠸ࡿἲேࡉࢀ࡚࠸ࡿẚ㍑ⓗ㛤ᴗᖺᩘࡢ▷࠸デ⒪ᡤ࡛࠶ࡿࠋ⏝ࡋ࡚࠸ ࡿ㟁Ꮚ࢝ࣝࢸ࠾ࡼࡧࣞࢭࣉࢺࢥࣥࣆ࣮ࣗࢱࡢ࣋ࣥࢲ࣮ࡶࡑࢀࡒࢀ␗࡞ࡗ࡚࠸ࡿࠋ ホ౯⏝࠸ࡓデ⒪ᣦᶆࡣᡃࠎࡀ㛤Ⓨࡋࠊࡇࢀࡲ࡛ᐇᆅ࠾࠸࡚⏝ࡋ࡚ࡁࡓࣉ࣐ࣛ ࣜࢣ㛵ࡍࡿデ⒪ᣦᶆࢆ⏝࠸ࡓࠋࡇࢀࡽࡣ 5 ࢝ࢸࢦ࣮ࣜ㸦ᖜᗈ࠸デ⒪࠾ࡼࡧᶆ‽ⓗデ⒪ࠊ ࢡࢭࢫࠊࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥࠊ㐃ᦠࠊᝈ⪅⫼ᬒࡢᑛ㔜㸧 ࠊ42 㡯┠ࡽᵓᡂࡉࢀ࡚࠸ࡿࠋࡲ ࡓࢹ࣮ࢱ※ࡣ 3 㡯┠ࡀࣞࢭࣉࢺㄪᰝࠊ18 㡯┠ࡀデ⒪㘓ㄪᰝࠊ21 㡯┠ࡀᝈ⪅ㄪᰝ࡛࠶ࡿࠋㄪ ᰝᮇ㛫ࡣࠊ2014 ᖺ 8 ᭶Ɇ2015 ᖺ 7 ᭶ࡋࠊࡇࡢᮇ㛫୰ࡢࣞࢭࣉࢺ࠾ࡼࡧデ⒪㘓ࢹ࣮ࢱࢆ ᑐ㇟ࡋࡓࠋᝈ⪅ㄪᰝࡣ 2015 ᖺ 8 ᭶ࡢࡑࢀࡒࢀ 1 㐌㛫ࡢཷデᝈ⪅ဨࢆᑐ㇟ࡋࡓࠋᝈ⪅ ㄪᰝࡣ⮬ᕫグධᘧࡢ㉁ၥ⣬ࢆ⏝࠸ࡓࣥࢣ࣮ࢺㄪᰝ࡛ࠊデ⒪ᡤࡢཷデཷࡢ㝿グධࡢ༠ ຊࢆ౫㢗ࡋࠊ༠ຊࡀᚓࡽࢀࡓᝈ⪅ᡭΏࡋࢆ⾜࠸ࠊࡑࡢሙ࡛グධࡋᅇࡍࡿࠊᚋ᪥ㄪᰝ ົᒁࡢ㒑㏦ࡢ࠸ࡎࢀࢆ౫㢗ࡋࡓࠋA デ⒪ᡤࡣ㝔ෆฎ᪉࡛࠶ࡗࡓࡓࡵࠊࣞࢭࣉࢺㄪᰝࡢ 㡯┠ࡣ⸆ሗࢆ⏝࠸࡚┤᥋ᐇ⋡ࢆ⟬ฟࡍࡿࡇࡀྍ⬟࡛࠶ࡗࡓࡀࠊB デ⒪ᡤࡣ㝔እฎ ᪉ࡢࡓࡵ⌧ᆅ࠾࠸࡚ฎ᪉ෆᐜࢆ㟁Ꮚ࢝ࣝࢸࡢグ㍕ෆᐜ࡛☜ㄆࢆ⾜࠺సᴗࡀⓎ⏕ࡋࡓࠋデ ⒪㘓ㄪᰝ㛵ࡋ࡚ࡣᮇ㛫ෆㄪᰝᑐ㇟ᝈ⪅ࡢศẕࡢୖ㝈ࢆ 100 ྡタᐃࡋࠊࡇࡢேᩘ㐩 ࡋࡓⅬ࡛ࡑࡢ㡯┠㛵ࡍࡿㄪᰝࡣ⤊ࡍࡿࡇࡋࡓࠋ ⤖ ᯝ A デ⒪ᡤ࡛ࡣࣞࢭࣉࢺୖࡢ⸆ሗࢆ⏝࠸࡚๓ᢳฟࢆ⾜࠺ࡇࡀྍ⬟࡛࠶ࡗࡓࡀࠊB デ ⒪ᡤ㛵ࡋ࡚ࡣ㝔እฎ᪉ࡢࡓࡵ⸆ሗࢆᢳฟ⬟࡞ࡾࠊ⌧ᆅ࡛デ⒪㘓ࢆ☜ㄆࡢୖ┠ど ࡛ヱᙜ⸆ࡀฎ᪉ࡉࢀ࡚࠸ࡓ㛵ࡍࡿ☜ㄆࡀᚲせ࡞ࡗࡓࠋලయⓗࡣࣞࢭࣉࢺࢹ࣮ࢱୖ ࡛ࡣฎ᪉ࡀ⾜ࢃࢀࡓࡇࡣุ᫂ࡍࡿࡀࠊヱᙜ⸆ࡀᐇ㝿ฎ᪉ࡉࢀ࡚࠸ࡿ☜ㄆࡀᚲせ ࡞ࡗࡓࠋලయⓗࡣࠊB デ⒪ᡤ࠾ࡅࡿ⌧ᆅㄪᰝ࡛ࡣ㝆ᅽᒀࠊ⢾ᒀ⸆ࠊǃ2 ่⃭ࡀ ฎ᪉ࡉࢀ࡚࠸ࡿࡢ☜ㄆࡣ 289 ྡࡀࠊ⢾ᒀ⸆࡛ࡣ 57 ྡࡀࠊǃ㸰่⃭࡛ࡣ 317 ྡࡢ☜ㄆ ࡀᚲせ࡞ࡗࡓࠋ ࡲࡓデ⒪㘓ㄪᰝ࠾࠸࡚ࡶ๓ᑐ㇟ᝈ⪅ࢆࣞࢭࣉࢺࡽࡢࢹ࣮ࢱࢆ⏝࠸࡚⤠ࡾࡇࢇࡔ ୖ࡛⌧ᆅㄪᰝࢆ⾜࠺ணᐃࡋ࡚࠸ࡓࡀࠊࡇࢀࡽ㛵ࡋ࡚ࡶྠᵝࡢసᴗࡀⓎ⏕ࡋࡓࠋࠕ㝆ᅽ ࢆෆ᭹ࡋ࡚࠸ࡿࡍ࡚ࡢ㧗⾑ᅽᝈ⪅ᑐࡋ࡚ࠊ᭱㏆ࡢ 1 ᖺ㛫࡛ࠊ⏕ά⩦័ᨵၿᣦᑟ㸦ῶ㔞ࠊ ―6― 㐠ື⒪ἲࠊ㣗⒪ἲࠊῶሷࠊ⠇㓇ࡢ࠸ࡎࢀ㸧ࡀ⾜ࢃࢀࡓࠊデ⒪㘓グ㍕ࡀ࠶ࡿࠖ㛵ࡍ ࡿ㡯┠࠾࠸࡚ࠊB デ⒪ᡤ࠾ࡅࡿㄪᰝ࡛ࡣࠊ㝆ᅽࡀฎ᪉ࡉࢀ࡚࠸ࡿྰࢆㄪᰝࡍࡿࡓ ࡵ 371 ྡࡢ࢝ࣝࢸࢆᐇ㝿☜ㄆࡋ࡞ࡅࢀࡤ࡞ࡽ࡞ࡗࡓࠋ ࡑࢀࡒࢀࡢ㡯┠࡛ࡢᐇ⋡ࡣ A デ⒪ᡤ࡛ࡣ 4.4㸣㹼69.0㸣ࠊB デ⒪ᡤ࡛ࡣ 0㸣㹼94.6㸣 ࡁ࡞ࡤࡽࡘࡁࡀ࠶ࡗࡓࠋࡲࡓࠊA デ⒪ᡤ B デ⒪ᡤ࡛ࡣࠊㄆ▱ᝈ⪅ࡢㆤ⪅ࡢྠ ᐃ㸦A デ⒪ᡤ 30% vs B デ⒪ᡤ 81.8㸣㸧ࠊ་ពぢ᭩ࢆグ㍕ࡋࡓᝈ⪅㛵ࡍࡿࢣ࣐ࢿࢪ ࣮ࣕࡢグ㍕㸦A デ⒪ᡤ 8.1㸣 vs B デ⒪ᡤ 94.6%㸧ࠊㆤ⪅ࡢྠᐃ࡛ࡣ B デ⒪ᡤࡢᐇ ⋡ࡀ㧗ࡗࡓࡀࠊ୍᪉ࠊ᪂つ㢌③Ⓨᝈ⪅࠾ࡅࡿⓎᵝᘧࡢグ㍕㸦A デ⒪ᡤ 58.3㸣 % vs B デ⒪ᡤ 3 㸣㸧,᪂つ⭜③ᝈ⪅ࡢ㤿ᑿೃ⩌ࡢ☜ㄆ㸦A デ⒪ᡤ 12㸣ࠊB デ⒪ᡤ 1.3㸣㸧 ྠ୍㡯┠ෆ࠾࠸࡚ࡇࡢ 2 デ⒪ᡤࡢ㛫࡛ࡶࡁ࡞ᕪ␗ࡀㄆࡵࡽࢀࡓࠋ ᝈ⪅ㄪᰝࡣ A デ⒪ᡤ 44 ྡࠊB デ⒪ᡤ 126 ྡࡽ㏉⟅ࡀᚓࡽࢀࡓࠋࡇࡢ୰࡛ᑜࡡࡽࢀ ࡓࠊ ࠕࡇࡢࡼ࠺࡞ࣥࢣ࣮ࢺㄪᰝࢆᐃᮇⓗ⾜࠺ࡇࢆዲࡲࡋࡃᛮ࠺ࠖࠊ࠸࠺㉁ၥ࡛ࡣࠊ A デ⒪ᡤ࡛ࡣ 72.7㸣㸦32 ྡ/ 44 ྡ㸧ࠊB デ⒪ᡤࡣ 67.5㸣㸦83 ྡ/ 123 ྡ㸧ࡀࠕࡑ࠺ᛮ ࠺ࠖ ࠕኚࡑ࠺ᛮ࠺ࠖ⟅࠼࡚࠾ࡾࠊᝈ⪅ࡢከࡃࡀ⫯ᐃⓗ࡞ពぢ࡛࠶ࡗࡓࠋࡲࡓࠊ ࠕᐃᮇⓗ እ㒊ホ౯ࢆཷࡅࡿࡇ㛵ࡋ࡚ዲࡲࡋ࠸ᛮ࠺ࠖࠊࡢၥ࠸ᑐࡋ࡚ࡶࠊA デ⒪ᡤ࡛ࡣ 72.7㸣 㸦32 ྡ/ 44 ྡ㸧ࠊB デ⒪ᡤ࡛ࡣ 72.1㸣㸦88 ྡ/ 122 ྡ㸧ࡀࠕࡑ࠺ᛮ࠺ࠖ ࠕኚࡑ࠺ᛮ࠺ࠖ ከࡃࡀ⫯ᐃⓗ࡞ពぢ࡛࠶ࡗࡓࠋࠖ ᮏ◊✲ࡢ⤖ᯝࡽࠊ␗࡞ࡿ㟁Ꮚ࢝ࣝࢸ࣭ࣞࢭࣉࢺࢥࣥࣆ࣮ࣗࢱࠊ࠾ࡼࡧ␗࡞ࡿ❧ᆅ᮲௳ୗ ࠾࠸࡚ࠊ୍ᐃࡢㄢ㢟ࡣ࠶ࡿࡶࡢࡢࠊࡇࢀࡲ࡛㛤Ⓨࡋࡓデ⒪ᣦᶆࢆ⏝࠸ࡓࣉ࣐ࣛࣜࢣ ࡢデ⒪ホ౯ࡣᐇ⾜ྍ⬟࡛࠶ࡿࡇࡀ᫂ࡽ࡞ࡗࡓࠋ ⾲㸯 ᑐ㇟タࡢ≉ᚩ 㸿デ⒪ᡤ 㹀デ⒪ᡤ ᡤ ᅾ ᆅ ᮾி㒔 ༓ⴥ┴ タ ಶ ே ་⒪ἲே タ ❧ ᖺ 44 ᖺ㸦1969 ᖺ㸧 ᖹᡂ 13 ᖺ㸦2001 ᖺ㸧 ᶆ ᴶ ⛉ ෆ⛉࣭ᑠඣ⛉ ᑠඣ⛉࣭ෆ⛉࣭⫶⭠⛉ ᙧ ែ ᡞᘓ࡚ࠊ⫋ఫ୍యᆺ ࣅࣝデ⒪ᡤ 㝔ෆฎ᪉ 㝔እฎ᪉ 㸿♫㸦ࣞࢭࢥࣥ㐃ືᆺ㸧 㹀♫㸦ࣞࢭࢥ୍ࣥయᆺ㸧 ฎ ❧ ᪉ ẕ ᙧ య ែ ⏝㟁Ꮚ࢝ࣝࢸ࣓࣮࣮࢝ ―7― ―8― ―9― ᪂つࡢ㧗⾑ᅽᝈ⪅ࡘ࠸࡚ึデ⢾ᒀ࣭⬡㉁␗ᖖࡢ᭷ ↓ࠊᚰ㡢ࡘ࠸࡚グ㍕ࡀ࠶ࡿ 㝆ᅽࢆෆ᭹ࡋ࡚࠸ࡿࡍ࡚ࡢ㧗⾑ᅽᝈ⪅ᑐࡋ࡚ࠊ᭱㏆ࡢ 1 ᖺ㛫࡛ࠊ⏕ά⩦័ᨵၿᣦᑟ㸦ῶ㔞ࠊ㐠ື⒪ἲࠊ㣗⒪ἲࠊῶ ሷࠊ⠇㓇ࡢ࠸ࡎࢀ㸧ࡀ⾜ࢃࢀࡓࠊデ⒪㘓グ㍕ࡀ࠶ࡿ ࡍ࡚ࡢ㧗⾑ᅽᝈ⪅ᑐࡋ࡚ࠊᐙᗞ⾑ᅽ ᐃ⤖ᯝࡢグ㍕ࡀ࠶ ࡿ ࡍ࡚ࡢ⢾ᒀᝈ⪅ࡘ࠸࡚ཷデẖࡢ⾑ᅽࡀ ᐃࡉࢀ࡚࠸ ࡿࠋ ࡍ࡚ࡢ⢾ᒀᝈ⪅ࡣ㐣ཤ 1 ᖺ௨ෆ║⛉⤂ࡀ⾜ࢃࢀ࡚ ࠸ࡿࠊ࠶ࡿ࠸ࡣ║⛉㏻㝔ࡀ☜ㄆ࡛ࡁ࡚࠸ࡿ ࡍ࡚ࡢ⢾ᒀᝈ⪅ࡣ㐣ཤ 1 ᖺ௨ෆ㊊ࡢデᐹ㸦ࣔࣀࣇࣛ ࣓ࣥࢺ࠶ࡿ࠸ࡣືぬ㸧ࡀ⾜ࢃࢀ࡚࠸ࡿ ᡂேẼ⟶ᨭႍᜥᝈ⪅ࡘ࠸࡚ࠊ᭱㏆ࡢ 1 ᖺ㛫࡛㹎㹃㹄㸦ࣆ࣮ ࢡࣇ࣮ࣟ㸧್ࡢグ㍕ࡀ࠶ࡿ 㧗⾑ᅽ࣭⬡㉁␗ᖖ࡚㐣ཤ 12 ࢝᭶ 4 ᅇ௨ୖ㏻㝔ࡋฎ᪉ࢆ ཷࡅ࡚࠸ࡿᝈ⪅ࡘ࠸࡚ࠊ1 ᖺ 1 ᅇ௨ୖࠊ㝔ࡶྵࡵࡍ ࡚ࡢෆ᭹ฎ᪉⸆ࡘ࠸࡚☜ㄆࡋグ㘓ࡋ࡚࠸ࡿ 㐣ཤ 12 ࢝᭶⥅⥆ࡋ࡚㧗⾑ᅽ࣭⬡㉁␗ᖖ࣭⢾ᒀࡢྠ୍ᝈ ࡚㏻㝔୰ࡢᝈ⪅ࡘ࠸࡚ࠊᶆⓗᝈᑐࡍࡿ⸆ࡀኚ᭦ ࡞ࡗࡓḟࡢデᐹࠊኚ᭦⸆㛵ࡍࡿస⏝࣭ຠᯝࡘ࠸ ࡚グ㍕ࡀ࠶ࡿ デ⒪ሗᥦ౪᭩ࡣ᪤ Ṕ࣭ࣞࣝࢠ࣮Ṕ࣭⌧ᅾࡢฎ᪉⸆ࡀ ࡍ࡚グ㍕ࡉࢀ࡚࠸ࡿ ་ពぢ᭩ࢆⓎ⾜ࡋࠊせㆤㄆᐃࢆ࠺ࡅࡓᝈ⪅ࡘ࠸࡚ࠊ デ⒪㘓⌧ᅾࡢᢸᙜࢣ࣐ࢿࢪ࣮ࣕࡀ㸦ࢣ࣐ࢿࢪ࣮ࣕᅾ ࡶྵࡵ㸧グ㍕ࡉࢀ࡚࠸ࡿ ᐃᮇⓗ㏻㝔㸦1 ᖺ 3 ᗘ௨ୖࡢ㏻㝔ࡀ 3 ᖺ௨ୖ⥆࠸࡚࠸ ࡿ㸧ࡋ࡚࠸ࡿ 20 ṓ௨ୖࡢᡂேᝈ⪅ࡘ࠸࡚ࠊྠᒃᐙ᪘ࡢ᭷ ↓ࠊ⫋ᴗ(⏕άୖࡢᙺ)ࡘ࠸࡚グ㍕ࡀ࠶ࡿ ― 10 ― 83 83 68 1 1.5 371 108 100 15 15. 0 100 100 100 16 73 73 73 45 73 73 73 14 73 73 73 15 317 317 80 3 3.7 78 78 76 47 61. 8 282 282 66 4 6.1 100 100 99 0 0.0 Ɇ 37 37 35 94. 6 100 100 100 52 52. 0 16. 0 61. 6 19. 2 20. 6 ࠝ⮫ᗋᏛ◊✲ᐊࠞ ⬤ᙅ㧗㱋⪅ࡢデ⒪ሗᥦ౪᭩ࣇ࢛࣮࣐ࢵࢺ㛤Ⓨ㛵ࡍࡿ ࣥࢱࣅ࣮ࣗㄪᰝ ᯇᮧ┿ྖ㸯ࠊᑿ⸨ㄔྖ㸯ࠊ᪂᳃ຍዉᏊ㸯 㸦⮫ᗋᏛ◊✲ᐊ㸧 せ ⣙ ࢣ⛣⾜ Care transition ࡣࠊ⒪ࡸࢣࡀ⾜ࢃࢀ࡚࠸ࡿሙᡤࡀኚࡍࡿࡇࢆࡉࡋࠊ ୍⯡ࡣᛴᛶᮇ㝔ࡢධ㏥㝔ࡸࠊタࡢධ㏥ᡤࠊ࡞ࡢࡇࢆ⾲ࡋ࡚࠸ࡿࠋࡇࢀࡽࡢ࠺ ࡕࠊᝈ⪅ࡢ≧ែࡀᝏࡋࠊ⒪ࡀ㞟୰ⓗ⾜ࢃࢀࡿᚲせᛶࡀ⏕ࡌ࡚ᛴᛶᮇ㝔ධ㝔ࡍࡿ㝿 ࠾ࡼࡧࠊ⒪ࡀ⤊ࡋ⮬Ꮿ࠶ࡿ࠸ࡣタ㏥㝔ࡋࡓࡢࡕ⥅⥆⒪ࡀᚲせ࡞ࡿ㝿ከࡃࡢ ၥ㢟ࡀⓎ⏕ࡍࡿࡇࡀ᫂ࡽ࡞ࡗ࡚࠸ࡿࠋ ᮏ◊✲࡛ࡣࠊࡾࢃࡅせㆤ㸰⛬ᗘ௨ୖࡢ⬤ᙅ㧗㱋⪅ࡀᚰࠊ⫵⅖㸪⬻⾑⟶㞀ᐖࠊᒀ㊰ ឤᰁ࡞ࡢᛴᛶᮇᝈࡼࡾձᛴᛶᮇ㝔ධ㝔ࡍࡿ㝿,㔜せᛮࢃࢀࡿデ⒪ሗ࠾ࡼࡧ ⏕ά࣭ࢣሗࠊ࠾ࡼࡧղᝈࡀ㍍ᛌࡋࠊᛴᛶᮇ㝔ࡽ㏥㝔ࡍࡿ㝿㔜せᛮࢃࢀࡿデ⒪ ሗ࠾ࡼࡧ⏕ά࣭ࢣሗࡣఱࠊࡉࡽճࡇࢀࡽࡢሗࡀ㏻ᖖࡢデ⒪ሗᥦ౪᭩ຍࢃ ࡾຍⓗ࡞ሗࣇ࢛࣮࣐ࢵࢺࡀసᡂࡉࢀࡿࡇࡼࡗ࡚ࠊᨵၿࡀᮇᚅࡉࢀࡿධ㝔୰ࡢデ⒪࣭ ࢣෆᐜ࠾ࡼࡧ㏥㝔ᚋࡢデ⒪࣭ࢣෆᐜࡣࡢࡼ࠺࡞ࡶࡢࡀ࠶ࡿࢆ᫂ࡽࡍࡿࡇ ࢆ┠ⓗࡋࡓࠋ ┠ ⓗ㸦ࡲࡓࡣ◊✲┠ⓗ㸧 㧗㱋ேཱྀࡀ⥲ேཱྀࡢ 20㸣ࢆ㉺࠼ࠊࡉࡽቑຍࢆ⥆ࡅ࡚࠸ࡿ⌧ᅾࠊᅾ㝔᪥ᩘࡢ▷⦰㏥㝔 ࡴࡅࡓ᪩ᮇࡽࡢㄪᩚࡣ་⒪ᶵ㛵ࠊࡾࢃࡅᛴᛶᮇ㝔࠾࠸࡚ࡣᴟࡵ࡚㔜せ࡞ၥ㢟 ࡞ࡗ࡚ࡁ࡚࠸ࡿࠋࡲࡓࠊࡢ៏ᛶ࣭」㞧ࠊ࠾ࡼࡧᝈ⪅୍ேࢃࡿ་⒪࣭⚟♴࣭ ㆤ⫋࡞ࡢከேᩘࡼࡾࠊ་⒪ሗࡶࠊࢣయไࡢ☜❧ᚲせ࡞ໟᣓⓗ㧗㱋⪅ᶵ⬟ ホ౯ࠊAdvance care planning ࡢྲྀᚓ≧ἣ࡞ࠊ⒪㣴ୖ࣭ㆤୖྍḞ࡞ࡉࡲࡊࡲ࡞ሗ ࡀồࡵࡽࢀࡿࡼ࠺࡞ࡗ࡚ࡁ࡚࠸ࡿࠋࡇࢀࡽࡣ㏻ᖖࠊᝈ⪅㛵ࢃࡿ」ᩘࡢᑓ㛛⫋ࡢ㛫࡛ಶู ྲྀᚓࡉࢀࠊࡇࢀࡽࡢሗࡢከࡃࡣࠊධ㏥㝔ࡸタධᡤ࡞ࡢ㝿ࡑࡢ㒔ᗘ᩿∦ⓗྲྀᚓ࣭ ✚ࡉࢀ࡚࠸ࡗ࡚࠸ࡿࡢࡀᐇ࡛࠶ࡿࠋ ࢣ⛣⾜ Care transition ࡣࠊ⒪ࡸࢣࡀ⾜ࢃࢀ࡚࠸ࡿሙᡤࡀኚࡍࡿࡇࢆࡉࡋࠊ ୍⯡ࡣᛴᛶᮇ㝔ࡢධ㏥㝔ࡸࠊタࡢධ㏥ᡤࠊ࡞ࡢࡇࢆ⾲ࡋ࡚࠸ࡿࠋࡇࢀࡽࡢ࠺ ࡕࠊᝈ⪅ࡢ≧ែࡀᝏࡋࠊ⒪ࡀ㞟୰ⓗ⾜ࢃࢀࡿᚲせᛶࡀ⏕ࡌ࡚ᛴᛶᮇ㝔ධ㝔ࡍࡿ㝿 ࠾ࡼࡧࠊ⒪ࡀ⤊ࡋ⮬Ꮿ࠶ࡿ࠸ࡣタ㏥㝔ࡋࡓࡢࡕ⥅⥆⒪ࡀᚲせ࡞ࡿ㝿ከࡃࡢ ၥ㢟ࡀⓎ⏕ࡍࡿࠋ ୍⯡ⓗධ㝔ࡣࡇࢀࡲ࡛ࡢᝈ⪅ࡢ㌟య≧ἣࡸ⌧Ṕࠊ᪤ Ṕࠊ᭹⸆≧ἣࠊࣞࣝࢠ࣮ Ṕ࡞ሗࢆయࡍࡿデ⒪ሗᥦ౪᭩ࡀࡾࡘࡅ་ࡼࡾᥦ౪ࡉࢀࡿࡇࡀ୍⯡ⓗ࡛ ࠶ࡿࡀࠊ㧗㱋⪅࠾࠸࡚ࡣᝈ⪅ࢆࡾࡲࡃ⎔ቃࡢ」㞧ࡼࡾࠊ་ᖌࡢࡳ࡞ࡽࡎࢣ࣐ࢿࢪ ࣮ࣕࡸㆤࢫࢱࢵࣇࠊࡣゼၥ┳ㆤᖌ࣭⸆ᖌ࣭⒪ἲኈ࡞ࡢࡉࡲࡊࡲ࡞ᑓ㛛⫋ࡽࡢ ሗࡶ⒪ࡣ㔜せ࡞ࡿࡇࡶከ࠸ࠋᝈ⪅ᥦ౪ࡉࢀࡿ⒪ࡸࢣࡣࠊ⒪ࢆᥦ౪ࡍࡿሙࡀ ␗࡞ࡗࡓࡋ࡚ࡶࠊ㐃⥆ᛶࢆࡶࡗ࡚⥅⥆ࡋ࡚ᥦ౪ࡉࢀࡿᚲせࡀ࠶ࡿࡀࠊࡑࡢࡓࡵࡣࠊ ― 11 ― ᪥ࡈࢁࡽࡢᝈ⪅ࡢ㑅ዲࠊ౯್ឤ࡞ࡢᝈ⪅ᅛ᭷ࡢሗࡀ୍ᐃࡢṇ☜ᛶࢆࡶࡗ࡚ⓗ☜⛣ ⾜ࡍࡿࡇࡀ㔜せ࡛࠶ࡿࠋ ࡾࢃࡅࠊࡼࡾὀព῝࠸ࠊ⥅⥆ࡋࡓデ⒪ࡀᚲせ࡞៏ᛶᝈࢆࡶࡘ⬤ᙅ㧗㱋⪅ࡢࢣ⎔ቃࡀ ኚࡍࡿ㝿ࡣࠊࡇࢀࡽࡢሗࢆ㝔ࡢ་⒪ࢫࢱࢵࣇᆅᇦࡢ་⒪࣭ㆤ⫋ࡢ㛫࡛ࢱ࣒ ࣮ࣜࡘ☜ᐇ⛣⾜ࡍࡿࡇࡀᚲせ࡛࠶ࡿࠋࡑࡋ࡚ࡑࡢࡇࡼࡗ࡚ࠊᛴᛶᮇ㝔ࡢධ㝔 ᮇ㛫ࢆ▷⦰ࡍࡿྠࠊࡼࡾᝈ⪅ࢽ࣮ࢬ༶ࡋࡓ⒪ࡀ⥅⥆ࡋ࡚⾜ࢃࢀࡿྍ⬟ᛶࢆ㧗ࡵ ࡿࡇࡀண ࡉࢀࡿࠋࡉࡽࠊࡇࢀࡽࡢሗࡀࡧᥦ౪ࡉࢀࡿࡇࡼࡗ࡚ࠊ㏥㝔ᚋ ࡣࡼࡾᏳᐃࡋࡓ⒪㣴⏕ά⛣⾜ࡍࡿࡢࡳ࡞ࡽࡎࠊᏳ࡛ࡘᝈ⪅࠾ࡼࡧᝈ⪅ᐙ᪘ࡗ࡚ ࡼࡾᮃࡲࡋ࠸⒪㣴⏕άࢆ⥅⥆ࡍࡿࡇࢆྍ⬟ࡍࡿࡇࡀண ࡉࢀࡿࠋ ධ㏥㝔࠾ࡅࡿࢣ⛣⾜㛵ࡋ࡚ࠊᅜእ࡛ࡣ 2000 ᖺ௦௨㝆ከࡃࡢ◊✲ࡀ⾜ࢃࢀࡿࡼ࠺ ࡞ࡗ࡚ࡁ࡚࠸ࡿࠋKriplalani ࡽࡼࡿࠊධ㝔ᢸᙜ་ᆅᇦࡢࣉ࣐ࣛࣜࢣ་ࡢ㛫ࡢ ┤᥋ࡢࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥࡀ⾜ࢃࢀࡿࡢࡣࡈࡃᑡᩘ㸦3㸫20㸣㸧࡛࠶ࡾࠊ㏥㝔ᚋึᅇࡢእ᮶ ཷデࡲ࡛㏥㝔ࢧ࣐࣮ࣜࡀᒆ࠸࡚࠸ࡿࡢࡶᑡᩘ㸦12-34㸣㸧࡛࠶ࡿࡇࢆ᫂ࡽࡋࠊࡇࢀ ࡽࡢሗ⛣⾜ࡀ༑ศ࡛࠶ࡿࡇࢆ♧ࡋ࡚࠸ࡿࠋࡲࡓࠊ㐺ษ࡞ሗ⛣⾜ࡼࡾࠊᝈ⪅‶㊊ ᗘࡢపୗࠊస⏝ࡢⓎ⏕ࠊධ㝔⋡ࡀቑຍࡍࡿࡇࡶ᫂ࡽ࡞ࡗ࡚࠸ࡿࠋࡇࡢࡼ࠺࡞ධ㏥ 㝔ࡢሗఏ㐩࢚࣮ࣛࢆ㜵ࡄࡓࡵࠊࢥࣥࣆ࣮ࣗࢱᢏ⾡ࢆ⏝ࡋࡓ㏥㝔ࢧ࣐࣮ࣜࡢᨵၿࡸࠊ ๓ࡢሗඹ᭷ࡢヨࡳࡀ⾜ࢃࢀ࡚࠾ࡾࠊ࠸ࡃࡘࡣᡂᯝࢆࡶࡓࡽࡋ࡚࠸ࡿࡶࡢࡶ࠶ࡿࡀࠊỴ ᐃⓗ࡞ᨵၿ⟇ࡣ⮳ࡗ࡚࠸࡞࠸ࡢࡀ⌧≧࡛࠶ࡿࠋ ᮏ㑥࠾࠸࡚ࡣ㏥㝔ᨭ࣭㏥㝔ㄪᩚ㛵ࡋ࡚ࠊ㧗㱋⪅࠾ࡅࡿ㏥㝔ᨭࢶ࣮ࣝࡢ㛤Ⓨࡸࠊ ᝈูࡢᆅᇦ㐃ᦠࣃࢫ࡞ࡢసᡂࡼࡿデ⒪ሗࡢ㐺ษ࡞ඹ᭷㛵ࡍࡿヨࡳࡣࡇࢀࡲ࡛ᩘ ከࡃ⾜ࢃࢀ࡚ࡁࡓࠋࡋࡋᛴᛶᮇ㝔ࡢධ㏥㝔ᥦ౪ࡉࢀࡿデ⒪ሗ㛵ࡍࡿෆᐜࡸࡑ ࢀࡽࡀࡑࡢᚋࡢデ⒪㠃࠼ࡿᙳ㡪ࡘ࠸࡚ࡣࢇ᳨ウࡀ࡞ࡉࢀ࡚࠸࡞࠸ࠋ2008 ᖺ ᘅ℩ࡽࡀ⾜ࡗࡓᛴᛶᮇᚰ➽᱾ሰ⒪ᚋࡢ 19 ࡢデ⒪ሗᥦ౪᭩ࡢㄪᰝ࡛ࡣࠊෙື⬦ᡤぢࡸ ⒪ෆᐜࡘ࠸࡚ࡢグ㍕ࡣከࡃࡢሙྜ⾜ࢃࢀ࡚࠸ࡿࡶࡢࡢࠊḟᅇࡢෙື⬦㐀ᙳணᐃࡸ⚗↮ ᣦᑟ࣭ᚰ⮚ࣜࣁࣅࣜࡢ᭷↓࡞ᚋࡢ⒪㣴ᚲせ࡞ሗࡀḞⴠࡋ࡚࠸ࡿࡇࡀ᫂ࡽ࡞ ࡗ࡚࠸ࡿࠋࡉࡽࠊ་⒪ሗ௨ୖࡢᝈ⪅ࡢ㸿㹂㹊ࡸㆤయไ࡞㛵ࡍࡿ⏕άሗࠊᝈ⪅ࡸ ᝈ⪅ᐙ᪘ࡢ౯್ほࡸ㑅ዲࠊᚋࡢ⒪㣴యไࡢᕼᮃࠊධ㝔୰ࡢࢣయ㦂ࠊAdvance care planning ࡢ≧ἣ࡞㛵ࡍࡿᐇドⓗ◊✲ࡣࡇࢀࡲ࡛ࢇ⾜ࢃࢀ࡚࠸࡞࠸ࠋ ࡇࢀࡽࡢඛ⾜◊✲ࡽࡢ⤖ᯝࢆࡩࡲ࠼ࠊᮏ◊✲࡛ࡣࠊࡾࢃࡅせㆤ㸰⛬ᗘ௨ୖࡢ⬤ᙅ㧗 㱋⪅ࡀᚰࠊ⫵⅖㸪⬻⾑⟶㞀ᐖࠊᒀ㊰ឤᰁ࡞ࡢᛴᛶᮇᝈࡼࡾձᛴᛶᮇ㝔ධ㝔 ࡍࡿ㝿,㔜せᛮࢃࢀࡿデ⒪ሗ࠾ࡼࡧ⏕ά࣭ࢣሗࠊ࠾ࡼࡧղᝈࡀ㍍ᛌࡋࠊᛴᛶᮇ 㝔ࡽ㏥㝔ࡍࡿ㝿㔜せᛮࢃࢀࡿデ⒪ሗ࠾ࡼࡧ⏕ά࣭ࢣሗࡣఱࠊࡉࡽճࡇࢀ ࡽࡢሗࡀ㏻ᖖࡢデ⒪ሗᥦ౪᭩ຍࢃࡾຍⓗ࡞ሗࣇ࢛࣮࣐ࢵࢺࡀసᡂࡉࢀࡿࡇ ࡼࡗ࡚ࠊᨵၿࡀᮇᚅࡉࢀࡿධ㝔୰ࡢデ⒪࣭ࢣෆᐜ࠾ࡼࡧ㏥㝔ᚋࡢデ⒪࣭ࢣෆᐜࡣࡢ ࡼ࠺࡞ࡶࡢࡀ࠶ࡿࢆ᫂ࡽࡍࡿࡇࢆ┠ⓗࡋࡓࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ ◊✲ࢹࢨࣥࡣ༙ᵓ㐀ࣥࢱࣅ࣮ࣗ࠾ࡼࡧࣇ࢛࣮࢝ࢫ࣭ࢢ࣮ࣝࣉࣥࢱࣅ࣮ࣗࢆ⏝ ࡋࡓ㉁ⓗ◊✲࡛࠶ࡿࠋ 2016 ᖺ 1 ᭶ࡼࡾࠊࢫࣀ࣮࣮࣎ࣝࢧࣥࣉࣜࣥࢢࢆ⏝࠸࡚ࠊᆅᇦࡢᅾᏯࢡࣜࢽࢵࢡົ་ᖌ 1 ྡࠊ㝔ົෆ⛉་་ᖌ 1 ྡࠊゼၥ┳ㆤᖌ 1 ྡࠊࢣ࣐ࢿࢪ࣮ࣕ1 ྡࠊᅾᏯㄪᩚ┳ㆤᖌ 1 ― 12 ― ྡࡢィ 5 ྡࡼࡾಶูࡢࣥࢱࣅ࣮ࣗࢆᐇࠋ๓タᐃࡋࡓࣥࢱࣅ࣮ࣗ࢞ࢻᇶ࡙ ࠸࡚ࠊࡑࢀࡒࢀ࠾ࡼࡑ 1 㛫ࡢ༙ᵓ㐀ࣥࢱࣅ࣮ࣗࢆᐇࡋࡓࠋ ࡲࡓࠊࡇࢀࡽࡢࣥࢱࣅ࣮ࣗෆᐜࢆࡶࠊࣔࢹ࣮ࣞࢱ࣮࢞ࢻࢆసᡂࠊ2016 ᖺ 2 ᭶ 11 ᪥ᛴᛶᮇ㝔ົࡍࡿ⫋ဨ㸦་ᖌ࣭㏥㝔ㄪᩚ┳ㆤᖌ࣭ࢯ࣮ࢩ࣮࣮ࣕࣝ࣡࢝㸧ࢆᑐ㇟ࢢ ࣮ࣝࣉࣥࢱࣅ࣮ࣗࢆᐇࠋ2 ᭶ 21 ᪥ࡣࠊᆅᇦࡢࣉ࣐ࣛࣜࢣࢆᢸᙜࡍࡿከ⫋✀ࢆᑐ ㇟ࢢ࣮ࣝࣉࣥࢱࣅ࣮ࣗࢆᗘᐇࡍࡿணᐃ࡛࠶ࡿࠋ ⤖ ᯝ ⌧ᅾಶูࣥࢱࣅ࣮ࣗ5 ྡࠊ࠾ࡼࡧᛴᛶᮇ㝔ົࡍࡿ⫋ဨ 8 ྡ㛵ࡍࡿࢢ࣮ࣝࣉࣥ ࢱࣅ࣮ࣗ㛵ࡋ࡚ࢹ࣮ࢱ㞟ࢆ⤊ࠋศᯒࡣᚋࠊᆅᇦࡢࣉ࣐ࣛࣜࢣࢆᢸᙜࡍࡿከ⫋✀ ࢆᑐ㇟ࡋࡓࢢ࣮ࣝࣉࣥࢱࣅ࣮ࣗࡀ⤊ᚋ㡰ḟ⾜࠺ணᐃ࡛࠶ࡿࠋ ― 13 ― ᨻ⟇་⒪⏬◊✲㒊 ་⒪⤒῭ሗ◊✲࣭㧗㱋⪅ࢣ◊✲ᐊ㛗 ᮏ⏣ ⨾Ꮚ ᖺࠊ་⒪⤒῭ሗ◊✲࣭㧗㱋⪅ࢣ◊✲ᐊ࡛ࡣ▱ぬ࣭ឤ࣭ゝㄒࡼࡿໟᣓⓗࢣ ᢏἲ㸸࣐ࣘࢽࢳ࣮ࣗࢻ+XPDQLWXGH㛵ࡍࡿ◊✲࣭Ⓨ⾲࣭◊ಟᴗࢆᐇࡋࡲࡋࡓࠋ◊ ✲ࡘ࠸࡚ࡣཌ⏕ປാ┬⛉Ꮫ◊✲㈝⿵ຓ㔠ࡼࡿ㸰ࡘࡢㄢ㢟ࠊձ㞀ᐖ⪅ᑐ⟇⥲ྜ◊✲ᴗ 㸦㞀ᐖ⪅ᨻ⟇⥲ྜ◊✲ᴗ㸦⢭⚄㞀ᐖศ㔝㸧㸧ࠕ⢭⚄㞀ᐖ⪅ࡢᆅᇦ⏕άᨭࡢᅾࡾ᪉ࢩࢫ ࢸ࣒ᵓ⠏㛵ࡍࡿ◊✲ࠖࡢศᢸ◊✲ࡋ࡚ࠊࠕᆅᇦ♫࡛ᬽࡽࡍㄆ▱㧗㱋⪅ࡢໟᣓⓗ ࡞ࢣᢏἲࡢຠᯝ㛵ࡍࡿ᳨ウࠖ࠾ࡼࡧղ࢚ࢬᑐ⟇◊✲ᴗ㸦࢚ࢬᑐ⟇ᨻ⟇◊✲ ᴗ㸧ࠕ+,9 ឤᰁࡢ་⒪యไࡢᩚഛ㛵ࡍࡿ◊✲ࠖࡢศᢸ◊✲ࠕㄆ▱ࢆྵࡴ㧗㱋 +,9 㝧ᛶ⪅ࡢ㛗ᮇ⒪㣴㛵ࡍࡿㄢ㢟ᢳฟࠖࢆ⾜࡞࠸ࡲࡋࡓࠋձࡘ࠸࡚ࡣࠊᮏᖺᗘࡣᆅ᪉㒔ᕷ ࠾ࡼࡧൢᆅ࡛⮬Ꮿㆤࢆ⾜࡞ࡗ࡚࠸ࡿᐙ᪘ࢣᢏ⾡◊ಟࢆ⾜࠸ࠊㄆ▱㧗㱋⪅ࡢㄆ▱ ⾜ືᚰ⌮≧࠾ࡼࡧㆤ⪅ࡢㆤ㈇ᢸឤࡢኚࡘ࠸࡚ࡢ᳨ドࢆ⾜࡞࠸ࡲࡋࡓࠋ◊ಟᚋ 㸯࣭㸱ࣨ᭶ᚋࡢㄆ▱⾜ືᚰ⌮≧ࡣ᭷ពᨵၿࡀㄆࡵࡽࢀࠊࡲࡓㆤ㈇ᢸឤࡢቑᝏࡶ࠶ ࡾࡲࡏࢇ࡛ࡋࡓࠋ᮶ᖺᗘࡣᑐ㇟ࢆᨻ௧ᣦᐃ㒔ᕷᗈࡆࡓ◊✲ࢆᐇࡍࡿணᐃ࡛ࡍࠋղࡘ ࠸࡚ࡣ +,9 ឤᰁ⪅ࡢవࡀᢠ +,9 ⒪⸆ࡢ㐍Ṍࡼࡾ㣕㌍ⓗྥୖࡋࡓ୍᪉࡛ࠊ᪂ࡓ ⏕ࡌࡓ +,9 ឤᰁ⪅ࡢ㧗㱋క࠺㛗ᮇ⒪㣴ࡢሙࡢᅽಽⓗ࡞㊊ᝈ⪅ࡣ┤㠃ࡋ࡚࠸ࡲ ࡍࠋᮏ◊✲࡛ࡣࠊࡾࢃࡅ⸆ᐖ࢚ࢬᝈ⪅ࡢ㛗ᮇ⒪㣴ࡢሙࡢ☜ಖࡢࡓࡵᚲせࡉࢀ࡚࠸ ࡿㄢ㢟ࡢᢳฟࡑࡢゎỴ⟇ࡢ᳨ウࠊ࠾ࡼࡧ⾑ᛶ㛵⠇➼ࡢ㌟యⓗၥ㢟㛵ࡋ࡚ᙺ❧ ࡘࠊ㉁ࡢ㧗࠸ࢣᢏ⾡ࡢ㛤Ⓨࢆ⾜ࡗ࡚࠸ࡲࡍࠋ᪥ᮏࣉ࣐ࣛࣜࢣᏛ࣭᪥ᮏ㞟୰⒪Ꮫ ࣭᪥ᮏ⢭⚄ಖ┳ㆤᏛ࣭᪥ᮏᅾᏯ་Ꮫ࣭᪥ᮏᚰ㌟་Ꮫ➼ከࡃࡢᏛ⾡ᅋయ࡛ࡢᩍ⫱ ㅮ₇ࡸࠊᏛ་Ꮫ㒊࡛ࡢㅮ⩏ࡶ⾜࡞࠸ࡲࡋࡓࠋࡲࡓࠊᾏእ࡛ࡢ┳ㆤ࣭ㆤࡢᏛ࠾ࡅࡿ Ⓨ⾲ࡶ⾜࡞࠸ࡲࡋࡓࠋ᭦ࠊ➨㸱ᅇ࡞ࡿࢣ㛵ࡍࡿᕷẸබ㛤ㅮᗙࠕࠗࡼ࠸ࢣࡣఱ ࠘ࢆ⪃࠼ࡿࠖࢆ㛤ദࠊࣇࣛࣥࢫࡽ⪁ᖺ་Ꮫᑓ㛛་ &DQGLGD'HOPDV ඛ⏕ࢆᇶㄪㅮ₇ ⪅ࡋ࡚࠾㏄࠼ࡋࡲࡋࡓࠋࡉࡽࠊᑐእⓗ࡞άືࡋ࡚ࠊ▱ぬ࣭ឤ࣭ゝㄒࡼࡿໟᣓⓗ ࢣᢏἲ࣭࣐ࣘࢽࢳ࣮ࣗࢻࡢ◊ಟࢆᐃᮇⓗ㛤ദࡋ࡚࠸ࡲࡍࠋ ᖺࡣᅜࡽ ྡࡀ࣐ࣘࢽࢳ࣮ࣗࢻࡢ◊ಟཧຍࡋࡲࡋࡓࠋ ― 14 ― [ ་⒪⤒Ⴀሗ◊✲ᐊ ] Ϩ㸬ඛኳᛶ㞴⫈ඣࡢデ᩿ேᕤෆ⪥⒪ࡢ 2015 ᖺࡢືྥ 2001 ᖺࡽ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢࡼࡗ࡚ඛኳᛶ㞴⫈ࡣ᪩ᮇⓎぢࡉࢀࡿࡼ࠺࡞ ࡗࡓࠋࡑࢀࡽ 14 ᖺࡀ㐣ࡂࡓࠋᮾி་⒪ࢭࣥࢱ࣮࡛ࡶ௵ព࡛ 6,700 ࡢ᳨ᰝᩱ࡛⌧ᅾᐇ ࡉࢀ࡚࠸ࡿࠋ2007 ᖺ 4 ᭶ࡼࡾຍᡃᯇỌ࡛㛤タࡋࡓࠕᗂᑠඣ㞴⫈࣭ゝㄒ㞀ᐖࢡࣜࢽࢵ ࢡࠖࡣᮾி࣭⚄ዉᕝ࣭༓ⴥ࣭ᇸ⋢ࢆ୰ᚰᅜࡼࡾ㞴⫈ࢆࢃࢀࡓ᪂⏕ඣ࣭ஙᗂඣࡀ୧ ぶ㐃ࢀࡽࢀ࡚ཷデࡋ࡚࠸ࡿࠋࡇࡢ 4 ࡘࡢᆅᇦࢆ Greater Tokyo ࡪேཱྀࡣ⣙ 3000 ே࡛࣮ࣚࣟࢵࣃࡢ୰ࡄࡽ࠸ࡢつᶍࡢᅜ┦ᙜࡍࡿࠋࣥࢱ࣮ࢿࢵࢺୖࠊࡇࡢእ᮶ࡣᑠඣ ࡢ㞴⫈㡿ᇦ࡛ࢡࢭࢫᩘࡀ࠸ࡎࢀ࡛ࡶ 2008 ᖺࡼࡾ 2015 ᖺࡢ⌧ᅾ⮳ࡿࡲ࡛ࡢ 6 ᖺ㛫㐃 ⥆ᅜ➨ 1 ࡞ࡗ࡚࠸ࡿࠋࡑࡢࡓࡵࣥࢱ࣮ࢿࢵࢺ࡛ぢࡘࡅ࡚㞴⫈ࡸᑠ⪥ࡢᝈ⪅ࡀእ ᮶ࡢࡓࡧཷデࡍࡿࠋᏛ㝔ཷデࡋ࡚࠸࡚ࡶᮾி་⒪ࢭࣥࢱ࣮ࡲ࡛㐲࠸ࡶࢃࡽ ࡎཷデࡍࡿࡇࡀᖺࠎቑ࠼࡚࠸ࡿࠋ ᗂᑠඣࡢ㞴⫈ࡢ་⒪ࡣḟࡢ㡰࡛㐍ࡵࡿࠋ⏘⛉࡛ࡢձ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢࡀᐇࡉ ࢀࠊḟࡽࢃࢀࢃࢀࡢ࡞ࡾࠊղ᪩ᮇ⢭ᐦ⫈ຊ᳨ᰝ࠾ࡼࡧᖹ⾮ᶵ⬟᳨ᰝࠊճ㌟య㞀ᐖ ⪅ᡭᖒ㸦⫈ぬ㞀ᐖ㸧⿵⫈ჾពぢ᭩ࡢⓎ⾜ࠊմ㞴⫈ඣ㏻ᅬタ࠶ࡿ࠸ࡣ⫈ぬཱྀヰἲࡢ ⚾❧࣭ᅜ❧࣭බ❧ࢁ࠺Ꮫᰯ⏕ᚋ 6 ࣨ᭶ࡲ࡛୧⪥⿵⫈ჾ⏝ୗࡢᩍ⫱ࢆ౫㢗ࡍࡿࠊյ㞴 ⫈ࡀ㔜ᗘ࡛ 1 ṓ 6 ࣨ᭶㹼2 ṓࡲ࡛ࡢ㛫⫈ぬゝㄒⓎ㐩ࡀ༑ศ࡛࡞࠸ሙྜࠊேᕤෆ⪥ᇙ㎸⾡ࢆ 2 ṓ๓ᚋ࡛⾜࠺ࠋࡓࡔࡋࠊ㞴⫈ࡀ 1㹼2 ṓ࡛ึࡵ࡚Ⓨぢࡉࢀࡓ㞴⫈ඣࡣࠊ⿵⫈ୗࡢᩍ⫱ࢆ⣙ 6 ࣨ᭶ほᐹࡋ࡚⿵⫈ຠᯝࡀ༑ศ࡛࠶ࢀࡤேᕤෆ⪥ᇙ㎸⾡ࢆ⾜࠺ࠋն⿵⫈ჾ࠾ࡼࡧேᕤෆ ⪥⏝ୗࡢ㞴⫈ඣࡢᑠᏛᰯ㑅ᢥࠊධᏛᚋࡢᏛᰯᩍ⫱࡛ࡢᚰࡢࢣࠊշ㧗➼ᩍ⫱࣭ᩍ⫱ᨭ ◊✲ࠊոᑵ⫋ࡘ࡞ࡆ࡚࠸ࡿࠋඛኳᛶ㞴⫈ࡢཎᅉࡣࠊ㑇ఏᏊኚ␗ࡀ⣙ 50㸣ࠊ࿘⏘ᮇ㞴⫈ ࡢ࠺ࡕࢧࢺ࣓࢞ࣟ࢘ࣝࢫࡀ 5㹼10㸣ࠊඛኳወᙧࠊᰁⰍయ␗ᖖࠊ᪂⏕ඣ㔜㯤⑇ࠊ௬Ṛ ࡞ࡀ࠶ࡿࠋேᕤෆ⪥ᡭ⾡ࡣ 2015 ᖺࡣ 50 ᐇࡋࠊᅜ࡛ࡶࢺࢵࣉࢢ࣮ࣝࣉධࡾࠊ 2015 ᖺ 12 ᭶࡛ 250 ௳ࢆ㉺࠼ࡓࠋ㏆ᖺ㞴⫈㑇ఏᏊ᳨ᰝࢆᕼᮃࡍࡿ୧ぶࡀቑ࠼ࠊᯇỌ㐩㞝ඛ ⏕ࡀᑐᛂࡋ࡚࠸ࡿࠋ 㸯㸬 ᪩ᮇⓎぢ࣭᪩ᮇᩍ⫱ᖺ㱋᪩ᮇධ㸦⿵⫈ჾ࣭ேᕤෆ⪥㸧ࡢຠᯝཬࡧ ANSD 㛵ࡍ ࡿ◊✲ ᖹᡂ 25 ᖺᗘ⌧ᅾ 5㹼7 ṓ࡞ࡗࡓᑠඣ࡛ࠊึデࠊ㞴⫈࣭ゝㄒ㞀ᐖ࡛ཷデࡋࡓ 177 ྡ ୰ࠊࢃࡎ 31㸣ࡋ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢࢆཷࡅ࡚࠸࡞ࡗࡓࡇࡀุ᫂ࡋࡓࡀࠊᖹ ᡂ 27 ᖺᗘࡶࡑࡢഴྥࡣኚࢃࡽ࡞࠸ࠋᮾி㒔ࡢࡇࡢࢫࢡ࣮ࣜࢽࣥࢢࡢᐇ⋡ࡣ 50㸣ప࠸ ࡇࡢ࡛ᫎ࠶ࡿࠋ᪩ᮇᖺ㱋࡛ேᕤෆ⪥ᇙ㎸⾡ࢆཷࡅࡓ㞴⫈ඣࡢゝㄒᛶ IQ ࡣ⫈ඣኚ ࢃࡽ࡞ࡗࡓࠋࢃࢀࢃࢀࡀ㐃ᦠࡋ࡚࠸ࡿᐩኈぢྎ⫈ࡇ࠼ࡇࡤࡢᩍᐊࡢᬑ㏻ᑠᏛᰯࡢ ᑵᏛ⋡ࡣ 80㸣㧗ࡃࠊࢁ࠺Ꮫᰯࡣ 15㸣⛬ᗘ㐣ࡂ࡞࠸ࠋAuditory Neuropathy Spectrum Disorder (ANSD)◊✲ࡣ AMED ࡢ◊✲㈝᥇ᢥࡉࢀࠊᖺᖺᗘ 2 ᅇ⌜㆟ࢆ⾜ࡗ ࡓࠋ 㸰㸬 ㍍࣭୰➼ᗘ㞴⫈ ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢࡼࡗ࡚㍍㹼୰➼ᗘ㞴⫈ࡀ 0㹼1 ṓ࡛᪩ᮇⓎぢࡉࢀࡿࡼ࠺ ― 15 ― ࡞ࡾࠊ᪩ᮇ⿵⫈ࡼࡗ࡚ゝㄒⓎ㐩ࡢ㐜ࢀࢆண㜵࡛ࡁࡿࡼ࠺࡞ࡗࡓࠋ᪩ᮇ⿵⫈ჾࢆ ⏝ࡋ࡚⏝ᮇ㛫ࡀ㛗࠸ゝㄒຊࡀࢃࡗ࡚࠸ࡿࡀࠊ1 ṓ௨ෆ࡛ࡢ☜ᐃデ᩿ࡣ㞴ࡋ࠸ࡢ࡛ ࣇ࢛࣮ࣟࢵࣉࡋ࡞ࡀࡽࡢ᳨ᰝࡀ㘽࡞ࡿࠋᮾி࡛ࡣ㍍࣭୰➼ᗘ㞴⫈ඣࡣ 13 2000 ࡀຓࡉࢀࡿࡼ࠺࡞ࡾࠊࡁ࡞㐍Ṍࡀࡶࡓࡽࡉࢀࡓࠋ ୍᪉ࠊ㞴⫈ຍ࠼࡚Ⓨ㐩㞀ᐖࢆྜేࡍࡿሙྜࡶᑡ࡞ࡃ࡞࠸ࡇࡀุ᫂ࡋࠊࡩࡉࢃࡋ࠸⒪ ⫱ඛ㐃ᦠࡋ࡚㐍ࡵ࡚࠸ࡿࠋ 㸱㸬ඛኳᛶ㞴⫈ඣࡢጼໃᑕ㐠ືࡢⓎ㐩㛵ࡍࡿ◊✲ ඛኳᛶ㞴⫈ࡣ୕༙つ⟶ࡸ⪥▼ჾࡢ㞀ᐖࡀ⣙ 10㹼20%ྜేࡍࡿࠋࢃࢀࢃࢀࡣ㧗ᛶ⬟ࡢᅇ ㌿᳔Ꮚ║᳨ᰝ⨨ࢆ⏝࠸࡚◊✲ࡋ࡚࠸ࡿࠋࡇࡢ⨨ࡣ౯᱁ࡀ⣙ 1000 㧗㢠࡛ࠊ ᅜ࡛ࡶ 3 ྎࡋ࣮ࣝࢳࣥ⏝ࡉࢀ࡚࠸࡞࠸ࠋ㞴⫈ඣ࡛㤳ࡢࡍࢃࡾࡸṌ⾜㛤ጞࡀ㐜ࢀࡿሙ ྜࠊᅇ㌿᳔Ꮚ║᳨ᰝࢆᐇࡋࠊㄏⓎࡉࢀࡿ║ࡀஈࡋ࠸ሙྜࡣᮎᲈᛶ࡛࠶ࡿデ᩿࡛ࡁ ࡿࠋᑠඣ⛉࡛ࡣ⢭⚄㐠ືⓎ㐩㞀ᐖㄗデࡉࢀࡿࡇࡀከ࠸ࠋ๓ᗞ㢕➽㟁ࡶᑟධࡋࠊෆ⪥ ወᙧඣ࡛ࡶࡇࡢᛂࡀฟ⌧ࡍࡿࡇࢆぢฟࡋࡓࠋ᮶ᖺᗘࡣ୰ᅜࡢすᏳࡽ␃Ꮫ⏕ࡀ᮶᪥ࡍ ࡿࠋࡇࡢၥ㢟ྲྀࡾ⤌ࢇ࡛ࡶࡽ࠺ணᐃ࡛࠶ࡿࠋ2015 ᖺᮏ◊✲ࡢᡂᯝࡣ᪥ᮏᑠඣ⪥㰯ဗႃ ⛉Ꮫㄅᥖ㍕ࡉࢀࡓࠋ 㸲㸬ඛኳᛶ┣ࢁ࠺ඣࡢᖹ⾮ࡢⓎ㐩◊✲࠾ࡼࡧᡂேࡢ┣ࢁ࠺⪅ࡢேᕤෆ⪥◊✲ ㉸పయ㔜ฟ⏕ඣ࠾ࡼࡧඛኳᛶ㢼⑈ೃ⩌ࡣ┣ࢁ࠺ඣࡢ㢖ᗘࡀ㧗࠸ࠋどぬ⫈ぬ࣭ᖹ⾮ ぬࡢ㔜㞀ᐖ࡛ࡣ≉ู࡞ᩍ⫱ࡀᚲせ࡛ࠊゐぬࡸືឤぬࠊႥぬࠊぬࢆ⏕ࡋࡓᩍ⫱ࡢᕤ ኵࡀᚲせ࡛࠶ࡿࠋࢃࢀࢃࢀࡢ㉸☢ṍᆺࡢ㦵ᑟ⣲Ꮚࡼࡿ่⃭ࡀ᭷ຠ࡛࠶ࡿࡇࢆぢฟࡋࠊ ᪥ᖖⓗ㡢ᴦࡢయ㦂ࡢࡓࡵ㈚ࡋฟࡋ࡚⏝ࡋ࡚ࡶࡽࡗ࡚࠸ࡿࠋ┣ࢁ࠺ඣ࡛ࡣ㤳ࡢࡍࢃࡾ ࡸṌ⾜㛤ጞࡀࡑࢀࡒࢀ༢⊂㞀ᐖࡼࡾࡶࡉࡽ㐜ࢀࡿࡇࢆぢฟࡋࠊゐぬࢆ㏻ࡋࡓࣜࣁࣅࣜ ࡢ᪉ἲࢆ◊✲୰࡛࠶ࡿࠋᡂேࡢ┣ࢁ࠺⪅ࡢேᕤෆ⪥ᇙ㎸⾡ࢆ᪤ 7 ྡᐇࡋࠊQOL ࡢ ᨵၿࡢ◊✲ࢆ㛤ጞࡋࡓࠋᑠඣࡣ࢘࢜ࣝࣇೃ⩌ࡢ 1 ᐇࡋࡓࠋேᕤෆ⪥ࡼࡗ࡚⫈ ぬࢆྲྀࡾᡠࡍࠊゐ㏻ヂࢆࡉࡎヰࡀྍ⬟࡞ࡾࠊQOL ࡢᅇࡣⴭࡋ࠸ࠋ 㸳㸬ேᕤෆ⪥ᇙ㎸⾡ࡢ EABR ◊✲ ⾡୰ࠊேᕤෆ⪥㟁ᴟࢆᤄධᚋࡢ EABR グ㘓ࢆࡇࡢ 2 ᖺ㛫⾜ࡗ࡚࠸ࡿࠋࡑࡢᡂᯝࡣ 2013 ᖺࡢ Polizter Ꮫ࡛Ꮫ㈹㑅ࡤࢀࡓࠋ2015 ᖺ Acta Oto-Laryngologica ห⾜ࡉࢀࡓࠋ ϩ㸬ඛኳᛶᑠ⪥࣭እ⪥㐨㛢㙐ࡢᡭ⾡ࡢ㛤ⓎẼᑟ⿵⫈ჾ⏝ࣉࣟࢪ࢙ࢡࢺࠊ㑇ఏ Ꮚゎᯒࣉࣟࢪ࢙ࢡࢺ 㸯㸬⪥⛉࣭ᙧᡂእ⛉ྜྠᡭ⾡ ᑠ⪥࣭እ⪥㐨㛢㙐ࡣ㑇ఏᏊኚ␗ࡼࡿࡶࡢࡣᑡ࡞ࡃࠊ༙ࡀ✺↛ኚ␗ࡼࡿࡶࡢ⪃ ࠼ࡽࢀ࡚࠸ࡿࡀࠊࡇࢀࡲ࡛ࡢ◊✲ࡣᑡ࡞࠸ࠋTreacher Collins ೃ⩌ࡣඃᛶ㑇ఏࡶ࠶ࡿࡀ ከࡃࡣ✺↛ኚ␗ࡼࡗ࡚⏕ࡲࢀ୧ഃᑠ⪥࣭እ⪥㐨ወᙧࢆ࿊ࡍࡿࠋ∦ഃ୧ഃࡢሙྜࡀ࠶ ― 16 ― ࡿࠋ∦ഃࡢሙྜࡣᑐࡣṇᖖ࡞ࡓࡵ∦ഃࡢ⪥ᙧᡂ⾡እ⪥㐨ᙧᡂ⾡ࢆ⾜࠺ࠋ୧ഃࡢሙྜ ࡣࠊ୧ഃఏ㡢㞴⫈㸦ᖹᆒ⫈ຊ⣙ 60dB㸧࡛ࠊᨺ⨨ࡍࡿゝⴥࡀ㐜ࢀࡿࡓࡵࠊࡲࡎ㦵ᑟ⿵⫈ჾ 1 ྎࢆ⏝ࡍࡿࠋᑠᏛᰯධᏛᖺ㱋࡞ࡗ࡚୧⪥㦵ᑟ⿵⫈ჾࢆ⏝ࡉࡏࡿࠋࡇࢀࡲ࡛୧⪥ 㦵ᑟ⿵⫈ࡢ᪉ྥឤࡸ㡢※ᐃࡣᡂ❧ࡋ࡞࠸ࡶࡢࡉࢀ࡚ࡁࡓࡀࠊࢃࢀࢃࢀࡢ◊✲࡛ࡣᡂ❧ ࡍࡿࡇࢆぢฟࡋࠊᑵᏛᚋࡢ୧⪥㦵ᑟ⿵⫈ჾࡢ⏝ࢆ✚ᴟⓗ㐍ࡵ࡚࠸ࡿࠋࡇࢀ㛵ࡍࡿ ㄽᩥࡣ 2000 ᖺࡢ Acta Oto-Laryngologica ᥖ㍕ࡉࢀࡓࠋᙧᡂᡭ⾡ࡣ 9 ṓ௨ᚋࠊ⪥ᙧᡂ ⾡እ⪥㐨࣭⫈ຊᨵၿᡭ⾡ࢆ⪥⛉࣭ᙧᡂእ⛉㸦⋊༠་㸧ྜྠ࡛⾜ࡗ࡚࠸ࡿࠋ∦ഃ 2 ᅇࡢ ᡭ⾡ࡀᚲせ࡛࠶ࡿࠋ2015 ᖺᮎ࡛ྜྠᡭ⾡ࡣ 200 ࢆ㉺࠼ࡓࠋࡇࢀࡲ࡛ࡢ◊✲࣭⮫ᗋάື ࡢᡂᯝࢆⱥᩥ༢⾜ᮏࡋ࡚ࢫࢫࡢ KARGER ♫ࡼࡾ 2013 ᖺᗘห⾜ࡋࡓࡇࢁᾏእ ࡽࡢᛂࡀ࠶ࡾࠊࣇࣛࣥࢫࡼࡾኟ 1 㐌㛫ᡭ⾡ぢᏛ᮶᪥ࡋࡓ་ᖌࡀ࠾ࡾࠊ⋊༠་ᮾ ி་⒪ࢭࣥࢱ࣮࡛ᡭ⾡ぢᏛࢆࡋ࡚ࡶࡽࡗࡓࠋ᮶ᖺᗘࡶ᮶᪥ࡍࡿணᐃ࡛࠶ࡿࠋ∦ഃᑠ⪥ ࡢ⾡ᚋ࢝ࢼࣝᆺ⿵⫈ჾ⏝ࣉࣟࢪ࢙ࢡࢺࡼࡿ୧⪥⫈◊✲㑇ఏᏊゎᯒࣉࣟࢪ࢙ࢡࢺࢆ ᖹᡂ 25 ᖺ 1 ᭶ࡼࡾ㛤ጞࡋࡓࠋཌ⏕ປാ⛉Ꮫ◊✲㈝ࡢ㞴ᛶᝈ➼ඞ᭹◊✲ᴗࡢศᢸ◊ ✲⪅ࡋ࡚ཧຍࡋࠊ㛫ᕪࡸ㡢ᅽᕪࡶᡂ❧ࡍࡿࡇࢆ᫂ࡽࡋࡓࠋᝈ⪅ࡶ⿵⫈ჾ⏝ࢆ ႐ࢇ࡛࠸ࡿࠋୡ⏺࡛ࡶᜍࡽࡃึࡵ࡚ࡢྲྀࡾ⤌ࡳ࡛ࠊ2015 ᖺࡢࢧࣥࣇࣛࣥࢩࢫࢥ࡛㛤ദࡉࢀ ࡓࢥࣞࢠ࣒࢘ࡢ࡛Ⓨ⾲ࡋࡓࠋ2016 ᖺㄽᩥࡀ ACTA ᥖ㍕ࡉࢀࡿணᐃ࡛࠶ࡿࠋ 㸰㸬㉸☢ṍᆺ㦵ᑟ⿵⫈ჾ㛤Ⓨ◊✲ ᚑ᮶ࡢ㟁☢ᘧ㦵ᑟ⿵⫈ࡣ㧗㡢ᇦࡢᛶ⬟ࡀ༑ศ࡛࠶ࡿࠋ㏆ᖺ㛤Ⓨࡉࢀࡓ㉸☢ṍᆺ㦵ᑟ➃ Ꮚࡣ 30,000Hz ࡲ࡛ࡢ㦵ᑟ่⃭ࡀྍ⬟࡛࠶ࡿࠋࡇࢀࢆ୧⪥㦵ᑟ⿵⫈ჾࡢࣉࣟࢺࢱࣉࡋ ࡚㛤Ⓨࡋࠊ≉㡢ᴦࡢࡓࡵ⏝࠸ࡿࡇࢆ┠ⓗ㛤ጞࡋࡓࠋᚑ᮶ࡢ㟁☢ᘧࡣప㡢㹼୰㡢ᇦࠊ ㉸☢ṍᘧࡣ୰㡢ᇦ㹼㧗㡢ᇦࡣࡇࢀࡲ࡛ࡢࡢࢹࣂࢫࡼࡾࡶඃࢀ࡚࠸ࡿࡇࡀࢃࡗࡓࠋ 2014 ᖺᗘࡣࢹࣂࢫࡢᑠᆺᡂຌࡋࠊࡑࡢ㧗࠸㡢㉁ࡀᝈ⪅ࡼࡾ႐ࡤࢀ࡚࠸ࡿࠋඹྠ㛤Ⓨ ࡢࣇ࢙ࣞࢹ࣮ࢩ࣮ࢩ࣮♫ࡼࡿࠊKAGA ࣔࢹࣝ࠸࠺ྡ⛠࡛ୡ⏺㈍ࢆィ⏬ࡋ࡚ ࠸ࡿࠋࣁ࣮ࣂ࣮ࢻࡢ᪂ᢏ⾡㛤Ⓨࡢࣞࣅ࣮ࣗࡶᥖ㍕ࡉࢀࡓࠋࡇࢀࡘ࠸࡚ࡶ᪉ྥឤ◊✲ࡢ ணᐃ࡛࠶ࡿࠋ 㸱㸬Treacher Collins ೃ⩌ࡢ◊✲ ୧ഃᑠ⪥◊✲ྲྀࡾ⤌ࢇ࡛ࡁࡓࡀࠊ300 ࢆ㉺࠼ࡿ㞴ᝈࣜࢫࢺࡢ୰ධࡗ࡚࠸࡞࠸ ࡇẼࡀࡘࡁࠊᚋ⊂❧ࡋࡓࢸ࣮࣐࡛◊✲ࢆ㐍ࡵࡿィ⏬࡛࠶ࡿࠋ Ϫ㸬୰ᯡ⫈ぬ◊✲ 㸯㸬85 ṓ௨ୖࡢ㉸㧗㱋⪅ࡢ㞴⫈◊✲ 1960 ᖺࡢ Kirikae ➼ࡢሗ࿌౫㢗ࠊຍ㱋క࠺⪁ேᛶ㞴⫈ࡣᮎᲈ୰ᯡࡢ㞀ᐖࡢྜࢃࡉ ࡗࡓࡶࡢ࡛࠶ࡿࡉࢀ࡚ࡁࡓࠋࡋࡋࢃࢀࢃࢀࡢ◊✲࡛ࡣ㧗㱋⪅࡛࠶ࡗ࡚ࡶᮎᲈᛶ㞀ᐖ࡛ ࠶ࡗ࡚୰ᯡᛶ㞀ᐖ࡛ࡣ࡞࠸ࡇࡀ᫂ࡽ࡞ࡗࡓࠋ⣧㡢⫈ຊ᳨ᰝ࡛㜈್ࡀୖ᪼ࡋࠊㄒ㡢᫂ ░ᗘ᳨ᰝࡼࡿ༢㡢ࡢ⫈ࡁྲྀࡾࡢṇ⟅⋡ࡀ 50%௨ୗࡢ㉸㧗㱋⪅࡛࠶ࡗ࡚ࡶࠊᩥࣞ࣋ࣝࡢㄆ ― 17 ― ▱᳨ᰝ࡛ࡣ 90%௨ୖࡢṇ⟅⋡ࢆ♧ࡋࠊᮎᲈࡢෆ⪥ᛶ㞴⫈࡛࠶ࡿࡇࢆ᫂ࡽࡋࡓࠋ80㹼 90 ṓ௦㸦Octogenarian㸧ࡢ㧗㱋⪅ࡢேᕤෆ⪥ᇙ㎸ᡭ⾡ࡢᡂᯝࡀⰋࡃࠊᚑ᮶ࡢ⪁ேᛶ㞴⫈ࡢ ࣓࣮ࢪࢆࡍࡗࡾኚ࠼ࠊ㧗㱋⪅ࡢேᕤෆ⪥ᇙ㎸⾡ࡣ Ageless ࡢ௦࡞ࡗ࡚࠸ࡿࠋ 㸰㸬Auditory Neuropathy (Auditory Nerve Disease)㸦AN㸧 1996 ᖺ Kaga ➼ Starr ➼ࡀูࠎሗ࿌ࡋࡓࡑࢀࡲ࡛▱ࡽࢀ࡚࠸࡞ࡗࡓ᪂ࡋ࠸⫈ ぬ㞀ᐖ࡛ࠊ⫈ຊࡣⰋዲ࡞ࡢࡶࢃࡽࡎࠊゝⴥࡢ⪺ࡁྲྀࡾࡀⴭࡋࡃᝏࡃࠊෆ᭷ẟ⣽⬊ ⼗∵⚄⤒ࡢ㛫ࡢࢩࢼࣉࢫࣞ࣋ࣝࡢ㞀ᐖࡀࢃࢀ࡚࠸ࡿࠋࢃࢀࢃࢀࡢࢡࣜࢽࢵࢡࡣࡇࡢ⛥ ࡞ඛኳᛶᚋኳᛶࡢᝈࡀᅜྛᆅࡼࡾ⤂ࡉࢀ࡚ࡁ࡚࠸ࡿࠋ୰ᅜࡽࡶᝈ⪅ࡀ⤂ ࡉࢀࡓࠋඛኳᛶࡢ AN ࡶ࠶ࡾ㛗ᮇⓎ㐩◊✲ࢆࡋ࡚࠸ࡿࠋ⫈ぬᶵ⬟ࡢ◊✲ࡢࡳ࡞ࡽࡎ㑇ఏᏊ ◊✲ࡶ⾜ࡗ࡚࠾ࡾࠊ OTOF 㑇ఏᏊ␗ᖖ OPA1 㑇ఏᏊ␗ᖖࡀぢฟࡉࢀ࡚࠸ࡿࠋඛኳᛶ Auditory Neuropathy Spectrum Disorders (ANSD)ࡀ㉸పయ㔜ฟ⏕ඣከ࠸ࡇࢆぢฟ ࡋࠊࡘᵝࠎ࡞ࢱࣉࡢ࠶ࡿࡇࢆࡶࢃࡗࡓࠋࡍ࡞ࢃࡕ DPOAE ABR ࡀṇᖖࡍࡿ ࢱࣉࠊDPOAE ࡶ ABR ࡶᾘኻࡍࡿࢱࣉࠊDPOAE㸦+㸧 ABR㸦㸫㸧ࡀᣢ⥆ࡍࡿሙྜࠊ ┿ᛶ AN ࢱࣉ⫈ぬ㞀ᐖࢆḞࡃ Pseudo Type ศࢀࡿࡇࡀࢃࡗࡓࠋANSD ◊✲ ࡣཌ⏕ປാ⛉Ꮫ◊✲㞀ᐖ⪅ᑐ⟇⥲ྜ◊✲ᴗࡢឤぬჾ㞀ᐖศ㔝࡛ 2014 ᖺ᥇ᢥࡉࢀࡓࠋ ᡂே࡛ࡣ ᗘឤཷᛶ AN ࡢ 1 ࢆⓎぢࡋࡓࠋ⫈ぬⓗ⌮ゎࡶⴭࡋࡃᝏ࠸ሙྜࠊேᕤෆ⪥ᇙ㎸ ⾡ࡣ 3 ⾜࠸ࠊⰋ࠸⤖ᯝ࡛࠶ࡿࠋEABR ࡶⰋዲ࡛࠶ࡿࠋࡇࡢศ㢮ࡣ ANL ㄅࣞࣅ࣮ࣗ ࡋ࡚ 2016 ᖺ 1 ᭶ᥖ㍕ࡉࢀࡿணᐃ࡛ࠊୡ⏺ⓗ࡞ΰ⤊Ṇ➢ࢆᡴࡘࡇࡘ࡞ࡀࡿࡇ ࢆᮇᚅࡋ࡚࠸ࡿࠋ 㸱㸬⫈ぬ⌮ゎࡢ㞀ᐖ⓶㉁⫏ ᕥ༙⌫ഃ㢌㢌㡬ⴥࡢᦆയࡼࡿ⫈ぬⓗ⌮ゎࡢ㞀ᐖࢆ 2 ࠊእ᮶࡛ゝㄒカ⦎ࢆ⾜࠸⬻ ࡢྍረᛶࢆほᐹࡋ࡚࠸ࡿࠋ⬻࡛ࣞ࣋ࣝ୧ഃࡢ⫈ᨺ⥺ࡀᦆയࡉࢀࡿࠊ㡢ࡣ⪺ࡇ࠼ࡿࡀゝ ⴥࡶ♫㡢ࡶ㡢ᴦࡶㄆ▱࡛ࡁ࡞ࡃ࡞ࡿࠋࡇࡢ≧ែࡣ⓶㉁⫏ࡸ⫈ぬኻㄆ࠸࠺ࠋឤぬᛶኻ㡢 ᴦࡣᕥྑࡢ࠸ࡎࢀࡢ∦ഃᛶࡢ⬻༙⌫㞀ᐖ࡛ࡶ⏕ࡌࡿࠋࡇࡢ≧ࢆ࿊ࡍࡿ⬻⾑⟶㞀ᐖ ࡣࡲࢀ࡛࠶ࡿࡀࠊ㝔ࡽ⤂ࡉࢀ࡚ཷデࡋ࡚࠸ࡿࠋࢃࢀࢃࢀࡢ㛤Ⓨࡋࡓࢸࢫࢺ࣭ࣂࢵ ࢸ࣮࡛ࣜㄪࠊࣜࣁࣅࣜࢸ࣮ࢩࣙࣥ᪉ἲࡶᕤኵࡋ࡚࠸ࡿࠋ㡢ࡀࡃ⪺ࡇ࠼࡞࠸⫏ࡢ⓶ ㉁⫏ࡢᏑᅾ࡛࠶ࡿࠋࡇࡢࡣ⬻ᖿࣞ࣋ࣝࡀṇᖖ࡛ࡶ⫈ぬᛂ⾜ືࡀ⏕ࡌ࡞࠸࠸࠺ 㔜せ࡞♧၀ࢆ࠼࡚࠸ࡿṔྐⓗ࡞࡛࠶ࡿࡓࡵࠊ2015 ᖺࡢ ACTA Otolaryngologica ᥖ㍕ࡉࢀࡓࠋࡇࡢㄽᩥࢆㄞࢇࡔ࢝ࢼࢲࡢ◊✲⪅ࡽࠊ᮶᪥ࡋ᳨࡚ᰝࢆࡋࡓ࠸ࡢᡭ⣬ࡀᒆ ࠸ࡓࠋ 㸦ᩥ㈐㸸ຍᡃྩᏕ㸧 ― 18 ― ࠝ་⒪⤒Ⴀሗ◊✲ᐊࠞ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫ࣭Ꮫ⾡ㅮ₇ 2015.5.23 ༓௦⏣༊ CORLAS Meeting 2015 2015.8.25 San Francisco ― 19 ― ࠝ་⒪⤒Ⴀሗ◊✲ᐊࠞ ඹྠ㏻ಙ㓄ಙグ 㸦ୗグࡣࡑࡢ୍㒊㸧 ᆅ᪉⣬ࡢᥖ㍕ከᩘ 㸦㸸⛅⏣᪂⪺ࠊ⚟ᓥẸሗࠊୗ㔝᪂⪺ࠊᇸ⋢᪂⪺ࠊ⚄ᡞ᪂⪺ࠊ᪥ᮏᾏ᪂⪺ࠊᚨᓥ᪂⪺ࠊ⌰⌫᪂⪺➼㸧 ― 20 ― ᨻ⟇་⒪⏬◊✲㒊 ᡭ⾡ᨭࣟ࣎ࢵࢺᢏ⾡ᛂ⏝◊✲ᐊ㛗 ᩧ⸨ ྐ㑻 ᡭ⾡ᨭࣟ࣎ࢵࢺᢏ⾡ᛂ⏝◊✲ᐊ࡛ࡣࠊᡭ⾡ᨭࣟ࣎ࢵࢺࢆ࠺ᡭ⾡ࡀᚋⓎᒎࡍࡿࡇ ࢆぢᤣ࠼ࠊື≀ࢆࡗࡓᡭ⾡ࡢࢺ࣮ࣞࢽࣥࢢࢭࣥࢱ࣮ࢆᖹᡂ ᖺ ᭶ ᪥ࡽ✌ാࡉ ࡏ࡚࠸ࡲࡍࠋᙜึࡣࢲࣦࣥࢳ 66L ࡀタ⨨ࡉࢀࡲࡋࡓࡀࠊᖹᡂ ᖺ ᭶ࡽࡣ 6L ༢⊂ࡢ ◊ಟ࡞ࡗ࡚࠸ࡲࡍࠋࡑࢀ௨እࡣ║⛉ᡭ⾡ࡢಟ⦎⏝㢧ᚤ㙾ࠊෆど㙾እ⛉ᡭ⾡ࢩ࣑࣮ࣗࣞࢱ ࣮ࠊᾘჾෆど㙾᳨ᰝࢩ࣑࣮ࣗࣞࢱ࣮ࡀ⨨ࢀ࡚࠾ࡾࠊከ᪉㠃ࡢᡭ⾡ᡭᢏࡢྥୖࢆᅗࡿࡇ ࡀ࡛ࡁࡿࡼ࠺࡞ࡗ࡚࠸ࡲࡍࠋᚋࡉࡽෆ⏝ࢆᐇࡉࡏࠊ᪂ࡋ࠸ᡭ⾡ᡭᢏࡢ㛤Ⓨࡸᕤኵ ࡘ࡞ࡀࢀࡤ⪃࠼࡚࠸ࡲࡍࠋ ᖹᡂ ᖺࡢ㛤タ௨᮶ࠊྛ⛉ࡢ⏝≧ἣࡣ⾲ ࡸᅗ㸯ࡢࡼ࠺࡞ࡗ࡚࠸ࡲࡍࠋࡲࡓ⏝ࡉ ࢀࡓ㇜ࡢ㢌ᩘࡣ⾲ ♧ࡍ㏻ࡾ࡛ࡍࠋ⌧Ⅼ࡛ࡣࣟ࣎ࢵࢺᨭᡭ⾡ࡢಖ㝤㐺ᛂࡀἪᒀჾ⛉ ࡔࡅ࡞ࡢ࡛Ἢᒀჾ⛉ࡢ⏝ࡀ┠❧ࡗ࡚࠸ࡲࡍࠋࣟ࣎ࢵࢺࡢᅜෆ⏝ྎᩘࡣࡲࡔቑຍࡋ࡚࠸ ࡿࡶ㛵ࢃࡽࡎ㛤タᙜึẚ࡚✌ാ௳ᩘࡀῶᑡࡋ࡚࠸ࡿࡢࡣࠊ㒔ෆ࣓࣮࣮࢝ࡀ᪂ࡋࡃ ࢺ࣮ࣞࢽࣥࢢࢭࣥࢱ࣮ࢆタࡅࡓࡓࡵ࡛ࡍࠋ ᚋᙜ◊✲ᐊ࡛ࡣࣟ࣎ࢵࢺࡢࢺ࣮ࣞࢽࣥࢢࡲࡽࡎࠊ⭡⭍㙾ࡢࢺ࣮ࣞࢽࣥࢢࡶᗈ ࡃ⏝ࡉࢀࡿࡼ࠺㐍ࡵ࡚࠸ࡁࡓ࠸⪃࠼࡚࠸ࡲࡍࠋࡲࡓἪᒀჾ⛉㡿ᇦ௨እ࡛ࡶಖ㝤㐺ᛂ ࡀྔࡗࡓሙྜࡣ㟂せࡣࡲࡓቑ࠼ࡿᛮࢃࢀࡲࡍࠋ ⾲ ࢺ࣮ࣞࢽࣥࢢࢭࣥࢱ࣮✌ാᐇ⦼௳ᩘ ᾘჾ⛉ Ἢᒀჾ⛉ ፬ே⛉ ⭡⭍㙾◊ ಟ ィ ᖹᡂ ᖺᗘ ᭶ࡽ㸧 ᖹᡂ ᖺᗘ ᖹᡂ ᖺᗘ ᖹᡂ ᖺᗘ ᭶ࡲ࡛㸧 ⾲ ㇜㢌ᩘ 㢌ᩘ ᖹᡂ ᖺᗘ ᭶ࡽ㸧 ᖹᡂ ᖺᗘ ᖹᡂ ᖺᗘ ᖹᡂ ᖺᗘ ᭶ࡲ࡛㸧 ― 21 ― ― 22 ― ᨻ⟇་⒪⏬◊✲㒊 ⮫ᗋ◊✲࣭㦂᥎㐍ᐊ㛗 ᵻᒣ ᖾᙪ 㸯㸬ࡣࡌࡵ ᙜᐊ࡛ࡣࠊ2010 ᖺ㸦ᖹᡂ 22 ᖺ㸧௨㝆ࠊ⸆ᢎㄆࢆ┠ⓗࡍࡿ㦂㝈ࡽࡎࠊ࢚ࣅࢹࣥ ࢫฟࢆ┠ⓗࡋࡓ⮫ᗋ◊✲ࡢ CRC ཬࡧົᒁᨭࢆ⾜ࡗ࡚࠸ࡿࡀࠊᮏᖺࡣᙜ㝔࠾ࡅ ࡿ⮫ᗋ◊✲యࡢရ㉁ࢆ☜ಖࡍࡃࠊ⮫ᗋ◊✲ᨭࢭࣥࢱ࣮タ⨨ྥࡅ‽ഛࢆ㐍ࡵ࡚ࡁࡓࠋ ࡲࡓࠊྡྂᒇ་⒪ࢭࣥࢱ࣮࠾ࡅࡿ⮫ᗋ◊✲ရ㉁☜ಖయไᩚഛᴗࡢᰕ࡛࠶ࡿ“ࣔࢽࢱࣜࣥ ࢢࣁࣈࢩࢫࢸ࣒”㛵ࡋ࡚ࡶ 2012 ᖺ㸦ᖹᡂ 24 ᖺ㸧௨㝆ཧ⏬ࡋ࡚࠾ࡾࠊICH-GCP ‽ᣐࡢ◊ ✲⪅ᑟࡢᅜ㝿ඹྠ⮫ᗋヨ㦂ࠊ་ᖌᑟ㦂ࡢࣔࢽࢱࣜࣥࢢᐤࡋ࡚࠸ࡿࡀࠊᮏᖺࡣ ࡉࡽ J-GCP ᑐᛂࡢ་ᖌᑟ㦂ࡘ࠸࡚ࠊ᪂ࡓ 2 ㄢ㢟ࡢࣔࢽࢱࣜࣥࢢࢆ㛤ጞࡋ࡚࠸ ࡿࠋ ࡇࡢࡼ࠺ᡃࠎࡢάືࡣࠊ᪤㦂≉ࡍࡿࡇ࡞ࡃࠊᖺࠎᴗົࢆᣑࡋ࡚࠾ࡾࠊᮏ ✏࡛ࡣࠊ2015 ᖺ㸦ᖹᡂ 27 ᖺ㸧࠾ࡅࡿᙜᐊࡢ㦂ཬࡧ⮫ᗋ◊✲ࡢᐇ⦼㛵ࡋ࡚ᴫㄝࡍࡿࠋ 㸰㸬㦂ࡢᐇ⦼ 2015 ᖺ㸦ᖹᡂ 27 ᖺ㸧࠾ࡅࡿᙜ㝔ࡢ㦂ࡘ࠸࡚ࡣࠊ2013 ᖺ㸦ᖹᡂ 25 ᖺ㸧ᐇࡋ ࡓ〇⸆ᴗᙜᐊࡢ┦ぢᏛࡢᡂᯝࡶ࠶ࡾࠊ〇⸆ᴗࡼࡿ᪂つ㦂ࡢ౫㢗ࡣᖺࠎቑ ຍࡋ࡚࠾ࡾࠊࢥࣥࢫࢱࣥࢺ 20 ㄢ㢟㏆ࡃࡢ㦂ࢆཷク࡛ࡁࡿࡼ࠺࡞ࡗ࡚࠸ࡿࠋࡲࡓࠊ 2014 ᖺ㸦ᖹᡂ 26 ᖺ㸧ࡽ H7N9 ࣥࣇ࢚ࣝࣥࢨ࣡ࢡࢳࣥࡢ First in Human㸦FIH㸧ࡢ ་ᖌᑟ㦂ࢆ㛤ጞࡋ࡚࠸ࡿࠋᙜ㝔࠾࠸࡚ FIH ࡢ㦂ࡣึࡢヨࡳ࡛࠶ࡗࡓࡶࡢࡢࠊᙜᐊ ࡢᵻᒣᖾᙪᐊ㛗ࡢ㈐௵་ᖌࡢୗࠊᙜᐊࢫࢱࢵࣇဨࡀ୍࡞ࡾࠊデ⒪㒊ࠊ┳ㆤ㒊ࠊ⸆ 㒊ࠊ⮫ᗋ᳨ᰝ⛉ࠊົ㒊➼ࡢ㛵ಀ㒊㛛ࡢከ࡞ࡿ༠ຊࡶ࠶ࡾࠊᮏᖺ↓⤊ࡍࡿࡇࡀ ࡛ࡁࡓࠋࡇࡢ⤒㦂ࢆ㏻ࡋ࡚ࠊ㞴ᗘࡢ㧗࠸ FIH ࡢ་ᖌᑟࡢ㦂ᑐࡋ࡚ࡶࠊᙜᐊࡣ༑ศ ᑐᛂ࡛ࡁࡿࡇࢆ࡙ࡅࡿࡇࡀ࡛ࡁࠊࢫࢱࢵࣇဨࡁ࡞⮬ಙ࡞ࡗ࡚࠸ࡿࠋᚋࠊከ ✀ከᵝࡢ㦂ࡢᐇ⦼ࢆ✚ࡴࡇࡼࡾࠊࡉࡽᖜᗈ࠸㦂ࡢཷクࡀྍ⬟࡞ࡿࡶࡢᮇᚅ ࡋ࡚࠸ࡿࠋ 㸱㸬⮫ᗋ◊✲ࡢᐇ⦼ ᮏᖺ࠾࠸࡚ࡶࠊᅜ❧㝔ᶵᵓࡢࢫࢣ࣮࣓ࣝࣜࢵࢺࢆάࡋࡓࠕEBM ᥎㐍ࡢࡓࡵࡢ つᶍ⮫ᗋ◊✲㸦௨ୗࠊ ࠕEBM ◊✲ࠖ㸧ࠖ㛵ࡋ࡚ᨭࢆ⾜ࡗࡓࠋࡉࡽࠊඛ㏙ࡢ࠾ࡾ⮫ᗋ ◊✲ᨭࢭࣥࢱ࣮タ⨨ྥࡅ‽ഛࢆ㐍ࡵࡿࡃࠊ2015 ᖺ 11 ᭶ 26 ᪥ྠࢭࣥࢱ࣮タ⨨ WG ࢆ❧ࡕୖࡆࠊྠᖺ 12 ᭶ 9 ᪥ࡢ WG ࠾࠸࡚ࠊ⮫ᗋ◊✲ᨭࢭࣥࢱ࣮ࡢタ⨨ࡀᢎㄆࡉࢀࡓࠋ ᙜࢭࣥࢱ࣮ࡣࠊᙜ㝔࠾ࡅࡿ⮫ᗋ◊✲యࡢရ㉁ࢆ☜ಖࡍࡿࡇࢆ┠ⓗタ⨨ࡉࢀࡿࡶࡢ ࡛࠶ࡾࠊ2016 ᖺ 3 ᭶ᴗົࢆ㛤ጞࡍࡿࡇ࡞ࡗ࡚࠸ࡿࠋᙜᐊࡽࡶேᮦࣀ࢘ࣁ࢘ࢆ ᥦ౪ࡍࡿࡇ࡞ࡗ࡚࠸ࡿࠋ 㸲㸬ࣔࢽࢱࣜࣥࢢࣁࣈࢩࢫࢸ࣒ࡼࡿάື ᙜᐊࡣࠊ2013 ᖺࡼࡾྡྂᒇ་⒪ࢭࣥࢱ࣮࠾ࡅࡿ⮫ᗋ◊✲୰᰾㝔ᴗ㸦⌧㸸⮫ᗋ◊✲ ― 23 ― ရ㉁☜ಖయไᩚഛᴗ㸧ࡢࣔࢽࢱࣜࣥࢢࣁࣈࢩࢫࢸ࣒ཧ⏬ࡋ࡚࠸ࡿࠋ๓ᖺࡼࡾࠊICH-GCP ᑐᛂࡋࡓࠕ➨୍Ⓨᑠඣᛴᛶࣜࣥࣃᛶⓑ⾑ᶆ‽ࣜࢫࢡ⩌ᑐࡍࡿ➨Ϫ┦ᅜ㝿ඹྠ⮫ᗋ ヨ㦂ࠖ࠾ࡼࡧ GCP ┬௧ᑐᛂࡍࡿࠕ㭜༸ᇵ㣴ά⢏Ꮚ㫽ࣥࣇ࢚ࣝࣥࢨ A㸦H7N9) ࣡ࢡࢳࣥࡢචཎᛶ࠾ࡼࡧᏳᛶࡢ᳨ウ㸦➨ϩ┦་ᖌᑟ㦂㸧ࠖࡢࣔࢽࢱࣜࣥࢢࢆ⾜ࡗ࡚ ࠾ࡾࠊᮏ᱁ⓗࡑࡢάືࢆ㛤ጞࡋ࡚࠸ࡿࠋᮏᖺࡣ᪂ࡓ GCP ┬௧ᑐᛂࡍࡿࠕⓎཪࡣ 㞴ᛶ ALK 㝧ᛶᮍศ⣽⬊ࣜࣥࣃ⭘ᝈ⪅ࢆᑐ㇟ࡋࡓ CH5424802 ࡢ➨ϩ┦ヨ㦂㸦་ ᖌᑟ㦂㸧ࠖ࠾ࡼࡧࠕᑠඣཬࡧⱝᖺᡂேࡢ㞴ᛴᛶࣜࣥࣃᛶⓑ⾑ᝈ⪅ᑐࡍࡿ࣎ࣝࢸࢰ ࣑ࣈే⏝ከᏛ⒪ἲࡢᏳᛶཬࡧ⸆≀ືែࢆ᳨ウࡍࡿ➨Ϩ┦ヨ㦂㸦་ᖌᑟ㦂㸧ࠖࡢࣔ ࢽࢱࣜࣥࢢࢆᐇࡋࠊ࢝ࢹ࣑ࣔࢽࢱ࣮ࡋ࡚ࡢ㈐ົࢆᯝࡓࡋࡓࠋ 㸳㸬♫ⓗάືᐇ⦼ ᙜᐊࡣࠊᏛ㝔ࠊᅜ❧㧗ᗘᑓ㛛་⒪◊✲ࢭࣥࢱ࣮㸦NC㸧➼ࠊ⮫ᗋ◊✲࣭㦂ࢆ࣮ࣜࢻ ࡍࡿᅜ 60 タࡀຍධࡋ࡚࠸ࡿࠕ⮫ᗋ◊✲࣭㦂άᛶ༠㆟ࠖࡸࠊ㛵ᮾಙ㉺ᆅ༊⟶ෆ ࠾ࡅࡿ NCࠊNHOࠊᅜ❧ࣁࣥࢭࣥ⒪㣴ᡤࡢ 41 タࡀຍ┕ࡍࡿࠕ㛵ಙᆅ༊ᅜ❧㝔➼ 㦂㐃⤡ࠖࡢົᒁࢆᢸࡗ࡚࠸ࡿࠋᮏᖺࡣ 2 ᭶ 27 ᪥ࠕ➨ 25 ᅇ㛵ಙᆅ༊ᅜ❧㝔➼㦂 㐃⤡ࠖࠊ6 ᭶ 26 ᪥ࠕ➨ 11 ᅇ㛵ಙᆅ༊ᅜ❧㝔➼㦂㐃⤡ᐇົ⪅㆟ࠖࢆࡑࢀࡒࢀ㛤 ദࡋࡓࠋ࠸ࡎࢀࡢࡶࠊከᩘࡢ㛵ಀ⪅ࡀཧຍࡋࠊ᭱᪂ࡢ▱ぢࡸࢺࣆࢵࢡࢫࡢሗඹ᭷ࡀ ࡞ࡉࢀࡿࡶࠊဨྠኈ࡛ࠊ㈗㔜࡞ሗࢆ⾜࠺ࡇࡀ࡛ࡁࡓࠋᙜᐊ࡛ࡣࠊࡇࢀࡽ ࡢάືࢆ㏻ࡋࠊᚋࡶ⥅⥆ࡋ࡚ࠊᅜẸࠊ⾜ᨻࠊ〇⸆ᴗᅋయࠊ◊✲⪅ࡶࠊ᪥ᮏࡢ་ ⒪Ỉ‽ࡢྥୖࠊ᪥ᮏⓎࡢࣀ࣮࣋ࢩࣙࣥࢆୡ⏺Ⓨಙࡍࡿࡇᑡࡋ࡛ࡶᐤ࡛ࡁࢀࡤ ⪃࠼࡚࠸ࡿࠋ ― 24 ― ࠝ⮫ᗋ◊✲࣭㦂᥎㐍ᐊࠞ Corrective and Preventative Actions (CAPA)ࡼࡿ㐓⬺㜵Ṇࡢྲྀࡾ⤌ࡳ ✄ྜྷ⨾⏤⣖ࠊᮏஂ⨾Ꮚࠊᔱᒸ ⥳ࠊ⸨ᕝᏊࠊ㧘ᮌᜨ⨾ ➉ୗᬛᜨࠊ▼㔛ࠊ㔠ග❶Ụࠊ୰ᕝ⏤⨾ࠊ㏆⸨┤ᶞ (㹌㹆㹍ᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲࣭㦂᥎㐍ᐊ) せ ⣙ ᙜᐊ࡛ࡣࠊ㦂ᐇィ⏬᭩➼ࡢ㐓⬺㜵Ṇࡢྲྀࡾ⤌ࡳࡋ࡚ࠊ་⸆ရ〇㐀࠾ࡅࡿရ㉁ ⟶⌮㒊㛛࡛ྲྀࡾධࢀࡽࢀ࡚࠸ࡿ CAPA ࡢᴫᛕࢆᑟධࡋࠊၥ㢟ࡢ᰿ᮏⓗ࡞ཎᅉࢆぢᴟࡵࠊ Ⓨ㜵Ṇ⟇ࢆ⪃ࡋ࡚࠸ࡃ QM ࢩࢫࢸ࣒ࡢ☜❧ࢺ࣮ࣞࢽࣥࢢࢶ࣮ࣝࡋ࡚ࡢά⏝ࢆヨࡳࡓࠋ 5 Whys ࢆ⏝࠸࡚Ⓨ㜵Ṇ⟇ࢆ⪃ࡋ࡚࠸ࡃࢶ࣮ࣝࢆ⪃ࡋࠊᐇ㝿㉳ࡇࡗࡓࡘ࠸ ࡚ࠊCAPA sheet ࢆ⏝࠸࡚Ⓨ㜵Ṇ⟇ࢆ᳨ウࡋࡓࠋࡲࡓࠊࡑࡢሗࢆά⏝ࡋࡓ CRC ᩍ⫱⏝ ࡢࢺ࣮ࣞࢽࣥࢢࢶ࣮ࣝࢆసᡂࡋࡓࠋᢸᙜ⪅㛫࡛ᨵၿ⟇ࢆ⪃࠼ࡿࡇ࡛ࠊ࠸ࡢᴗົࣉࣟࢭ ࢫࡢ☜ㄆ࡞ࡾࠊຠᯝⓗ࡞Ⓨ㜵Ṇ⟇ࢆㅮࡌࡿࡇࡀ࡛ࡁࡓࠋࡲࡓࠊሗࢆ㞟⣙ࡍࡿࡇ ࡛ࠊᐇ㊶ⓗ࡞ࢺ࣮ࣞࢽࣥࢢࢶ࣮ࣝࡋ࡚ࡢά⏝ࡶྍ⬟࡛࠶ࡿ⪃࠼ࡿࠋ ┠ ⓗ ⡿ᅜ࡛ࡣ Quality Management㸦QM㸧ࡀ㔜せどࡉࢀ࡚࠾ࡾࠊACRP Global Conference2014 ࡛ࡣ CAPA 㛵ࡍࡿㅮ₇➼ࡀከࡃⓎ⾲ࡉࢀ࡚࠸ࡓࠋCAPA ࡢᴫᛕࡣ་⸆ ရ〇㐀࠾ࡅࡿရ㉁⟶⌮㒊㛛࡛ࡍ࡛ᾐ㏱ࡋ࡚࠸ࡿࡀࠊ㏆ᖺࡣ㦂ᐇタ࠾࠸࡚ࡶ㐺 ⏝ࡋ࡚࠸ࡃࡇࡀồࡵࡽࢀ࡚ࡁ࡚࠸ࡿࠋࡑࡇ࡛ࠊᙜᐊ࡛ࡣ CAPA ࡢᴫᛕࢆᑟධࡋࠊࣉࣟࢺ ࢥ࣮ࣝ㐓⬺➼ࡘ࠸࡚ၥ㢟ࡢ᰿ᮏⓗ࡞ཎᅉࢆぢᴟࡵࠊⓎ㜵Ṇ⟇ࢆ⪃ࡋ࡚࠸ࡃ QM ࢩࢫ ࢸ࣒ࡢ☜❧ࢺ࣮ࣞࢽࣥࢢࢶ࣮ࣝࡋ࡚ࡢά⏝ࢆヨࡳࡓࡢ࡛ሗ࿌ࡍࡿࠋ ᪉ ἲ 5 Whys ࢆ⏝࠸࡚Ⓨ㜵Ṇ⟇ࢆ⪃ࡋ࡚࠸ࡃࢶ࣮ࣝࢆ⪃ࡋࠊᐇ㝿㉳ࡇࡗࡓࡘ ࠸࡚ࠊCAPA sheet ࢆ⏝࠸࡚Ⓨ㜵Ṇ⟇ࢆ᳨ウࡋࡓࠋࡲࡓࠊࡑࡢሗࢆά⏝ࡋࡓ CRC ᩍ⫱ ⏝ࡢࢺ࣮ࣞࢽࣥࢢࢶ࣮ࣝࢆసᡂࡋࡓࠋ ⤖ ᯝ ᙜ㝔࡛ࡣ་⒪Ᏻ⟶⌮ࢩࢫࢸ࣒ࡀᑟධࡉࢀ࡚࠾ࡾࠊࣥࢩࢹࣥࢺ࣏࣮ࣞࢺࡢ⟶⌮ࠊሗ ඹ᭷ࡀࡉࢀ࡚࠸ࡿࠋ㦂࠾࠸࡚ࡣࠊ㐓⬺ࡢⓎ㜵Ṇ⟇ࡣྛ⮬௵ࡉࢀ࡚࠾ࡾࠊࡑࡢෆ ᐜࡘ࠸࡚ࡣ࣑࣮ࢸࣥࢢ࡛ሗ࿌ࡍࡿࡢࡳ࡛࠶ࡗࡓࠋᅇࠊCAPA ࡢᴫᛕࡢᑟධ࠶ࡓࡾࠊ ་⒪Ᏻ⟶⌮ࢩࢫࢸ࣒ࡢᑟධࢆ᳨ウࡋࡓࡀࠊࡑࡢᡭἲࡀ㦂ࡢ QM ࡋ࡚ࡣ༑ศ࡛࠶ࡿ ⪃࠼ࠊ5 Whys ࢆ⏝࠸ࡓ CAPA sheet ࢆ⪃ࡋࡓࠋࡲࡓࠊᐇ㝿㉳ࡇࡗࡓ㐓⬺ࡘ ࠸࡚ᢸᙜ⪅㛫࡛ 5 Whys ࢆグ㍕ࡋࠊ᰿ᮏⓗ࡞ཎᅉࡢぢᴟࡵⓎ㜵Ṇ⟇ࡢ⪃ྲྀࡾ⤌ࢇ ࡔࠋࡇࡢྲྀࡾ⤌ࡳࡼࡗ࡚ࠊ᳨ᰝ࣐ࢽࣗࣝࡢグ㍕ഛࡸᥦ౪㈨ᮦࡢၥ㢟ⅬࡀⓎぬࡋࠊຠ ᯝⓗ࡞Ⓨ㜵Ṇ⟇ࢆㅮࡌࡿࡇࡀ࡛ࡁࡓࠋࡲࡓࠊᢸᙜ⪅㛫࡛ྲྀࡾ⤌ࡴࡇ࡛ࠊᴗົࣉࣟࢭ ― 25 ― ࢫࢆ┦࡛☜ㄆࡍࡿࡇࡀ࡛ࡁࡓࠋసᡂࡋࡓ CAPA sheet ࡢෆᐜࡣࢫࢱࢵࣇ㛫࡛ሗඹ᭷ ࡛ࡁࡿࡼ࠺ࢫࢱࢵࣇ࣑࣮ࢸࣥࢢ࡛ሗ࿌ࡋࠊࢺ࣮ࣞࢽࣥࢢࢶ࣮ࣝࡋ࡚ಖ⟶ࡋ࡚࠸ࡃࡇ ࡋࡓࠋࡉࡽࠊCRC ᩍ⫱ࢶ࣮ࣝࡋ࡚ࠊ㐣ཤ㉳ࡇࡗࡓࢆᥦ♧ࡋ 5 Whys ࢆ⏝࠸࡚ ண㜵⟇ࢆ⪃࠼࡚࠸ࡃ CAPA sheet for training ࢆ⪃ࡋࡓࠋ 㦂ᐇタ࠾ࡅࡿ CAPA ࡢᴫᛕࢆᑟධࡋࡓ QM ࢩࢫࢸ࣒ࡣࣉࣟࢺࢥ࣮ࣝ㐓⬺ࡢຠᯝ ⓗ࡞Ⓨ㜵Ṇ⟇ࡢ⪃᭷⏝࡛࠶ࡾࠊᢸᙜ⪅㛫࡛ᨵၿ⟇ࢆ⪃࠼ࡿࡇ࡛ࠊ࠸ࡢᴗົࣉࣟ ࢭࢫࡢ☜ㄆ࡞ࡿࠋࡲࡓࠊሗࢆ㞟⣙ࡍࡿࡇ࡛ࠊᐇ㊶ⓗ࡞ࢺ࣮ࣞࢽࣥࢢࢶ࣮ࣝࡋ࡚ࡢ ά⏝ࡶྍ⬟࡛࠶ࡿ⪃࠼ࡿࠋ ― 26 ― ࠝ⮫ᗋ◊✲࣭㦂᥎㐍ᐊࠞ )LUVWLQKXPDQ ➨Ϩ┦་ᖌᑟ㦂 ࡢᐇࢆ㏻ࡋ࡚ࡢホ౯⪃ᐹ 㧘ᮌ ᜨ⨾ࠊ⸨ᕝ Ꮚࠊ➉ୗ ᬛᜨࠊඵ௦ ᬛᏊࠊ✄ྜྷ⨾⏤⣖ࠊ㔠ග ❶Ụࠊ୰ᕝ ⏤⨾ࠊ ᮏஂ⨾Ꮚࠊᔱᒸ ⥳ࠊ▼ 㔛ࠊ㏆⸨ ┤ᶞࠊᾏ Ꮫࠊ༓⏣ ᫀஅࠊஂಖ⏣⠜ྖࠊ ㇂ᆅ ㇏ࠊ㕥ᮌ ⩏ᙪࠊᵻᒣ ᖾᙪ 㹌㹆㹍ᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲࣭㦂᥎㐍ᐊ せ ⣙ ᙜᐊ࡛ࡣࡌࡵ࡚ )LUVWLQKXPDQ㸦),+㸧࡛࠶ࡿ⏕≀Ꮫⓗ〇ࡢ➨Ϩ┦་ᖌᑟ㦂ࢆᐇ ࡋࡓࡇࡽࠊ&5& ཬࡧ㦂ົᒁࡢ❧ሙࡽࠊࡑࡢホ౯ࠊᚋࡢ➨Ϩ┦་ᖌᑟ 㦂ࡢཷࡅධࢀయไࢆ࠺ᩚ࠼࡚࠸ࡃࢆ᳨ウࡋࡓࠋࡑࡢ⤖ᯝࠊࡇࢀࡲ࡛ࡢ་ᖌᑟ㦂 ➼ࡢ⤒㦂ࡸࠊ᪥ࡈࢁࡢ㛵㐃㒊㛛ࡢ㐃ᦠࡀ࡛࠶ࡗࡓࡇࠊ㔜⠜࡞᭷ᐖ㇟ࡢⓎ⏕ࡀ࡞ ࡗࡓࡇࡶ࠶ࡾࠊࡘ㐺ṇᐇࡍࡿࡇࡀ࡛ࡁࡓࠋ ),+ 㦂ࡣ≉Ᏻᛶࢆ᭱㝈㔜どࡋ࡞ࡀࡽࠊࡼࡾៅ㔜ᐇࡍࡿᚲせࡀ࠶ࡿࠋࡑࡢࡓ ࡵᚋࠊ),+ 㦂ࢆᐇࡍࡿᶵࡀ࠶ࡿሙྜࡣࠊ᭷ᐖ㇟࡞ᐃ࡛ࡁ࡞࠸㇟ࡶᑐ ᛂ࡛ࡁࡿࡼ࠺࡞ุ᩿⬟ຊᐇయไᩚഛࡀᚲせ⪃࠼ࡿࠋ ┠ ⓗ ᙜ㝔ࡣᗋᩘ ᗋࠊデ⒪⛉ ⛉ࡽ࡞ࡿタ࡛࠶ࡿࠋᙜᐊ࡛ࡣࡌࡵ࡚ )LUVWLQKXPDQ ࡛࠶ࡿ⏕≀Ꮫⓗ〇ࡢ➨Ϩ┦་ᖌᑟ㦂ࢆᐇࡋࡓࡇࡽࠊࡑࡢホ౯ࠊᚋࡢ➨Ϩ ┦་ᖌᑟ㦂ࡢཷࡅධࢀయไࢆ࠺ᩚ࠼࡚࠸ࡃࢆ᳨ウࡋࡓࠋࡑࡢ⤖ᯝࠊ㦂ᑐࡍ ࡿ㐃ᦠཬࡧᐇయไࡀࢀ࡚࠸ࡓࡓࡵ㐍ࡵࡿࡇࡀ࡛ࡁࠊ㦂ࢆ⤊ࡍࡿᐇ⦼ࡘ ࡞ࡀࡗࡓࠋ ᪉ ἲ 㦂ᐇ࠶ࡓࡾୗグᴗົࡘ࠸࡚ྲྀࡾ⤌ࢇࡔࠋ ձ 㦂ㄪᩚົᒁࡢ㐃ᦠ ղ ᖖே࢝ࣝࢸࡢసᡂධ㝔➼ࡢົᡭ⥆ࡁࡢ☜ಖ ճ ⿕㦂⪅ເ㞟ࢧࢺࡢά⏝ࢫࢣࢪ࣮ࣗࣝㄪᩚ մ ᩆᩆᛴ་ࡢ༠ຊ౫㢗ከデ⒪⛉ඹྠࡼࡿ㦂ᐇయไࡢ☜ಖ յ Ᏻࡘ࡞యไࢆᅗࡿࡇࡀ࡛ࡁࡿᲷࡢ㑅ᐃㄪᩚ ն ࢝ࢹ࣑ࣔࢽࢱ࣮ࡢཷࡅධࢀ շ ◊✲㈝ࡢ㓄ศ ⤖ ᯝ 㞴᫆ᗘࡢ㧗࠸➨Ϩ┦་ᖌᑟ㦂ࢆᏳ㐙⾜࡛ࡁࡿࡼ࠺ࠊࡇࢀࡲ࡛ࡢ་ᖌᑟ㦂ࡢ ― 27 ― ⤒㦂ࢆάࡋࠊ㛵㐃㒊㛛ࡢ㐃ᦠࢆᅗࡾࠊయไᩚഛࢆ࠾ࡇ࡞ࡗࡓ⤖ᯝࠊୗグࡢ࠾ࡾ ࡘ㐺ṇ㦂ࢆᐇࡍࡿࡇࡀ࡛ࡁࡓࠋࡲࡓࠊᐇ୰ࡣᙜึᐃࡋ࡚࠸࡞ࡗࡓ ➼ࡶ㉳ࡇࡗࡓࡀࠊ㦂ᑐࡍࡿ㐃ᦠཬࡧᐇయไࡀࢀ࡚࠸ࡓࡓࡵ㐍ࡵࡿࡇࡀ࡛ ࡁࠊ㦂ࢆ⤊ࡍࡿᐇ⦼ࡘ࡞ࡀࡗࡓࠋ ձ 㦂ㄪᩚົᒁࡢ㐃ᦠ 㦂ㄪᩚົᒁඹྠ࡛ࢫࢱ࣮ࢺࢵࣉ࣑࣮ࢸࣥࢢࢆ㛤ദࠋ 㦂㛤ጞ┤๓ &5& ࡼࡾ་ᖌ࣭Ჷᖌ㛗ࢫࢱ࣮ࢺࢵࣉ࣑࣮ࢸࣥࢢ ࢆ㛤ദࡋࠊලయⓗ࡞ᙺศᢸࢆ᫂☜ࡍࡿࠋ ղ ᖖே࢝ࣝࢸࡢసᡂධ㝔➼ࡢົᡭ⥆ࡁࡢ☜ಖ ๓་ㄢ⿕㦂⪅ሗࢆఏ࠼ࠊධ㝔ࡢᡭ⥆ࡁࢆࢫ࣒࣮ࢬ࡞ࡿࡼ࠺㓄 ៖ࠋ ᳨ᰝࡢ࣮࢜ࢲ࣮ࢭࢵࢺࠊ⸆࣐ࢫࢱ࣮Ⓩ㘓ࠊほᐹ㡯┠ࡢࢸࣥࣉ࣮ࣞࢺࠊࣇ ࣮ࣟ࡞ࡗࡓ࣮࣡ࢡࢩ࣮ࢺసᡂࠋ ճ ⿕㦂⪅ເ㞟ࢧࢺࡢά⏝ࢫࢣࢪ࣮ࣗࣝㄪᩚ ເ㞟㛤ጞࡋࡓ᪥ࡼࡾᛂເ࠶ࡾࠊ▷ᮇ㛫ࡢࢫࢣࢪ࣮ࣗࣝࡢ୰࡛⿕㦂⪅᮶㝔ࡢ ᪥⛬ࢆ⤌ࡴࡇࡀฟ᮶ࡓࠋ մ ᩆᩆᛴ་ࡢ༠ຊ౫㢗ከデ⒪⛉ඹྠࡼࡿᐇయไ☜ಖ ⥲ྜෆ⛉་ᖌࡼࡾ ,&࣭ᢞ๓デᐹ࣭ὀᑕ࣭ᢞᚋデᐹࡢᐇࠋ ᩆ་ᖌࡼࡿኪ㛫ᖏデᐹࢆ⾜࠸ࠊグ㘓ṧࡍࠋ ࢘ᚠ⎔ჾ⛉་ᖌ㸦ᙜᐊ㛗㸧ࢫࢡ࣮ࣜࢽࣥࢢ᳨ᰝࡢ␗ᖖ್ࡢ☜ㄆ࠾ࡼࡧ᭷ᐖ ㇟ࡢุ᩿ࠋ յ Ᏻࡘ࡞యไࢆᅗࡿࡇࡀ࡛ࡁࡿᲷࡢ㑅ᐃㄪᩚ 㛫ࣔࢽࢱࣜࣥࢢ࣭ᛴኚᑐᛂྍ⬟ࠋ &5& ࡼࡾᲷ┳ㆤᖌ㦂ᴫせᐇෆᐜࡘ࠸࡚ㄝ᫂ࠋ ն ࢝ࢹ࣑ࣔࢽࢱ࣮ࡢཷࡅධࢀ 6'9 ᅇ㸦㹼 ᅇ㸭᭶㸧 ┘ᰝ ᅇ ࢘'0 ࡽࡢࢡ࢚ࣜ⥲ᩘ շ ◊✲㈝ࡢ㓄ศ 㛵㐃㒊㛛ࡢ㈐௵⪅◊✲㈝ࡢ㔠㢠ࢆㄪᩚࡋྜពࡋࡓࠋ ⪃ ᐹ ࡇࢀࡲ࡛ࠊ་ᖌᑟ㦂ࢆᙜ㝔࡛ࡣ ㄢ㢟⤒㦂ࡋ࡚࠸ࡿࡀࠊ➨Ϩ┦་ᖌᑟ㦂ࢆࡣࡌ ࡵ࡚⤒㦂ࡍࡿࡇࡀ࡛ࡁࡓࠋᙜヱ㦂ࡣᏳᛶࢆ᭱㝈㔜どࡋ࡞ࡀࡽࠊࡼࡾៅ㔜ᐇࡍ ࡿᚲせࡀ࠶ࡾࠊ 㛫┘どୗࡼࡿ㦂ࡢᐇࡀᚲせ࡛࠶ࡿࠋࡑࢀక࠸ࠊ㦂㈐௵་ᖌࠊ ศᢸ་ᖌࠊ&5& ࡢ㈇ᢸࡣࡁࡃࠊࡑࡢᐇయไࡶ☜ᐇᩚഛࡋ࡚࠾࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ᅇࡣ㔜⠜ࡘ㔜࡞᭷ᐖ㇟ࡣⓎ⌧ࡇࡑࡋ࡞ࡗࡓࡀࠊᚋࠊྠᵝࡢ㦂ࢆᐇࡍࡿࡓ ࡵࡣࠊ᭷ᐖ㇟࡞ᐃ࡛ࡁ࡞࠸㇟ࡶᑐᛂ࡛ࡁࡿࡼ࠺࡞ุ᩿⬟ຊᐇయไᩚഛࡀ ᚲせ⪃࠼ࡿࠋ ― 28 ― ࠝ⮫ᗋ◊✲࣭㦂᥎㐍ᐊࠞ Portfolio ᐇ⏝∧ࡢసᡂ ̿ᶆ‽࣒࢝ࣜ࢟ࣗࣛᇶ࡙࠸ࡓホ౯ࢶ࣮ࣝࢆ᳨ウ̿ ✄ྜྷ ⨾⏤⣖㸯ࠊᚋ⸨ ⨾✑㸰ࠊ῝ᕝᜨ⨾Ꮚ㸱 (㹌㹆㹍ᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲࣭㦂᥎㐍ᐊ㸯ࠊࢺࣛࢻࢪࣕࣃࣥᰴᘧ♫ ᪂⸆㛤 Ⓨᨭ㒊㸰ࠊᗈᓥᏛ㝔 ⥲ྜ་⒪◊✲᥎㐍ࢭࣥࢱ࣮㸱) せ ⣙ 2013 ᖺᗘ᪥ᮏ⮫ᗋ⸆⌮Ꮫ CRC ᾏእ◊ಟࡢ◊ಟဨࡋ࡚࢜ࣛࣥࢲ࠾ࡅࡿ CRC ࡢㄆ ᐃไᗘࡸᩍ⫱ࡘ࠸࡚▱ࡿᶵࢆᚓࡓࠋ࢜ࣛࣥࢲ࠾ࡅࡿ Portfolio ࢆ⏝࠸ࡓ CRC ࡢᩍ⫱ ࣉࣟࢢ࣒ࣛࡣࠊᏛ⩦㌶㊧ࡢ୍ඖࠊࢹࢫ࢝ࢵࢩࣙࣥᙧᘧࡢᩍ⫱ࢆ㔜せどࡋ࡚࠸ࡿࠋࡑ ࡇ࡛ࠊ᪥ᮏࡢ CRC ᩍ⫱ࡢά⏝ࢆ┠ⓗࡋࠊPortfolio ᐇ⏝∧ࢆసᡂࡋࡓࠋᅜ㝿ඹྠ㦂 ࡢᑐᛂࡶど㔝ධࢀࠊⱥㄒ∧ࡢ CV Training Log ࢩ࣮ࢺࢆྲྀࡾධࢀࡓᵓᡂࢆ⪃ࡋࡓࠋ Competencies㸦⬟ຊ㸧ࡋ࡚ࠊ ࠕ⮫ᗋ◊✲࣭㦂άᛶ 5 ᖺィ⏬ 2012ࠖ࠾ࡅࡿࠕ⮫ᗋ ◊✲ࢥ࣮ࢹࢿ࣮ࢱ࣮㣴ᡂ࣒࢝ࣜ࢟ࣗࣛࡢᶆ‽㛵ࡍࡿ◊✲⌜ࠖࡼࡾ⟇ᐃࡉࢀࡓึ⣭⪅/ ୖ⣭⪅ CRC 㣴ᡂ࣒࢝ࣜ࢟ࣗࣛᥖࡆࡽࢀ࡚࠸ࡿ 14 ࡢ Content Areas㸦ᙺ࣭㈐ົ㸧 ࢆ ྲྀࡾධࢀࠊྛ Competencies㸦⬟ຊ㸧ࡢ⮬ᕫホ౯ࡑࡢෆᐜࡘ࠸࡚ホ౯⪅ࢹࢫ࢝ࢵ ࢩࣙࣥࡋࠊࢹࢫ࢝ࢵࢩࣙࣥࡢෆᐜࡸࢥ࣓ࣥࢺࢆグ㘓ࡋ࡚࠸ࡃᙧᘧࡋࡓࠋࡲࡓࠊྛᮇ㛫 ࠾ࡅࡿ⮬ᕫ㛤Ⓨࣉࣛࣥ㸦POP㸧⾜ືィ⏬㸦PAP㸧ࢆタᐃࡋࠊẁ㝵ⓗ⮬ᕫ฿㐩┠ᶆࢆ ホ౯ࡋ࡚࠸ࡃࡇ࡛ࠊྛࣞ࣋ࣝᛂࡌࡓࢫ࢟ࣝࢵࣉࣔࢳ࣮࣋ࢩࣙࣥࡢྥୖ⧅ࡀࡿ ⪃࠼ࡿࠋᚋࡣࠊྛタ࠾ࡅࡿά⏝㐺ษ࡞ぢ┤ࡋࢆࡍࡿࡇ࡛ࠊࡉࡽ࡞ࡿᐇ⏝ࢆᅗ ࡾࡓ࠸ࠋ ┠ ⓗ ㏆ᖺࠊ᪥ᮏࡢᅜ㝿ඹྠ㦂ࡢቑຍక࠸ CRC ࡢᴗົࡀከᵝ࣭↹㞧ࡋ࡚࠸ࡃ୰࡛ࠊ CRC ࡢேᮦ⫱ᡂཬࡧ☜ಖࡢᚲせᛶࡀồࡵࡽࢀࠊ ࠕ⮫ᗋ◊✲࣭㦂άᛶ 5 ᖺィ⏬ 2012ࠖ ࠾࠸࡚◊ಟෆᐜ➼ࡢᩚഛࡀ㐍ࡵࡽࢀ࡚࠸ࡿࠋ➨ 35 ᅇ᪥ᮏ⮫ᗋ⸆⌮ᏛᏛ⾡⥲࡛ࡣࠊ 2013 ᖺᗘ᪥ᮏ⮫ᗋ⸆⌮Ꮫ CRC ᾏእ◊ಟࡢ◊ಟဨࡋ࡚ࠊ᪥ᮏࡢ CRC ᩍ⫱ά⏝ࡍࡿ ࡇࡣ᭷┈࡛࠶ࡿሗ࿌ࡋࡓࠋࡑࡇ࡛ࠊᅇࡣ᪥ᮏࡢ CRC ᩍ⫱ࡢά⏝ࢆ┠ⓗࡋࠊ Portfolio ᐇ⏝∧ࢆసᡂࡋࡓࡢ࡛ሗ࿌ࡍࡿࠋ ᪉ ἲ ᪥ᮏ࠾ࡅࡿ Portfolio ᐇ⏝∧ࡢෆᐜࢆ᳨ウࡋࠊ௨ୗࡢᇶᮏᵓᡂ࡛సᡂࡋࡓࠋ 1)Curriculum Vitae㸦CV㸧 Training Log 2)ึ⣭⪅ CRC/ୖ⣭⪅ CRC 㣴ᡂ࣒࢝ࣜ࢟ࣗࣛᇶ࡙࠸ࡓ Competencies ホ౯ 3)⫋ᴗࢹࣥࢸࢸㄪᰝ 4)⮬ᕫ㛤Ⓨࣉࣛࣥ㸦POP㸧⾜ືィ⏬㸦PAP㸧 ― 29 ― ⤖ ᯝ ᅜ㝿ඹྠ㦂࠾࠸࡚ࠊCRC ࡢⱥㄒ∧ CV ࡢᥦ♧ࡸ Training ᐇࡢ᭷↓ࡀồࡵࡽࢀࡿ ࡇࡀ࠶ࡿࠋࡑࡇ࡛ࠊPortfolio ᐇ⏝∧࡛ࡣࡑࡢࡼ࠺࡞ᅜ㝿ඹྠ㦂ࡢᑐᛂࡶど㔝ධࢀࠊ ⱥㄒ∧ࡢ CV Training Log ࢩ࣮ࢺࢆྲྀࡾධࢀࡓᵓᡂࢆ⪃ࡋࡓࠋPortfolio ᐇ⏝∧࠾ ࡅࡿ Competencies㸦⬟ຊ㸧ࡋ࡚ࠊࠕ⮫ᗋ◊✲࣭㦂άᛶ 5 ᖺィ⏬ 2012ࠖ࠾ࡅࡿ ࠕ⮫ᗋ◊✲ࢥ࣮ࢹࢿ࣮ࢱ࣮㣴ᡂ࣒࢝ࣜ࢟ࣗࣛࡢᶆ‽㛵ࡍࡿ◊✲⌜ࠖࡼࡾ⟇ᐃࡉࢀࡓ ึ⣭⪅/ୖ⣭⪅ CRC 㣴ᡂ࣒࢝ࣜ࢟ࣗࣛᥖࡆࡽࢀ࡚࠸ࡿ 14 ࡢ Content Areas㸦ᙺ࣭㈐ົ㸧 ࢆྲྀࡾධࢀࡓࠋ࢜ࣛࣥࢲ∧ྠᵝࠊ⬟ຊࣞ࣋ࣝࡣ㸵ẁ㝵ࡢホ౯࡛⮬ᕫホ౯ࡋ࡚࠸ࡃࡇ ࡋࠊホ౯⪅ࡼࡿ᭱⤊ホ౯ࡣࠕ฿㐩࡛ࣞ࣋ࣝࠖホ౯ࡍࡿࡇࡋࡓࠋホ౯ᮇ㛫ࡣࠊ➨㸯ᮇ 㸦1 ᖺᮍ‶㸧ࠊ ➨㸰ᮇ㸦1 ᖺ௨ୖ 3 ᖺᮍ‶㸧ࠊ➨㸱ᮇ 㸦3 ᖺ௨ୖ㸧ࡢ 3 ᮇศࡅࠊྛ Competencies 㸦⬟ຊ㸧ࡘ࠸࡚ྛᮇ㛫ࡢᮇᮎ࠾ࡅࡿ฿㐩⬟ຊࣞ࣋ࣝࢆ᭩ࡁධࢀࡿࡼ࠺ࡋࡓࠋ➨㸱ᮇ ࠾࠸࡚ࡣಶேࡢࣞ࣋ࣝྜࢃࡏ࡚ホ౯ᮇ㛫ࢆタᐃࡋ࡚࠸ࡃࡇࡋࡓࠋホ౯ࢩ࣮ࢺࡣྛ ᮇ㛫࠾ࡅࡿ┠ᶆᮇ㤳ࠊ୰㛫ࠊᮇᮎ࠾ࡅࡿ⬟ຊࣞ࣋ࣝࡢ⮬ᕫホ౯ࢆ୍ඖⓗ᭩ࡁධࢀ ࡿᙧᘧࡋࠊ┠ᶆ⬟ຊࣞ࣋ࣝࡢ฿㐩≧ἣࡢᢕᥱࢆᅗࡗࡓࠋࡲࡓࠊ࢜ࣛࣥࢲ࡛㔜せどࡉࢀ ࡚࠸ࡓࢹࢫ࢝ࢵࢩࣙࣥᙧᘧࡢᩍ⫱ࢆྲྀࡾධࢀࠊᮇ㤳ࠊ୰㛫ࠊᮇᮎ࠾࠸࡚⬟ຊࣞ࣋ࣝࢆ ⮬ᕫホ౯ࡋࡓᚋࠊホ౯⪅ࡢࢹࢫ࢝ࢵࢩࣙࣥࢆ⾜࠸ࠊ⮬ᕫホ౯㛵ࡍࡿㄝ᫂ࢆ᭩ࡁධࢀ ࡚࠸ࡃࡇࡋࡓࠋ✚ᴟᛶࡢྥୖࡸከゅⓗ࡞どⅬࢆព㆑ࡋࡓ⫋ᴗࢹࣥࢸࢸࡢグ㍕ ࡣ᪥ᮏࡢ CRC ᩍ⫱᭷┈࡛࠶ࡿ⪃࠼ࠊPortfolio ᐇ⏝∧ᑟධࡋࡓࠋ⮬ᕫ㛤Ⓨࣉࣛࣥ 㸦POP㸧⾜ືィ⏬㸦PAP㸧࡛ࡣࠊྛᮇ㛫ࡢᮇ㤳ࠊ⮬ศࡀ≉ࢫ࢟ࣝࢵࣉࢆᅗࡾࡓ࠸ ⬟ຊࡘ࠸࡚⮬ᕫ㛤Ⓨࣉࣛࣥ㸦POP㸸࠸ࡘࡲ࡛ࠊఱࢆࠊࡢỈ‽ࡲ࡛㸧ࠊࡑࢀᑐࡍ ࡿ⾜ືィ⏬㸦PAP㸸┠ᶆࢆ㐩ᡂࡍࡿࡓࡵࡢᐇ⾜ィ⏬㸧ࢆ❧࡚ࡿࠋࡑࡢෆᐜࡘ࠸࡚ホ౯⪅ ࢹࢫ࢝ࢵࢩࣙࣥࡋࠊࢹࢫ࢝ࢵࢩࣙࣥࡢෆᐜࡸࢥ࣓ࣥࢺࢆグ㘓ࡋ࡚࠸ࡃࠋ୰㛫ࠊᮇᮎ ࡛ࡣ㐩ᡂ≧ἣሗ࿌㸦㐩ᡂ≧ἣࠊ≧ἣኚࠊࡑࡢ≉➹ࡍࡁ㡯㸧ࢆ⾜࠸ࠊホ౯⪅ࢹ ࢫ࢝ࢵࢩࣙࣥࡋࠊࡑࡢෆᐜࢆグ㘓ࡍࡿࠋホ౯⪅ࡣ᭱⤊ホ౯࠾࠸࡚฿㐩ࣞ࣋ࣝࢆホ౯ࡋグ 㘓ࡍࡿࡇࡋࡓࠋホ౯ᮇࡣྛ Competencies㸦⬟ຊ㸧ࡢホ౯ࢱ࣑ࣥࢢྜࢃࡏࠊ POP/PAP ࡢホ౯࠾࠸࡚ࡶࢹࢫ࢝ࢵࢩࣙࣥᙧᘧࡢᩍ⫱ࢆྲྀࡾධࢀࡓࠋ Portfolio ᐇ⏝∧ࡣࠊ࢜ࣛࣥࢲ∧ྠᵝྛ Competencies㸦⬟ຊ㸧ࡢ⮬ᕫホ౯ࢹࢫ ࢝ࢵࢩࣙࣥᙧᘧࡢᩍ⫱ࢆྲྀࡾධࢀ࡚సᡂࡋࡓࠋ Competencies㸦⬟ຊ㸧ࡣࠊᶆ‽࢝ࣜ࢟ ࣒ࣗࣛᥖࡆࡽࢀ࡚࠸ࡿ 14 ࡢ Content Areas ᇶ࡙࠸࡚ホ౯ࡍࡿࡇ࡛ࠊ⏝⠊ᅖࡢᗈ ࠸ホ౯ࢶ࣮ࣝ࡞ࡿ⪃࠼ࡽࢀࡿࠋホ౯ᮇ㛫ࡣ 3 ᮇศࡅࡿࡇ࡛ࠊྛ⮬ࡢࣞ࣋ࣝᛂࡌ ࡚タᐃ࡛ࡁࡿࡼ࠺⪃ࡋࡓࠋྛᮇ㛫࠾ࡅࡿ⮬ᕫ㛤Ⓨࣉࣛࣥ㸦POP㸧⾜ືィ⏬㸦PAP㸧 ࢆタᐃࡋࠊẁ㝵ⓗ⮬ᕫ฿㐩┠ᶆࢆホ౯ࡋ࡚࠸ࡃࡇ࡛ࠊྛࣞ࣋ࣝᛂࡌࡓࢫ࢟ࣝࢵࣉ ࣔࢳ࣮࣋ࢩࣙࣥࡢྥୖ⧅ࡀࡿ⪃࠼ࡿࠋࡲࡓࠊᅜ㝿ඹྠ㦂ࡢయไᩚഛࢆど㔝ධ ࢀ࡚ CV ⱥㄒ∧ Training Log ࢆྲྀࡾධࢀࠊホ౯ࢩ࣮ࢺࡣᏛ⩦㌶㊧ࡢ୍ඖࢆព㆑ࡋ࡚స ᡂࡋࡓࠋᚋࡣࠊྛタ࠾ࡅࡿά⏝㐺ษ࡞ぢ┤ࡋࢆࡍࡿࡇ࡛ࠊࡉࡽ࡞ࡿᐇ⏝ࢆᅗ ࡾࡓ࠸ࠋ ― 30 ― 㻌 㻌 㻌 㻌 どぬ◊✲㒊㻌 㻌 㒊㛗㻌 㻌 㻌 ゅ⏣㻌 ⦾㻌 㻌 どぬ⏕⌮Ꮫ◊✲ᐊ㻌 㻌 㻌 ゅ⏣㻌 ⦾㻌 㒊㛗ව௵㻌 䝻䞊䝡䝆䝵䞁◊✲ᐊ㻌 㻌 㻌 㔝⏣㻌 ᚭ㻌 ᐊ㛗㻌 ║⛉Ꮫ◊✲ᐊ㻌 㻌 㻌 㻌 㸺どぬ◊✲㒊㸼 㸦ձどぬ⏕⌮Ꮫ◊✲ᐊࠊղ࣮ࣟࣅࢪࣙࣥ◊✲ᐊ㸧 どぬ◊✲㒊㛗 ゅ⏣⦾ どぬ◊✲㒊࡛ࡣࠊどぬ㛵ࡍࡿ⏕⌮Ꮫⓗ◊✲࠾ࡼࡧ║ᝈ㛵ࡍࡿᵝࠎ࡞ᇶ♏ⓗ࣭⮫ᗋⓗ ◊✲ࢆ⾜ࡗ࡚࠸ࡲࡍࠋ どぬ⏕⌮Ꮫ◊✲ᐊ㸦ゅ⏣⦾ᐊ㛗㸧࡛ࡣࠊᵝࠎ࡞࣓࣮ࢪࣥࢢᢏ⾡㸦ගᖸ΅᩿ᒙィࠊ║ᗏ ⮬Ⓨ⺯ග㸧ࡸ㟁Ẽ⏕⌮Ꮫⓗ᳨ᰝ㸦⥙⭷㟁ᅗ㸧ࢆ⏝࠸࡚ࠊ⥙⭷ࡢ⏕⌮Ꮫⓗᶵ⬟ࢆᐈほⓗホ౯ ࡍࡿ◊✲ࢆ⾜ࡗ࡚࠸ࡲࡍࠋࡲࡓࠊᵝࠎ࡞㑇ఏᛶ⥙⭷ᝈࡢヲ⣽࡞ែࢆศᏊ㑇ఏᏛⓗゎ᫂ ࡍࡿࡃࠊᅜࡢᏛࡸឤぬჾࢭࣥࢱ࣮ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊ࡢඹྠ◊✲ࢆ⾜ࡗ࡚࠸ࡲ ࡍࠋᮏᖺᗘࡼࡾᅜ୕༑ࡢᏛࠊ◊✲ᶵ㛵ࡀཧ⏬ࡋࠊつᶍඹྠ◊✲ࡀᮏ᱁ⓗࢫࢱ࣮ࢺࡋ ࡲࡋࡓࠋࡇࢀࡼࡾࠊ㑇ఏᛶ⥙⭷ᝈࡢែࡢ⌮ゎࡀ᱁ẁ῝ࡲࡿࡶࠊ⮫ᗋ㦂ྥ ࡅࡓ‽ഛࢆᩚ࠼ࡿࡇࡀ࡛ࡁࡲࡍࠋࡉࡽどぬ⏕⌮Ꮫ◊✲ᐊ࡛ࡣࠊ⡆౽࡞║ᗏᙳ⨨ࢆ㛤 Ⓨࡍࡿࡇ࡛ᅾᏯࠊ㐲㝸ᆅ࠾࠸࡚ࡶ㉁ࡢ㧗࠸║⛉デ⒪ࢆྍ⬟ࡍࡿ ᐃࢩࢫࢸ࣒ࡢ㛤Ⓨ ╔ᡭࡋࠊࣉࣟࢺࢱࣉ⨨ࢆ㛤Ⓨࡋ࡚࠾ࡾࡲࡍࠋ ࣮ࣟࣅࢪࣙࣥ◊✲ᐊ㸦㔝⏣ᚭᐊ㛗㸧࡛ࡣࠊ║ෆࣞࣥࢬᤄධ║ࡢ║ᗏどㄆᛶࢆホ౯ࡍࡿࡓ ࡵࡢࣄࢺ║⌫ࣔࢹࣝࡢ㛤Ⓨࡸࠊ║ෆࣞࣥࢬࡀᤄධࡉࢀࡓ║⌫ࣔࢹࣝࢆ⏝࠸࡚ᐇ㝿⥙⭷ ᢞᙳࡉࢀࡿᫎീࡢᙳࢆྍ⬟ࡍࡿࢹࣂࢫ㛤Ⓨ➼ࢆ⾜ࡗ࡚࠸ࡲࡍࠋ ― 31 ― ࠝどぬ⏕⌮Ꮫ◊✲ᐊࠞ 㑇ఏᛶ⥙⬦⤡⭷ᝈࡢⓏ㘓ࢿࢵࢺ࣮࣡ࢡ ゅ⏣⦾ 㸦どぬ◊✲㒊ࠊどぬ⏕⌮Ꮫ◊✲ᐊ㸧 せ⣙ ᅜࡢඹྠ◊✲タࡽ㞟ࡵࡽࢀࡓ㑇ఏᛶ⥙⭷ど⚄⤒ᝈࡢ⾲⌧ᆺࠊ㑇ఏᏊᆺ㛵ࡍࡿ ࢹ࣮ࢱࢆ㞟✚ࡍࡿᅜึࡢⓏ㘓ࢩࢫࢸ࣒ࡀᵓ⠏ࡉࢀࡓࠋᖹᡂ 27 ᖺᗘᮎࡼࡾ㐠⏝ࡀ㛤ጞ ࡉࢀࠊᚋࡢ⒪ᑟධࢆぢᤣ࠼ࡓᅜෆ࠾ࡅࡿつᶍࢥ࣮࣍ࢺࡢసᡂࠊ㑇ఏᏊᆺ⾲⌧ᆺ㛵㐃 ࢹ࣮ࢱ࣮࣋ࢫࡢసᡂ࠾ࡅࡿᡂᯝࡀᮇᚅࡉࢀࡿࠋ ┠ⓗ ║⛉㡿ᇦ࡛ࡣ㑇ఏᏛⓗ࡞せᅉࡼࡾ⥙⭷࠾ࡼࡧど⚄⤒ኚᛶࢆ᮶ࡍᝈࡀᩘከࡃᏑᅾࡍ ࡿࠋࡇࢀࡽࡢ㑇ఏᛶ⥙⭷ᝈࡣ㞴࡛࠶ࡾࠊඛ㐍ㅖᅜ࡛ࡣ୕୰㏵ኻ᫂ཎᅉࡢࡦࡘ࡛࠶ࡿࠋ ᝈ⪅ᩘࡣᮏ㑥࡛⣙ 5 ேࠊୡ⏺࡛ࡣ⣙ 300 ே᥎ᐃࡉࢀࠊ௦⾲ᝈࡋ࡚ Stargardt 㸦ࢫࢱ࣮࢞ࣝࢺ:STGD㸧ࠊ⥙⭷Ⰽ⣲ኚᛶ(RP)ࠊ࣮ࣞ࣋ࣝඛኳ㯮ෆ㞀(LCA)ࠊ㯤ᩬࢪࢫࢺ ࣟࣇ(MD)ࠊ㗹య㸦ᮞయ㸧ࢪࢫࢺࣟࣇ(CORD)➼ࡀᣲࡆࡽࢀࡿࠋ ୍㒊ࡢᝈࡘ࠸࡚ࡣḢ⡿ࢆ୰ᚰ⸆≀⒪ἲࠊ㑇ఏᏊ⒪ࠊ⏕⣽⬊⛣᳜➼ࡢ⮫ᗋ㦂ࡀ 㛤ጞࡉࢀ࡚࠸ࡿࠋࡋࡋᮏ㑥࠾࠸࡚⮫ᗋ㦂ࢆྵࡵࡓ⒪ᑟධࡣ㐜ࢀ࡚࠾ࡾࠊࡇࢀࡣ⮫ᗋ ᳨ᰝࠊ㑇ఏᏊデ᩿ࣞ࣋ࣝ࠾࠸࡚ᶆ‽ࡉࢀࡓデ᩿ᇶ‽ᚑࡗࡓ⒪ᑐ㇟ࢥ࣮࣍ࢺసᡂࡀ ⾜ࢃࢀ࡚ࡇ࡞ࡗࡓṔྐⓗ⫼ᬒ㉳ᅉࡍࡿࠋ ࡇࡢࡼ࠺࡞≧ἣࡢ୰ࠊ⒪ᑟධࢆぢᤣ࠼ࡓᅜෆ࠾ࡅࡿつᶍࢥ࣮࣍ࢺࡢసᡂࠊ㑇ఏᏊᆺ ⾲⌧ᆺ㛵㐃ࢹ࣮ࢱ࣮࣋ࢫࡢసᡂࡣ㔜せ࡞ㄢ㢟࡞ࡗ࡚࠸ࡿࠋᙜ㝔࡛ࡣᩘᖺ๓ࡽᅜෆࡢඹ ྠ◊✲⤌⧊ࢆᣑࡋࠊᮏᖺᗘ⮳ࡗ࡚ᅜ 30 వࡾࡢᏛ◊✲ᶵ㛵ࢆ⤫ྜࡍࡿᝈⓏ㘓ࢩࢫ ࢸ࣒ࡀᵓ⠏ࡉࢀࡓࡢ࡛ࡇࡇ⤂ࡍࡿࠋ ᪉ἲࠊ⤖ᯝ ᅗ㞟ࡢࡓࡵࡢ⤌⧊ᅗࢆ♧ࡍࠋᮾி་⒪ࢭࣥࢱ࣮ࡢ⤫ᣓࡢୗࠊྛᝈẖ㈐௵⪅ ࡋ࡚ࡢᝈࢳ࣮࣒࣮ࣜࢲ࣮ࢆタࡅࡓ㸦ᅗ㸯㸧ࠋᝈࢳ࣮࣒࣮ࣜࢲ࣮ࡢᙺࡣ௨ୗࡢ㏻ࡾ࡛࠶ ࡿࠋ 㸯㸧◊✲ィ⏬ࡢసᡂࡋ࡚ࠊa ◊✲┠ⓗࠊデ᩿ᇶ‽ࠊࣜࢡ࣮ࣝࢺᇶ‽ࡢタᐃ㸦ᩘࠊᐙ᪘ ᥇⾑ࡢᚲせᛶࠊࢵࣉ࣮ࣟࢻࡀᚲせ࡞᳨ᰝ㡯┠➼ࢆྵࡵࡿ㸧 ࠊb 㑇ఏᏊゎᯒࡢὶࢀࢆỴࡵࡿࠋ 㸦ࢲࣞࢡࢺࢩ࣮ࢡ࢚ࣥࢫࠊExomeࠊከタࡢඹྠ◊✲➼㸧ࠊc ඹྠ◊✲⪅ୖグࢆศ ࡾࡸࡍࡃᗈሗࡋࠊ᳨యࡢ㞟ດࡵࡿࠋ 㸰㸧ࢵࣉ࣮ࣟࢻࡉࢀࡓࡢࢹ࣮ࢱ☜ㄆࡋ࡚ࠊ a Ⓩ㘓ࡀࣜࢡ࣮ࣝࢺᇶ‽ࢆ‶ࡓࡋ ࡓ࡚࠸ࡿ㸽 bࠊᝈศ㢮ࡣṇࡋ࠸ࠋ cࠊ࢚ࢡࢯ࣮࣒ゎᯒᚲせ࡞ᐙ᪘᥇⾑ࡀ⾜ࢃࢀ࡚ ࠸ࡿ㸽 ➼ࡢ᳨ドࢆ⾜࠺ࠋ ― 32 ― 㸦ᅗ㸯㸧 ᪂つⓏ㘓ࢩࢫࢸ࣒࡛ࡣࠊ࠶ࡽࡺࡿ㑇ఏᛶᝈᑐᛂ࡛ࡁࡿࡼ࠺ࠊᑐ㇟ᝈࢆ 56 ศ㢮 ᗈࡆࠊࡉࡽ㑇ఏᏊᆺࢆ㔜どࡋࡓศ㢮ἲࡋࡓ㸦ᅗ㸰㸧ࠋ 㸦ᅗ㸰㸧 Ⓩ㘓ࠊ᳨యᥦฟࡽ⤖ᯝᥦ♧ࡲ࡛ࡢὶࢀࢆࠊࢩࢫࢸ࣐ࢸࢵࢡᵓ⠏ࡋࡓ㸦ᅗ㸱㸧ࠋ ྛᝈࢳ࣮࣒࣮ࣜࢲ࣮ࡣࠊࡑࢀࡒࢀࡀ❧ࡋࡓࣜࢡ࣮ࣝࢺࣉࣛࣥᇶ࡙ࡁࠊྛタ ― 33 ― Ⓩ㘓ࢆࡧࡅࡿࠋᖹᡂ 27 ᖺᗘ⌧ᅾࠊ≉㔜どࡋ࡚ࣜࢡ࣮ࣝࢺࢆ⾜࠺ࣉࣛࣥࡣ௨ୗࡢ ㏻ࡾ࡛࠶ࡿࠋ ձ ⥙⭷Ⰽ⣲ኚᛶࠊLCA ղ ࢜࢝ࣝࢺ㯤ᩬࢪࢫࢺࣟࣇ㸦୕Ꮿ㸧ࣉࣟࢪ࢙ࢡࢺ 㸨 RP1L1 ኚ␗ 30 ௨ୖࡢኚ␗࣭⾲⌧ᆺࡘ࡚ࡢሗ࿌ 㸨 AR࣭OMD ࡢཎᅉ㑇ఏᏊࡢ᥈⣴ 㸨 RP1L1 ኚ␗ࡼࡗ࡚⏕ࡌࡿ OMD ௨እࡢ⾲⌧ᆺ ճ ᮞయ୍ⰍぬࠊAchromatopsia 㸨 」ᩘࡢ᪂つ㑇ఏᏊኚ␗ࡀ㛵ࡢྍ⬟ᛶ ࡇࡢ࠺ࡕ㑇ఏᏊ A ࡘ࠸࡚ࡣࠊከ◊✲タᶵ⬟ゎᯒࢆ౫㢗୰ մ ࢫࢱ࣮࢞ࣝࢺ 㸨 㑇ఏᏊ⒪ᑟධࢆぢᤣ࠼ࡓ᪥ᮏே Stargardt ࡢࢥ࣮࣍ࢺసᡂ ⌧ᅾࠊ20 ᩘ᳨యࡀࢥࣟࣥࣅᏛ࡚ゎᯒ୰ յ ຎᛶ BestrophinopathyࠊARB 㸨 ᪥ᮏ࡛ሗ࿌ࡢ↓ࡗࡓ ARB ࡢࡘࡁࠊྡࢆ୰ᚰኚ␗࣭⾲⌧ᆺࡢሗ࿌ ն ᆺඛኳṆᛶኪ┣ 㸨 AR ᐙ⣔᪂つ㑇ఏᏊ B ࡀ㛵ࡢྍ⬟ᛶ ᾏእඹྠ◊✲タ㑇ఏሗࢆඹ᭷ࡋࠊᶵ⬟ゎᯒࢆ౫㢗ணᐃࠋ շ ࣮ࣞ࣋ࣝど⚄⤒ 㸨 ࣑ࢺࢥࣥࢻࣜ DNA ኚ␗ࢆᣢࡘᐙ⣔ࢆᑐ㇟ࠊX ᰁⰍయࡢ㛵ࢆ࢚ࢡࢯ࣮࣒ ࡼࡾゎ᫂ࡍࡿࠋ 㸦ᅗ㸱㸧 ゎᯒ⤖ᯝࡘ࠸࡚ࡣࠊᐙ⣔ෆ Segregation ࡀ⤊ࡋࡓࡶࡢࡽྛࢳ࣮࣒࣮ࣜࢲ࣮ࢆ㏻ࡌ ― 34 ― ࡚་㏻▱ࡉࢀࡿࠋᝈ㛵㐃ኚ␗ࢆ♧ࡍሗ࿌ࢩ࣮ࢺࡀసᡂࡉࢀࠊࡇࢀࡣᝈࡢ㛵ಀ ࡀᙉ࠸ Major mutationࠊ࠾ࡼࡧᙉࡃࡣ࡞࠸ࡀ㛵ࡀࢃࢀࡿ Minor mutation ➼ࡀࣜࢫࢺ ࢵࣉࡉࢀ࡚࠸ࡿ㸦ᅗ㸲㸧ࠋ 㸦ᅗ㸲㸧 Ⓩ㘓ࢩࢫࢸ࣒ࡢ࡞࡛ࠊඹྠ◊✲⪅ࡀ⌧ᅾⓏ㘓ࡉࢀ࡚࠸ࡿࡢᴫせࢆ㜀ぴࡍࡿࡇࡀ ࡛ࡁࡿࠋࡇࢀࡣᐙ⣔ᅗࠊ≧⤒㐣ࡢࠊ║ᗏࠊOCT ➼ࡢ⏬ീࡶྵࡲࢀࠊࡦࡘࡢࣇ ࣝࡋ࡚⡆༢ែࢆᢕᥱࡍࡿࡇࡀ࡛ࡁࡿࠋ㜀ぴࣇࣝࡢ୍㒊ࢆ㸦ᅗ㸳ࠊ㸴㸧♧ࡍࠋ 㸦ᅗ㸳㸧ሗࣜࢫࢺࡢ୍㒊 ― 35 ― 㸦ᅗ㸴㸧⏬ീࣜࢫࢺࡢ୍㒊 ⤖ㄽ ᮏᖺᗘࡽᵓ⠏ࢆ㛤ጞࡋࡓ᪂つⓏ㘓ࢩࢫࢸ࣒ࡀࠊᮏᖺ 3 ᭶ࡼ࠺ࡸࡃ㐠⏝㛤ጞࡉࢀࡿࡇ ࡞ࡗࡓࠋࡇࢀࡼࡾࠊᕼᑡᝈࡢᝈሗࠊ㑇ఏሗࡀຠ⋡ࡼࡃࠊࡘつᶍ㞟✚ࡉ ࢀࠊ᪥ᮏே࠾ࡅࡿ⥙⭷ど⚄⤒ᝈࡢ㑇ఏᆺ⾲⌧ᆺࡢᤸᥱࡀ᪩ᮇᐇ⌧ࡉࢀࡿࡇࡀᮇᚅ ࡉࢀࡿࠋ ― 36 ― ࣮ࠝࣟࣅࢪࣙࣥ◊✲ᐊࠞ ᪂ࡓ࡞㧗⢭ᗘ║ෆࣞࣥࢬᗘᩘィ⟬⌮ㄽᘧࡢ㛤Ⓨ 㔝⏣ᚭࠊ୍ᙪ 㸦どぬ◊✲㒊ࠊ࣮ࣟࣅࢪࣙࣥ◊✲ᐊ㸧 せ⣙ ᪂ࡓ࡞║ෆࣞࣥࢬᗘᩘィ⟬ᘧࢆࠋ ┠ⓗ ᮏ◊✲ࡣࠊゅ⭷࠾ࡼࡧ║ෆࣞࣥࢬࡢཌࡳࢆ⪃៖ࡋࡓ㧗⢭ᗘ࡞║ෆࣞࣥࢬᗘᩘィ⟬⌮ㄽᘧ ࡢᥦࢆ┠ⓗࡍࡿࠋࡇࢀࡲ࡛ࡣ⾡๓⾡ᚋࡢ║ෆࣞࣥࢬࡢ⨨ࢆṇ☜᥎ᐃࡍࡿࡇࡣ ᅔ㞴ࡉࢀࠊࡑࢀࢆᵝࠎ࡞ィ ್ࡽ᥎ᐃࡍࡿィ⟬ᘧࡀᥦࡉࢀ࡚ࡁࡓࠋࡋࡋࠊᚑ᮶ࡢ║ ෆࣞࣥࢬࡢᗘᩘィ⟬ᘧࡢከࡃࡣゅ⭷๓㠃᭤⋡࠾ࡼࡧ║㍈㛗ࡢ್ࡽᗘᩘࡢ⟬ฟࢆࡍࡿࡶࡢ ࡀከࡃࠊࡑࢀࡽࡣࠊࣞࣥࢬࡢཌࡳࢆ⪃៖ࡏࡎ⢭ᗘࡀప࠸ࠊゅ⭷๓㠃ᚋ㠃᭤⋡ࢆ୍ᐃẚ⋡ ࡍࡿࡓࡵᒅᢡ▹ṇᡭ⾡║࡛ࡣㄗᕪࡀࡁࡃ࡞ࡿࠊゅ⭷๓㠃ᒅᢡ್ࡀ║ෆࣞࣥࢬ⨨ࡢ᥎ᐃ ㄗᕪࢆ⏕ࡌࡿࠊ࡞ࡢၥ㢟ࡼࡾィ⟬⢭ᗘࡣ㝈ࡽࢀ࡚࠸ࡓࠋࢃࢀࢃࢀࡣࠊ㏆ᖺ᪂ࡓ㛤Ⓨ ࡉࢀࡓ๓║㒊 OCT ࡼࡾ⾡๓ᙳࡉࢀࡓ๓║㒊⏬ീሗࡽ⾡ᚋࡢ║ෆࣞࣥࢬ⨨ࢆ㧗 ࠸⢭ᗘ࡛ண ࡍࡿࡇࡀ࡛ࡁࡿࡇࢆ๓ᥦࠊࡑࡢ║ෆࣞࣥࢬ⨨ሗࢆ⏝࠸ࠊゅ⭷ࠊ║ෆ ࣞࣥࢬࡢཌࡳࢆ⪃៖ࡋࡓࡓࡼࡾ⢭ᗘࡢ㧗࠸║ෆࣞࣥࢬィ⟬⌮ㄽᘧࡢᥦࡋࠊࡑࡢ᭷⏝ᛶࢆ ᳨ドࡍࡿࠋ ᪉ἲ ࠙㸯ࠚ᪂ࡓ࡞║ෆࣞࣥࢬィ⟬ᘧࡢ⟇ᐃ ᅗ㸯 ║ගᏛ⣔࠾ࡅࡿࢫࢿࣝࡢἲ๎ᇶ࡙ࡃග⥺㏣㊧ἲ ― 37 ― ― 38 ― ― 39 ― ― 40 ― ― 41 ― ― 42 ― 㻌 㻌 㻌 㻌 ⫈ぬ䞉ᖹ⾮ぬ◊✲㒊㻌 㻌 㒊㛗㻌 㻌 㻌 ⸨㻌 ṇே㻌 㻌 ⫈ぬ㞀ᐖ◊✲ᐊ㻌 ᯇỌ㻌 㐩㞝㻌 ᐊ㛗㻌 ᖹ⾮ぬ㞀ᐖ◊✲ᐊ㻌 ᓥ㻌 ྐ⾜㻌 ᐊ㛗㻌 ⏕་⒪◊✲ᐊ㻌 㻌 㻌 㻌 㻌 ⴠྜ㻌 ༤Ꮚ㻌 ᐊ㛗㻌 ࠝ⫈ぬᖹ⾮ぬ◊✲㒊ࠞ ⫈ぬᖹ⾮ぬ◊✲㒊 㒊㛗 ⸨ṇே ᮏᖺࡣࠊ1+2 ࢿࢵࢺ࣮࣡ࢡ◊✲࠙ឤぬჾࠚඹྠ◊✲ࠊ࠾ࡼࡧ㞴⫈㑇ఏᏊࡢ◊✲ࡶ࠸ࡃࡘ ࡢࣉࣟࢪ࢙ࢡࢺ࡛㐍⾜ࡋ࡚࠸ࡿࠋ◊✲ဨࡼࡿᇶ♏ⓗ◊✲࡛ࡣࠊㄽᩥࡶᥖ㍕ࡉࢀᐇ⦼ࡀୖ ࡀࡗ࡚ࡁ࡚࠸ࡿࠋ୍᪉ࠊ㢌㢕㒊⒴ᑐࡍࡿᇶ♏◊✲ከタඹྠ◊✲ࡸࠊ⏕་⒪◊✲ᐊ ࡢ⒕◊✲ࡶ⾜ࢃࢀ࡚࠸ࡿࠋ ⫈ぬ㞀ᐖ◊✲ᐊ㛗 ᯇỌ㐩㞝 ᖺᗘࡣ࢚ࢡࢯ࣮࣒ゎᯒ࠸࠺᪉ἲࢆ⏝࠸ࡓࣄࢺ㑇ఏᏊࡢゎᯒࢆ୰ᚰ㐍ࡵࡓࠋᴟࡵ ࡚⭾࡞ሗ㔞ࡢࢹ࣮ࢱࢆᢅ࠺ࡓࡵࠊ࠶ࡽࡺࡿഃ㠃࡛ከ࡞ປຊࢆせࡋࡓࡀࠊṇ☜ゎ ᯒ࡛ࡁࡿὶࢀࢆ☜❧࡛ࡁࡓࠋࡇࢀࡼࡾ᪂ࡓ࡞㞴⫈ᐙ⣔ࡢゎᯒࢆࠊᏳ࡞ࡃࠊ㐜ࢀ࡞ࡃࠊ ุᐃࢆୗࡏࡿయไࢆᩚ࠼ࡿࡇࡀ࡛ࡁࡓࠋࡇࡢ⤖ᯝࠊ᪂つࡢ㞴⫈࠶ࡿ࠸ࡣ᪂つࡢ㞴⫈ཎᅉ 㑇ఏᏊࡢೃ⿵ࢆḟࠎⓎぢࡀ⥆࠸࡚࠸ࡿࠋࡑࡢ་Ꮫ⏕≀Ꮫⓗ᳨ドࡢࡓࡵࡢࠊ⣽⬊ࠊື≀ᐇ 㦂ࡶ㐍ࡳࠊ☜ドࡀᚓࡽࢀࡘࡘ࠶ࡿࠋࡉࡽࠊ᪂ࡓ࡞⒪ἲ㛤Ⓨࡢ◊✲ࡋ࡚ࠊᛂ⩏ሿ Ꮫඹྠ࡛ Pendred ೃ⩌ᑐࡍࡿ㦂ᐇྥࡅࡓ‽ഛࢆ㐍ࡵࡓࠋࡑࡢࡓࡵࡢᇶ♏ሗ ࡋ࡚ࡢࠊᮏ㞴⫈ᝈ⪅ࡢከᩘࡘ࠸࡚ࠊ㛗ᮇࢃࡓࡿ⫈ຊ⤒㐣ࡢゎᯒࢆ㐍ࡵࡓࠋ ≉ᚩⓗ࡞⫈ຊᅗ㸦࣮࢜ࢪ࢜ࢢ࣒ࣛ㸧ࢆ࿊ࡍࡿ㞴⫈⪅࠾ࡅࡿࠊ≉ᐃࡢ㞴⫈㑇ఏᏊࡢ㛵 ࢆ᳨ウࡋࡓࠋලయⓗࡣ㇂ᆺ㸦୰㡢ᇦ㞀ᐖ㸧ࠊప㡢㞀ᐖᆺ㸦ప㡢ᇦ㞀ᐖ㸧ࠊ㧗㡢㞀ᐖᆺ㸦㧗 㡢ᇦ㞀ᐖ㸧ࡢ㞴⫈⪅࠾࠸࡚ࠊࡑࢀࡒࢀ TECTA 㑇ఏᏊࠊWFS1 㑇ఏᏊࠊCDH23 㑇ఏᏊࡢ ኚ␗ࢆゎᯒࡋࡓࠋࡇࡢ⤖ᯝࠊࡑࢀࡒࢀ୍ᐃࡢ㢖ᗘ࡛ྠᐃࡉࢀࡿࡇࡀุ᫂ࡋࠊࡇࢀࡽࡢ㞴 ⫈ᝈ⪅ࡢែࡢண ࠊ㑇ఏᏊ᳨ᰝࡢጇᙜᛶࠊ㑇ఏᏊ᳨ᰝ๓ᝈ⪅ཎᅉࡀุ᫂ࡍࡿྍ⬟ᛶ ࡘ࠸࡚ࡢㄝ᫂ά⏝ྍ⬟࡞ࡗࡓࠋࡲࡓࠊᑠඣ㞴⫈య࠾ࡅࡿ IP-III ᆺࡢෆ⪥ወᙧࡢ 㢖ᗘࠊᮏෆ⪥ወᙧࢆᣢࡘ㞴⫈⪅࠾ࡅࡿ POU3F4 㑇ఏᏊ ࡢኚ␗ࢆゎᯒࡋ࡚ࠊᮏෆ⪥ወᙧࡢ㢖ᗘࡣ㠀ᖖప࠸ࡀࠊᮏෆ⪥ወᙧࢆ᭷ࡍࡿ㞴⫈⪅࡛ࡣ POU3F4 㑇ఏᏊࡢኚ␗ࡀྠᐃࡉࢀࡿࡇࡀุ᫂ࡋࡓࠋࡲࡓࠊᮏෆ⪥ወᙧ࡛ࡣ๓ᗞỈ⟶ ᣑࢆㄆࡵࠊࡑࡢ≉ᚩࡋ࡚ෆ⪥ഃࡢᣑࡀ㢧ⴭ࡛࠶ࡾࠊ୰㢌❐ഃࡢᣑࢆㄆࡵ ࡿ Pendred ೃ⩌/DFNB4 ␗࡞ࡿࡇࢆึࡵ࡚☜ㄆ࡛ࡁࡓࠋࡇࡢᙧែⓗ≉ᚩࡀࠊᮏ㞴⫈ ࡛ࡣ㐍⾜ࠊኚືࢆ࿊ࡉ࡞࠸ཎᅉ࡛࠶ࡿ᥎ ࡉࢀࡓࠋࡇࢀࡽࡢ⤖ᯝࡽࠊෆ⪥ወᙧࡢᏛ ሗࠊ㑇ఏᏊ᳨ᰝࡢ㐺ᛂุ᩿ࠊែணᚋࡢ᥎ ࢆྥୖ࡛ࡁࡓࠋ ᖹ⾮ぬ㞀ᐖ◊✲ᐊᐊ㛗 ᓥྐ⾜ ᖺᗘࡣᖺ㛫⣙ 250 ྡࡢ㞴ᛶࡵࡲ࠸ᝈ⪅ᑐࡋ࡚ධ㝔ࡢୖ㞟ᅋࣜࣁࣅࣜࢸ࣮ࢩࣙࣥ⒪ ― 43 ― ࢆ⾜ࡗࡓࠋ⾲ᅾឤぬ࠾ࡼࡧయᛶឤぬ᳨ᰝࢆᑟධࡋࠊ᪂ࡋ࠸ࡵࡲ࠸ࡢᝈᴫᛕࡋ࡚ࡢయᛶ ឤぬࡵࡲ࠸ࡢ◊✲ࢆ⾜ࡗࡓࠋࡲࡓႥぬㄆ▱ᶵ⬟ᖹ⾮ᶵ⬟ࡢ㛵ಀࡘ࠸᳨࡚ウࢆ⾜ࡗࡓࠋ ࠶ࡓࡽࡋ࠸⒪ᡭẁࡋ࡚㞴ᛶ∦ഃ๓ᗞ㞀ᐖ௦ൾᝈ⪅ᑐࡋ࡚ tDCS(┤ὶ㟁Ẽ่⃭) ࡼࡿᖹ⾮ࣜࣁࣅࣜࢸ࣮ࢩࣙࣥࡢቑᙉຠᯝࡘ࠸࡚ி㒔Ꮫඹྠ◊✲ࢆ⾜ࡗࡓࠋࡲࡓᮥ ᯘᏛ⢭⚄⛉ࡢඹྠ◊✲࡛ rTMS(☢Ẽ่⃭)ࡼࡿ⒪◊✲ࡶ⾜ࡗࡓ㸦⌧ᅾᢞ✏୰㸧ࠋ ᖇிᏛබ⾗⾨⏕Ꮫᩍᐊࡢඹྠ◊✲࡛ࡵࡲ࠸ࡢ㞴ࡢᚰ⌮♫ⓗᐜ᫆ࡘ࠸࡚⤫ィᏛ ⓗᡭἲࢆ⏝࠸࡚᫂ࡽࡋࡓࠋ ⏕་⒪◊✲ᐊᐊ㛗 ⴠྜ༤Ꮚ ᙜ◊✲ᐊࡣࠊᙧᡂእ⛉㡿ᇦ࡛ࡢ⮫ᗋᛂ⏝ࢆ┠ᣦࡋࡓ◊✲ࢆ⾜ࡗ࡚࠸ࡿࠋ㏆ᖺࡣࠊᙧᡂእ⛉࣭ ᩚᙧእ⛉㡿ᇦ࠾࠸࡚⏝㢖ᗘࡀ㧗࠸ேᕤ㦵㛵ࡍࡿື≀ᐇ㦂ࢆ⾜ࡗࡓࠋḟୡ௦ேᕤ㦵 ࡋ࡚ࠊ⏕య㦵㏆࠸⤌ᡂࢆᣢࡗࡓࣁࢻࣟ࢟ࢩࣃࢱࢺ㸭ࢥ࣮ࣛࢤࣥ」ྜయ㸦௨ୗ HA/Col㸧 ࡀᐇ⏝ࡉࢀࡓࡀࠊ㢌㡿ᇦ࡛ࡢᏳᛶ࣭᭷ຠᛶࡣド᫂ࡉࢀ࡚࠸࡞࠸ࠋ⚾ࡓࡕࡣࠊࣛࢵࢺ 㢌㡬㦵 HA/Col ேᕤ㦵ࢆ⛣᳜ࡋࠊࡑࡢ㦵⒵ྜࢆ⤌⧊Ꮫⓗ᳨ウࡋࠊ᭷ຠᛶࢆ᳨ウࡋࡓࠋࡲ ࡓࠊ㦵㧊⏤᮶㛫ⴥ⣔ᖿ⣽⬊ࡼࡿ⓶⒕ᙧᡂᢚไ◊✲ࡣࠊᅜ❧ᡂ⫱་⒪◊✲ࢭࣥࢱ࣮ ࡢඹྠ◊✲࡛⮫ᗋᛂ⏝ࡀᐇࡉࢀ࡚࠾ࡾࠊᚋࡣࡢ⣽⬊㸦MUSE ⣽⬊࡞㸧ࡼࡿ⒕ ᢚไຠᯝࡶ᳨ドணᐃ࡛࠶ࡿࠋ ― 44 ― ࠝ⫈ぬ㞀ᐖ◊✲ᐊࠞ ࣮࣡ࣝࢹࣥࣈࣝࢢೃ⩌Ϩᆺࡢ᪂ࡓ࡞㑇ఏⓗཎᅉࡢ᳨ウ ᯇỌ㐩㞝ࠊົྎⱥᶞࠊ㞴Ἴ୍ᚨ 㸦⫈ぬ㞀ᐖ◊✲ᐊ㸧 せ ⣙ ⮫ᗋᡤぢࡽࡣ :6 デ᩿ࡉࢀࡓᝈ⪅ࡽ 3$; 㑇ఏᏊ␗ᖖࡀ࡞ࡃࠊ('15% 㑇ఏᏊࡢ࣑ ࢫࢭࣥࢫኚ␗࣍ࣔ᥋ྜయࡀㄆࡵࡽࢀࡓࠋࡇࡢࡇࡼࡾࠊ:6 ࡢ୍㒊ࡢᝈ⪅ࡀ ('15% 㑇ఏᏊࡢ ≉ᐃࡢኚ␗ࡢຎᛶ㑇ఏࡋ࡚Ⓨࡍࡿྍ⬟ᛶࡀ♧ࡉࢀࡓࠋᮏᐙ⣔࡛ㄆࡵࡽࢀࡓ ('15% 㑇ఏ Ꮚኚ␗ࡣ +LUVFKVSUXQJ ࡢཎᅉ㑇ఏᏊࡉࢀ࡚࠸ࡿࡀࠊᮏᐙ⣔࡛ࡣ +LUVFKVSUXQJ ࡣⓎ ࡏࡎࠊࡇࢀࡣᮏᝈࡀከᅉᏊ㑇ఏ࡛࠶ࡿࡓࡵ⪃࠼ࡽࢀࡓࠋ ┠ ⓗ ࣮࣡ࣝࢹࣥࣈࣝࢢೃ⩌:6ࡣ⚄⤒ሐ⣽⬊ࡢⓎ⏕␗ᖖࡼࡾឤ㡢㞴⫈ⓑ㧥ࠊᙬ␗Ⰽ ࠊ⓶ࡢⓑᩬ࡞ࡢⰍ⣲␗ᖖࢆ≧ࡍࡿᖖᰁⰍయඃᛶ㑇ఏ㸦$'㸧࠶ࡿ࠸ࡣᖖᰁⰍయ ຎᛶ㑇ఏ㸦$5㸧ࡢᝈ࡛࠶ࡿࠋ⮫ᗋ≧ࡽ :6 ᆺศ㢮ࡉࢀࠊࡇࢀࡲ࡛ ✀㢮ࡢཎ ᅉ㑇ఏᏊࡀྠᐃࡉࢀ࡚࠸ࡿ㸦⾲㸧 ࠋ:6 ࡣෆ║ゅ㞳ࡀ࠶ࡾࠊࡰࡀ 3$; 㑇ఏᏊኚ␗㸦$'㸧 ࡛Ⓨࡍࡿࠋ:6 ࡣෆ║ゅ㞳ࡣ࡞ࡃࠊ:6 ࡣ :6 ᅄ⫥ࡢወᙧࡀຍࢃࡾࠊ:6 ࡣ :6 +LUVFKVSUXQJ ࢆక࠺ࠋ('15% ኚ␗ࡲࡓࡣ ('1 ኚ␗ࡣࡇࢀࡲ࡛ :6 ࡢ 㸫㸣 $' ࠶ ࡿ࠸ࡣ $5 ࡋ࡚ሗ࿌ࡉࢀ࡚࠾ࡾࠊ:6 ࡢࡈࡃ୍㒊࡛ࡶᾐ㏱ࡢ $' ࡋ࡚ሗ࿌ࡀ࠶ࡿࠋ ᅇࠊ⮫ᗋⓗࡣ :6 ᆺデ᩿ࡉࢀࡓඣᑐࡋ࡚ 3$; ௨እࡢ㑇ఏⓗཎᅉࡢゎ᫂ࢆ⾜ࡗࡓࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ 㛗ዪࡣ⫈ࠊẕ᪉ࡢ᭮♽ẕࡣ㞴⫈㸦ヲ⣽᫂㸧࡛࠶ࡗࡓࠋ ṓዪඣࠊࡁ࡞㡢ᛂࡋ࡞ ࠸ࡇ୧ぶࡀẼࡁࠊ㞴⫈ࡀࢃࢀ࡚ᙜ㝔ཷデࡋࡓࠋ$%5 ࡛ࡣ FOLFN 㡢ࡼࡾ G% ࡛୧ ഃᛂࢆㄆࡵࡎࠊ$665 ࡛ࡣྑ G%ࠊᕥ G% 㜈್ࡀୖ᪼ࠊ⣧㡢⫈ຊ᳨ᰝ࡚୧ഃ G% ࡛࠶ࡗࡓࠋ୧ഃࡢᙬࡀ㟷ࡃࠊෆ║ゅ㞳ࡀㄆࡵࡽࢀࡓ:LQGH[㸸㸦㸼㸧ࠋࡲࡓࠊ 㰯᰿㒊ࡀ┠❧ࡗࡓࡀࠊⓑ㧥ࡣㄆࡵ࡞ࡗࡓࠋ║⛉᳨ᰝ࡛ࡣ୍ഃྠどᙅどࡀㄆࡵࡽࢀࡓࠋ ᅄ⫥ࡢወᙧࠊ⭠⟶㐠ື␗ᖖࡣㄆࡵࡽࢀ࡞ࡗࡓࠋഃ㢌㦵 &7 ࡛ࡣෆ⪥ወᙧࢆㄆࡵ࡞ࡗࡓࠋ ௨ୖࡢᡤぢࡽ :6 ᆺデ᩿ࡉࢀࡓࠋ▱ⓗⓎ㐩ࡣᖺ㱋┦ᙜ࡛࠶ࡾࠊ ṓྑேᕤෆ⪥␃⨨ ⾡ࢆ⾜ࡋࡓࡀゝㄒⓎ㐩ࡶ㡰ㄪ࡛࠶ࡿࠋ୧ぶࠊ࠾ࡼࡧࡢぶ㢮ࡣ :6 ࡢ≧ࡣ࡞ࡗ ࡓࠋ㑇ఏᏊゎᯒࡣᮎᲈ⾑ '1$ ࡢࢧ࣮ࣥ࢞ἲࡼࡿ᳨ᰝ࡛⾜ࡗࡓࠋ ― 45 ― ⤖ ᯝ ዪඣࡽࡣ ('15% 㑇ఏᏊ࣑ࢫࢭࣥࢫኚ␗ࡢ࣍ࣔ᥋ྜయࡀㄆࡵࡽࢀࡓࠋࡲࡓࠊ୧ぶࡣྠ 㑇ఏᏊኚ␗ࡢ࣊ࢸࣟ᥋ྜయࡀࡑࢀࡒࢀㄆࡵࡽࢀࡓࠋ3$; 㑇ఏᏊࠊ0,7) 㑇ఏᏊࠊ62; 㑇ఏ Ꮚኚ␗ࡣㄆࡵࡽࢀ࡞ࡗࡓࠋᮏࡣࠊ⮫ᗋⓗࡣෆ║ゅ㞳ࡀࡳࡽࢀࡿࡣ :6 ࡢࢧࣈ ࢱࣉ≉ᚩⓗ࡞ᡤぢࡶ࡞ࡃࠊ:6 デ᩿ࡉࢀࡓࠋࡋࡋ㑇ఏᏊゎᯒ࡛ࡣࠊࡇࢀࡲ࡛ :6 ࡛ࡢሗ࿌ࡀ࡞࠸ ('15% 㑇ఏᏊኚ␗ࡢ࣍ࣔ᥋ྜయࡀㄆࡵࡽࢀࡓࠋࡇࡢࡓࡵࠊ㑇ఏᏊゎᯒ⤖ᯝ ⮫ᗋᡤぢࡢ㛵㐃ࡘ࠸᳨࡚ウࡋࡓࠋ ࡲࡎ ('15% 㑇ఏᏊኚ␗ࡢᖖᰁⰍయຎᛶ㑇ఏᙧᘧ㸦$5㸧ࡼࡿ :6 ࡋ࡚ࡢ᳨ウࢆ⾜ࡗࡓࠋ :6 ࡣ 㸣௨ୖ 3$; 㑇ఏᏊኚ␗ࡀㄆࡵࡽࢀ࡚࠾ࡾࠊࡍ࡛ ㏆࠸ኚ␗ࡀሗ࿌ࡉࢀ࡚࠸ ࡿࠋᮏࡣ 3$; ࡢ㑇ఏᏊゎᯒ࡛ࡇࢀࡽࡢኚ␗ࢆㄆࡵ࡞ࡗࡓࡶࡢࡢࠊ:6 ࡢ⮫ᗋ≧ࢆ ࿊ࡋࡓࡇࡽࠊ:6 ࡢࡈࡃ୍㒊ࡢ ('15% 㑇ఏᏊኚ␗ࡢຎᛶ㑇ఏࡀྵࡲࢀ࡚࠸ࡿྍ⬟ ᛶࡀ♧၀ࡉࢀࡓࠋ ḟ ࠸ ࡛ ྠ ୍ ࡢ ('15% ኚ ␗ ࣞ ࣝ ࡢ ࣊ ࢸ ࣟ ᥋ ྜ య ࣍ ࣔ ᥋ ྜ య ࡼ ࡿ :6 ࠾ ࡼ ࡧ +LUVFKVSUXQJ ࡢⓎ㠀Ⓨࡢ᳨ウࢆ⾜ࡗࡓࠋᮏᐙ⣔࡛ྠᐃࡉࢀࡓ ('15% 㑇ఏᏊࡢ࣑ࢫ ࢭࣥࢫኚ␗ࡣ࣊ࢸࣟ᥋ྜయࡋ࡚ +LUVFKVSUXQJ ࢆ༢⊂࡛࿊ࡋࡓᝈ⪅࡛ሗ࿌ࡉࢀ࡚࠸ࡿࠋ ࡋࡋࠊᮏᐙ⣔࡛ࡣࡇࡢኚ␗ࡢ࣍ࣔ᥋ྜ࡛࠶ࡿⓎ➃⪅࣊ࢸࣟ᥋ྜ࡛࠶ࡿ୧ぶࡣ +LUVFKVSUXQJ ࢆᣢࡓ࡞ࡗࡓࠋ('15% 㑇ఏᏊࡣ⫾⏕ᮇࡢ⚄⤒ሐࡢⓎ⏕ࠊ≉⭠⟶ࡢ⚄⤒ ࣓ࣛࣀࢧࢺࡢⓎ⏕㠀ᖖ㔜せ࡞ᙺࢆᢸࡗ࡚࠾ࡾࠊ:6 +LUVFKVSUXQJ ࡢཎᅉ㑇ఏ Ꮚࡢ ࡘࡉࢀ࡚࠸ࡿࠋࡉࡽᮏኚ␗ࡣ㔞౫Ꮡᛶ࠸ࢃࢀ࡚࠾ࡾࠊ࣊ࢸࣟ᥋ྜ࣍ࣔ᥋ྜ ࡼࡗ࡚㝶ࡍࡿ :6 ࡢ≧ࡸ +LUVFKVSUXQJ ࡢᾐ㏱⋡ࡶ␗࡞ࡾࠊྠࡌ ('15% ኚ␗ࢆ᭷ ࡍࡿᐙ⣔ෆ࡛ࡶྛ≧ࡢ᭷↓ࡀ␗࡞ࡿࡇࡶከ࠸ሗ࿌ࡉࢀ࡚࠸ࡿࠋᮏࡣ :6 ࡢ⮫ᗋ ≧ࡀ࠶ࡾࠊ୧ぶࡣ࡞ࡗࡓࡢࡣࠊ('15% ࡢኚ␗ࣞࣝࡢ㔞౫Ꮡᛶࡼࡿࡶࡢ࡛࠶ࡿࡇ ࡀ᥎ᐹࡉࢀࡓࠋ :6 ࢆకࢃ࡞࠸ +LUVFKVSUXQJ ࡣ ('15% 㑇ఏᏊኚ␗ࡸ 5(7 㑇ఏᏊኚ␗࡞」ᩘࡢ㑇ఏᏊᗙ ࡛ࡢ᫆⨯ᝈᛶࣞࣝࡢ┦ຍⓗస⏝ࡼࡾⓎࡍࡿከᅉᏊᝈࡉࢀ࡚࠸ࡿࠋᮏࡢ⮫ᗋ ≧ࡢ୰ +LUVFKVSUXQJ ࡀྵࡲࢀ࡞ࡗࡓ⌮⏤ࡣࠊ+LUVFKVSUXQJ ࡢⓎᚲせ࡞ࡢ 㑇ఏᅉᏊࢆᣢࡓ࡞ࡗࡓࡓࡵ⪃࠼ࡽࢀࡓࠋ ᮏ◊✲ࡣᡂ⫱་⒪◊✲ࢭࣥࢱ࣮⪥㰯ဗႃ⛉ᏲᮏᏊඛ⏕ࡢඹྠ◊✲࡛࠶ࡿࠋ ― 46 ― ࠝ⫈ぬ㞀ᐖ◊✲ᐊࠞ Exome ゎᯒࢆ⏝࠸ࡓೃ⩌ᛶ㞴⫈ᑐࡍࡿཎᅉ㑇ఏᏊྠᐃࡢヨࡳ ົྎⱥᶞ 1࣭௰㔝ᩔᏊ 2࣭᭷ᮏᏘᏊ 2࣭ᯇỌ㐩㞝 13 㸦1 ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ ឤぬჾࢭࣥࢱ࣮ ⫈ぬ㞀ᐖ◊✲ᐊ 㝔 ⪥㰯ဗႃ⛉ 3 ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ 2 ༓ⴥ┴ࡇࡶ ⮫ᗋ㑇ఏࢭࣥࢱ࣮㸧 せ ⣙ 㑇ఏᛶ㞴⫈ࡀࢃࢀࡿᝈ⪅࠾࠸࡚ࠊ㞴⫈㑇ఏᏊࡢಖ㝤᳨ᰝࡸ᪤▱ࡢ㞴⫈㑇ఏᏊࢆᑐ㇟ ࡋࡓḟୡ௦ࢩ࣮ࢣࣥࢧ࣮ࡼࡿゎᯒ࡛ࡣཎᅉࡀྠᐃ࡛ࡁ࡞࠸ࡇࡶከ࠸ࠋࡇࡢ୰ࡣᮍ ▱ࡢཎᅉ㑇ఏᏊࡢᏑᅾࡀ⌮⏤࡛࠶ࡿሙྜࡶྵࡲࢀࡿࠋᅇࠊ」ᩘࡢᑠወᙧࢆ࿊ࡍࡿೃ⩌ ᛶ㞴⫈ᝈ⪅ᑐࡍࡿ㑇ఏᏊࡢ࢚ࢡࢯࣥ㡿ᇦ㸦Exome㸧ࡢゎᯒࢆᐇࡋࠊཎᅉೃ⿵ኚ␗ࡢ ྠᐃࢆヨࡳࠊDLX5 ࡢ᪂⏕ኚ␗ࢆཎᅉೃ⿵ࡋ࡚ྠᐃࡋࡓࠋ ┠ ⓗ ඛኳᛶ㞴⫈ࡣ᪂⏕ඣ 1,000 ே 1 ேࡢྜ࡛Ⓨࡋࠊࡑࡢ⣙༙ᩘࡣ㑇ఏᏊᝈ⪃࠼ࡽࢀ ࡚࠸ࡿࠋወᙧࢆక࠺㞴⫈ࡢཎᅉࡣࡲࡔᩘ✀㢮ࡋ▱ࡽࢀ࡚࠾ࡽࡎࠊከࡃࡣཎᅉ࡛᫂࠶ࡿࠋ ᙜ◊✲ᐊ࡛ࡣࡇࢀࡲ࡛᪤▱ࡢೃ⩌ᛶ࣭㠀ೃ⩌ᛶ㞴⫈㑇ఏᏊ 119 ✀ࢆᑐ㇟ࡋࡓ⥙⨶ⓗ 㑇ఏᏊゎᯒࢆ⾜ࡗ࡚ࡁࡓࡀࠊࡇࢀࡣෆ⪥ወᙧࡢཎᅉ㑇ఏᏊࡀྵࡲࢀ࡚࠸࡞࠸ྍ⬟ᛶࡀ࠶ ࡿࠋᮏ◊✲࡛ࡣࢱࣥࣃࢡ㉁ࢆࢥ࣮ࢻࡍࡿ㑇ఏᏊ(⣙ 20,000 ✀)ࡢࢥ࣮ࢻ㡿ᇦ㸦Exome㸧ࢆ ᑐ㇟ࡋࡓゎᯒࣃࣉࣛࣥࢆᵓ⠏ࡋࠊෆ⪥ወᙧ࡞ࢆ࿊ࡍࡿ㞴⫈ཎᅉ㑇ఏᏊࢆ᥈⣴ࡍࡿ ࡇࢆ┠ⓗࡍࡿࠋᮏ◊✲ࡢᡂᯝࡣෆ⪥Ⓨ⏕࡞ࡽࡧෆ⪥ወᙧⓎࡢศᏊᶵᗎᑐࡍࡿ⌮ ゎࢆ῝ࡵࠊࡼࡾṇ☜࡞㞴⫈㑇ఏᏊデ᩿ἲࡸ⒪ἲࡢ㛤Ⓨࡘ࡞ࡀࡿࡇࡀᮇᚅࡉࢀࡿࠋ ᪉ἲ ᑐ㇟ࡣ୧⼗∵๓ᗞపᙧᡂࠊཱྀ၁ཱྀࠊඛኳᛶ⮻ᙧᡂࢆ࿊ࡋࡓዪඣ࡛࠶ࡿࠋᝈ⪅ ࡣ⏕ᚋᚎࠎ㡢ᑐࡍࡿᛂࡀపୗࡋࠊ1 ṓ 11 ᭶ ࡢ ABR ࡛୧ഃࡶ 105dB ࡢ㡢่⃭ ࡛↓ᛂ࡛࠶ࡗࡓࠋᝈ⪅ࡣ GJB2 ኚ␗࠾ࡼࡧ m.1555A>G, m.3243A>G ኚ␗ࡣ࡞ࡗࡓࠋ ࡲࡓྜేࡍࡿወᙧࡢ≉ᚩࡽࠊ᪤▱ࡢ㠀ೃ⩌ᛶ㞴⫈㑇ఏᏊࢆᑐ㇟ࡋࡓゎᯒࡼࡾཎᅉ ኚ␗ࡀྠᐃࡉࢀࡿྍ⬟ᛶࡣప࠸ணࡉࢀࡓࠋ ᝈ⪅࠾ࡼࡧ⫈⪅୧ぶࡢ᳨య⾑ᾮ⏤᮶ DNA ࡽࠊAgilent ♫〇 SureSelect Exome V4 ࠾ࡼࡧ Illumina ♫〇 Hiseq2000 ࢩ࣮ࢣࣥࢧ࣮ࢆ⏝࠸ DNA 㓄ิࢆᚓࡓࠋࣜࣇࣞࣥࢫ㓄ิ hg19/GRCh37 ୖ࣐ࢵࣆࣥࢢᚋࠊ᳨ฟࡉࢀࡓኚ␗ࡢ࠺ࡕබඹࢹ࣮ࢱ࣮࣋ࢫ(1000Genome, ESP6500, HGVD)ୖࡢ㢖ᗘࡀ㧗࠸ࡶࡢࢆ㝖ࡁࠊ࣑ࣀ㓟㓄ิᙳ㡪ࡢ࠶ࡿኚ␗ࡘ࠸࡚ື ― 47 ― ≀✀㛫ಖᏑᛶࠊin house ࢹ࣮ࢱ࣮࣋ࢫࡢẚ㍑࠾ࡼࡧᐙ⣔ෆゎᯒࡼࡾཎᅉೃ⿵ࡢ⤠ࡾ㎸ ࡳࢆᐇࡋࡓࠋ㑅ᢥࡉࢀࡓኚ␗ࡣ Sanger ἲࡼࡾ☜ㄆࡋࡓࠋ ⤖ᯝ Exome ゎᯒࡼࡾ DLX5 ࡢ᪂つ࣑ࢫࢭࣥࢫኚ␗(c.569C>A; p.S190Y)ࡀ᪂⏕✺↛ኚ␗ࡋ ࡚ྠᐃࡉࢀࡓࠋDLX5 ࡣᙧែᙧᡂ㛵ࢃࡿ㌿ᅉᏊ࡛࠶ࡾࠊྠ࣑ࣀ㓟ṧᇶࡣ࣓࣍࢜ࢻ࣓ ࣥ⨨ࡋ⬨᳝ື≀ 99 ✀࡚࡛ಖᏑࡉࢀ࡚࠸ࡓࠋࡲࡓࠊ❧యᵓ㐀ண ࡽࠊp.S190Y ኚ␗ ࡣ DLX5 ࢱࣥࣃࢡ㉁ࡢ DNA ⤖ྜ㒊᪂ࡓ࡞Ỉ⣲⤖ྜࢆᙧᡂࡋࠊDNA ⤖ྜ⬟ᙳ㡪ࢆ ࠼ࡿࡇࡀண ࡉࢀࡓ㸦ᅗ㸯㸧ࠋ ᅗ㸯 DLX5 ࡣ BMP ࡞ඹ㦵ᙧᡂ㔜せ࡞ᙺࢆᯝࡓࡍࡇࡀ▱ࡽࢀࠊࡲࡓ Dlx5/Dlx6 ୧ Ḟኻ࣐࢘ࢫࡀෆ⪥࣭ୖ㢡࣭ୗ㢡పᙧᡂࢆ♧ࡍࡇࡽࠊᅇྠᐃࡉࢀࡓኚ␗ࡀᮏࡢ ≧ࡢཎᅉ࡛࠶ࡿྍ⬟ᛶࡀ⪃࠼ࡽࢀࡓ㸦2002 Science 298:381-385㸧ࠋᮏ㑇ఏᏊࡣᡭ㊊ࢆ ≧ࡋឤ㡢㞴⫈ࡶ࿊ࡍࡿ SHFM1D ࡢཎᅉࡋ࡚ሗ࿌ࡉࢀ࡚࠾ࡾ(2012 JMedGenet 49: 16-20. 2014 BirthDefResA 100:764. 2014 EurJHumGenet 22: 1105)ࠊᅇゎᯒᑐ㇟ࡋࡓ ᝈ⪅ࡢ≧୍⮴ࡋ࡞࠸Ⅼࡶ࠶ࡗࡓࠋ୍᪉ࠊDLX5 ࡢ enhancer 㒊ࢆ㏫క࠸Ḟᦆࡋࡓ ᐙ⣔ࡀ୍ሗ࿌ࡉࢀ࡚࠾ࡾ㸦2010 HumGenet 127: 19-31㸧ࠊ㞴⫈࠾ࡼࡧ㢌㒊㢦㠃␗ᖖࡢ ≧ࡀ㢮ఝࡋ࡚࠸ࡿ⪃࠼ࡽࢀࡓ㸦ᅗ 2㸧ࠋᅇࡢ DLX5 ኚ␗ࢆⓗኚ␗ྠᐃࡍࡿࡓࡵࡣࠊ ྠᵝࡢ≧ࢆࡶࡘ」ᩘࡢࡢゎᯒࡀᚲせ⪃࠼ࡽࢀࡓࠋ ― 48 ― ᅗ㸰 ― 49 ― ࠝ⫈ぬ㞀ᐖ◊✲ᐊࠞ 㞴⫈㑇ఏᏊ LOXHD1 ࡢ᪂つኚ␗యࡢศᏊែࡢ᳨ド 㞴Ἴ୍ᚨ 㸦⫈ぬ㞀ᐖ◊✲ᐊ㸧 せ ⣙ LOXHD1 ࡣෆ⪥ࡢ᭷ẟ⣽⬊ࡢືẟࡢ⣽⬊⭷ᒁᅾࡋࠊࡑࡢ㑇ఏᏊࡢⓗኚ␗ࡣ㐍⾜ᛶ 㞴⫈ࡢཎᅉ࡞ࡿࠋᡃࠎࡣ 2014 ᖺ᪥ᮏ⪥㰯ဗႃ⛉Ꮫ⥲࠾࠸࡚ࠊ⣧㡢⫈ຊ᳨ᰝ࡛୧ഃ ᛶ㧗㡢ഴᆺࡢឤ㡢㞴⫈ࢆ࿊ࡋࡓᝈ⪅࠾࠸࡚ LOXHD1 ࡢ᪂つ㑇ఏᏊኚ␗(p.V1892F) ࢆሗ࿌ࡋࡓࠋLOXHD1 ࡣࠊ㣬⬡⫫㓟㓟㓝⣲ lipoxygenase ࡀ᭷ࡍࡿ PLAT ࢻ࣓ࣥ ࡢࡳࡀከᩘ┤ิࡋࡓᵓ㐀ࢆࡶࡕࠊᮏኚ␗ࡶࡇࡢ PLAT ࢻ࣓ࣥㄆࡵࡽࢀࡓࠋLOXHD1 ࡢ ⫈ぬ࠾ࡅࡿᶵ⬟ࡣࡲࡔ࡛᫂࠶ࡿࡀࠊPLAT ࢻ࣓ࣥࡣ Ca 2+ ౫Ꮡⓗ࡞⬡㉁⭷ࡢ⤖ྜ ാࡃ⪃࠼ࡽࢀ࡚࠸ࡿࠋ ᮏ◊✲࡛ࡣᮏኚ␗ࡢ㞴⫈ࡢཎᅉࡋ࡚ࡢ᳨ドࢆ┠ⓗࡋ࡚ࠊLOXHD1 ࡢ PLAT ࢻ࣓ࣥ ࡢ⺮ⓑ㉁❧యᵓ㐀ࢆண ࡋࡓࡇࢁࠊPLAT ࢻ࣓ࣥࡢෆഃ⨨ࡋ࡚࠸ࡓ 1892 ␒┠ࡢࣂ ࣜࣥ(V)ࡀࣇ࢙ࢽࣝࣛࢽࣥ(F)⨨ࡉࢀࡿࡇࡼࡾࠊ࣑ࣀ㓟ഃ㙐ࡢཎᏊྠኈࡢ≀⌮ⓗ ┦స⏝ࡼࡿ⾪✺ࡀ⏕ࡌࡿࡇࡀゎࡗࡓࠋࡇࢀࡼࡾ LOXHD1 ࡢ PLAT ࢻ࣓ࣥࡢșࣂ ࣞࣝᵓ㐀㸦ᶡ≧ࡢᵓ㐀㸧ࡀኚᙧࡋ࡚⬡㉁⭷ࡢ⤖ྜ⬟ࡀపୗࡋࠊ᭷ẟ⣽⬊ືẟࡢᶵ⬟ࡀ 㞀ᐖࡉࢀ࡚㞴⫈ࢆⓎࡋࡓண ࡉࢀࡓࠋ ┠ ⓗ p.V1892F ኚ␗ࡼࡾ LOXHD1 ࡢ PLAT ࢻ࣓ࣥࡢ❧యᵓ㐀ࡀࡢࡼ࠺㞀ᐖࡉࢀࡿࡇ ࡼࡾ㞴⫈ࡢཎᅉ࡞ࡾ࠺ࡿ᳨ドࡍࡿࡇࢆ┠ⓗࡋࠊLOXHD1 ࡢ PLAT ࢻ࣓ࣥࡢ⺮ ⓑ㉁❧యᵓ㐀ࢆண ࡋࠊᮏኚ␗ࡼࡿᙳ㡪ࢆゎᯒࡋࡓࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ LOXHD1 ࡢ ⤖ ᬗ ᵓ 㐀 ࡀ ᮍ ▱ ࡢ ࡓ ࡵ ࠊ ࣑ ࣀ 㓟 㓄 ิ ࡢ 㧗 ࠸ ಖ Ꮡ ᛶ ࢆ ♧ ࡋ ࡓ ࢧ ࣥ ࢦ lipoxygenase ࡢ PLAT ࢻ࣓ࣥࡢ⤖ᬗᵓ㐀(PDB:2fnq)ࢆ㗪ᆺࠊṇᖖᆺኚ␗ᆺࣄࢺ LOXHD1 ࡢ PLAT ࢻ࣓ࣥࡢ❧యᵓ㐀ண ࢆ⾜ࡗࡓࠋᮏᵓ㐀ண ⏝ࡋࡓࣉࣟࢢ࣒ࣛࡣࠊ Swiss Model㸦ศᏊࣔࢹࣜࣥࢢ㸧ࠊ࠾ࡼࡧ UCSF Chimera㸦ศᏊ⾲♧㸧ࢆ⏝࠸ࡓࠋ ― 50 ― ⤖ ᯝ V1892 ࡣࠊșࣂࣞࣝࢆᵓᡂࡍࡿ 7 ࡘࡢșࢩ࣮ࢺ㸦ᖹ㠃≧ࡢᵓ㐀࡛ᮏᶡ≧ᵓ㐀ࡢഃቨ㠃ࢆ ᵓᡂ㸧ࡢ࠺ࡕ N ᮎ➃ࡽ 4 ␒┠ࡢșࢩ࣮ࢺ࠶ࡾࠊࡑࡢ࣑ࣀ㓟ഃ㙐ࡣșࣂࣞࣝࡢෆ㒊 ⨨ࡋࡓ(ࢫࢸࣞ࢜ᅗ 1, ▮༳)ࠋ 㟁Ⲵࢆᣢࡓ࡞࠸࣑ࣀ㓟ྠኈ࡛ࡣࠊ࣑ࣀ㓟ࢆᵓᡂࡍࡿྛཎᏊࡢ༙ᚄ㊥㞳㸦ࣇࣥࢹࣝ ࣮࣡ࣝࢫ༙ᚄ㸧ࢆࡿ᪉ྥ≀⌮ⓗ࡞┦స⏝ࡀാࡃࠋࡇࡢኚ␗㒊ࡢ࣑ࣀ㓟ࡢࣇࣥ ࢹ࣮ࣝ࣡ࣝࢫ༙ᚄࢆ᳨ウࡋࡓࡇࢁࠊṇᖖᆺࡢ V1892 ࡣ࣑ࣀ㓟ഃ㙐ࡀșࣂࣞࣝෆࡢࡢ ࣑ࣀ㓟ഃ㙐⾪✺ࡋ࡞࠸ࡀࠊ⨨ࡉࢀࡓ F1892 ࡛ࡣ⾪✺ࡍࡿࡇࡀゎࡗࡓࠋ୍᪉ࠊV1892 ࡣ Ca2+ ⤖ྜ㒊ࡽ㞳ࢀࡓ㊥㞳࠶ࡗࡓࡓࡵࠊᮏኚ␗ࡣ Ca2+ ࡢ⤖ྜࡣᙳ㡪ࡋ࡞࠸ࡇ ࡀゎࡗࡓ(ࢫࢸࣞ࢜ᅗ 1, ྑ 3 ࡘࡢ⌫㸧 ࠋ ࢫࢸࣞ࢜ᅗ㸯 ศᏊࣔࢹࣜࣥࢢࡼࡿ LOXHD1 ࡢᵓ㐀ࠋᖹ㠃≧ࢺ࣏ࣟࢪ࣮㸸 șࢩ࣮ࢺࠋࣛࣥ≧ࢺ࣏ࣟࢪ࣮㸸࣮ࣝࣉࠋ⌫≧ᵓ㐀㸸Ca2+ ― 51 ― ࠝ⫈ぬ㞀ᐖ◊✲ᐊࠞ ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤Ⓨ㛵ࡍ ࡿ◊✲ ༡ಟྖ㑻 㸦⮫ᗋ◊✲ࢭࣥࢱ࣮ ⫈ぬᖹ⾮ぬ◊✲㒊㸧 せ ⣙ ୰⪥ᖖᅾ⳦ྀࢆ᫂ࡽࡍࡿࡓࡵࠊ୰⪥⅖ࡢ↓࠸⪥⛉ᡭ⾡㸦⫏ᑐࡍࡿேᕤෆ⪥ࠊ⪥ ◳ᑐࡍࡿࣈ࣑㦵ᡭ⾡ࠊ࣋ࣝ㯞⑷ᑐࡍࡿ㢦㠃⚄⤒ῶⲴ⾡ࠊ୰⪥ወᙧᑐࡍࡿ㰘ᐊ ᙧᡂ⾡㸧ࢆ⾜ࡗࡓ 66 ࡽ୰⪥ࢫ࣡ࣈࢧࣥࣉࣝࢆ᥇ྲྀࡋࠊ16S rRNA ࣓ࢱࢤࣀ࣒ゎᯒࢆ ࡋࡓࠋ࠸ࡎࢀࡢࢧࣥࣉࣝࡽࡶ⣽⳦ࡢᏑᅾࢆ♧ࡍ 16S rRNA 㡿ᇦࡀ PCR ࡼࡾᚓࡽࢀࡓࠋ ᡂே୰⪥ᖖᅾ⳦ྀࡣࠊ㛛࡛ࣞ࣋ࣝ Proteobacteria 55%ࠊActinobacteria 29%ࠊFirmicutes 12%ࠊBacteroidetes 2%࠸࠺⤖ᯝ࡛࠶ࡗࡓࠋ៏ᛶ୰⪥⅖ࡢ⣽⳦ྀࢆ᫂ࡽࡍࡿࡓࡵࠊ៏ ᛶ୰⪥⅖ᝈ⪅ 88 ࡼࡾᡭ⾡୰⪥ࢫ࣡ࣈࢧࣥࣉࣝࢆ᥇ྲྀࡋࠊ16S rRNA ࣓ࢱࢤࣀ࣒ゎᯒ ࢆࡋࡓࠋ⪥₃ࡢ࡞࠸⇱ࡋࡓ㠀άືᛶ៏ᛶ୰⪥⅖⪥㸦㠀άືᛶ COM㸧࡛ࡣࠊࢥࣥࢺࣟ ࣮ࣝ⩌㢮ఝࡋࡓ⣽⳦ྀ࡛࠶ࡗࡓࡀࠊ⪥₃ࡢ࠶ࡿάືᛶ៏ᛶ୰⪥⅖⪥㸦άືᛶ COM㸧࡛ࡣࠊ Proteobacteria ࡢྜࡀపୗࡋࠊFirmicutes ࡢྜࡀቑຍࡋ࡚࠸ࡓࠋ⌧ᅾࡲ࡛୰⪥ᖖᅾ ⳦ྀࢆୡ⏺࡛ึࡵ࡚᫂ࡽࡋࠊ㞴ᇵ㣴ᚤ⏕≀ࡢ៏ᛶ୰⪥⅖ࡢ㛵ࢆ᫂ࡽࡋࡓࠋ㠀 άືᛶ COM ࡛ࡣᖖᅾ⳦ྀ㢮ఝࡋࡓ⣽⳦ྀ࡛࠶ࡗࡓࡀࠊάືᛶ COM ࡛ࡣ⣽⳦ྀࡣᖖᅾ⳦ ྀࡣ᫂ࡽኚࡋ࡚࠸ࡿࡇࡀุ᫂ࡋࡓࠋ ┠ ⓗ㸦ࡲࡓࡣ◊✲┠ⓗ㸧 ே㛫ࡢయࡣࠊከ✀ከᵝ࡞⣽⳦ྀࡀᏑᅾࡍࡿࡀࠊࡑࡢከࡃࡀᚑ᮶ࡢᇵ㣴ἲࡼࡿ⣽⳦᳨ ᰝ࡛ࡣྠᐃᅔ㞴࡞㞴ᇵ㣴ᚤ⏕≀ࡉࢀࡿࠋḟୡ௦ࢩ࣮ࢡ࢚ࣥࢧ࣮ࢆ⏝࠸ࡓ 16S rRNA ࣓ࢱ ࢤࣀ࣒ゎᯒ࡛ࡣࠊ㞴ᇵ㣴ᚤ⏕≀ࡶྵࡵࡓ࡚ࡢ⣽⳦ྀྵࡲࢀࡿ DNA ࢆࡈゎᯒࡋࠊ⣽ ⳦ࢆ᳨ฟ࣭ྠᐃࡍࡿࡇࡀྍ⬟࡛࠶ࡿࠋᮏ◊✲ࡢ┠ⓗձࡣୡ⏺࡛ึࡵ࡚ேࡢ୰⪥ᖖᅾ⳦ྀ ࢆ᫂ࡽࡍࡿࡇ࡛࠶ࡿࠋ┠ⓗղࡣ៏ᛶ୰⪥⅖ࡢᝈ⪅ࢆᑐ㇟୰⪥⣽⳦ྀࢆ᫂ࡽࡍ ࡿࡇ࡛࠶ࡿࠋᚑ᮶ࡢᇵ㣴ἲ࡛ࡣྠᐃࡉࢀ࡞࠸㞴ᇵ㣴ᚤ⏕≀ࡀⓗ⣽⳦ࡋ࡚㛵ࢃࡗ࡚࠸ ࡿࡇࡀணࡉࢀࡿࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ㸦ࡲࡓࡣ᪉ἲ㸧 ◊✲ࢹࢨࣥࡣࠊ୰⪥⅖ࡢ࡞࠸⪥⛉ᡭ⾡ࠊ៏ᛶ୰⪥⅖ࡢ㰘ᐊᙧᡂ⾡ࡽࠊ ୰⪥⢓⭷ࢫ࣡ࣈࢆヨᩱࡋࠊ16S rRNA ࣓ࢱࢤࣀ࣒ゎᯒࢆ⾜࠺ほᐹ◊✲࡛࠶ࡿࠋ16S rRNA ࣓ࢱࢤࣀ࣒ゎᯒࡣࢧࣥࣉࣝࡼࡾ DNA ᢳฟᚋ 16S 㑇ఏᏊࡢྍኚ㡿ᇦ V4 ࢆྵࡴ㡿ᇦࡢ PCR ― 52 ― ቑᖜ࠾ࡼࡧࢩ࣮ࢡ࢚ࣥࢫࢆ⾜࠸ࠊࡑࢀࡒࢀࡢ㓄ิ㛫ࡢ㢮ఝᗘࡽ⳦✀ࡢ≉ᐃࡸ⳦ྀయࡢ ᵓ㐀ࢆゎᯒࡋࡓࠋ┠ⓗձࡢ୰⪥ᖖᅾ⳦ྀࢆ᫂ࡽࡍࡿࡓࡵࠊ୰⪥⅖ࡢ↓࠸⪥⛉ᡭ⾡ 㸦⫏ᑐࡍࡿேᕤෆ⪥ࠊ⪥◳ᑐࡍࡿࣈ࣑㦵ᡭ⾡ࠊ࣋ࣝ㯞⑷ᑐࡍࡿ㢦㠃⚄⤒ῶⲴ ⾡ࠊ୰⪥ወᙧᑐࡍࡿ㰘ᐊᙧᡂ⾡㸧ࢆ⾜ࡗࡓ 66 ࡽ୰⪥ࢫ࣡ࣈࢧࣥࣉࣝࢆ᥇ྲྀࡋࠊ16S rRNA ࣓ࢱࢤࣀ࣒ゎᯒࢆࡋࡓࠋ┠ⓗղࡢ៏ᛶ୰⪥⅖ࡢ⣽⳦ྀࢆ᫂ࡽࡍࡿࡓࡵࠊ៏ᛶ ୰⪥⅖ᝈ⪅ 88 ࡼࡾᡭ⾡୰⪥ࢫ࣡ࣈࢧࣥࣉࣝࢆ᥇ྲྀࡋࠊ16S rRNA ࣓ࢱࢤࣀ࣒ゎᯒࢆ ࡋࡓࠋ ⤖ ᯝ㸦ࡲࡓࡣᡂ⦼㸧 ࠸ࡎࢀࡢࢧࣥࣉࣝࡽࡶ⣽⳦ࡢᏑᅾࢆ♧ࡍ 16S rRNA 㡿ᇦࡀ PCR ࡼࡾᚓࡽࢀࡓࠋᑠඣࡢ ୰⪥ᖖᅾ⳦ྀࡣࠊ㛛࡛ࣞ࣋ࣝ Proteobacteria 62%ࠊActinobacteria 33%ࠊBacteroidetes 2%ࠊ Firmicutes 2%࠸࠺⤖ᯝ࡛࠶ࡗࡓࠋᡂேࡢ୰⪥ᖖᅾ⳦ྀࡣࠊ㛛࡛ࣞ࣋ࣝ Proteobacteria 55%ࠊActinobacteria 29%ࠊFirmicutes 12%ࠊBacteroidetes 2%࠸࠺⤖ᯝ࡛࠶ࡗࡓࠋᒓ ࡛ࣞ࣋ࣝࡣ 62 ⳦✀ࡀ୰⪥ᖖᅾ⳦ࡋ࡚᫂ࡽ࡞ࡗࡓࠋ⪥₃ࡢ࡞࠸⇱ࡋࡓ㠀άືᛶ៏ᛶ ୰⪥⅖⪥㸦㠀άືᛶ COM㸧࡛ࡣࠊ┿⌔⭘ࡢ࡞࠸༢⣧៏ᛶ୰⪥⅖࡛ Proteobacteria (46%)ࠊ Actinobacteria (28%)ࠊFirmicutes (22%)ࠊBacteroidetes (3%)࡛࠶ࡾࠊ┿⌔⭘ࢆక࠺┿⌔ ⭘ ᛶ ୰ ⪥ ⅖ ࡛ Proteobacteria (62%) ࠊ Actinobacteria (25%), Firmicutes (10%) ࠊ Bacteroidetes (3%)࡛࠶ࡗࡓࠋ୍᪉ࠊ⪥₃ࡢ࠶ࡿάືᛶ៏ᛶ୰⪥⅖⪥㸦άືᛶ COM㸧࡛ࡣࠊ ┿⌔⭘ࡢ࡞࠸༢⣧៏ᛶ୰⪥⅖࡛ Proteobacteria (40%)ࠊFirmicutes (29%)ࠊActinobacteria (26%)ࠊBacteroidetes (3%)࡛࠶ࡾࠊ┿⌔⭘ࢆక࠺┿⌔⭘ᛶ୰⪥⅖࡛ Firmicutes(41%)ࠊ Actinobacteria (30%)ࠊProteobacteria (23%)ࠊBacteroidetes (4%) Firmicutes ࡢྜࡀ ቑຍࡋࠊProteobacteria ࡢྜࡀపୗࡋ࡚࠸ࡓࠋ ࡲࡵࡿࠊ⌧ᅾࡲ࡛୰⪥ᖖᅾ⳦ྀࢆୡ⏺࡛ึࡵ࡚᫂ࡽࡋࠊ㞴ᇵ㣴ᚤ⏕≀ࡢ៏ᛶ ୰⪥⅖ࡢ㛵ࢆ᫂ࡽࡋࡓࠋ㠀άືᛶ COM ࡛ࡣᖖᅾ⳦ྀ㢮ఝࡋࡓ⣽⳦ྀ࡛࠶ࡗࡓࡀࠊ άືᛶ COM ࡛ࡣ⣽⳦ྀࡣᖖᅾ⳦ྀࡣ᫂ࡽኚࡋ࡚࠸ࡿࡇࡀุ᫂ࡋࡓࠋ ― 53 ― ᅗ㸯㸸16S rRNA ࣓ࢱࢤࣀ࣒ゎᯒ⤖ᯝ ― 54 ― ࠝ⫈ぬ㞀ᐖ◊✲ᐊࠞ ෆ⪥እഃቨ⥺⥔⣽⬊ࡢ⏕⼗∵ෆ㟁 Ỉ㊊㑥㞝 㸦⫈ぬᖹ⾮ぬ◊✲㒊㸧 せ ⣙ ࣐࢘ࢫ࠾࠸࡚QLWURSURSLRQLFDFLG13ࡼࡿᛴᛶෆ⪥࢚ࢿࣝࢠ࣮ࣔࢹࣝࢆస ᡂࡋࡓࠋࡑࡢ⤖ᯝ࣐࢘ࢫ࠾࠸࡚13ᢞᚋࡢ⫈ᛶ⬻ᖿㄏⓎᛂ$%5㜈್ୖ᪼ࡀㄆࡵࡽࢀ ࡓࠋࡉࡽ⤌⧊Ꮫⓗ࡞᳨ウࢆ⾜ࡗࡓࡇࢁࠊࡑࡢཎᅉࡀ⼗∵እഃቨ⥺⥔⣽⬊≉␗ⓗ⏕ ࡌࡿ࣏ࢺ࣮ࢩࢫࡼࡿࡶࡢ࡛࠶ࡿࡇࢆගᏛ㢧ᚤ㙾ୗ☜ㄆࡋࡓࠋࡇࡢ13ࣔࢹ࣐ࣝ࢘ ࢫࢆ13ᢞᚋࣨ᭶ࡲ࡛⤒㐣ほᐹࡍࡿࠊప㡢ᇦࡽ୰㡢ᇦࡲ࡛ࡢ$%5㜈್᭷ព࡞ᨵၿ ࡀㄆࡵࡽࢀࡓࠋࡉࡽࠊ⼗∵ෆ㟁HQGRFRFKOHDUSRWHQWLDOࢆ ᐃࡋࡓࡇࢁࠊ13ᢞ ࡼࡗ࡚పୗࡋࡓ㟁ࡀᨵၿࡋ࡚࠸ࡿࡇࡀ᫂ࡽ࡞ࡗࡓࠋࡇࡢ㟁ࡢᅇࡣ⼗∵እ ഃቨ࠾ࡅࡿFRQQH[LQ࠾ࡼࡧ1DN$73DVHࡢⓎ⌧ࡼࡗ࡚⏕ࡌࡿࡇࢆ☜ㄆࡋࡓࠋ௨ୖ ࡼࡾࠊ⮬Ⓨⓗ࡞⼗∵እഃቨ⥺⥔⣽⬊ࡢ⏕ࡼࡿ⼗∵ෆ㟁ࡢᅇࡼࡾ⫈ຊࡢᨵၿࢆ ᮶ࡋ࡚࠸ࡿࡇࡀ᫂ࡽ࡞ࡗࡓࠋ ┠ ⓗ㸦ࡲࡓࡣ◊✲┠ⓗ㸧 ࣑ࢺࢥࣥࢻࣜࡢ㟁Ꮚఏ㐩⣔ࡢྍ㏫ⓗ㜼ᐖ࡛࠶ࡿ QLWRURSURSLRQLF DFLG13ࢆෆ⪥ ᒁᡤᢞࡋసᡂࡋࡓᛴᛶෆ⪥࢚ࢿࣝࢠ࣮ࣔࢹࣝࢆ⏝࠸࡚ࠊ⼗∵እഃቨ⥺⥔⣽⬊ࡢ⮬ Ⓨⓗእഃቨ⏕ࡢ࣓࢝ࢽࢬ࣒ࢆゎᯒࡋࠊࡉࡽእഃቨ⥺⥔⣽⬊⏕ࡀ⼗∵ෆ㟁࠼ࡿ ᙳ㡪ࢆ᫂ࡽࡍࡿࡇࢆ┠ⓗࡍࡿࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ㸦ࡲࡓࡣ᪉ἲ㸧 QLWURSURSLRQLFDFLG13ࡼࡿᛴᛶෆ⪥࢚ࢿࣝࢠ࣮ࣔࢹࣝࢆ &%$&D- ࣐࢘ࢫࢆ⏝࠸ ࡚సᡂࡍࡿࠋࡑࡢᚋ⤒ⓗ⫈ᛶ⬻ᖿㄏⓎᛂ$%5ࢆ㌟㯞㓉ୗ⾜࠸ࠊ$%5 㜈್ኚ ࢆ⏕ࡌࡿ☜ㄆࡍࡿࠋ࣐࢘ࢫ࠾࠸࡚ 13 ᢞᚋ $%5 㜈್ୖ᪼ࡀㄆࡵࡽࢀࢀࡤࠊࡲࡎග Ꮫ㢧ᚤ㙾ୗእഃቨ⥺⥔⣽⬊ࠊ⾑⟶᮲ࠊ࠾ࡼࡧࢥࣝࢳჾࡽࡏࢇ⚄⤒⠇ࡢほᐹࢆ⾜࠺ࠋ⥆ ࠸࡚ࠊ⤒ⓗ࡞⼗∵ෆ㟁㸦HQGRFRFKOHDUSRWHQWLDO(3㸧ࡢ ᐃࢆ⾜࠺ࠋࡉࡽࠊ⤒ⓗ࡞⼗ ∵እഃቨ࠾ࡅࡿ FRQQH[LQ ࠾ࡼࡧ 1DN$73DVH ࡢⓎ⌧ࢆචᰁⰍࡼࡾ☜ㄆࡍࡿࠋ ͤ1 ⾜࠶ࡅࡿ ⤖ ᯝ㸦ࡲࡓࡣᡂ⦼㸧 QLWURSURSLRQLFDFLG13ࡼࡿᛴᛶෆ⪥࢚ࢿࣝࢠ࣮ࣔࢹࣝࢆ &%$&D- ࣐࢘ࢫࢆ ― 55 ― ⏝࠸࡚సᡂࡋࡓࠋࡑࡢ⤖ᯝ࣐࢘ࢫ࠾࠸࡚ࣛࢵࢺ࠾࠸࡚ほᐹࡉࢀࡓ 13 ᢞᚋࡢ $%5 㜈 ್ୖ᪼ࡀྠᵝㄆࡵࡽࢀࡓࠋࡉࡽ⤌⧊Ꮫⓗ࡞᳨ウࢆ⾜ࡗࡓࡇࢁࠊෆ⪥ᒁᡤⓗ࡞࣑ࢺࢥ ࣥࢻࣜᶵ⬟㜼ᐖࡼࡾ㧗ᗘࡢ⫈ᛶ⬻ᖿㄏⓎᛂ$%5㜈್ୖ᪼ࡀㄆࡵࡽࢀ+R\DHWDO 1HXURUHSRUWࠊࡑࡢཎᅉࡀ⼗∵እഃቨ⥺⥔⣽⬊≉␗ⓗ⏕ࡌࡿ࣏ࢺ࣮ࢩࢫࡼ ࡿࡶࡢ࡛࠶ࡿࡇࢆගᏛ㢧ᚤ㙾ୗ☜ㄆࡋࡓࠋࡇࡢ 13 ࣔࢹ࣐ࣝ࢘ࢫࢆ 13 ᢞᚋ ࣨ ᭶ࡲ࡛⤒㐣ほᐹࡍࡿࠊప㡢ᇦࡽ୰㡢ᇦࡲ࡛ࡢ $%5 㜈್᭷ព࡞ᨵၿࡀㄆࡵࡽࢀࡓࠋ⤌ ⧊Ꮫⓗࡣእഃቨ⥺⥔⣽⬊ࠊ≉ , ᆺࠊ,9 ᆺ࠾࠸࡚⣽⬊ศࢆక࠺⮬Ⓨⓗ࡞⏕ࡀㄆࡵ ࡽࢀࡓࠋࡉࡽࠊ⼗∵ෆ㟁HQGRFRFKOHDUSRWHQWLDOࢆ ᐃࡋࡓࡇࢁࠊ13 ᢞࡼ ࡗ࡚పୗࡋࡓ㟁ࡀᨵၿࡋ࡚࠸ࡿࡇࡀ᫂ࡽ࡞ࡗࡓࠋࡉࡽච⤌⧊Ꮫⓗ᳨ウࡼࡾࠊ ⼗∵እഃቨ࠾ࡅࡿ FRQQH[LQ ࠾ࡼࡧ 1DN$73DVH ࡢⓎ⌧ࡀぢࡽࢀࡓࠋ௨ୖࡼࡾࠊ⮬ Ⓨⓗ࡞⼗∵እഃቨ⥺⥔⣽⬊ࡢ⏕ࡣ⼗∵ෆ㟁ࡢᅇࡼࡾ⫈ຊࡢᨵၿࢆ᮶ࡋ࡚࠸ࡿࡇ ࡀ᫂ࡽ࡞ࡗࡓࠋ ― 56 ― ࠝᖹ⾮ぬ㞀ᐖ◊✲ᐊࠞ 㞴ᛶᮎᲈᛶࡵࡲ࠸ࡢ㔜ᗘᙳ㡪ࡍࡿᚰ⌮♫ⓗせᅉࡢ᳨ウ ᓥྐ⾜ࠊⲨ⨾ᕼࠊ∦ᒸᯞ㔛Ꮚࠊఀ㐩ዉ⨾ࠊ୕ᾆṇ⛱ 㸦ᖹ⾮ぬ㞀ᐖ◊✲ᐊ㸧 せ ⣙ ୍⯡ⓗ⒪ࡶࢃࡽࡎࡵࡲ࠸ࡼࡿ⏕ά㞀ᐖࢆッ࠼ࡿ㞴ᛶᮎᲈᛶࡵࡲ࠸ᝈ⪅ࢆᑐ ㇟ࡋ࡚㔜ᗘᙳ㡪ࡍࡿᚰ⌮♫ⓗせᅉࢆ᳨ウࡋࡓࠋ㞴ᛶࡵࡲ࠸࠾࠸࡚㌟యឤぬ ᑐࡍࡿ◚ᒁⓗᛮ⪃ࡣ㔜ᗘᙳ㡪ࢆ࠼࡚࠸ࡿࡇࡀ᫂ࡽ࡞ࡾㄆ▱ࡢṍࡳࡀᙳ㡪ࢆཷ ࡅࡿែ࡛࠶ࡿࡇࡀ♧၀ࡉࢀࡓࠋࡑࡢࡢ⫼ᬒᅉᏊࡢ୰࡛ࡣࡵࡲ࠸㔜ᗘ⩌࡛ࡣᑵປࡋ࡚ ࠸ࡿࡶࡢࡀከࡃᚋࡢ᳨ウ㡯እⓗ࡞せᅉࡋ࡚⫋ሙ࡛ࡢே㛫㛵ಀࡸࢧ࣏࣮ࢺ࡞ࡢ♫ ⓗ⎔ቃᅉᏊࡀ⪃࠼ࡽࢀࡓࠋ ┠ ⓗ ࡵࡲ࠸ࡣᵝࠎ࡞せᅉ࡛⏕ࡌࡿࠋཎᅉࡣ࣓ࢽ࢚࣮ࣝࡸ๓ᗞ⚄⤒⅖࡞ࡢ๓ᗞᝈࡼࡿᮎ ᲈ๓ᗞᛶࡵࡲ࠸⬻⾑⟶㞀ᐖ࡞ࡢ୰ᯡ⚄⤒ᝈࡼࡿ୰ᯡᛶࡵࡲ࠸⢭⚄་Ꮫⓗ࣭ᚰ⌮ⓗせ ᅉࡼࡿࡵࡲ࠸ศࡅࡿࡇࡀฟ᮶ࡿࠋࣉ࣐ࣛࣜࢣእ᮶ᩆᛴእ᮶ࡵࡲ࠸ᑓ㛛እ᮶࠾ ࡅࡿࡵࡲ࠸ࡢཎᅉࡢྜࡣ࠾࠾ࡴࡡ୍⮴ࡋᮎᲈ๓ᗞᛶࡀ 㸣୰ᯡᛶࡀ 㸣⢭⚄㞀 ᐖࡀ 㸣ࡢཎᅉࡀ 㸣ཎᅉ᫂ࡀ 㸣࡛࠶ࡗࡓ ࠋⓎࡢཎᅉࡋ࡚ᚰ⌮ ♫ⓗࢫࢺࣞࢫࡣ㔜せ࡞ࡶࡢ࡛࠶ࡿࠋ⒪ࡣ୍⯡ⓗࡣ⸆≀⒪ࡀ⾜ࢃࢀࡿࡀ୍㒊ࡢ ࡛ࡣ≧ࡢᨵၿࡀᚓࡽࢀࡎ㞴ࡍࡿࠋࡵࡲ࠸≧ࡢ㞴ࡣᝈ⪅ࡢㄆ▱ࡢၥ㢟ࡀᙳ㡪 ࡋ࡚࠸ࡿྍ⬟ᛶࡀ࠶ࡿࠋᅇ≉㌟య⾲⌧ᛶ㞀ᐖ࡛ὀ┠ࡉࢀ࡚࠸ࡿ㌟యឤぬቑᖜ㌟యឤ ぬᑐࡍࡿ◚ᒁⓗᛮ⪃ὀ┠ࡋࡓࠋ ㌟యឤぬቑᖜࡣ㌟యឤぬࢆᙉࡃ᭷ᐖᨭ㞀࠶ࡿࡶࡢࡋ࡚ឤࡌࡿഴྥࡢࡇࢆ࠸࠺ ࠋ ࡇࡢഴྥࡣ⏕ୗࡽഛࢃࡗࡓᏳᐃⓗ࡞▱ぬ≉ᛶ࡛࠶ࡿྠ≉ᐃࡢឤぬࡘ࠸࡚␗ ࡞ࡗࡓ≧ἣ࡛ࡣ␗࡞ࡗࡓ⛬ᗘ࡛ឤ▱ࡋ࠺ࡿ࠸࠺≧ែ≉ᛶࡢ୧᪉ࡢᛶ㉁ࢆྵࢇ࡛࠸ࡿࠋ㌟ యឤぬᑐࡍࡿ◚ᒁⓗᛮ⪃ࡣ㌟య≧ᙳ㡪ࢆཬࡰࡍせᅉࡢ୍ࡘ⪃࠼ࡽࢀ࡚࠸ࡿࠋᮏ◊ ✲࡛ࡣࡑࡢㄪᰝࢆ┠ⓗࡋࡓ㸳ᅉᏊ 㡯┠ࡽ࡞ࡿࠕ㌟యឤぬᑐࡍࡿ◚ᒁⓗᛮ⪃ᑻᗘࠖ ࢆ⏝࠸ࡓࠋྛᅉᏊࡣࠕ㌟యឤぬᑐࡍࡿὀពࠖࠕ᪥ᖖ⏕άୖࡢᨭ㞀ࠖࠕ㔜⠜࡞Ẽࡢᠱᛕࠖ ࠕ≧ᑐࡍࡿ↓ຊឤࠖ࠾ࡼࡧࠕ⤯ᮃឤ࡛ࠖ࠶ࡿࠋ ᮏ◊✲࡛ࡣ㞴ᛶࡵࡲ࠸ᝈ⪅ࢆᑐ㇟ࡋ࡚ᝈ⪅ࡢ♫ⓗ⫼ᬒࢆྵࡵࡓ⮬グᘧ㉁ၥ⣬ࢆ⏝࠸ ࡵࡲ࠸ࡢ㔜࠾ࡅࡿᚰ⌮ⓗせᅉࡘ࠸᳨࡚ウࢆ⾜ࡗࡓࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ 㒔ෆ༢୍་⒪タ⪥㰯ဗႃ⛉እ᮶࡚ ࣧ᭶௨ୖ୍⯡ⓗ⒪ࢆ⾜ࡗࡓࡶࢃࡽࡎࡵ ࡲ࠸≧ࡀ㑄ᘏࡋࡓᝈ⪅ࡢ࠺ࡕ ᖺ ᭶ࡽ ᭶ࡢ㛫ධ㝔ࡼࡿ✚ᴟⓗ࡞⒪ࢆ ― 57 ― ᕼᮃࡋࡓ㞴ᛶᮎᲈᛶࡵࡲ࠸ 210 (ዪ 75%, ᖹᆒᖺ㱋 65 ṓ)ࢆᑐ㇟ࡋࡓࠋ᳨ウࡋࡓ㡯 ┠ࡣᛶู,ᖺ㱋,ᑵປࡢ᭷↓(↓⫋㸭ᑵປ),᭱⤊ᏛṔ(▷௨ୗ㸭Ꮫ௨ୖ),ᚰ⌮ᑻᗘ࡛࠶ࡿࠋᚰ ⌮ᑻᗘࡣ,(a)㌟యឤぬᑐࡍࡿ◚ᒁⓗᛮ⪃ᑻᗘ(Somatosensory Catastrophizing Scale, SSCS), (b) ㌟ య ឤ ぬ ቑ ᖜ ᑻ ᗘ (Somatosensory Amplification Scale), (c) ㌟ య ≧ ホ ౯ (Medical Symptom Checklist), (d) ⮬ᕫホᐃᘧᢚ࠺ࡘᑻᗘ(Self-rating Depression Scale, SDS)ࡢࡑࢀࡒࢀࡘ࠸࡚⮬グᘧ㉁ၥ⣬ࢆ⏝࠸࡚ᑜࡡࡓࠋࡵࡲ࠸ࡢ㢖ᗘࢆ㐌୍ᅇ௨ୖࢆࡵ ࡲ࠸㔜ᗘ⩌,ࡑࢀᮍ‶ࢆࡵࡲ࠸㍍ᗘ⩌ᐃ⩏ࡋ,ࡑࢀࡒࢀࡢᅉᏊࡢ㛵㐃ࢆ⤫ィᏛⓗ᳨ウ ࡋࡓࠋ ⤖ ᯝ ࡵࡲ࠸㍍ᗘ⩌ẚ࡚,ࡵࡲ࠸㔜ᗘ⩌ࡣ᭷ពⱝࡃ(p=0.001),ᑵປࡋ࡚࠾ࡾ(p=0.001),᭱ ⤊ᏛṔࡣᏛ௨ୖ࡛࠶ࡗࡓ(p=0.013)ࠋࡲࡓ,ᚰ⌮ᑻᗘࡢ SSCS (p<0.0001)࡞ࡽࡧ SDS (p=0.049)ࡢᖹᆒⅬࡣࡵࡲ࠸㔜ᗘ⩌ࡀ㍍ᗘ⩌ࡼࡾࡶ᭷ព㧗ࡗࡓࠋࡵࡲ࠸ࡢ㔜ᗘᙳ㡪 ࡍࡿᅉᏊࢆ᳨ウࡍࡿࣟࢪࢫࢸࢵࢡᅇᖐศᯒ࡛ࡣㄝ᫂ኚᩘࡋ࡚ SSCS ࡢྜィ್ࢆᢞධࡋ ࡓࣔࢹࣝ㸯 SSCS ࡢྛᅉᏊࡢ್ࢆᢞධࡋࡓࣔࢹࣝ㸰ࢆ⾜࠸,ᑵປࡋ࡚࠸࡞࠸ሙྜẚᑵ ປࡋ࡚࠸ࡿࡵࡲ࠸ࡣ 3 ಸ㔜ࡋࡸࡍࡃ(ࣔࢹࣝ 1 OR 3.47,95%CI:1.51-8.00; ࣔࢹࣝ 2 OR 3.18, 95%CI:1.36-7.45),ࣔࢹࣝ㸯࡚ SSCS ࡢྜィⅬࡀ 1 Ⅼୖ᪼ࡍࡿࡈࡵࡲ࠸ࡣ 3㸣(95%CI: 1.01-1.05)㔜ഴࡁࡸࡍ࠸ഴྥࢆ,ࣔࢹࣝ㸰࡚ SSCS ࡢ➨ᅉᏊ㸦⏕άୖࡢ ᨭ㞀㸧ࡀ 1 Ⅼୖ᪼ࡍࡿࡈࡵࡲ࠸ࡣ 11%㔜㌿ࡌࡿഴྥ(OR 1.11, 95%CI:1.03-1.19) ࢆㄆࡵࡓࠋ ― 58 ― ― 59 ― 㢌㢕㒊ᡥᖹୖ⓶⒴࠾ࡅࡿࣄࢺங㢌⭘࢘ࣝࢫ㸦+39㸧ࡢ㛵 ᚨ ⿱ࠊ⸨ṇே ⫈ぬᖹ⾮ぬ◊✲㒊 せ⣙ Ḣ⡿࡛ࡣᛶάືࡢከᵝࠊάⓎక࠸ +39 㛵㐃ࡋࡓ୰ဗ㢌⒴ࡀቑຍഴྥ࠶ࡿࠋ ᚋࠊᮏ㑥࠾࠸࡚ࡶḢ⡿ࡢὶࢀࢆ㏣㝶ࡋࠊ+39 㛵㐃୰ဗ㢌⒴ࡀቑຍࡍࡿ⪃࠼ࡽࢀࡿࠋ+39 㛵㐃ࡢ୰ဗ㢌⒴ࡣ㠀ႚ↮⪅ࡸẚ㍑ⓗⱝᖺ⪅ከࡃⓎ⏕ࡋࠊࡲࡓணᚋࡀⰋዲ࡛࠶ࡿ࡞ࠊࡇ ࢀࡲ࡛ࡢ㢌㢕㒊⒴ࡣ␗࡞ࡿ⮫ᗋീࢆ࿊ࡍࡿࠋ+39 㝧ᛶࡢ୰ဗ㢌⒴ࡣࠊᚑ᮶ࡢ㢌㢕㒊⒴ࡣ ␗࡞ࡿⓎ⒴࣓࢝ࢽࢬ࣒ࡼࡗ࡚Ⓨ⏕ࡋࡓ⪃࠼ࡽࢀࠊࡇࢀࡽࡢ୰ဗ㢌⒴ᑐࡋ࡚ࡣࠊ ᪂ࡓ࡞⒪ᡓ␎ࡀᚲせ࡛࠶ࡿ⪃࠼ࡽࢀࡓࠋ ⫼ᬒࠊ┠ⓗ ࣄࢺங㢌⭘࢘ࣝࢫ㸦KXPDQSDSLOORPDYLUXV+39㸧ࡣࣃ࣏ࣂ࢘ࣝࢫᒓࡍࡿ࢘ࣝࢫ ࡛ࠊṇ༑㠃యᵓ㐀ࡢ࢟ࣕࣉࢩࢻᵓ㐀ෆᮏ㙐⎔≧ '1$ ࢆࢤࣀ࣒ࡋ࡚ᣢࡗ࡚࠾ࡾࠊ ✀㢮௨ୖࡢᆺࡀ▱ࡽࢀ࡚࠸ࡿࠋࡁࡃపࣜࢫࢡ⩌㧗ࣜࢫࢡ⩌ศ㢮ࡉࢀࠊపࣜࢫࢡ⩌ ࡣࢱࣉ 㸪ࠊ㸪㸪 ࡞ࡀᒓࡋࠊࡸᑤᆂࢥࣥࢪ࣮࣐ࣟࡢⓎ⏕㛵㐃ࡋ࡚࠸ࡿࠋ ୍᪉ࠊ㧗ࣜࢫࢡ⩌ࡣࢱࣉ 㸪㸪ࠊ㸪ࠊ࡞ࡀྵࡲࢀࠊࡑࡢᣢ⥆ឤᰁࡣᏊᐑ㢕 ⒴࡞ࡢᝏᛶ⭘⒆ࡢཎᅉ࡞ࡿࡉࢀ࡚࠸ࡿ㸯㸧ࠋ㢌㢕㒊⒴ +39 ࡢ㛵㐃ࡘ࠸࡚ࡣ௨๓ ࡼࡾ♧ࡉࢀ࡚ࡁࡓࡀࠊ᭱㏆ࡢႚ↮⋡ࡸ㣧㓇㔞ࡢపୗక࠸ࠊᨵࡵ࡚ +39 㛵㐃ࡢ㢌㢕㒊⒴ࠊ ≉୰ဗ㢌⒴ࡀὀ┠ࡉࢀࡿࡼ࠺࡞ࡗ࡚ࡁࡓࠋᙜ⛉࡛ຍ⒪ࡋࡓ㢌㢕㒊⒴ࢆᑐ㇟㹆㹎 㹔ឤᰁࡢ᳨ウࢆ⾜࠺ࡶࠊ୰ဗ㢌⒴㹆㹎㹔ࡢ㛵㐃ࡘ࠸࡚ゝཬࡍࡿࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ ᑐ㇟ࡣᙜ⛉࡚ຍ⒪ࡋࡓ㢌㢕㒊ᡥᖹୖ⓶⒴ ࡛ࠊཎⓎ㒊ู࡛ࡣୗဗ㢌 ࠊ ႃ㢌 ࠊ୰ဗ㢌 ࠊཱྀ⭍ ࡛࠶ࡗࡓ ࡋࡓࠋᛶูࡣ⏨ᛶ ࠊዪᛶ ࡛ࠊ ᖺ㱋ࡢ୰ኸ್ࡣ ṓ࡛࠶ࡗࡓࠋᮇศ㢮࡛ࡣࢫࢸ࣮ࢪϩࡀ 㸦㸧 ࠊࢫࢸ࣮ࢪϪࡀ 㸦㸧ࠊࢫࢸ࣮ࢪϫࡀ 㸦㸧㐍⾜⒴ࡀ㒊ศࢆ༨ࡵࡓࠋᡭ⾡ࡶࡋࡃࡣ⏕᳨࡚᥇ ྲྀࡉࢀࡓ᳨యࡣࠊ㏿ࡸ㸫 ᗘ࡛ಖᏑࡋࠊࡑࡢᚋ '1$ ࢆᢳฟࡋࡓࠋ㹆㹎㹔ࡢ᳨ฟࢱ ― 60 ― ࣆࣥࢢࡣ 3&5+XPDQ3DSLOORPDYLUXV'HWHFWLRQ6HW ࠾ࡼࡧ 3&5+XPDQ3DSLOORPDYLUXV7\SLQJ 6HWඹࢱ࢝ࣛࣂ࢜ᰴᘧ♫ࢆ⏝࠸ࡓࠋ'HWHFWLRQVHW ࡛ࡣ㹆㹎㹔ࠊࠊ࠾ࡼࡧ ᆺ ࢆࡑࢀࡒࢀ≉␗ⓗቑᖜࡍࡿࣉ࣐࣮ࣛࢆ⏝࠸࡚㹎㹁㹐ࢆ⾜࠸ࠊ㹆㹎㹔ࢆ᳨ฟࡋࡓࠋࡲࡓ 7\SLQJ6HW ࡛ࡣࡲࡎ㹆㹎㹔ࡢ ( ( ࢆྵࡴ㡿ᇦ㸦㹼ES㸧ࢆࢥࣥࢭࣥࢧࢫࣉ࣐ࣛ ࣮࡚ቑᖜࡋࡓࠋቑᖜࡉࢀࡓ '1$ ࣇࣛࢢ࣓ࣥࢺࡣᩘ✀㢮ࡢไ㝈㓝⣲࡛ฎ⌮ࡋࠊࡑࡢ㟁ẼὋ ືࣃࢱ࣮ࣥࡼࡾ㹆㹎㹔ࡢࢱࣉࢆุูࡋࡓࠋ 㧗ࣜࢫࢡ㹆㹎㹔࡛࠶ࡿࢱࣉ ࠾ࡼࡧపࣜࢫࢡ㹆㹎㹔࡛࠶ࡿࢱࣉ ࡢྜィ ✀㢮ࡢ㹆㹎㹔ࡀ᳨ฟྍ⬟࡛ ࠶ࡿࠋ ⤖ ᯝ ᑐ㇟ ୰ࠊ 㸦㸧㹆㹎㹔ࡢឤᰁࢆㄆࡵࠊ࠸ࡎࢀࡶ୰ဗ㢌⒴࡛࠶ࡗࡓࠋ୰ဗ 㢌⒴ࡢࡳ࡛ࡣ ୰ 㸦㸧㹆㹎㹔ࡀ᳨ฟࡉࢀࡓࠋ㹆㹎㹔ࡢࢱࣆࣥࢢࡢ⤖ᯝࡣࢱ ࣉ ࡀ ࠊࢱࣉ ࡀ ࡛࠶ࡗࡓࠋ㹆㹎㹔ឤᰁࡢ᭷↓⭘⒆ࡢள㒊ࡢ㛵ಀࢆ ࡳ࡚ࡳࡿࠊ㹆㹎㹔㝧ᛶ୰ဗ㢌⒴࡛ࡣཱྀᡥ᱈ ࠊ⯉᰿ ࡛࠶ࡗࡓࡀࠊ㝜ᛶࡣཱྀ ᡥ᱈ ࠊ⯉᰿ ࡛ࠊࡑࡢࡢ ࡣᚋቨࠊ㌾ཱྀ࡛࠶ࡗࡓࠋࡇࢀࡲ࡛ࡢሗ࿌ྠᵝࠊ ཱྀᡥ᱈⯉᰿ࡀ㹆㹎㹔ឤᰁᙉ࠸㛵㐃ࡀ࠶ࡿࡇࡀ♧ࡉࢀࡓࠋႚ↮≧ែࡢ㛵㐃ࢆぢࡿ ࠊ㹆㹎㹔㝧ᛶࡣ㠀ႚ↮⪅ࡀ ࠊႚ↮⪅ࡶࡋࡃࡣ㐣ཤࡢႚ↮⪅ࡀ ࡛࠶ࡗࡓࡀࠊ 㹆㹎㹔㝜ᛶ࡛ࡣ㠀ႚ↮⪅ࡀ ࠊႚ↮⪅ࡶࡋࡃࡣ㐣ཤࡢႚ↮⪅ࡀ ࡛࠶ࡗࡓࠋ㹆㹎 㹔㝧ᛶࡣ᭷ព㠀ႚ↮⪅ࡀከ࠸ഴྥࡀㄆࡵࡽࢀࡓࠋࡲࡓ㹆㹎㹔ឤᰁࡢ᭷↓㹒ศ㢮ࠊ 㹌ศ㢮ࠊᮇศ㢮ࡢ㛵㐃ࡣㄆࡵࡽࢀ࡞ࡗࡓࠋ ⪃ᐹࠊᚋࡢ᳨ウㄢ㢟 ࣄࢺங㢌⭘࢘ࣝࢫ㸦+39㸧ࡣࣄࢺᐜ᫆ឤᰁࡍࡿࡓࡵࠊዪᛶࡢ⣙ ̺ࡣ୍⏕ࡢ࠺ ࡕ୍ᗘࡣᛶჾ +39 ឤᰁࡀ⏕ࡌࡿࡉࢀ࡚࠸ࡿࠋࡋࡋ࡞ࡀࡽࠊከࡃࡢሙྜࡣ⮬ᕫࡢච ຊ࡛㝖ࡉࢀ⣙ 㸫ࡀᣢ⥆ឤᰁ࡞ࡾࠊᩘᖺࡽ ᩘᖺᚋ㧗ᗘࡢ⣽⬊␗ᆺࢆ㉳ࡇࡍ ࡢࡣ ⛬ᗘ࡛࠶ࡿࠋ᭱⤊ⓗᏊᐑ㢕⒴ࡲ࡛⮳ࡿࡢࡣឤᰁ⪅ࡢ⣙ 㸣⛬ᗘࡉࢀ࡚࠸ࡿࠋ ࡇࡢࡼ࠺㒊ศࡢ +39 ឤᰁࡀ୍㐣ᛶឤᰁ⤊ࢃࡿࡢࡣࠊ1. ⣽⬊ࡸ࣐ࢡࣟࣇ࣮ࢪ࡞ࡢ ⣽⬊ࠊࣥࢱ࣮ࣇ࢙ࣟࣥ࡞ࡢࢧࢺ࢝ࣥࡀᶵ⬟ࡋ࡚⏕ࡌࡿᐟࡢචᛂ⟅ࡼࡿࠋ 㧗ࣜࢫࢡ +39 ࡀᐟ⣽⬊ࡢ '1$ ⤌ࡳ㎸ࡲࢀࡿࠊ+39 ࡢ୰ࡢ ( 㑇ఏᏊࡀษ᩿ࡉࢀࠊࡑ ࡢ ( 㑇ఏᏊࡼࡾⓎ⌧ࡀᢚไࡉࢀ࡚࠸ࡓࠊ+39 ⏤᮶ࡢ⒴⺮ⓑ (ࠊ( ࡀ㧗Ⓨ⌧ࡍࡿࠋ(ࠊ( ࡣࠊ⒴ᢚไ㑇ఏᏊࡋ࡚᭷ྡ࡞ S ࡸ5E ࠸ࡗࡓ㑇ఏᏊࡢാࡁࢆάࡍࡿࡓࡵࠊࡑࡢ⤖ ᯝࠊ⒴ࡘ࡞ࡀࡿ⪃࠼ࡽࢀ࡚࠸ࡿࠋࡑࡢࠊ࣏ࢺ࣮ࢩࢫࡢᢚไࠊࢸ࣓ࣟࡢቑ㛗ࠊ ⣽⬊ቑṪࡢஹ㐍࡞ࡢ⒴㛵㐃ࡋࡓാࡁࡶሗ࿌ࡉࢀ࡚࠸ࡿࠋ ― 61 ― 㢌㢕㒊⒴ +39 ࡢ㛵㐃ࡘ࠸࡚ࡣᮏ㑥࠾࠸࡚ࡶ௨๓ࡼࡾ♧ࡉࢀ࡚ࡁࡓࡀࠊ᭱㏆ࡢႚ ↮⋡ࡸ㣧㓇㔞ࡢపୗక࠸ࠊᨵࡵ࡚ +39 㛵㐃ࡢ㢌㢕㒊⒴ࠊ≉୰ဗ㢌⒴ࡀὀ┠ࡉࢀࡿࡼ࠺ ࡞ࡗ࡚ࡁࡓࠋ࠸࠺ࡢࡶḢ⡿ࢆ୰ᚰࡋ࡚ࠊ+39 ࡀ㝧ᛶ࡛࠶ࡿ୰ဗ㢌⒴ࡢⓎ⏕⋡ࡀୖ᪼ࡋ ࡚࠸ࡿࡽ࡛࠶ࡿࠋࡑࡢ⌮⏤ࡋ࡚ࡣࠊⱝᖺ⪅ࡢᛶάືࡢάⓎࠊከᵝࡀᣲࡆࡽࢀ࡚࠾ ࡾࠊYDJLQDOVH[SDUWQHUV ࡸ RUDOVH[SDUWQHU ࡢᩘ +39 ឤᰁ⋡ࡸ୰ဗ㢌⒴ࡢⓎ⏕⋡ ࡢ┦㛵ࡀ♧ࡉࢀ࡚࠸ࡿࠋࡲࡓࢫ࢙࣮࢘ࢹࣥ࠾࠸࡚ࡶཱྀᡥ᱈ཎⓎࡢᡥᖹୖ⓶⒴ࡀᛴቑ ࡋ࡚࠾ࡾࠊ+39 ࡢ㝧ᛶ⋡ࡶࡲࡓୖ᪼ࡋ࡚࠸ࡿࡇࡀሗ࿌ࡉࢀ࡚࠸ࡿࠋ ࡇࢀࡽࡢ +39 㛵㐃㢌㢕㒊⒴ࡣࡇࢀࡲ࡛ࡢ㢌㢕㒊⒴ẚ㍑ࡋࠊ࠸ࡃࡘࡢ⮫ᗋୖࡢ≉ᚩࡀ ࠶ࡿࠋ࠼ࡤ +39 㝧ᛶ㢌㢕㒊⒴ᝈ⪅ࡣࠊ㠀ႚ↮⪅࡛ẚ㍑ⓗⱝᖺ⪅Ⓨ⏕ࡍࡿࡇࡸணᚋࡀ Ⰻዲ࡛࠶ࡿࡇ࡞ࡀሗ࿌ࡉࢀ࡚࠸ࡿࠋணᚋࡀⰋዲ࡛࠶ࡿ⌮⏤ࡣࡣࡗࡁࡾࡣゎ᫂ࡉࢀ࡚ ࠸࡞࠸ࡀࠊ+39 㝧ᛶ㢌㢕㒊⒴࡛ࡣ ILHOGFDQFHUL]DWLRQ ࡀ⏕ࡌ࡚࠾ࡽࡎ㔜」⒴ࡀⓎ⏕ࡋࡃ ࠸ࡇࡸࠊ⒴ᢚไ㑇ఏᏊ࡛࠶ࡿ S ࡀ ( ࡛ᢚไࡉࢀ࡚࠸ࡿࡶࡢࡢࡑࡢ㑇ఏᏊኚ␗ࡀᑡ࡞ࡃ 㸧ࠊᏛ⒪ἲࡸᨺᑕ⥺⒪ᑐࡍࡿឤཷᛶࡀ㧗࠸ࡇ࡞ࡀ⪃࠼ࡽࢀ࡚࠸ࡿࠋ+39 㛵㐃㢌 㢕㒊⒴࡛ࡣࠊᚑ᮶ࡽᥦၐࡉࢀ࡚ࡁࡓⓎ⒴࣓࢝ࢽࢬ࣒ࡣ␗࡞ࡿᶵᗎࡀാ࠸࡚࠾ࡾ⮫ᗋⓗ ࡶ⏕≀Ꮫⓗࡶᚑ᮶ࡢ㢌㢕㒊⒴ࡣ␗࡞ࡿ≉ᚩࢆ♧ࡋ࡚࠸ࡿࠋ ᚋࠊᮏ㑥࠾࠸࡚ࡶ⡿ᅜ࡛ࡢഴྥࢆ㏣ᚑࡋ +39 㛵㐃ࡢ㢌㢕㒊⒴ࡀቑຍࡍࡿࡇࡀண ࡉࢀࠊ⌧Ⅼ࡛ࡢ +39 ឤᰁࡢ㢖ᗘࡸࢱࣆࣥࢢࢆ᳨ウࡍࡿࡇࡣ㔜せ࡛࠶ࡿ⪃࠼ࡽࢀࡿࠋ ᡃࠎࡣᙜ⛉࡚⒪ࢆ⾜ࡗࡓ㢌㢕㒊⒴ࡘ࠸࡚ +39 ឤᰁࡢ᭷↓ࢆ᳨ウࡋࡓࡀࠊ⤖ᯝࡣ୰ဗ 㢌⒴ࡢࡳ +39 㝧ᛶࡀㄆࡵࡽࢀࠊࡑࡢ㢖ᗘࡣ ࡛࠶ࡗࡓࠋ㢌㢕㒊⒴ࡢ +39 ឤᰁࡘ࠸ ࡚ࡣࠊႃ㢌⒴ࡸཱྀ⭍⒴࡛ࡢ᳨ฟࡶሗ࿌ࡉࢀ࡚࠸ࡿࡀࠊ᭱㏆࡛ࡣࢇࡀ୰ဗ㢌⒴࠾ࡅ ࡿሗ࿌ࡀከ࠸ࠋࡲࡓᡃࠎࡢ +39 ࢱࣆࣥࢢࡢ⤖ᯝࡣ㒊ศࡢࡀ +39 ࡛࠶ࡾࠊࡑࢀ௨ እ࡛ࡣࢱࣉ ࡀ ㄆࡵࡽࢀࡓࡔࡅ࡛࠶ࡗࡓࠋ+39 ࡢࢱࣉࡣ ✀㢮௨ୖࡀ▱ࡽࢀ࡚ ࠸ࡿࡀࠊⓎ⒴㛵㐃ࡋ࡚࠸ࡿࡢࡣ࠸ࢃࡺࡿ㧗ࣜࢫࢡ⩌ศ㢮ࡉࢀࡿ +39 ࡛࠶ࡿࠋ୰࡛ࡶ +39 ࡢឤᰁࡀ㒊ศࢆ༨ࡵ࡚࠾ࡾࠊ⡿ᅜ࡛ࡢሗ࿌࡛ࡣ㢌㢕㒊⒴᳨࡛ฟࡉࢀࡿ +39 ࡣ ௨ୖࡀ +39 ࡛࠶ࡿࠋ+39 ࡢឤᰁ㛵㐃ࡀ῝࠸Ꮚᐑ㢕⒴ࡢሙྜࡣࠊ⡿ᅜ࡛ࡣ +39ࠊ ࡢឤᰁࡀ 㒊ศࢆࡋࡵࡿࡀࠊᮏ㑥࡛ࡣ 㸪 ࡢࡳ࡞ࡽࡎ 㸪ࠊ㸪 ࠸ࡗࡓࡢ㧗ࣜࢫࢡࢱ ࣉࡢ +39 ࡶẚ㍑ⓗ㢖ᗘࡀ㧗ࡃ᳨ฟࡉࢀ࡚࠸ࡿࠋ+39 㛵㐃ࡢ㢌㢕㒊⒴ࡀᛶάືᐦ᥋࡞㛵㐃ࡀ ࠶ࡿࡢ࡛࠶ࢀࡤࠊᮏ㑥ࡢ㢌㢕㒊⒴࠾ࡅࡿ +39 ࡢࢱࣉࡣᏊᐑ㢕⒴ࡢࢱࣉูࡢྜྠ ➼ࡢศᕸࢆ♧ࡍ᥎ ࡉࢀࡿࠋᚋࡢከタ࡛ࡢゎᯒࡀᚲせ࡛࠶ࡿ⪃࠼ࡽࢀࡿࠋ ᭱㏆࡞ࡾ +39 㝧ᛶ୰ဗ㢌⒴ࡢணᚋࡀⰋዲ࡛࠶ࡿࡢሗ࿌ࡀ⥆࠸࡚࠸ࡿࠋᚋࡢࡉࡽ࡞ ࡿ᳨ウࡼࡗ࡚ࠊ+39 ឤᰁࡢ᭷↓㸦Ꮫ㸧ᨺᑕ⥺⒪ᑐࡍࡿឤཷᛶࡸணᚋ࡞ࡢ㛵㐃 ࡀ᫂☜࡞ࢀࡤࠊ+39 ឤᰁࡢ≧ែࡀ⒪᪉㔪ࢆỴᐃࡍࡿୖ࡛㔜せ࡞ࣂ࣐࣮࣮࢜࢝࡞ࡿྍ ⬟ᛶࡀ࠶ࡿࠋࡲࡓ +39 ᳨ᰝࡢಖ㝤㐺ᛂࡸࡼࡾ⡆౽࡛くࡢᑡ࡞࠸᳨ฟ᪉ἲࡢ㛤Ⓨ࡞ࡘ ࠸࡚ࡶ᳨ウࡍࡿࡁ⪃࠼ࡽࢀࡿࠋ ― 62 ― ⫈ぬᖹ⾮ぬ◊✲㒊 㢌㢕㒊ᡥᖹୖ⓶⒴࠾ࡅࡿࡀࢇᖿ⣽⬊ᵝ⣽⬊࣐࣮࣮࢝ࡢⓎ⌧ࡑࡢ ⮫ᗋⓗព⩏㛵ࡍࡿ᳨ウ -StageϨ/ϩ⯉ᡥᖹୖ⓶⒴࠾ࡅࡿᚋⓎ㢕㒊ࣜࣥࣃ⠇㌿⛣࠾࠸࡚⩚⏕᪼ ⸨ṇே㸦⫈ぬᖹ⾮ぬ◊✲㒊㸧 ࠙せ⣙ࠚ ㏆ᖺ⒴ᖿ⣽⬊ࡢᴫᛕࡀᥦၐࡉࢀࠊ㢌㢕㒊⒴࠸࡚ࡶ Side Population㸦SP㸧⣽⬊ࡣࠊ ⒴ᖿ⣽⬊ࢆከࡃྵࢇࡔ⣽⬊ሗ࿌ࡉࢀ࡚࠸ࡿࡀࠊࡑࡢᙺࡣ༑ศゎ᫂ࡉࢀ࡚࠸࡞࠸ࠋ ⒴ᖿ⣽⬊ࡣ⒪ᢠᛶࠊⓎࠊ㌿⛣㛵ࡋ࡚࠸ࡿ࠸ࢃࢀ࡚࠸ࡿࠋ StageϨ/ϩ⯉⒴ࡣࠊ㏻ᖖ⯉㒊ศษ㝖⾡ࡀ⾜ࢃࢀࡿࡀࠊࡑࡢ࠺ࡕ⣙ 14-48㸣ཎⓎᕢࡣไ ᚚࡉࢀ࡚࠸ࡿࡶࢃࡽࡎࠊᚋⓎ㢕㒊ࣜࣥࣃ⠇㌿⛣ࡀ⏕ࡌࡿࠋᚋⓎ㢕㒊ࣜࣥࣃ⠇ࡣ⏕ Ꮡ⋡ࢆపୗࡉࡏࡿࠋ ᚋⓎ㢕㒊ࣜࣥࣃ⠇㌿⛣࠾࠸࡚⒴ᖿ⣽⬊ࡢ㛵㐃ࡘ࠸᳨࡚ウࡋࡓࠋ ࡑࡇ࡛ᡃࠎࡣձ⯉ᡥᖹୖ⓶⒴⣽⬊ᰴ࠾ࡅࡿ SP ⣽⬊ࡢ᭷↓㸪ղSP ⣽⬊࠾ࡅࡿ⒴ᖿ ⣽⬊㛵㐃㑇ఏᏊࡢⓎ⌧㸪ճSP ⣽⬊ࡢᶵ⬟ࡋ࡚ࠊቑṪ⬟࣭㐟㉮⬟࣭ᾐ₶⬟, մ⯉⒴⮫ᗋ ᳨య࠾ࡅࡿྠ㛵㐃㑇ఏᏊࡢⓎ⌧ࡑࡢ⮫ᗋⓗព⩏ࡘ࠸᳨࡚ウࡋࡓࠋ ࠙ᑐ㇟࠾ࡼࡧ᪉ἲ࣭⤖ᯝࠚ ձ DNA ⤖ྜⰍ⣲ Hoechst33342 ࢆ⏝࠸⯉⒴ᡥᖹୖ⓶⒴⣽⬊ᰴ(SAS,HSC4,SCC4)ࢆ flowcytometry ࡚ sorting ࡋࡓ⤖ᯝ㸪SP ࡣ SAS ࡚ 0.9㸣ࠊHSC4 ࡚ 0.9%ࠊSCC 㸲࡚ 10.2㸣ࠊࡑࢀࡒࢀㄆࡵࡽࢀࡓࠋABC transporter 㜼ᐖ࡚ࡑࢀࡒࢀ SP ࡢ ྜࡀⴭ᫂ῶᑡࡍࡿࡇࡽ⒴ᖿ⣽⬊ᵝ⣽⬊⪃࠼ࡽࢀࡓࠋ ղ SCC4 ࡢ SP ⣽⬊ non SP ⣽⬊ࢆ Microarray ࡚ゎᯒࡋࡓࠋSP ⣽⬊࡛ࡣ Oct3/4,Ntohc1,CD44,ABCG2 ࡀ non SP ⣽⬊ࡼࡾⓎ⌧ࡀ㧗ࡗࡓࠋࡘࡂ RT-PCR ࡚⒴ᖿ⣽⬊㛵㐃㑇ఏᏊࡢⓎ⌧ࢆ SCC4 ࡢ SP ⣽⬊ non SP ⣽⬊ࡢ㛫࡛ẚ㍑ࡋࡓ⤖ ᯝࠊSP ⣽⬊࡛㌿ᅉᏊ Oct3/4ࠊNanog ࡢⓎ⌧ࡀ㧗ࡃ㸦ᅗ㸯㸧ࠊච⤌⧊ᏛᰁⰍ ࡚ࡶྠᵝࡢ⤖ᯝࡀ♧ࡉࢀࡓࠋ ճ SCC4 ࡢ SP ⣽⬊ non SP ⣽⬊ࡢ㛫࡛ࠊ㸲㸶㛫࠾ࡅࡿ proliferation assay, migration assay, invasion assay ࢆ⾜࠸ࠊẚ㍑ࡋࡓࠋ⣽⬊ቑṪ⬟᫂ࡽ࡞᭷ពᕪࡣ ㄆࡵ࡞ࡗࡓࠋ㐟㉮⬟ᾐ₶⬟ࡣ SP ⣽⬊ࡀඃ㧗ࡗࡓࠋ ― 63 ― մ ᠕⩏ሿᏛ㝔⪥㰯ဗႃ⛉࡛ึᅇ⒪ࡋ࡚⯉㒊ศษ㝖ࡢࡳࢆ⾜࠸ࠊ3 ᖺ௨ୖ⤒㐣 ほᐹࡋࡓ stage I/II ⯉ᡥᖹୖ⓶⒴ࡢ࠺ࡕཎⓎᕢᶆᮏࢆධᡭࡋ࠼ࡓ 50 ࢆᑐ㇟ࠊ Oct3/4 Nanog ࡢⓎ⌧ࢆචᰁⰍ࡚ホ౯ࡋ㸪ᚋⓎ㢕㒊ࣜࣥࣃ⠇㌿⛣(delayed neck metastasis: DNM)ࡢ㛵ಀࡘ࠸᳨࡚ウࡋࡓࠋDNM ࡣ 13 (267%)ㄆࡵࡽࢀࠊ Oct3/4ࠊNanog ࡢⓎ⌧ࡢ㛫ṇࡢ┦㛵ࡀㄆࡵࡽࢀࡓࠋ⮫ᗋ⌮ᏛⓗᅉᏊ DNM ࡛ ࡣ, muscular invasion, vascular invasion, Mode of invasion(3.4 v.s 1.2)ࡀṇࡢ┦㛵 ࡀㄆࡵࡽࢀࡓࠋ༢ኚ㔞ゎᯒ࡛┦㛵ࡀㄆࡵࡽࢀࡓ Oct3/4 expression, Nanog expression, Mode of invasion, vascular invasion, muscular invasion ࢆ logistic regression ࡼ ࡿከኚ㔞ゎᯒࢆ⾜࠺ࠊDNM ᑐࡍࡿ⊂❧┦㛵ᅉᏊࡣ Oct3/4 expression vascular invasion ࡛࠶ࡗࡓ(ᅗ㸰)ࠋ ࠙⪃ᐹࠚ 㢌㢕㒊⒴ᖿ⣽⬊ࡢᣦᶆࡋ࡚ Oct3/4 Nanog ࡣ᭷⏝࡞ೃ⿵࡞ࡾ࠺ࡿྍ⬟ᛶࡀ♧၀ࡉ ࢀࡓࠋࡉࡽࡇࢀࡽࡢᣦᶆࢆⓎ⌧ࡍࡿ⒴ᖿ⣽⬊ᵝ⣽⬊ࡢᏑᅾࡀࠊ⣽⬊㐟㉮⬟࠾ࡼࡧᾐ₶ ⬟ࡢஹ㐍ࢆࡋ࡚ࠊstage I/II ⯉ᡥᖹୖ⓶⒴ࡢ DNM ᐤࡋ࡚࠸ࡿྍ⬟ᛶࡀ♧၀ࡉࢀࡓࠋ ᅗ㸯 ― 64 ― ᅗ㸰 ― 65 ― 㹙⫈ぬᖹ⾮ぬ◊✲㒊㹛 ࢹࢢ࢚ࣜࣥࡣ㢌㢕㒊ᡥᖹୖ⓶⒴⣽⬊ᰴ࠾࠸࡚ EGFR ࣥࣄࣅࢱ࣮ࡢᢠ⭘⒆ຠ ᯝࢆቑࡉࡏࡿ 㤿ሙඃ ⸨ṇே 㸦⫈ぬᖹ⾮ぬ◊✲㒊㸧 せ⣙ 㢌㢕㒊ᡥᖹୖ⓶⒴࡛ࡣࠊEGFR ࡀ㧗Ⓨ⌧ࡋ࡚࠾ࡾࠊࡲࡓ EGFR ࡢ㧗Ⓨ⌧ணᚋࡢ┦㛵 㛵ಀࡀゝࢃࢀ࡚࠸ࡿࠋࡋࡋ࡞ࡀࡽࠊEGFR ࣥࣄࣅࢱ࣮༢࡛ࡢዌຠ⋡ࡣỴࡋ࡚㧗࠸ ࡣ࠸࠼࡞࠸ࠋࡑࡢཎᅉࡢ୍ࡘࡋ࡚ࠊEGFR IGF1R ࡢࠊPI3kinase/Akt pathway ࢆ ࡋࡓ cross talk ࡢᏑᅾࡀ⪃࠼ࡽࢀ࠺ࡿࠋࡇࡇ࡛ࠊ ᡃࠎࡣࠊࣇࣜ࢝ࡢ᳜≀ Mundulea sericea ⏤᮶ࡢኳ↛≀࡛࠶ࡿࢹࢢ࢚ࣜࣥࡀ㢌㢕㒊ᡥᖹୖ⓶⒴⣽⬊ᰴ࠾࠸࡚ࠊEGFR ࣥࣄࣅࢱ࣮ ࡢᢠ⭘⒆ຠᯝࢆቑࡉࡏࡿࡇࢆሗ࿌ࡍࡿࠋ ┠ⓗ 㢌㢕㒊ᡥᖹୖ⓶⒴࡛ࡣࠊEGFR ࡀ㧗Ⓨ⌧ࡋ࡚࠾ࡾࠊࡲࡓ EGFR ࡢ㧗Ⓨ⌧ணᚋࡢ┦㛵 㛵ಀࡀゝࢃࢀ࡚࠸ࡿࠋࡋࡋ࡞ࡀࡽࠊEGFR ࣥࣄࣅࢱ࣮༢࡛ࡢዌຠ⋡ࡣỴࡋ࡚㧗࠸ ࡣ࠸࠼࡞࠸ࠋࡑࡇ࡛ᡃࠎࡣࠊ㢌㢕㒊ᡥᖹୖ⓶⒴࠾ࡅࡿ EGFR ࣥࣄࣅࢱ࣮⪏ᛶᶵᵓࡢゎ ᫂ࡑࡢඞ᭹ἲࡘ࠸᳨࡚ウࡋࡓࠋ ᪉ἲ 㸯ࠊ ᑐ㇟ࡣᙜ⛉࡚ຍ⒪ࡋࡓ㢌㢕㒊ᡥᖹୖ⓶⒴ 86 ࡛࠶ࡿࠋᡭ⾡ࡶࡋࡃࡣ⏕᳨࡚᥇ ྲྀࡉࢀࡓ᳨యࡣࠊ㏿ࡸ࣮80 ᗘ࡛ಖᏑࡋࠊࡑࡢᚋ DNA ࢆᢳฟࡋࡓࠋCycleave PCR ἲ࡚ࠊEGFR sensitive mutation ࠸ࢃࢀ࡚࠸ࡿࠊEGFR ࡢ exon19 ࡢḞኻ࠾ࡼࡧ L858, G719X, L861Q ࡢⅬ✺↛ኚ␗ࡢ᳨ฟࢆヨࡳࡓࠋ 㸰ࠊ CycleavePCR ἲ࡚ࠊEGFR resistant mutation ࠸ࢃࢀ࡚࠸ࡿࠊEGFR ࡢ T790M ኚ␗ࡢ᳨ฟࢆヨࡳࡓࠋ 㸱ࠊ 㢌㢕㒊ᡥᖹୖ⓶⒴࠾ࡅࡿ EGFR ࣥࣄࣅࢱ࣮⪏ᛶᶵᵓࡢゎ᫂ࡑࡢඞ᭹ἲࡘ ࡁࠊ㐣ཤࡢᩥ⊩ࢆᇶࠊ௬ㄝࡋࡓࠋ㸦ᩥ⊩ review㸧 㸲ࠊ 㢌㢕㒊ᡥᖹୖ⓶⒴⏤᮶⣽⬊ᰴ HSC-4 ࢆ⏝࠸࡚ࠊࢹࢢ࢚ࣜࣥࡣ㢌㢕㒊ᡥᖹୖ⓶⒴⣽ ⬊ᰴ࠾࠸࡚ EGFR ࣥࣄࣅࢱ࣮ࡢᢠ⭘⒆ຠᯝࢆቑࡉࡏࡿྰࢆ᳨ウࡋࡓࠋ ⤖ᯝ 㸯ࠊ㢌㢕㒊ᡥᖹୖ⓶⒴࠾࠸࡚ࠊEGFR sensitive mutation ࡣ᳨ฟࡉࢀ࡞ࡗࡓࠋ㸦0/86㸧 㸰ࠊ㢌㢕㒊ᡥᖹୖ⓶⒴࠾࠸࡚ࠊEGFR resistant mutation ࡣ᳨ฟࡉࢀ࡞ࡗࡓࠋ㸦0/86㸧 㸱ࠊ㢌㢕㒊ᡥᖹୖ⓶⒴࠾࠸࡚ࠊEGFR IGF1R ࡢࠊPI3kinase/Akt pathway ࢆࡋࡓ cross talk ࡢᏑᅾࡀ EGFR ࣥࣄࣅࢱ࣮⪏ᛶᶵᵓࡢ࡛࠶ࡿ௬ㄝࡋࡓࠋ ― 66 ― 㸲ࠊ≉␗ⓗ EGFR ࣥࣄࣅࢱ࣮࡛࠶ࡿ AG1478 ࡣ HSC4 ⣽⬊࠾࠸࡚⇥㓟ᆺ AKT ⺮ⓑ Ⓨ⌧ࢆ᭷ពࡣῶᑡࡉࡏ࡞ࡗࡓࠋ 㸳ࠊAG1478 ࢹࢢ࢚ࣜࣥࡢే⏝ࡼࡾ⇥㓟ᆺ AKT ⺮ⓑⓎ⌧ࡣ᫂ࡽῶᑡࡋࠊࡑࢀ క࠸࣏ࢺ࣮ࢩࢫࡀㄏᑟࡉࢀࡓࠋ ⪃ᐹ ௨ୖࡢ⤖ᯝࡼࡾࠊࢹࢢ࢚ࣜࣥࡣ㢌㢕㒊ᡥᖹୖ⓶⒴⣽⬊ᰴ࠾࠸࡚ EGFR ࣥࣄࣅࢱ࣮ࡢ ᢠ⭘⒆ຠᯝࢆቑࡉࡏࡿࡇࡀ♧ࡉࢀࡓࠋ ― 67 ― >⫈ぬᖹ⾮ぬ◊✲㒊@ ⮬ᐙ㦵⨨ᆺ྾ᛶேᕤ㦵ࡢຠ⋡ⓗ࡞㦵⏕ࡴࡅ࡚ ⴠྜ༤Ꮚ 1ࠊᆏᮏዲ 2 㸦⏕་⒪◊✲ᐊ 1ࠊ᠕⩏ሿᏛᙧᡂእ⛉Ꮫᩍᐊ 2㸧 せ⣙ ᙜ◊✲ᐊ࡛ࡣࣛࢵࢺࡢ㢌Ḟᦆࣔࢹࣝࢆ㛤Ⓨࡋࠊ2010 ᖺࡼࡾேᕤ㦵⛣᳜ࡢ᭷ຠᛶࡢᐇ㦂 ࢆ⾜࠸ሗ࿌ࡋ࡚ࡁࡓࠋᖺࡣࠊ⏕య㦵㏆࠸⤌ᡂࢆᣢࡗࡓࣁࢻࣟ࢟ࢩࣃࢱࢺ㸭ࢥࣛ ࣮ࢤࣥ」ྜయ㸦௨ୗ HA/Col㸧ࡀࠊ㢌㢡㢦㠃㡿ᇦ࠾࠸࡚ࡶ᭷ຠ࡛࠶ࡿࡇࢆሗ࿌ࡋࡓࠋ ᅇࡣࠊHA/Col ࢆࣛࢵࢺ㢌㦵Ḟᦆ㒊⛣᳜ࡍࡿࡇ࡛ࠊேᕤ㦵ࢆ㊊ሙࡋ࡚㦵᪂⏕ࡀ⏕ ࡌࡿࡇࡀ☜ㄆ࡛ࡁࡓྠࠊ◚㦵⣽⬊ࡀேᕤ㦵⾲㠃ᏑᅾࡋࠊHA ࢆ㊊ሙࡋ࡚◚㦵⣽ ⬊ࡀศㄏᑟࡉࢀ࡚࠸ࡿࡇࡀ♧၀ࡉࢀࡓࠋࡲࡓࠊ㦵⭷࡛⿕そࡋࡓ᳨య࠾࠸࡚ࠊRANKL 㝧ᛶ⣽⬊◚㦵⣽⬊ࡀከࡃⓎ⌧ࡋ࡚࠾ࡾࠊ㦵⭷ࡽ RANKL ศἪಁ㐍స⏝ࡀാ࠸࡚࠸ࡿྍ ⬟ᛶࡀ♧၀ࡉࢀࡓࠋ ⫼ᬒ࠾ࡼࡧ┠ⓗ ཱྀᑐࡍࡿ⒪ࡋ࡚㢡㒊ࡢ⛣᳜㦵ࡣ⭠㦵࡞⮬ᐙ㦵⤌⧊ࢆ⏝࠸ࡿࡢࡀ୍⯡ ⓗ࡛࠶ࡿࡀࠊ༑ศ࡞᥇㦵㔞ࡀ☜ಖ࡛ࡁ࡞࠸࡞ࡢၥ㢟ࡶ࠶ࡿࠋࡑࡢ㝿ࠊࣁࢻࣟ࢟ࢩࣃ ࢱࢺ㸦HA㸧ࡸșᆺࣜࣥ㓟୕࢝ࣝࢩ࣒࢘㸦ș-TCP㸧௦⾲ࡉࢀࡿࢭ࣑ࣛࢵࢡࢫேᕤ㦵ࡢ㑅 ᢥࡶ࠶ࡿࡀࠊHA ࡣ㠀྾ᛶᮦᩱ࡛࠶ࡿࡓࡵࠊ㢡ᙧᡂᚋࡢṑ⛉▹ṇࡢၥ㢟ࡸேᕤ≀ࡀṧ Ꮡࡍࡿࡇ࡛⾡ᚋឤᰁ࡞ࡢࣜࢫࢡࡀṧࡿࠋࡲࡓࠊș-TCP ࡣ྾ᛶᮦᩱ࡛࠶ࡿࡀ༑ศ࡞㦵 ⤌⧊そࢃࢀࡓ≧ែ࡛࡞࠸ᮦᩱࡢࡳࡢ྾ࡀ㉳ࡇࡿ࠸ࡗࡓၥ㢟ࡶ࠶ࡿࠋ ୍᪉ࠊḟୡ௦ேᕤ㦵ࡋ࡚ࠊ⏕య㦵㏆࠸⤌ᡂࢆᣢࡗࡓࣁࢻࣟ࢟ࢩࣃࢱࢺ㸭ࢥࣛ ࣮ࢤࣥ」ྜయ㸦௨ୗ HA/Col㸧ࡀᐇ⏝ࡉࢀࡓࠋHA/Col ࡣ྾ᛶࢆ♧ࡋࠊࢫ࣏ࣥࢪ≧ࡢ≀ ᛶࢆ᭷ࡍࡿࡓࡵࠊ⾑ᾮࡸ㦵㧊ᾮ࡞ࢆྵᾐࡉࡏࡸࡍ࠸࠸࠺ᛶ㉁ࡶ࠶ࡾࠊ⮫ᗋ㦂ࡢ⤖ᯝ ࡛ࡣᚑ᮶ࡢșTCP ேᕤ㦵ẚࠊඃࢀࡓ㦵ᙧᡂ⬟ࢆ᭷ࡍࡿࡇࡀ♧ࡉࢀ࡚࠸ࡿࠋࡋࡋࠊ 㢌㢡㢦㠃㡿ᇦ࡛ࡢ᭷ຠ࡞࠸᪉ࠊ⭷ᛶ㦵ࡢ㦵ᙧᡂࡢ࣓࢝ࢽࢬ࣒㛵ࡋ࡚ࡣࡲࡔ▱ࡽࢀ࡚ ࠸࡞࠸ࠋ ࡑࡇ࡛ࠊᮏ◊✲࡛ࡣࣛࢵࢺ㢌㡬㦵 HA/Col ேᕤ㦵ࢆ⛣᳜ࡋࠊ㦵⭷ࡢ᭷↓ࡼࡿ ᕪ␗ࢆ⤌⧊Ꮫⓗ᳨ウࡋࠊ᭷ຠᛶࢆ♧ࡍࡇࢆ┠ⓗࡍࡿࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ 1㸧 ᐇ㦂ື≀ ࢜ࢫ Slc:SD ࣛࢵࢺ 㸺ධⲴ㸼య㔜 200g 11 ༉ ― 68 ― 2㸧 ᇙ᳜ᮦᩱ࠾ࡼࡧࢧࢬ HA/Col ேᕤ㦵㸦Ț⥺⁛⳦῭ࡳ㸧ȭ41~2mm 3㸧 ⛣᳜㦵 㢌㡬㦵ᕥྑࢺࣞࣃࣥࢆ⏝࠸࡚ȭ4mm ࡢ㦵ᒙḞᦆࢆసᡂࡋࠊୗグࡢ⩌ᵓᡂ࡛⛣᳜㦵ࢆ ᇙ᳜ࡍࡿࠋ ࣭Ḟᦆ⩌㸸 HAP/Col ⿵ሸ࡞ࡋࠊ㦵⭷⿕そ↓ࡋ ࣭Ḟᦆ⩌㸸 HAP/Col ⿵ሸ࡞ࡋࠊ㦵⭷⿕そ᭷ࡾ ࣭HAP/Col ⿵ሸ⩌ࠊ㦵⭷⿕そ↓ࡋ ࣭HAP/Col ⿵ሸ⩌ࠊ㦵⭷⿕そ᭷ࡾ ࣭HAP/Col ⿵ሸ+PRP ⩌ࠊ㦵⭷⿕そ᭷ࡾ 4㸧 ฎ⌮ホ౯ 㦵⭷⓶ࢆ⦭ྜ㛢ࡋࠊ㒊ᑐࡋ࡚㌾⭯ࡢእ⏝࣭࣮࢞ࢮ⿕そ࡞ࡢࢻࣞࢵࢩࣥࢢࡣ⾜ ࢃࡎ 4ࠊ8 㐌┠᳨యࢆᅇࡋࠊ⤌⧊Ꮫⓗ᳨ウ㸦࣐࣍ࣝࣜࣥᅛᐃᚋࠊ⬺⅊ᶆᮏ㹆㹃ᰁⰍࠊච ᰁⰍ㸧࡞ࡽࡧ࣐ࢡࣟ㹁㹒ࡼࡿホ౯ࢆ⾜ࡗࡓࠋ ⤖ᯝ 㦵⭷Ꮡᅾୗࡢ⬺⅊ᶆᮏ㹆㹃ᰁⰍ㸸㸲㐌┠࡛ࡣᇙ᳜≀ࡀࡲࡔࡽ≧Ꮡᅾࡋࠊ⥺⥔ᛶ⤖ྜ⤌⧊ ࡢቑ⏕␗≀ᕧ⣽⬊ࢆㄆࡵࡓࠋ 㐌㛫࡛ࡣḞᦆ㒊ࡣᮍࡔ㦵࡛ࡣ⿕そࡉࢀ㑰ෆࡀࠊᚎࠎ㦵᪂ ⏕ࡀ㐍ࢇ࡛࠸ࡿ≧ែ࡛࠶ࡗࡓࠋ ࢜ࢫࢸ࢜࢝ࣝࢩࣥᰁⰍ㸸◚㦵⣽⬊ࡢ࣐࣮࣮࢝ࡋ࡚࢝ࢸࣉࢩࣥ .㦵ⱆ⣽⬊ࡢ࣐࣮࣮࢝ࡋ ࡚࢜ࢫࢸ࢜࢝ࣝࢩࣥࡼࡿචᰁⰍࡢ⤖ᯝ࡛ࡣࠊ㦵Ḟᦆ⩌࡛ࡣࢇ㝧ᛶ⣽⬊ࢆㄆࡵࡎࠊ ࢃࡎ㦵Ḟᦆ㒊᩿➃࢜ࢫࢸ࢜࢝ࣝࢩࣥ㝧ᛶ⣽⬊ࢆㄆࡵࡓࠋ୍᪉ࡢ +$3&RO ⿵ሸ⩌࠾ ࠸࡚ࡣ࢝ࢸࣉࢩࣥ . 㝧ᛶ⣽⬊ࡀ☜ㄆ࡛ࡁࠊ⯆῝࠸ࡇࡑࢀࡣᑐഃࡢ㒊ศ࢜ࢫࢸ࢜ ࢝ࣝࢩࣥ㝧ᛶ⣽⬊ࢆㄆࡵࡓࠋ ࣐ࢡࣟ㹁㹒㸸㦵Ḟᦆ⩌࡛ࡣ㦵ᱱࢆࡲࡗࡓࡃㄆࡵ࡞ࡗࡓࠋ+$3&RO ⿵ሸ༢⊂⩌࡛ࡣࠊ⛣᳜ ࡋࡓ㹆㸿ࡢᵓ㐀ࡀࠊ㸶㹕ῶᑡࡋ࡚࠸ࡿഴྥࢆㄆࡵࡓࡀࠊ㸯㸰㹕ࡣ᪂⏕㦵⨨ࡉࢀ࡚ ࡁ࡚࠸ࡿ⌧㇟ࢆㄆࡵࡓࠋ ⪃ᐹ 㦵ࣜࣔࢹࣜࣥࢢࡣࠊ㦵ࢆቯࡍാࡁࢆࡍࡿࠕ◚㦵⣽⬊ࠖࡀ㦵ࢆ྾㸦㦵྾㸧ࡍࡿ୍᪉࡛ࠊ 㦵ࢆసࡿാࡁࢆࡍࡿࠕ㦵ⱆ⣽⬊ࠖࡀࠊ◚㦵⣽⬊ࡼࡗ࡚྾ࡉࢀࡓ㒊ศ᪂ࡋ࠸㦵ࢆసࡿ 㸦㦵ᙧᡂ㸧ࡇ࡛࠶ࡿࠋࡇࡢࣜࣔࢹࣜࣥࢢࡀ⤯࠼ࡎ⥆ࡅࡽࢀࡿࡇ࡛ࠊ ᖺ㛫 㹼㸣 ࡢ㦵ࡀ᪂ࡋ࠸㦵ධࢀ᭰ࢃࡗ࡚࠸ࡿࠋ+$3&RO ࡢ⮬ᐙ㦵⨨࠾࠸࡚ࡶࡇࡢ㦵ࣜࣔࢹࣜࣥࢢ ― 69 ― ࡀ⏕ࡌ࡚࠸ࡿࡇࡣᐜ᫆᥎ ࡛ࡁࡿࠋࡑࡋ࡚ࠊࡇࡢࣂࣛࣥࢫࡀᔂࢀࠊ◚㦵⣽⬊ࡼࡿ྾ ࡀಁ㐍ࡋࡓ≧ែࡀ㦵⢒ࡋࡻ࠺ࡸ㛵⠇࣐ࣜ࢘ࢳ࡛࠶ࡿࠋ୍᪉◚㦵⣽⬊ࡀാࡃ࡞ࡗࡓࡶࡢ ࡀ⌮▼࡞ࡿࡼ࠺ࡇࢀࡽࡢࣂࣛࣥࢫࡣ㔜せ࡛࠶ࡿࡉࢀ࡚࠸ࡿࠋ ᅇࡣࠊ◚㦵⣽⬊ࡀேᕤ㦵⾲㠃Ꮡᅾࡋࠊ+$ ࢆ㊊ሙࡋ࡚◚㦵⣽⬊ࡀศㄏᑟࡉࢀ࡚࠸ࡿ ࡇࡀ♧၀ࡉࢀࡓࠋ◚㦵⣽⬊ࡢศㄏᑟࡢഐࡽ࡛ࠊ㦵ⱆ⣽⬊ࡣᏑᅾࡏࡎࠊ୧⪅ࡢ㛵㐃ࡢ㏣ ồࡀᚲせ࡛࠶ࡿ⪃࠼ࡽࢀࡓࠋࡲࡓࠊ㦵⭷࡛⿕そࡋࡓ᳨య࠾࠸࡚ࠊ5$1./ 㝧ᛶ⣽⬊◚㦵 ⣽⬊ࡀከࡃⓎ⌧ࡋ࡚࠾ࡾࠊ㦵⭷ࡽ 5$1./ ศἪಁ㐍స⏝ࡀാ࠸࡚࠸ࡿྍ⬟ᛶࡀ♧၀ࡉࢀࡓࠋ ᅗ 㢡㒊ࡢ⮫ᗋᛂ⏝㸸'&7㸦ᕥ㸸⾡๓ࠊྑ㸸⾡ᚋ ࢝᭶㸧 ᅗ ࣛࢵࢺ㢌㡬㒊㦵Ḟᦆࢆసᡂࡋࠊேᕤ㦵ࢆ⛣᳜ࡋࡓࠋ ― 70 ― ― 71 ― ― 72 ― ― 73 ― 㻌 㻌 㻌 㻌 ேᕤ⮚ჾ䞉ᶵჾ㛤Ⓨ◊✲㒊㻌 㻌 㒊㛗㻌 㻌 㻌 ゅ⏣㻌 ୍㻌 ேᕤ⮚ჾ࣭ᶵჾ㛤Ⓨ◊✲㒊㛛 㒊㛗 ゅ⏣୍ ௦⏝⮚ჾ㛤Ⓨ◊✲ᐊ Ⓨ⏕་Ꮫ◊✲ᐊ 㡢ኌ࣭ゝㄒࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ◊✲ᐊ 1723 ࡋ࡚㐍⾜୰ࡢཱྀ⭍ဗ㢌㙾ࡢᶵჾ㛤Ⓨ◊✲ࡣࠊᮾி࣭ྡྂᒇ་⒪ࢭ ࣥࢱ࣮ຍ࠼ࠊி㒔ᗓ❧་ࠊᮾிᏛࠊᮾி་⛉ṑ⛉Ꮫࠊ⮬་⛉Ꮫ ⪥㰯ဗႃ⛉ᅜෆィ ᡤ࡛་ᖌᑟ㦂ࢆ⾜࠸ࠊணᐃࡢ ࡢⓏ㘓ࢆ⤊ ࡋ᭷ຠ࡞⤖ᯝᨵⰋⅬࡀ᫂ࡽ࡞ࡗࡓࠋᮏᖺᗘࡣࡑࢀᇶ࡙ࡁ㍍㔞ᗮ౯࡞ ྕᶵࡢ㛤Ⓨࢆ⾜࠸ࠊ᮶ᖺᗘࡽ᪂ࡓ 1723 ࡋ࡚ࠊᮾிࠊྡྂᒇ་⒪ࢭࣥ ࢱ࣮ࡢ ᡤ࡛◊✲ࢆ㐍ࡵ࡚⾜ࡁࡓ࠸ࠋ 1+2 ឤぬჾᨻ⟇་⒪◊✲ࡢࠕຍ㱋ࡼࡿ⏕⌮ⓗኌᖏⴎ⦰ࡼࡿⓎኌ㞀ᐖᝈ⪅ ᑐࡍࡿ⮬ᕫカ⦎ἲࡢ⒪ධຠᯝ㛵ࡍࡿᐇ㦂◊✲ࠖ㛵ࡋ ᖺ┠ࡢᮏᖺᗘ ධ࣭㠀ධྜィ ࡀࡑࢁ࠸ࠊศᯒࡢ⤖ᯝࠊᖺࢆྲྀࡗࡓࡽኌᖏࡢ⏕⌮ⓗⴎ⦰ ᑐࡋ࡚ヰࢆࡘ࡙ࡅࡿࡀษ࡛ࠊ࡛ࡁ࡞࠸ሙྜࡣ㡢ኌ⮬ᕫカ⦎ࡀ᭷ຠ࡛࠶ ࡿࡇࡀ᫂ࡽ࡞ࡾࠊᮾᏛ㝔Ꮫ⏕࡛་ᖌࡢ◊✲ဨࡢ⸨ᕳⴥᏊࡀᖺᗘከ ࡃࡢせᏛ࡛Ⓨ⾲ࡋࡓࠋࠕᗣ㛗ᑑࡣヰࡽࠖࡢ୍ゝᑾࡁࡿࠋ 㛵ᮏⲮኴ㑻༤ኈࠊఀ⸨᠇༤ኈ㒊㛗ࡢゅ⏣ࡣඹྠ࡛⡆᫆㉥እ⥺ࢺ࣏ࢢ࣒ࣛࡢ ⮫ᗋᛂ⏝ࢆ┠ᣦࡍᇶ♏◊✲ࡣࡑࡢᡂᯝࡀᚓࡽࢀࠊ᫇ࡽᣦࡉࢀ࡚࠸ࡿ᪥ᮏㄒ ࡛⫱ࡗࡓே㛫࠾ࡅࡿࡢኌࡢฎ⌮ᶵ⬟ࡢ㠀᪥ᮏㄒ⎔ቃ࡛⫱ࡗࡓே㛫ࡢ㐪࠸ ࡢド᫂ࡀ࡞ࡉࢀࠊⱥᩥㄅⓎ⾲ࡋࡓࠋ㸦7VXQRGD.6HNLPRWR6,WRK. 1HDULQIUDUHGVSHFWURVFRSLFVWXG\RQSURFHVVLQJRIVRXQGVLQWKHEUDLQDFRPSDULVRQ EHWZHHQQDWLYHDQGQRQQDWLYHVSHDNHUVRI-DSDQHVH Acta Otolaryngol.)HE >(SXEDKHDGRISULQW@ ᙜ◊✲㒊㛛࡛ࡣᐇ࡛ࡁ࡞࠸ :HW ࣛ࣎ࡢ◊✲ࢆࠊᮾிᏛ⪥㰯ဗႃ⛉ࡢࢢࣝ ࣮ࣉ࡛࠶ࡿ⸨ᕳⴥᏊඛ⏕ኌᖏࡢ⏕ᇶ♏◊✲ࢆࠊྠࡌࡃ⳥⏣࿘ඛ⏕ࠊୖ⩚⍠ ⨾ඛ⏕ࡣࠊႥぬ㞀ᐖࡢ◊✲ࢆࠊ୰ᯡࠊ⢓⭷ୖ⓶ࡸႥ⌫ࢆ୰ᚰචᏛⓗほⅬ ࡽ◊✲ࢆᮾிᏛ࡚⾜ࡗ࡚࠸ࡿࠋ⳥⏣࿘ࡢά㌍ࡣ┠ぬࡲࡋࡃࠊᩘᖺ๓ࡢ 31$6 ࡢ⾲⣬⥆ࡁࠊᮏᖺᗘࡣ J Neurosci.᥇ᢥࡉࢀ࡚࠸ࡿࠋ 67 ࡢᑠᯘ⌮㤶ඛ⏕ࡣゅ⏣ඹࠊཱྀࠊ㌾ཱྀ㯞⑷ࡼࡿ㰯ဗ⭍㛢㙐ࡢ ᐃ㔞ⓗデ᩿ἲࢆ㛤Ⓨ୰࡛࠶ࡾࠊᖺᗘࡣࠊ࠸࡞ࡿሙྜ࡛࠶ࡗ࡚ࡶႍᜥ࡞ཱྀ ࡽࡢ྾ධ୧᪉ࡢሙྜࡣ㰯ࢆࡘࡲࢇ࡛྾ධࡋࡓ࠺ࡀຠ⋡ࡀⰋ࠸ࡇࢆゎ᫂ࡋࠊ Ann Allergy Asthma Immunol.Ⓨ⾲ࡋࡓࠋ ― 75 ― 㰯୰㝸✸Ꮝᝈ⪅ࡢ㛢㙐⾡๓ᚋࡢ ḟඖẼὶゎᯒࢆ⾜࠸ࠊ⾡๓ࡳࡽࢀࡓὶ ࡣ⾡ᚋᨵၿࢆࡳࡿࢆ᫂ࡽࡋࡓ㔝ᮧົ༤ኈࡣࠊᮏᖺᗘከࡃࡢⱥㄒㄽᩥࢆ Ⓨ⾲ࡋࡓࠋ ᖺࡣⴠࡕࡓࡀࠊゝㄒ⫈ぬኈ㸦67㸧ࡢᑠᯘࡣ 723-RXUQDO ࡢ DFFHSW ࢆཷࡅࠊ᮶ ᖺࡇࡑࡣ (%0 ࡛ႍᜥ⒪⸆ࡢ᭷ຠ࡞⒪ἲࡢࣛࣥࢲ࣒ẚ㍑ヨ㦂ࢆ 1+2 ⏦ㄳ ࡋ࡚࠸ࡿࠋ 㐕㏕ࡋࡓᅜࡢᅜẸࡢࡓࡵࡢ་⒪⤒῭ࢆ⪃࠼ࠊᡃࠎࡢணഛ᳨ドࡽ᭷ຠᛶࡀ♧ ၀ࡉࢀࡓࠊࠕኌᖏ࣏࣮ࣜࣉࠊኌᖏ⤖⠇ࡢ⤒῭ⓗಖᏑⓗ⒪ࡢ᭷ຠᛶࠖࡘ ࠸࡚ࡣࠊࠕኌࡢ⾨⏕ᩍ⫱ࠖᝈ⪅ၨⓎࡼࡿኌᖏ࣏࣮ࣜࣉࡢಖᏑⓗ⒪ࠊࡑࡢ᭷ ຠᛶࡢ᳨ド 㸫ၨⵚࡽၨⓎ࣮ࠖࡋ࡚ᖺ᥇⏝ࡉࢀࡓࠋᖾ࠸ከࡃࡢ 1+2 ◊ ✲タࡢ༠ຊࡀᚓࡽࢀ࡚ࠊᅜ❧㝔ᶵᵓ㝔 ᡤ࡛◊✲ࢆ㛤ጞࡋࠊᖖᅾ ࡢᘯ๓㝔⪥㰯⛉ࡀ◊✲ྍ⬟࡞ࡾࠊኚࢃࡗ࡚㔠ἑ་⒪ࢭࣥࢱ࣮ࡀຍࢃࡾࠊ ᖺᮎ࡛ ணᐃ㏻ࡾ㐍⾜ࡋ࡚࠸ࡿࠋ᮶ᖺᗘࡽࡣᰣᮌ་⒪ࢭࣥࢱ࣮ࡶ ຍࢃࡾྜィ ᡤ࡛Ⓩ㘓ࡉࡽᙎࡳࡀ࠸ࡓࠋᮏ◊✲ࡀᡂᑵࡍࢀࡤ་⒪ ㈝ࡢ๐ῶࡢࡳ࡞ࡽࡎࠊゝㄒ⫈ぬኈࡢ᪂ࡋ࠸ά㌍ࡢሙࡀ㛤ᣅࡉࢀࠊࢳ࣮࣒་⒪ ࡋ࡚ࡢ㡢ኌ㞀ᐖᑐ⟇ࡀ㛤ࢀࡿணࡉࢀࡿࠋ ᮶ᖺᗘࡣࠊ⬻࠾ࡅࡿᕥྑᕪ➼ࡉࡽ࡞ࡿ◊✲ᒎ㛤ࡣࡶࡕࢁࢇࠋࣄࢺື≀ ࡢẚ㍑ゎ๗࡞ࠕゝㄒࡢ㐍ࡑࢀక࠺ㄗᄟ㜵Ṇࡢ་Ꮫࠖࠊࠕ⬻᱾ሰࡢ᪂ࡋ ࠸༴㝤ᅉᏊࡢࢧࣥࡋ࡚ࡢဗႃ㢌␗ᖖឤࠖࡢ◊✲ၨⓎࡶຊࢆධࢀࡿᡤᏑ࡛ ࠶ࡿࠋᝈ⪅ࠊᐙ᪘ࡢẼᣢࡕ࡞ࡗ࡚◊✲⢭㐍ࡋせᏛࡸⱥᩥ࡛Ⓨ⾲ࡋ⥆ࡅ ࡿࡇ࡛ࠊከࡃࡢ࣐ࢫ࣓ࢹ㛵ᚰࢆᣢࡗ࡚࠸ࡓࡔࡁࠊ⮬ࡎ◊✲άືࡑ ࡢ◊✲ᡂᯝࡣຠ⋡ࡼࡃࠊ᭷ຠⓎ⾲ࠊᅜẸၨⓎ࡛ࡁ࡚࠸ࡿࠋ ― 76 ― ᢒ㘓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― 77 ―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― 78 ― ― 79 ― ― 80 ― ― 81 ― ― 82 ― ― 83 ― ― 84 ― ― 85 ― ― 86 ― 㻌 㻌 㻌 㻌 ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊㻌 㻌 㒊㛗㻌 㻌 㻌 ᒾ⏣㻌 ᓅ㻌 ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊 㒊㛗 ᒾ⏣ ᓅ ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊ࡣ㑇ఏᏊኚ␗ࡸ㑇ఏᏊከᆺࡢᙳ㡪ࢆᙉࡃཷࡅࡿ⥙⭷ᝈࡢᅉ࣭ ែᶵᗎࡢゎ᫂⒪ࢆ┠ⓗࡋ࡚ࠊᅜෆእࡢ◊✲ᐊඹྠ◊✲యไࢆ⤌ࢇ࡛ࢢ࣮ࣟࣂࣝ ◊✲ࢆᒎ㛤ࡋ࡚࠸ࡿࠋᑐ㇟࡞ࡿᝈࡣ⥳ෆ㞀ࠊຍ㱋㯤ᩬኚᛶࠊ㑇ఏᛶࡢ⥙⬦⤡⭷ᝈ ⩌ࡀྵࡲࢀࡿࠋឤཷᛶ㑇ఏᏊࡸཎᅉ㑇ఏᏊࡀࢥ࣮ࢻࡍࡿࢱࣥࣃࢡ㉁ࡢ⥙⭷࡛ࡢ⏕⌮ᶵ⬟ࡸ ኚ␗యࡢᙳ㡪ࠊኚ␗యࢆⓎ⌧ࡍࡿ㑇ఏᏊᨵኚ࣐࢘ࢫࢆ⏝࠸ࡓື≀ᐇ㦂ࢆ⾜ࡗ࡚࠸ࡿࠋᾏእ ࡽࡢ◊✲⏕ࡸ◊✲ဨࡶᅾ⡠ࡍࡿࡼ࠺࡞ࡾࠊ◊✲ሗ࿌ࡸᖺᗘࡣ᪥ᮏ་⒪◊✲㛤Ⓨᶵ ᵓ㸦AMED㸧ࡢ◊✲ᴗ⛣⾜ࡋࠊデ᩿ࡸ⒪ྥࡅࡓ◊✲యไࡀࡼࡾồࡵࡽࢀࡿࡼ࠺ ࡞ࡗࡓࠋ 㑇ఏᛶ⥙⬦⤡⭷ᝈࡢ࢚ࢡࢯ࣮࣒ゎᯒ ᖹᡂ㸰㸱ᖺᗘཌ⏕ປാ┬ࡢ㞴࣭ࡀࢇ➼ࡢᝈศ㔝ࡢᐇ⏝◊✲ᴗࡋ࡚Ⓨ㊊ࡋࡓ ḟୡ௦ DNA ࢩ࣮ࢡ࢚ࣥࢧ࣮ࢆ⏝࠸ࡓ㑇ఏᛶ⥙⬦⤡⭷ᝈࡢ⥙⨶ⓗ㑇ఏᏊゎᯒࡣ㸲ᖺࡢᮇ 㛫ࢆ⤒࡚ࠊAMED ࡢ◊✲ᴗࡋ࡚⥅⥆ࡉࢀࠊ㸰㸴ࡢ║⛉ᩍᐊࡸ║⛉㛵㐃タࡀཧຍࡍࡿ ࢥࣥࢯ࣮ࢩ࣒ᡂ㛗ࡋࠊ࣮࢜ࣝࢪࣕࣃࣥయไ࡛㸱㸴ᝈࡢሗ㞟⾑ᾮ࣭ၚᾮ ࡢ㞟ࢆ⾜ࡗ࡚࠸ࡿࠋᑐ㇟࡞ࡿᝈࡣᴟࡵ࡚⛥࡞ࡇࡽࠊᅜⓗ࡞ඹྠయไࡼࡗ࡚ ᩘࢆ☜ಖࡋࠊᅜ㝿ⓗ࡞➇தຊࡶቑࡋ࡚ࡁࡓࠋ ᮏᖺᗘࡣデ᩿యไࢆぢ┤ࡋࠊ࢜ࣥࣛࣥሗࢩࢫࢸ࣒ࢆⱥㄒࡋ࡚ࠊ࢚ࢡࢯ࣮࣒ ゎᯒࢆ◊✲㒊ෆ࡛⾜࠼ࡿయไࢆᵓ⠏ࡋࡓࠋࢤࣀ࣒ࡢ㸯㸣ࢆ༨ࡵࡿ㑇ఏᏊ࢚ࢡࢯࣥࢆ㸷㸷㸣 ௨ୖࡢ⋡࡛࢟ࣕࣉࢳ࣮ࣕࡋࠊࡇࢀࢆᖹᆒ㸯㸮㸮ᅇ௨ୖࡋ࡚ࢩ࣮ࢡ࢚ࣥࢫࡍࡿ࢚ࢡࢯ ࣮࣒ࢩ࣮ࢡ࢚ࣥࢫἲࡀ⏝࠸ࡽࢀ࡚࠸ࡿࠋࡇࡢ᪉ἲࡼࡗ࡚ࡇࢀࡲ࡛ᅔ㞴࡛࠶ࡗࡓᐙ⣔༢ ࡢཎᅉ㑇ఏᏊ᥈⣴ࡀྍ⬟࡞ࡾࠊࡇࡢ㸲ᖺ㛫࡛㞟ࡋࡓ᳨య㸦⣙㸯㸪㸰㸮㸮DNA ᳨ య㸧ࡢ࢚ࢡࢯ࣮࣒ࢩ࣮ࢡ࢚ࣥࢫࡀ⾜ࢃࢀࡓࠋࡑࡢ⤖ᯝࠊ᪂つ㑇ఏᏊኚ␗㸦᪤▱㑇ఏᏊ㸧 ࡸ᪂つ㑇ఏᏊࡀከᩘⓎぢࡉࢀࡓࠋᖺᗘࡣຎᛶ㑇ఏᏊᙧᘧࡢ㯤ᩬࢪࢫࢺࣟࣇ࣮ࠊ࣮ࣞ࣋ ࣝ㯮ෆ㞀ࠊ⥙⭷Ⰽ⣲ኚᛶࠊ㗹య࣭ᮞయࢪࢫࢺࣟࣇ࣮ࠊඛኳᛶኪ┣ࠊⰍ┣࡞ࢆ୰ᚰ ゎᯒࡋࠊ᫂ࡽࡉࢀࡓ୍㒊ࡢཎᅉ㑇ఏᏊኚ␗ࡘ࠸࡚ࡣኚ␗యࡢᶵ⬟ゎᯒࡸࢱࣥࣃࢡ㉁ ᵓ㐀ゎᯒࠊࣀࢵࢡ࣐ࣥ࢘ࢫࡀస〇ࡉࢀࡓࠋᖹᡂ㸰㸶ᖺᗘබ㛤ணᐃࡢ㑇ఏᏊኚ␗ែ ࡢබ㛤⏝ࢹ࣮ࢱ࣮࣋ࢫࡶ‽ഛ୰࡛࠶ࡿࠋⓎぢࡉࢀࡓ㑇ఏᏊኚ␗ࡣデ᩿࢟ࢵࢺࡋ࡚ၟရ ࡀィ⏬ࡉࢀ࡚࠾ࡾࠊᖹᡂ㸰㸶ᖺᗘࡢ㛤ጞࢆࡵࡊࡋ࡚࠸ࡿࠋ ᖹᡂ㸰㸴ᖺᗘᮾி་⒪ࢭࣥࢱ࣮ National Eye Institute, NIH ࡢඹྠ◊✲ዎ⣙ࢆ ⤖ࡧࠊAsian Eye Genetics Consortium (AEGC)ࢆ❧ࡕୖࡆࡓࡀࠊࢪྛᅜࡢ║⛉Ꮫ ࡛ࡇࡢάືࢆ⤂ࡋࡓࡇࢁࠊࡁ࡞㈶ྠࢆᚓ࡚ࠊࢪᇦࡢ࡞║⛉タඹྠ◊✲ ࡀጞࡲࡗ࡚࠸ࡿࠋ ― 87 ― ຍ㱋㯤ᩬኚᛶࡢⓎᶵᗎ࢝ࢽࢡࢨࣝࣔࢹࣝࡸ࣐࢘ࢫࣔࢹࣝࡢゎᯒ ຍ㱋㯤ᩬኚᛶࡣ⡿ᅜ࡛ࡣ᭱ࡶኻ᫂⋡ࡢ㧗࠸║ᝈ࡛࠶ࡾࠊ᪥ᮏ࡛ࡶ㧗㱋ࡀ㐍ࡴࡇ ࡼࡗ࡚ᝈ⪅ᩘࡣቑຍഴྥ࠶ࡿࠋ⥙⭷ࡢࡰ୰ᚰ⨨ࡍࡿ㯤ᩬࡣ୍㒊ࡢ㟋㛗㢮ࡸ㫽㢮࡛ Ⓨ㐩ࡋ࡚࠾ࡾࠊ㏻ᖖࡢᐇ㦂⏝࠸ࡽࢀࡿ࣐࢘ࢫࡸࣛࢵࢺࡣᏑᅾࡋ࡞࠸ࠋᡃࠎࡣ⏕ᚋࡲࡶ ࡞ࡃ㯤ᩬ࡛ࢻ࣮ࣝࢮࣥࡀほᐹࡉࢀࡿୡ⏺࡛၏୍ࡢ㟋㛗㢮ࣔࢹࣝ㸦Umeda et al, IOVS 2005, Umeda et al, FASEB J 2005㸧ࢆ◊✲ᮦᩱࡋ࡚ࡁࡓࠋࡇࡢ࢝ࢽࢡࢨࣝࡣែึ ᮇ࠾ࡅࡿ⥙⭷ࡢ≧ែࢆㄪࡿࡇ⏝ࡋ࡚࠸ࡿࡀࠊྠᅜෆእࡢᏛࡸ〇⸆ᴗࡢ ᪂⸆ࡢ㛤Ⓨࡶ⏝ࡉࢀ࡚࠸ࡿࠋࡇࢀࡲ࡛㸴ࡘࡢ⸆ຠヨ㦂ࡀ⾜ࢃࢀࡓࠋࡲࡓᚎᨺࡘ ࠸࡚ࡶྡྂᒇᕷ❧ᏛࡸᮾᏛࡢඹྠ◊✲ࡼࡗ࡚ᝈ࢝ࢽࢡࢨࣝᑐࡋ࡚ヨ㦂ࡀ ᐇࡉࢀ࡚࠸ࡿࠋ ຍ㱋㯤ᩬኚᛶࡣከᅉᏊᝈ⪃࠼ࡽࢀ࡚࠾ࡾࠊ㑇ఏᏊࡸ⎔ቃࡀ㛵ࡍࡿ⪃࠼ࡽࢀ࡚࠸ ࡿࠋ≉㑇ఏᏊゎᯒࡘ࠸࡚ࡣᡃࠎࢆྵࡵࠊከᩘࡢㄽᩥࡀⓎ⾲ࡉࢀࠊ⣙㸱㸮✀㢮ࡢ㑇ఏᏊࡀ ឤཷᛶ㑇ఏᏊࡋ࡚ሗ࿌ࡉࢀ࡚࠸ࡿࠋࡇࡢ୰࡛ࡶ᭱ࡶ┦㛵ࡢ㧗࠸㸦p ್ࠊ࢜ࢵࢬẚ㸧HTRA1 㑇ఏᏊࡣࢭࣜࣥࣉࣟࢸ࣮ࢮࢆࢥ࣮ࢻࡍࡿࠋᝈ⪅࡛ࡣ HTRA1 ࡢⓎ⌧ࡀቑຍࡍࡿ⪃࠼ࡽ ࢀ࡚࠾ࡾࠊࡇࡢቑຍࡢཎᅉࡀࡇࢀࡲ࡛࡛᫂࠶ࡗࡓࠋᡃࠎࡣ HTRA1 ࡢ㌿㡿ᇦࢆ◊✲ࡋࠊ ࡁ࡞ሷᇶ㓄ิࡢḞᦆࡀᏑᅾࡍࡿࡇࠊࡉࡽࡑࡢḞᦆࡼࡗ࡚ᢚไᅉᏊࡀ⤖ྜ࡛ࡁ࡞࠸ ࡇࡼࡗ࡚㌿άᛶࡀୖ᪼ࡍࡿࡇࢆ᫂ࡽࡋࡓ(Iejima et al., JBC 2014)ࠋ㓄ิࡢḞ ᦆ㡿ᇦࡣ᪂ࡓ㌿ಁ㐍ᅉᏊࡀ⤖ྜࡋ࡚࠸ࡿࡇࡀ᫂ࡽࡋࠊࡇࢀࡽࢆ㉁㔞ศᯒィ ࡼࡗ࡚ྠᐃࡋࡓࠋᚋ HTRA1 ࡢᢚไࡀ㔜せ࡞ࡗ࡚ࡃࡿ⪃࠼࡚࠸ࡿࠋ ࡉࡽ HTRA1 ࡢቑຍࡀຍ㱋㯤ᩬኚᛶ㛵ಀࡍࡿ᳨ドࡍࡿࡓࡵࠊHTRA1 ࢆ㧗Ⓨ⌧ ࡍࡿ㑇ఏᏊᨵኚ࣐࢘ࢫࢆస〇ࡋࡓ⤖ᯝࠊࣄࢺྠᵝ࡞⬦⤡⭷ࡽ⥙⭷ࡴࡅ࡚ࡢ⾑⟶᪂⏕ ࡀほᐹࡉࢀࡓ(Nakayama, et al., IOVS 2014)ࠋࡇࢀࡽࡢ࣐࢘ࢫࡣࡉࡽ㸯ᖺ㛫㣫⫱ࡉࢀࠊ ὶ↮ࡼࡿႚ↮ᐇ㦂ࡀ⾜ࢃࢀࡓࠋຍ㱋ႚ↮ࡣຍ㱋㯤ᩬኚᛶࡢࣜࢫࢡᅉᏊ⪃࠼ࡽࢀ࡚ ࡁࡓࡀࠊᅇࡢᐇ㦂࡛ࡣ HTRA1 㑇ఏᏊᨵኚ࣐࢘ࢫṇᖖ࣐࢘ࢫࡢᕪࡣほᐹࡉࢀ࡞ࡗ ࡓࠋ᪥ᮏேከ࠸ⁱฟᆺຍ㱋㯤ᩬኚᛶࡢែࢆ⌧ࡍࡿ࣐࢘ࢫࣔࢹࣝࡋ࡚ࠊᚋከࡃࡢ ◊✲⏝ࡉࢀࡿணࡉࢀࡿࠋᖹᡂ㸰㸶ᖺᗘࡣࡇࡢ HTRA1 ࡢᢚไࢆヨࡳࡿࠋ ― 88 ― ࠝศᏊ⣽⬊⏕≀Ꮫ◊✲㒊ࠞ ⁱฟᆺຍ㱋㯤ᩬኚᛶឤཷᛶ㑇ఏᏊ $506+75$ ࡢゎᯒ ᐙᓥ㍜ 㸪୰ᒣ┿ኸ 㸪㔝⏣ᚭ 㸪ᒾ⏣ᓅ 㸦ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊 ࠊᮾி་⒪ࢭࣥࢱ࣮║⛉ 㸧 せ ⣙ ⁱฟᆺຍ㱋㯤ᩬኚᛶ㸦ZHW$0'㸧ࡣࠊࡾࢃࡅ᪥ᮏேከ࠸ࢱࣉࡢ $0' ࡛ࠊຍ㱋ࡶ ⥙⭷ࡢ㯤ᩬ㒊⬦⤡⭷ഃࡽ⾑⟶᪂⏕ࡀ⏕ࡌࠊ㯤ᩬࡢ⥙⭷⤌⧊ࢆയᐖࡍࡿࡇ࡛ࠊ᭱⤊ ⓗᴟᗘࡢどຊపୗࡸኻ᫂ࢆᣍࡃᝈࡋ࡚▱ࡽࢀ࡚࠸ࡿࠋZHW$0' ࡢࣜࢫࢡᅉᏊࡋ࡚ࠊ ႚ↮ࡸ㧗⬡⫫㣗࡞ࡢ⏕ά⩦័ࡸ࠸ࡃࡘࡢ⎔ቃせᅉࡀ▱ࡽࢀ࡚࠸ࡿࡀࠊ୍᪉࡛ࠊ࠸ࡃࡘ ࡢ㑇ఏᏊኚ␗ࡀࣜࢫࢡᅉᏊࡋ࡚ሗ࿌ࡉࢀ࡚࠸ࡿࠋඛ⾜◊✲࠾࠸࡚ࠊࢤࣀ࣒࣡ࢻ㛵 㐃ゎᯒ*HQRPHZLGHDVVRFLDWLRQVWXG\*:$6࡞ࢆ⏝࠸ࡓゎᯒࡼࡾࠊ≉ࠊࣄࢺᰁⰍ యࡢ T ⨨ࡍࡿ $506+75$ 㡿ᇦࡢኚ␗ࡣ ZHW$0' ࡢᝈᙉࡃ┦㛵ࡋ࡚࠸ࡿࡇ ࡀሗ࿌ࡉࢀ࡚࠾ࡾ'Z:HQ$HWDO6FLHQFHࠊᡃࠎࡢࢢ࣮ࣝࣉ࠾࠸࡚ࡶࠊ᪥ ᮏேࡢ ZHW$0' ᝈ⪅ࢆᑐ㇟ࡋࡓゎᯒࡼࡾࠊ$506+75$ 㡿ᇦࡢኚ␗ࡀᙉࡃ┦㛵ࡋ࡚࠸ ࡿࡇࢆሗ࿌ࡋ࡚࠸ࡿ*RWR$$NDKRUL0HWDO-2%',ࠋࡋࡋࠊ⌧ᅾࡲ ࡛ࠊࡇࡢ㡿ᇦࡢࡢኚ␗ࡀࡢࡼ࠺࡞࣓࢝ࢽࢬ࣒࡛ᝈࡢⓎᐤࡋ࡚࠸ࡿࡢ࠸ ࡗࡓࠊ⏕≀Ꮫⓗ࡞࣓࢝ࢽࢬ࣒ࡣ᫂ࡽ࡞ࡗ࡚࠸࡞࠸ࠋࡇࡢࡼ࠺࡞⫼ᬒࡽࠊᮏ◊✲࡛ࡣࠊ ࡇࡢ㡿ᇦࡢኚ␗ࡀᝈཬࡰࡍ࣓࢝ࢽࢬ࣒ࢆ᫂ࡽࡍࡿࡓࡵࠊZHW$0' ᝈ⪅ࡢྠពࡢࡶ ᥇ྲྀࡋࡓᝈ⪅⏤᮶ࡢ᳨యࢆ⏝࠸࡚ࠊ$0' ᝈ⪅࠾ࡅࡿ $506+75$ 㡿ᇦࡢヲ⣽࡞ゎᯒ ࢆ⾜ࡗࡓࠋ ᝈ⪅⏤᮶ࡢ '1$ ࡢ T 㡿ᇦࡢヲ⣽࡞ࢩ࣮ࢡ࢚ࣥࢫࢆㄪࡓ⤖ᯝࠊ$506 ࡢ➨ ࢚ࢡࢯ ࣥୖὶ EDVH ࡢ⨨ࠊ$506 ࡢ➨ ࢚ࢡࢯࣥ +75$ ୖὶࡢࣥࢺࣟࣥ㡿ᇦࡲࡓࡀ ࡿ⨨ $0' ᝈ⪅᭷ព┦㛵ࡍࡿ≉ᚩⓗ࡞ኚ␗ࡀྠᐃࡉࢀࡓࠋࡉࡽࠊࡇࡢኚ␗ࡀ $506 ࠾ࡼࡧ +75$ ࡢࣉ࣮ࣟࣔࢱ࣮㡿ᇦࢆྵࡴࡇࡽࠊࡇࡢኚ␗ࢆྵࡴ᩿∦ࢆࢡ࣮ࣟࢽࣥࢢࡋࠊ ࡇࢀࡽࡢ᩿∦ࢆ⥙⭷⣽⬊ࡢ FHOOOLQH ࡛࠶ࡿ $53(㸪5*&㸪: ᑟධࡋࠊ/XFLIHUDVH DVVD\ ࢆ⏝࠸࡚ࣉ࣮ࣟࣔࢱ࣮άᛶࢆㄪࡓࠋࡑࡢ⤖ᯝࠊ$506 ࡢࣉ࣮ࣟࣔࢱ࣮ࡘ࠸࡚ࡣࠊ ࠸ࡎࢀࡢ⣽⬊࡛ࡶάᛶࡣࡳࡽࢀ࡞ࡗࡓࡀࠊኚ␗ࢆྵࡴ +75$ ࣉ࣮ࣟࣔࢱ࣮᩿∦ࢆᑟධࡋ ࡓ⩌࡛ࡣࠊ⥙⭷ࡢ⚄⤒⣔ࡢ⣽⬊ᰴ࡛࠶ࡿ 5*&: ࠾࠸࡚ṇᖖᆺẚ㍑ࡋ࡚ࣉ࣮ࣟࣔ ࢱ࣮άᛶࡀୖ᪼ࡍࡿ⤖ᯝ࡞ࡗࡓ,HMLPD'HWDO-%&ࠋ୍᪉࡛ࠊ⥙⭷Ⰽ⣲ୖ ⓶⣽⬊ᰴ࡛࠶ࡿ $53( +75$ ࣉ࣮ࣟࣔࢱ࣮ࢆᑟධࡋࡓ⩌࡛ࡣࠊ+75$ ࣉ࣮ࣟࣔࢱ࣮άᛶ ࡑࡢࡶࡢࡣࡳࡽࢀࡓࡀࠊṇᖖᆺࡢ㛫᭷ព࡞ᕪࡣࡳࡽࢀ࡞ࡗࡓࠋࡲࡓࠊ&$* ࣉ࣮ࣟࣔ ࢱ࣮࡛࣐࢘ࢫ +WU$ ࢆᙉไⓎ⌧ࡉࡏࡿࢺࣛࣥࢫࢪ࢙ࢽࢵࢡ࣐࢘ࢫࢆస〇ࡋࠊ+WU$ ࡢⓎ⌧ ୖ᪼ࡀ⥙⭷ཬࡰࡍᙳ㡪ࢆㄪࡓ⤖ᯝࠊ+WU$ ࢆᙉไⓎ⌧ࡉࡏࡓ࣐࢘ࢫ࠾࠸࡚ࠊ⣙ 㸣 ࡢಶయ࠾࠸࡚ࠊ⥙⭷᪂⏕⾑⟶ࡀほᐹࡉࢀࡓ1DND\DPD0,HMLPD'HWDO,296 ࠋ ௨ୖࡢᐇ㦂⤖ᯝࡼࡾࠊ࣐࢘ࢫࣔࢹࣝ࠾࠸࡚ +WU$ ࡢⓎ⌧ୖ᪼ࡀ⥙⭷࠾ࡅࡿ⾑⟶᪂⏕ ࢆㄏⓎࡍࡿࣜࢫࢡ࡞ࡿࡇࡀ♧၀ࡉࢀࠊ$0' ᝈ⪅ࡢከࡃࡳࡽࢀࡿ +75$ 㑇ఏᏊୖὶࡢ ― 89 ― ኚ␗ࡀࠊୗὶ࠶ࡿ +75$ ࡢⓎ⌧ୖ᪼ࢆಁࡍࡇࡀ♧၀ࡉࢀࡓࠋ ┠ ⓗ ຍ㱋㯤ᩬኚᛶ$0'ࡣࠊග⥺᭚㟢࡞ࡢ⎔ቃⓗせᅉࠊႚ↮ࡸ㧗⬡⫫㣗࡞ࡢ⩦័ⓗせᅉࠊ ࠸ࡃࡘࡢឤཷᛶ㑇ఏᏊࡢኚ␗ࡼࡿ㑇ఏⓗせᅉࡼࡾ⏕ࡌࡿከᅉᏊᝈ࡛࠶ࡿࡇ⪃࠼ ࡽࢀ࡚࠾ࡾࠊ≉㑇ఏⓗせᅉ㛵ࡋ࡚ࡣࡇࢀࡲ࡛࠸ࡃࡘࡢឤཷᛶ㑇ఏᏊࡀⓎぢࡉࢀሗ ࿌ࡉࢀ࡚࠸ࡿ㸦.ODYHU&&HWDO㸦㸧$UFK2SKWKDOPRO̽.OHLQ%( HWDO㸦㸧$P-(SLGHPLRO̽0H\HUV60HWDO㸦㸧$P- 2SKWKDOPRO̽㸪+DPPRQG&-HWDO㸦㸧2SKWKDOPRORJ\̽㸧 ㏆ᖺࠊ࣓ࣜ࢝ேࡢ $0' ᝈ⪅ࢆᑐ㇟ࡋࡓࢤࣀ࣒࣡ࢻ㛵㐃ゎᯒ*:$6ࡼࡗ࡚ ␒ᰁ ⰍయᏑᅾࡍࡿ⿵య + ᅉᏊ&)+ࡢ㑇ఏᏊከᆺࠊ≉ࠊ+ ᅉᏊࡢ <+ ࡢ㑇ఏᏊᆺ UVࡀࠊࡇࡢᝈᙉࡃ┦㛵ࡍࡿࡇࡀሗ࿌ࡉࢀ࡚࠸ࡿࡀ.OHLQ5-HWDO 6FLHQFH+DJHPDQ*6HWDO31$6ࠊࡇࢀࡲ࡛ ࡢ◊✲ࡼࡾࠊ<+ ࡣḢ⡿ே࡞ࡢⓑே࡛ࡣࠊᝈᙉࡃ┦㛵ࡋ࡚࠸ࡿࡶࡢࡢࠊ᪥ᮏே ࡸ୰ᅜே࡞ࡢࢪே࡛ࡣࠊ<+ ࡢ┦㛵ࡣほᐹࡉࢀ࡚࠸࡞࠸ࡇࡀሗ࿌ࡉࢀ࡚࠸ࡿ 2NDPRWR+HWDO0RO9LV*RWRK1HWDO+XP*HQHW ࠋ ୍᪉࡛ࠊ᭱㏆ࠊᰁⰍయ ␒࠾ࡅࡿࠊ/2&$506DJHUHODWHGPDFXORSDWK\ VXVFHSWLELOLW\ +75$+75$VHULQHSHSWLGDVH㑇ఏᏊ㡿ᇦࡢ㑇ఏᏊከᙧࡀࠊZHW$0' ᝈ⪅ᙉࡃ┦㛵ࡍࡿࡇࡀሗ࿌ࡉࢀ࡚࠸ࡿࠋᡃࠎࡣࠊࡇࢀࡲ࡛ࠊ᪥ᮏேࡢ ZHW$0' ᝈ⪅ ࢆᑐ㇟ࡋࡓ *:$6 ࡚ゎᯒࢆ⾜ࡗࡓ⤖ᯝࠊḢ⡿ே࡛ᙉࡃ┦㛵ࡋࡓ⿵య + ᅉᏊࡢ㑇ఏᏊከᆺ ࡣ┦㛵ࡏࡎࠊ$506+75$ ࡢ㑇ఏᏊ㡿ᇦࡢ㑇ఏᏊከᆺࡀᙉࡃ┦㛵ࡍࡿࡇࢆ᫂ࡽࡋࡓ *RWR$$NDKRUL0HWDO-2%',ࠋࡇࢀࡲ࡛ࡢゎᯒࡼࡾࠊ*:$6 ࡼࡗ࡚ࠊ ZHW$0' ࠾࠸࡚ᰁⰍయ ␒ࡢ T 㡿ᇦᙉ࠸┦㛵ࡀほᐹࡉࢀ࡚࠾ࡾࠊࡇࡢ㡿ᇦࡢࢱࢢ 613 ࡛࠶ࡿ UV ࡀᙉࡃ┦㛵ࡍࡿࡇࡀ♧ࡉࢀ࡚࠸ࡿࠋ௨ୖࡼࡾࠊUV 㐃㙐 ᖹ⾮ࢆඹ᭷ࡍࡿ㡿ᇦࡣࠊ$506 +75$ ࡢ 㑇ఏᏊࡲࡓࡀࡗ࡚࠸ࡿࡇࡀ▱ࡽࢀ࡚࠸ࡿ ࡀࠊ⌧ᅾࡢࡇࢁࠊࡇࡢ㡿ᇦࡀࡢࡼ࠺ᝈࡢⓎ㛵ࢃࡗ࡚࠸ࡿࡣศࡗ࡚࠸࡞࠸ࠋ ࡇࡢࡼ࠺࡞⫼ᬒࢆ㋃ࡲ࠼ࠊᮏ◊✲ࡣࠊࡇࡢ㡿ᇦ࠾ࡅࡿ $0' ᝈ⪅᭷ព࡞ኚ␗ࢆㄪࠊࡑ ࢀࡽࡢኚ␗ࡀࡢࡼ࠺࡞࣓࢝ࢽࢬ࣒࡛ $0' ࡢⓎᐤࡍࡿࢆヲ⣽ࡋࡽࡿࡇࢆ┠ ⓗࡋ࡚ᐇ㦂ࢆ⾜ࡗࡓࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ ࠙$0' ᝈ⪅≉␗ⓗ࡞ኚ␗ࡢ᳨ฟࠚࣥࣇ࢛࣮࣒ࢻࢥࣥࢭࣥࢺࡼࡾ◊✲㊃᪨ࢆ༑ศㄝ ᫂ࡋ࡚ྠពࢆᚓࡓ ZHW$0' ᝈ⪅ ே࠾ࡼࡧࠊࢥࣥࢺ࣮ࣟࣝ⩌ࡋ࡚ⓑෆ㞀ᝈ⪅ ேࡼ ࡾ᥇⾑ࢆ⾜࠸ࠊࡑࢀࡒࢀࡢᝈ⪅᳨యࡼࡾࢤࣀ࣒ '1$ ࢆᢳฟࡋࡓࠋࡑࢀࡒࢀࡢᝈ⪅⏤᮶ࡢ '1$ ᑐࡋ࡚ࠊඛ⾜◊✲ࡼࡾ ZHW$0' ᝈ⪅≉␗ⓗ࡞ኚ␗ࡢᏑᅾࡀணࡉࢀࡿ ␒ᰁⰍయࡢ $506 ࠾ࡼࡧ +75$ ࡢ㑇ఏᏊࡲࡓࡀࡿ NES ࡢ㡿ᇦࡢࢩ࣮ࢡ࢚ࣥࢫࢆ⾜࠸ࠊࡇࡢ㡿ᇦ ྵࡲࢀࡿ 613V ࡸ LQVHUWLRQࠊGHOHWLRQ ࡘ࠸࡚ࠊ$0' ᝈ⪅⩌┦㛵ࡢ㧗࠸ࡶࡢࢆ᳨ฟࡋ ࡓࠋ ࠙$0' ឤཷᛶ㑇ఏᏊࡢࣉ࣮ࣟࣔࢱ࣮άᛶࡢ ᐃࠚࢩ࣮ࢡ࢚ࣥࢫࡢ⤖ᯝࢆ㋃ࡲ࠼࡚ࠊ$0' ― 90 ― ᝈ⪅≉ᚩⓗ࡞ኚ␗ࡀ᳨ฟࡉࢀࡓࠊ$506 㑇ఏᏊࡢ࢚ࢡࢯࣥ㸯ୖὶ ES ࡲࡓࡀࡿ㡿ᇦ ࠊ$506 ࡢ࢚ࢡࢯࣥ㸰ࡢ୍㒊ࢆྵࡴࠊ+75$ 㑇ఏᏊࡢ࢚ࢡࢯࣥ㸯ୖὶ⣙ NES ࡲࡓࡀ ࡿ㡿ᇦࢆࢡ࣮ࣟࢽࣥࢢࡋࠊࣝࢩࣇ࢙࣮ࣛࢮࢵࢭࡼࡗ࡚ࠊࣉ࣮ࣟࣔࢱ࣮άᛶࢆ ᐃࡋ ࡓࠋ ࠙+WU$ ࡢⓎ⌧㒊ࡢゎᯒࠚ࣐࢘ࢫ⥙⭷⤌⧊ෆ࠾ࡅࡿ +WU$ ࡢⓎ⌧ࣃࢱ࣮ࣥࢆㄪࡿࡓ ࡵࠊș࢞ࣛࢡࢺࢩࢲ࣮ࢮࢆ࣏࣮ࣞࢱ࣮㑇ఏᏊࡋ࡚⤌ࡳ㎸ࢇࡔ +WU$ ࣀࢵࢡ࢘ࢺ࣐࢘ࢫ ࡢ࣊ࢸࣟᆺࢆ⏝࠸࡚ࠊ࣐࢘ࢫ⥙⭷⤌⧊࠾ࡅࡿ +WU$ ࡢⓎ⌧ࣃࢱ࣮ࣥࢆචᰁⰍࡼࡾ᳨ ฟ࣭ྠᐃࡋࡓࠋ ⤖ ᯝ ࠙$506+75$ ࡢࣉ࣮ࣟࣔࢱ࣮㡿ᇦࡢゎᯒࠚ ࢩ࣮ࢡ࢚ࣥࢫࡼࡾຍ㱋㯤ᩬኚᛶᝈ⪅ࡢࢤ ࣀ࣒㓄ิࢆㄪࡓ⤖ᯝࠊ$506 ࡢ➨ ࢚ࢡࢯࣥࡽ ES ୖὶࡢ⨨ࠊ ࡘࡢ & ࡀ $ ࡍ ࡚⨨ࡁࢃࡾࠊ$ ࡀ ಶ㐃⥆ࡍࡿ ZHW$0' ᝈ⪅┦㛵ᛶࡢ㧗࠸≉ᚩⓗ࡞㓄ิࡀ᳨ฟࡉࢀࠊ ࡲࡓࠊ+75$ ࡢ➨ ࢚ࢡ ࢯࣥࡼࡾ NES ୖὶࡢࠊ $506 ➨ ࢚ࢡࢯࣥࡲ ࡓࡀࡿ⨨ࠊSE ࢃࡓࡗ࡚Ḟᦆࡸ⨨ࡀ⏕ ࡌ࡚࠸ࡿ ZHW$0' ᝈ⪅ࡢ ࢤࣀ࣒┦㛵ᛶࡢ㧗࠸ኚ ␗㒊㸦LQGHO ኚ␗㸧ࢆ ☜ㄆࡋࡓ㸦ᅗ 㸧ࠋ ࡉࡽࠊࡇࡢኚ␗㒊 ࢆྵࡴᙧ࡛ $506 ࠾ࡼࡧ +75$ ࡢࣉ࣮ࣟࣔࢱ࣮㡿 ᇦࢆࢡ࣮ࣟࢽࣥࢢࡋࠊ ᅗ 㸸ARMS2-HTRA1 ࡢࢩ࣮ࢡ࢚ࣥࢫ⤖ᯝ ࣄࢺ⥙⭷Ⰽ⣲ୖ⓶⣽⬊ࡢ ⣽⬊ᰴ࡛࠶ࡿ $53(ࠊࣛࢵࢺ⥙⭷⚄⤒⠇⣽⬊ࡢ⣽⬊ᰴ࡛࠶ࡿ 5*&ࠊ࣐࢘ࢫど⣽⬊⣽⬊ᰴ࡛ ࠶ࡿ : ࢆ⏝࠸࡚ࣝࢩࣇ࢙࣮ࣛࢮࢵࢭࡼࡾࣉ࣮ࣟࣔࢱ࣮άᛶࢆㄪࡓ⤖ᯝࠊ$506 ୖὶࡢኚ␗ࢆྵࡴ㓄ิ࠾࠸࡚ࡣࠊࡍ࡚ࡢ⣽⬊ᰴ࡛ࢇࣉ࣮ࣟࣔࢱ࣮άᛶࡣ࡞ࡃࠊ ࢥࣥࢺ࣮ࣟࣝ⩌ẚ㍑ࡋ࡚ࡶ᭷ព࡞ᕪࡣ࡞ࡗࡓࠋ୍᪉ࠊ+75$ ୖὶࡢ LQGHO ኚ␗ࢆྵࡴ 㓄ิࡢࣉ࣮ࣟࣔࢱ࣮άᛶࢆㄪࡓ⤖ᯝࠊ$53( ࡛ࡣ᭷ព࡞ᕪࡣࡳࡽࢀ࡞ࡗࡓࡶࡢࡢࠊ 5*& : ࡛ࡣࠊࢥࣥࢺ࣮ࣟࣝ⩌ẚ㍑ࡋ࡚ࠊZHW$0' ᝈ⪅ከࡃࡳࡽࢀࡿ LQGHO ᆺࡢ㓄 ิࢆࡶࡘࣉ࣮ࣟࣔࢱ࣮ࡢάᛶࡀ᭷ព 㧗࠸⤖ᯝ࡞ࡗࡓࠋࡇࢀࡼࡾࠊ LQGHO ᆺࡢ㓄ิࢆࡶࡘ࡛ࡣࠊ +75$ ࡢⓎ⌧ࡀ᭷ពୖ᪼ࡋ࡚࠸ࡿࡇࡀ ♧၀ࡉࢀࡿ⤖ᯝ࡞ࡗࡓ㸦ᅗ 㸧 ࠋ ࡉࡽࡣࠊෆᅾᛶࡢࣄࢺ +75$ ࡢ ― 91 ― Ⓨ⌧ࢆㄪࡿࡓࡵࠊᖖ⪅࠾ࡼࡧ $0' ᝈ⪅⏤᮶ࡢ L36 ⣽⬊ࢆస〇ࡋࠊ㑇ఏᏊᆺࡈࡢ +75$ ࡢⓎ⌧ࢆㄪࡓ⤖ᯝࠊ1RUPDOLQGHO࣊ࢸࣟᆺ࠾ࡼࡧ LQGHOLQGHO࣍ࣔᆺࡢ㑇ఏᏊᆺ ࡢ L36 ⣽⬊࠾࠸࡚ࠊ1RUPDO1RUPDOṇᖖᆺẚ࡚ +75$ ࡢ㧗࠸Ⓨ⌧ࡀぢࡽࢀࡓࠋ ࡉࡽࠊ$506 ࣉ࣮ࣟࣔࢱ࣮ࡢኚ␗㡿ᇦࡀࠊ+75$ ࣉ࣮ࣟࣔࢱ࣮࠼ࡿᙳ㡪ࢆㄪࡿࡓ ࡵࠊኚ␗㡿ᇦࢆྵࡴ $516 ࣉ࣮ࣟࣔࢱ࣮᩿∦ LQGHO ࢆྵࡴ +75$ ࣉ࣮ࣟࣔࢱ࣮᩿∦ࢆ㐃 ᅗ 㸸HTRA1 SURPRWHU ࡢάᛶ ⥆ࡋ࡚࣋ࢡࢱ࣮ࢡ࣮ࣟࢽࣥࢢࡋࠊࣝࢩ ࣇ࢙࣮ࣛࢮࢵࢭࢆ⾜ࡗࡓࠋࡑࡢ⤖ᯝࠊ $506 ࣉ࣮ࣟࣔࢱ࣮ࡢ㓄ิࡢ᭷↓ࡸኚ␗ ࡢ㐪࠸࡛άᛶ್ᕪࡣ࡞ࡃࠊ$506 ࣉࣟ ࣮ࣔࢱ࣮ࡢኚ␗ࡣࠊࡑࡢୗὶࡢ +75$ ࡢ Ⓨ⌧ࡣᙳ㡪ࢆཬࡰࡉ࡞࠸ࡇࡀศࡗ ࡓࠋ ࠙+WU$ ࡢⓎ⌧㒊ࡢゎᯒࠚḟࠊ๓㏙ ࡢ⤖ᯝࡼࡾࠊ$0' ᝈ⪅࠾࠸࡚ +75$ ࡢ ࣉ࣮ࣟࣔࢱ࣮άᛶࡢୖ᪼ࡀ⏕ࡌ࡚࠸ࡿྍ ⬟ᛶࡀ♧၀ࡉࢀࡓࡇࡽࠊș࢞ࣛࢡࢺ ࢩࢲ࣮ࢮࢆ࣏࣮ࣞࢱ࣮㑇ఏᏊࡋ࡚⤌ࡳ ㎸ࢇࡔ +WU$ ࣀࢵࢡ࢘ࢺ࣐࢘ࢫࡢ࣊ࢸ ᅗ 㸸ARMS2 ࣉ࣮ࣟࣔࢱ࣮㡿ᇦࡀ HTRA1 ࣟᆺࢆ⏝࠸࡚ࠊ⥙⭷࠾ࡅࡿ +WU$ ࡢⓎ ࠼ࡿᙳ㡪 ⌧㒊ࡢ᳨ฟࢆ⾜ࡗࡓࠋࡑࡢ⤖ᯝࠊ+WU$ ࡢࣉ࣮ࣟࣔࢱ࣮άᛶࢆ♧ࡍș࢞ࣛࢡࢺ ࢩࢲ࣮ࢮࡣ⥙⭷እ㢛⢏ᒙከࡃⓎ⌧ࡋ࡚ ࠾ࡾࠊ+WU$ ࡢࢱࣥࣃࢡ㉁ࡣど⣽⬊ࡢෆ ⠇࠾ࡼࡧእ⠇ከࡃⓎ⌧ࡋ࡚࠸ࡓᅗ ࠋ ࠙ࣉ࣮ࣟࣔࢱ࣮⤖ྜศᏊࡢྠᐃࠚ๓㏙ࡢ ᅗ 㸸࣐࢘ࢫ⥙⭷࠾ࡅࡿ HtrA1 ࡢⓎ⌧ ⤖ᯝࡼࡾࠊ+75$ ୖὶࡢ LQGHO ኚ␗ࡀ +75$ ࡢⓎ⌧ㄪ⠇ᐤࡋ࡚࠸ࡿࡇࡀ ணࡉࢀࡿࡇࡽࠊ/&0606 ࢆ⏝࠸࡚ࠊ ࡇࡢ㡿ᇦ⤖ྜࡍࡿศᏊࡢྠᐃࢆ⾜ࡗࡓࠋࣅ࢜ࢳࣥᶆ㆑ࡋࡓ LQGHO ྠࡌ㓄ิࡢ᩿∦ࢆ '\QD%HDGV ྾╔ࡉࡏࠊࡇࡢ '\QD%HDGV : ⣽⬊ࡢࢱࣥࣃࢡ㉁ /\VDWH ࢆΰࡋࠊ࣏ࣜ ࢡ࣑ࣜࣝࢻ㟁ẼὋືࡼࡾࠊࡇࡢ LQGHO 㓄ิ⤖ྜࡋࡓࢱࣥࣃࢡ㉁ࢆ༢㞳ࡋࠊ/&0606 ࡛ྠᐃࡋࡓ⤖ᯝࠊ࠸ࡃࡘࡢೃ⿵ศᏊࡀྠᐃࡉࢀࠊ≉ࠊ1)ȡ% ࡸ +,) ࡢไᚚᅉᏊ࡛࠶ ࡿ /\ULF ࡀ㧗࠸ࢫࢥࢆ♧ࡋࡓ㸦ᅗ 㸧ࠋ ― 92 ― ࠙+WU$ ࢺࣛࣥࢫࢪ࢙ࢽࢵࢡ࣐࢘ࢫࡢゎᯒࠚ&$*ࣉ࣮ࣟࣔࢱ࣮ࢆ⏝࠸࡚࣐࢘ࢫ +WU$ ࢆᙉ ไⓎ⌧ࡉࡏࡿࢺࣛࣥࢫࢪ࢙ࢽࢵࢡ࣐࢘ࢫࢆస〇ࡋࠊࡇࡢ࣐࢘ࢫࡢ⥙⭷ࢆゎᯒࡋࡓ⤖ᯝࠊ⏕ ᚋ⣙ ᖺࡢ࣐࢘ࢫ࠾࠸࡚ࠊ⣙ 㸣ࡢ☜❧࡛ $0' 㢮ఝࡋࡓ⥙⭷ࡢ᪂⏕⾑⟶ࡀほᐹࡉࢀࠊ +WU$ ࡀ⥙⭷࠾࠸࡚⾑⟶᪂⏕ࢆㄏⓎࡉࡏࡿస⏝ࡀ࠶ࡿࡇࡀ♧၀ࡉࢀࡓᅗ 㸧ࠋ ᅗ 㸸LQGHO ኚ␗㡿ᇦ⤖ྜೃ⿵ศᏊ ᅗ 㸸HtrA1 ࢺࣛࣥࢫࢪ࢙ࢽࢵࢡ࣐࢘ࢫࡢゎᯒ⤖ᯝ ࡲࡵ ᮏ◊✲࡛ࡣ $0' ᝈ⪅┦㛵ᛶࡢ㧗࠸ $506+75$ 㡿ᇦࡢኚ␗╔┠ࡋࠊZHW$0' ᝈ⪅ ⏤᮶ࡢ᳨యࢆ⏝࠸࡚ࠊ$0' ᝈ⪅࠾ࡅࡿ $506+75$ ࡢࢩ࣮ࢡ࢚ࣥࢫࢆㄪࡓ⤖ᯝࠊ$506 ࡢ➨ ࢚ࢡࢯࣥୖὶࠊ$506 ࡢ➨ ࢚ࢡࢯࣥ +75$ ୖὶࡢࣥࢺࣟࣥࡲࡓࡀࡿ⨨ $0' ᝈ⪅᭷ព┦㛵ࡍࡿኚ␗ࡀྠᐃࡉࢀࡓࠋḟࠊࡇࡢኚ␗ࡀ $506 ࠾ࡼࡧ +75$ ࡢ ࣉ࣮ࣟࣔࢱ࣮㡿ᇦ┦ᙜࡍࡿࡇࡽࠊࡇࡢኚ␗ࢆྵࡴ᩿∦ࢆࢡ࣮ࣟࢽࣥࢢࡋࠊࡇࢀࡽࡢ ᩿∦ࢆ⥙⭷⣽⬊ࡢ FHOOOLQH ࡛࠶ࡿ $53(㸪5*&㸪: ᑟධࡋࠊࣉ࣮ࣟࣔࢱ࣮άᛶࢆ ㄪࡓࠋࡑࡢ⤖ᯝࠊ$506 ࣉ࣮ࣟࣔࢱ࣮᩿∦ࡘ࠸࡚ࡣࠊ࠸ࡎࢀࡢ⣽⬊࡛ࡶάᛶࡣࡳࡽࢀ ࡞ࡗࡓࡀࠊ+75$ ࣉ࣮ࣟࣔࢱ࣮᩿∦ࢆᑟධࡋࡓ⩌࡛ࡣࠊ5*&: ࠾࠸࡚ṇᖖᆺẚ ㍑ࡋ࡚ኚ␗ᆺࡢࣉ࣮ࣟࣔࢱ࣮άᛶࡀୖ᪼ࡍࡿ⤖ᯝ࡞ࡗࡓࠋࡉࡽࠊ+WU$ ࢆᙉไⓎ⌧ࡉ ― 93 ― ࡏࡿࢺࣛࣥࢫࢪ࢙ࢽࢵࢡ࣐࢘ࢫࢆస〇ࡋࠊࡇࡢ࣐࢘ࢫࡢ⥙⭷ࢆゎᯒࡋࡓ⤖ᯝࠊ$0' 㢮ఝ ࡋࡓ⥙⭷ࡢ᪂⏕⾑⟶ࡀほᐹࡉࢀࡓࠋ௨ୖࡢ⤖ᯝࡼࡾࠊ+75$ ୖὶࣉ࣮ࣟࣔࢱ࣮άᛶࢆୖ ᪼ࡉࡏࡿኚ␗ࡀᝈ⪅᭷ពᏑᅾࡋ࡚࠾ࡾࠊࡇࡢάᛶୖ᪼ࡀᝈࣜࢫࢡࢆୖ᪼ࡉࡏࡿ୍ᅉ ࡞ࡗ࡚࠸ࡿ⪃࠼ࡽࢀࡿࠋ ― 94 ― ࠝศᏊ⣽⬊⏕≀Ꮫ◊✲㒊ࠞ 㑇ఏᛶ⥙⭷Ⰽ⣲ኚᛶᝈ⪅㗹యᮞయࢪࢫࢺࣟࣇ࣮ᝈ⪅ࡑࢀࡒࢀࡽぢࡘࡗࡓ &RUI 㑇ఏᏊࡢ᪂つኚ␗ࡢྠᐃ 㸯 㸰 㸱 ᒸᮏᬗᏊ ࠊ⁁⏣῟ ࠊຍ⸨ගᘯ ࠊᅧྜྷ୍ᶞ㸲ࠊྜྷṊᩄ㸳ࠊ:LOOLDP&6XOWDQ㸯ࠊ ᒣᓮṇᚿ㸴ࠊゅ⏣⦾㸵ࠊᒾ⏣ᓅ㸯 㸦㸯ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊ࠊ㸰ᖇிᏛ་Ꮫ㒊║⛉Ꮫㅮᗙࠊ㸱Ꮫ་Ꮫ㒊ᑠඣ⛉Ꮫㅮ ᗙࠊ㸲㏆␥Ꮫ་Ꮫ㒊║⛉Ꮫᩍᐊࠊ㸳᪥ᮏࢯࣇࢺ࢙࣐࢘ࢿࢪ࣓ࣥࢺᰴᘧ♫ࠊ㸴⟃Ἴ Ꮫ་Ꮫ㒊ᩚᙧእ⛉ࠊ㸵どぬ◊✲㒊ࠊ 㸧 せ ⣙ ᮏ◊✲ᐊ࡛ࡣ᪥ᮏேࡢ㑇ఏᛶ⥙⭷ኚᛶࡢཎᅉ㑇ఏᏊࢆྠᐃࡍࡿ㑇ఏゎᯒࢆ⾜ࡗ࡚࠸ࡿࠋ ᅇࠊ⥙⭷Ⰽ⣲ኚᛶᝈ⪅㗹యᱰయࢪࢫࢺࣟࣇ࣮ᝈ⪅ࢆྵࡴ ᐙ⣔ࡢ࢚ࢡࢯࣥ㓄ิゎ ᯒ㸦:(6㸧ࡽࠊཎᅉ㑇ఏᏊೃ⿵ࡋ࡚ &RUI ࡀぢࡘࡗࡓࠋ&RUI ࡣ⧄ẟ㑇ఏᏊ࡛࠶ ࡾࠊࡍ࡛㌟ᛶᝈ࡛࠶ࡿ྾ᛶ⬚㒌␗ᙧᡂ㯤ᩬ㒊ࡢ␗ᖖࢆక࠺⥙⭷ኚᛶࡢཎ ᅉ㑇ఏᏊࡋ࡚ሗ࿌ࡉࢀ࡚࠸ࡓࡀࠊࢪேࡽࡣึࡵ࡚ࠊࡲࡓ⥙⭷Ⰽ⣲ኚᛶᝈ⪅ࡽࡣ ึࡵ࡚ࡢሗ࿌࡛࠶ࡿࠋࡲࡓࠊ࡛ࡣሗ࿌ࡉࢀ࡚࠸࡞࠸࣑ࣀ㓟⨨ࡢኚ␗ࡀ࠶ࡗࡓࠋ&RUI ࢱࣥࣃࢡ㉁ࡣ⥙⭷ど⣽⬊ࡢእ⠇̺ෆ⠇ᒁᅾࡋ࡚࠸ࡓࠋኚ␗ᆺࢱࣥࣃࢡ㉁ࡢⓎ⌧ゎᯒࡢ⤖ ᯝࠊᝈ⪅ࡽぢࡘࡗࡓ㑇ఏᏊኚ␗ࡼࡗ࡚ࢱࣥࣃࢡ㉁㔞ࡀῶᑡࡍࡿࡇࡀ♧၀ࡉࢀࡓࠋ ࡇࢀࡽࡢ⤖ᯝࡽࠊᝈ⪅࡛ࡣ &RUI ࢱࣥࣃࢡ㉁ࡢ㔞ࡀ㊊ࡍࡿࡓࡵど⣽⬊ࡢእ⠇̺ෆ ⠇ࢆᨭ࠼ࡿ⧄ẟ㒊ศࡢᙧᡂ࣭⥔ᣢࡀ࡛ࡁࡎど⣽⬊ࡀኚᛶࡋࠊ⥙⭷Ⰽ⣲ኚᛶཪࡣ㗹యᮞయ ࢪࢫࢺࣟࣇ࣮ࡢ≧ࡀ⌧ࢀࡿ⪃࠼ࡽࢀࡓࠋ ┠ ⓗ ࣄࢺࡣእ㒊ሗࡢ ௨ୖࢆどぬ౫Ꮡࡋ࡚࠸ࡿゝࢃࢀ࡚࠾ࡾࠊ⥙⭷ኚᛶᝈ࡛ぢࡽࢀ ࡿࡼ࠺࡞どຊࡢᣢ⥆ⓗపୗࡸኻ᫂ࡣ⏕άࡢ㉁ࡁ࡞ᙳ㡪ࢆ࠼ࡿࠋ㑇ఏᛶ⥙⭷ኚᛶᝈ ࡣ⌧ᅾᑐฎ⒪ἲࡋ࡞ࡃࠊཎᅉ㑇ఏᏊࡢᶵ⬟ゎᯒࡀ᪂ࡋ࠸⒪᪉ἲࡢ㛤Ⓨࡘ࡞ࡀࡿ ⪃࠼ࡽࢀ࡚࠸ࡿࡀࠊ᪤▱ࡢཎᅉ㑇ఏᏊࡣኚ␗ࡀぢࡽࢀ࡞࠸ᝈ⪅ࡶከ࠸ࠋࡲࡓ㑇ఏᏊኚ␗ ࡢ㢖ᗘࡣே✀㛫࡛␗࡞ࡗ࡚࠾ࡾࠊ᪥ᮏேᝈ⪅ࡢཎᅉ㑇ఏᏊྠᐃࡣ᪥ᮏཬࡧࢪ࡛᭷ຠ࡞ ⒪᪉ἲࡢ㛤Ⓨ㔜せ࡞ᇶ┙ሗ࡞ࡿࠋᮏ◊✲ࡣࠊ᪥ᮏேᝈ⪅ࢆᑐ㇟ࡋ࡚⾜ࢃࢀࡓ :(6 ࡢ⤖ᯝࢆࡶࠊ᪂つኚ␗ࡀぢࡘࡗࡓ &RUI ࡘ࠸࡚ሗ࿌ࡍࡿࠋ ᑐ㇟࠾ࡼࡧ᪉ἲ ⥙⭷Ⰽ⣲ኚᛶᝈ⪅ࢆྵࡴᐙ⣔㸯㗹యᱰయࢪࢫࢺࣟࣇ࣮ᝈ⪅ࢆྵࡴᐙ⣔㸰ᑐࡋ࡚ :(6 ࢆ⾜ࡗࡓᅗ㸯ࠋྛᝈ⪅ࡽᚓࡽࢀࡓ㑇ఏᏊኚ␗ࡽ᪤▱ࡢ୍ሷᇶከᆺ㢖ᗘࢹ࣮ࢱ࣮࣋ࢫ ሗ࿌ࡀ࠶ࡿࡶࡢࢆ㝖ࡁࠊࡲࡓ㑇ఏᙧᘧࡼࡿ⤠ࡾ㎸ࡳࢆ⾜ࡗࡓࠋཎᅉ㑇ఏᏊೃ⿵࡞ࡗ ࡓ &RUI ࡢ P51$ ࢱࣥࣃࢡ㉁ࡀ⥙⭷࡛Ⓨ⌧ࡋ࡚࠸ࡿ࠺ࢆࡑࢀࡒࢀ 573&5 ࢙࢘ ― 95 ― ࢫࢱࣥࣈࣟࢵࢸࣥࢢ࡛☜ㄆࡋࡓࠋࡲࡓࠊච⤌⧊ᰁⰍࡼࡾࢱࣥࣃࢡ㉁ࡢᒁᅾࢆ☜ㄆࡋ ࡓࠋ㑇ఏᏊኚ␗ࡀᶵ⬟࠼ࡿᙳ㡪ࢆ᳨ウࡍࡿࡓࡵ㔝⏕ᆺ㑇ఏᏊኚ␗ᆺ㑇ఏᏊࡢ F'1$ ࢆࡑࢀࡒࢀⓎ⌧࣋ࢡࢱ࣮ࢧࣈࢡ࣮ࣟࢽࣥࢢࡋࠊᇵ㣴⣽⬊࡛Ⓨ⌧ࡉࡏ࡚Ⓨ⌧㔞ࢆ᳨ウࡋࡓࠋ ⤖ ᯝ ⥙⭷Ⰽ⣲ኚᛶᝈ⪅㸦ࠊ㸧㗹యᱰయࢪࢫࢺࣟࣇ࣮ᝈ⪅㸦㸧ࡽ &RUI 㑇ఏ Ꮚࡢ」ྜ࣊ࢸࣟኚ␗㸦S90S<+㸧ຎᛶ࣍ࣔኚ␗㸦S<&㸧ࢆྠᐃࡋࡓ㸦ᅗ㸯㸧ࠋ ᅗ䠍㻌 ⥙⭷Ⰽ⣲ኚᛶᝈ⪅ᐙ⣔䠄㻲㼍㼙㼕㼘㼥㻌 㻝䠅䛸㗹యᮞయ䝆䝇䝖䝻䝣䜱䞊ᝈ⪅ᐙ⣔䠄㻲㼍㼙㼕㼘㼥㻌 㻞䠅䚹㯮ሬ䜚䛿Ⓨ⪅䜢♧䛩䚹䜰䝇䝍䝸䝇䜽䛷♧䛥䜜䛯ಶே䛾䝀䝜䝮䛻ᑐ䛧䛶䜶䜽䝋䞁 ゎᯒ䜢⾜䛳䛯䚹ୗ䛻グ㍕䛥䜜䛶䛔䜛䛾䛿 㻯㻞㻝㼛㼞㼒㻞 䛾䜰䝭䝜㓟ኚ␗䚹㻌 &RUI ࡣ ᖺ㗹యᱰయࢪࢫࢺࣟࣇ࣮ࢆక࠺྾ᛶ⬚㒌␗ᙧᡂࡢཎᅉ㑇ఏ Ꮚ࠾ࡼࡧ㯤ᩬ㒊ࡢ␗ᖖࢆక࠺⥙⭷ኚᛶࡢཎᅉ㑇ఏᏊࡋ࡚ሗ࿌ࡉࢀ࡚࠸ࡓࠋ㗹యᮞయࢪࢫ ࢺࣟࣇ࣮ࡣ㗹యࡢኚᛶࡀඛ⾜ࡍࡿࡢᑐࡋࠊ⥙⭷Ⰽ⣲ኚᛶࡣ㏻ᖖᮞయど⣽⬊ࡽኚᛶࡀ 㐍ࡴࠋ⮫ᗋࢹ࣮ࢱࡽࡶ )DPLO\ )DPLO\ ࡢ㐪࠸ࡣ᫂ࡽ࡛࠶ࡾࠊᅇࡢࡣ &RUI ࡀཎᅉ࡞ࡿ⥙⭷Ⰽ⣲ኚᛶࡘ࠸࡚ࡢ᪂ࡋ࠸ሗ࿌࡞ࡿࠋ ⥙⭷ኚᛶᝈࡢཎᅉ㑇 ఏᏊࡢከࡃࡣ⥙⭷࡛Ⓨ⌧ W/ͬϮϭŽƌĨϮͬĂĐdh W/ͬĂĐdh ࡋ࡚࠸ࡿࡓࡵࠊ&RUI 㑇ఏᏊࡘ࠸࡚ࡶ⥙⭷࡛ KE> ࡢⓎ⌧ࢆ᳨ウࡋࡓࡇࢁࠊ ࣐࢘ࢫ⥙⭷࡛ࡣど⣽⬊ࡢ ෆ⠇̺እ⠇Ώࡗ࡚ࢱࣥ /^ͬK^ ࣃࢡ㉁ࡢᒁᅾࡀ☜ㄆࡉࢀ ࡓ㸦ᅗ㸰㸧ࠋࣄࢺྠࡌ㟋 㛗㢮࡛࠶ࡿࢧࣝࡢ⥙⭷⤌ ⧊ᰁⰍ࡛ࡶෆ⠇̺እ⠇㒊 ศᰁⰍࡀ☜ㄆࡉࢀࡓࠋ ᅗ䠎㻌 㻯㻞㻝㼛㼞㼒㻞 䝍䞁䝟䜽㉁䛾ᒁᅾ䚹ど⣽⬊ෆ⠇䇲እ⠇䠄㻵㻿㻛㻻㻿䠅䛷 䜰䝉䝏䝹䝏䝳䝤䝸䞁䠄㼍㼏㼀㼁㻮㻭䠅䛸୍㒊ඹᒁᅾ䛩䜛䚹㻰㻭㻼㻵 䛷ᰁ Ⰽ䛥䜜䛶䛔䜛䛾䛿ど⣽⬊䛾᰾䛜䛒䜛⥙⭷እ㢛⢏ᒙ䠄㻻㻺㻸䠅䚹㻌 ど⣽⬊ࡢෆ⠇̺እ⠇ࡣ ⧄ẟᵓ㐀ࡀ࠶ࡾࠊ&RUI ࡀ⧄ẟᙧᡂᚲせ࡞ࡇᒁᅾࡣࡼࡃྜ⮴ࡋ࡚࠸ࡿࠋࡋࡋ௨ ๓ࡢሗ࿌࡛ࡣ &RUI ࢱࣥࣃࢡ㉁ࡢᒁᅾࡣ⧄ẟᇶᗏ㒊ࡢࡳⅬ≧ぢࡽࢀ࡚࠾ࡾࠊᅇࡢ ― 96 ― ⤖ᯝࡣᢠయࡢ㐪࠸ࠊࡲࡓ࣐࢘ࢫࡢ㐌㱋࡞ࡀᙳ㡪ࡋ࡚࠸ࡿྍ⬟ᛶࡀ࠶ࡿࠋ &RUI ࢱࣥࣃ >ZZĐĂƉ ࢡ㉁ࡣ 1 ᮎഃࣟ >ZZ >ZZ >ZZ ࢩࣥࣜࢵࢳࣜࣆ ࣮ࢺ㸦/55㸧ࢆࡶࡘ zϭϬϳ, zϭϬϳ sϭϭϭD ▷࠸ࢱࣥࣃࢡ㉁࡛ ࠶ࡿᅗ㸱ࠋࡇࢀ ࡲ࡛ሗ࿌ࡉࢀ࡚ ࠸ࡿ㑇ఏᏊኚ␗ࡀ /55 㡿ᇦࡸ & ᮎഃ ϮϱϲĂĂ ᅗ䠏㻌 㻯㻞㻝㼛㼞㼒㻞 䝍䞁䝟䜽㉁䛾䝗䝯䜲䞁ᵓ㐀䛸ኚ␗䛾⨨䚹㻸㻾㻾㻦㻌 䝻䜲䝅䞁䝸 䝑䝏䝸䝢䞊䝖䚹㻌 ࡢ㡿ᇦ⨨ࡋ࡚࠸ࡓࡢᑐࡋࠊᅇྠᐃࡋࡓኚ␗ࡣ࠸ࡎࢀࡶ /55FDS ࢻ࣓ࣥ࠸࠺ࢱ ࣥࣃࢡ㉁ࡢᢡࡾࡓࡓࡳ❧యᵓ㐀ࡢ⨨㔜せ࡞㡿ᇦ⨨ࡋ࡚࠸ࡓࠋᩥ⊩ⓗࡣ < ┦ᙜࡍࡿࢳࣟࢩࣥṧᇶࡣ /55FDS ࡢᮎ➃࠶ࡿࢫࣃࣛࢠࣥ㓟Ỉ⣲⤖ྜࢆసࡾࠊ< 9 ࡕࡽ┦ᙜࡍࡿ࣑ࣀ㓟ࢆࡢ࣑ࣀ㓟⨨ࡋࡓሙྜࡶࢱࣥࣃࢡ㉁ࡢᏳᐃᛶ ࡀపୗࡍࡿࡇࡀ♧ࡉࢀ࡚࠸ࡿࠋ 㑇ఏᏊኚ␗ࡀࢱࣥࣃࢡ㉁ᶵ⬟࠼ࡿᙳ㡪ࢆ᳨ウࡍࡿࡓࡵ㔝⏕ᆺࢱࣥࣃࢡ㉁ኚ␗ᆺ ࢱࣥࣃࢡ㉁ࡢⓎ⌧ᐇ㦂ࢆ⾜ࡗࡓ⤖ᯝࠊኚ␗ᆺࢱࣥࣃࢡ㉁ࡣ㔝⏕ᆺࢱࣥࣃࢡ㉁ࡢ༙ศ⛬ᗘࡢ Ⓨ⌧㔞ࡋぢࡽࢀ࡞ࡗ ␗ᖖ࡞ࡓࢇࡥࡃ㉁ࡣ⣽⬊ td ෆࡢࣘࣅ࢟ࢳ࣭ࣥࣉࣟࢸ ࢯ࣮࣒ࢩࢫࢸ࣒ࡼࡗ ࡚ศゎࡉࢀࡿࡇࡀ▱ࡽ ࢀ࡚࠸ࡿࠋࢱࣥࣃࢡ㉁ศ ゎ ࡼ ࡗ ࡚ ኚ ␗ ᆺ zϭϬϳ, sϭϭϭD ŵŽĐŬ ࡓࠋ &ůĂŐ d &RUI ࡢࢱࣥࣃࢡ㉁㔞 ࡀᑡ࡞ࡃ࡞ࡗ࡚࠸ࡿࡢ ࠺ࢆ☜ࡵࡿࡓࡵࠊ ࣉࣟࢸࢯ࣮࣒㜼ᐖࢆ ῧຍࡋࡓ≧ែ࡛ࢱࣥࣃࢡ ᅗ䠐㻌 㔝⏕ᆺ䛸ኚ␗ᆺ 㻯㻞㻝㼛㼞㼒㻞 䝍䞁䝟䜽㉁䛾Ⓨ⌧㔞ẚ㍑䚹ᕥ䛿 ௦⾲ⓗ䛺䚸ྑ䛿 㻟 㝵䛾ᐇ㦂䛾ᖹᆒ್䚹Ⓨ⌧㔞䛿䜰䜽䝏䞁䛾 Ⓨ⌧㔞䛷ᖹᆒ䛧䛶䛔䜛䚹㻌 ㉁㔞ࢆẚ㍑ࡍࡿᐇ㦂ࢆ⾜ࡗࡓࠋࡑࡢ⤖ᯝࠊࣉࣟࢸࢯ࣮࣒㜼ᐖᏑᅾୗ࡛ࡣ <+ ኚ␗య ࡢࢱࣥࣃࢡ㉁㔞ࡀᅇࡍࡿഴྥࡀぢࡽࢀࡓࠋ ࡇࢀࡽࡢ⤖ᯝࡽࠊ⥙⭷Ⰽ⣲ኚᛶᝈ⪅࠾ࡼࡧ㗹యᱰయࢪࢫࢺࣟࣇ࣮ᝈ⪅ࡽྠᐃࡉࢀ ࡓ &RUI 㑇ఏᏊࡢኚ␗ࡣࢱࣥࣃࢡ㉁ࡢᏳᐃᛶࢆపୗࡉࡏࠊ&RUI ࡢ㊊ࡼࡾど⣽⬊ ࡢᶵ⬟㔜せ࡞⧄ẟᙧᡂ࣭⥔ᣢࡀ␗ᖖ࡞ࡾど⣽⬊ࡢኚᛶࢆᘬࡁ㉳ࡇࡍ⪃࠼ࡽࢀࡓࠋ ᮏ◊✲⤖ᯝࡣ⌧ᅾㄽᩥᢞ✏୰࡛࠶ࡿࠋ ― 97 ― ࠝศᏊ⣽⬊⏕≀Ꮫ◊✲㒊ࠞ 21 ᆺᴟ⣽⬊␗ᖖࢆక࠺㯤ᩬኚᛶᐙ⣔ࡢཎᅉ㑇ఏᏊゎᯒ ᕝᮧ㞝୍ ࠊ⸨ᕳᣅ㑻 ࠊྜྷṊᩄ ࠊゅ⏣⦾㸲ࠊᮧୖ ᬗ ࠊᒾ⏣ ᓅ 㸦 ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊ࠊ 㡰ኳᇽᏛᏛ㝔་Ꮫ◊✲⛉║⛉Ꮫㅮᗙࠊ ᪥ᮏࢯࣇࢺ࢙࢘ࠊ 㸲 どぬ◊✲㒊㸧 せ ⣙ 㡰ኳᇽᏛ║⛉ࢆཷデ୰ࡢᖖᰁⰍయඃᛶ㑇ఏᙧᘧࢆࡿ㯤ᩬࢪࢫࢺࣟࣇ࣮ᐙ⣔ࠊ&5;ࠊ ,03'+ࠊ$,3/ࠊ/&$ ࡞ࡢ᪤▱㯤ᩬኚᛶཎᅉ㑇ఏᏊኚ␗ࡀㄆࡵࡽࢀ࡞࠸ࢣ࣮ࢫࡀ࠶ࡗࡓ ࡓࡵࠊᮏᐙ⣔࠾ࡅࡿ㯤ᩬࢪࢫࢺࣟࣇ࣮ࡢ᪂つኚ␗࠶ࡿ࠸ࡣ᪂つ㑇ఏᏊࡢ᥈⣴ࢆ┠ⓗ ࡋ࡚ࠊᮏᐙ⣔ࡢ㑇ఏᏊゎᯒࢆ⾜ࡗࡓࠋᮏᐙ⣔㸱ୡ௦ィ㸶ྡࡽၚᾮࢆᥦ౪㡬ࡁࠊࢤࣀ࣒ '1$ ࢆᢳฟࡋࠊH[RPH ゎᯒࢆ⾜ࡗࡓࠋࡑࡢ⤖ᯝࠊ㸱✀㢮ࡢೃ⿵㑇ఏᏊࡲ࡛⤠ࡾ㎸ࡳࠊࡇࡢ࠺ࡕ ᭱ࡶྍ⬟ᛶࡋ࡚㧗࠸㸯✀㢮ࡢ㑇ఏᏊ ; ࡘ࠸࡚ࠊ⥙⭷࠾ࡅࡿⓎ⌧ゎᯒࢆ⾜ࡗࡓࠋࡑࡢ ⤖ᯝࠊ㑇ఏᏊ ; ࡣ࣐࢘ࢫ࠾ࡼࡧ࢝ࢽࢡࢨࣝ⥙⭷ࡢࢩࢼࣉࢫ࡛Ⓨ⌧ࡋ࡚࠸ࡿࡇࡀࢃࡾࠊ ࡑࡢ⏘≀࡛࠶ࡿ⺮ⓑ㉁ ; ࡣ࣐࢘ࢫ⥙⭷࠾࠸࡚⥙⭷ࢩࢼࣉࢫᙧᡂᮇࢆቃⴭࡋࡃୖ᪼ࡍࡿ ࡇࡀࢃࡗࡓࠋࡲࡓࠊ⺮ⓑ㉁ ; ࢆච⤌⧊ᏛᰁⰍࡋࡓࡇࢁࠊ࣐࢘ࢫ࢝ࢽࢡࢨࣝ ⥙⭷ษ∦ࡢ᪉࡛እ⥙≧ᒙࢩࢼࣉࢫ⺮ⓑ㉁ᵝࡢࣃࢱ᳨࣮࡛ࣥฟࡍࡿࡇࡀ࡛ࡁࠊྛ✀⣽ ⬊࣐࣮࣮࢝ࢆࡗ࡚ඹᰁⰍࡋࡓ⤖ᯝࠊ⺮ⓑ㉁ ; ࡣ 21 ᆺᴟ⣽⬊ࡢど⣽⬊ഃࡢࢩࢼࣉࢫ≉ ␗ⓗᒁᅾࡋ࡚࠸ࡿࡇࡀ᫂ࡽ࡞ࡗࡓࠋ௨ୖࡼࡾࠊ㑇ఏᏊ ; ࡣ့ஙື≀ࡢ⥙⭷࡛Ⓨ⌧ ࡋ࡚࠾ࡾࠊ⥙⭷ࢩࢼࣉࢫఱࡽࡢᶵ⬟ࢆᯝࡓࡋ࡚࠸ࡿࡇࡀ♧ࡉࢀࠊᮏኚ␗ࡀᮏᝈ 㛵ࡋ࡚࠸ࡿྍ⬟ᛶࡀ⪃࠼ࡽࢀࡓࠋ ◊✲┠ⓗ 㯤ᩬࢪࢫࢺࣟࣇ࣮ࡣࠊ/HEHU ඛኳ┣ࡸ 6WDUJDUGW ࡞ࡀ࠶ࡾࠊཎᅉ㑇ఏᏊኚ␗ࡘ ࠸࡚᫂ࡽࡉࢀ࡚ࡁ࡚࠸ࡿࠋࡇࡢᗘࠊᖖᰁⰍయඃᛶ㑇ఏᙧᘧࢆࡿ㯤ᩬࢪࢫࢺࣟࣇ࣮ ᐙ⣔㸦ᅗ㸯㸧ࡀ㡰ኳᇽᏛ║⛉ࢆཷデࡋࠊ㯤ᩬኚᛶཎᅉ㑇ఏᏊࡢ &5;ࠊ,03'+ࠊ$,3/ࠊ/&$ ࡞ࡢ㑇ఏᏊ᳨ᰝࡀᐇࡉࢀࡓࠋࡋࡋࠊࡇࢀࡽࡢ㑇ఏᏊከᆺࡣㄆࡵࡓࡶࡢࡢ᪤▱ࡢཎ ᅉ㑇ఏᏊኚ␗ࡣぢࡽࢀ࡞ࡗࡓࠋࡑࡢࡓࡵࠊᮏᐙ⣔࠾ࡅࡿཎᅉ㑇ఏᏊࡀ᪂つࡢኚ␗࠶ࡿ ࠸ࡣ᪂つ㑇ఏᏊ࡛࠶ࡿྍ⬟ᛶࡀ㧗ࡃ࡞ࡾࠊཎᅉ㑇ఏᏊࡢࢫࢡ࣮ࣜࢽࣥࢢࢆヨࡳࡿࡇ࡞ ࡗࡓࠋᡃࠎࡣࡍ࡛ࠊࡇࡢᐙ⣔㸱ୡ௦ࡢࢤࣀ࣒ '1$ ࢆ H[RQ 㓄ิゎᯒ㸦H[RPH ゎᯒ㸧ࡋ࡚ࠊ ᮏᐙ⣔࠾ࡅࡿ㯤ᩬኚᛶ≉␗ⓗ࡞᪂つ㑇ఏᏊ ; ࡢኚ␗ࢆྠᐃࡋࡓࠋ ࡇࡢ㑇ఏᏊ ; ࡢኚ␗ࡘ࠸࡚ࡼࡾヲ⣽ゎᯒࡋࠊᮏኚ␗ᮏᝈⓎ㛵ࡍࡿศᏊᶵᵓ ࢆ᫂ࡽࡍࡿࡇࢆ┠ⓗࡋ࡚◊✲ࢆ⾜ࡗࡓࠋ㑇ఏᏊ ; ࡣ⬨᳝ື≀ࡢ⬻⚄⤒࠾࠸࡚ࢩ ࢼࣉࢫᙧᡂ㔜せ࡞ࡇࡀ▱ࡽࢀ࡚࠾ࡾࠊࡑࡢ⏘≀࡛࠶ࡿ⺮ⓑ㉁ ; ࡣࢩࢼࣉࢫᚋ⣽⬊๓ ⣽⬊ࡢศไᚚࢆᢸࡗ࡚࠸ࡿࡇࡀࢃࡗ࡚࠸ࡿࠋᮏᖺᗘࡣࠊ㑇ఏᏊ ; ࡢࠊ⥙⭷࠾ࡅࡿ Ⓨ⌧ᒁᅾࡘ࠸࡚ヲ⣽ゎᯒࢆ⾜ࡗࡓࠋࡉࡽࠊᝈ⪅ (5* ࢆ ᐃࡋࠊ⥙⭷ෆᒙࡢ␗ᖖ ࡘ࠸࡚ࡶ᳨ウࡋࡓࠋ ― 98 ― ᪉ ἲ ⏕ᚋ㸮ࠊ㸵ࠊࠊ ᪥┠ࡢ࣐࢘ࢫ ⥙⭷ࡽ⺮ⓑ㉁ᢳฟᾮࢆㄪ〇ࡋࠊ⺮ⓑ ㉁ ; ᑐࡍࡿᢠయࢆ⏝࠸ࡓ࢙࢘ࢫࢱࣥ ࣈࣟࢵࢸࣥࢢࢆ⾜࠸ࠊ⺮ⓑ㉁ࣞ࣋ࣝ ࡛ࡢⓎ⌧ࢆ☜ㄆࡋࡓࠋࡇࡢࡁᚓࡽࢀ ࡓࣂࣥࢻࡢ⃰ࡉࢆ ,PDJH- ࢆ⏝ࡋ࡚ ᐃ㔞ࡋࠊྛࢫࢸ࣮ࢪ࠾ࡅࡿ⺮ⓑ㉁ ; ࡢⓎ⌧㔞ࢆẚ㍑ࡋࡓࠋࡲࡓࠊ࢝ࢽࢡ ࢨࣝ⥙⭷ࡢ⺮ⓑ㉁ᢳฟ≀ࢆ⏕Ꮫⓗ ศ⏬ࡋ࡚ࢩࢼࣉࢫ㢛⢏⏬ศࢆㄪ〇ࡋࠊ ࡇࢀࡶ࢙࢘ࢫࢱࣥࣈࣟࢵࢺࡼࡗ࡚ゎ ᯒࡋࠊ⺮ⓑ㉁ ; ࡢศᕸࢆ⏕Ꮫⓗ᳨ ドࡍࡿࡇࢆヨࡳࡓࠋࡉࡽࠊ࣐࢘ࢫ ᅗ㸯 ᐙ⣔ᅗ NCMD ࢆࢃࢀࡓᝈ⪅ࡢᐙ⣔ࠋᖖᰁⰍయඃᛶ㑇 ఏᙧᘧࡢⓎ࡛࠶ࡿࡇࠋⓎ➃⪅ III-2ࠋExome ゎᯒᑐ㇟⪅ࡣ I-1,2,3,5, II-1,2, III-1,2 ࡛࠶ࡿࠋ ࡲࡓࡣ࢝ࢽࢡࢨࣝࡢ║⌫ࢆ㸲㸣ࣃ࣒ࣛ࣍ࣝࣝࢹࣄࢻ࡛ᅛᐃࡋ࡚⤖ษ∦ࢆస〇ࡋࠊᢠ ⺮ⓑ㉁ ; ᢠయࡸᴟ⣽⬊࣐࣮࣮࢝➼ࡢྛ✀࣐࣮࣮࢝ᢠయඹච⤌⧊ᏛᰁⰍࢆ⾜࠸ࠊ ඹ↔Ⅼ࣮ࣞࢨ࣮㢧ᚤ㙾࡛ほᐹࡋࡓࠋ୍᪉ࠊᝈ⪅ࡢ⥙⭷ෆᒙ࠾ࡅࡿ㞀ᐖࡘ࠸࡚ㄪࡿࡓ ࡵࠊᙜ㝔࡚ど㔝⥙⭷㟁ᅗ㸦(5*㸧ࢆᱰయᛂ࣭ᱰయ㗹యᛂ࣭㗹యᛂ࣭IOLFNHU࣭㛗 ᮇ㛫ග่⃭ࡘ࠸࡚ ᐃࡋࡓࠋ ⤖ ᯝ 㑇ఏᏊ ; ࡀ⥙⭷࡛Ⓨ⌧ࡋ࡚࠸ࡿ࠺☜ㄆࡍࡿࡓࡵࠊ(3 㐌㱋㸦:㸧ࡢྛ࣐࢘ ࢫ࢝ࢽࢡࢨࣝࡢ⥙⭷ 51$ ࢆ 573&5 ࡋ࡚ゎᯒࡋࡓ㸦ᅗ㸰$㸧 ࠋࡑࡢ⤖ᯝࠊ࣐࢘ࢫࡢྛ㐌㱋 ࠾ࡼࡧ࢝ࢽࢡࢨࣝ⥙⭷࡛㑇ఏᏊ ; ࡢⓎ⌧ࢆ☜ㄆࡋࡓࠋࡉࡽࠊ㑇ఏᏊ ; ࡢ㑇ఏᏊ⏘≀ ࡋ࡚ࠊ⺮ⓑ㉁ ; ࡀ⥙⭷ࡢ⺮ⓑ㉁ᢳฟ≀୰ྵࡲࢀ࡚࠸ࡿ࠺☜ㄆࡍࡿࡓࡵࠊ⏕ᚋ㸮᪥ ┠㸦3㸧ࠊ㸵᪥┠㸦3㸧ࠊ ᪥┠㸦3㸧ࠊ ᪥┠㸦3㸧ࡢ࣐࢘ࢫ⥙⭷ࡽ⺮ⓑ㉁ᢳฟ≀ࢆ ㄪ〇ࡋࠊ࢙࢘ࢱࣥࣈࣟࢵࢸࣥࢢࡼࡿゎᯒࢆヨࡳࡓ㸦ᅗ㸰%㸧ࠋࡑࡢ⤖ᯝࠊ࣐࢘ࢫࡢ⥙⭷ ᢳฟ≀୰ࡼࡾ⺮ⓑ㉁ ; ࢆ᳨ฟࡋࡓࠋࡉࡽ⺮ⓑ㉁ ; ࡢࣂࣥࢻࢆᐃ㔞ࡋࡓࡇࢁࠊ3 ࡽ 3 ࡢ⥙⭷ࢩࢼࣉࢫᙧᡂᮇࢆቃⴭࡋࡃ⺮ⓑ㉁㔞ࡀୖ᪼ࡋ࡚࠸ࡿࡇࡀ᫂ࡽ࡞ࡾࠊ⺮ ⓑ㉁ ; ࡀ⥙⭷ࢩࢼࣉࢫࡢᙧᡂ⥔ᣢ࠾࠸࡚㠀ᖖ㔜せ࡞ᙺࢆᢸࡗ࡚࠸ࡿࡇࡀ♧၀ࡉ ࢀࡓ㸦ᅗ &㸧 ࠋࡲࡓࠊ⺮ⓑ㉁ ; ࡣࢩࢼࣉࢫⓎ⌧ࡋ࡚࠸ࡿ⺮ⓑ㉁࡛࠶ࡿࡓࡵࠊ࢝ࢽࢡࢨ ࣝ⥙⭷ᢳฟ≀ࢆ⏕Ꮫⓗᡭἲࡼࡾศ⏬ࡋࠊ᰾⏬ศ࣭୰㛫⏬ศ࣭ࢩࢼࣉࢫ㢛⢏⏬ศศࡅ ࡚࢙࢘ࢫࢱࣥࣈࣟࢵࢺࡋࡓࠋࡑࡢ⤖ᯝࠊ⺮ⓑ㉁ࡣ⥙⭷࠾࠸࡚ࡶࢩࢼࣉࢫ㢛⢏⏬ศ㇏ᐩ Ꮡᅾࡋ࡚࠸ࡿࡇࡀ⏕Ꮫⓗ᫂ࡽ࡞ࡗࡓ㸦ᅗ '㸧ࠋࡉࡽࠊ࣐࢘ࢫ⥙⭷ษ∦ࢆ⺮ ⓑ㉁ ; ᢠయ࡛චᰁⰍࡋࠊ⥙⭷ࡢࡢ㒊ศࡢࢩࢼࣉࢫᒁᅾࡋ࡚࠸ࡿ☜ࡵࡓࠋࡑࡢ⤖ ᯝࠊ⺮ⓑ㉁ ; ࡣ⏕Ꮫⓗᡭἲ࡛᫂ࡽࡋࡓ㏻ࡾ㸦ᅗ '㸧 ࠊእ⥙≧ᒙ㸦23/㸧ࡢࢩࢼࣉࢫᙧ ᡂ㒊ࢩࢼࣉࢫᵝࡢᙧែ᳨࡛ฟࡉࢀࠊⓎ⏕ẁ㝵ࡈⓎ⌧㔞ࢆゎᯒࡋࡓ࢙࢘ࢫࢱࣥࣈࣟ ࢵࢺࡢ⤖ᯝࡢ㏻ࡾ㸦ᅗ %&㸧ࠊ3 ௨㝆ࡢ⥙⭷ࢩࢼࣉࢫᙧᡂࡀࡋࡓษ∦࡛ࡢࡳ᳨ฟࡉࢀ ࡓ㸦ᅗ (㸧ࠋ ― 99 ― ௨ୖࡼࡾࠊ⥙⭷࡛ࡢ㑇ఏᏊ ; ࡢⓎ⌧࠾ࡼࡧࡑࡢ⏘≀࡛࠶ࡿ⺮ⓑ㉁ ; ࡀ⥙⭷ࡢࢩࢼࣉࢫ ᒁᅾࡋ࡚࠸ࡿࡇࡀ᫂ࡽ࡞ࡗࡓࠋ ḟࠊ⺮ⓑ㉁ ; ࡀࡢ⣽⬊ࡢࢩࢼࣉࢫ࡛Ⓨ⌧ࡋࠊᶵ⬟ࡋ࡚࠸ࡿࡢゎᯒࡍࡿࡓࡵࠊ࣐࢘ ࢫ࢝ࢽࢡࢨ ࣝࡢ⥙⭷ษ∦ࢆ ⏝࠸ࡓච⤌⧊ ᏛᰁⰍࢆ⾜ࡗ ࡓ㸦ᅗ㸱㸧ࠋࡣࡌ ࡵど⣽⬊ᮎ➃ ࡢ࣐࣮࣮࡛࢝࠶ ࡿ 36' ᢠయ ᱰయᴟ⣽⬊࣐ ࣮࣮࢝ࡢ 3.&Ș ᢠయ࡛චᰁⰍ ࡋࡓࠋࡑࡢ⤖ᯝࠊ ࣐࢘ࢫ࠾ࡼࡧ࢝ ࢽࢡࢨࣝࡢ୧ ᪉࠾࠸࡚ࠊ⺮ ⓑ㉁ ; ࡀᴟ⣽ ⬊࣐࣮࣮࢝ࡢᰁ Ⰽീ㔜࡞ࡿ ⨨᳨ฟࡉࢀࡿ ࡇࢆぢฟࡋࡓ 㸦ᅗ㸱$ࠊⓑ▮༳ ࡢࢻࢵࢺ㸧ࠋࡉࡽ ࠊ⺮ⓑ㉁ ; ࡀ ࢩࢼࣉࢫᙧᡂ㒊 ᒁᅾࡋ࡚࠸ ࡿ࠺ㄪ ࡿࡓࡵࠊ21 ᆺ ᴟ⣽⬊ࢩࢼࣉࢫ ࣐ ࣮ ࢝ ࣮ ࡢ P*OX5 ᢠ య ど⣽⬊ 21 ᆺࢩ ࢼࣉࢫ࣐࣮࣮࢝ ࡛࠶ࡿ &W%3 ᢠ యඹචᰁ Ⰽࡋࡓࠋࡇࡢඹ ᰁⰍࡼࡾࠊ⺮ ᅗ㸰 ࣐࢘ࢫ࠾ࡼࡧ࢝ࢽࢡࢨࣝ⥙⭷࠾ࡅࡿ 㑇ఏᏊ X ࡢⓎ⌧ゎᯒ E16, P7, 5 㐌㱋㸦5W㸧࣐࢘ࢫ࢝ࢽࢡࢨࣝࡢ⥙⭷ RNA ࠾ࡅ ࡿ RT-PCR ࡼࡾࠊ㑇ఏᏊ X ࡀ࣐࢘ࢫࡢྛ㐌㱋࠾ࡼࡧ࢝ࢽࢡ ࢨࣝ⥙⭷࡛Ⓨ⌧ࡋ࡚࠸ࡿࡇࡀศࡗࡓ㸦A㸧ࠋࡉࡽࠊ⥙⭷࠾ ࡅࡿ⺮ⓑ㉁ X ࡢⓎ⌧ࡀⓎ⏕ẁ㝵ⓗࡢࡼ࠺ኚࡍࡿㄪ ࡿࡓࡵࠊP0, P7, P21, P60 ࣐࢘ࢫ⥙⭷ᢳฟ≀ࢆ࢙࢘ࢫࢱࣥࣈࣟࢵ ࢺࡼࡗ࡚ゎᯒࡋࡓ㸦B㸧ࠋ࡞࠾ࠊ࣐࢘ࢫࡢ⬻ࢧࣥࣉࣝࡣ࣏ࢪࢸ ࣈࢥࣥࢺ࣮ࣟࣝࠊ⭈⮚ࢧࣥࣉࣝࡣࢿ࢞ࢸࣈࢥࣥࢺ࣮ࣟࣝࡋ࡚ ⏝ࡋࡓࠋ᳨ฟࡋࡓࣂࣥࢻࢆᐃ㔞ࡋ࡚Ⓨ⏕ẁ㝵ࡈẚ㍑ࡋࡓ ⤖ᯝࠊ࣐࢘ࢫ⥙⭷࠾࠸࡚ P7 ࡽ P21 ࡅ࡚᭷ព⺮ⓑ㉁㔞 ࡀቑຍࡋ࡚࠸ࡓ㸦*:p<0.05㸧㸦C㸧ࠋࡉࡽ࢝ࢽࢡࢨࣝ⥙⭷ᢳฟ ≀ࢆ᰾⏬ศࢩࢼࣉࢫ㢛⢏⏬ศ㸦୰㛫⏬ศࢆ S2, S3 ࡛♧ࡍ㸧 ศࡅ࡚࢙࢘ࢫࢱࣥࣈࣟࢵࢺࡼࡗ࡚⺮ⓑ㉁ X ࢆ᳨ฟࡋࡓ⤖ᯝࠊࢩ ࢼࣉࢫ㢛⢏⏬ศ࡚㇏ᐩ X ࢆ᳨ฟࡋࡓ㸦D㸧ࠋ࣐࢘ࢫ⥙⭷ษ∦ ࢆ⏝࠸࡚⺮ⓑ㉁ X ᑐࡍࡿචᰁⰍࢆ⾜ࡗࡓ⤖ᯝࠊP21 ௨㝆ࡢ࣐ ࢘ࢫ⥙⭷ࡢእ⥙≧ᒙ㸦OPL㸧ࢩࢼࣉࢫ⏝ࡢࢻࢵࢺ≧ࡢࢩࢢࢼࣝ ࡋ᳨࡚ฟ࡛ࡁࡓ㸦E㸧ࠋ ⓑ㉁ ; ࡢ ― 100 ― ࢩࢢࢼࣝࡣᱰయࢩࢼ ࣉࢫᙧᡂ㒊⨨ ࡍࡿ 21 ᆺᴟ⣽⬊ ࢩࢼࣉࢫ࣐࣮࣮࢝ ୍⮴ࡋࡓ㸦ᅗ 㸱%ࠊⓑ▮༳ࡀ♧ࡍࢻ ࢵࢺ㸧ࠋ୍᪉ࠊ㗹యࢩ ࢼࣉࢫᙧᡂ㒊ࡢ 21 ᆺᴟ⣽⬊ࢩࢼ ࣉࢫࡢࢩࢢࢼࣝࡣ 㔜࡞ࡽ࡞࠸ࡇࡽ 㸦ᅗ㸱%ࠊ㯮▮༳ࡀ♧ ࡍࢻࢵࢺࡢࡓࡲ ࡾ㸧ࠊ⺮ⓑ㉁ ; ࡣ 21 ᆺᴟ⣽⬊ࡢᱰయࢩ ࢼࣉࢫ≉␗ⓗᒁ ᅾࡋ࡚࠸ࡿࡇࡀ᫂ ࡽ࡞ࡗࡓࠋࡲࡓࠊ ࢝ࢽࢡࢨࣝ࠾࠸ ࡚ࡣど⣽⬊ࡢᱰయ⣽ ⬊㗹య⣽⬊ࡢศᕸ ᐦᗘࡀ⥙⭷ࡢ୰ᚰ ㏆࿘㎶㒊࡛␗࡞ࡿ ࡓࡵࠊࡇࢀࡽࡢ㐪࠸ ࡼࡿ⺮ⓑ㉁ ; ࡢᒁ ᅾኚࡀ࠶ࡿ ࠺☜ࡵࡿࡓࡵࠊ ⥙⭷ࡢ୰ᚰ㒊࿘㎶ 㒊ࢆࡑࢀࡒࢀほᐹࡋ ࡓࡀࠊᅇ⾜ࡗࡓほ ᐹ࠾࠸࡚ࡣ୰ᚰ㒊 ࿘㎶㒊ࡼࡿ⺮ⓑ ㉁ ; ࡢᒁᅾࣃࢱ࣮ࣥ ࡢኚࡣぢฟࡏ࡞ ࡗࡓࠋ ⺮ⓑ㉁ ; ࡀ 21 ᆺ ᴟ⣽⬊࡛Ⓨ⌧ࡋ࡚࠸ ࡿࡇࡀ᫂ࡽ࡞ ࡾࠊᡃࠎࡣ⺮ⓑ㉁ ; ࡢኚ␗యࡀ 21 ᆺ ᅗ㸱 ࢝ࢽࢡࢨࣝ⥙⭷ษ∦࠾ࡅࡿච⤌⧊ᏛᰁⰍ ど⣽⬊ᮎ➃࣐࣮࣮࢝㸦PSD95㸧ᴟ⣽⬊࣐࣮࣮࢝㸦PKC Ș㸧ඹ⺮ⓑ㉁ X ࢆචᰁⰍࡋࡓ㸦A㸧ࠋࡑࡢ⤖ᯝࠊⓑ▮ ༳ࡀ♧ࡍࡼ࠺⺮ⓑ㉁ X ࡢࢻࢵࢺࡣᴟ⣽⬊࣐࣮࣮࢝ࡀ♧ ࡍᶞ≧✺㉳ࡢୖ㔜࡞ࡗ࡚ぢ࠼ࡓࠋON ᆺᴟ⣽⬊ࢩࢼࣉ ࢫ࣐࣮࣮࢝㸦mGluR6㸧ど⣽⬊ ON ᆺࢩࢼࣉࢫ࣐࣮࣮࢝ 㸦CtBP2㸧ඹචᰁⰍࡍࡿࠊ⺮ⓑ㉁ X ࡢࢻࢵࢺࡣⓑ ▮༳࡛♧ࡋࡓᱰయࢩࢼࣉࢫࡢᴟ⣽⬊ഃࡢࢩࢼࣉࢫ࣐࣮࢝ ࣮㔜࡞ࡾࠊ⺮ⓑ㉁ X ࡣ ON ᆺᴟ⣽⬊ࡢᱰయࢩࢼࣉࢫ ᒁᅾࡋ࡚࠸ࡿࡇࡀ᫂ࡽ࡞ࡗࡓࠋ୍᪉ࠊ㯮▮༳ࡀ♧ࡍ 㗹యࢩࢼࣉࢫഃ⺮ⓑ㉁ X ࡢࢩࢢࢼࣝࡣ↓࠸ࠋྛษ∦ඹ ୰ ᚰ ㏆ 㸦 center 㸧 ୰ 㛫 㒊 㸦 cent.-peri. 㸧 ࿘ ㎶ 㒊 㸦periphery㸧ࢆࡑࢀࡒࢀほᐹࡋࡓࠋ እ㢛⢏ᒙ㸸ONL, እ⥙≧ᒙ㸸OPL, ෆ㢛⢏ᒙ㸸INL, ෆ⥙ ≧ᒙ㸸IPLࠋ ― 101 ― ᴟ⣽⬊࡛ఱࡽࡢ␗ᖖࢆⓎ⏕ࡉࡏ࡚ኚᛶ⮳ࡾࠊࡑࡇ᥋⥆ࡋ࡚࠸ࡓど⣽⬊ࡽࡢ㟁Ẽࢩ ࢢࢼࣝࡢఏ㐩ࡀࡿࡇࡼࡗ࡚ど⣽⬊ࡲ࡛ኚᛶࡀᣑࡍࡿࡇ࡛ࠊᮏᝈࡀⓎࡋ࡚࠸ ࡓࡢ࡛ࡣ࡞࠸௬ᐃࡋࡓࠋࡑࡇ࡛ࠊᝈ⪅ࡢ⥙⭷㟁ᅗࢆ ᐃࡋ࡚ࠊ⥙⭷ෆᒙ࠾ࡅࡿ㟁Ẽ ఏ㐩➼ࡢࢹ࣮ࢱࡽᴟ⣽⬊࡞ࡢḟࢽ࣮ࣗࣟࣥ㞀ᐖࡀ㉳ࡇࡗ࡚࠸ࡿࡇࡀ᳨ฟ࡛ࡁ ࡞࠸ࠊᝈ⪅ࡈ༠ຊࡢୖ࡛ヨࡳࡓࠋࡑࡢ⤖ᯝࠊᝈ⪅ ,,ࠊ,,ࠊ,,, ࡢ㸱ே࡛ᱰయ ᛂࡀᖜῶ⾶ࡋ࡚࠸ࡓࠋࡲࡓࠊẚ㍑ⓗ≧ࡢ㐍⾜ࡀ⦆ᚎ࡞ ,, ࠾࠸࡚ࡣ IOLFNHU(5* ࡛ࢃࡎ࡞ࡀࡽᛂ⟅ࡀぢࡽࢀࠊ㛗ᮇ㛫ග่⃭ࡼࡿ᫂㡰ᛂ (5* ࡛ࡣ 21 ᆺᴟ⣽⬊⏤᮶ࡢ E Ἴࡣῶ⾶ࡋ࡚࠸ࡿࡶࢃࡽࡎࠊ2)) ᆺᴟ⣽⬊⏤᮶ࡢ G Ἴࡣ᳨ฟࡉࢀࡿ࠸࠺㠀ᖖ ⌋ࡋ࠸ഴྥࢆ♧ࡋࡓࠋ ௨ୖࡢᝈ⪅ (5* ࡢ⤖ᯝࡼࡾࠊ21 ᆺᴟ⣽⬊ࡢ␗ᖖࢆక࠺ࠊ࠶ࡿ࠸ࡣⓎ➃࡞ࡿど⣽⬊ኚ ᛶࢆᘬࡁ㉳ࡇࡍ㠀ᖖ⌋ࡋ࠸⾲⌧ᆺࢆ♧ࡍ࡛࠶ࡿࡇࡀศࡗࡓࠋࡲࡓࠊᮏ◊✲࡛ྠ ᐃࡉࢀࡓ㑇ఏᏊ ; ࡣ 21 ᆺᴟ⣽⬊ࡢᱰయࢩࢼࣉࢫ≉␗ⓗᒁᅾࡋ࡚࠸ࡿࡇࡽࠊᮏኚ ␗యࡼࡗ࡚ࡣࡌࡵᱰయᴟ⣽⬊࠾ࡼࡧᱰయど⣽⬊␗ᖖࡀฟ࡚ࠊࡑࡢᙳ㡪ࡀ㗹యど⣽ ⬊Ἴཬࡍࡿࡇ࡛Ⓨࡋ࡚࠸ࡿྍ⬟ᛶࡀ⪃࠼ࡽࢀࡿࠋࡇࡢࡼ࠺࡞࣓࢝ࢽࢬ࣒ࢆ௨ࡗ࡚ど ᅗ㸲 ᝈ⪅ࡢ⥙⭷㟁ᅗ ᕥࡽ㡰ᱰయᛂ㸦ᬯ㡰ᛂ㸸rod㸧ࠊᱰయ/㗹యᛂ㸦ᬯ㡰ᛂ㸸rod/cone㸧ࠊ㗹యᛂ㸦᫂ 㡰ᛂ㸸cone㸧 ࠊflicker㸦᫂㡰ᛂ㸸flicker㸧ࠊ㛗㛫ග่⃭㸦᫂㡰ᛂ㸸long-flash㸧ࢆ♧ࡍࠋ ᖖ⪅࡛ࡣྛ ERG ࡛≉ᚩⓗ࡞Ἴᙧࢆ♧ࡍࡀ㸦A㸧ࠊᝈ⪅࡛ࡣࡑࢀࡽࡢἼᙧࡀῶ⾶࣭㐜 ࡲࡓࡣ↓࠸ࠋ≉ࠊᝈ⪅ II-1 ᝈ⪅ III-2 ࡣྛ ERG ࡛ࢇᛂࡀぢࡽࢀ࡞࠸㸦B,D㸧ࠋ ୍᪉࡛ࠊᝈ⪅ II-2 ࡣࡢேẚ࡚≧ࡀ㍍࠸ࡓࡵࠊᖖ⪅ẚᖜ࡞ῶᑡࡀぢࡽ ࢀࡿࡶࡢࡢᛂࢆᩓぢ࡛ࡁࡿ㸦C㸧ࠋ≉ࠊ㛗㛫ග่⃭ ERG ࡛ࡣࠊど⣽⬊⏤᮶ࡢἼᙧ 㸦a Ἴ㸸㟷㸧 OFF ᆺᴟ⣽⬊⏤᮶ࡢἼᙧ㸦d Ἴ㸸⥳㸧ࡣࡲࡔぢࡽࢀࡿࡶࡢࡢࠊON ᆺᴟ⣽⬊⏤᮶ࡢἼᙧࡢࡳῶ⾶ࡋ࡚࠸ࡿ㸦b Ἴ㸸㉥㸧ࠋ ― 102 ― ⣽⬊ኚᛶࡸ㯤ᩬኚᛶࢆᘬࡁ㉳ࡇࡍࡣᴟࡵ࡚⌋ࡋ࠸ࡇࡽࠊᮏᝈࡣ㑇ఏᏛⓗࡶ ⌮Ꮫⓗࡶ᪂つࡢ㑇ఏᛶ║ᝈ࡛࠶ࡿ⪃࠼ࡽࢀࡿࠋ ᚋࡣࠊ㑇ఏᏊ ; ࡢኚ␗యࡀᮏᝈࡢⓎࡢཎᅉ࡛࠶ࡿ☜ドࢆᚓࡿࡓࡵࠊࡲࡓᮏᝈࡢ Ⓨ࣓࢝ࢽࢬ࣒ࢆゎ᫂ࡍࡿࡓࡵࠊᮏኚ␗యࢆࣀࢵࢡࣥࡋࡓ࣐࢘ࢫࣔࢹ࡛ࣝ⥙⭷࠾ࡅࡿ ⾲⌧ᆺࢆゎᯒࡋ࡚ࠊᮏ㑇ఏᏊ㯤ᩬࢪࢫࢺࣟࣇ࣮ࡢ㛵㐃ᛶࡘ࠸࡚⪃ᐹࡋ࡚࠸ࡃணᐃ࡛ ࠶ࡿࠋ ཧ⪃ᩥ⊩ >@-&%ODQNVHWDO͂6\QDSWRJHQHVLVLQWKHSKRWRUHFHSWRUWHUPLQDORIWKHPRXVH UHWLQD̓-&RPS1HXUROS̽ >@/-)LVKHU͂'HYHORSPHQWRIUHWLQDOV\QDSWLFDUUD\VLQWKHLQQHUSOH[LIRUP OD\HURIGDUNUHDUHGPLFH̓M(PEU\ROH[S0RUSKS >@'06KHUU\HWDO͂([SUHVVLRQRIYHVLFXODUJOXWDPDWHWUDQVSRUWHULQWKH PRXVHUHWLQDUHYHDOVWHPSRUDORUGHULQJLQGHYHORSPHQWRIURGYVFRQHDQG21YV2)) FLUFXLWV̓-&RPS1HXUROS̽ ― 103 ― 㻌 㻌 㻌 㻌 䊡㻌 ᴗ⦼㞟䠄ᏛⓎ⾲䚸ㄽᩥ䚸ദ䝅䞁䝫䝆䜴䝮䠅㻌 㻌 㻌 㻌 㻞㻜㻝㻡 ᖺᴗ⦼㞟㻌 ┠㻌 㻌 ḟ㻌 㻌 䠍䠊ᨻ⟇་⒪⏬◊✲㒊㻌㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㻌㻌 105 䠎䠊どぬ◊✲㒊㻌㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㻌㻌 167 䠏䠊⫈ぬ䞉ᖹ⾮ぬ◊✲㒊㻌㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㻌㻌 177 䠐䠊ேᕤ⮚ჾ䞉ᶵჾ㛤Ⓨ◊✲㒊㻌㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㻌㻌 215 䠑䠊ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊㻌㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㽂㻌㻌 221 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 ᨻ⟇་⒪⏬◊✲㒊㻌 㻌 ⮫ᗋᏛ◊✲ᐊ 㹙ㄽᩥ㹛 Bito S, Miyata S, Migita K, Nakamura M, Shinohara K, Sato T, Tonai T, Shimizu M, Shibata Y, Kishi K, Kubota C, Nakahara S, Mori T, Ikeda K, Ota S, Minamizaki T, Yamada S, Shiota N, Kamei M, Motokawa S Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery Blood㸸2015.12.9 Impact factor 10.45 Izumi M, Migita K, Nakamura M, Jiuchi Y, Sakai T, Yamaguchi T, Asahara T, Nishino Y, Bito S, Miyata S, Kumagai K, Osaki M, Mawatari M, Motokawa S Risk of venous thromboembolism after total knee arthroplasty in patients with rheumatoid arthritis J Rheumatol 42(6)㸸928-34㸪2015.6 Impact factor 3.19 Bito S, Yamamoto T, Tominaga H;JAPOAN Investigators Prospective cohort study comparing the effects of different artificial nutrition methods on long-term survival in the elderly Japan Assessment Study on Procedures and Outcomes of Artificial Nutrition (JAPOAN) 39(4)㸸456-64㸪2015.5 Impact factor 3.15 Saito S, Ito K, Yorozu A, Aoki M, Koga H, Satoh T, Ohashi T, Shigematsu N, Maruo S, Kikuchi T, Kojima S, Dokiya T, Fukushima M, Yamanaka H Nationwide Japanese prostate cancer outcomes study of permanent iodine-125 seed implantation (J-POPS) Int J Clin Oncol 20㸸375-385㸪2015 Impact factor 2.13 ᩧ⸨ྐ㑻ࠊすᒣᚭࠊ▮ᮌᗣேࠊ୰ᮧ᠇ࠊᑠὠ୍㑻ࠊ㟷ᮌၨࠊᡞ▮ோࠊⴙ⠜᠇ ๓❧⭢ࡀࢇᑐࡍࡿᨺᑕ⥺⒪᭱๓⥺ 2. ᨺᑕ⥺⒪ᚋⓎᑐࡍࡿᑐᛂ ⒪Ⓨᚋࡢ Salvage Implant Prostate Journal 2(1)㸸43-50, 201㸪2015 ― 105 ― 2) ᨺᑕ⥺ Yorozu A, Kuroiwa N, Takahashi A, Toya K, Saito S, Nishiyama T, Yagi Y, Tanaka T, Shiraishi Y, Ohashi T Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan; Outcomes of 1300 patients Brachytherapy 14(2)㸸111-117㸪2015 Impact factor 2.76 Satoh T, Dokiya T, Yamanaka H, Saito S, Ishiyama H, Itami J, Shibuya H, Nakano T, Shigematsu N, Aoki M, Egawa S, Hashimoto M, Nishimura T, Yorozu A Postmortem radiation safety and issues pertaining to permanent prostate seed implantation in Japan Brachytherapy 14(2)㸸136-141㸪2015 Impact factor 2.76 Saito S Is focal prostate therapy just psychotherapy? Surveillance versus focal therapy: Pros and cons Focal therapy of prostate cancer.㸸19-25㸪2015 ᩧ⸨ྐ㑻ࠊ▮ᮌᗣேࠊすᒣᚭࠊ୰ᮧ᠇ࠊ㟷ᮌၨࠊᐊᝆࠊᑠὠ୍㑻ࠊⓑ▼ᝆࠊᡞ▮ோࠊ ⴙ⠜᠇, ๓❧⭢⒴ᒁᡤ⒪ἲࡢ㛗ᮇᡂ⦼ࠊᨺᑕ⥺⒪ࠊBrachytherapy㸦ᑠ⥺※⒪ἲ㸧 Japanese J Endourology 28(2)㸸207-214㸪2015 Ohashi T, Yorozu A, Saito S, Tanaka N, Katayama N, Kojima S, Maruo S, Kikuchi T, Dokiya T, Fukushima M, Yamanaka H Urinary and rectal toxicity profiles after permanent iodine-125 implant brachytherapy in Japanese men: Nationwide J-POPS multi-institutional prospective cohort study. Int J Radiation Oncol Biol Phys 93(1)㸸141-149㸪2015 impact factor 2.466 Hotta K, Katsuki S, Ohata K, Abe T, Endo M, Shimatani M, Nagaya T, Kusaka T, Matsuda T, Uraoka T, Yamaguchi Y, Murakami Y, Saito Y Efficacy and safety of endoscopic interventions using the short double-balloon endoscope in patients after incomplete colonoscopy. Dig Endosc 27㸸95-8㸪2015 impact factor 2.058 ― 106 ― Uraoka T, Tanaka S, Oka S, Matsuda T, Saito Y, Moriyama T, Higashi R, Matsumoto T Feasibility of a novel extra-wide-angle-view colonoscope: a clinical study. Endoscopy 47㸸444-8㸪2015 impact factor 5.053 Uraoka T, Higashi R, Horii J, Harada K, Hori K, Okada H, Mizuno M, Tomoda J, MD, Ohara N, Tanaka T, MD, Chiu HM, Yahagi N, Yamamoto K Prospective evaluation of endoscopic criteria characteristic of sessile serrated adenoma/polyps J Gastroentrol 50㸸555-63㸪2015 impact factor 4.523 Pioche M, Rivory J, Aguero-Garcete G, Guillaud O, O'Brien M, Lafon C, Reversat N, Uraoka T, Yahagi N, Ponchon T New isolated bovine colon model dedicated to colonic ESD hands-on training: development and first evaluation Surg Endosc 29㸸3209-15㸪2015 impact factor 3.256 Oka S, Tamai N, Ikematsu H, Kawamura T, Sawaya M, Takeuchi Y, Uraoka T, Moriyama T, Kawano H, Matsuda T Improved visibility of colorectal flat tumors using image-enhanced endoscopy Dig Endosc 27(1)㸸35-9㸪2015 impact factor 2.058 Goto O, Fujimoto A, Shimoda M, Ochiai Y, Matsuda T, Takeuchi H, Kawakubo H, Maehata T, Uraoka T, Kameyama K, Kitagawa Y, Yahagi N Estimation of subepithelial lateral extent in submucosal early gastric cancer: retrospective histological analysis Gastric Cancer 18㸸810-6㸪2015 impact factor 3.719 Goto O, Takeuchi H, Kawakubo H, Matsuda S, Kato F, Sasaki M, Fujimoto A, Ochiai Y, Horii J, Uraoka T, Kitagawa Y, Yahagi N Feasibility of non-exposed endoscopic wall-inversion surgery with sentinel node basin dissection as a new surgical method for early gastric cancer: a porcine survival study Gastric Cancer 18㸸440-5㸪2015 impact factor 3.719 ― 107 ― Uraoka T, Ochiai Y, Fujimoto A, Goto O, Kawahara Y, Kobayashi N, Kanai T, Matsuda S, Kitagawa Y, Yahagi N A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissectionɔinduced ulcer in the stomach Gastrointest Endosc 2015 [Epub ahead of print] impact factor 5.369 Schölvinck DW, Goto O, Seldenrijk CA, Bisschops R, Horii J, Ochiai Y, Schoon EJ, Schenk BE, Uraoka T, van Oijen MG, Bergman JJ, Yahagi N, Weusten BL Detection of palisade vessels as a landmark for Barrett's esophagus in a Western population J Gastroenterol 2015 [Epub ahead of print] impact factor 4.523 Yoshioka T, Nishida T, Tsujii M, Kato M, Hayashi Y, Komori M, Yoshihara H, Nakamura T, Egawa S, Yoshio T, Yamada T, Yabuta T, Yamamoto K, Kinoshita K, Kawai N, Ogiyama H, Nishihara A, Michida T, Iijima H, Shintani A, Takehara T Renal dysfunction is an independent risk factor for bleeding after gastric ESD Endosc Int Open 3㸸E39-45㸪2015 impact factor not yet assigned Tsujii Y, Kato M, Inoue T, Yoshii S, Nagai K, Fujinaga T, Maekawa A, Hayashi Y, Akasaka T, Shinzaki S, Watabe K, Nishida T, Iijima H, Tsujii M, Takehara T Integrated diagnostic strategy for the invasion depth of early gastric cancer by conventional endoscopy and EUS Gastrointest Endosc 82㸸452-9㸪2015 impact factor 5.369 Tsujii Y, Nishida T, Nishiyama O, Yamamoto K, Kawai N, Yamaguchi S, Yamada T, Yoshio T, Kitamura S, Nakamura T, Nishihara A, Ogiyama H, Nakahara M, Komori M, Kato M, Hayashi Y, Shinzaki S, Iijima H, Michida T, Tsujii M, Takehara T Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study Endoscopy 47㸸775-83㸪2015 impact factor 5.053 ― 108 ― Ying J, Tsujii M, Kondo J, Hayashi Y, Kato M, Akasaka T, Inoue T, Shiraishi E, Inoue T, Hiyama S, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells Int J Oncol 46㸸1551-9 㸪2015 impact factor 3.025 Yamada T, Hirota M, Tsutsui S, Kato M, Takahashi T, Yasuda K, Sumiyama K, Tsujii M, Takehara T, Mori M, Doki Y, Nakajima K Gastric endoscopic submucosal dissection under steady pressure automatically controlled endoscopy (SPACE); a multicenter randomized preclinical trial Surg Endosc 29㸸2748-55㸪2015 impact factor 3.256 Akasaka T, Tsujii M, Kondo J, Hayashi Y, Ying J, Lu Y, Kato M, Yamada T, Yamamoto S, Inoue T, Tsujii Y, Maekawa A, Fujinaga T, Shiraishi E, Hiyama S, Inoue T, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T 5̻FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53̻mutated colon cancer cells Int J Oncol 46㸸63-70㸪2015 impact factor 3.025 Kato M, Nishida T, Hamasaki T, Kawai N, Yoshio T, Egawa S, Yamamoto K, Ogiyama H, Komori M, Nakahara M, Yabuta T, Nishihara A, Hayashi Y, Yamada T, Takehara T Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysis Surg Endosc 29㸸1560-6㸪2015 impact factor 3.256 Yoshii S, Kato M, Honma K, Fujinaga T, Tsujii Y, Maekawa A, Inoue T, Hayashi Y, Akasaka T, Shinzaki S, Nishida T, Iijima H, Tsujii M, Morii E, Takehara T Esophageal adenocarcinoma with white opaque substance observed by magnifying endoscopy with narrow band imaging Dig Endosc 27㸸392-6㸪2015 impact factor 2.058 ― 109 ― Kikuchi M, Ushida Y, Shiozawa H, Umeda R, Tsuruya K, Aoki Y, Suganuma H, Nishizaki Y Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects World J Gastroenterol 21㸸12457–67㸪2015 impact factor 2.369 Kikuchi M, Horie Y, Ebinuma H, Taniki N, Nakamoto N, Kanai T Alcoholic Liver Cirrhosis and Significant Risk Factors for the Development of Alcohol-related Hepatocellular Carcinoma-Japan Jpn. J.Alcohol & Drug Dependence 50㸸222-34㸪2015 impact factor not yet assigned. Nishizawa T, Uraoka T, Ochiai Y, Suzuki H, Goto O, Fujimoto A, Maehata T, Kanai T, Yahagi N The "two-sword fencing" technique in endoscopic submucosal dissection Clin Endosc 48㸸85-620㸪2015 impact factor 5.369 Ikehara H, Saito Y, Uraoka T, Matsuda T, Miwa H Specimen retrieval method using a sliding overtube for large colorectal neoplasm following endoscopic submucosal dissection Endoscopy 47(1)㸸E168-9㸪2015 Nishizawa T, Uraoka T, Suzuki H, Goto O, Ochiai Y, Fujimoto A, Maehata T, Kanai T, Yahagi N New endoscopic suturing method: slip knot clip suturing Gastrointest Endosc 82㸸570-1㸪2015 impact factor 5.369 Tsujii Y, Kato M, Shinzaki S, Takigawa A, Hayashi Y, Nishida T, Iijima H, Tsujii M, Takehara T Polyglycolic acid sheets for repair of refractory esophageal fistula Endoscopy 47(1)㸸E39-40㸪2015 impact factor 5.053 Matsui S, Uraoka T, Hasegawa H, Kitagawa Y A case of asymptomatic incidental live anisakid worm infestation on a large rectal polyp BMJ Case Report 2015㸸9㸪2015 impact factor not yet assigned. ― 110 ― Seishima, Uraoka T, Hasegawa H, Okabayashi K, Tsuruta M, Hayashi Y, Kitagawa Y Colon cancer arising from a sessile serrated adenoma/polyp detected on positron emission tomography/computed tomography Gastrointest Endosc 82㸸570-1㸪2015 impact factor 5.369 Goto O, Takeuchi H, Kawakubo H, Sasaki M, Matsuda T, Matsuda S, Kigasawa Y, Kadota Y, Fujimoto A, Ochiai Y, Horii J, Uraoka T, Kitagawa Y, Yahagi N First case of non-exposed endoscopic wallinversion surgery with sentinel node basindissection for early gastric cancer Gastric Cancer 18㸸434-9㸪2015 impact factor 3.719 Kato M, Uraoka T, Wada M, Banno S, Kinoshita S, Takabayashi K, Kikuchi M A case of gastric adenocarcinoma of fundic gland type resected by combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET) Clin J Gastroenterol 8㸸393-9㸪2015 impact factor not yet assigned. Takatori Y, Kato M, Sakaguchi E, Banno S, Abe K, Takada Y, Hirata T, Wada M, Kinoshita S, Takabayashi K, Kikuchi M, Kikuchi M, Fujiyama Y, Uraoka T A case of extramedullary involvement of acute monocytic leukemia that presented as obstructive jaundice Gastrointest Endosc 2015 [Epub ahead of print] impact factor 5.369 Kato M, Uraoka T, Wada M, Banno S, Kinoshita S, Takabayashi K, Kikuchi M Large muscle layer defect of stomach caused by ESD closed by using the endoloopclips technique Gastrointest Endosc 2015 [Epub ahead of print] impact factor 5.369 Yamaguchi T, Inoue T, Nishida T, Kato M, Hayashi Y, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Nagai K, Yoshii S, Hiyama S, Shinzaki S, Iijima H, Tsujii M, Takehara T Localized gastric amyloidosis mimicking a submucosal tumor-like gastric cancer Gastrointest Endosc 82(1)㸸175-7㸪2015.7 impact factor 5.369 ― 111 ― Makino Y, Miyazaki M, Shigekawa M, Ezaki H, Sakamori R, Yakushijin T, Ohkawa K, Kato M, Akasaka T, Shinzaki S, Nishida T, Miyake Y, Hama N, Nagano H, Honma K, Morii E, Wakasa K, Hikita H, Tatsumi T, Iijima H, Hiramatsu N, Tsujii M, Takehara T Solitary fibrous tumor of the liver from development to resection Intern Med 54㸸765-70㸪2015 impact factor 0.904 ᩧ⸨⿱㍜, ᒸ ᚿ㑻, ⏣୰ಙ, ᩪ⸨ ㇏, ụᯇᘯᮁ, ༑ᔒṇᗈ, ⏣⚈ᇛ, ᕤ⸨㐍ⱥ, ᑠ ᯘΎ, ୖ㞝ᚿ, ᾆᒸಇኵ, 㣤 ᾈᗣ, ᒣ㔝Ὀ✑, 㭯⏣ ಟ, Ọ⏣ಙ, ⶶཎ୍, ᒣཱྀ ⿱୍㑻, బ㔝 ᑀ, ᶔ⏣༤ྐ, ᇼᯇ㧗༤, ᩪ⸨ᙲ୍, ୖ㔝⚽ᶞ, ▼㯮ࡵࡄࡳ, ▼ᕝ⚽ᶞ, ᒸ ὒ୍, ᗣ⏨, ⸨┒Ꮥ༤, Ώ㑓⪽᫂, ᮡཎ୍ ෆど㙾㝖ᚋ⭠ T1(SM)⒴ࡢ㌿⛣࣭Ⓨ㛵ࡍࡿከタඹྠ◊✲ ⭠⒴◊✲ ࣉࣟࢪ࢙ࢡࢺ◊✲ࡢ⤖ᯝࡽ ⫶⭠ 50(4)㸸448-56㸪2015 Mori N, Kagawa N, Higuchi A, Aoki Y, Ohkusu Sepsis due to a novel urease-positive Helicobacter species in a young man J Clin Microbiol. 53(7)㸸378-380㸪2015 IF 3.993 Mori N, Yoshizawa S, Saga T, Ishii Y, Murakami H, Iwatani M, Collins AD, Riley TV, Tateda K Incorrect diagnosis of Clostridium difficile infection in a university hospital in Japan J Infect Chemother 21(10)㸸718-722㸪2015 IF 1.486 Mori N, Aoki Y Clinical characteristics and risk factors for community-acquired Clostridium difficile infection: A retrospective, case-control study in a tertiary hospital in Japan J Infect Chemother 21(12)㸸864-867㸪2015 IF 1.486 Asakura T, Ito T, Souma T, Mori N Postsystemic encephalopathy without liver cirrhosis masquerading as depression Intern Med 54(13)㸸1619-22㸪2015 IF 0.904 ― 112 ― Asakura T, Mori N Roving eye movements in a patient with hypoglycemic coma Clin Case Reports 3㸸335-336㸪2015 ⣽ᑿဏᏊࠊ᳃ఙࠊᯇᾆ୍ࠊ᳃┤ᕭࠊᒣ⏣ᜨ㔛ዉࠊᖹᒣ⨾ࠊ⸨ᮏᚿࠊᑠᒣ⏣ྜྷᏕ ᆺ A ⩌ ǃ ⁐㐃⳦ឤᰁࢆ࿊ࡋࡓ⫵⅖ࡢ୍ ᪥ᮏෆ⛉Ꮫ㞧ㄅ 104(12)㸸2556-2562ࠊ 2015 㓇 ㅬ, ᶫ 㟹, ᒣᓮ , ᩪ⸨ ᙲಙ, ᯇΎ ❧, ㇂ 㝯ಇ, ᭹㒊 ྜྷᡂ, 㛛ᯇ ㈼, 㩾ῲ Ύே, ᐑᇛ ┒῟, ⏣୰ ோⱥ, ┦ᕝ ཌ PD࣭HD ే⏝⒪ἲ࠾ࡅࡿデ⒪ሗ㓘ᨵᐃᚋࡢືྥࡑࡢᒎᮃࡘ࠸࡚ ⭈㏱ᯒ 79(ู⭡⭷㏱ᯒ 2015)㸸95-96ࠊ2015.10 㹙⥲ㄝ㹛 ᑿ⸨ㄔྖ ࣐ࣝࢳࣔࣅࢹࢸ࠾ࡅࡿ⒪ඃඛ㡰⌮ⓗࢪ࣐ࣞࣥࠕ࠶ࡕࡽࢆ❧࡚ࢀࡤ,ࡇࡕ ࡽࡀ❧ࡓࡎࠖࡽࡢྜពᙧᡂ እ᮶࡛ࠕ」ᩘࡢᝈࠖࢆࡶࡘᝈ⪅ࢆデࡿ࣐ࣝࢳࣔࣅࢹ ࢸࡢ௦ࡢࣉ࣐࣭ࣛࣜࢣ ⥲ྜデ⒪ 25(12)㸸1131-1134㸪2015.12 Ụཱྀ◊㸪ᑠᮁᏊ㸪ᑿ⸨ㄔྖ㸪ᖹ㔝ᜨ㸪ࣀᆏಖ႐ ⤊ᮎᮇ་⒪ ྾ჾᝈࡢ⤊ᮎᮇ་⒪ࢣࡢㄢ㢟 ྾ 34(8)㸸748-757㸪2015.8 ୕ᾆஂᖾ, ᮌ⃝⩏அ, ᑿ⸨ㄔྖ, ᑠ㔝ἑ, ΎỈဴ㑻, ᵽཱྀ⠊㞝, 㧗᪩ⱑ, すᕝ‶๎, ཎ⏣ᩔ, 㫽⩚◊ ࠕே⏕ࡢ᭱⤊ẁ㝵࠾ࡅࡿ་⒪ࡿ┦ㄯဨࡢ◊ಟࣉࣟࢢ࣒ࣛࠖࡢ᭷⏝ᛶ 㔞ⓗ㉁ⓗ࣑ࢵࢡࢫἲ ᪥ᮏ⪁ᖺ་Ꮫ㞧ㄅ 52㸸77㸪2015.5 ᑿ⸨ㄔྖ ࢚ࣥࢻ࣭࢜ࣈ࣭ࣛࣇࢣ࠾ࡅࡿពᛮỴᐃࡢ⪃࠼᪉ ⌧ሙ࡛ά⏝࡛ࡁࡿ ពᛮỴᐃᨭࡢࢃࡊ ⦆ࢣ 25(3)㸸207-212㸪2015.5 ᑿ⸨ㄔྖ ࠕࡸࡵࡽࢀ࡞࠸ࡽࡣࡌࡵ࡞࠸ࠖࡽᢤࡅฟࡑ࠺ ᪥⤒࣓ࢹ࢝ࣝ࢜ࣥࣛࣥ㸸2015.1.21 ― 113 ― ᑿ⸨ㄔྖ 㸦⫗యⓗ㸧③࠸ᛮ࠸ࢆࡋ࡚┬ࡋࡲࡋࡓ ᪥⤒࣓ࢹ࢝ࣝ࢜ࣥࣛࣥ㸸2015.3.13 ᑿ⸨ㄔྖ ࠕᏳᚰ࣭Ᏻࠖࡣࡢࢁ࠸ࡢ࿚ᩥ ᪥⤒࣓ࢹ࢝ࣝ࢜ࣥࣛࣥ㸸2015.4.24 ᑿ⸨ㄔྖ ⮬Ꮿ࡛ࡢ┳ྲྀࡾࢆ࠶ࡲࡾၨⵚࡋ࡞࠸࡛ࡋ࠸ ᪥⤒࣓ࢹ࢝ࣝ࢜ࣥࣛࣥ㸸2015.7.24 ᑿ⸨ㄔྖ ࠕ⌮ࢧ࣏࣮ࢺࢳ࣮࣒ࠖࡣࡌࡵࡲࡋࡓ ᪥⤒࣓ࢹ࢝ࣝ࢜ࣥࣛࣥ㸸2015.9.8 ᑿ⸨ㄔྖ ࠕ࠾௵ࡏࡋࡲࡍࠖࡣࢲ࣓ฟࡋࡢྜᅗ ᪥⤒࣓ࢹ࢝ࣝ࢜ࣥࣛࣥ㸸2015.11.18 Uraoka T, Hosoe N, Yahagi N Colonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening? Expert Rev Gastroenterol Hepatol 9㸸129-32㸪2015 impact factor 2.417 Moriyama T, Uraoka T, Esaki M, Matsumoto T Advanced technology for the improvement of adenoma and polyp detection during colonoscopy Dig Endosc 27(1)㸸40-4㸪2015 Impact factor 2.06 Kato M Diagnosis and therapies for gastric non-invasive neoplasia World J Gastroenterol 21㸸12513-8㸪2015 impact factor 2.369 ― 114 ― Nishida T, Kato M, Yoshio T, Akasaka T, Yoshioka T, Michida T, Yamamoto M, Hayashi S, Hayashi Y, Tsujii M, Takehara T Endoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditions World J Gastrointest Endosc7㸸524-31㸪2015 impact factor not yet assigned. Bunchorntavakul C, Jones LM, Kikuchi M, Valiga ME, Kaplan DE, Nunes FA, Aytaman A, Reddy KR, Chang KM Distinct features in natural history and outcomes of acute hepatitis C J Clin Gastroenterol 49㸸e31-40㸪2015 impact factor 3.498 㧗ᯘ 㤾, ᾆᒸಇኵ, ຍ⸨ඖᙪ, ⴠྜᗣ, ▮స┤ஂ LST ࡢศ㢮ࡑࡢ≉ᚩ ⮫ᗋᾘჾෆ⛉ 30(9)㸸1149-54ࠊ2015 ⴠྜᗣ,㣬ᮏဴර,ᮌୗ ⪽,┦Ⰻㄔ,๓⏿ᛅ㍤,⸨ᮏឡ,ᚋ⸨ಟ,୰ᮧ⌮ᜨᏊ,す⃝ಇᏹ, ᾆᒸಇኵ,▮స┤ஂ ༑ᣦ⭠⭢⭘࣭⭢⒴ࡢ㚷ูデ᩿⒪ ᾘჾෆど㙾 27(1)㸸133-40㸪2015 ᾆᒸಇኵ, ▮స┤ஂ ᮍ᮶ࡢ⭠ෆど㙾ࣔࢲࣜࢸ࣮ ᾘჾෆど㙾 27(4)㸸696-8ࠊ2015 ⴠྜᗣ, 㣬ᮏဴර, ┦Ⰻㄔ, ๓⏿ᛅ㍤, ⸨ᮏ ឡ, ୰ᮧ⌮ᜨᏊ, す⃝ಇᏹ, ᚋ⸨ ಟ, ᾆᒸಇኵ, ▮స┤ஂ ༑ᣦ⭠⾲ᅾᛶ⭘⒆ᑐࡍࡿෆど㙾⒪ࡢ᪉㔪 ᾘჾෆど㙾 27(7)㸸1095-102ࠊ2015 ⴠྜᗣ, ᾆᒸಇኵ, ▮స┤ஂ ࠕ⫶࣭༑ᣦ⭠ࠖࡽࡎ ༑ᣦ⭠ ESD ࠶࡞ࡓࡣࡸࡗ࡚ࡣ࠸ࡅ࡞࠸ ᾘჾෆど㙾 27(2)㸸244-5ࠊ2015 㧗ᯘ 㤾, ᾆᒸಇኵ, ▮స┤ஂ ࠕ⭠ࠖࡽࡎ ESD ඛ➃⣔࡛ࡇࢀࡣࡸࡗ࡚ࡣ࠸ࡅ࡞࠸ ᾘჾෆど㙾 27(2)㸸279-81ࠊ2015 ― 115 ― బ㔝 ᑀ, ⏣୰ಙ, ᕤ⸨㐍ⱥ, ᩪ⸨ᙲ୍, ᯇ⏣ᑦஂ, ⏣⚈ᇛ, ⸨㝯ᗈ, ụᯇᘯᮁ, ᾆᒸಇኵ, ᑠᯘ ᮃ, ୰ᮧᑦᚿ, ᇼ⏣Ḡ୍, ᇼᯇ㧗༤, ᆏᮏ┤ே, ഌ ග⩏, 㭯⏣ ಟ, Ἑ㔝ᘯᚿ, ᶔ⏣༤ྐ, ➉ෆὒྖ, ⏫⏣ᾈஂ, ᪥ୗᗈ, ྜྷ⏣┤ஂ, ᖹ⏣୍㑻, ᑎ Ẏ, ᒣ㔝Ὀ✑, 㔠Ꮚᘯ, ୰ᓥ , ᆏᮏ ⌶, ᒣཱྀ⿱୍㑻, ⋢ᑦே, ᒣᑦᏊ, ᯘ ዉ㑣, ᒸ ᚿ㑻, ᒾ㤋ᓠ㞝, ▼ᕝ⚽ᶞ, ᮧୖ⩏Ꮥ, ྜྷ⏣ⱱ, ᩪ⸨ ㇏, The Japan NBI Expert Team(JNET) The Japan NBI Expert Team(JNET)⭠ᣑ Narrow Band Imaging(NBI)ศ㢮 Intestine 19(1)㸸5-13ࠊ2015 ᾆᒸಇኵ ࠙ෆ⛉ᝈࡢデ᩿ᇶ‽࣭ᆺศ㢮࣭㔜ᗘࠚ(➨ 2 ❶) ᾘჾ ⭠⭘⒆ ෆ⛉ 115(6)㸸960-4ࠊ2015 ᾆᒸಇኵ, ᮌୗ ⪽, 㧗ᯘ 㤾, ຍ⸨ ඖᙪ, ⳥ụ ┿ Cold Polypectomy ࡢ᭷⏝ᛶࢥࢶ ᾘჾෆど㙾 27(10)㸸1718-23ࠊ2015 ๓⏿ᛅ㍤, 㣬ᮏဴර, ┦Ⰻㄔ, ⸨ᮏ ឡ, ⴠྜᗣ, ୰ᮧ⌮ᜨᏊ, す⃝ಇᏹ, ᚋ⸨ ಟ, ᾆᒸಇኵ, ▮స┤ஂ ᾘ⟶⒴ࡢ⒪᪉㔪ࡢ❧࡚᪉࣭㐍ࡵ᪉ ⭠⒴ࡢෆど㙾⒪㐺ᛂࠊእ⛉࣭⸆≀⒪ἲ 㛤ጞ࣭⛣⾜ࡢࢱ࣑ࣥࢢ ᪥ᮏࢥࣥࣆ࣮ࣗࢱእ⛉Ꮫㄅ 17(2)㸸91-100ࠊ2015 ᾆᒸಇኵ, ᯇ⏣ᑦஂ ᑠᆺ⭠࣏࣮ࣜࣉᑐࡍࡿ Cold polypectomy Gastroenterological Endoscopy 57(9)㸸2370-8ࠊ2015 㧘ᯘ 㤾, ᾆᒸಇኵ, ᮌୗ⪽, ຍ⸨ඖᙪ, ▮స┤ஂ ESD ⏝ඛ➃ࢱࢵࢳ࣓ࣥࢺࢆ࠸ࡇ࡞ࡍࢥࢶ ᾘჾෆど㙾 27(8)㸸1308-12ࠊ2015 ຍ⸨ඖᙪ, ㉥ᆏᬛྐ, ୖᣅஓ, 㔜ᕝ ⛱ ࠙⾑౽ࢆࡳࡓࡽࠚ ⾑౽ࢆࡁࡓࡍᝈࡢ≉ᚩ࣭ෆど㙾ീᑐฎἲ ⭠⟶Ꮚᐑෆ⭷ ᾘჾෆど㙾 27(10)㸸1691-1695ࠊ2015.11.16 ⸨ᇛගᘯ, ཱྀᖿᓫ, ゅᔱ┤⨾, ຍ⸨ඖᙪ, ᆏ⏣㈨ᑦ, ᕸ⿄ᒇ ಟ, ∦ᒸᖿ⤫, ᓥᒸಇ, ▮స┤ஂ, ⸨ᮏ୍┾, ᪥ᮏᾘჾෆど㙾Ꮫ 㠀㟼⬦⒗ᛶୖ㒊ᾘ⟶ฟ⾑࠾ࡅࡿෆど㙾デ⒪࢞ࢻࣛࣥ Gastroenterological Endoscopy 57(8)㸸1648-66ࠊ2015 ― 116 ― ຍ⸨ඖᙪ, 㜿㒊ᆂ୍㑻, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ State of the art ⭠ ESD ࢆࡵࡄࡗ࡚ ⭠ ESD ࡢࢹࣂࢫࡢ≉ᚩ࣭࠸ศࡅ ⭠ࡀࢇ perspective 2㸸2188-4560ࠊ2015 ⳥ụ┿, ᱵ⏣⍠⨾Ꮚ, 㭯㇂ᗣኴ, ሷ⃝ᏹ, ᯇᔱᡂᚿ, 㜿㒊ᆂ୍ᮁ, ⳥ụ⨾✑, 㧗ᶫṇᙪ, ᒣᓊ⏤ᖾ, すᓮὈᘯ, ᇼỤ⩏๎, 㔠㝯 㠀くⓗ⫢⬡⫫ ᐃ Controlled Attenuation Parameter (CAP)ࡼࡿࣝࢥ࣮ࣝᛶ ⫢㞀ᐖᝈ⪅ࡢ㚷ู ᪥ᮏࣝࢥ࣮࣭ࣝ⸆≀་Ꮫ㞧ㄅ 50㸸235-47ࠊ2015 ᇼỤ⩏๎, ᾏ⪁ᾈ, ⳥ụ┿, ୰ᮏఙᏹ, 㔠㝯 ᮏ㑥࠾ࡅࡿࣝࢥ࣮ࣝᛶ⫢◳ኚࡢᐇែ ⫢⮚ 56㸸366-8ࠊ2015 ❑⃝㝧Ꮚࠊ㧘ᯘ㤾ࠊ㧗ྲྀ♸సࠊ㜿㒊ᆂ୍ᮁࠊ㧗⏣♸᫂ࠊᖹ⏣ဴࠊబ⸨㐨Ꮚࠊᡂ℩ᬛᗣࠊ ຍ⸨ඖᙪࠊ⳥ụ┿ࠊ⸨ᒣὒ୍ࠊᩧ⸨ඃᏊࠊᒣᮏ⣪つᏊࠊᮧ⏣᭷ஓࠊ๓ᓥ᪂ྐࠊ㧗ᶫṇᙪࠊ బ⸨㝯ࠊᾆᒸಇኵ ከ⮚ჾ㌿⛣ࢆ᮶ࡋࡓ㣗㐨ཎⓎ↓Ⰽ⣲ᛶᝏᛶ㯮Ⰽ⭘ࡢ 1 Progress of Digestive Endoscopy 87(1)㸸96-7ࠊ2015 బ⸨㐨Ꮚࠊ㧘ᯘ㤾ࠊ㜿㒊ᆂ୍ᮁࠊ㧗⏣♸᫂ࠊᖹ⏣ဴࠊ㧗ྲྀ♸సࠊᡂ℩ᬛᗣࠊຍ⸨ඖᙪࠊ ⸨ᒣὒ୍ࠊ㧗ᶫṇᙪࠊຓ⏣ⵇࠊⓑ▼῟୍ࠊᾆᒸಇኵ ⚄⤒ෆศἪ⣽⬊ࡢศࢆ♧ࡍపศ⭢⒴ᡂศࢆకࡗࡓ㝯㉳ᆺ⫶⢓⭷ෆ⒴ࡢ 1 Progress of Digestive Endoscopy 87(1)㸸124-5ࠊ2015 ᯇᮧ┿ྖ 㧗㱋⪅࢚࣐࣮ࢪ࢙ࣥࢩ࣮ࠕᩆᛴ㏦ࡗࡓᚋࡢ㧗㱋⪅࣐ࢿࢪ࣓ࣥࢺɆᖐࡾࡓࡃ࡚ࡶᖐࢀ࡞ ࠸ ⥲ྜデ⒪ 25(5)㸸482-486ࠊ2015.5 [ⴭ᭩] ᑿ⸨ㄔྖ ་⪅ࡢゝ࠺ࡇࡣヰ༙ศ࡛࠸࠸ 207 ࣮࣌ࢪࠊ㹎㹆㹎◊✲ᡤࠊ2015.12.3 ᑿ⸨ㄔྖ ᬑ㏻ࡢ⤒⭠ᰤ㣴ែู⤒⭠ᰤ㣴ච㈿ά⣔⤒⭠ᰤ㣴ࡢẚ㍑ ⸆ࡢࢹࢠࣗࢫࢱࢩ࢜ࣥɆ〇⸆࣓࣮࣮࢝㢗ࡽࡎ⸆ຮᙉࡍࡿࡓࡵɆࠊ (ᒾ⏣ኴ㑻)ࠊ251-259ࠊ㔠ⰾᇽࠊ2015.11.20 ― 117 ― ⳥ụ┿ ⭡Ỉ ࢪ࢙ࢿࣛࣜࢫࢺࡢࡓࡵࡢእ᮶ึ⒪࣭ฎ⨨࢞ࢻࠊ་Ꮫ᭩㝔ࠊ2015 ᳃ఙ ㉁ᛂ⟅ ProпPro ෆ⛉㸸ឤᰁ 㧗ཎᛶࢡࣟࢫࢺࣜࢪ࣒࣭࢘ࢹࣇࢩࣝࡼࡿ ⭠⅖ࡢ⒪ ᪥ᮏ་᪂ሗ㸶᭶㸳㐌ྕࠊNo.4766ࠊ2015 ᯇᮧ┿ྖࠊୖ㔝༓㭯Ꮚ ࠕࢣࡢ࢝ࣜࢫ࣐ࡓࡕ㸫┳ྲྀࡾࢆᨭ࠼ࡿࣉࣟࣇ࢙ࢵࢩࣙࢼࣝࠖࠊ49-86ࠊள⣖᭩ᡣࠊ 2015.3 ᮌᮧ⌶☻ࠊᯇᮧ┿ྖ 㢗ࢀࡿ་࡞ࡿࡓࡵࡢ㧗㱋⪅デ⒪ࡢࢥࢶࢆྛ⛉ᑓ㛛་ࡀᩍ࠼ࡲࡍࠊ⨺ᅵ♫ࠊ2015.4 ᯇᮧ┿ྖࠊ⚟ኴ㑻ࠊᒣ⏣ᗣ ᪥ᮏㄒ∧࣭ᐙᗞ་⒪ࡢ㉁Ɇデ⒪ᡤ࡛࠺ࢶ࣮ࣝࣈࢵࢡɆࠊ࢝᭩ᯘࠊ2015.4 ᪥ᮏࣉ࣐࣭ࣛࣜࢣ㐃ྜᏛ࣭⩻ヂࢳ࣮࣒ ᯇᮧ┿ྖ ⏥≧⭢ᶵ⬟ஹ㐍࣭పୗ ࢚ࣆࢯ࣮ࢻࢆぢ㏨ࡍ࡞㸟 ᚎࠎ㐍⾜ࡍࡿᝈࡢ㐃ᦠࣉ࣮ࣟࢳࠊ(ෆᒣᐩኈ㞝࣭ すᮧ┿⣖)ࠊ98-102ࠊࣉ࣓ࣜࢻ♫ࠊ2015.6 [ᏛⓎ⾲] ᑿ⸨ㄔྖ ࠕࢃࡾ࠶࠼࡞࠸ࠖ௦ࡢᝈ⪅-་⒪⪅㛫ࠊከ⫋✀㛫ࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ ࠕ┳ㆤᖌࠊ⸆ᖌ⫵ࡀࢇᑓ㛛་ᖌࡢᑐヰ✵㛫 4㹼⌧ሙ࡛ࡢࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ㹼 ➨ 56 ᅇ᪥ᮏ⫵⒴ᏛᏛ⾡㞟ࠊ⚄ዉᕝ┴ᶓᕷࠊ2015.11.27 㐲ᒣ⩏ᙪ, ᒸ⏣⨾⳯Ꮚ, Ṋ┿ᑑ௦, ┠㯮ᗣᖹ, Ⲩዉ, ᑠᖭᩄ, ☾㒊㝧, ᑿ⸨ㄔྖ, ▼ᕝ࣋ࣥࢪ࣑ࣕࣥග୍ ᆅᇦ་⒪ᵓࡢ་⒪㟂せ᥎ィࢆ⏝ࡋࡓ㧗ᗘᛴᛶᮇᗋࡢ᳨ド ➨ 69 ᅇᅜ❧㝔⥲ྜ་Ꮫࠊᾏ㐨ᮐᖠᕷࠊ2015.10.2-3 ᮏᕝဴ, ᑿ⸨ㄔྖ, ᐑ⏣ⱱᶞ, ྑ⏣Ύᚿ, ୰ᮧ┿₻, ⇃㇂ㅬ, J-PSVT ◊✲⌜ ேᕤ㛵⠇⨨⾡ᚋࡢ⾑ᰦண㜵ࡋ࡚ࡢᶵᲔⓗᅽ㏕ἲࡼࡿ࣊ࣃࣜࣥ㉳ᅉᛶ⾑ᑠᯈ ῶᑡ(HIT)ࡢⓎせᅉ ➨ 69 ᅇᅜ❧㝔⥲ྜ་Ꮫࠊᾏ㐨ᮐᖠᕷࠊ2015.10.2-3 ― 118 ― ᑿ⸨ㄔྖ ⮫ᗋ◊✲࠾ࡅࡿ┈┦ࢆ⪃࠼ࡿ ࠕ࡛ࡁࡿࡇࡽጞࡵࡼ࠺ࠖ Ⴀᴗ⮫ᗋ་࣭◊✲⪅ࡢ㐺ษ࡞㛵ಀసࡾ ➨ 69 ᅇᅜ❧㝔⥲ྜ་Ꮫࠊᾏ㐨ᮐᖠᕷࠊ2015.10.2-3 ୰ᮧ᠇ࠊ㟷ᮌၨࠊᐊᝆࠊ▮ᮌᗣேࠊᑠὠ୍㑻ࠊすᒣᚭࠊᡞ▮ோࠊⴙ⠜᠇ࠊᩧ⸨ྐ㑻, ๓❧⭢⒴ᐦᑒᑠ⥺※Ọஂᤄධ⒪ἲ(BT)ᚋࡢ⢭ᄞⓎᑐࡋ salvage BT ࢆ⾜ࡗࡓ㸯 ➨ 127 ᅇ᪥ᮏἪᒀჾ⛉ᏛἈ⦖ᆅ᪉ࠊ㑣ぞࠊ2015.1.31 Yorozu A, Eriguchi T, Saito S, Kuroiwa N, Takahashi A, Toya K, Shiraishi Y, Nishiyama T, Yagi Y Dose effects on long-term urinary morbidity after permanent prostate brachytherapy with or without external beam radiotherapy in 1,300 petients 36th Annual Meeting of the American Brachytherapy Society 㸪 Orlando,USA 㸪 2015.4.9 Nakamura K, Aoki K, Yagi Y, Ozu C, Nishiyama T, Toya K, Yorozu A, Saito S Clinical outcomes of I-125 seed implantation brachytherapy for high risk prostate cancer 36th Annual Meeting of the American Brachytherapy Society 㸪 Orlando,USA 㸪 2015.4.9 ୰ᮧ ᠇ࠊ㟷ᮌၨࠊ▮ᮌᗣேࠊᑠὠ୍㑻ࠊすᒣ ᚭࠊᡞ▮ோࠊⴙ ⠜᠇ࠊᩧ⸨ྐ㑻 ๓❧⭢⒴ࣚ࢘⣲ 125 ᐦᑒᑠ⥺※⒪ἲᚋ PSA ୖ᪼࠾ࡅࡿ⤒㝜ⓗ๓❧⭢⏕᳨ ➨ 103 ᅇ᪥ᮏἪᒀჾ⛉Ꮫ⥲ࠊ㔠ἑࠊ2015.4.18 ▮ᮌᗣேࠊ㟷ᮌၨࠊ⩚┤ஓࠊ୰ᮧ᠇ࠊᑠὠ୍㑻ࠊすᒣᚭࠊᡞ▮ோࠊⴙ⠜᠇ࠊ ᩧ⸨ྐ㑻 ๓❧⭢⒴ᐦᑒᑠ⥺※⒪ࡢ QOL እ↷ᑕ⒪ࡸෆศἪࡀཬࡰࡍᙳ㡪 ➨ 103 ᅇ᪥ᮏἪᒀჾ⛉Ꮫ⥲ࠊ㔠ἑࠊ2015.4.19 すᒣᚭࠊ㟷ᮌၨࠊ⩚┤ஓࠊ୰ᮧ᠇ࠊ▮ᮌᗣேࠊᑠὠ୍㑻ࠊᩧ⸨ྐ㑻 ᙜ㝔࠾ࡅࡿ㦵┙ෆ⮚ჾ⬺ᑐࡍࡿ tension-free vaginal mesh (TVM) ᡭ⾡ ➨ 103 ᅇ᪥ᮏἪᒀჾ⛉Ꮫ⥲ࠊ㔠ἑࠊ2015.4.20 㟷ᮌၨࠊ୰ᮧ᠇ࠊᖹἑ㝧ࠊ⩚┤ஓࠊ▮ᮌᗣேࠊᑠὠ୍㑻ࠊすᒣᚭࠊᩧ⸨ྐ㑻 ᙜ㝔࠾ࡅࡿࣟ࣎ࢵࢺᨭୗ᰿ⓗ๓❧⭢㝖⾡ࡢᑟධ୍ᖺࡢึᮇᡂ⦼ ➨ 103 ᅇ᪥ᮏἪᒀჾ⛉Ꮫ⥲ࠊ㔠ἑࠊ2015.4.20 ― 119 ― Tanaka N, Yorozu A, Maruo S, Kojima S, Ohashi T, Katayama N, Saito S, Dokiya T, Fukushima M, Yamanaka H, Fujimoto K To predict a good candidate who undergo a permanent iodine-125 seed implantation in respect of urinary morbidity from the results of a nationwide cohort study in Japan 2015 American Urological Association Annual Meeting 㸪 New Orleans,USA 㸪 2015.5.19 Shiro Saito Long term outcomes of prostate brachytherapy in Japan 2015 The first Beijing International Conference of Modern Brachytherapy㸪ி, ୰ᅜ㸪2015.8.21 㟷ᮌၨࠊᑠὠ୍㑻ࠊ୰ᮧ ᠇ࠊᐊ ᝆࠊ▮ᮌᗣேࠊすᒣ ᚭࠊᩧ⸨ྐ㑻 ࣟ࣎ࢵࢺᨭୗ๓❧⭢㝖⾡ࡢ⭤⬔ᒀ㐨࿀ྜ࠾ࡅࡿ⦎⩦ learning curve ࡢ┦㐪 ➨ 80 ᅇ᪥ᮏἪᒀჾ⛉Ꮫᮾ㒊⥲ࠊᮾிࠊ2015.9.26 ᐊᝆࠊ㟷ᮌၨࠊ୰ᮧ᠇ࠊ▮ᮌᗣேࠊᑠὠ୍㑻ࠊすᒣᚭࠊᩧ⸨ྐ㑻 㔜⢏Ꮚ⒪ᚋ salvage ࣟ࣎ࢵࢺᨭୗ๓❧⭢㝖⾡ࢆ⾜ࡋࡓ๓❧⭢⒴ࡢ 1 ➨ 80 ᅇ᪥ᮏἪᒀჾ⛉Ꮫᮾ㒊⥲ࠊᮾிࠊ2015.9.27 ᩧ⸨ྐ㑻ࠊすᒣᚭࠊ▮ᮌᗣேࠊ୰ᮧ᠇ࠊ㟷ᮌၨࠊᐊᝆࠊᑠὠ୍㑻ࠊᡞ▮ோࠊⴙ⠜᠇ ᑠ⥺※⒪ἲࡢ᭷ຠᛶࡑࢀࢆᨭ࠼ࡿᢏ ➨ 80 ᅇ᪥ᮏἪᒀჾ⛉Ꮫᮾ㒊⥲ࠊᮾிࠊ2015.9.27 ⴙ⠜᠇ࠊ㯮ᒾಙᏊࠊ㧗ᶫⲁࠊබ⏣㱟୍ࠊ㧗ᕝె᫂ࠊᩧ⸨ྐ㑻ࠊすᒣᚭࠊ▮ᮌᗣே ๓❧⭢⒴ࡢ↷ᑕᚋⓎᑐࡍࡿᩆ῭ෆศἪ⒪ἲࡢධணᚋ ➨ 53 ᅇ᪥ᮏ⒴⒪ᏛᏛ⾡㞟ࠊி㒔ࠊ2015.10.29 Ἀཎᏹࠊ௰㔝ṇ༤ࠊⴙ⠜᠇ࠊ⏣୰ᐉ㐨ࠊྂ㈡ᐶྐࠊᩧ⸨ྐ㑻ࠊᑿఙ୍㑻ࠊ⚟ᓥṇ๎ࠊ ᅵჾᒇ༟ᚿࠊᒣ୰ⱥኖ ࣍ࣝࣔࣥࢼ࣮ࣈᐦᑒᑠ⥺※⒪ᝈ⪅࠾ࡅࡿ⏨ᛶᶵ⬟ホ౯ ➨ 53 ᅇ᪥ᮏ⒴⒪ᏛᏛ⾡㞟ࠊி㒔ࠊ2015.10.29 ▮ᮌᗣேࠊ㟷ᮌၨࠊᐊᝆࠊすᒣᚭࠊᡞ▮ோࠊⴙ⠜᠇ࠊᩧ⸨ྐ㑻 ๓❧⭢⒴ᐦᑒᑠ⥺※⒪ᚋ࠾ࡅࡿ PSA Ⓨࡢ᳨ウ ➨ 53 ᅇ᪥ᮏ⒴⒪ᏛᏛ⾡㞟ࠊி㒔ࠊ2015.10.29 ― 120 ― ᩧ⸨ྐ㑻ࠊ▮ᮌᗣேࠊすᒣᚭࠊ୰ᮧ᠇ࠊ㟷ᮌၨࠊᐊᝆࠊᑠὠ୍㑻ࠊⓑ▼ᝆࠊᡞ▮ோࠊ ⴙ⠜᠇ ప⥺㔞⋡ᑠ⥺※⒪ἲࡢᮏ㑥㛗ᮇᡂ⦼ ᪥ᮏἪᒀჾ⭘⒆Ꮫ➨ 1 ᅇᏛ⾡㞟ࠊி㒔ࠊ2015.10.31 Shiro Saito Recent aspects of permanent prostate brachytherapy The 15th National Conference of Radioactive Seed Brachytherapyࠊ⁚ᕞ,୰ᅜࠊ 2015.11.07, 㟷ᮌၨࠊᐊ ᝆࠊ୰ᮧ ᠇ࠊ▮ᮌᗣேࠊᑠὠ୍㑻ࠊすᒣ ᚭࠊᩧ⸨ྐ㑻 ഃ᪉ࣉ࣮ࣟࢳࡼࡿ⭤⬔๓❧⭢㞳᩿ࡢ᭷⏝ᛶࡢ᳨ウ ➨ 29 ᅇ᪥ᮏἪᒀჾෆど㙾Ꮫ⥲ࠊᮾிࠊ2015.11.20 Pioche M, Rivory J, Aguero G, Guillaud O, O'Brien M, Uraoka T, Yahagi N, Ponchon T New isolated bovine colon model dedicated to colonic ESD hands-on training: development and first evaluation Digestive Disease Week 2015㸪Washington D.C./USA㸪2015.5 Fujimoto A, Ochiai Y, Goto O, Nishizawa T, Nakamura R, Maehata T, Kinoshita S, Sagara S, Uraoka T, Yahagi N Efficacy of a 2% rebamipide solution as a novel submucosal injection agent for gastric endoscopic submucosal dissection Digestive Disease Week 2015㸪Washington D.C./USA㸪2015.5 Uraoka T, Fujimoto A, Ochiai Y, Goto O, Kawahara Y, Hori K, Masayuki S, Yahagi Y High pressure carbon dioxide submucosal injection in endoscopic submucosal dissection Digestive Disease Week 2015㸪Washington D.C./USA㸪2015.5 Takatori Y, Kato M, Suzuki M, Abe K, Hirata T, Takada Y, Naruse T, Takabayashi K, Kikuchi M, Fujiyama Y, Takahashi M, Uraoka T History of gastro-duodenal ulcer as an independent predictor for requirement of endoscopic intervention for non-variceral upper gastrointestinal bleeding Digestive Disease Week 2015㸪Washington D.C./USA㸪2015.5 Sato M, Kato M, Suzuki M, Abe K, Takada Y, Hirata T, Takatori Y, Naruse T, Takabayashi K, Kikuchi M, Fujiyama Y, Takahashi M, Uraoka T Should all patients with colonic diverticular hemorrhage undergo urgent colonoscopy? Digestive Disease Week 2015㸪Washington D.C./USA㸪2015.5 ― 121 ― Uraoka T, Tanaka S, Saito Y, Matsumoto T, Saito S, Oka S, Matsuda T, Moriyama T, Ogata H, Yahagi N, Tajiri H, Ishikawa H Diagnostic value of extra-wide-angle-view colonoscope in the aAdenoma detection: a multicenter randomized controlled trial. Digestive Disease Week 2015㸪Washington D.C./USA㸪2015.5 Uraoka T, Fujimoto A, Ochiai Y, Goto O, Maehata T, Nishizawa T, Kawahara Y, Hori K, Kato M, Shimoda M, Yahagi N A novel high-pressure carbon dioxide submucosal injection technique in endoscopic submucosal dissection United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Kato M, Sakaguchi E, Abe K, Takada Y, Hirata T, Banno S, Wada M, Takatori T, Kinoshita S, Kikuchi H, Takabayashi K, Kikuchi M, Kikuchi M, Fujiyama Y, Suzuki M, Ohishi T, Uraoka T Screening colonoscopy for subjects older than 85 years old United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Wada M, Kato M, Sakaguchi E, Ishibashi Y, Banno S, Abe K, Takada Y, Hirata T, Takatori Y, Kinoshita S, Takabayashi, Kikuchi M, Kikuchi M, Fujiyama Y, Suzuki M, Uraoka T The history of colonic diverticular hemorrhage and colonoscopic hemostasis are independent predictors for reccurent hemorrhage United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Hirata T, Uraoka T, Kato M, Sakaguchi E, Ishibashi Y, Banno S, Abe K, Takada Y, Takatori Y, Wada M, Kinoshita S, Takabayashi, Kikuchi M, Kikuchi M, Fujiyama Y, Suzuki M, Ohishi T Endoscopic management for sigmoid volvulus : Should we perform endoscopic detorsion all cases? United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Takatori Y, Kato M, Sakaguchi E, Ishibashi Y, Banno S, Abe K, Takada Y, Hirata T, Wada M, Kinoshita S, Takabayashi, Kikuchi M, Kikuchi M, Fujiyama Y, Suzuki M, Uraoka T History of gastro-duodenal ulcer is an independent predictor for requirement of endoscopic hemostasis for non-variceral upper gastrointestinal bleeding United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 ― 122 ― Maehata T, Uraoka T, Goto O, Akimoto T, Sagara S, Ochiai Y, Fujimoto A, Nishizawa T, Yahagi N Varidity of endoscopic submucosal dissection for colorectal T1 (submucosal invation) cancer. United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Ochiai Y, Akimoto T, Sagara S, Maehata T, Fujimoto A, Nakamura R, Nishizawa T, Goto O, Uraoka T, Yahagi N Clinical outcome of endoscopic submucosal dissection for superficial duodenal neoplasm in 60 lesions United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Pioche M, Rivory J, Nishizawa T, Uraoka T, Lienhart I, Ponchon T, Yahagi N Randomized comparative evaluation of an ESD self-learning software in France and Japan United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Fujimoto A, Goto O, Akimoto T, Maehata T, Ochiai Y, Nishizawa T, Nakamura R, Sagara S, Akimoto T, Shimoda M, Uraoka T, Yahagi N Evaluation of the speed and quality of gastric ulcer healing after ESD using 2% rebamipide solution as a novel submucosal injection material United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Kato M, Nishida T, Yamamoto T, Kitamura S, Yamada T, Egawa S, Komori M, Kawai N, Nishihara A, Nakanishi F, Nakahara M, Ogiyama H, Mukai A, Hayashi Y, Tsujii M, Takehara T Severe atrophic gastritis is a significant risk factor of metachronous multiple gastric cancer: A Multicentre Retrospective Cohort Study by the Osaka Gut Forum United Enropean Gastroenterology 2015㸪Barcelona/Spain㸪2015.10 Masahiro Kikuchi, Rumiko Umeda, Kota Tsuruya, Hirokazu Shiozawa, Miho Kikuchi, Masahiko Takahashi,Yoshinori Horie, Yasuhiro Nishizaki Diagnostic accuracy for non-alcoholic fatty liver disease (NAFLD) with controlled attenuation parameter (CAP) measured by transient elastography The 66th American Association for the Study of the Liver㸪San Francisco(USA)㸪 2015.11.17 ― 123 ― Yasuhiro Nishizaki,Chizumi Yamada, Noriaki Kishimoto, Nobushige Yukumatsu, Hirokazu Shiozawa, Norihito Watanabe, Rumiko Umeda, Masahiro Kikuchi, Takanori Kanai, Naoaki Tshii Ferritin derived oxidative stress is a risk for liver damage even within reference range in male The 10th World Congress for Microcirculation㸪Kyoto㸪2015.9.25 㧗ྲྀ♸స, ຍ⸨ඖᙪ, 㕥ᮌ㞞அ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, ᡂ℩ᬛᗣ, 㧗ᯘ㤾, ⳥ụ┿, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ ⫶༑ᣦ⭠₽⒆ࡢ᪤ ࡣୖ㒊ᾘ⟶ฟ⾑ᝈ⪅࠾࠸࡚ෆど㙾ⓗṆ⾑⾡ࡢ⊂❧ࡋࡓ༴㝤 ᅉᏊ࡛࠶ࡿ ➨ 11 ᅇ᪥ᮏᾘ⟶Ꮫ⥲Ꮫ⾡㞟ࠊᮾி㒔᪂ᐟ༊ࠊ2015.2 ᚋ⸨ ಟ, ๓⏿ᛅ㍤, ⸨ᮏ ឡ, ୗ⏣ᑗஅ, ᯇ⏣ 㐩㞝, బࠎᮌ ᇶ, ⴠྜᗣ, ᇼᇛ୍ᮁ, ᾆᒸಇኵ, ᕝஂಖ༤ᩥ, ➉ෆ⿱ஓ, ᕝ㞝ග, ▮స┤ஂ SM ⫶⒴ᑐࡍࡿෆど㙾ⓗᒙษ㝖⾡࠾ࡅࡿ㐺ษ࡞ษ㞳᩿➃㊥㞳ࡢ᳨ウ ➨ 11 ᅇ᪥ᮏᾘ⟶Ꮫ⥲Ꮫ⾡㞟ࠊᮾி㒔᪂ᐟ༊ࠊ2015.2 ᇼ ᆂ, ᾆᒸಇኵ, ཎ⏣㤾ኴ, ᮾ ⋹, Ἑཎ⚈ᮁ, ᒸ⏣⿱அ, ▮స┤ஂ ᒣᮏ⚽ ࣮ࣛࢽࣥࢢ࣮࢝ࣈᛂࡌࡓ⭠ ESD ᅔ㞴ࡢண ᅉᏊ㛵ࡍࡿ᳨ウ ➨ 11 ᅇ᪥ᮏᾘ⟶Ꮫ⥲Ꮫ⾡㞟ࠊᮾி㒔᪂ᐟ༊ࠊ2015.2 㣬ᮏဴර, ᚋ⸨ ಟ, ᮌୗ ⪽, ┦Ⰻㄔ, ⸨ᮏ ឡ, ⴠྜᗣ, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ᾆᒸಇኵ, ⥴᪉ᬕᙪ, ᆏᮏ㛗㐓, ▮స┤ஂ. ᙜ㝔࡛῝㐩ᗘデ᩿ࡀᅔ㞴࡛࠶ࡗࡓ᪩ᮇ⫶⒴ෆど㙾⒪ࡢ᳨ウ ➨ 11 ᅇ᪥ᮏᾘ⟶Ꮫ⥲Ꮫ⾡㞟ࠊᮾி㒔᪂ᐟ༊ࠊ2015.2 ๓⏿ᛅ㍤, ᚋ⸨ ಟ, ➉ෆ⿱ஓ, 㣬ᮏဴර, ᮌୗ ⪽, ┦Ⰻㄔ, す⃝ಇᏹ, ⸨ᮏ ឡ, ⴠྜᗣ, ᾆᒸಇኵ, ➉ෆ⿱ஓ, ᕝ㞝ග, ▮స┤ஂ NEWS ࢭࣥࢳࢿࣝࣜࣥࣃ⠇ࢼࣅࢤ࣮ࢩࣙࣥᡭ⾡ࡢ⼥ྜࡼࡿ᪂ࡋ࠸⫶⒴⦰ ᑠᡭ⾡ ➨ 87 ᅇ᪥ᮏ⫶⒴ᏛᏛ⾡㞟ࠊᗈᓥࠊ2015 3 ᾆᒸಇኵ, ຍ⸨ඖᙪ, ▮స┤ஂ ⭠ ESD ⒪ᅔ㞴ᑐࡍࡿࣉ࣮ࣟࢳ ɆDual knifeɆ ➨ 101 ᅇ᪥ᮏᾘჾᏛᏛ⾡㞟ࠊᐑᇛ┴ྎᕷࠊ2015.4 ຍ⸨ඖᙪ, ▼ᓫ, ᾆᒸಇኵ ↓≧ࡢ 85 ṓ௨ୖࡢ㉸㧗㱋⪅⭠ෆど㙾᳨ᰝࡣᚲせ㸽 ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ― 124 ― ⸨ᮏឡ, ᾆᒸಇኵ, ▮స┤ஂ Dual Red Imaging ࡢ⌧≧ᒎᮃ ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ⴠྜᗣ, ᾆᒸಇኵ, ▮స┤ஂ ┤⭠⫠㛛㒊⭘⒆࠾ࡅࡿෆど㙾⒪ᅔ㞴ኚᑐࡍࡿ ESD ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ᾆᒸಇኵ, ᚋ⸨ಟ, ▮స┤ஂ ⫶ ESD ᚋ₽⒆ᑐࡍࡿ᪂つ⮬ᕫ⤌⧊࣌ࣉࢳࢻỈ⁐ᾮࡢ⮫ᗋᛂ⏝ࡢྍ⬟ᛶ ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ๓⏿ᛅ㍤, ᾆᒸಇኵ, 㣬ᮏဴර, ᮌୗ⪽, ┦Ⰻㄔ, బࠎᮌᇶ, す⃝ಇᏹ, ᚋ⸨ಟ, ⸨ᮏឡ, ⴠྜᗣ, ▮స┤ஂ ᪩ᮇ⭠⒴ pT1(SM)ᑐࡍࡿ ESD ࡢጇᙜᛶ ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ┦Ⰻㄔ, ᚋ⸨ಟ, 㣬ᮏဴර, ᮌୗ⪽, ⸨ᮏឡ, ⴠྜᗣ, ๓⏿ᛅ㍤, す⃝ಇᏹ, ᾆᒸಇኵ, ⥴᪉ᬕᙪ, ▮స┤ஂ ᙜ⛉࠾ࡅࡿࢹ࢟ࢧ࣓ࢹࢺ࣑ࢪࣥ㙠㟼ୗ㧗㞴ᗘ ESD ࡢᐇ㝿 ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 㧗ྲྀ♸స, ຍ⸨ඖᙪ, 㕥ᮌ㞞அ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ဴ, బ⸨㐨Ꮚ, ᡂ℩ᬛᗣ, 㧗ᯘ㤾, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ ⫶༑ᣦ⭠₽⒆ࡢ᪤ ࡣୖ㒊ᾘ⟶ฟ⾑ᝈ⪅࠾ࡅࡿෆど㙾ⓗṆ⾑⾡ࡢせྰᑐࡍࡿ ⊂❧ࡋࡓண ᅉᏊ࡛࠶ࡿ ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ᮌୗ ⪽, す⃝ಇᏹ, 㣬ᮏဴර, ┦Ⰻㄔ, ᚋ⸨ಟ, ๓⏿ᛅ㍤, ⸨ᮏឡ, ⴠྜᗣ, ୰ᮧ⌮ᜨᏊ, ᾆᒸಇኵ, ▮స┤ஂ ༑ᣦ⭠⭘⒆ᑐࡍࡿෆど㙾⒪⒪ᡓ␎ࡢ⌧≧ ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 బ⸨㐨Ꮚ, ຍ⸨ඖᙪ, 㕥ᮌ㞞அ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ဴ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, 㧗ᯘ㤾, ⳥ụ┿, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ ⭠᠁ᐊฟ⾑ෆど㙾ⓗṆ⾑⾡ࢆ⾜ࡍࡁ㸽㹼ฟ⾑ࣜࢫࢡᅉᏊ㛵ࡍࡿᚋ ᪉どⓗࢥ࣮࣍ࢺ◊✲㹼 ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ― 125 ― 㣬ᮏဴර, ᚋ⸨ಟ, ᮌୗ⪽, ┦Ⰻㄔ, ⸨ᮏឡ, ⴠྜᗣ, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ᳜ᮌಙỤ, ᾆᒸಇኵ, ㎮ཱྀ⠜ᚿ, ୕Ꮿ୍ᫀ, ᆏᮏ㛗㐓, ▮స┤ஂ H.pylori 㝖⳦ᚋ⫶⒴࠾ࡼࡧ⫼ᬒ⢓⭷⏕ࡌࡿ⤌⧊Ꮫⓗኚෆど㙾デ᩿ࡢ᳨ウ ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ᴿᾈ⾜, ཎ⏣㤾ኴ, ᾆᒸಇኵ, 㧗ᔱᚿಖ, ཱྀಇ༤, ➉, ᮡཎ㞝⟇, ༙᫂᪥㤶, 㧗ཎᨻᏹ, ᑠᯘἋ௦, 㧗ᶫ⣴┿, 㰺⸨ಇ, ᇼᇛ୍ᮁ, ᮾ⋹, ᖹᒸబつᏊ, ᒸ⏣⿱அ, ᒣᮏ⚽ ෆど㙾ⓗ⢓⭷ୗᒙ㞳⾡(ESD)ࡀ⾜ࡉࢀࡓ⭠ T1(SM)⒴ࡢ⒪ᡂ⦼ணᚋࡢ᳨ウ ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ᾆᒸಇኵ, ▮స┤ஂ ⭠⒴ࢫࢡ࣮ࣜࢽࣥࢢ࠾ࡅࡿ㏆ᮍ᮶ࡢ⭠ෆど㙾ࣔࢲࣜࢸ࣮ ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.6 㧗ᯘ 㤾, 㜿㒊ᆂ୍㑻, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, ຍ⸨ඖᙪ, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ ⭠ ESD ࠾ࡅࡿᡭᢏⓗᅔ㞴ࠊ⾡ᚋ⊃✽ᑐࡍࡿ᳨ウ ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.6 ⸨ᮏ ឡ,ⴠྜ ᗣ,ᚋ⸨ ᮌୗ ಟ, ๓⏿ᛅ㍤, ᇼᇛ୍ᮁ, 㧗ᯘ 㤾, 㣬ᮏဴර, ┦Ⰻㄔ, ⪽, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ᾆᒸಇኵ, ▮స ┤ஂ Dual Red Imaging ࡢ⌧≧ᒎᮃ ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.6 ᖹ⏣ ဴ, ຍ⸨ ඖᙪ, 㜿㒊ᆂ୍ᮁ 㧗⏣♸᫂, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, 㕥ᮌ㞞அ, 㧗ᶫṇᙪ, ᾆᒸಇኵ S ≧⤖⭠㌿ᑐࡍࡿෆど㙾ⓗᩚࡢព⩏ࡘ࠸࡚ࡢ᳨ウ ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.6 ⴠྜᗣ, 㣬ᮏဴර, ᮌୗ ⪽, ┦Ⰻㄔ, ๓⏿ᛅ㍤, ⸨ᮏ ឡ, ᚋ⸨ ಟ, ୰ᮧ⌮ᜨᏊ, す⃝ಇᏹ, ᾆᒸಇኵ, ▮స┤ஂ ᙜ㒊㛛࠾ࡅࡿ༑ᣦ⭠ ESD ࡢᏳᛶ࠾ࡼࡧ᭷ຠᛶࡢホ౯ ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.6 ❑⃝㝧Ꮚ, 㧗ᯘ 㤾, 㧗ྲྀ♸స, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨ 㐨Ꮚ, ᡂ℩ᬛᗣ, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, 㰺⸨ඃᏊ, ᒣᮏ⣪つᏊ, ᮧ⏣᭷ஓ, ๓ᓥ᪂ྐ, 㧗ᶫṇᙪ, బ⸨㝯, ᾆᒸಇኵ ከ⮚ჾ㌿⛣ࢆ᮶ࡋࡓ㣗㐨ཎⓎ↓Ⰽ⣲ᛶᝏᛶ㯮Ⰽ⭘ࡢ 1 ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.6 ― 126 ― 㣬ᮏဴර, ᚋ⸨ ಟ, 㭯⏣ 㞞ኈ, ᮌୗ ⪽, ┦Ⰻㄔ, ⸨ᮏ ឡ, ⴠྜᗣ, ๓⏿ᛅ㍤, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ᾆᒸಇኵ, ⥴᪉ᬕᙪ, டᒣ㤶⧊, ▮స ┤ஂ ESD ࡛ษ㝖ࡉࢀࡓ SM ῝㒊ᾐ₶⒴ࡀ▷ᮇ㛫࡛ᒁᡤⓎࡋࡓ 1 ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.6 ┦Ⰻㄔ, ᚋ⸨ ಟ, 㣬ᮏဴර, ᮌୗ ⪽, ⸨ᮏ ឡ, ⴠྜᗣ, ๓⏿ᛅ㍤, す⃝ಇᏹ, ᾆᒸಇኵ, ▮స┤ஂ ESD ⒪㏵୰ࡼࡾࢹࢡࢫ࣓ࢹࢺ࣑ࢪࣥࢆᑟධࡋⰋዲ࡞㙠㟼ࡀᚓࡽࢀࡓ 2 ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.6 㧗⏣♸᫂, ຍ⸨ඖᙪ, 㜿㒊ᆂ୍㑻, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, 㕥ᮌ㞞அ, 㧗ᶫṇᙪ, ᾆᒸಇኵ ᑠ⭠ࢽࢧ࢟ࢫࡢ⮫ᗋീࡘ࠸࡚ࡢ᳨ウ Japan Digestive Disease Weekࠊරᗜ┴⚄ᡞᕷࠊ2015.10 ⳥ụ┿, すᓮὈᘯ, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ຍ⸨ඖᙪ, ⳥ụ⨾✑, ⸨ᒣὒ୍, ᾆᒸಇኵ, 㧗ᶫṇᙪ, ᒣᓊ⏤ᖾ, ᇼỤ⩏๎, ຍ⸨┾୕, 㔠㝯 CAP(Controlled Attenuation Parameter)┦㛵࣐࣮࣮࢝ࡢ᳨ウ㸪ࣝࢥ࣮ࣝᛶ⫢㞀 ᐖ࣭㠀ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈࡢ㚷ู Japan Digestive Disease Weekࠊරᗜ┴⚄ᡞᕷࠊ2015.10 ⸨ᮏ ឡ, ୗ⏣ᑗஅ, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ⴠྜᗣ, ๓⏿ᛅ㍤, ᚋ⸨ ಟ, ┦Ⰻㄔ, ᮌୗ ⪽, 㣬ᮏဴර, ᾆᒸಇኵ, ▮స┤ஂ ᒙษ㝖௦ࡢ᪩ᮇ⫶⒴⠊ᅖデ᩿ - ഃ᪉ఙᒎ㊥㞳㛵ࡍࡿ⌮Ꮫⓗ᳨ウ Japan Digestive Disease Weekࠊරᗜ┴⚄ᡞᕷࠊ2015.10 ຍ⸨ඖᙪ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, ⳥ụᘯே, 㧗ᯘ 㤾, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, ▼ ᓫ, ᾆᒸಇኵ ㉸㧗㱋⪅ᑐࡍࡿ⭠ෆど㙾᳨ᰝࡢ㐺ᛂࡘ࠸࡚ࡢ᳨ウ Japan Digestive Disease Weekࠊරᗜ┴⚄ᡞᕷࠊ2015.10 ┦Ⰻㄔ, ᚋ⸨ ಟ, 㣬ᮏဴර, ⸨ᮏ ឡ, ๓⏿ᛅ㍤, ⴠྜᗣ, す⃝ಇᏹ, ᾆᒸಇኵ, ▮స┤ஂ ⭠ ESD ᅔ㞴࠾ࡅࡿࣂ࣮ࣝࣥෆど㙾ࡢ᭷⏝ᛶࡢ᳨ウ Japan Digestive Disease Weekࠊරᗜ┴⚄ᡞᕷࠊ2015.10 㜿㒊ᆂ୍ᮁ, ⳥ụ┿, ᮌୗ ⪽, 㧗ᯘ 㤾, ຍ⸨ඖᙪ, ⳥ụ⨾✑, ⸨ᒣὒ୍, ᾆᒸಇኵ ࣝࢥ࣮ࣝᛶ៏ᛶ⮅⅖ࡼࡿ⮅ᛶ⭡Ỉᑐࡋ࡚࢜ࢡࢺࣞ࢜ࢳࢻ㓑㓟ሷࡀዌຌࡋࡓ 1 ➨ 50 ᅇࣝࢥ࣮࣭ࣝ⸆≀౫Ꮡ㛵㐃ᏛྜྠᏛ⾡⥲ࠊරᗜ┴⚄ᡞᕷࠊ2015.10 ― 127 ― 㧘ᯘ 㤾ࠊᆏཱྀᜨ⨾ࠊ㜿㒊ᆂ୍ᮁࠊ㧗⏣♸᫂ࠊᖹ⏣ ဴࠊక㔝⦾㞝ࠊ⏣㐨Ꮚࠊ㧗ྲྀ♸సࠊ ▼ᶫᗣ๎ࠊᮌୗ ⪽ࠊ⳥ụ⨾✑ࠊຍ⸨ඖᙪࠊ⳥ụ┿ࠊ⸨ᒣὒ୍ࠊᾆᒸಇኵ ☜ᐇ࡞ Cold snare polypectomy ࢆᛕ㢌⨨࠸ࡓࢫࢿࡢ㑅ᢥ ᪥ᮏ⭠᳨ᰝᏛࠊᮾி㒔༓௦⏣༊ࠊ2015.11 ᖹ⏣ ဴ, ⳥ụ┿, ᆏཱྀᐇ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ⏣㐨Ꮚ, క㔝⦾㞝, 㧗ྲྀ♸స, ᮌୗ ⪽, 㧘ᯘ 㤾, ⳥ụ⨾✑, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ ᙜ㝔࠾ࡅࡿ⫢ᛶ⭡Ỉᑐࡍࡿࢺࣝࣂࣉࢱࣥᑟධ ➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫࠊᮾி㒔ୡ⏣㇂༊ࠊ2015.12 㜿㒊ᆂ୍㑻, ⳥ụ┿, ᆏཱྀᐇ, 㧗⏣♸᫂, ᖹ⏣ ဴ, ⏣㐨Ꮚ, క㔝⦾㞝, 㧗ྲྀ♸స, ᮌୗ ⪽, 㧘ᯘ 㤾, ⳥ụ⨾✑, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ ERCP(ෆど㙾ⓗ㏫⾜ᛶ⮅⫹⟶㐀ᙳ)࠾ࡅࡿ⮅⟶ࢫࢸࣥࢺࡢ᭷⏝ᛶ ➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫࠊᮾி㒔ୡ⏣㇂༊ࠊ2015.12 క㔝⦾㞝, 㧘ᯘ 㤾, ᆏཱྀᐇ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, ⏣㐨Ꮚ, 㧗ྲྀ♸స, ᮌୗ ⪽, ⳥ụ⨾✑, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, ⓑ▼῟୍, ᾆᒸಇኵ ᙜ㝔࡛ෆど㙾ⓗ⢓⭷ୗᒙ㞳⾡ࢆ⾜ࡋࡓ Barrett ⭢⒴ࡢ᳨ウ ➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫࠊᮾி㒔ୡ⏣㇂༊ࠊ2015.12 ຍ⸨ඖᙪ, ☾㒊 㝧, ᆏཱྀᐇ, 㧘ᯘ 㤾, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ⏣㐨Ꮚ, క㔝⦾㞝, 㧗ྲྀ♸స,ᮌୗ ⪽, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ ୖ㒊ᾘ⟶⭘⒆ᑐࡍࡿ⭡⭍㙾ෆど㙾ྜྠᡭ⾡(LECS)ࡼࡿపく⒪ ➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫࠊᮾி㒔ୡ⏣㇂༊ࠊ2015.12 㧗ྲྀ♸స, ຍ⸨ඖᙪ, 㕥ᮌ㞞அ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, ᡂ℩ᬛᗣ, 㧗ᯘ㤾, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ ESD ࡢᬑཬࡣෆど㙾ⓗṆ⾑⾡࡞ࢆࡶࡓࡽࡋࡓ ➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫࠊᮾி㒔ୡ⏣㇂༊ࠊ2015.12 క㔝⦾㞝, 㧘ᯘ 㤾, ᆏཱྀᜨ⨾, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, ⏣㐨Ꮚ, 㧗ྲྀ♸స, ▼ᶫᗣ๎,ᮌୗ ⪽, ⳥ụ⨾✑, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ NBI ే⏝ᣑほᐹ࠾ࡼࡧ㉸㡢Ἴෆど㙾ࡀ῝㐩ᗘデ᩿᭷⏝࡛࠶ࡗࡓ 0-IIc㸩Is ᆺ㣗㐨⒴ ࡢ୍ ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔༓௦⏣༊ࠊ2015.12 㧗⏣♸᫂, ຍ⸨ඖᙪ, ᆏཱྀ⨾, 㜿㒊ᆂ୍ᮁ, ᖹ⏣ ဴ, 㧗ྲྀ♸స, క㔝⦾㞝, ⏣㐨Ꮚ, ᮌୗ ⪽, 㧗ᯘ 㤾, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, 㕥ᮌ㞞அ, ᾆᒸಇኵ ⭢⒴ᡂศࡀΰᅾࡋࡓ㣗㐨⫶᥋ྜ㒊ཎⓎ⚄⤒ෆศἪ⒴ࡢ 1 ๗᳨ ᪥ᮏᾘჾᏛ➨ 337 ᅇ㛵ᮾᨭ㒊ࠊᮾி༓௦⏣༊ࠊ2015.12 ― 128 ― ఀᮾఙ๛, ┦㤿ᓫᏹ, ጒᑿ⪽⨾, ☾㒊⩏᠇, ᆏཱྀ⨾, ⳥ụ┿ ྤ⾑࡛Ⓨࡋࡓ Budd-Chiari ೃ⩌ࡢ୍ ᮾிࣥࢠ࣭࢜㹇㹔㹐ࠊ ᮾிࠊ2015.12.10 ᪂ᓥ㍜, ᐑཎ᫂㔛, ᶲ ᭸⨾, 㛗㇂㒊ࡺࡾ, 㜿㒊ᆂ୍ᮁ, ⳥ụ⨾✑, ⳥ụ┿ ᙜ㝔࠾ࡅࡿ⫢⮚ᩍᐊࡢྲྀࡾ⤌ࡳ ➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫࠊᮾி㒔ୡ⏣㇂༊ࠊ2015.12 ᇼỤ⩏๎㸪ᾏ⪁ᾈ㸪୰ᮏఙᏹ㸪⳥ụ┿㸪㔠㝯 ᮏ㑥࠾ࡅࡿࣝࢥ࣮ࣝᛶ⫢⅖ࡢᐇែɆ2013 ᖺᗘࡢࡢゎᯒɆ ➨ 41 ᅇ᪥ᮏ⫢⮚Ꮫす㒊ࠊឡ▱┴ྡྂᒇᕷࠊ2015.12 ᱵ⏣⍠⨾Ꮚ㸪ሷ⃝ᏹ㸪⳥ụ┿㸪すᓮὈᘯ ࣝࢥ࣮ࣝᛶ⫢◳ኚࡢ㞴ᛶ⭡Ỉᑐࡋ⭡Ỉ✸่ CART㸦Cell-free and Concentrated AscitesReinfusion Therapy㸧ࢆే⏝ࡋⰋዲ࡞⤖ᯝࢆᚓࡓ 2 ➨ 41 ᅇ᪥ᮏ⫢⮚Ꮫす㒊ࠊឡ▱┴ྡྂᒇᕷࠊ2015.12 ⳥ụ┿㸪ᇼỤ⩏๎㸪⏣ㅬ࿃㸪ᱵ⏣⍠⨾Ꮚ㸪㭯㇂ᗣኴ㸪ሷ⃝ᏹ㸪すᓮὈᘯ㸪⳥ụ⨾✑㸪 㧗ᶫṇᙪ㸪㔠㝯 ࣝࢥ࣮ࣝᛶ⫢㞀ᐖ㠀ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈ࠾ࡅࡿ⫢◳ᗘ⭁⭘ࡢ㐃㛵ᛶ 㛵ࡍࡿ᳨ウ ➨ 41 ᅇ᪥ᮏ⫢⮚Ꮫす㒊ࠊឡ▱┴ྡྂᒇᕷࠊ2015.12 ᇼỤ⩏๎㸪⳥ụ┿㸪㔠㝯 ෆ⛉་ࡢ❧ሙࡽࡢࣝࢥ࣮ࣝ⒪࠾ࡅࡿ་⒪㐃ᦠᚰ⌮♫ⓗ⒪ ➨ 50 ᅇ᪥ᮏࣝࢥ࣮࣭ࣝ⸆≀་Ꮫ㸪රᗜ௳⚄ᡞᕷ㸪2015.10 ⳥ụ┿ࠊᇼỤ⩏๎ࠊ⏣ㅬ࿃ࠊᱵ⏣⍠⨾Ꮚࠊ㭯㇂ᗣኴࠊሷ⃝ᏹࠊすᓮὈᘯࠊ ⳥ụ⨾✑ࠊ㧗ᶫṇᙪࠊ㔠㝯 ࣝࢥ࣮ࣝᛶ⫢㞀ᐖ㠀ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈ࠾ࡅࡿ⫢◳ᗘ⭁⭘ࡢ┦㛵ᛶ ➨ 50 ᅇ᪥ᮏࣝࢥ࣮࣭ࣝ⸆≀་Ꮫ㸪රᗜ௳⚄ᡞᕷ㸪2015.10 ⳥ụ┿ࠊすᓮὈᘯࠊᮌୗ⪽ࠊᡂ℩ᬛᗣࠊ㧗ᯘ㤾ࠊຍ⸨ඖᙪࠊ⳥ụ⨾✑ࠊ⸨ᒣὒ୍ࠊ ᾆᒸಇኵࠊ㧗ᶫṇᙪࠊᒣᓊ⏤ᖾࠊᇼỤ⩏๎ࠊຍ⸨┾୕ࠊ㔠㝯 CAP(Controlled Attenuation Parameter)┦㛵࣐࣮࣮࢝ࡢ᳨ウࣝࢥ࣮ࣝᛶ⫢㞀 ᐖ࣭㠀ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈࡢ㚷ู ➨ 23 ᅇ Japan Digestive Disease Weekࠊᮾிࠊ2015.10 ― 129 ― ⳥ụ┿ࠊᇼỤ⩏๎ࠊ⳥ụ⨾✑ࠊ㧗ᶫṇᙪࠊᱵ⏣⍠⨾Ꮚࠊሷ⃝ᏹࠊすᓮὈᘯࠊ ᒣᓊ⏤ᖾࠊຍ⸨┾୕ࠊ㔠㝯 ࣝࢥ࣮ࣝᛶ⫢㞀ᐖ㠀ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈ࠾ࡅࡿ⫢◳ᗘ⭁⭘ࡢ㛵ಀ ➨ 22 ᅇ᪥ᮏ㛛⬦ᅽஹ㐍Ꮫ せᮃ₇㢟ࠊᶓࠊ2015.9.11 ⳥ụ┿, 㧗ᯇ༓⧊, 㕥ᮌᰤ㔛Ꮚ, ㏆⸨┿, ᒣ⏣༓✚,ᓊᮏ᠇᫂,ᱵ⏣⍠⨾Ꮚ ,㭯㇂ᗣኴ, ሷ⃝ᏹ, すᓮὈᘯ, ⳥ụ⨾✑, 㧗ᶫṇᙪ,㔠㝯 ே㛫ࢻࢵࢡ࡛ࡢ⢾ᒀᝈ⪅࠾ࡅࡿ⫢ᶵ⬟␗ᖖ⋡࣭⬡⫫⫢㝧ᛶ⋡ࡢゎᯒࠊFibroscan ࢹ࣮ࢱࡢ᳨ウ ➨㸰ᅇ⫢⮚⢾ᒀࠊ௦ㅰ◊✲ࠊᒣཱྀ┴ୗ㛵ᕷࠊ2015.5.23 ᓊᮏ᠇᫂ࠊᒣ⏣༓✚ࠊ➉⏣㯞⨾ࠊᑿᙧ⌔ᜨࠊ㯮⏣ᜨ⨾Ꮚࠊ⳥ụ┿ࠊ㇂㔝㝯୕㑻ࠊஂಖ᫂ࠊ ▼┤᫂ࠊすᓮὈᘯ HDL ࢥࣞࢫࢸ࣮ࣟࣝளศ⏬⬡㉁࣭࣏ࣜ⺮ⓑ௦ㅰࣉࣟࣇࣝࡢ㛵㐃ᛶ ➨ 43 ᅇ᪥ᮏ⥲ྜデᏛࠊᐩᒣ┴ᐩᒣᕷࠊ2015.2.20 ⳥ụ┿ࠊᒣ⏣༓✚ࠊᓊᮏ᠇᫂ࠊᱵ⏣⍠⨾Ꮚࠊ㭯㇂ᗣኴࠊሷ⃝ᏹࠊすᓮὈᘯ ⢾ᒀᝈ⪅࠾ࡅࡿ⫢ᶵ⬟␗ᖖ⋡ࠊ⬡⫫⫢㝧ᛶ⋡ࡢኚ㑄 ➨ 43 ᅇ᪥ᮏ⥲ྜデᏛࠊᐩᒣ┴ᐩᒣᕷࠊ2015.2.20 ⳥ụ┿ࠊᇼỤ⩏๎ࠊ⳥ụ⨾✑ࠊ㧗ᶫṇᙪࠊᱵ⏣⍠⨾Ꮚࠊሷ⃝ᏹࠊすᓮὈᘯࠊ ᒣᓊ⏤ᖾࠊຍ⸨┾୕ࠊ㔠㝯 ࣝࢥ࣮ࣝᛶ⫢㞀ᐖࡢᛴᛶᮇ࠾ࡅࡿ Fibroscan ⫢◳ᗘࡢព⩏ ➨ 3㸲ᅇࣝࢥ࣮ࣝ་Ꮫ⏕≀Ꮫ◊✲ࠊ୕㔜ࠊ2015.1.24 ⳥ụ┿ࠊ㧗ᯇ༓⧊ࠊ㕥ᮌᰤ㔛Ꮚࠊᱵ⏣⍠⨾Ꮚࠊሷ⃝ᏹࠊ⳥ụ⨾✑ࠊ㧗ᶫṇᙪࠊ ㏆⸨┿ࠊᒣ⏣༓✚ࠊすᓮὈᘯ ே㛫ࢻࢵࢡ࡛ࡢ⢾ᒀᝈ⪅࠾ࡅࡿ⫢ᶵ⬟␗ᖖ⋡࣭⬡⫫⫢㝧ᛶ⋡ࡢゎᯒࠊ Fibroscan ࢹ࣮ࢱࡢ᳨ウ ➨ 18 ᅇ᪥ᮏែᰤ㣴Ꮫࠊி㒔ᗓி㒔ᕷࠊ2015.1.10 ᒣ⏣༓✚ࠊ㏆⸨┿ࠊ⳥ụ┿ࠊᓊᮏ᠇᫂ࠊ㛗㝧Ꮚࠊᰘ⏣㞝ࠊすつࠊ➟ཱྀ㝯㔜ࠊ ▼┤᫂ࠊすᓮὈᘯ ᖖே࠾ࡅࡿ⫢ᶵ⬟⾑୰࣑ࣀ㓟⃰ᗘࡢ㛵㐃 ➨ 18 ᅇ᪥ᮏែᰤ㣴Ꮫࠊி㒔ᗓி㒔ᕷࠊ2015.1.10 ㏆⸨┿ࠊᒣ⏣༓✚ࠊඖᮧஂಙࠊᓊᮏ᠇᫂ࠊすᓮὈᘯࠊ⳥ụ┿ࠊⓑ▼ග୍ࠊ ᮌᮧᏲḟࠊ㇏⏣㞞ኵࠊ῝ᕝ㞞ྐ ప࢚ࢿࣝࢠ࣮㣗 SGLT-2 㜼ᐖ⸆ే⏝ࡼࡾ 1 ᭶࡛ 10 ࡢῶ㔞ᡂຌࡋࡓ 2 ᆺ⢾ ᒀࡢ 1 ➨ 18 ᅇ᪥ᮏែᰤ㣴Ꮫࠊி㒔ᗓி㒔ᕷࠊ2015.1.10 ― 130 ― ᾆᒸಇኵ, 㮚ᑿಇ㐩, ▮స┤ஂ ᪩ᮇ༑ᣦ⭠⒴ᑐࡍࡿෆど㙾ษ㝖⾡࠾ࡼࡧእ⛉ᡭ⾡ࡢ㐺ᛂ 㸫 ከタ㐳ཬⓗ᳨ウ ᅜ❧ࡀࢇ◊✲ࢭࣥࢱ࣮◊✲㛤Ⓨ㈝࣭ᩪ⸨ ㇏ ⌜㸦25-A-12㸧 ࠕෆど㙾⒪ࡢᡂ⦼ࠊணᚋࠊ ࣂ࢜ࣂࣥࢡ➼ࡢሗࢆ⤫ྜࡍࡿ⥲ྜⓗ◊✲ᇶ┙ࡢᩚഛࠖ ࠊᮾி㒔୰ኸ༊ࠊ2015.9 Mori.N, Aoki Y Clinical characterization and risk factors of community-acquired Clostiridium difficile infection in a tertiary hospital in Japan 25th European Congress of Clinical Microbiology and Infectious Diseases 㸪 Copenhagen/Denmark㸪2015.4.26 ᳃ఙࠊᵽཱྀᬗᏊࠊ▼ᚿ⣫ࠊ㟷ᮌὈᏊ ࢹࣥࢢ⇕ࡢᅜෆឤᰁࡀࢃࢀࡿ㛵ࢃࡿ⾜ᨻㄪᰝせ௳ヱᙜࡋࡓ㸶ࡢ㞟 ✚◊✲ ➨ 89 ᅇ᪥ᮏឤᰁᏛ⥲Ꮫ⾡ㅮ₇ࠊி㒔ࠊ2015.4.16 ᳃ఙࠊᮌᮧ᭷ࠊ㟷ᮌὈᏊ ࣜࢿࢰࣜࢻᢞ୰ங㓟ࢩࢻ࣮ࢩࢫࢆ࿊ࡋࡓࡢ᳨ウ㸸ࢩ࣮ࣜࢬ◊✲ ➨ 64 ᅇ᪥ᮏឤᰁᏛᮾ᪥ᮏᆅ᪉ࠊ➨ 62 ᅇ᪥ᮏᏛ⒪ἲᏛᮾ᪥ᮏᨭ㒊ᆅ᪉ࠊ ᮐᖠࠊ2015.10.22 ᒇᐶ❶ࠊ᳃ఙࠊ㟷ᮌὈᏊ ࣓ࢺࣟࢽࢲࢰ࣮ࣝ㛗ᮇ⏝୰࣓ࢺࣟࢽࢲࢰ࣮ࣝㄏⓎᛶ⬻ࢆࡁࡓࡋࡓ㸯 ➨ 64 ᅇ᪥ᮏឤᰁᏛᮾ᪥ᮏᆅ᪉ࠊ➨ 62 ᅇ᪥ᮏᏛ⒪ἲᏛᮾ᪥ᮏᨭ㒊ᆅ᪉ࠊ ᮐᖠࠊ2015.10.22 ⸨ᮏᚿࠊ᳃ఙࠊ⯞ὠὒᖹࠊᑠᒣ⏣ྜྷᏕ ៏ᛶ྾ჾᝈྜేࡋࡓ㞴ᛶ⥳⮋⳦ឤᰁᑐࡋࠊࢺࣈ࣐ࣛࢩࣥ྾ධ⏝㔞ࡼࡾ ⒪ࡢᡂྰࡀ␗࡞ࡗࡓ㸯 ➨ 64 ᅇ᪥ᮏឤᰁᏛᮾ᪥ᮏᆅ᪉ࠊ➨ 62 ᅇ᪥ᮏᏛ⒪ἲᏛᮾ᪥ᮏᨭ㒊ᆅ᪉ࠊ ᮐᖠࠊ2015.10.22 ἨᩔᏊࠊ㉺㒊㯞Ꮚࠊᖹᝆ୍㑻ࠊᯘဴᮁࠊ᳃ఙ ⥳⮋⳦ឤᰁⓎண ᅉᏊࡢᵓ⠏ጇᙜᛶࡢ᳨ド ➨ 64 ᅇ᪥ᮏឤᰁᏛᮾ᪥ᮏᆅ᪉ࠊ➨ 62 ᅇ᪥ᮏᏛ⒪ἲᏛᮾ᪥ᮏᨭ㒊ᆅ᪉ࠊ ᮐᖠࠊ2015.10.22 㣤ᑿ⨾ࠊ᳃ఙࠊᒣᮏᗣ༤ࠊ⣽ᑿဏᏊࠊᒣ⏣ᜨ㔛ዉࠊ⸨ᮏᚿࠊ⯞ὠὒᖹࠊ㔛ぢⰋ㍜ࠊ ⱝᮌ⨾బࠊᑿ௰❶⏨ࠊᑠᒣ⏣ྜྷᏕ పᐜ㔞ࢺࣈ࣐ࣛࢩࣥ྾ධࡀᛶ⥳⮋⳦ᛶ⫵⅖ࡢⓎண㜵᭷⏝࡛࠶ࡗࡓ୍ ➨ 217 ᅇ᪥ᮏ྾ჾᏛ㛵ᮾᆅ᪉ࠊᮾிࠊ2015.11.21 ― 131 ― Ⳣཎ᱈Ꮚࠊ㤶ᕝᡂேࠊᵽཱྀᬗᏊࠊゅ⏣ⴌࠊ᳃ఙࠊ㟷ᮌὈᏊ ⾑ᾮᇵ㣴ࡽ Streptobacillus moniliformis ࡀศ㞳ࡉࢀࡓ㸯 ➨㸰㸵ᅇ᪥ᮏ⮫ᗋᚤ⏕≀Ꮫ⥲ࠊྎࠊ2016.1.30 ᳃ఙ Antimicrobial Stewardship ࢆ㐍ࡵࡿࡓࡵࡢࠕቨࠖࢆ࠺ࡾ㉺࠼ࡿࠊࠕASP ࢆ㐍ࡵ ࡿࡓࡵࡢ࣐ࣥࣃ࣮࣡ࢆ࠸ࡋ࡚☜ಖࡍࡿࠖ ➨ 63 ᅇ᪥ᮏᏛ⒪ἲᏛ⥲ࠊᮾிࠊ2015.6.6 ᯇᮧ┿ྖࠊᑠᓮ┿つᏊࠊ⚄㇂ㅍࠊእᒣᏛࠊᮾᑦᘯࠊᑿ⸨ㄔྖࠊᗙ୍ᘯ ㉁ᣦᶆࢆ⏝࠸ࡓᆅᇦデ⒪ᡤ࠾ࡅࡿࣉ࣐ࣛࣜࢣࡢホ౯ࡑࡢㄢ㢟 ➨ 10 ᅇ་⒪ࡢ㉁࣭ᏳᏛࠊᮾி㒔Ụᮾ༊ࠊ2015.11.22 ⏣῟ᚿ, ᑠᓥឡ, 㣤ᒸ⥴⨾ ࡢ」㞧ࡉࡣከ⫋✀࠾ࡅࡿྜពᙧᡂ┠ᶆタᐃࡢࡼ࠺࡞ᙳ㡪ࢆ࠼ࡿࡢ? ➨ 47 ᅇ᪥ᮏ་Ꮫᩍ⫱Ꮫࠊ᪂₲ᕷ 2015.7.24 ᔱ ὒభ, ᰩཎ , ᐑୗ Ꮨ, ᑠᯘ బ⣖Ꮚ, ᶓ⏣ ୍, ᇛ ⌮⤮, 㛛ᯇ ㈼, Ṋ⏣ ᙬ, ᑠ㯮 ⲡኴ, ᐑᔱ ဴ, டᒣ 㤶⧊, ఀ⸨ ⿱ 」ᩘࡢ⭘⒆ࡀ࠶ࡿ PA ࠾ࡅࡿ㉸㑅ᢥⓗ⭈㟼⬦ࢧࣥࣉࣜࣥࢢࡢព⩏ ➨ 25 ᅇ⮫ᗋෆศἪ௦ㅰ Updateࠊᮾி༓௦⏣༊ࠊ2015.11.27-28 㛫℩ ⱱᶞ, ᒸ⏣ ᩫᏊ, 㧗ᶫ 㒓, ᰩᒣ 㝧Ꮚ, すཎ భ୍, 㭯 ὒ, 㛛ᯇ ㈼ ࠕ᪂㣗ḧᑐ⟇㣗(᪂ࡑࡵ࠸ࡼࡋࡢ㣗)ࠖᑟධྥࡅ࡚ 1 ᖺ㛫ࡢ NST ධࢆ ࡾ㏉ࡗ࡚ ➨ 69 ᅇᅜ❧㝔⥲ྜ་Ꮫࠊᮐᖠࠊ2015.10.2-3 ᮾ㑚 ⨾㔛, 㛛ᯇ ㈼, ⏣ᓥ ᜨⳀ㤶, 㧗ᶫ ዉ, ᳃ ┤ᕫ, ᒾᓮ ᫀᶞ, ᵽᒣ ⯙㞷, Ᏻᐩ ♸, ᯇᾆ ୍ ᡂேࡢࢿࣇ࣮ࣟࢮೃ⩌Ⓨྜేࡋࡓ⬻㟼⬦Ὕ⾑ᰦࡢ୍ ➨ 45 ᅇ᪥ᮏ⭈⮚Ꮫす㒊Ꮫ⾡ࠊ㔠ἑࠊ2015.10.23-24 ᳃ ┤ᕫ, 㛛ᯇ ㈼, 㧗ᶫ ዉ, ⏣ᓥ ᜨⳀ㤶, ᮾ㑚 ⨾㔛, ⸨ᮧ Ꮚ, ⓑ▼ ῟୍, 㧗ᶫ ၨ, ᯇᾆ ୍ ⫗ⱆ⭘ᛶ⾑⟶⅖ࢆక࠺⫗ⱆ⭘ᛶ㛫㉁ᛶ⭈⅖ࡢཎᅉ㚷ูⱞ៖ࡋࡓ୍ ➨ 45 ᅇ᪥ᮏ⭈⮚Ꮫᮾ㒊Ꮫ⾡ࠊᮾி ༊ࠊ2015.10.2-3 ― 132 ― ᮾ㑚 ⨾㔛, ᯇᾆ ୍, ⏣ᓥ ᜨⳀ㤶, 㧗ᶫ ዉ, ᳃ ┤ᕫ, ᒾᓮ ᫀᶞ, ⓑ▼ ῟୍, 㛛ᯇ ㈼ 㐍⾜ᛶ⫶⒴ࡢᏛ⒪ἲ୰ Proliferative Glomerulonephritis with Monoclonal IgG Deposits(PGNMID)ࢆㄆࡵࡓ୍ ➨ 45 ᅇ᪥ᮏ⭈⮚Ꮫᮾ㒊Ꮫ⾡ࠊᮾி ༊ࠊ2015.10.2-3 ᯇᾆ ୍, ᳃ ┤ᕫ, 㧗ᶫ ዉ, ⏣ᓥ ᜨⳀ㤶, ᮾ㑚 ⨾㔛, ⸨ᮧ Ꮚ, ᒾᓮ ᫀᶞ, ⓑ▼ ῟୍, 㛛ᯇ ㈼ ࣐ࢳࢽࣈࡼࡿ⾑ᰦᛶᚤᑠ⾑⟶㞀ᐖࢆࡗࡓ୍ ➨ 45 ᅇ᪥ᮏ⭈⮚Ꮫᮾ㒊Ꮫ⾡ࠊᮾி ༊ࠊ2015.10.2-3 ᮾ㑚 ⨾㔛, ᭹㒊 ྜྷᡂ, ᯇ ᾈ㍜, ᳃ ┤ᕫ, ᒾᓮ ᫀᶞ, 㛛ᯇ ㈼, ❑⏣ ᐇ, ᯇᾆ ୍ ⥙ษ㝖⾡ᚋ⥙ᕳ⤡ࡢⓎࢆㄆࡵࡓ⭡⭷㏱ᯒᑟධᝈ⪅ࡢ୍ ➨ 60 ᅇ᪥ᮏ㏱ᯒ་ᏛᏛ⾡㞟⥲ࠊᶓࠊ2015.6.26-28 ᳃ ┤ᕫ, ᮾ㑚 ⨾㔛, ᒾᓮ ᫀᶞ, 㛛ᯇ ㈼, ⣽ᑿ ဏᏊ, ᑠᒣ⏣ ྜྷᏕ, ᯇᾆ ୍ ᆺ A ⩌ ǃ ⁐㐃⳦ឤᰁࢆዎᶵ↓ᒀ࡞ࡾ⾑ᾮ㏱ᯒࢆᚲせࡋࡓ୍ ➨ 60 ᅇ᪥ᮏ㏱ᯒ་ᏛᏛ⾡㞟⥲ࠊᶓࠊ2015.6.26-28 ᇛ ⌮⤮, ᒾ℩ ᜤᏊ, ஂ⏣ ⨾, ᯇᾆ ୍, 㛛ᯇ ㈼, ᓥ ஂ ࢫࢸࣟࢻ⿵㛤ጞᚋ 5 ᪥┠㏥⦰ࢆㄆࡵࡓ IgG4 㛵㐃ୗᆶయ⅖ࡢ୍ ➨ 88 ᅇ᪥ᮏෆศἪᏛᏛ⾡⥲ࠊᮾி༓௦⏣༊ࠊ2015.4.23-25 [ㅮ₇] ᑿ⸨ㄔྖ ᝈ⪅ࡢពᛮỴᐃᨭ㛵ࡍࡿㅮ₇ ➨ 5 ᅇࡀࢇᏛ⒪ἲຮᙉࠊᒱ㜧┴㫽⩚㒆ࠊ2015.2.6 ᑿ⸨ㄔྖ ་⒪࠾ࡅࡿࣉࣟࣇ࢙ࢵࢩࣙࢼࣜࢬ࣒ࡣఱ ᮐᖠ་⛉Ꮫࠊᾏ㐨ᮐᖠᕷࠊ2015.3.13 ᑿ⸨ㄔྖ ་⒪ࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥࡘ࠸࡚ ᡞ⏣୰ኸ┳ㆤᑓ㛛Ꮫᰯࠊᇸ⋢┴ᡞ⏣ᕷࠊ2015.4.16 ᑿ⸨ㄔྖ ࢢ࣮ࣝࣉ◊ಟ㸦Teem STEPPS㸧 ➨ 19 ᅇ㛵ಙᆅ༊ᅜ❧㝔⸆ᖌ᪂௵◊ಟࠊᮾி㒔┠㯮༊ࠊ2015.6.6 ― 133 ― ᑿ⸨ㄔྖ ་ࡢ⌮Ꮫ࣭♫Ꮫ ᮾᏛࠊᐑᇛ┴ྎᕷࠊ2015.6.8 ᑿ⸨ㄔྖ ⦆་⒪࠾ࡅࡿ་⒪ᑓ㛛⫋ࡢࣉࣟࣇ࢙ࢵࢩࣙࢼࣜࢬ࣒ ➨ 19 ᅇ᪥ᮏ⦆་⒪Ꮫᩍ⫱ࢭ࣑ࢼ࣮ࠊ⚄ዉᕝ┴ᶓᕷࠊ2015.6.18 ᑿ⸨ㄔྖ ᝈ⪅㸫་⒪⪅ࠊ་⒪⪅㸫་⒪⪅ࡢࡼࡾⰋ࠸㛵ಀ࡙ࡃࡾࡘ࠸࡚ ➨ 2 ᒸᮏ⥲ྜ㝔 ➨ 12 ᅇࠕᆅᇦ㐃ᦠࡢኤࠖࠊி㒔ᗓᏱᕷࠊ2015.7.11 ᑿ⸨ㄔྖ ࠕ་⒪ᑐேຓ࠾ࡅࡿࢼࣛࢸࣈ࣭ࣉ࣮ࣟࢳࠖ ㄒࡾࡽ⣳ࡄຓࡢ㛵ಀᛶࢆᏛࡪ ⥲ྜデ⒪࠾ࡅࡿᝈ⪅ࡢㄒࡾ࠺ྥࡁྜ࠺ LPC ᅜ㝿ࣇ࢛࣮࣒ࣛ 2015 ࡼࡾ㉁ࡢ㧗࠸ࢣࢆ┠ᣦࡍ Next Stepࠊᮾி㒔୰ኸ༊ࠊ 2015.8.8 ᑿ⸨ㄔྖ ᩆᛴ࣭㞟୰⒪࠾ࡅࡿ⥲ྜෆ⛉་ࡋ࡚ࡢどⅬࡘ࠸࡚ ᒱ㜧ᩆᛴ㞟୰⒪ࢭ࣑ࢼ࣮ࠊᒱ㜧┴ᒱ㜧ᕷࠊ2015.9.18 ᑿ⸨ㄔྖ ࣉࣟࣇ࢙ࢵࢩࣙࢼࣜࢬ࣒㸦ᣦᑟ་ࡢᅾࡾ᪉㸧 ឡோ་ᖌ⮫ᗋ◊ಟᣦᑟ་ࢭ࣑ࢼ࣮ࠊ㜰ᗓ㧗ᵳᕷࠊ2015.9.27 ᑿ⸨ㄔྖ ་⒪ᑓ㛛⫋ᚲせ࡞ࣉࣟࣇ࢙ࢵࢩࣙࢼࣜࢬ࣒ ᖹᡂ 27 ᖺᗘ୰ᑠ࣭⢭⚄࣭⒪㣴⸆ᖌᐇ㊶ࢭ࣑ࢼ࣮ࠊ㜰ᗓ㜰ᕷࠊ2015.10.10 ᑿ⸨ㄔྖ ▱⬟ᶵᲔሗᏛ≉ูㅮ⩏ ᮾிᏛᏛ㝔ሗ⌮ᕤᏛ⣔◊✲⛉ࠊᮾி㒔ᩥி༊ࠊ2015.10.7 ᑿ⸨ㄔྖ ᪥ᖖ⮫ᗋ࡛㐼㐝ࡍࡿ⌮ࢪ࣐ࣞࣥ㸸ࡑࡢ⪃࠼᪉ពᛮỴᐃ ᮾி࣭࣋ᾆᏳᕷᕝ་⒪ࢭࣥࢱ࣮ ⌮㛵ࡍࡿㅮ₇ࠊ༓ⴥ┴ᾆᏳᕷࠊ2015.10.13 ᑿ⸨ㄔྖ ་⒪ᶵ㛵ࡢࡾ᪉ࠊ㑅ࡧ᪉ Ύ℩ᕷ≉ᐃಖᣦᑟᴗࠊᮾி㒔Ύ℩ᕷࠊ2015.10.27 ― 134 ― ᑿ⸨ㄔྖ ་⒪࠺ࡁྜ࠺ ༓ⴥᕷ༠ാᴗ ➨ 2 ᅇཷデࢧ࣏࣮ࢱ࣮㣴ᡂㅮᗙࠊ༓ⴥ┴༓ⴥᕷࠊ2015.11.14 ᑿ⸨ㄔྖ ་⒪♫ ⚟ᓥ┴❧་⛉Ꮫࠊ⚟ᓥ┴⚟ᓥᕷࠊ2015.11.20 ᑿ⸨ㄔྖ ⸆㛵ࡍࡿሗࡢᤊ࠼᪉⮫ᗋᛂ⏝ࡘ࠸࡚ ᮾᾏ⸆ᖌᏛ⾡ࠊ୕㔜┴ᅄ᪥ᕷᕷࠊ2015.11.29 ᑿ⸨ㄔྖ 㝔ᶵ⬟ホ౯ཷᑂ࠶ࡓࡗ࡚ࡢ࣏ࣥࢺࡣ ᅜ❧ᅜ㝿་⒪◊✲ࢭࣥࢱ࣮⫋ဨྥࡅㅮ⩦ࠊᮾி㒔᪂ᐟ༊ࠊ2015.12.2 ᑿ⸨ㄔྖ ࡇࢀࡽࡢᝈ⪅Ᏻࣥࣇ࢛࣮࣒ࢻ࣭ࢥࣥࢭࣥࢺ 㹼┦ಙ㢗ࢆ┠ᣦࡍࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥࡢ࠶ࡾ᪉ࡘ࠸࡚㹼 㛵ᮾಙ㉺ཌ⏕ᒁ ᖹᡂ㸰㸵ᖺᗘ་⒪Ᏻ㛵ࡍࡿ࣮࣡ࢡࢩࣙࢵࣉࠊࡉ࠸ࡓࡲᕷࠊ 2015.12.15 ᾆᒸಇኵ Extra-wide-angle-view colonoscope ➨ 14 ᅇ⭠⏬ീ࢝ࢹ࣑࣮ࠊᮾி༓௦⏣༊ࠊ2015.1 ᾆᒸಇኵ ᳨デ࡛Ẽ࡞ࡿࣆࣟࣜ⳦౽₯⾑᳨ᰝ ᕷẸබ㛤ㅮᗙࠕேᏊ౪ࡢ࠾࡞ࡢẼࡘ࠸࡚ࠖࠊᮾி┠㯮༊ࠊ2015.3 Uraoka T Dual knife technique. 7th Workshop on ESD Expert Training 7th ESD Expert Training Workshop, Saltzburg/Austria㸪2015.6 Uraoka T Clipping of ESD-margin- vs. ESD -ground-, perforation, Loop trick 7th ESD Expert Training Workshop㸪Saltzburg/Austria㸪2015.6 Uraoka T Three-hands-technique, Skills and Strategies for ESD 7th Endoskills Update 2015㸪Saltzburg/Austria㸪2015.6 ― 135 ― ᾆᒸಇኵ ࡇࡇࡲ࡛࡛ࡁࡿᾘ⟶ෆど㙾デ᩿⒪ ᮾࡀୣᾘჾデ㐃ᦠࡢࠊᮾி㒔㇂༊ࠊ2015.6 ᾆᒸಇኵ ⭠ Polypectomy࣭EMR ࡢࢥࢶ᭱㏆ࡢヰ㢟 㟷᳃┴ Polypectomy ࢭ࣑ࢼ࣮ࠊ㟷᳃┴㟷᳃ᕷࠊ2015.9 ᾆᒸಇኵ ⭠ෆど㙾⒪ࢆ⾜࠺ୖ࡛ᚲせ࡞ࡇ 㹼 ࣏ࣜ࣌ࢡࢺ࣑࣮ࡽ ESD ࡲ࡛ 㹼 ➨ 4 ᅇ ᰣᮌᾘჾ CLUB Jr.ࠊᰣᮌ┴Ᏹ㒔ᐑᕷࠊ2015.9 Uraoka T Practical Tips for ESD Beginners and Management of Common Complications INTERNATIONAL ESD LIVE MADRID 2015㸪Madrid/Spain㸪2015.9 ᾆᒸಇኵ ⣽ᚄከᶵ⬟ࢆᐇ⌧ࡋࡓෆど㙾ࢆ⏝࠸ࡓ⭠ࡀࢇࢫࢡ࣮ࣜࢽࣥࢢ JDDW 2015㸦➨ 53 ᅇ᪥ᮏᾘჾࡀࢇ᳨デᏛ㸧࣭ࢧࢸࣛࢺࢩ࣏ࣥࢪ࣒࢘ࠊ ᮾி㒔ရᕝ༊ࠊ2015.10 ᾆᒸಇኵ ESD ࠾ࡅࡿᏳ⒪ᡓ␎ 㹼അⓎᑐ⟇㹼 ➨ 6 ᅇᗈᓥ EMR/ESD ࣁࣥࢬ࢜ࣥࢭ࣑ࢼ࣮ࠊᗈᓥ┴ᗈᓥᕷࠊ2015.11 ᾆᒸಇኵ Ᏻ࣭☜ᐇ࣭ࢫࣆ࣮ࢹ࣮࡞ ESD ࢆ┠ᣦࡋ࡚ 㸫 ᶆ‽ⓗኚࡽᢏ⾡ⓗᅔ㞴ࡲ࡛ 㸫 ➨ 106 ᅇ᪥ᮏᾘჾᏛᕞᨭ㒊 / ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫᕞᨭ㒊 ࣭ࣛࣥࢳࣙࣥࢭ࣑ࢼ࣮ࠊ⚟ᒸ┴⚟ᒸᕷࠊ2015.12 ᾆᒸಇኵ ⾲㠃ᆺ⭠⭘⒆ᑐࡍࡿෆど㙾デ᩿࣭⒪ࡢࢳࣕࣞࣥࢪ ⮫ᗋ⌮ࡢ᥋Ⅼࢆ⪃࠼ࡿ 㹼⮫ᗋ࣭⌮࠾ࡅࡿࣈࣜࢵࢪ◊✲㹼ࠊᒾᡭ┴┒ᒸᕷࠊ 2015.12 㧘ᯘ 㤾 㛗ᘬࡃ⭡③࣭ୗ⑩࣭⾑౽ࢆࡳࡓࡽ㹼⭠ࡢ⌧௦ ⅖ᛶ⭠ᝈࡢែ⒪㹼 ᮾி་⒪ࢭࣥࢱ࣮ᕷẸබ㛤ㅮᗙࠊᮾி㒔┠㯮༊ࠊ2015.3 ― 136 ― 㧘ᯘ 㤾 ⅖ᛶ⭠ᝈࡢデ᩿⒪ –デ㐃ᦠࡢどⅬࡽୡ⏣㇂༊┠㯮༊་ᖌㅮ₇ࠊᮾி㒔㇂༊ࠊ2015.4 㧘ᯘ 㤾 ⅖ᛶ⭠ᝈࡢデ᩿⒪ ᇛ༡ IBD ࣇ࢛࣮࣒ࣛࠊᮾி㒔᪂ᐟ༊ࠊ2015.8 㧘ᯘ 㤾 ⅖ᛶ⭠ᝈࡢデ᩿⒪ –⪃࠼᪉᭱㏆ࡢࢺࣆࢵࢡᮾࡀୣᾘ⟶ࢿࢵࢺ࣮࣡ࢡࠊᮾி㒔┠㯮༊ࠊ2015.11 ຍ⸨ඖᙪ ୖ㒊ᾘ⟶⭘⒆ᑐࡍࡿෆど㙾⒪ࡢ up to date ࠥṧࡉࢀࡓㄢ㢟ࡣ㸽ࠥ 㤶ᕝᾘჾ᠓ぶࠊ㤶ᕝࠊ2015 ᖺ 1 ᭶ 17 ᪥ ຍ⸨ඖᙪ ⫶ᝈᑐࡍࡿෆど㙾デ᩿ࡢࠕࡇࢀࡲ࡛ࠖࠕࡇࢀࡽࠖ ➨ 101 ᅇᮾி་⒪ࢭࣥࢱ࣮ᆅᇦ་⒪࢝ࣥࣇࣞࣥࢫࠊᮾிࠊ2015.5.21 ຍ⸨ඖᙪ Case conference 2 ⫶ ESD ESD Forum Kobe 2015ࠊ⚄ᡞࠊ2015.6.5 ຍ⸨ඖᙪ ୖ㒊ᾘ⟶ ESD ᚋࡢ㐺ษ࡞ࢧ࣮࣋ࣛࣥࢫἲࡘ࠸࡚ ᮾࡀୣᾘჾࢿࢵࢺ࣮࣡ࢡࠊᮾிࠊ2015.6.30 ຍ⸨ඖᙪ ᳨ウࢭࢵࢩࣙࣥ㸱ࠕ⫶ࠖᣦᐃㄞᙳ་ ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾிࠊ2015.6.14 ⳥ụ┿ NASH࣭ASH ࡘ࠸࡚ Medical Association Hepatitis Seminarࠊᮾிࠊ2015.11.27 ⳥ụ┿ ࡑ࠺㸟࠶࡞ࡓࡢ⬡⫫⫢ ➨ 30 ᅇ⫢⮚ᩍᐊࠊᮾிࠊ2015.10.17 ― 137 ― ⳥ụ┿ ᙜ㝔࠾ࡅࡿ⮅⟶ࢫࢸࣥࢺ⤒㦂 Pancreatic stent ◊✲ࠊᮾிࠊ2015.8.19 ⳥ụ┿ ⫢ࡀࢇࡘ࠸࡚ ➨ 29 ᅇ⫢⮚ᩍᐊࠊᮾிࠊ2015.7.18 ⳥ụ┿ ⫢ᝈࡢኚ㑄⬡⫫⫢デ⒪ ᮾி་⒪ࢭࣥࢱ࣮་ᒁබ㛤ㅮᗙ࢝ࣥࣇࣞࣥࢫࠊᮾிࠊ2015.7.9 ⳥ụ┿ ኵ፬㛫ឤᰁࡢྍ⬟ᛶࡀ⪃࠼ࡽࢀࡓᛴᛶ C ᆺ⫢⅖ࡢ៏ᛶ ᇛ༡⫢ᝈࣇ࢛࣮࣒ࣛࠊᮾிࠊ2015.6.3 ⳥ụ┿ ⫢⮚⏕ά⩦័ ┠㯮༊ෆ⛉㒊Ꮫ⾡ㅮ₇ࠊᮾி, 2015.5.13 ⳥ụ┿ ⫢ᝈ᳨ᰝ್ࡢぢ᪉ ᮾி་⒪ࢭࣥࢱ࣮ ࣭➨ 28 ᅇ⫢⮚ᩍᐊࠊᮾிࠊ2015.4.11 ⳥ụ┿ ⬡⫫⫢ࢆぢ㏨ࡋ࡚࠸ࡲࡏࢇ㹼࣓ࢱ࣎௦ࠊࡼࡾ㧗⢭ᗘࡢ⬡⫫⫢ࠊ⫢⥺⥔デ᩿ ࢆࠋ㠀くⓗᐃ㔞 ᐃ CAP ᦚ㍕ Fibroscan ࡢ᭷⏝ᛶ㹼 ➨ 43 ᅇ ᪥ᮏ⥲ྜデᏛ ࣛࣥࢳࣙࣥࢭ࣑ࢼ࣮ࠊᐩᒣࠊ 2015.2.20 ⳥ụ┿ ⫢ᝈ⏕ά⩦័ ➨ 98 ᅇᮾி་⒪ࢭࣥࢱ࣮ᆅᇦ་⒪࢝ࣥࣇࣞࣥࢫࠊᮾிࠊ2015.1.29 ⳥ụ┿ 㣧㓇⫢㞀ᐖ ᮾி་⒪ࢭࣥࢱ࣮ ࣭➨ 27 ᅇ⫢⮚ᩍᐊࠊᮾிࠊ2015.1.17 ᳃ఙ ⌧ሙ࠾ࡅࡿ CRE ᑐ⟇ࡢၥ㢟Ⅼㄢ㢟 ➨ 22 ᅇࣥࣇ࢙ࢡࢩࣙࣥࢥࣥࢺ࣮ࣟࣝࢭ࣑ࢼ࣮ࠊᮾி⏣༊ࠊ2015.7.10 ― 138 ― ᳃ఙ ᕷ୰㝔࡛ CRE ࡛ᅔࡗ࡚࠸ࡿࡇ ➨ 4 ᅇឤᰁ⒪ᡓ␎㆟ࠊᮾிࠊ2015.11.8 ᳃ఙ ࢡࣟࢫࢺࣜࢪ࣒࣭࢘ࢹࣇࢩࣝឤᰁࡘ࠸࡚ࠥ⤒⟶ᰤ㣴ࡢどⅬࡶධࢀ࡚ࠥ ➨ 17 ᅇ༊す༡㒊⥲ྜデ⒪࣭ឤᰁ◊✲ࠊᮾி┠㯮༊ࠊ2015.11.12 ᯇᮧ┿ྖ ᆅᇦࡢデ⒪ᡤ࠾ࡅࡿࣉ࣐࣭ࣛࣜࢣࡢホ౯ࡢヨࡳ ᮾிᏛ་Ꮫᩍ⫱ࢭ࣑ࢼ࣮ࠊᮾி㒔ᩥி༊ࠊ2015.9.2 㣤ᒸ⥴⨾㸪⏣῟ᚿ 」㞧ᛶࡢどⅬ࡛ከ⫋✀࡛ࡢ᳨ウࢆࡾ㏉ࡿ ➨ 55 ᅇ་Ꮫᩍ⫱ࢭ࣑ࢼ࣮࣮࣡ࢡࢩࣙࢵࣉࠊᒱ㜧ᕷࠊ2015.2.1 㣤ᒸ⥴⨾ ⩏↷㛵ࡍࡿࣉࣟࢺࢥ࣮ࣝࡼࡿṧ⸆ㄪᩚ᭹⸆ࢻࣄࣛࣥࢫࡢྥୖ ࡇࢀࡽࡢ་⸆࣭⸆⸆㐃ᦠࢆ⪃࠼ࡿࠊᮾி㒔ᩥி༊ࠊ2015.6.16 㣤ᒸ⥴⨾ ➨ 11 ᅇ RIAS ࢺ࣮ࣞࢽࣥࢢ࣮࣡ࢡࢩࣙࢵࣉ RIAS Japanࠊᒱ㜧ᕷࠊ2015.8.7-9 㣤ᒸ⥴⨾ࠊDebra Roterࠊ㔝࿅ᗄஂᏊ ་⒪࠾ࡅࡿࢪ࢙ࣥࢲ࣮ࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ ➨ 57 ᅇ་Ꮫᩍ⫱ࢭ࣑ࢼ࣮࣮࣡ࢡࢩࣙࢵࣉࠊᒱ㜧ᕷࠊ2015.8.9 㣤ᒸ⥴⨾ࠊᏞ㍜ ࣉ࣐ࣛࣜࢣㄆᐃ⸆ᖌ࣏࣮ࢺࣇ࢛ࣜ࢜Ⓨ⾲࣭ㅮ₇ ᪥ᮏࣉ࣐࣭ࣛࣜࢣᏛㄆᐃ⸆ᖌ◊ಟࠊᮾி㒔ᩥி༊ࠊ2015.10.11 [ࡑࡢ] ᑿ⸨ㄔྖ 㸦ᰯ㜀㸧ከᵝᛶ௦ࡢ་⒪ࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ-᪂ࡋ࠸ಙ㢗㛵ಀࢭ࣑ࢼ࣮ሗ࿌᭩ LPC ᅜ㝿ࣇ࢛࣮࣒ࣛ 2014 ࡼࡾ㉁ࡢ㧗࠸་⒪ࢆ┠ᣦࡍ Next Stepࠊ2015.2 ᑿ⸨ㄔྖ 㸦ⴭ᭩ࡢ୍㒊⏝㸧ࠗࠕ་ᖌࢱ࣐ࠖࡢࡁྜ࠸᪉ ᝈ⪅་⪅ࡣࢃࡾ࠶࠼ࡿ ୰ኸබㄽ᪂♫ࡼࡾᘬ⏝ ಙᕞᏛ 2012 ᖺᗘධヨၥ㢟 Ꮫᰯἲே㥴ἙྎᏛᅬ㥴ྎணഛᏛᰯᩍᮦࠊ2015.4 2015 ᖺᗘ∧ධヨၥ㢟ࢹ࣮ࢱ࣮࣋ࢫࡢᥖ㍕ࠊ2015.6 ― 139 ― ᑿ⸨ㄔྖ 㸦ⴭ᭩ࡢ୍㒊⏝㸧ࠕ་ᖌࢱ࣐ࠖ་Ꮫ᭩㝔ࡼࡾᘬ⏝ ᒣཱྀᏛ 2014 ᖺᗘධヨၥ㢟 Ꮫᰯἲே㥴ἙྎᏛᅬ㥴ྎணഛᏛᰯᩍᮦࠊ2015.4 2015 ᖺᗘ∧ධヨၥ㢟ࢹ࣮ࢱ࣮࣋ࢫࡢᥖ㍕ࠊ2015.6 ᑿ⸨ㄔྖ 㸦ⴭ᭩ࡢ୍㒊⏝㸧ࠕ་ᖌࢱ࣐㸫་ᖌᝈ⪅ࡣ࡞ࡐࡍࢀ㐪࠺ࡢ㸽ࠖ་Ꮫ᭩㝔 2016-2018 ᖺ∧Ꮫධヨࢩ࣮ࣜࢬࠕᅜබ❧ࠖ་Ꮫ㒊་Ꮫ⛉ ᥎⸀ 㸿㹍ධヨ ᰴᘧ♫ୡ⏺ᛮ♫ᩍᏛ♫ࠊ2015.5 ᑿ⸨ㄔྖ 㸦ⴭ᭩ࡢ୍㒊⏝㸧་ᖌࡢ㢌ࡢ୰ࡣࠕࢩࢱ࣐࡛ࠖ࠶ࡿ㸦ࠕ་ᖌࢱ࣐ࠖᡤ㸧 ᒣཱྀᏛධヨၥ㢟 Ꮫධヨࢹ࣮ࢱ࣮࣋ࢫ 2014 ᖺᗘ㧗ᰯඹ㏻ Web ࡢ㌿㍕ࠊᰴᘧ♫࣋ࢿࢵࢭࢥ࣮࣏ ࣮ࣞࢩࣙࣥࠊ2015.6 ᑿ⸨ㄔྖ 㸦ⴭ᭩ࡢ୍㒊⏝㸧ࠕ་ᖌࢱ࣐ࠖࡢࡁྜ࠸᪉㸫ᝈ⪅་⪅ࡣࢃࡾ࠶࠼ࡿ 2012 ᖺಙᕞᏛධヨၥ㢟 ཷ㦂ㅮᗙ ᑠㄽᩥ㐣ཤၥᑐ⟇ 2015㸫2017 ᖺᗘ㧗ᰯ 3 Web ࡢ㌿㍕ࠊ2015.6 ᑿ⸨ㄔྖ 㸦ᰯ㜀㸧 ࠕ⮫ᗋ◊✲࠾ࡅࡿ⌮◊✲⪅ࡢࣉࣟࣇ࢙ࢵࢩࣙࢼࣜࢬ࣒ࠖ 㸦➨ 36 ᅇ᪥ᮏ 㝔⸆ᖌ ᐇົ◊ಟ࡛ࡢㅮ₇ࡢᥖ㍕㸧࠾ࡅࡿࢧࢺࢹ࣮ࢱࡢᰯ㜀ࠊ☜ㄆࢸࢫࢺࡢ ᰯ㜀ࠊ୍⯡♫ᅋἲே ᪥ᮏ㝔⸆ᖌࡢ e-࣮ࣛࢽࣥࢢࠊ2015.10 ᑿ⸨ㄔྖ 㸦ㅮᖌࠊࣇࢩࣜࢸ࣮ࢱ࠾ࡼࡧࣥࢱࣅ࣮ࣗ㸧ᖹᡂ 26 ᖺᗘே⏕ࡢ᭱⤊ẁ㝵࠾ࡅࡿ ་⒪యไᩚഛᴗᡂᯝሗ࿌ ࢢ࣮ࣝࣉ࣮࣡ࢡཬࡧ┦ㄯဨࡢࣥࢱࣅ࣮ࣗ ឡ▱┴ᗓᕷࠊ2015.2.21 ᑿ⸨ㄔྖ 㸦ᗙㄯ࠾ࡅࡿㄽ㆟㸧⤊ᮎᮇ་⒪ ୍⯡♫ᅋἲே྾◊✲ࠊᮾி㒔༓௦⏣༊ࠊ2015.3.27 ᑿ⸨ㄔྖ 㸦ᩍᮦࡢసᡂ㸧་⒪⌮࣭ࣉࣟࣇ࢙ࢵࢩࣙࢼࣜࢬ࣒㛵ࡍࡿ㹃-࣮ࣛࢽࣥࢢᩍᮦ ᰴᘧ♫ࣜࣥࢡࣥࢻࢣ࣭ࣛࣇ Clinical Practice Academia-CLiPࠊ2015.5.8 ― 140 ― ᑿ⸨ㄔྖ 㸦㈨᱁ㄆᐃヨ㦂ၥ㢟సᡂ㸧➨ 110 ᅇ་ᖌᅜᐙヨ㦂ཬࡧᖹᡂ 27 ᖺᗘ་ᖌᅜᐙヨ㦂ணഛヨ 㦂ၥ㢟ࡢసᡂ ཌ⏕ປാ┬་ᨻᒁࠊᮾி㒔༓௦⏣༊ࠊ2015.5.26-27 ᑿ⸨ㄔྖ 㸦ⴭ᭩ࡢ୍㒊⏝㸧ࠕ་ᖌࢱ࣐ࠖࡢࡁྜ࠸᪉ ᝈ⪅་⪅ࡣࢃࡾ࠶࠼ࡿ Ꮫᰯἲே㧗ᐑᏛᅬ௦ࠎᮌࢮ࣑ࢼ࣮ࣝ,ࠕ་⣔ᑠㄽᩥࠖࡢᥖ㍕ࠊ2015.9.1-2015.12.5 ᑿ⸨ㄔྖ 㸦ウㄽ㸧ᖹᡂ 27 ᖺᗘே⏕ࡢ᭱⤊ẁ㝵࠾ࡅࡿ་⒪యไᩚഛᴗࣉࣟࢢ᳨࣒ࣛウ࠾ ࡅࡿ┦ㄯဨ◊ಟࣉࣟࢢ࣒ࣛࡘ࠸࡚ࡢウㄽ ᮾி㒔୰ኸ༊ࠊ2015.7.2 ᑿ⸨ㄔྖ 㸦ࣇࢩࣜࢸ࣮ࢱ㸧࣮࣡ࢡࢩࣙࢵࣉࠕࢼࣛࢸࣈ࣭ࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥࢆ㣴࠺ࠖ ࢹࢫ࢝ࢵࢩࣙࣥࠕᝈ⪅Ṍࡴࢼࣛࢸࣈ࣭ࣉ࣮ࣟࢳࡢᾐ㏱ࡢࡓࡵࠖ LPC ᅜ㝿ࣇ࢛࣮࣒ࣛ 2015 ࡼࡾ㉁ࡢ㧗࠸ࢣࢆ┠ᣦࡍ Next Stepࠕ་⒪㏥㝕ຓ ࠾ࡅࡿࢼࣛࢸࣈ࣭ࣉ࣮ࣟࢳࠖㄒࡾࡽ⣳ࡄຓࡢ㛵ಀᛶࢆᏛࡪࠊᮾி㒔୰ኸ༊ࠊ 2015.8.9 ᑿ⸨ㄔྖ 㸦◊ಟ࠾ࡅࡿㅮᖌ㸧ᖹᡂ 27 ᖺᗘே⏕ࡢ᭱⤊ẁ㝵࠾ࡅࡿ་⒪యไᩚഛᴗ┦ㄯဨ ◊ಟࠊᮾி㒔ᩥி༊ࠊ2015.8.12-13 ᑿ⸨ㄔྖ 㸦ࣇࢩࣜࢸ࣮ࢱ㸧ᖹᡂ 27 ᖺᗘே⏕ࡢ᭱⤊ẁ㝵࠾ࡅࡿ་⒪యไᩚഛᴗ୰㛫ሗ࿌ ࢢ࣮ࣝࣉ࣮࣡ࢡ ᮾி㒔༓௦⏣༊ࠊ2015.11.4 ᑿ⸨ㄔྖ 㸦㈨᱁ㄆᐃヨ㦂ၥ㢟సᡂ㸧ᖹᡂ 27 ᖺᗘ୍⯡♫ᅋἲே᪥ᮏෆ⛉Ꮫ㈨᱁ㄆᐃヨ㦂ၥ㢟 2015.9 ᑿ⸨ㄔྖ 㸦⏬⦅㞟㸧౯್ᇶ࡙ࡃ་⒪㸫ᝈ⪅ࡗ࡚ࡢ᭱ၿࡢ㑅ᢥࢆ┠ᣦࡋ࡚ Modern Physician 36 ᕳ 5 ྕࠊ᪂⯆་Ꮫฟ∧♫ ― 141 ― Uraoka T (ࣁࣥࢬ࢜ࣥࣞࢡࢳ࣮ࣕ) 7th Workshop on ESD Expert Training Salzburg/Austria, 2015.6 Uraoka T (ࣁࣥࢬ࢜ࣥࣞࢡࢳ࣮ࣕ) INTERNATIONAL ESD LIVE MADRID 2015.㸪Madrid/Spain㸪2015.9 ᾆᒸಇኵ (ࣁࣥࢬ࢜ࣥࣞࢡࢳ࣮ࣕ) ➨ 6 ᅇᗈᓥ EMR/ESD ࣁࣥࢬ࢜ࣥࢭ࣑ࢼ࣮ࠊᗈᓥ┴ᗈᓥᕷࠊ2015.11 ᾆᒸಇኵ (ᗙ㛗) ࠗୖ㒊ᾘ⟶ᝈデ⒪ࡢ᪂ࡓ࡞ࡿࣉ࣮ࣟࢳ࠘₇⪅㸸᠕⩏ሿᏛ་Ꮫ㒊 ෆ⛉Ꮫ㸦ᾘ ჾ㸧ᩍᤵ 㕥ᮌ ⚽ ඛ⏕ ᾘჾᝈࢆ⪃࠼ࡿࠊᮾி㒔㇂༊ࠊ2015.4 ᾆᒸಇኵ (ᗙ㛗) ୍⯡ཱྀ₇㸦SSA/P㸧 ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲ࠊឡ▱┴ྡྂᒇᕷࠊ2015.5 ᾆᒸಇኵ (ᗙ㛗) ୍⯡ཱྀ₇㸦⫶ ESD-4㸧 ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔᪂ᐟ༊ࠊ2015.6 ᾆᒸಇኵ (ᗙ㛗) ᳨ウ࣭ㅮ₇ ➨୍ᅇ࣭ᮾࡀୣᾘჾࢿࢵࢺ࣮࣡ࢡࠊᮾி㒔┠㯮༊ࠊ2015.8 ᾆᒸಇኵ (ᗙ㛗) ࠗ⭠ෆど㙾ࢺ࣮ࣞࢽࣥࢢἲ-⌧≧ㄢ㢟-࠘㡰ኳᇽᏛ་Ꮫ㒊 ᩍᤵ ᆏᮏ ┤ே ඛ⏕ COLONetwork 2015ࠊᮾி㒔༓௦⏣༊ࠊ2015.8 ― 142 ― ᾆᒸಇኵ (ᗙ㛗) ᳨ウ࣭ㅮ₇ ➨ 11 ᅇ Gut Challenge Meetingࠊᮾி㒔Ụᮾ༊ࠊ2015.8 ⳥ụ┿ (ᗙ㛗) TACE ᇛ༡⫢ᝈࣇ࢛࣮࣒ࣛࠊᮾிࠊ2015.11.13 ⳥ụ┿ (ᗙ㛗) ⭡㒊㉸㡢Ἴ ➨ 43 ᅇ᪥ᮏ⥲ྜデᏛࠊᐩᒣࠊ2015.2.20 ᾆᒸಇኵ (᳨ウࢭࢵࢩࣙࣥࢥ࣓ࣥࢸ࣮ࢱ࣮) ➨ 12 ᅇ᪥ᮏᾘ⟶ᏛᏛ⾡㞟ࠊᮾி㒔᪂ᐟ༊ࠊ2015.2 ᾆᒸಇኵ (᳨ウࢭࢵࢩࣙࣥㄞᙳ⪅) ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾி㒔᪂ᐟ༊ࠊ2015.6 ຍ⸨ඖᙪ (᳨ウࢭࢵࢩࣙࣥ㸱ࠕ⫶ࠖᣦᐃㄞᙳ་) ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉ࠊᮾிࠊ2015.6.14 ᾆᒸಇኵ ㌟㏆࡞ẼࠊẼ࡞ࡿ≧ 㹼࠸ࡲࡁࡣࡇ࠺┤ࡍ㸟㹼 ⭠࣏࣮ࣜࣉ㸦๓⦅㸧 ᮾிࢫ࣏࣮ࢶࠊ2015.10.20 ᾆᒸಇኵ ㌟㏆࡞ẼࠊẼ࡞ࡿ≧ 㹼࠸ࡲࡁࡣࡇ࠺┤ࡍ㸟㹼 ⭠࣏࣮ࣜࣉ㸦ᚋ⦅㸧 ᮾிࢫ࣏࣮ࢶࠊ2015.10.27 ⳥ụ┿ 㸦TV ฟ₇㸧ࣈࣟࢵࢥ࣮ࣜࢫࣉࣛ࢘ࢺ㸦SFN㸧ࡢຠᯝ NHK ࢧࢳࠊ2015.6.8 ― 143 ― ⳥ụ┿ 㸦TV ฟ₇㸧ᗣண㜵ࡢࡓࡵ㣗ࡿⰋ࠸㔝⳯ TBS ࢧࢱࢹ࣮ࣉࣛࢫࠊ2015.11.28 ᳃ఙ ᪥⤒࣓ࢹ࢝ࣝ REPORTࠕⓎ⇕ᝈ⪅ࢹࣥࢢ⇕ࢆࡗࡓࡽࠖ2015.8 ࣛࢪ࢜ NIKKEI ᮥᯘࢩ࣏ࣥࢪࠕClostridium difficile ឤᰁࠖ2015.10.11 㛛ᯇ㈼ 㸦ᗙ㛗㸧୍⯡₇㢟࣏ࢫࢱ࣮, PD ᇶ♏ ➨ 60 ᅇ᪥ᮏ㏱ᯒ་ᏛᏛ⾡㞟⥲ࠊᶓࠊ2015.6.26-28 ― 144 ― 㧗㱋⪅ࢣ◊✲ᐊ [ ⥲ㄝ ] ᮏ⏣⨾Ꮚ (࣓ࢹ) ࠙≉㞟ࠚㄆ▱㧗㱋⪅ࡢ⏕ά⎔ቃ ⪁ᖺ་Ꮫᇶ࡙࠸ࡓ㧗㱋⪅ࡢࣉࣟ ࣮ࢳ▱ぬ࣭ឤ࣭ゝㄒࡼࡿໟᣓⓗࢣᢏ⾡ Humanitude 㝔タഛ 322 2015 ᖺ 3 ᭶ྕࠊ57(2)㸸31-35ࠊ୍⯡♫ᅋἲே᪥ᮏ་⒪⚟♴タഛ༠ࠊ 2015.3 ᮏ⏣⨾Ꮚ (࣓ࢹ) ᅾᏯ࣭ᆅᇦ࠾ࡅࡿά⏝ྍ⬟ᛶ 㧗㱋⪅ᐙ᪘ࡀᚲせࡍࡿᅾᏯࢣࡣ ㄆ▱ࡢᐙ᪘ㆤ࣐ࣘࢽࢳ࣮ࣗࢻࡢྍ⬟ᛶ ᅾᏯ࣭ᆅᇦ࡛ࡇࡇࡲ࡛࡛ࡁࡿ㸟ゼၥ┳ㆤㆤ 2015 ᖺ 5 ᭶ྕࠊ20(5)㸸368-373ࠊ་Ꮫ ᭩㝔ࠊ2015.5.15 ᮏ⏣⨾Ꮚ (࣓ࢹ) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡࣐ࣘࢽࢳ࣮ࣗࢻ ᪥ᮏᅾᏯ་Ꮫ㞧ㄅ 2015 ᖺ 7 ᭶ࠊ17(1)㸸98ࠊ୍⯡♫ᅋἲே᪥ᮏᅾᏯ་Ꮫࠊ2015.7 ᮏ⏣⨾Ꮚ (࣓ࢹ) ඃࡋࡉࢆఏ࠼ࡿ▱ぬ࣭ឤ࣭ゝㄒࡼࡿໟᣓⓗ࡞ࢣࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ ᢏ⾡ ࣐ࣘࢽࢳ࣮ࣗࢻࠊ᭶ห⸆ 2015 ᖺ 11 ᭶ࠊ57(12)㸸93-97ࠊᰴᘧ♫ࡌ࠺ࠊ 2015.11 ᮏ⏣⨾Ꮚ (࣓ࢹ) ⪁ᖺ་Ꮫᇶ࡙࠸ࡓ㧗㱋⪅⪅ࡢࣉ࣮ࣟࢳ▱ぬ࣭ឤ࣭ゝㄒࡼࡿ ໟᣓⓗࢣᢏ⾡ Hunnanitude ᦤ㣗࣭ᄟୗ㞀ᐖࢆ⪃࠼ࡿ ཱྀࡽ㣗ࡿᖾࡏ࡙ࡃࡾ࠙➨ 9 㞟ࠚ㸸4-7ࠊ㣗ㆤ◊✲ [ Ꮫ ] ᮏ⏣⨾Ꮚ (ࢩ࣏ࣥࢪ࣒࢘) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᪥ᮏᅾᏯ་Ꮫࢩ࣏ࣥࢪ࣒࢘ㄆ▱ࢣࡢ᰿ᖿࢆぢࡘࡵࡿ ➨ 17 ᅇ᪥ᮏᅾᏯ་Ꮫࡶ ࡾ࠾ࠊ┒ᒸᕷࠊ2015.4.26 ᮏ⏣⨾Ꮚ (ᩍ⫱ㅮ₇) ▱ぬ࣭ឤ࣭ゝㄒࡼࡿໟᣓⓗࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ®ࡑࡢᇶᮏ ᐇ㊶ ➨ 6 ᅇ᪥ᮏࣉ࣐ࣛࣜࢣ㐃ྜᏛᏛ⾡ࠊࡘࡃࡤᕷࠊ2015.6.13 ― 145 ― ᮏ⏣⨾Ꮚ (ᩍ⫱ㅮ₇) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻࡢᐇ㊶ ➨ 56 ᅇ᪥ᮏᚰ㌟་ᏛࠊỤᡞᕝ༊ࠊ2015.6.26 ᮏ⏣⨾Ꮚࠊ⮉⏿ᩔᏊ (┳ㆤᢏ⾡ࢭ࣑ࢼ࣮) ࣐ࣘࢽࢳ࣮ࣗࢻ㸫ဴᏛࡶ࡙࠸ࡓᐇ㊶ⓗྡࢣࡢᒎ㛤㸫ࠊ ࡏ࠸ࢀ࠸┳ㆤᏛ➨ 6 ᅇᏛ⾡㞟ࠊᯇᕷࠊ2015.9.12 ᮏ⏣⨾Ꮚ (ࢩ࣏ࣥࢪ࣒࢘) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ➨ 3 ᅇ ᪥ᮏㆤ⚟♴࣭ᗣ࡙ࡃࡾᏛࠊᯈᶫ༊ࠊ2015.11.15 ᮏ⏣⨾Ꮚ (≉ูㅮ₇) ㄆ▱ࢣ࠾ࡅࡿ࣐ࣘࢽࢳ࣮ࣗࢻɆぢࡿ࣭ヰࡍ࣭ゐࢀࡿ࣭❧ࡘɆ ➨ 55 ᅇ㏆␥⌮Ꮫ⒪ἲᏛ⾡ࠊ⚄ᡞᕷࠊ2015.11.21 ᮏ⏣⨾Ꮚ (≉ูㅮ₇) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ࢯ࣮ࢩࣕࣝࢫ࢟ࣝࢺ࣮ࣞࢽࣥࢢᬑཬ༠➨ 20 ᅇᏛ⾡㞟ࠊ㇏୰ᕷࠊ2015.11.27 [ ㅮ₇ ] ᮏ⏣⨾Ꮚࠊఀᮾ⨾⥴ ▱ぬ࣭ឤ࣭ゝㄒࡼࡿໟᣓⓗࢣᢏ⾡ ᮾி㒔ᗣ㛗ᑑ་⒪ࢭࣥࢱ࣮ㅮ₇ࠊᯈᶫ༊ࠊ2015.1.6 ᮏ⏣⨾Ꮚ ▱ぬ࣭ឤ࣭ゝㄒᇶ࡙ࡃࠊඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡㸸࣐ࣘࢽࢳ࣮ࣗࢻ ከᦶす㒊་⒪ᅪᆅᇦࣜࣁࣅࣜࢸ࣮ࢩࣙࣥᨭࢭࣥࢱ࣮බ㛤ㅮᗙࠊ❧ᕝᕷࠊ2015.1.15 ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚ ࣐ࣘࢽࢳ࣮ࣗࢻࡑࡢேࡽࡋࡉࢆᅇࡉࡏࡿࢣᢏ⾡ ⇃ᮏ┴ಖ㝤་༠ࠊ⇃ᮏᕷࠊ2015.1.17 ᮏ⏣⨾Ꮚࠊఀᮾ⨾⥴ ᩍ⫱ㅮ₇ࡸࡉࡋࡉࢆఏ࠼ࡿࢣᢏ⾡࣐ࣘࢽࢳ࣮ࣗࢻ 㮵ᒇ┳ㆤᑓ㛛Ꮫᰯࠊ㮵ᒇᕷࠊ2015.1.19 ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚࠊఀᮾ⨾⥴ ඃࡋࡉࢆఏ࠼ࡿᢏ⾡㹼࣐ࣘࢽࢳ࣮ࣗࢻ㹼 ୍⯡♫ᅋἲே㒆ᒣ་ᖌࠊ㒆ᒣᕷࠊ2015.1.31 ― 146 ― ᮏ⏣⨾Ꮚ ࡸࡉࡋࡉࢆఏ࠼ࡿࢣᢏ⾡࣭࣐ࣘࢽࢳ࣮ࣗࢻ® ⏣༊୕་ᖌㄆ▱◊✲ ༊Ẹබ㛤ㅮᗙ ദ㸸⏣༊୕་ᖌㄆ▱◊✲ ඹ ദ㸸⏣༊࣭᳃་ᖌ࣭ⵦ⏣་ᖌ࣭⏣ᅬㄪᕸ་ᖌࠊ⏣༊ࠊ2015.1.24 ᮏ⏣⨾ᏊࠊYves Gineste ࡸࡉࡋࡉࢆఏ࠼ࡿࢣᢏ⾡㹼࣐ࣘࢽࢳ࣮ࣗࢻ㹼 NPO ἲே ୰✵▱࣭ᆅᇦ࡛ㄆ▱ࢆᨭ࠼ࡿࠊ◁ᕝᕷࠊ2015.2.6 ᮏ⏣⨾Ꮚ ඃࡋࡉఏ࠼ࡿ ࢣᢏ⾡㸸ࠕ࣐ࣘࢽࢳ࣮ࣗࢻࠖጞ⪅ㅮ₇㹼▱ぬ࣭ឤ࣭ゝㄒࡼࡿ ໟᣓⓗࢥ࣑ࣗࢽࢣ࣮ࢩ࣭ࣙࣥࢣᢏἲ㹼 㔠ἑ་⛉Ꮫ㝔 ㅮ₇ࠊἙ㒆ࠊ2015.2.13 ᮏ⏣⨾ᏊࠊYves Gineste ࣐ࣘࢽࢳ࣮ࣗࢻ≉ูㅮ₇ 㜰ᗓಖ⚟♴ᑓ㛛Ꮫᰯ ➨㸯ᅇ་⒪࣭⚟♴ᆅᇦ㐃ᦠ◊✲ࠊ㜰ᕷࠊ2015.2.21 ᮏ⏣⨾Ꮚ (≉ูㅮ₇) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡㸸࣐ࣘࢽࢳ࣮ࣗࢻ ➨ 7 ᅇ ༊ᮾ㒊࣭ᮾ㒊ࣈࣟࢵࢡᏛ⾡㞟 බ┈♫ᅋἲே ᮾி㒔⌮Ꮫ⒪ἲኈ༠༊ᮾ 㒊࣭ᮾ㒊ࣈࣟࢵࢡദࠊỤᮾ༊ࠊ2015.2.22 ᮏ⏣⨾ᏊࠊYves Ginesteࠊ᐀ᙧึᯞࠊ㐲⸨῟Ꮚࠊ㤶ᒣኊኴࠊ▼ᕝ⩧࿃ࠊఀᮾ⨾⥴ ᕷẸබ㛤ㅮᗙ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡㸸࣐ࣘࢽࢳ࣮ࣗࢻ® ࣐ࣘࢽࢳ࣮ࣗࢻᕷẸබ㛤ㅮᗙ ⏕Ꮡ⛉Ꮫ◊✲ᡤຓᡂࠊ༓௦⏣༊ࠊ2015.2.22 ᮏ⏣⨾ᏊࠊYves Ginesteࠊఀᮾ⨾⥴ ࣐ࣘࢽࢳ࣮ࣗࢻ◊ಟ 㞃ᒱᗈᇦ㐃ྜ❧ 㞃ᒱᓥ๓㝔ࠊ㞃ᒱ㒆ࠊ2015.2.23-5 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆࡘࡓ࠼ࡿᢏ⾡㸸㧗㱋⪅ࢣ࣓ࢯࢵࢻ࣐ࣘࢽࢳ࣮ࣗࢻ ᫂ࢼ࣮ࢫࢭ࣑ࢼ࣮ࠊ༤ከᕷࠊ2015.3.1 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᒾᡭ┴⮫ᗋ◊ಟ་ྜྠ࢚࢜ࣜࣥࢸ࣮ࢩࣙࣥࠊඵᖭᖹᕷࠊ2015.4.10 ― 147 ― ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ⦕ࢆࡴࡍࡪ ࢩ࣏ࣥࢪ࣒࢘ࠊ༓௦⏣༊ࠊ2015.4.18 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ⪁ᖺ◊✲ᡤ㝃ᒓ㝔ㄆ▱ᝈ་⒪ࢭࣥࢱ࣮ㅮ₇ࠊ๓ᶫᕷࠊ2015.5.31 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡㸸࣐ࣘࢽࢳ࣮ࣗࢻ®ࡢ⌮ᛕᢏ⾡ ⩌㤿ㄆ▱࢝ࢹ࣑࣮➨ 10 ᅇࡢ◊ಟࠊ๓ᶫᕷࠊ2015.5.31 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® 㒆ᒣ་ᖌࠊ㒆ᒣᕷࠊ2015.6.5 ᮏ⏣⨾Ꮚࠊᯘ⣪⨾ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᛴᛶᮇ㝔࠾ࡅࡿㄆ▱ࢣࡢᐇ㊶ ➨ 73 ᅇᮾி㒔་ᖌ┳ㆤᖌ༞ᚋᩍ⫱ㅮ⩦ࠊᩥி༊ࠊ2015.6.7 ᮏ⏣⨾Ꮚ ࣐ࣘࢽࢳ࣮ࣗࢻ®ධ㛛 ᖹᡂ 27 ᖺᗘឡ▱┴┳ㆤ⟶⌮◊✲ࠊྡྂᒇᕷࠊ2015.6.20 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᖹᡂ 27 ᖺㄆ▱㧗㱋⪅◊ಟࠊ㜰ᗓ┳ㆤ༠ࠊ㜰ᕷࠊ2015.6.21 ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ♫⚟♴ἲேᜠ㈷㈈ᅋ ῭⏕⇃ᮏ㝔ࠊ⇃ᮏᕷࠊ2015.6.24 ᮏ⏣⨾Ꮚ (බ㛤ㅮᗙ) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ®ࡢᐇ㊶ ➨ 25 ᅇ᪥ᮏ⢭⚄ಖ┳ㆤᏛ බ㛤ㅮᗙࠊࡘࡃࡤᕷࠊ2015.6.27 ᮏ⏣⨾ᏊࠊYves Gineste ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᖹᡂ 27 ᖺᗘ ➨ 7 ᅇ 㔩▼་ᖌᏛ⾡ㅮ₇ࠊ㔩▼ᕷࠊ2015.6.29 ― 148 ― ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᒾᡭ┴❧୰㒊㝔ࠊୖᕷࠊ2015.6.30 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ῭⏕⇃ᮏ㝔ࠊ⇃ᮏᕷࠊ2015.7.9 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ®ࡢᐇ㊶ ་⒪ἲே♫ᅋ㧗㍯ゼၥ⥲ࠊရᕝ༊ࠊ2015.7.21 ᮏ⏣⨾Ꮚ (ࢩ࣏ࣥࢪ࣒࢘) ゐࢀࡿࡇࡢព⩏ ➨ 4 ᅇ࢚ࣅࢹࣥࢫᇶ࡙ࡃ⤫ྜ་⒪◊✲ࠊ㜰ᕷࠊ2015.8.1 ᮏ⏣⨾ᏊࠊYves Gineste ࣐ࣘࢽࢳ࣮ࣗࢻࡘ࠸࡚ 㜰ᗓ❧⢭⚄་⒪ࢭࣥࢱ࣮ࠕᗣ་⒪㒔ᕷࡦࡽࡓࢥࣥࢯ࣮ࢩ࣒ࠖ㐃ᦠᴗㅮ₇ࠊ ∾᪉ᕷࠊ2015.8.2 ᮏ⏣⨾Ꮚ (ᩍဨ◊ಟ≉ูㅮ₇) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ➨ 46 ᅇ ୰ᅄᆅ༊་ᖌ┳ㆤ༠㆟ࠊูᗓᕷࠊ2015.8.23 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ศ┴ಖ་ᖌࠊศᕷࠊ2015.8.24 ᮏ⏣⨾Ꮚ ࣐ࣘࢽࢳ࣮ࣗࢻ®ࡘ࠸࡚ බ┈♫ᅋἲே ㇏ᓥ༊་ᖌࠊ㇏ᓥ༊ࠊ2015.9.5 ᮏ⏣⨾Ꮚ ࣐ࣘࢽࢳ࣮ࣗࢻ® ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡ ᮾி་⛉ṑ⛉Ꮫ་Ꮫ㒊㝃ᒓ㝔ࠊᩥி༊ࠊ2015.9.10 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᓊ⏣ᕷẸ㝔 㝔ෆ◊ಟࠊᓊ⏣ᕷࠊ2015.9.11 ― 149 ― ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ®ࡢᐇ㊶ ➨ 46 ᅇ᪥ᮏ┳ㆤᏛ(ᅾᏯ┳ㆤ)ࠊྡྂᒇᕷࠊ2015.10.3 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᶓ≉ูᨭᩍ⫱◊ಟ ᶓᕷᩍ⫱ጤဨࠊᶓᕷࠊ2015.10.9 ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚ ࣐ࣘࢽࢳ࣮ࣗࢻ® ࡑࡢேࡽࡋࡉࢆᅇࡉࡏࡿࢣᢏ⾡ ᅜ❧㝔ᶵᵓ⇃ᮏ་⒪ࢭࣥࢱ࣮ࠊ⇃ᮏᕷࠊ2015.10.14 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᯽ᓮᕷส⩚㒆་ᖌ ᯽ᓮส⩚ࢣ◊✲ㅮ₇ࠊ᯽ᓮᕷࠊ2015.10.20 ᮏ⏣⨾Ꮚ ࣐ࣘࢽࢳ࣮ࣗࢻ®㹼ඃࡋࡉࢆఏ࠼ࡿㄆ▱ࢣᢏ⾡㹼 ㄪᕸᮾᒣ㝔 ➨ 89 ᅇ࠺ࡊࢇ⏕ά⩦័ᩍᐊࠊㄪᕸᕷࠊ2015.10.31 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᗈᓥᩥᏛᅬᏛ ┳ㆤᏛ㒊ࠊ࿋ᕷࠊ2015.11.22 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᖹᡂ 27 ᖺᗘ㍍⡿⏫ࣇ࢛࣮࣒ࣛࠊᡞ㒆ࠊ2015.11.23 ᮏ⏣⨾Ꮚ (グᛕㅮ₇) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᅜಶูࣘࢽࢵࢺᆺタ᥎㐍༠㆟ ➨㸷ᅇᅜ◊ಟ in ᐑᇛ࣭ྎ 2015㹼་⒪ ㆤࢆ㐃ᦠࡍࡿ⤫ྜຊ㹼ࠊྎᕷࠊ2015.11.25 ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚࠊᯘ⣪⨾ࠊ᳃㇂㤶Ꮚ (ᩍ⫱ࢭ࣑ࢼ࣮) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ➨ 13 ᅇᅜ❧㝔┳ㆤ◊✲ᏛᏛ⾡㞟ࠊ༓ⴥᕷࠊ2015.11.28 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ➨ 2 ᅇឿᜨ་᯽㝔 ⥲ྜデ⒪ࢭ࣑ࢼ࣮ࠊ᯽ᕷࠊ2015.12.2 ― 150 ― [ ◊ಟ ] ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 1 ᅇධ㛛ࢥ࣮ࢫ 2 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.1.10-11 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 2 ᅇධ㛛ࢥ࣮ࢫ 2 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.2.2-3 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 3 ᅇධ㛛ࢥ࣮ࢫ 2 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.5.26-27 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 1 ᅇタᑟධ‽ഛࢥ࣮ࢫ 10 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.3.2-6 4.14-16 5.28-29 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 4 ᅇධ㛛ࢥ࣮ࢫ 2 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.7.18-19 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 5 ᅇධ㛛ࢥ࣮ࢫ 2 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.9.22-23 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 6 ᅇධ㛛ࢥ࣮ࢫ 2 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.10.10-11 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 2 ᅇタᑟධ‽ഛࢥ࣮ࢫ 10 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.8.31-9.4 10.6-8 11.5-6 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 7 ᅇධ㛛ࢥ࣮ࢫ 2 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.11.19-20 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ࣐ࣘࢽࢳ࣮ࣗࢻ®◊ಟ ➨ 8 ᅇධ㛛ࢥ࣮ࢫ 2 ᪥㛫 ᮾி་⒪ࢭࣥࢱ࣮ ࢹࢪࢱࣝࢭࣥࢭ࣮ࢩࣙࣥᰴᘧ♫ࠊ┠㯮༊ࠊ15.12.5-6 ― 151 ― ᮏ⏣⨾Ꮚ (ゼၥ◊ಟ) ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® 㒆ᒣ་ᖌࠊ㒆ᒣᕷࠊ15.6.5 ᮏ⏣⨾Ꮚࠊࣥࢫࢺࣛࢡࢱ࣮┳ㆤᖌ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᪥ᮏ㝔༠ㄆ▱◊ಟࠊ༓௦⏣༊ࠊ2015.11.3-4 [ ㅮᖌ ] ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚ ㄆ▱ㅮ⩏࣭࣐ࣘࢽࢳ࣮ࣗࢻ ᮾி་⒪ಖᏛࠊ┠㯮༊ࠊ2015.1.8 ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚ ᚰ⌮ࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥᐇ⩦ ᪫ᕝ་⛉Ꮫ་Ꮫ㒊 1 ᖺ⏕ㅮ⩏ࠊ᪫ᕝᕷࠊ2015.2.7 ᮏ⏣⨾Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ஂ␃⡿Ꮫ་Ꮫ㒊┳ㆤᏛ⛉≉ูㅮ⩏ࠊஂ␃⡿ᕷࠊ2015.6.23 ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚ ㄆ▱ᝈ⪅ࡢࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ ⪷㊰ຍᅜ㝿Ꮫᩍ⫱ࢭࣥࢱ࣮ᴗ ㄆᐃ┳ㆤᖌᩍ⫱ㄢ⛬(ㄆ▱┳ㆤࢥ࣮ࢫ)ࠊ୰ኸ༊ࠊ 2015.7.3 ᮏ⏣⨾Ꮚࠊ┒┿▱Ꮚ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡:࣐ࣘࢽࢳ࣮ࣗࢻ® ᪫ᕝ་⛉Ꮫ་Ꮫ㒊 1 ᖺ⏕ㅮ⩏ࠊ᪫ᕝᕷࠊ2015.12.7 [ ࡑࡢ ] ᮏ⏣⨾Ꮚࠊ᐀ീᏊ (࣓ࢹ) ࢣࢆᥦ౪ࡍࡿ“ඃࡋࡉ”ࢆ⾲ࡍࡇࡢ࡛ࡁࡿ࣐ࣘࢽࢳ࣮ࣗࢻࡢྍ⬟ᛶ ┳ㆤ ⮫ቑหྕ 2015 ᖺ 3 ᭶ 67(4)㸸92ࠊ᪥ᮏ┳ㆤ༠ฟ∧ࠊ2015.3.15 ᮏ⏣⨾ᏊࠊYves Ginesteࠊఀᮾ⨾⥴ࠊ➉ᯘὒ୍ࠊ㓇㇂⸅ࠊୖ㔝⚽ᶞࠊᒣཱྀᬕಖࠊ⏣୰ᚿᏊ (࣓ࢹ) ≉㞟 ࣐ࣘࢽࢳ࣮ࣗࢻࡣఱࡀ㐪࠺Ϩࡑࡢ᭷ຠᛶྍ⬟ᛶ ᅾᏯ࣭ᆅᇦ࡛ࡇࡇࡲ࡛࡛ࡁࡿ㸟ゼၥ┳ㆤㆤ 2015 ᖺ 4 ᭶ྕ 20㸦4㸧226㸸275-302ࠊ ་Ꮫ᭩㝔ࠊ2015.4 ― 152 ― ᮏ⏣⨾Ꮚ (࣓ࢹ) ඃࡋࡉఏ࠼ࡿᢏ⾡ ᙺ❧ࡘㄆ▱᪂ࢣ ࣇࣛࣥࢫ࡛⪃ࠕ࣐ࣘࢽࢳ࣮ࣗ ࢻࠖ ᪥ᮏ㎰ᴗ᪂⪺ 2015 ᖺ 4 ᭶ 16 ᪥ࠊᰴᘧ♫᪥ᮏ㎰ᴗ᪂⪺ࠊ2015.4.16 ᮏ⏣⨾Ꮚ (࣓ࢹ) ᚰయᐤࡾῧ࠺ ㄆ▱ࢣࡢᢏἲ NHK ࢸࣞࣅࢸ࢟ࢫࢺ ࡁࡻ࠺ࡢᗣ 2015 ᖺ 5 ᭶ྕ㸸94-100ࠊNHK ฟ∧ࠊ2015.4.21 ᮏ⏣⨾Ꮚ (࣓ࢹ) ≉㞟 ࠕே㛫ࡽࡋࡉࢆᑛ㔜ࡍࡿࠖࣇࣛࣥࢫ࡛⏕ࡲࢀࡓࢣᢏἲ ࣐ࣘࢽࢳ ࣮ࣗࢻ ࢣࢆᚲせࡍࡿࡍ࡚ࡢே UA ࢮࣥࢭࣥ᪥ᮏㆤࢡࣛࣇࢺࣘࢽ࢜ࣥ(NCCU)ᶵ㛵ㄅ(ᖺ 6 ᅇⓎ⾜) NCCU NEWS 㸦࢚ࢾࢩ࣮ࢩ࣮࣮ࣘ㸧VOL.9 2015.4㸸3-6ࠊUA ࢮࣥࢭࣥ᪥ᮏㆤࢡࣛࣇࢺࣘࢽ࢜ࣥࠊ 2015.4 ᮏ⏣⨾ᏊࠊYves Ginesteࠊ▼ᆏ⨾༓௦ࠊ┒┿▱Ꮚࠊ᐀ᙧึᯞࠊ㤶ᒣኊኴࠊఀᮾ⨾⥴ࠊ ᯘ⣪⨾ࠊ⸨⏤⣖ࠊᮌᮧὒᏊࠊ⮉⏿ᩔᏊࠊᯇᮧ┿ྖ (࣓ࢹ) ≉㞟 ࣐ࣘࢽࢳ࣮ࣗࢻࡣఱࡀ㐪࠺ϩᅾᏯ࣭ᆅᇦ࡛ࡢά⏝ྍ⬟ᛶ ᅾᏯ࣭ᆅᇦ࡛ࡇࡇࡲ࡛࡛ࡁࡿ㸟ゼၥ┳ㆤㆤ 2015 ᖺ 5 ᭶ྕ 20(5)㸸367-404ࠊ་Ꮫ ᭩㝔ࠊ2015.5.15 ᮏ⏣⨾Ꮚ (࣓ࢹ) ඃࡋࡉఏ࠼ࡿ ࣇࣛࣥࢫⓎ⚈ ㆤᢏ⾡ ࠕ࣐ࣘࢽࢳ࣮ࣗࢻࠖ ᅄࡘࡢᇶᮏ ᪥ᮏ㎰ᴗ᪂⪺ 2015 ᖺ 5 ᭶ 28 ᪥ࠊᰴᘧ♫᪥ᮏ㎰ᴗ᪂⪺ࠊ2015.5.28 ᮏ⏣⨾Ꮚ (࣓ࢹ) ㄆ▱ࢣࢆゎㄝ 㒆ᒣᕷ་⒪ㆤ㝔 9 ࿘ᖺㅮᗙ ⚟ᓥẸሗ 2015 ᖺ 6 ᭶ 5 ᪥ࠊ⚟ᓥẸሗ♫ࠊ2015.6.5 ᮏ⏣⨾Ꮚ (࣓ࢹ) ࣇࣛࣥࢫࡢㄆ▱ࢣ ࣐ࣘࢽࢳ࣮ࣗࢻ⤂ ⚟ᓥẸ HOMETOWN 㒆ᒣ࣡ࢻ 2015 ᖺ 6 ᭶ 5 ᪥ࠊ⚟ᓥẸ᪂⪺♫ࠊ2015.6.5 ᮏ⏣⨾Ꮚ (࣓ࢹ) ␗ᴗ✀ࡢᗈሙ ே┤ᧁࣥࢱࣅ࣮ࣗ ᮏ⏣⨾Ꮚࡉࢇ ᑠභᩍ⫱ᢏ⾡ 2015 ᖺ 7/8 ᭶ྕ 68(4)㸸46-49ࠊᑠᏛ㤋ࠊ2015.7 ― 153 ― ᮏ⏣⨾ᏊࠊYves Gineste (࣓ࢹ) ᖹᡂ 27 ᖺᗘ ➨ 7 ᅇ㔩▼་ᖌᏛ⾡ㅮ₇ ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡㸸 ࣐ࣘࢽࢳ࣮ࣗࢻ㹼ࡑࡢᇶᮏᐇ㊶㹼 㔩▼་ᖌሗ ᖹᡂ 27 ᖺ 8 ᭶ྕ No.319㸸15-16ࠊ㔩▼་ᖌࠊ2015.8 ᮏ⏣⨾Ꮚ (࣓ࢹ) ࣐ࣘࢽࢳ࣮ࣗࢻࡣࢇ࡞ࢣ? NHK ࠶ࡉࢳ࣐࢞ࢪࣥ vol.12㸸33ࠊᐆᓥ♫ࠊ2015.9.15 ᮏ⏣⨾ᏊࠊYves Gineste (࣓ࢹ) ࢢࣛࣇ D ࢝ࣇ࢙ࡢ㢼ᬒࠕࢧࣉࣛࢬ㸟ㅦࡢࣇࣛࣥࢫே⌧ࢀࡿࠖ ㆤ⪅ࡀࡘࡃࡿㄆ▱ሗㄅ ࡛࠷ࡵࢇࡋ࠶ No.3 㸸18ࠊ≉ᐃ㠀Ⴀάືἲே D ࢝ࣇ࢙ࡲࡕ࡙ࡃࡾࢿࢵࢺ࣮࣡ࢡࠊ2015.9.15 ᮏ⏣⨾Ꮚ (࣓ࢹ) column ㄆ▱ㆤࡀᴦே࡞ࡿヰ㢟“࣐ࣘࢽࢳ࣮ࣗࢻ”ࡣ㸽 Adviser ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ ⥲ྜෆ⛉་㛗ᮏ⏣⨾Ꮚࡉࢇ ᪥⤒࠾࡞ࡢ OFF 2015 ᖺ 10 ᭶ྕ⮫ቑห㸸47ࠊ᪥⤒ BP ♫ࠊ2015.9.16 ᮏ⏣⨾Ꮚ (࣓ࢹ) ே㛫ࡢᑛཝࢆษࡍࡿㄆ▱ࢣࠊࠕ࣐ࣘࢽࢳ࣮ࣗࢻࠖࢆ᪥ᮏ SPUR(ࢩࣗࣉ࣮ࣝ)11 ᭶ྕ㸸364ࠊ㞟ⱥ♫ࠊ2015.9.23 ᮏ⏣⨾Ꮚࠊᯇୗṇ᫂ࠊYves Ginesteࠊఀᮾ⨾⥴ࠊཎᑑኵࠊ᐀ᙧึᯞࠊ㐲⸨῟Ꮚࠊ㤶ᒣኊኴࠊ ▼ᕝ⩧࿃ࠊṊ⏣⣧୕ (࣓ࢹ) ᕷẸබ㛤ㅮᗙ㸻ඃࡋࡉࢆఏ࠼ࡿࢣᢏ⾡-࣐ࣘࢽࢳ࣮ࣗࢻ ⏕Ꮡ⛉Ꮫ 2015,9 26(1)㸸127-159ࠊබ┈ಙクṊぢグᛕ⏕Ꮡ⛉Ꮫ◊✲ᇶ㔠බ┈㈈ᅋἲே ⏕Ꮡ⛉Ꮫ◊✲ᡤࠊ2015.9.30 ᮏ⏣⨾ᏊࠊYves Gineste (࣓ࢹ) ㄡࡶࡀᏛࠊᐇ㊶࡛ࡁࡿ࣐ࣘࢽࢳ࣮ࣗࢻࠋ5 ࡘࡢࢫࢸࢵࣉ࡛ᝈ⪅ࡢᚰ ㏆࡙ࡃ HELPMAN JAPANࠊ2015.10.16 ᮏ⏣⨾Ꮚ (࣓ࢹ) ㄆ▱་⒪ࡣ࢟ࣗࡼࡾࢣ ✜ࡸవ⏕ࢆ㐣ࡈࡍࡓࡵ ࣐ࣘࢽࢳ࣮ࣗࢻࢆᑟධ AERA 2015 ᖺ 11 ᭶ 2 ᪥ྕ 28(47)㸸26-27ࠊᮅ᪥᪂⪺ฟ∧ࠊ2015.10.26 ― 154 ― ་⒪⤒Ⴀሗ◊✲ᐊ [ ㄽᩥ ] Nakatomi H, Miyazaki H, Tanaka M, Kin T, Yoshino M, Oyama H, Usami M, Moriyama H, Kojima H, Kaga K, Saito N Improved preservation of function during acoustic neuroma surgery Journal of Nuerosurgery 122(1):24-33, 2015.1 impact factor 3.227 Zhang Q, Xu X, Xu M, Hu J, Liang J, Kaga K Ocular and cervical vestibular evoked myogenic potentials in patients with peripheral vestibular disorders Journal of Clinical Otorhinolaryngology, Head & Neck Surgery (Chinese) 29(2):147-151, 2015.1 impact factor 0.00 Kaga K, Shinjo Y, Enomoto C, Sindo M A case of cortical deafness and loss of vestibular and somatosensory sensations caused by cerebrovascular lesions in bilateral primary auditory cortices, auditory radiations, and postcentral gyruses-complete loss of hearing despite normal DPOAE and ABR Acta Oto-Laryngologica 135(4):389-394, 2015.4 impact factor 1.099 Ọ㑈ᩯࠊ༡ಟྖ㑻ࠊ❶Ꮚࠊᴮᮏ༓ỤᏊࠊ⸨ṇேࠊຍᡃྩᏕ ┣⫏ࡢ㧗㱋⪅ᑐࡍࡿேᕤෆ⪥⾡ᚋࡢ⫈ぬ⋓ᚓ QOL ⪥㰯ဗႃ⛉࣭㢌㢕㒊እ⛉ 83(2):165-167, 2015.2 ❶Ꮚࠊ༡ಟྖ㑻ࠊỌ㑈ᩯࠊᯇỌ㐩㞝ࠊᴮᮏ༓ỤᏊࠊᆏ⏣ⱥ᫂ࠊ⸨ṇேࠊຍᡃྩᏕ Waardenburg ೃ⩌ 2 ᆺᑐࡍࡿேᕤෆ⪥ᇙࡵ㎸ࡳ⾡ᚋࡢ⫈ぬ࣭ゝㄒⓎ㐩 ⪥㰯ဗႃ⛉࣭㢌㢕㒊እ⛉ 83(2):173-175, 2015.2 [ ⥲ㄝ ] ຍᡃྩᏕ (୍㐌୍ㄒ)┣⫏㔜㞀ᐖᑐࡍࡿேᕤෆ⪥ᡭ⾡Ɇࡧ⪺࠸࡚ヰࡍ႐ࡧ ᪥ᮏ་᪂ሗ No.4734ࠊp53ࠊ2015.1 ຍᡃྩᏕ ࢫࢺࣞࢫࡣఱ㸽 JOHNS 31(3):269-271ࠊ2015.3 ― 155 ― ຍᡃྩᏕ ࢫ࣏࣮ࢶᖹ⾮ᶵ⬟㸦୕༙つ⟶࣭⪥▼ჾࡢᙺ㸧㹼ጼໃᑕ vs. 㝶ព㐠ື㹼 ᪥ᮏ⮫ᗋࢫ࣏࣮ࢶ་Ꮫㄅ 23(2):198-200ࠊ2015.4 ຍᡃྩᏕ ୰ᯡᛶ㢦㠃⚄⤒㯞⑷ࢆぢ㏨ࡉ࡞࠸ࢥࢶ JOHNS 31(6):711-715ࠊ2015.6 ຍᡃྩᏕ Auditory Neuropathy㸦ᡂேᆺ㸧ᑐࡍࡿேᕤෆ⪥ᡭ⾡ࡼࡿ⫈ぬࡢ⋓ᚓ ENTONI No.181㸸61-67ࠊ2015.6 ᴮᮏ༓ỤᏊࠊຍᡃྩᏕ ┣ࢁ࠺⪅ᑐࡍࡿேᕤෆ⪥ࡢࣜࣁࣅࣜࢸ࣮ࢩࣙࣥ ENTONI No.181㸸68-71ࠊ2015.6 ຍᡃྩᏕ AN ANSD JOHNS 31(11):1601-1606ࠊ2015.11 㐍⸨⨾ὠᏊࠊຍᡃྩᏕ ⫈ぬኻㄆ⓶㉁⫏ JOHNS 31(11):1607-1611ࠊ2015.11 ຍᡃྩᏕ ኻ㡢ᴦ⬻ࡢᒁᅾᛶ࠾ࡼࡧ㡢ᴦேᕤෆ⪥ JOHNS 31(11):1612-1618ࠊ2015.11 ຍᡃྩᏕࠊቑ⏣Ẏ ᑠඣࡢ๓ᗞᶵ⬟ࡢ㞀ᐖⓎ㐩Ɇඛኳᛶ㞴⫈ඣࡢ๓ᗞ༙つ⟶㞀ᐖࡢ㐠ືⓎ㐩ཬࡰࡍ ᙳ㡪ࡘ࠸࡚Ɇ ᑠඣ⪥㰯ဗႃ⛉ 36(3):251-258ࠊ2015.12 ຍᡃྩᏕ Sensory deprivation ࡋ࡚ࡢ⫈ぬ㞀ᐖɆேᕤෆ⪥ࡽぢࡓ⫈ぬࡢྍረᛶɆ ㄆ▱⚄⤒⛉Ꮫ 217(3,4):113-117ࠊ2015.12 ― 156 ― [ ⴭ᭩ ] ຍᡃྩᏕࠊ୰ᮧ㞞Ꮚ ⫈ぬࡢᶵ⬟పୗɆ㉸㧗㱋ᮇࡢ㞴⫈࠾ࡼࡧ┣⫏㔜㞀ᐖேᕤෆ⪥ 㧗㱋⪅ࡢᏳࡑࡢᑐ⟇Ɇ⤒῭࣭ᗣ࣭Ꮩ⊂ࠊpp.97-105 බ┈㈈ᅋἲே 㛗ᑑ⛉Ꮫ⯆㈈ᅋࠊ2015.3 ຍᡃྩᏕࠊᒣ୰᪼⦅ ࡉࡽ⪺ࡅ࡞࠸㸟ᑠඣࡢࡳࡳ࣭ࡣ࡞࣭ࡢデ⒪ Q&A. Ϩᕳ ᪥ᮏ㝔ฟ∧ 2015.4 ᒣ୰᪼ࠊຍᡃྩᏕ⦅ ࡉࡽ⪺ࡅ࡞࠸㸟ᑠඣࡢࡳࡳ࣭ࡣ࡞࣭ࡢデ⒪ Q&A. ϩᕳ ᪥ᮏ㝔ฟ∧ 2015.4 ຍᡃྩᏕ ➨ 15 ❶⪥㰯ဗႃ⛉ࣜࣁࣅࣜࢸ࣮ࢩࣙࣥ┳ㆤ 1.ඛኳᛶ㞴⫈ඣࡢࣜࣁࣅࣜࢸ࣮ࢩࣙࣥ ┳ㆤ ⪥㰯ဗႃ⛉࢚࢟ࢫࣃ࣮ࢺࢼ࣮ࢩࣥࢢ ᨵゞ➨ 2 ∧ࠊ᳃ᒣᐶ࣭ᑠᓥ༤ᕫ⦅ࠊpp.481-484ࠊ ༡Ụᇽࠊ2015 [ ᏛⓎ⾲ ] ຍᡃྩᏕࠊᯇỌ㐩㞝ࠊᮅᡞ⿱㈗ ୧ഃᑠ⪥㸦እ⪥ወᙧ㸧 ࣭እ⪥㐨㛢㙐 ᖹᡂ 26 ᖺᗘཌ⏕ປാ⛉Ꮫ◊✲㈝⿵ຓ㔠㞴ᛶᝈ➼ඞ᭹◊✲ᴗࠕ㞴ᛶ⫈ぬ㞀ᐖ 㛵ࡍࡿㄪᰝ◊✲⌜ࠖ◊✲ᡂᯝሗ࿌ࠊ2015.2.15 ရᕝ༊ ᮌᮧඃࠊቑ⏣ẎࠊຍᡃྩᏕ Cochlear nerve deficiency ࡢ 4 ࡢ㐠ືᶵ⬟Ⓨ㐩 ➨ 206 ᅇ᪥⪥㰯ᮾி㒔ᆅ᪉㒊ࠊ2015.3.14 ᪂ᐟ༊ Kitamura M, Minami S, Matsunaga T, Masuda T, Enomoto C, Kaga K Cochlear implantation in a patient with Adult-onset auditory neuropathy 10th Asia Pacific Symposium on Cochlear Implantࠊ2015.5.2 Beijing Enomoto C, Minami S, Kitamura M, Kaga K The efficacy of cochelar implantation and intraoperatvie measurement of NRT and EABR in deaf-blind subjects XXIV Biennial symposium of International Evoked Response Audiometry Study Groupࠊ2015.5.10-14, Busan ― 157 ― ຍᡃྩᏕࠊ༡ಟྖ㑻ࠊ᪂ṇ⏤⣖Ꮚ 㧗㱋┣⫏㔜㞀ᐖࡢ 1 ᑐࡍࡿ୧ഃேᕤෆ⪥ᡭ⾡ࡼࡿ QOL ࡢኚ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊ2015.5.21 ༓௦⏣༊ ᪂ṇ⏤⣖Ꮚࠊ༡ಟྖ㑻ࠊຍᡃྩᏕ Wolfram ೃ⩌ࡼࡿどぬ㞀ᐖྜేᑠඣࡢ୧ഃேᕤෆ⪥ᇙ㎸⾡ᚋࡢ QOL ࡢᨵၿ ࡘ࠸࡚ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊ2015.5.21 ༓௦⏣༊ ᮌᮧඃࠊቑ⏣ẎࠊຍᡃྩᏕ ෆ⪥ወᙧ Common cavity6 ࡢ㐠ືᶵ⬟Ⓨ㐩Ɇ୍᪉ྥῶ⾶ᅇ㌿᳔Ꮚ᳨ᰝࡼࡿ๓ᗞᶵ ⬟ࡢ㛵ಀࡘ࠸࡚Ɇ ➨ 208 ᅇ᪥⪥㰯ᮾி㒔ᆅ᪉㒊ࠊ2015.7.18 Kaga K, Asato H Sound lateraziation test in patients with unilateral microtia and atresia after reconstuction surgery of the auricle and external canal and fitting of a canal-tiyp hearing aids 2015 Annual CORLAS Meetingࠊ2015.8.25 San Francisco ෆᒣຮࠊᚨග⿱Ꮚࠊ㯮ᮌᏊࠊኳ㐨ᩥᏊࠊᴋᒃ⿱Ꮚࠊఀ㞟㝔ுᏊࠊຍᡃྩᏕ ேᕤෆ⪥⏝ඣࡢ᪩ᮇ⒪⫱ຠᯝࡘ࠸࡚ ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲ࠊ2015.10.23 ᪂ᐟ༊ ᮌᮧඃࠊቑ⏣Ẏࠊ༡ಟྖ㑻ࠊຍᡃྩᏕ Common cavityࠊcochlear nerve deficiency ࡢࣂࣛࣥࢫᶵ⬟Ⓨ㐩ࡢẚ㍑ ➨ 74 ᅇ᪥ᮏࡵࡲ࠸ᖹ⾮་Ꮫ⥲ࠊ2015.11.26 ᒱ㜧ᕷ [ ㅮ₇ ] ຍᡃྩᏕ ∦ഃᑠ⪥࣭እ⪥㐨㛢㙐⾡ᚋࡢ⿵⫈ჾ⏝ࡼࡿࠊ୧᪉ࡢ⪥࡛⫈ࡃ ➨ 10 ᅇ㟷✵ࡢࠊ➨㸷ᅇ TC ࡢࠊ2015.1.18 ༓௦⏣༊ ຍᡃྩᏕ ぬࢆឤࡌࡿ⯉ࡢⷣ⬻ࡢࡋࡃࡳ ᮾிಖ་⒪Ꮫୡ⏣㇂࢟ࣕࣥࣃࢫㅮ⩏ࠕ་⒪ᰤ㣴Ꮫᴫㄽϩࠖࠊ2015.1.20 ୡ⏣㇂༊ ຍᡃྩᏕ ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢࠊᚋ㏞㊰ᛶ㞴⫈ࡢ᳨ᰝɆ୰ᯡᛶ⫈ぬ㞀ᐖࡢᫎീ⤂ ᖹᡂ 27 ᖺᗘ⫈ຊ ᐃᢏ⾡ㅮ⩦ ➨ 19 ᅇ⫈ぬ་Ꮫ࣭་ᖌㅮ⩦ 2015.2.13 ရᕝ༊ ― 158 ― ຍᡃྩᏕ ୰ᯡ⫈ぬࡢࡋࡃࡳ⫈ぬㄆ▱㞀ᐖ ⟃ἼᏛᏛ㝔ே㛫⥲ྜ⛉Ꮫ◊✲⛉ ឤᛶㄆ▱⬻⛉Ꮫᑓᨷࠕឤᛶㄆ▱⬻⛉Ꮫᇶ♏ㄽ 2ࠖ 2015.2.20 ࡘࡃࡤᕷ ຍᡃྩᏕ AN ANSD ࡢ⣽ศ㢮 ᖹᡂ 26 ᖺᗘཌ⏕ປാ⛉Ꮫ◊✲ጤク㈝㞀ᐖ⪅ᑐ⟇⥲ྜ◊✲㛤Ⓨጤク㈝㸦ឤぬჾ㞀ᐖศ 㔝㸧ࠕ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢ࠾ࡅࡿ Auditory Neuropathy Spectrum Disorders ࡢ㛗ᮇ㏣㊧◊✲ࠖ⌜ ⌜㆟ 2015.3.1ࠊ┠㯮༊ ຍᡃྩᏕࠊቑ⏣Ẏࠊᮌᮧඃࠊ⸆ᖌ௧Ꮚࠊ୰ᮧ㞞Ꮚ ୰ᅜࡢྎ㐃ࡽࡁࡓ AN ࡢ୰Ꮫ 1 ᖺ⏕ዪᏊ ᖹᡂ 26 ᖺᗘཌ⏕ປാ⛉Ꮫ◊✲ጤク㈝㞀ᐖ⪅ᑐ⟇⥲ྜ◊✲㛤Ⓨጤク㈝㸦ឤぬჾ㞀ᐖศ 㔝㸧ࠕ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢ࠾ࡅࡿ Auditory Neuropathy Spectrum Disorders ࡢ㛗ᮇ㏣㊧◊✲ࠖ⌜㆟ 2015.3.1ࠊ┠㯮༊ ຍᡃྩᏕ 80㹼90 ṓ௦ࡢேᕤෆ⪥ࡼࡿ⫈ぬࡢ⋓ᚓ ཌປ┬⛉Ꮫ◊✲㈝⿵ຓ㔠㞀ᐖ⪅ᑐ⟇⥲ྜ◊✲ᴗ◊✲ᡂᯝⓎ⾲㸦୍⯡ྥࡅ㸧 ➨ 10 ᅇᕷẸබ㛤ㅮᗙ㸦⫈ぬ㞀ᐖࢩ࣮ࣜࢬ㸧ᗂᑠඣᡂே㧗㱋⪅ࡢ㞴⫈ேᕤෆ⪥ࡢ᪂ ࡋ࠸ືࡁ 2015.3.27ࠊ┠㯮༊ Kaga K, Masuda T, Minami S Significant of rotational chair vestibular test for pediatric cochlear implant candidates 10th Asia Pacific Symposium on Cochlear Implant 2015.5.2ࠊBeijing ຍᡃྩᏕ ᩍ⫱ࢭ࣑ࢼ࣮4㸬ᑠඣࡢ๓ᗞᶵ⬟ࡢ㞀ᐖⓎ㐩Ɇඛኳᛶ㞴⫈ඣࡢ๓ᗞ༙つ⟶㞀ᐖࡢ㐠ື Ⓨ㐩ཬࡰࡍᙳ㡪 ➨ 10 ᅇ᪥ᮏᑠඣ⪥㰯ဗႃ⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ 2015.5.8ࠊ㍍ἑ ຍᡃྩᏕ ࢃࡀᅜࡢ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢࡢගᙳɆㅖእᅜࡢẚ㍑Ɇ ᮾி་⒪ಖᏛ 㧗ᗘᐇ㊶┳ㆤࢥ࣮ࢫ ࠕᨻ⟇་⒪≉ㄽࠖ 2015.5.22ࠊ┠㯮༊ ຍᡃྩᏕ ேᕤෆ⪥ࡀྲྀࡾᡠࡍ⫈ぬࡢୡ⏺Ɇᗂඣ㧗㱋⪅Ɇ ᮾிᏛᕤᏛ㒊 Ꮫ㒊 4 ᖺ⏕࣭Ꮫ㝔⏕ྥㅮ⩏ࠕ㔞Ꮚㄽ㸭⏕ㄽࠖ 2014.6.12ࠊᩥி༊ ― 159 ― ຍᡃྩᏕ ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢ⌧ᅾࡢၥ㢟ㄢ㢟 ➨ 60 ᅇឡ▱┴⪥㰯ဗႃ⛉་◊ಟ㸦ឡ▱┴⪥㰯ဗႃ⛉་ᖹᡂ 27 ᖺᗘ◊ಟ㸧 2015.6.20ࠊྡྂᒇᕷ ຍᡃྩᏕ ≉ูㅮ₇㸬Sensory Deprivation ࡋ࡚ࡢ⫈ぬ㞀ᐖɆேᕤෆ⪥ࡽࡳࡓ⫈ぬࡢྍረᛶ ࠾ࡼࡧ⓶㉁⫏ࡘ࠸࡚ ➨ 20 ᅇㄆ▱⚄⤒⛉ᏛᏛ⾡ㅮ₇ 2015.8.8ࠊᩥி༊ ຍᡃྩᏕ ேᕤෆ⪥ᡭ⾡ࡼࡗ࡚ඞ᭹ࡉࢀࡓඛኳᛶ㞴⫈ᚋኳᛶ㞴⫈ 㣁⏣་ᏛዡᏛࠕ10 ᭶ࡢ㞟࠸ࠖ2015.10.3ࠊᩥி༊ ຍᡃྩᏕ ୧⪥⫈ɆDirectional HearingɆ ➨ 2 ᅇᅜゝㄒ⫈ぬኈ◊ಟ 2015.11.22ࠊ⦎㤿༊ ຍᡃྩᏕ ⥴᪉ὥᗡࡢỤᡞ࡛ࡢᐈṚ࠾ࡼࡧຍ⸨ᩍᤵࡢ 1910㹼1912 ࣮࢘ࣥ␃Ꮫࡑࡢά㌍ࢆ ࡵࡄࡗ࡚ ➨ 84 ᅇཧ㸦㜰Ꮫ⪥㰯ဗႃ⛉࣭㢌እ⛉Ꮫᩍᐊ㸧⥲ 2015.11.28ࠊ㜰ᕷ Kaga K (Keynote Lecture) Historical development of Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery 13th Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery 2015.12.3ࠊTokyo [ࡑࡢ] ຍᡃྩᏕ 㸦ྖ㸧⫈ぬ㞀ᐖ࠾ࡅࡿཎᅉ㑇ఏᏊࡢ᪂ࡓ࡞ᒎ㛤 ➨ 10 ᅇឤぬჾࢩ࣏ࣥࢪ࣒࢘ 2015.3.6ࠊ┠㯮༊ Kaga K (Moderator) Changes in cortical resource allocation in hearing loss XXIV Biennial Symposium of International Evoked Response Auditory Study Group 2015.5.13ࠊBusan ― 160 ― Kaga K (Modrator) Round Table 26: Auditory neuropathy and cochlear nerve dificiency The 30th Politzer Society Meeting 2015.7.3ࠊNiigata ― 161 ― ⮫ᗋ◊✲࣭㦂᥎㐍ᐊ [ ㄽᩥ ] Yajima.A㸪Uesawa.Y㸪Ogawa.C㸪Yatabe.M㸪Kondo.N㸪Saito.S㸪Suzuki.Y,Atsuda.K.㸪 Kagaya.H Construction Of a Model for Predicting Creatinine Clearance in Japanese Patients Treated with Cisplatin Therapy ANTICANCER RESEARCH㸹35㸸2904-2915㸪2015.5 impact factor 1.604 ᭷㤿 ⚽ᶞ㸪㏆⸨ ┤ᶞ㸪⏣ᓮ ṇಙ㸪ᑎඖ ๛㸪Ỉ ㈗モ㸪Ώ㑓 㐩ஓ ་⸆ရࣜࢫࢡ⟶⌮ィ⏬ྥࡅࡓ㝔⸆ᖌࡢ〇㐀㈍ᚋㄪᰝᨭ㛵ࡍࡿ᳨ウ Journal of Japanese Society of Hospital Pharmacists㸦᪥ᮏ㝔⸆ᖌ㞧ㄅ㸧㸹 51(10)㸸1163-1168㸪2015.10 ࣥࣃࢡࢺࣇࢡࢱ࣮ 0.00 [ ⥲ㄝ ] ➉ୗ ᬛᜨ㸪┠㯮 ᩥỤ㸪୰ᑿ ㈗Ꮚ㸪ᯇ ࠸࡙ࡳ㸪⩚⏣ ࠾ࡿ㸪ྜྷ ୍ᜨ㸪⋪㡲 ࡉࡘ ࡁ㸪ஂ㒊 ὒᏊ㸬 Clinical Research Coordinator㸦CRC㸧ࡢ࢟ࣕࣜ㛤Ⓨࡴࡅ࡚ࡢ⌧≧ㄢ㢟㸫ࡸࡾ ࡀ࠸➼ࡢព㆑ㄪᰝ⤖ᯝࡼࡾ ⸆⌮⒪㸹43(1)㸸17-20㸬 ࣥࣃࢡࢺࣇࢡࢱ࣮ 0.00 ୰ᕝ ⏤⨾ ࠕ➨ 35 ᅇ ᪥ᮏ⮫ᗋ⸆⌮ᏛᏛ⾡⥲ࠖཧຍࡋ࡚㹼ࠕ➨ 3 ḟᆏࡢୖࡢ㞼ࠖ㸪◊✲ ⌮ᣦ㔪ࡢᨵṇ➼㸪㦂ࡢຠ⋡ྥୖࣉࣟࢪ࢙ࢡࢺ Clinical Research Professionals㸹46㸸34-37 ✄ྜྷ ⨾⏤⣖ ACRP 2015 Global Conference ࠾ࡼࡧ⌧ᆅ་⒪ᶵ㛵どᐹձࠕCAPA ࡢᡭἲࢆ⏝࠸ࡓ㐓 ⬺Ⓨ㜵Ṇྥࡅࡓྲྀࡾ⤌ࡳࠖ Clinical Research Professionals㸹48㸸28-29 ✄ྜྷ⨾⏤⣖ ࠕᅜ㝿ඹྠ㦂ࡢ⌧≧ᐇ㝿ࡍࡿὀពⅬࠖ Ᏻᚰฎ᪉ infobox㸦http://anshinshoho.ims-japan.co.jp/㸧ࠖ㸹100㸪2015.7 ࣥࣃࢡࢺࣇࢡࢱ࣮ 0.00 ― 162 ― ㏆⸨ ┤ᶞ ࠕேࢆᑐ㇟ࡍࡿ་Ꮫ⣔◊✲㛵ࡍࡿ⌮ᣦ㔪ࠖࡢゎㄝ ⸆᪂ሗ; 2901(2015):817-823㸪2015.7 ࣥࣃࢡࢺࣇࢡࢱ࣮ 0.00 ㏆⸨ ┤ᶞ㸪ᒣཱྀ ᣅὒ ◊✲⪅ᑟ⮫ᗋヨ㦂ࡢ㉁ࡢྥୖࡢࣉ࣮ࣟࢳ㸫⮫ᗋ◊✲ࡢಙ㢗ᛶ☜ಖࡢྲྀࡾ⤌ࡳ ࠕ⏬ࡢពᅗࡲࡵࠖ Jpn Pharmacol Ther㸦⸆⌮⒪㸧㸹43(8)㸸1084㸪2015.8 ࣥࣃࢡࢺࣇࢡࢱ࣮ 0.00 ㏆⸨ ┤ᶞ ࠗ㦂ಀࡿ ಖ㝤እే⏝⒪㣴㈝ ゎㄝ Q㸤A࠘ Journal of Japanese Society of Hospital Pharmacists㸦᪥ᮏ㝔⸆ᖌ㞧ㄅ㸧㸹 51(11)㸸1359㸪2015.11 ࣥࣃࢡࢺࣇࢡࢱ࣮ 0.00 ㏆⸨ ┤ᶞ ࠕேࢆᑐ㇟ࡍࡿ་Ꮫ⣔◊✲㛵ࡍࡿ⌮ᣦ㔪ࠖࡢ࣏ࣥࢺ␃ពⅬɆ⮫ᗋ◊✲ ົᒁࡋ࡚ࡢ❧ሙࡽɆ㸬Clinical Research Professionals㸹50㸸4-11㸪2015.10 ࣥࣃࢡࢺࣇࢡࢱ࣮ 0.00 ➉ୗ ᬛᜨ ➨ 15 ᅇ CRC ⮫ᗋヨ㦂ࡢ࠶ࡾ᪉ࢆ⪃࠼ࡿ㆟ 2015ࠖཧຍࡋ࡚ Clinical Research Professionals㸹51㸸6-7㸪2015.12 ࣥࣃࢡࢺࣇࢡࢱ࣮ 0.00 [ ⴭ᭩ ] ఀ⸨ ᙪ㸪ᴋᒸ ⱥ㞝㸪㏆⸨ ┤ᶞ㸪ᒣᮏ ὒ୍㸪ఀ⸨ ಙ㸪ᒣᮏ Ꮫ㸪ⱝ ಟ㸪᳃ୗ Ꮚ㸪✄ྜྷ⨾⏤⣖㸪ᕝᮧ 㝧Ꮚ㸪ᱵᰁ ⣫⨾㸪Ặཎ ῟㸪᭷ἑ ⣖Ꮚ㸬 ⮫ᗋ◊✲࣭㦂άᛶ㸳ᖺィ⏬ 2012 ࡢホ౯ྥࡅࡓ㦂࣭⮫ᗋ◊✲ᇶ┙ᩚഛ≧ ἣㄪᰝࡢෆᐜ᳨ウ⤖ᯝ㞟ィ࣭ホ౯ ᖹᡂ 26 ᖺᗘཌ⏕ປാ⛉Ꮫ◊✲ሗ࿌᭩㸬2015.4 [ ᏛⓎ⾲ ] Miyuki Inayoshi Implementing CRC education system using Corrective and Preventative Actions 㸦CAPA㸧 System on site ACRP 2015 Global Conference & Exhibition, Salt Lake City, 20150425 ― 163 ― ᐑᮏ ಇ୍ࠊ㏆⸨ ┤ᶞࠊ⃰ ᨻ⨾ࠊᯇᔱ⏤⣖Ꮚࠊ㔝ᮧ ஂ⚈ࠊᒣᓮ୕బᏊࠊΏ㒊 ḷ⧊ࠊ ஂಖ⏣⠜ྖࠊ ᴮᮏ᭷ᕼᏊ ᮾி㒔㝔⸆ᖌ⮫ᗋ◊✲ᑓ㛛⸆ᖌ㣴ᡂ≉ูጤဨࡢάືሗ࿌㸦3 ሗ㸧㸬᪥ᮏ㝔 ⸆ᖌ㛵ᮾࣈࣟࢵࢡ➨ 45 ᅇᏛ⾡㸪ࡘࡃࡤ㸪2015.8.1㸬 ✄ྜྷ ⨾⏤⣖㸪ᮏ ஂ⨾Ꮚ㸪ᔱᒸ ⥳㸪⸨ᕝ Ꮚ㸪㧗ᮌ ᜨ⨾㸪➉ୗ ᬛᜨ㸪▼ 㔛㸪 㔠ග ❶Ụ㸪୰ᕝ ⏤⨾㸪㏆⸨ ┤ᶞ Corrective and Preventative Action(CAPA)ࡼࡿ㐓⬺㜵Ṇࡢྲྀࡾ⤌ࡳ ➨ 15 ᅇ CRC ⮫ᗋヨ㦂ࡢ࠶ࡾ᪉ࢆ⪃࠼ࡿ㆟㸪⚄ᡞ㸪2015.9.13㸬 ㏆⸨ ┤ᶞ㸪ᶫ 㣴㈼㸪㧗ᶫ 㒓㸪㔝ᮧ ஂ⚈㸪ኴ⏣ ㈗ὒ㸪㉥ᮌ ♸㈗㸪ᕝᓮ ᩄඞ㸪 ஂಖ⏣ ⠜ྖ㸪ᒣཱྀ ᣅὒ㸪⃰ ᨻ⨾㸪ᶓᡭ ಙ㸪బᶫ ᖾᏊ㸪㰺⸨ ┿୍㑻 ⮫ᗋ◊✲᥎㐍ྥࡅࡓ㛵ಙᆅ༊ᅜ❧㝔⸆ᖌࡢྲྀ⤌ࡳࡘ࠸࡚㹼➨ 2 ሗ㹼 ➨ 69 ᅇᅜ❧㝔⥲ྜ་Ꮫ㸪ᮐᖠ㸪2015.10.1㸬 㧗ᮌ ᜨ⨾㸪⸨ᕝ Ꮚ㸪➉ୗ ᬛᜨ㸪ඵ௦ ᬛᏊ㸪✄ྜྷ ⨾⏤⣖㸪㔠ග ❶Ụ㸪୰ᕝ ⏤⨾㸪 ᮏ ஂ⨾Ꮚ㸪ᔱᒸ ⥳㸪㏆⸨ ┤ᶞ㸪ᾏ Ꮫ㸪༓⏣ ᫀஅ㸪ஂಖ⏣ ⠜ྖ㸪㇂ᆅ ㇏㸪 㕥ᮌ ⩏ᙪ㸪ᵻᒣ ᖾᙪ First-in-human ➨Ϩ┦་ᖌᑟ㦂ࡢᐇࢆ㏻ࡋ࡚ࡢホ౯⪃ᐹ ➨ 69 ᅇᅜ❧㝔⥲ྜ་Ꮫ㸪ᮐᖠ㸪2015.10.2㸬 ᭷㤿 ⚽ᶞ㸪㏆⸨ ┤ᶞ㸪㏆⸨ ᬛᏊ㸪⏣ᓮ ṇಙ㸪ᑎඖ ๛㸪Ỉ ㈗モ㸪Ώ㑓 㐩ஓ ་⸆ရࣜࢫࢡ⟶⌮ィ⏬ྥࡅࡓ㝔⸆ᖌࡢ〇㐀㈍ᚋㄪᰝᨭ㛵ࡍࡿ᳨ウ ᖹᡂ 27 ᖺᗘ᪥ᮏ㝔⸆ᖌ㝔⸆ᒁ༠㆟㸭Ꮫ⾡ࣇ࢛࣮࣒ࣛ㸪ᶓ㸪2015.11.22 ✄ྜྷ⨾⏤⣖, ᚋ⸨⨾✑, ῝ᕝᜨ⨾Ꮚ Portfolio ᐇ⏝∧ࡢసᡂ Ɇᶆ‽࣒࢝ࣜ࢟ࣗࣛᇶ࡙࠸ࡓホ౯ࢶ࣮ࣝࢆ᳨ウɆ ➨ 36 ᅇ ᪥ᮏ⮫ᗋ⸆⌮ᏛᏛ⾡⥲, ᮾி, 2015.12.10 [ ㅮ₇ ] ㏆⸨ ┤ᶞ 㦂࣭⮫ᗋ◊✲ᚲせ࡞▱㆑ࢆ⸆ᖌࡢᢏ⬟ྥୖ࠺ᒎ㛤ࡍࡿ㸽 ᖹᡂ 26 ᖺᗘᕞᆅ༊ᅜ❧㝔⸆ᖌࢫ࢟ࣝࢵࣉ◊ಟ㸪༤ከ㸪2015.2.21㸬 ✄ྜྷ ⨾⏤⣖ ᅜ㝿ඹྠ㦂ࡢ⌧≧ᐇࡢ␃ពⅬ ᪥ᮏ㝔⸆ᖌദ ➨ 17 ᅇ CRC 㣴ᡂࣇ࢛࣮ࣟࢵࣉ◊ಟࣉࣟࢢ࣒ࣛ㸪ᮾி㸬 2015.3.7 ― 164 ― ✄ྜྷ⨾⏤⣖ ◊✲ࢆᨭࡍࡿࡇࡢᮏ㉁ ⮫ᗋ◊✲ࣥࢸࣥࢩࣈࣇ࢙࣮ࣟࢩࢵࣉ࢟ࢵࢡ࢜ࣇࢩ࣏ࣥࢪ࣒࢘㸪Ἀ⦖㸪2015.5.8 ᒣཱྀ ᣅὒ㸪㏆⸨ ┤ᶞ ࡀࢇ⮫ᗋヨ㦂 ⮫ᗋ◊✲ࣥࢸࣥࢩࣈࣇ࢙࣮ࣟࢩࢵࣉ㸪Ἀ⦖㸪2015.5.10 ㏆⸨ ┤ᶞ ࠕேࢆᑐ㇟ࡍࡿ་Ꮫ⣔◊✲㛵ࡍࡿ⌮ᣦ㔪ࠖᑐᛂࡢ࣏ࣥࢺ ᐩኈᕷ❧୰ኸ㝔⌮ጤဨㅮ₇㸪㟼ᒸ㸪2015.5.21 ㏆⸨ ┤ᶞ ࠕேࢆᑐ㇟ࡍࡿ་Ꮫ⣔◊✲㛵ࡍࡿ⌮ᣦ㔪ࠖᑐᛂࡢ࣏ࣥࢺ ᮾி㒔㝔⸆ᖌ➨㸯ᅇ⮫ᗋ◊✲ᑓ㛛⸆ᖌ㣴ᡂ◊✲㸪ᮾி㸪2015.5.22 ✄ྜྷ⨾⏤⣖ CRC ᴗົࡢᐇ㝿㸦᭷ᐖ㇟ᑐࡍࡿᑐᛂ㸧 ᅜ❧㝔ᶵᵓᮏ㒊ദᖹᡂ 27 ᖺᗘึ⣭⪅⮫ᗋ◊✲ࢥ࣮ࢹࢿ࣮ࢱ࣮㣴ᡂ◊ಟ㸪ᮾி㸪 2015.5.28 ⸨ᕝ Ꮚ CRC ᴗົࡢᐇ㝿㸦᭷ຠᛶཬࡧᏳᛶࡢホ౯⏝࠸ࡿ᳨ᰝᶵჾ➼ࡢ⢭ᗘ⟶⌮ࠊ ᳨ᰝࢹ࣮ࢱࡢ㉁ࢆᢸಖࡍࡿ᪉ἲ㸧 ᅜ❧㝔ᶵᵓᮏ㒊ദᖹᡂ 27 ᖺᗘึ⣭⪅⮫ᗋ◊✲ࢥ࣮ࢹࢿ࣮ࢱ࣮㣴ᡂ◊ಟ㸪ᮾி㸪 2015.5.28 ㏆⸨ ┤ᶞ ᅜ❧㝔ᶵᵓࡢ⮫ᗋ◊✲㦂ࡢ⌧≧ᚋ㸬 CRO ◊ಟ㸪ᮾி㸬2015.5.28 ㏆⸨ ┤ᶞ 㦂ᑂᰝጤဨࡢᙺᶵ⬟ ᖹᡂ 27 ᖺᗘᅜබ⚾❧Ꮫ㝔་⒪ᢏ⾡㛵ಀ⫋ဨ◊ಟ㸪ᮾி㸪2015.6.24 ㏆⸨ ┤ᶞ ேࢆᑐ㇟ࡍࡿ་Ꮫ⣔◊✲㛵ࡍࡿ⌮ᣦ㔪ࠖᨵṇࡢ࣏ࣥࢺ㸬 ᮾி㒔㝔⸆ᖌ◊✲ึᚰ⪅ࡢࡓࡵࡢ⤫ྜ◊✲⌮ᣦ㔪㛵ࡍࡿ◊ಟ㸪ᮾி㸬 2015.7.25 ― 165 ― ㏆⸨ ┤ᶞ ⮫ᗋ◊✲ᚲせ࡞▱㆑ࢆ⌮ゎࡍࡿࡓࡵ㹼ࠕேࢆᑐ㇟ࡍࡿ་Ꮫ⣔◊✲㛵ࡍࡿ⌮ ᣦ㔪ࠖࢆࡩࡲ࠼࡚㹼㸬 ☬⏣ᕷ❧⥲ྜ㝔⮫ᗋ◊✲◊ಟ㸪㟼ᒸ㸬2015.7.30 ㏆⸨ ┤ᶞ 㦂ᑂᰝጤဨࡢᙺᶵ⬟ ᪥ᮏ㝔⸆ᖌദ➨ 18 ᅇ CRC 㣴ᡂ◊ಟ㸪ᮾி㸪2015.9.2 ㏆⸨ ┤ᶞ ⮫ᗋ◊✲ᚲせ࡞ไᗘ࣭ᡭ⥆ࡁࡣ ᮾி་⛉ṑ⛉Ꮫ➨ 46 ᅇᏛ㝔ࢭ࣑ࢼ࣮㸪ᮾி㸪2015.9.17 [ࡑࡢ] ㏆⸨┤ᶞ 㸦ᗙ㛗㸧CRC ࡀᐇ㊶ࡍࡁ Site Management ࡣ㸽 ➨ 15 ᅇ CRC ⮫ᗋヨ㦂ࡢ࠶ࡾ᪉ࢆ⪃࠼ࡿ㆟ 2015 ࠊ⚄ᡞࠊ2015.9.12 ✄ྜྷ⨾⏤⣖ 㸦ᗙ㛗࣭₇⪅㸧ࢡࣜࢽ࢝ࣝࢡ࢚ࢵࢩࣙࣥࡽࣜࢧ࣮ࢳࢡ࢚ࢵࢩࣙࣥࠊ◊✲ィ⏬ࡽ 㐺ษ࡞ࢹ࣮ࢱࢭࢵࢺゎᯒ㸬CRC ࡋ࡚ࡢ⮫ᗋ◊✲ࡢ㛵ࢃࡾ ➨ 36 ᅇ ᪥ᮏ⮫ᗋ⸆⌮ᏛᏛ⾡⥲, ᮾி, 2015.12.09 ― 166 ― 㻌 㻌 㻌 㻌 どぬ◊✲㒊㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 どぬ◊✲㒊 1. ⱥᩥㄽᩥ Fujinami K, Zernant J, Chana RK, Wright GA, Tsunoda K, Ozawa Y, Tsubota K, Robson AG, Holder GE, Allikmets R, Michaelides M, Moore AT. Clinical and molecular characteristics of childhood-onset Stargardt disease. Ophthalmology. 2015 Feb;122(2):326-34. 3.732 Kuniyoshi K, Ikeo K, Sakuramoto H, Furuno M, Yoshitake K, Hatsukawa Y, Nakao A, Tsunoda K, Kusaka S, Shimomura Y, Iwata T. Novel nonsense and splice site mutations in CRB1 gene in two Japanese patients with early-onset retinal dystrophy. Doc Ophthalmol. 2015 Feb;130(1):49-55. 0.832 Kato Y, Tsunoda K, Fujinami K, Iwata T, Saga M, Oguchi Y. Association of Retinal Artery and Other Inner Retinal Structures With Distribution of Tapetal-like Reflex in Oguchi's Disease. Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2162-72. 1.840 1.840 Yamane M, Ogawa Y, Fukui M, Kamoi M, Saijo-Ban Y, Yaguchi S, Mukai S, Kawakita T, Simmura S, Tsubota K. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. Optom Vis Sci. 2015 Apr;92(4 Suppl 1):S25-32. 0.671 Kato Y, Tsunoda K, Fujinami K, Iwata T, Saga M, Oguchi Y. Association of Retinal Artery and Other Inner Retinal Structures With Distribution of Tapetal-like Reflex in Oguchi's Disease. Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2162-72. 1.840 Miyake Y, Tsunoda K. Occult macular dystrophy. Jpn J Ophthalmol. 2015 Mar;59(2):71-80. 1.058 ― 167 ― Katagiri S, Hayashi T, Yoshitake K, Sergeev Y, Akahori M, Furuno M, Nishino J, Ikeo K, Tsunoda K, Tsuneoka H, Iwata T. Congenital Achromatopsia and Macular Atrophy Caused by a Novel Recessive PDE6C Mutation (p.E591K). Ophthalmic Genet. 2015 Jun;36(2):137-44. 0.600 Kuniyoshi K, Sakuramoto H, Yoshitake K, Ikeo K, Furuno M, Tsunoda K, Kusaka S, Shimomura Y, Iwata T. Reduced rod electroretinograms in carrier parents of two Japanese siblings with autosomal recessive retinitis pigmentosa associated with PDE6B gene mutations. Doc Ophthalmol. 2015 Aug;131(1):71-9. 0.832 Mizuno M, Fujinami K, Watanabe K, Akiyama K. Macular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage. Case Rep Ophthalmol. 2015 Sep 15;6(3):328-32 Fukui M, Ogawa Y, Shimmura S, Hatou S, Ichihashi Y, Yaguchi S, Hirayama M, Kawakita T, Tsubota K. Possible involvement of epithelial-mesenchymal transition in fibrosis associated with IgG4-related Mikulicz's disease. Mod Rheumatol. 2015 Sep;25(5):737-43. Nakamura N, Akiyama K, Shigeyasu C, Yamada M. Surgical repair of orbital fat prolapse by conjunctival fixation to the sclera. Clin Ophthalmol. 2015 Sep 18;9:1741-4. 0.661 Nakanishi A, Ueno S, Kawano K, Ito Y, Kominami T, Yasuda S, Kondo M, Tsunoda K, Iwata T, Terasaki H. Pathologic Changes of Cone Photoreceptors in Eyes With Occult Macular Dystrophy. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7243-9. 1.840 ― 168 ― Kaido M, Kawashima M, Yokoi N, Fukui M, Ichihashi Y, Kato H, Yamatsuji M, Nishida M, Fukagawa K, Kinoshita S, Tsubota K. Advanced dry eye screening for visual display terminal workers using functional visual acuity measurement: the Moriguchi study. Br J Ophthalmol. 2015 Nov;99(11):1488-92. 1.532 Otake K, Azukizawa S, Takeda S, Fukui M, Kawahara A, Kitao T, Shirahase H. Novel 2,7-Substituted (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids: Peroxisome Proliferator-Activated Receptor DŽ Partial Agonists with Protein-Tyrosine Phosphatase 1B Inhibition. Chem Pharm Bull (Tokyo). 2015;63(12):998-1014. Iida K, Ohkuma Y, Hayashi T, Katagiri S, Fujita T, Tsunoda K, Matsuura T, Yamada H, Tsuneoka H. A novel splice site OPA1 mutation causes exon 10 skipping in Japanese patients with dominant optic atrophy. Ophthalmic Genet. In press. 0.600 Kuniyoshi K, Muraki S, Ueyama H, Toyoda F, Sakuramoto H, Ogita H, Irifune M, Nakao A, Yamamoto S, Tsunoda K, Iwata T, Ohji M, Shimomura Y. Novel mutations in the gene for ǂ-subunit of retinal cone cyclic nucleotide-gated channels in a Japanese patient with congenital achromatopsia. Jpn J Ophthalmol. In press. 2. ᩥㄽᩥ 3. ⴭ᭩࣭⥲ㄝ ゅ⏣⦾ ࠙Diagnosticsࠚ⮬Ⓨ⺯ගࡼࡿ║ᗏほᐹ 㑇ఏᛶ⥙⭷ᝈ ║⛉ࢢࣛࣇࢵࢡ 4(2): 140-147, 2015. ▼⏣ࠊᑠἑὒᏊࠊ㏆⸨ᓠ⏕ࠊ୰⃝ᚭࠊᖹぢᜤᙪࠊ⸨ἼⰾࠊᏳᕝຊࠊᒣᇛඣ㸬 ᗙㄯ ⥙⭷◊✲࣭デ⒪ࡢᮍ᮶ணᅗ Retina Medicine 4(1): 1 -9 2015 ― 169 ― ⸨Ἴⰾ ≉㞟㸸⥙⭷ศ㔝ࡢᮍ᮶ணᅗ ⥙⭷㟁Ẽ⏕⌮Ꮫࡢᮍ᮶ணᅗ Retina Medicine 4(1): 38 -49 2015. ⸨Ἴⰾ ◪Ꮚయ࣭⥙⭷ኚࡢデࡓ㸫⚾ࡣࡇ࠺デࡿ㸫/ 3.ᡤぢែ 3) Stargardt ║⛉ 57(4):624-640, 2015. ⸨Ἴⰾ ◪Ꮚయ࣭⥙⭷ኚࡢデࡓ㸫⚾ࡣࡇ࠺デࡿ㸫/ 1.≧㚷ูデ᩿ 5)⩈ ᝈ ║⛉ 57(4):575-584, 2015. ⚟ṇᶞ ゅ⭷⛣᳜ᚋࡢ Phakic IOL ࠶ࡓࡽࡋ࠸║⛉ࠊ32 (5): 669-670, 2015. ゅ⏣⦾ ࢜࢝ࣝࢺ㯤ᩬࢪࢫࢺࣟࣇ㸦୕Ꮿ㸧 ║⛉་ࡢᡭᘬࡁ ᪥ᮏࡢ║⛉ 86 (8), 48-49, 2015 ゅ⏣⦾ ࠕ║ᗏ⮬Ⓨ⺯ගࡼࡿ⥙⭷ᝈࡢデ᩿ࠖ ᮾி㒔║⛉་ሗ 233:2-10, 2015 ゅ⏣⦾ ༸㯤ᵝ㯤ᩬࢪࢫࢺࣟࣇ ║⛉ 57 (4): 641-645, 2015 ⸨Ἴ ⰾ ⤖ᯝࡢぢࡓղ ᒁᡤ ERG ║⛉ࢣ 17(11):47-56, 2015 Ώ㎶ࠊゅ⏣⦾ 16㸬ගᖸ΅᩿ᒙィ 2) ᚋ║㒊 OCT յ⥙⭷⳼ⷧ ║⛉᳨ᰝ࢞ࢻ➨ 2 ∧㸦In press㸧 ― 170 ― ࣭᫂┣ࡢ㚷ู 4. ᏛⓎ⾲ 㸺ᅜ㝿ᏛⓎ⾲㸼 ARVO annual meeting 2015 (The Association for Research in Vision and Ophthalmology), Denver, Colorado, USA, 3rd to 7th, May, 2015 Fujinami K, Hayashi T, Kuniyoshi K, Kondo M, Ueno S, Shinoda K, Tsubota K, Miyake Y, Tsunoda K, Iwata T. Japan Whole Exome Project for Inherited Retinal Diseases 2014 Sasaki M, Kato Y, Hirakata T, Fujinami K, Tsunoda K, Watanabe K, Akiyama K, Noda T. Value of quantitative changes in pigment epithelial detachments predictive of recurrent exudative age-related macular degeneration. Segreev Y, Pogrebniak K, Fujinami K, Falsini B, Zein WM, Goetz KE, Jayasundera T, Michaelides M, Brooks BP, Sieving PA Stargardt ABCA4 muration analysis in trans-membrane and nucleotide-binding domain Fakin A, Robson AG, Holder GE, Fujinami K, Allikmets R, Zernant J, Moore AT, Michaelides M, Webster AR. Phenotype and progression of retinal degeneration in patients nullizygous for ABCA4. ISCEV symposium 2015 (International Society for Clinical Electrophysiology of Vision), Ljubljana, Slovenia, 22nd-27th, July, 2015 Tamaki S, Nakamura N, Mizuno Y, Noda T, Fujinami K, Tsunoda K. ‘Screening of cone dysfunction by a handheld ERG device, RETevalTM.’ Hata M, Fujinami K, Iwata T, Noda T, Tsunoda K. Clinical and genetic characteristics of a Japanese family with autosomal dominant retinitis pigments. Akiyama K, Fujinami K, Watanabe K, Nakamura N, Noda T, Miyake Y, Tsunoda K. ― 171 ― Inner retinal macular dysfunction in patients with ‘macula-on’ rhegmatogenous retinal detachment. Fujinami K, Hayashi T, Kuniyoshi K, Kondo M, Ueno S, Shinoda K, Tsubota K, Miyake Y, Tsunoda K, Iwata T. Japan whole exome project for inherited retinal diseases 2014 Fakin A, Robson AG, Fujinami K, Moore AT, Webster AR, Michaelides M, Holder GE. Retina-wide disease and foveal sparing in ABCA4-related retinopathy. World Ophthalmology Congress (WOC), Guadalajara, Mexico, 5th-9th, February 2016. Mizuno M, Akiyama K, Mizuno Y, Fukui M, Ozu C, Saito S, Noda T: Association between intraocular pressure elevation and anterior chamber depth during robot-assisted radical prostatectomy in the steep Trendelenburg position Fujii A, Akiyama K, Fujinami K, Watanabe K, Noda T: One-year outcome of intravitreal aflibercept injections for age-related macular degeneration: comparison between treatment-naïve and treatment-converted cases. Akiyama K, Fujinami K, Watanabe K, Tsunoda K, Noda T: Epiretinal membrane development after vitrectomy for rhegmatogenous retinal detachment: visual outcome and clinical characteristics. 㸺ᅜ㝿ᣍᚅㅮ₇㸼 Asia-ARVO 2015 (The Association for Research in Vision and Ophthalmology), Yokohama, Japan, 16th-19th, February, 2015. Fujinami K. Stargardt Disease with Foveal Sparing Phenotype. Special Interest Group 4 Mechanism of Retinal Degeneration. APAO congress 2015(Asia-Pacific Academy of Ophthalmology), Guangzhou, China, April 1, 2015. Fujinami K. Stargardt Disease with Foveal Sparing Phenotype. ― 172 ― The 9th APVRS Congress (Asia Pacific Vitreo-retina Socoity), Sydney, Australia, August 1, 2015. Fujinami K. Comprehensive clinical and electrophysiological assessment crucial for targeted genetic screening and molecular genetic diagnosis. The seminar of the Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institute of Health, Bethesda, MA, USA. October 7, 2015. Fujinami K. ABCA4-associated retinal disorder -Translational approach aiming for treatment-. 4th Japan-Korea Joint Symposium of Clinical Electrophysiology of Vision, Seoul, South Korea, October 31, 2015. Fujinami K. Japan whole exome project for inherited retinal diseases 2014. Ophthalmic Genetics Seminar 2016, UCL Institute of Ophthalmology, London, United Kingdom, February 17, 2016. Fujinami K. Inherited retinal dystrophy in Japanese population. 㸺ᅜෆᏛⓎ⾲㸼 ゅ⭷࢝ࣥࣇࣛࣥࢫࠊ㧗▱ࠊ2015 ᖺ 2 ᭶ 12 ᪥ ⚟ṇᶞ, ᡭṊ ࠊᕷᶫஅࠊ୕ᮌᜨ⨾Ꮚࠊᕝဴஓࠊ⚟ᮏගᶞࠊᆤ⏣୍⏨ࠊ ᡞ⏣㑳Ꮚ Ⓨࡍࡿ࣋ࣜࣀゅ⭷ࢪࢫࢺࣟࣇᑐࡋ࡚ KeraKlear ேᕤゅ⭷⛣᳜⾡ࢆ⾜ࡗࡓ 1 ⛙ᮍ⛥ࠊ⚟ṇᶞࠊỈ㔝ಙࠊ㔝ᘓࠊ㔝⏣ᚭ ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮࠾ࡅࡿ 1 ᖺ㛫ࡢゅ⭷⛣᳜ࡢ᳨ウ ➨ 119 ᅇ᪥ᮏ║⛉Ꮫ⥲ࠊᮐᖠࠊ2015 ᖺ 4 ᭶ 16 ᪥ Ỉ㔝㞞ࠊ⸨ἼⰾࠊΏ㎶ࠊ⛅ᒣ㑥ᙪࠊゅ⏣⦾ࠊ㔝⏣ᚭ Vogt-ᑠᰗ-ཎ⏣⨯ᝈᚋⓎࡋࡓ㯤ᩬᏍᑐࡋ◪Ꮚయᡭ⾡ࢆ⾜ࡗࡓ୍ ― 173 ― ᐙஂ୍ගࠊᚋ⸨⪽ࠊ୍ᙪࠊ๓⏣┤அࠊ㔝⏣ᚭ ๓║㒊ගᖸ΅᩿ᒙィࢆ⏝࠸ࡓ⾡ᚋ๓ᡣ῝ᗘண ⢭ᗘࡢ║ෆࣞࣥࢬูẚ㍑ ⋢⨨୍ᮁࠊ୰ᮧዉὠᏊࠊ⸨ἼⰾࠊỈ㔝ಙࠊ㔝⏣ᚭࠊゅ⏣⦾ ⡆᫆ᆺࣇࣜࢵ࣮࢝⥙⭷㟁ィࡼࡿ࢜࢝ࣝࢺ㯤ᩬࢪࢫࢺࣟࣇࡢ㗹యᶵ⬟ホ౯ బࠎᮌ┿⌮Ꮚࠊᖹᙧᑑᙯࠊຍ⸨ᝆࠊ⸨Ἴⰾࠊゅ⏣⦾ࠊΏ㎶ࠊ⛅ᒣ㑥ᙪࠊ㔝⏣ᚭ ࣇࣜ࣋ࣝࢭࣉࢺ⒪㸯ᖺᚋࡢどຊᑐࡍࡿ⥙⭷Ⰽ⣲ୖ⓶ୗኚࡢᙳ㡪 ࣇ࢛࣮ࢧ࣒ 2015 ➨ 58 ᅇ᪥ᮏࢥࣥࢱࢡࢺࣞࣥࢬᏛ⥲ࠊ㜰ࠊ2015 ᖺ 7 ᭶ 11 ᪥ ⸨࠶ࡡࠊ⚟ṇᶞࠊỈ㔝ಙࠊ㔝⏣ᚭ ୧║ࢥࣥࢱࢡࢺࣞࣥࢬࡼࡿゅ⭷ឤᰁࢆ᮶ࡋࡓ㧗㱋⪅ࡢ୍ ➨ 52 ᅇ᪥ᮏ║ឤᰁᏛࠊ㜰ࠊ2015 ᖺ 7 ᭶ 10 ᪥ Ỉ㔝㞞ࠊ⚟ṇᶞࠊỈ㔝ಙࠊ㔝⏣ᚭ ୧║ࡪ࠺⭷⅖ࢆకࡗࡓ∦║ᛶ࢝ࣥࢺ࣓࣮ࣂゅ⭷⅖ࡢ୍ ➨ 63 ᅇ᪥ᮏ⮫ᗋどぬ㟁Ẽ⏕⌮Ꮫ ྡྂᒇࠊ2015 ᖺ 8 ᭶ 29 ᪥ ๓⏣ளᕼᏊࠊ⸨Ἴⰾࠊ㔝⏣ᚭࠊᒾ⏣ᓅࠊ୕Ꮿ㣴୕ࠊゅ⏣⦾ ࠕ⮬ぬ≧ࢆᣢࡓ࡞࠸࢜࢝ࣝࢺ㯤ᩬࢪࢫࢺࣟࣇ≉ᚩⓗ࡞⮫ᗋᡤぢࠖ ୰ᮧዉὠᏊࠊ⋢⨨୍ᮁࠊ㔝⏣ᚭࠊ⸨Ἴⰾࠊゅ⏣⦾ RETeval Complete™ࡼࡾデ᩿⮳ࡗࡓ㑇ఏᛶ⥙⭷ᝈࡢᑠඣ ⸨ἼⰾࠊᯘᏕᙲࠊᅧྜྷ୍ᶞࠊ㏆⸨ᓠ⏕ࠊୖ㔝┿ࠊ⠛⏣ၨࠊᆤ⏣୍⏨ࠊᒾ⏣ᓅࠊ ୕Ꮿ㣴୕ࠊゅ⏣⦾ Japan whole exome project for inherited retinal diseases 2014 ➨ 69 ᅇ᪥ᮏ⮫ᗋ║⛉Ꮫࠊྡྂᒇࠊ2015 ᖺ 10 ᭶ 22 ᪥ ゅ⏣⦾ࠊ▼㱟㕲ᶞࠊ㣤⏣▱ᘯࠊᏊ୍ᮁࠊྂἨⱥ㈗ ࣥࢫࢺࣛࢡࢩࣙࣥࢥ࣮ࢫ ║ᗏ⮬Ⓨ⺯ගࢆ࠸ࡇ࡞ࡍ ⚟ṇᶞࠊᑠᕝⴥᏊࠊࣞࢨ࣭ࢲࢼࠊ࣒࣭࢟ࢫࢸࣛࠊࣅࢡࢱ࣮࣭࣌ࣞࢵࢶࠊ❧ᯇ⏤ెᏊࠊ ― 174 ― ᒣ᰿ࡳ࠾ࠊᑠᕝㆤࠊすᲄ⿱⨾Ꮚࠊ㬞ᒃ⍞ຍࠊᆤ⏣୍⏨ ║៏ᛶ⛣᳜∦ᑐᐟࡢᅜ㝿デ᩿ᇶ‽ࡢឤᗘ≉␗ᗘࡢ᳨ウ ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ⱝᡭ◊✲⪅Ⓨ⾲ࠊᮾிࠊ2015 ᖺ 11 ᭶ 2 ᪥ Ỉ㔝㞞ࠊ⛅ᒣ㑥ᙪࠊỈ㔝ಙࠊ㔝⏣ᚭࠊᑠὠ୍㑻ࠊᩧ⸨ྐ㑻 ࣟ࣎ࢵࢺᨭ᰿ⓗ๓❧⭢ฟ⾡࠾ࡅࡿ⾡୰ࡢ║ᅽୖ᪼୕ḟඖ๓║㒊 OCT ࢆ ⏝࠸ࡓ⾡๓ࡢ๓ᡣ῝ᗘ㛵ࡍࡿ᳨ウ ゅ⭷࢝ࣥࣇࣛࣥࢫࠊ㛗㔝ࠊ2016 ᖺ 2 ᭶ 19 ᪥ ⚟ṇᶞࠊᑠᕝⴥᏊࠊྥៅࠊᏳ㔛㍤ࠊ㬞ᒃ⍞ຍࠊᆤ⏣୍⏨ ║៏ᛶ⛣᳜∦ᑐᐟ࠾ࡅࡿ VAMP8 ࡢⓎ⌧ࡢ᳨ウ ⛙ᮍ⛥ࠊ⚟ṇᶞࠊỈ㔝ಙࠊ㔝⏣ᚭ ほ⾑ᘧ⾑ᅽィࢆ⏝࠸ࡓゅ⭷ෆ⓶⛣᳜ graft సᡂࡢேᕤ๓ᡣෆᅽࡢ ᐃ 㸺ᅜෆㅮ₇㸼 ࡵࡊࡏ㸟ࢥࣝࢽࡢ㕲ேࠊᮾிࠊ2015 ᖺ 2 ᭶ 27 ᪥ ⚟ṇᶞ ࠶ࡓࡽࡋ࠸ேᕤゅ⭷⛣᳜⾡㸹KeraKlear ேᕤゅ⭷ ➨ 786 ᅇᮾி㒔║⛉㞟ᅋࠊᮾிࠊ2015 ᖺ 8 ᭶ 20 ᪥ ⚟ṇᶞࠊᡭṊࠊ⛙ᮍ⛥ࠊỈ㔝ಙࠊ୕ᮌ⨾ᜨᏊࠊᆤ⏣୍⏨ࠊᡞ⏣㑳Ꮚ ⒪ⓗ࣮ࣞࢨ࣮ゅ⭷ษ㝖⾡ 㸦PTK㸧ࡢᐇ㝿 ║⛉ᡭ⾡ࡢᑎᏊᒇࠊᮾிࠊ2015 ᖺ 7 ᭶ 2 ᪥ ⛅ᒣ㑥ᙪ ࣂࢵࢡࣝᡭ⾡ࡢࢥࢶ ࡅ᪉እࡋ᪉ ⥙⭷ᝈࢆ⪃࠼ࡿࠊᮾிࠊ2015 ᖺ 9 ᭶ 2 ᪥ ⛅ᒣ㑥ᙪ ⚾ࡢデ㐃ᦠࡢ⪃࠼᪉ ຍ㱋㯤ᩬኚᡂ ― 175 ― ➨ 2 ᅇ⥙⭷ᝈデ⒪ࢭ࣑ࢼ࣮ in South Tokyoࠊᮾிࠊ2015 ᖺ 9 ᭶ 10 ᪥ ⸨࠶ࡡ ⛅ᒣ㑥ᙪ㸸PCV ᑐࡍࡿᢠ VEGF ⒪ᡂ⦼࣮Aflibercept ࡼࡿ༢⊂ึᅇ⒪ࡢ㸯ᖺ ᡂ⦼ ⛅ᒣ㑥ᙪࠊᮧୖᬛࠊᰘ᫂ࠊඵᮌᩥᙪ ࣃࢿࣝࢹࢫ࢝ࢵࢩࣙࣥ DME ᳨ウ ➨ 11 ᅇ㥖ࡢࠊᮾிࠊ2015 ᖺ 11 ᭶ 26 ᪥ ⛅ᒣ㑥ᙪ ᮾி་⒪ࢭࣥࢱ࣮ 㝔⤂࣭║⛉እ᮶⤂ ᡂᑿ㯞Ꮚ ⥳ෆ㞀⟶⌮デ㐃ᦠ ⚟ṇᶞ ゅ⭷ᝈࡢࣆࢵࢺࣇ࢛࣮ࣝ 㔝⏣ᚭ ࢺ࣮ࣜࢵࢡ IOL ࢆ⏝࠸ࡓⓑෆ㞀ᡭ⾡ wAMD Round Table Meetingࠊᮾிࠊ2016 ᖺ 1 ᭶ 24 ᪥ 㣤⏣▱ᘯࠊ⛅ᒣ㑥ᙪࠊᑿⰼ᫂ࠊ㓇ຮࠊᏳᕝຊࠊྜྷ⏣ࡺࡳᏊ EYLEA ⱝᡭ║⛉་◊✲ 2016ࠊ⚟ᒸࠊ2016 ᖺ 2 ᭶ 27 ᪥ ⚟ṇᶞ ゅ⭷࠶ࢀࡇࢀ 㹼࠶ࡿ║⛉་ࡢ 10 ᖺ㛫ࡽᏛࡪ㹼 ― 176 ― 㻌 㻌 㻌 㻌 ⫈ぬ䞉ᖹ⾮ぬ◊✲㒊㻌 ⫈ぬ࣭ᖹ⾮ぬ◊✲㒊 [ ㄽᩥ ] Homma, A., K. Nakamura, K. Matsuura, J. Mizusawa, R. Onimaru, H. Fukuda and M. Fujii. "Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC)." Jpn J Clin Oncol 45(1): 119-122, 2015 IF: 2.016 Tahara, M., N. Kiyota, J. Mizusawa, K. Nakamura, R. Hayashi, T. Akimoto, Y. Hasegawa, S. Iwae, N. Monden, K. Matsuura, H. Fujii, Y. Onozawa, A. Homma, A. Kubota, H. Fukuda and M. Fujii. "Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)." Cancer Sci 106(6): 726-733. 2015 IF㸸 3.523 Tsukahara, K., A. Kubota, Y. Hasegawa, H. Takemura, T. Terada, T. Taguchi, K. Nagahara, H. Nakatani, K. Yoshino, Y. Higaki, S. Iwae, T. Beppu, Y. Hanamure, K. Tomita, N. Kohno, K. Kawabata, M. Fukushima, S. Teramukai and M. Fujii. "Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTSHNC)." PLoS One 10(2): e0116965. 2015 IF㸸3.730 Yamashita D, Sun GW, Cui Y, Mita S, Otsuki N, Kanzaki S, Nibu KI, Ogawa K, Matsunaga T. Neuroprotective effects of cutamesine, a ligand of the sigma-1 receptor chaperone, against noise-induced hearing loss. J Neurosci Res 93㸸788-795, 2015 impact factor 2.594 Mutai H, Miya F, Fujii M, Tsunoda T, Matsunaga T. Attenuation of Progressive Hearing Loss in DBA/2J Mice by Reagents that Affect Epigenetic Modifications Is Associated with Up-Regulation of the Zinc Importer Zip4. PLoS ONE impact factor 10(4) 㸸e0124301, 2015 3.234 ― 177 ― Mizutari K, Mutai H, Namba K, Miyanaga Y, Nakano A, Arimoto Y, Masuda S, Morimoto N, Sakamoto H, Kaga K, Matsunaga T. High prevalence of CDH23 mutations in patients with congenital high-frequency sporadic or recessively inherited hearing loss. Orphanet J Rare Dis. 10㸸60, 2015 impact factor 3.358 Wasano K, Mutai H, Obuchi C, Masuda S, Matsunaga T. A novel frameshift mutation in KCNQ4 in a family with autosomal recessive nonsyndromic hearing loss. Biochem Biophys Res Commun. impact factor 463㸸582-586, 2015 2.297 Miya F, Mutai H, Fujii M, Boroevich KA, Matsunaga T, Tsunoda T. Gene expression profiling of DBA/2J mice cochleae treated with L-methionine and valproic acid. Genomic Data. 5㸸323-325, 2015 Shujiro B. Minami1, Hideki Takegoshi2, Yukiko Shinjo1, Chieko Enomoto1, and Kimitaka Kaga Usefulness of Measuring Electrically Evoked Auditory Brainstem Responses in Children with Inner Ear Malformations During Cochlear Implantation Acta Otolaryngol. 2015;135(10):1007-15. impact factor 1.106 Minami SB, Oishi N, Watabe T, Uno K, Kaga K, Ogawa K. Auditory resting-state functional connectivity in tinnitus and modulation with transcranial direct current stimulation. Acta Otolaryngol. 2015 Dec;135(12):1286-92 impact factor 1.106 Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer. Kurioka T, Mizutari K, Niwa K, Fukumori T, Inoue M, Hasegawa M, Shiotani A. Gene Ther. 2015 Sep 11. doi: 10.1038/gt.2015.94. Impact factor;3.10 High prevalence of CDH23 mutations in patients with congenital high-frequency sporadic or recessively inherited hearing loss. Mizutari K, Mutai H, Namba K, Miyanaga Y, Nakano A, Arimoto Y, Masuda S, Morimoto N, Sakamoto H, Kaga K, Matsunaga T. Orphanet J Rare Dis. 2015 May 13;10:60. Impact factor;3.36 ― 178 ― Baba Y, Fujii M, Maeda T, Suzuki A, Yuzawa S, Kato Y. Deguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines. BioMed research international. 2015; Epub 2015/06/16. eng. Habu, N., Y. Imanishi, K. Kameyama, M. Shimoda, Y. Tokumaru, K. Sakamoto, R. Fujii, S. Shigetomi, K. Otsuka, Y. Sato, Y. Watanabe, H. Ozawa, T. Tomita, M. Fujii and K. Ogawa "Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma." BMC Cancer 15: 730. 2015. Hotta K, Katsuki S, Ohata K, Abe T, Endo M, Shimatani M, Nagaya T, Kusaka T, Matsuda T, Uraoka T, Yamaguchi Y, Murakami Y, Saito Y. Efficacy and safety of endoscopic interventions using the short double-balloon endoscope in patients after incomplete colonoscopy. Dig Endosc 2015;27:95-8 impact factor 2.058 Uraoka T, Tanaka S, Oka S, Matsuda T, Saito Y, Moriyama T, Higashi R, Matsumoto T. Feasibility of a novel extra-wide-angle-view colonoscope: a clinical study. Endoscopy 2015;47:444-8 impact factor 5.053 Uraoka T, Higashi R, Horii J, Harada K, Hori K, Okada H, Mizuno M, Tomoda J, MD, Ohara N, Tanaka T, MD, Chiu HM, Yahagi N, Yamamoto K. Prospective evaluation of endoscopic criteria characteristic of sessile serrated adenoma/polyps. J Gastroentrol 2015;50:555-63 impact factor 4.523 Pioche M, Rivory J, Aguero-Garcete G, Guillaud O, O'Brien M, Lafon C, Reversat N, Uraoka T, Yahagi N, Ponchon T. New isolated bovine colon model dedicated to colonic ESD hands-on training: development and first evaluation. Surg Endosc 2015;29:3209-15 impact factor 3.256 Oka S, Tamai N, Ikematsu H, Kawamura T, Sawaya M, Takeuchi Y, Uraoka T, Moriyama T, Kawano H, Matsuda T. Improved visibility of colorectal flat tumors using image-enhanced endoscopy. Dig Endosc 2015;27 Suppl 1:35-9 impact factor 2.058 ― 179 ― Goto O, Fujimoto A, Shimoda M, Ochiai Y, Matsuda T, Takeuchi H, Kawakubo H, Maehata T, Uraoka T, Kameyama K, Kitagawa Y, Yahagi N. Estimation of subepithelial lateral extent in submucosal early gastric cancer: retrospective histological analysis. Gastric Cancer 2015;18:810-6 impact factor 3.719 Goto O, Takeuchi H, Kawakubo H, Matsuda S, Kato F, Sasaki M, Fujimoto A, Ochiai Y, Horii J, Uraoka T, Kitagawa Y, Yahagi N. Feasibility of non-exposed endoscopic wall-inversion surgery with sentinel node basin dissection as a new surgical method for early gastric cancer: a porcine survival study. Gastric Cancer 2015;18:440-5 impact factor 3.719 Uraoka T, Ochiai Y, Fujimoto A, Goto O, Kawahara Y, Kobayashi N, Kanai T, Matsuda S, Kitagawa Y, Yahagi N. A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissectionɔinduced ulcer in the stomach. Gastrointest Endosc 2015 [Epub ahead of print] impact factor 5.369 Schölvinck DW, Goto O, Seldenrijk CA, Bisschops R, Horii J, Ochiai Y, Schoon EJ, Schenk BE, Uraoka T, van Oijen MG, Bergman JJ, Yahagi N, Weusten BL. Detection of palisade vessels as a landmark for Barrett's esophagus in a Western population. J Gastroenterol 2015 [Epub ahead of print] impact factor 4.523 Yoshioka T, Nishida T, Tsujii M, Kato M, Hayashi Y, Komori M, Yoshihara H, Nakamura T, Egawa S, Yoshio T, Yamada T, Yabuta T, Yamamoto K, Kinoshita K, Kawai N, Ogiyama H, Nishihara A, Michida T, Iijima H, Shintani A, Takehara T. Renal dysfunction is an independent risk factor for bleeding after gastric ESD. Endosc Int Open 2015:3㸸E39-45 impact factor not yet assigned. Tsujii Y, Kato M, Inoue T, Yoshii S, Nagai K, Fujinaga T, Maekawa A, Hayashi Y, Akasaka T, Shinzaki S, Watabe K, Nishida T, Iijima H, Tsujii M, Takehara T. Integrated diagnostic strategy for the invasion depth of early gastric cancer by conventional endoscopy and EUS. Gastrointest Endosc 2015:82:452-9 impact factor 5.369 ― 180 ― Tsujii Y, Nishida T, Nishiyama O, Yamamoto K, Kawai N, Yamaguchi S, Yamada T, Yoshio T, Kitamura S, Nakamura T, Nishihara A, Ogiyama H, Nakahara M, Komori M, Kato M, Hayashi Y, Shinzaki S, Iijima H, Michida T, Tsujii M, Takehara T. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study. Endoscopy 2015: 47 :775-83 impact factor 5.053 Ying J, Tsujii M, Kondo J, Hayashi Y, Kato M, Akasaka T, Inoue T, Shiraishi E, Inoue T, Hiyama S, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. Int J Oncol 2015:46:1551-9 impact factor 3.025 Yamada T, Hirota M, Tsutsui S, Kato M, Takahashi T, Yasuda K, Sumiyama K, Tsujii M, Takehara T, Mori M, Doki Y, Nakajima K. Gastric endoscopic submucosal dissection under steady pressure automatically controlled endoscopy (SPACE); a multicenter randomized preclinical trial. Surg Endosc 2015:29 :2748-55 impact factor 3.256 Akasaka T, Tsujii M, Kondo J, Hayashi Y, Ying J, Lu Y, Kato M, Yamada T, Yamamoto S, Inoue T, Tsujii Y, Maekawa A, Fujinaga T, Shiraishi E, Hiyama S, Inoue T, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T. 5ǦFU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53Ǧmutated colon cancer cells. Int J Oncol 2015:46 :63-70 impact factor 3.025 Kato M, Nishida T, Hamasaki T, Kawai N, Yoshio T, Egawa S, Yamamoto K, Ogiyama H, Komori M, Nakahara M, Yabuta T, Nishihara A, Hayashi Y, Yamada T, Takehara T. Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysis. Surg Endosc 2015:29:1560-6 impact factor 3.256 ― 181 ― Yoshii S, Kato M, Honma K, Fujinaga T, Tsujii Y, Maekawa A, Inoue T, Hayashi Y, Akasaka T, Shinzaki S, Nishida T, Iijima H, Tsujii M, Morii E, Takehara T. Esophageal adenocarcinoma with white opaque substance observed by magnifying endoscopy with narrow band imaging. Dig Endosc 2015:27 :392-6 impact factor 2.058 Kikuchi M, Ushida Y, Shiozawa H, Umeda R, Tsuruya K, Aoki Y, Suganuma H, Nishizaki Y. Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects. World J Gastroenterol 2015:21:12457–67 impact factor 2.369 Kikuchi M, Horie Y, Ebinuma H, Taniki N, Nakamoto N, Kanai T. Alcoholic Liver Cirrhosis and Significant Risk Factors for the Development of Alcoholrelated Hepatocellular Carcinoma-Japan, 2012 Jpn. J.Alcohol & Drug Dependence 2015:50㸸222-34 impact factor not yet assigned. Nishizawa T, Uraoka T, Ochiai Y, Suzuki H, Goto O, Fujimoto A, Maehata T, Kanai T, Yahagi N. The "two-sword fencing" technique in endoscopic submucosal dissection. Clin Endosc 2015;48:85-620. impact factor 5.369 Ikehara H, Saito Y, Uraoka T, Matsuda T, Miwa H. Specimen retrieval method using a sliding overtube for large colorectal neoplasm following endoscopic submucosal dissection. Endoscopy 2015;47 Suppl 1 UCTN:E168-9 impact factor Nishizawa T, Uraoka T, Suzuki H, Goto O, Ochiai Y, Fujimoto A, Maehata T, Kanai T, Yahagi N. New endoscopic suturing method: slip knot clip suturing. Gastrointest Endosc 2015;82:570-1 impact factor 5.369 Tsujii Y, Kato M, Shinzaki S, Takigawa A, Hayashi Y, Nishida T, Iijima H, Tsujii M, Takehara T. Polyglycolic acid sheets for repair of refractory esophageal fistula. Endoscopy 2015: 47 (Suppl 1)㸸E39-40 impact factor 5.053 ― 182 ― Matsui S, Uraoka T, Hasegawa H, Kitagawa Y. A case of asymptomatic incidental live anisakid worm infestation on a large rectal polyp. BMJ Case Report 2015:9;2015 impact factor not yet assigned. Seishima, Uraoka T, Hasegawa H, Okabayashi K, Tsuruta M, Hayashi Y, Kitagawa Y. Colon cancer arising from a sessile serrated adenoma/polyp detected on positron emission tomography/computed tomography. Gastrointest Endosc 2015;82:570-1 impact factor 5.369 Goto O, Takeuchi H, Kawakubo H, Sasaki M, Matsuda T, Matsuda S, Kigasawa Y, Kadota Y, Fujimoto A, Ochiai Y, Horii J, Uraoka T, Kitagawa Y, Yahagi N. First case of non-exposed endoscopic wallinversion surgery with sentinel node basindissection for early gastric cancer. Gastric Cancer 2015;18:434-9 impact factor 3.719 Kato M, Uraoka T, Wada M, Banno S, Kinoshita S, Takabayashi K, Kikuchi M. A case of gastric adenocarcinoma of fundic gland type resected by combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET). Clin J Gastroenterol. 2015;8:393-9 impact factor not yet assigned. Takatori Y, Kato M, Sakaguchi E, Banno S, Abe K, Takada Y, Hirata T, Wada M, Kinoshita S, Takabayashi K, Kikuchi M, Kikuchi M, Fujiyama Y, Uraoka T. A case of extramedullary involvement of acute monocytic leukemia that presented as obstructive jaundice. Gastrointest Endosc 2015 [Epub ahead of print] impact factor 5.369 Kato M, Uraoka T, Wada M, Banno S, Kinoshita S, Takabayashi K, Kikuchi M. Large muscle layer defect of stomach caused by ESD closed by using the endoloop-clips technique. Gastrointest Endosc 2015 [Epub ahead of print] impact factor 5.369 ― 183 ― Yamaguchi T, Inoue T, Nishida T, Kato M, Hayashi Y, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Nagai K, Yoshii S, Hiyama S, Shinzaki S, Iijima H, Tsujii M, Takehara T. Localized gastric amyloidosis mimicking a submucosal tumor-like gastric cancer. Gastrointest Endosc 82 (1)㸸175-7 Jul (2015) impact factor 5.369 Makino Y, Miyazaki M, Shigekawa M, Ezaki H, Sakamori R, Yakushijin T, Ohkawa K, Kato M, Akasaka T, Shinzaki S, Nishida T, Miyake Y, Hama N, Nagano H, Honma K, Morii E, Wakasa K, Hikita H, Tatsumi T, Iijima H, Hiramatsu N, Tsujii M, Takehara T. Solitary fibrous tumor of the liver from development to resection. Intern Med 2015:54:765-70 impact factor 0.904 Ozawa H, Imanishi Y, Ito F, Watanabe Y, Kato T, Nameki H, Isobe K, Ogawa K. PiCO2 monitoring of transferred jejunum perfusion using an air tonometry technique after hypopharyngeal cancer surgery. Medicine 2015:94, e632. Yuh Baba, Masato Fujii, Toyonobu Maeda, Atsuko Suzuki, Satoshi Yuzawa, and Yasumasa Kato Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines BioMed Research International, Article ID 657179, 9 pages, 2015 Impact factor 1.579 Yuh Baba, Yasumasa Kato. The role of bavacizumab in the management of Head and Neck Squamous Cell Carcinoma Patients Chemotherapy Open Access4:163, 2015 Impact factor 0.455 Toyonobu Maeda, Atsuko Suzuki, Satoshi Yuzawa, Yuh Baba, Yuichi Kimura, and Yasumasa Kato. Mineral trioxide aggregate induces osteoblastogenesis via Atf6 Bone reports2:36-43, 2015 Impact factor 㸫 ― 184 ― Ochiai H, Ikei H, Song C, Kobayashi M, Takamatsu A, Miura T, Kagawa T, Li Q, Kumeda S, Imai M and Miyazaki Y. Communication: Physiological and Psychological Effects of Forest Therapy on Middle-Aged Males with High-Normal Blood Pressure. Int. J. Environ. Res. Public Health 2015 Feb;12(3): 2532-2542 Impact factor 2.493 Ochiai H, Ikei H, Song C, Kobayashi M, Takamatsu A, Miura T, Kagawa T, Li Q Kumeda S, Imai M and Miyazaki Y. Communication: Physiological and Psychological Effects of a Forest Therapy Progr am on Middle-Aged Females. Int. J. Environ. Res. Public Health 2015 Dec;12(12): 15222-15232 Impact factor 2.493 ⸨ṇே ୰ဗ㢌⒴࠾ࡅࡿࣄࢺங㢌⭘࢘ࣝࢫឤᰁᏛᨺᑕ⥺⒪ἲ 㢌㢕㒊⒴42(3) 325-329,2015 ᓥ⏣㈗ಙ ⸨ṇே 㢌㢕㒊ᡥᖹୖ⓶⒴ࡢ⦆ⓗᏛ⒪ἲ JOHN 31,1362-1365, 2015 ⸨ṇே 㢌㢕㒊⒴ᑐࡍࡿ㞟Ꮫⓗ⒪ࡢ㐍Ṍ㸫Ꮫᨺᑕ⥺⒪ἲࢆ୰ᚰ㸫 㢌㢕㒊እ⛉ 25(2),2015 ❶Ꮚࠊ༡ಟྖ㒄ࠊỌ㑈ᩯࠊᯇỌ㐩㞝ࠊᴮᮏ༓ỤᏊࠊᆏ⏣ⱥ᫂ࠊ⸨ṇேࠊຍᡃྩᏕ Waardenburg ೃ⩌ 2 ᆺᑐࡍࡿࠊேᕤෆ⪥ᇙࡵ㎸ࡳ⾡ᚋࡢ⫈ぬ࣭ゝㄒⓎ㐩ࡘ࠸࡚ ⪥㰯ဗႃ⛉࣭㢌㢕㒊እ⛉. 87(2) 㸸173-175, 2015 ༡ ಟྖ㑻, ᒣᮏ ಟᏊ, ⸨ ṇே ࣅ࢝ࣝࢱ࣑ࢻ༢ᢞࡼࡾዌຠࢆᚓࡓၚᾮ⭢ᑟ⟶⒴⫵㌿⛣ࡢ 1 㢌㢕㒊እ⛉ 2015 25 ᕳ 2 ྕ Page247-251 ᩧ⸨⿱㍜, ᒸ ᚿ㑻, ⏣୰ಙ, ᩪ⸨ ㇏, ụᯇᘯᮁ, ༑ᔒṇᗈ, ⏣⚈ᇛ, ᕤ⸨㐍ⱥ, ᑠᯘ Ύ, ୖ㞝ᚿ, ᾆᒸಇኵ, 㣤 ᾈᗣ, ᒣ㔝Ὀ✑, 㭯⏣ ಟ, Ọ⏣ಙ, ⶶཎ୍, ᒣཱྀ⿱୍㑻, బ㔝 ᑀ, ᶔ⏣༤ྐ, ᇼᯇ㧗༤, ᩪ⸨ᙲ୍, ୖ㔝⚽ᶞ, ▼㯮ࡵࡄࡳ, ▼ᕝ⚽ᶞ, ᒸὒ୍, ᗣ⏨, ⸨┒Ꮥ༤, Ώ㑓⪽᫂, ᮡཎ୍. ෆど㙾㝖ᚋ⭠ T1(SM)⒴ࡢ㌿⛣࣭Ⓨ㛵ࡍࡿከタඹྠ◊✲ ⭠⒴◊✲ࣉࣟࢪ࢙ ࢡࢺ◊✲ࡢ⤖ᯝࡽ㸬 ⫶⭠ 50 ᕳ 4 ྕ 448-56,2015 ― 185 ― 㧗ᯘ 㤾, ᾆᒸಇኵ, ຍ⸨ඖᙪ, ⴠྜᗣ, ▮స┤ஂ. LST ࡢศ㢮ࡑࡢ≉ᚩ㸬 ⮫ᗋᾘჾෆ⛉ 30 ᕳ 9 ྕ 1149-54,2015 ⴠྜᗣ, 㣬ᮏဴර, ᮌୗ ⪽, ┦Ⰻㄔ, ๓⏿ᛅ㍤, ⸨ᮏ ឡ, ᚋ⸨ ಟ, ୰ᮧ⌮ᜨᏊ, す⃝ಇ ᏹ, ᾆᒸಇኵ, ▮స┤ஂ㸬 ༑ᣦ⭠⭢⭘࣭⭢⒴ࡢ㚷ูデ᩿⒪㸬 ᾘჾෆど㙾 27 ᕳ 1 ྕ 133-40,2015 ᾆᒸಇኵ, ▮స┤ஂ㸬 ᮍ᮶ࡢ⭠ෆど㙾ࣔࢲࣜࢸ࣮㸬 ᾘჾෆど㙾 27 ᕳ 4 ྕ 696-8,2015 ⴠྜᗣ, 㣬ᮏဴර, ┦Ⰻㄔ, ๓⏿ᛅ㍤, ⸨ᮏ ឡ, ୰ᮧ⌮ᜨᏊ, す⃝ಇᏹ, ᚋ⸨ ಟ, ᾆᒸ ಇኵ, ▮స┤ஂ㸬 ༑ᣦ⭠⾲ᅾᛶ⭘⒆ᑐࡍࡿෆど㙾⒪ࡢ᪉㔪㸬 ᾘჾෆど㙾 27 ᕳ 7 ྕ 1095-102,2015 ⴠྜᗣ, ᾆᒸಇኵ, ▮స┤ஂ㸬 ࠕ⫶࣭༑ᣦ⭠ࠖࡽࡎ ༑ᣦ⭠ ESD ࠶࡞ࡓࡣࡸࡗ࡚ࡣ࠸ࡅ࡞࠸㸬 ᾘჾෆど㙾 27 ᕳ 2 ྕ 244-5,2015 㧗ᯘ 㤾, ᾆᒸಇኵ, ▮స┤ஂ㸬 ࠕ⭠ࠖࡽࡎ ESD ඛ➃⣔࡛ࡇࢀࡣࡸࡗ࡚ࡣ࠸ࡅ࡞࠸㸬 ᾘჾෆど㙾 27 ᕳ 2 ྕ 279-81,2015 బ㔝 ᑀ, ⏣୰ಙ, ᕤ⸨㐍ⱥ, ᩪ⸨ᙲ୍, ᯇ⏣ᑦஂ, ⏣⚈ᇛ, ⸨㝯ᗈ, ụᯇᘯᮁ, ᾆᒸಇ ኵ, ᑠᯘ ᮃ, ୰ᮧᑦᚿ, ᇼ⏣Ḡ୍, ᇼᯇ㧗༤, ᆏᮏ┤ே, ഌ ග⩏, 㭯⏣ ಟ, Ἑ㔝ᘯᚿ, ᶔ⏣༤ ྐ, ➉ෆὒྖ, ⏫⏣ᾈஂ, ᪥ୗᗈ, ྜྷ⏣┤ஂ, ᖹ⏣୍㑻, ᑎ Ẏ, ᒣ㔝Ὀ✑, 㔠Ꮚᘯ, ୰ᓥ , ᆏᮏ ⌶, ᒣཱྀ⿱୍㑻, ⋢ᑦே, ᒣᑦᏊ, ᯘ ዉ㑣, ᒸ ᚿ㑻, ᒾ㤋ᓠ㞝, ▼ᕝ⚽ᶞ, ᮧୖ ⩏Ꮥ, ྜྷ⏣ⱱ, ᩪ⸨ ㇏, The Japan NBI Expert Team(JNET)㸬 The Japan NBI Expert Team(JNET)⭠ᣑ Narrow Band Imaging(NBI)ศ㢮㸬 Intestine 19 ᕳ 1 ྕ 5-13,2015 ᾆᒸಇኵ㸬 ࠙ෆ⛉ᝈࡢデ᩿ᇶ‽࣭ᆺศ㢮࣭㔜ᗘࠚ(➨ 2 ❶) ᾘჾ ⭠⭘⒆㸬 ෆ⛉ 115 ᕳ 6 ྕ 960-4,2015 ᾆᒸಇኵ, ᮌୗ ⪽, 㧗ᯘ 㤾, ຍ⸨ ඖᙪ, ⳥ụ ┿㸬 Cold Polypectomy ࡢ᭷⏝ᛶࢥࢶ㸬 ᾘჾෆど㙾 27 ᕳ 10 ྕ 1718-23, 2015 ― 186 ― ๓⏿ᛅ㍤, 㣬ᮏဴර, ┦Ⰻㄔ, ⸨ᮏ ឡ, ⴠྜᗣ, ୰ᮧ⌮ᜨᏊ, す⃝ಇᏹ, ᚋ⸨ ಟ, ᾆᒸ ಇኵ, ▮స┤ஂ㸬 ᾘ⟶⒴ࡢ⒪᪉㔪ࡢ❧࡚᪉࣭㐍ࡵ᪉ ⭠⒴ࡢෆど㙾⒪㐺ᛂࠊእ⛉࣭⸆≀⒪ἲ㛤ጞ࣭ ⛣⾜ࡢࢱ࣑ࣥࢢ㸬 ᪥ᮏࢥࣥࣆ࣮ࣗࢱእ⛉Ꮫㄅ 17 ᕳ 2 ྕ 91-100,2015 ᾆᒸಇኵ, ᯇ⏣ᑦஂ㸬 ᑠᆺ⭠࣏࣮ࣜࣉᑐࡍࡿ Cold polypectomy㸬 Gastroenterological Endoscopy 57 ᕳ 9 ྕ 2370-8,2015 㧘ᯘ 㤾, ᾆᒸಇኵ, ᮌୗ ⪽, ຍ⸨ඖᙪ, ▮స┤ஂ㸬 ESD ⏝ඛ➃ࢱࢵࢳ࣓ࣥࢺࢆ࠸ࡇ࡞ࡍࢥࢶ. ᾘჾෆど㙾 27 ᕳ 8 ྕ, 1308-12, 2015 ຍ⸨ඖᙪ, ㉥ᆏᬛྐ, ୖᣅஓ, 㔜ᕝ ⛱ ࠙⾑౽ࢆࡳࡓࡽࠚ ⾑౽ࢆࡁࡓࡍᝈࡢ≉ᚩ࣭ෆど㙾ീᑐฎἲ ⭠⟶Ꮚᐑෆ⭷ ᾘჾෆど㙾 27(10)㸸1691-1695 Nov 16 (2015) ⸨ᇛගᘯ, ཱྀᖿᓫ, ゅᔱ┤⨾, ຍ⸨ඖᙪ, ᆏ⏣㈨ᑦ, ᕸ⿄ᒇ ಟ, ∦ᒸᖿ⤫, ᓥᒸಇ, ▮ స┤ஂ, ⸨ᮏ୍┾, ᪥ᮏᾘჾෆど㙾Ꮫ 㠀㟼⬦⒗ᛶୖ㒊ᾘ⟶ฟ⾑࠾ࡅࡿෆど㙾デ⒪࢞ࢻࣛࣥ. Gastroenterological Endoscopy 2015:57(8)㸸1648-66 ຍ⸨ඖᙪ, 㜿㒊ᆂ୍㑻, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ⸨ᒣ ὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ State of the art ⭠ ESD ࢆࡵࡄࡗ࡚ ⭠ ESD ࡢࢹࣂࢫࡢ≉ᚩ࣭࠸ศࡅŌŌ⭠ࡀ ࢇ perspective 2015: 2㸸2188-4560 ⳥ụ┿, ᱵ⏣⍠⨾Ꮚ, 㭯㇂ᗣኴ, ሷ⃝ᏹ, ᯇᔱᡂᚿ, 㜿㒊ᆂ୍ᮁ, ⳥ụ⨾✑, 㧗ᶫṇᙪ, ᒣ ᓊ⏤ᖾ, すᓮὈᘯ, ᇼỤ⩏๎, 㔠㝯 㠀くⓗ⫢⬡⫫ ᐃ Controlled Attenuation Parameter (CAP)ࡼࡿࣝࢥ࣮ࣝᛶ⫢㞀ᐖ ᝈ⪅ࡢ㚷ู ᪥ᮏࣝࢥ࣮࣭ࣝ⸆≀་Ꮫ㞧ㄅ 2015:50㸸235-47 ᇼỤ⩏๎, ᾏ⪁ᾈ, ⳥ụ┿, ୰ᮏఙᏹ, 㔠㝯 ᮏ㑥࠾ࡅࡿࣝࢥ࣮ࣝᛶ⫢◳ኚࡢᐇែ ⫢⮚ 2015:56㸸366-8 ― 187 ― ᒸ ឡᏊࠊỈ㇂ ே, ඵᮌ ┤Ꮚ, 㯮ᓥ ⩏᫂, ⴠྜ ༤Ꮚ㸬 ᯈ㛫ᒙ㢮⾲⓶ᄞ⬊ࡀ㢌ෆᑤ✸◚ࡋࡓ1. ᪥ᮏᙧᡂእ⛉Ꮫㄅ2015 Jan;35(1):51-55 ⴠྜ༤ᏊࠊỈ㇂ேࠊඵᮌ┤ᏊࠊᒸឡᏊࠊ㈗ᚿ⏕㸬 ࣄࣝࣟࣥ㓟ὀධࡼࡿ㰯⩼ቯṚࡢ1㸬 ᙧᡂእ⛉ 2015 Sep;58(9):989-992 ⴠྜ༤ᏊࠊỈ㇂ேࠊඵᮌ┤ᏊࠊᒸឡᏊࠊᆏᮏዲ㸬 ຍ㱋ᛶ║▛ୗᆶᑐࡍࡿᡭ⾡ࡢ᳨ウ㸬 ᙧᡂእ⛉ 2015 Nov;58(11):1199-1205 [ ⥲ㄝ ] Homma, A., R. Onimaru, K. Matsuura, K. T. Robbins and M. Fujii. "Intra-arterial chemoradiotherapy for head and neck cancer." Jpn J Clin Oncol 46(1): 4-12.2016 Kiyota, N., M. Tahara and M. Fujii. "Adjuvant treatment for post-operative head and neck squamous cell carcinoma." Jpn J Clin Oncol 45(1): 2-6. 2015 ᯇỌ㐩㞝 ඛኳᛶ㞴⫈ඣࡢ㑇ఏᏊኚ␗ࡢ◊✲デ⒪࠾ࡅࡿ᪂ࡋ࠸ືྥ 㡢ኌゝㄒ་Ꮫ 56(3)㸸219-225ࠊ2015 ᯇỌ㐩㞝ࠊ℧ཱྀὒ୍㑻 ✺Ⓨᛶ㞴⫈ࡢែ ⪥㰯ဗႃ⛉࣭㢌㢕㒊እ⛉ 87(8) 㸸564–572ࠊ2015 ༡ ಟྖ㑻 ࠙㢦㠃⚄⤒ࡑࡢ࿘㎶-᭱㏆ࡢ㐍Ṍࢺࣆࢵࢡࢫࠚ デ᩿ࡢࢺࣆࢵࢡࢫ 㢦㠃⚄⤒㯞⑷ᑐࡍ ࡿ⏬ീデ᩿ JOHNS 31 ᕳ 6 ྕ Page703-707(2015) ༡ ಟྖ㑻 ࠙ࡇࢇ࡞ࡁࡢᑐᛂἲࡀࢃࡿ ⪥㰯ဗႃ⛉ᡭ⾡࢞ࢻࠚ ⪥ࡢᡭ⾡ ேᕤෆ⪥ᡭ⾡ ⪥㰯ဗႃ⛉࣭㢌㢕㒊እ⛉ 87 ᕳ 5 ྕ Page66-70(2015.04) ༡ ಟྖ㑻 ࠙ࢫࢺࣞࢫ⪥㰯ဗႃ⛉࣭㢌㢕㒊እ⛉ࠚ ࢫࢺࣞࢫ㞴⫈ JOHNS 31 ᕳ 3 ྕ Page297-300(2015) ― 188 ― Ỉ㊊ 㑥㞝 ࠙㧗㱋⪅ࡢࡳࡳ࣭ࡣ࡞࣭ࡢࠚ ⮫ᗋᙺ❧ࡘ Q&A ෆ⪥⏕ࡀࡢ⛬ᗘ㐍ࢇ࡛࠸ࡿࡢᩍ ࠼࡚ࡃࡔࡉ࠸ Geriatric Medicine 53 ᕳ 4 ྕ Page367-369(2015.04) Ỉ㊊㑥㞝 ࠕ⚾ࡢ␃Ꮫࠖ࣎ࢫࢺࣥ MEEI ␃Ꮫ ௰㛫ࡶᨭ࠼ࡽࢀෆ⪥᭷ẟ⣽⬊⏕ࡢᛌᣲ ⨾ⷣ No.117 p34-36, 2015 ᖺ 3 ᭶ 20 ᪥ ᒣ⃝୍ᶞ ᅗㄝࠕ┠࡛ぢࡿ㑇ఏ་Ꮫࠖࢩ࣮ࣜࢬ ࢤࣀ࣒௦ࡢ฿᮶㑇ఏࣜࢸࣛࢩ࣮ ᅜ❧་⒪Ꮫㄅ ་⒪ 2016;70(2):106-109 ᒣ⃝୍ᶞ ᭶ࡢ⏝ㄒࠕḟୡ௦ࢩ࣮ࢡ࢚ࣥࢧ࣮ࠖ ᅜ❧་⒪Ꮫㄅ ་⒪ 2015;69(8/9):383 Uraoka T, Hosoe N, Yahagi N. Colonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening? Expert Rev Gastroenterol Hepatol 2015;9:129-32 impact factor 2.417 Moriyama T, Uraoka T, Esaki M, Matsumoto T. Advanced technology for the improvement of adenoma and polyp detection during colonoscopy. Dig Endosc 2015;27 Suppl 1:40-4 impact factor Kato M Diagnosis and therapies for gastric non-invasive neoplasia. World J Gastroenterol 2015: 21㸸12513-8 impact factor 2.369 Nishida T, Kato M, Yoshio T, Akasaka T, Yoshioka T, Michida T, Yamamoto M, Hayashi S, Hayashi Y, Tsujii M, Takehara T. Endoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditions. World J Gastrointest Endosc 2015: 7㸸524-31 impact factor not yet assigned. ― 189 ― Bunchorntavakul C, Jones LM, Kikuchi M, Valiga ME, Kaplan DE, Nunes FA, Aytaman A, Reddy KR, Chang KM. Distinct features in natural history and outcomes of acute hepatitis C. J Clin Gastroenterol 2015:49:e31-40 impact factor 3.498 Matsubara K, Kagami M, Nakabayashi K, Hata K, Fukami M, Ogata T, Yamazawa K. Exploration of hydroxymethylation in Kagami-Ogata syndrome caused by hypermethylation of imprinting control regions. Clinical Epigenetics 2015;7(1):90 Impact factor 4.5 Strogantsev R, Krueger F, Yamazawa K, Shi H, Gould P, Goldman-Roberts M, McEwen K, Sun B, Pedersen R, Ferguson-Smith AC. Allele-specific binding of ZFP57 in the epigenetic regulation of imprinted and nonimprinted monoallelic expression. Genome Biology 2015;16(1):112 Impact factor 10.8 [ ⴭ᭩ ] ᯇỌ㐩㞝 ✺Ⓨᛶ㞴⫈ ᪥ࡢ⒪ᣦ㔪 2015 ᖺ∧㸦⚟ḟኵࠊ㧗ᮌㄔࠊᑠᐊ୍ᡂ࣭⥲⦅㞟㸧ࠊ1410-1411ࠊ་Ꮫ᭩ 㝔ࠊ2015.1 ᯇỌ㐩㞝 እࣜࣥࣃ⒦ ᪥ࡢ⒪ᣦ㔪 2015 ᖺ∧㸦⚟ḟኵࠊ㧗ᮌㄔࠊᑠᐊ୍ᡂ࣭⥲⦅㞟㸧ࠊ1410-1411ࠊ་Ꮫ᭩ 㝔ࠊ2015.1 ᯇỌ㐩㞝 Waardenburg ೃ⩌ ᑠඣෆ⛉ 2015 ᖺ 47 ᕳቑหྕ㸦ࠗᑠඣෆ⛉࠘ ࠗᑠඣእ⛉࠘⦅㞟ጤဨඹ⦅㸧ࠊᰴᘧ♫ᮾி་ Ꮫ♫ࠊ210-212ࠊ2015.11 ༡ಟྖ㑻 EABR ࡣఱ࡛ࡍ㸽 ࡉࡽ⪺ࡅ࡞࠸㸟ᑠඣࡢࡳࡳ࣭ࡣ࡞࣭ࡢデ⒪Ϩᕳ㸦ຍᡃྩᏕࠊᒣ୰᪼㸧᪥ᮏ㝔ฟ∧ 66-68 2015.4.20 ― 190 ― ༡ಟྖ㑻 ⿵⫈ჾேᕤෆ⪥ࡢ㐪࠸ࡣఱ࡛ࡍ㸽 ࡉࡽ⪺ࡅ࡞࠸㸟ᑠඣࡢࡳࡳ࣭ࡣ࡞࣭ࡢデ⒪Ϩᕳ㸦ຍᡃྩᏕࠊᒣ୰᪼㸧᪥ᮏ㝔ฟ∧ 74-76 2015.4.20 ༡ಟྖ㑻 㟁Ẽ⫈ぬࡣఱ࡛ࡍ㸽 ࡉࡽ⪺ࡅ࡞࠸㸟ᑠඣࡢࡳࡳ࣭ࡣ࡞࣭ࡢデ⒪Ϩᕳ㸦ຍᡃྩᏕࠊᒣ୰᪼㸧᪥ᮏ㝔ฟ∧ 105-107 2015.4.20 ༡ಟྖ㑻 ேᕤෆ⪥ࡣ MRI ࡛ᨾ㞀ࡋࡲࡍ㸽 ࡉࡽ⪺ࡅ࡞࠸㸟ᑠඣࡢࡳࡳ࣭ࡣ࡞࣭ࡢデ⒪Ϩᕳ㸦ຍᡃྩᏕࠊᒣ୰᪼㸧᪥ᮏ㝔ฟ∧ 116-119 2015.4.20 ⳥ụᏲࠊⴠྜ༤Ꮚࠊ㕥ᮌྖࠊጲ⏣༑ ➨Ϫ⦅ ࢣࣟࢻ࣭⫧ཌᛶ⒕デ⒪࢞ࢻࣛࣥࠊ➨❶ ⫧ཌᛶ⒕ ᙧᡂእ⛉デ⒪࢞ࢻࣛࣥࠊ137-148ࠊ㔠ཎฟ∧ᰴᘧ♫ࠊ2015.4.10. Yuh Baba, Takanori Nishiyama, Yasumasa Kato Diagnosis and treatment of accessory parotid gland tumors International Manual of Oncology Practice, chapter27, pp629-636, Ramon Andrade de Mello, Springer, 2015 [ ᏛⓎ⾲ ] Mutai H, Miya F, Fujii M, Matsunaga T. Attenuation of Progressive Hearing Loss in DBA/2J Mice by Epigenetic-Modifying Reagents Is Associated with Up-Regulation of the Zinc-Importer Zip4 /Slc39a4. Association for research in otolaryngology 38th Annual MidWinter Meeting, Baltimore, Maryland, 2015.2.21-25. Watabe T, Matsunaga T, Wakabayashi S, Kojima T, Oishi N, Kanzaki S, Ogawa K. Study of the Association Between the Tinnitus Annoyance and the Genetic Background. 9th international TRI Tinnitus Conference, Michigan,USA, 2015.6.7-10. ― 191 ― Hosoya M, Fujioka M, Matsunaga T, Ogawa K, Okano H. A mutated PENDRIN formed intracellular aggregations and caused increase of susceptibilities for cell stress in the inner ear cells induced from Pendred syndrome patients-specific iPS cells The 38th Annual Meeting of the Japan Meuroscience Society, Hyogo, Japan, 2015. 7.2831. Matsunaga T, Morimoto N, Mutai H. Audiological Characteristics in Patients Carrying Mutations in SLC26A5 Which Encodes Prestin- a Longitudinal Study. Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum,San Francisco, California USA, 2015.8.23-26. Matsunaga T. Promises and challenges of next generation sequencing in personalized medicine for sensorineural hearing loss. Symposium11: Sensorineural Hearing Loss. 13th Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery, Tokyo, Japan, 2015.12.3-4. Yuh Baba Deguelin induces apoptosis by targeting EGFR-Akt and IGF1R-Akt pathways in head and neck cancer. The joint meeting of 4th congress of asian society of head and neck oncology and 39th annual meeting of japan society for head and neck cancer, Kobe, Japan, June3-6, 2015 ❶ᏊࠊᮧࠊỌ㑈ᩯࠊ༡ಟྖ㑻ࠊᓥ⏣㈗ಙࠊᯇỌ㐩㞝ࠊᓥྐ⾜ࠊゅ⏣୍ࠊ⸨ ṇேࠊຍᡃྩᏕ ᙜ㝔࠾ࡅࡿ Pendred ೃ⩌࠶ࡿ࠸ࡣ࠸ࡢ⫈ຊ⤒㐣ࡘ࠸࡚ ᪥ᮏ⪥㰯ဗႃ⛉Ꮫᮾி㒔ᆅ᪉㒊 ➨ 206 ᅇᏛ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.3.14. ⸨ᒸṇேࠊ⣽㇂ㄔࠊᯇỌ㐩㞝ࠊᑠᕝ㑳ࠊᒸ㔝ᰤஅ MYO15A ᪂つ㑇ఏᏊኚ␗ࡽࡢᝈ≉␗ⓗ iPS ⣽⬊ࡢᶞ❧ ➨ 14 ᅇ᪥ᮏ⏕་⒪Ꮫ⥲ࠊ⚄ዉᕝ┴ࠊ2015.3.19-21. ⣽㇂ㄔࠊ⸨ᒸṇேࠊΏ㒊Ꮥኴ㑻ࠊᒸᮏ⌮ᚿࠊ᭮᰿ᓅྐࠊᯇỌ㐩㞝ࠊ㉥ᯇᅵࠊᑠᕝ㑳ࠊᒸ㔝 ᰤஅ ࣄࢺᝈ⪅⏤᮶ PENDRED ೃ⩌≉␗ⓗ iPS ⣽⬊ࢆ⏝࠸ࡓࣄࢺෆ⪥ PENDRIN 㝧ᛶ⣽⬊ࡢ ゎᯒ ➨ 14 ᅇ᪥ᮏ⏕་⒪Ꮫ⥲ࠊ⚄ዉᕝ┴ࠊ2015.3.19-21. ― 192 ― 㔠Ꮚ⏤ెࠊ᭷ᮏᏘᏊࠊ௰㔝ᩔᏊࠊᕤ⸨௦ࠊᯇỌ㐩㞝 ඃᛶ㑇ఏࡢ㞴⫈㑇ఏᏊኚ␗ࢆㄆࡵࡓᐙ᪘Ṕࡢ࡞࠸㞴⫈ ➨ 10 ᅇ᪥ᮏᑠඣ⪥㰯ဗႃ⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊ㛗㔝┴ࠊ2015.5.8-9. ㈏㔝ᙬᏊࠊ᳃⏣カᏊࠊ௰㔝ᩔᏊࠊ᭷ᮏᏘᏊࠊᑠἙཎ᪼ࠊᮡෆᬛᏊࠊᒸᮏᗣ⚽ࠊᑠᕝ㑳ࠊᯇ Ọ㐩㞝 Incomplete partition type Ϫወᙧࡢ⮫ᗋ㑇ఏᏛⓗ᳨ウ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊᮾி㒔ࠊ2015.5.20-23. బ㔝ᾈ୍㑻ࠊົྎⱥᶞࠊᑠᕝ㑳ࠊᯇỌ㐩㞝 KCNQ4 ኚ␗క࠺㑇ఏᛶ㞴⫈ 10 ᐙ⣔ࡢ᳨ウ 㹼ຎᛶ㑇ఏࢆ♧ࡋࡓᐙ⣔ࡶྵࡵ࡚㹼 ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊᮾி㒔ࠊ2015.5.20-23. ᑿᜤᏊࠊᏲᮏᏊࠊ௰㔝ᩔᏊࠊ᭷ᮏᏘᏊࠊᮡෆᬛᏊࠊቑ⏣బᏊࠊᒸᮏᗣ⚽ࠊᏲᮏカᏊࠊ ຍᡃྩᏕࠊᯇỌ㐩㞝 㑇ఏᏊゎᯒࢆࡋࡓ Auditory Neuropathy Spectrum Disorder(ANSD)ࡢ DPOAE ࡢ⤒㐣 ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊᮾி㒔ࠊ2015.5.20-23. ➟ዉὠᏊࠊቑ⏣ṇḟࠊቑ⏣బᏊࠊ㜰ᮏᾈ୍ࠊᑠἙཎ᪼ࠊ୕⃝㐓ேࠊ⏥⬟┤ᖾࠊᯇỌ㐩㞝 ప㡢㞀ᐖᆺឤ㡢㞴⫈ࡢ࣮࢜ࢪ࢜ࢢ࣒ࣛࡢヲ⣽࡞≉ᚩ㞴⫈㑇ఏᏊኚ␗ࡢ᳨ウ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊᮾி㒔ࠊ2015.5.20-23. Ỉ㊊㑥㞝ࠊົྎⱥᶞࠊ௰㔝ᩔᏊࠊ᭷ᮏᏘᏊࠊቑ⏣బᏊࠊᏲᮏᏊࠊ㜰ᮏᾈ୍ࠊຍᡃྩᏕࠊ ᯇỌ㐩㞝 ཎᅉ᫂ࡢ㧗㡢㒊㞀ᐖࢆㄆࡵࡿඛኳᛶ㞴⫈࠾ࡅࡿ CDH23 㑇ఏᏊኚ␗ࡢ㢖ᗘ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊᮾி㒔ࠊ2015.5.20-23. ⣽㇂ㄔࠊ⸨ᒸṇேࠊᯇỌ㐩㞝ࠊᑠᕝ㑳 PENDRED ೃ⩌ᝈ≉␗ⓗ iPS ⣽⬊⏤᮶ෆ⪥⣽⬊ࢆ⏝࠸ࡓ⸆ࢫࢡ࣮ࣜࢽࣥࢢ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊᮾி㒔ࠊ2015.5.20-23. ༡ಟྖ㑻ࠊົྎⱥᶞࠊᇼ᪂ࠊబ㔝ᾈ୍㑻ࠊ᱇㈨Ὀࠊ⏣୰⸨ಙࠊ℧ཱྀဴஓࠊ▼┤ᶞࠊ ᮧࠊ❶ᏊࠊỌ㑈ᩯࠊᓥྐ⾜ࠊᯇỌ㐩㞝ࠊ⸨ṇேࠊຍᡃྩᏕ ୰⪥ᖖᅾ⳦ྀ៏ᛶ୰⪥⅖⣽⳦ྀࡢ 16SrRNA ⳦✀⤌ᡂゎᯒ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫࠊᮾி㒔ࠊ2015.5.20-23. ົྎⱥᶞࠊᐑᶞࠊ⸨ṇேࠊゅ⏣㐩ᙪࠊᯇỌ㐩㞝 ࣓ࢳ࢜ࢽ࣭ࣥࣂࣝࣉࣟ㓟ࡼࡿ DBA/2J ࣐࢘ࢫࡢ㞴⫈㐍⾜ᢚไࡣள㖄࣏࣮ࣥࢱ࣮Zip4 Ⓨ ⌧ࡢୖ᪼㛵㐃ࡍࡿ ➨ 9 ᅇ᪥ᮏ࢚ࣆࢪ࢙ࢿࢸࢡࢫ◊✲ᖺࠊᮾி㒔ࠊ5.25-26. ― 193 ― ᳃㈆┤ဢࠊ㔝ὠᐶࠊᯇỌ㐩㞝ࠊ㣤ᓥ୍ㄔ 㑇ఏᏊኚ␗ࢆྠᐃࡋࡓ branchio-oto-renal㸦BOR㸧ೃ⩌ࡢ⭈≧㛵ࡍࡿ᳨ウ ᪥ᮏᑠඣ⭈⮚ᏛᏛ⾡㞟 ➨ 50 ᅇグᛕࠊරᗜ┴ࠊ2015.6.18-20. ຍ⸨⚽ᩄࠊ༡ಟྖ㑻ࠊ㕥ᮌࠊ▮㒊⪽ᏊࠊⱝᯘẎࠊỌ㑈ᩯࠊ❶Ꮚࠊᓥ⏣㈗ಙࠊᓥ ྐ⾜ࠊᯇỌ㐔㞝ࠊゅ⏣୍ࠊ⸨ṇேࠊຍᡃྩᏕ ᙜ⛉࠾ࡅࡿ⿵⫈እ᮶ࡢྲྀࡾ⤌ࡳ ᪥ᮏ⫈ぬ་Ꮫ ➨ 1 ᅇ ⪥㬆࣭㞴⫈◊✲ࠊᮾி㒔᪂ᐟ༊ࠊ2015.7.11. ⣽㇂ㄔࠊ⸨ᒸṇேࠊᒸᮏ⌮ᚿࠊ᭮᰿ᓅྐࠊᯇỌ㐩㞝ࠊ㉥ᯇᅵࠊᑠᕝ㑳ࠊᒸ㔝ᰤஅ PENDRED ೃ⩌ᝈ≉␗ⓗ iPS ⣽⬊⏤᮶ෆ⪥⣽⬊ࢆ⏝࠸ࡓ⸆ࢫࢡ࣮ࣜࢽࣥࢢ ➨ 36 ᅇ᪥ᮏ⅖࣭⏕་Ꮫࠊᮾி㒔ࠊ2015.7.21-22. ⸨ᒸṇேࠊ⣽㇂ㄔࠊᯇỌ㐩㞝ࠊᑠᕝ㑳ࠊᒸ㔝ᰤஅ MYO15A ᪂つ㑇ఏᏊኚ␗ࡽࡢᝈ≉␗ⓗ iPS ⣽⬊ࡢᶞ❧ゎᯒ ➨ 38 ᅇ ᪥ᮏ⚄⤒⛉Ꮫࠊරᗜ┴ࠊ2015.7.28-31. ᑿᜤᏊࠊ㞴Ἴ୍ᚨࠊ༡ಟྖ㑻ࠊቑ⏣ẎࠊᯇỌ㐩㞝ࠊຍᡃྩᏕ OPA1 㑇ఏᏊኚ␗క࠺ᡂேᮇⓎࡢ Auditory Neuropathy ࡢ⫈ຊ᳨ᰝᖹ⾮᳨ᰝࡢ≉ᚩ ➨ 25 ᅇ᪥ᮏ⪥⛉Ꮫࠊ㛗ᓮ┴ࠊ2015.10.7-10. ົྎⱥᶞࠊ௰㔝ᩔᏊࠊ᭷ᮏᏘᏊࠊᯇỌ㐩㞝 Exome ゎᯒࢆ⏝࠸ࡓೃ⩌ᛶ㞴⫈ᑐࡍࡿཎᅉ㑇ఏᏊྠᐃࡢヨࡳ ➨ 25 ᅇ᪥ᮏ⪥⛉Ꮫࠊ㛗ᓮ┴ࠊ2015.10.7-10. 㞴Ἴ୍ᚨࠊົྎⱥᶞࠊ༡ಟྖ㑻ࠊᆏᮏᾈ୍ࠊᯇỌ㐩㞝 㞴⫈㑇ఏᏊ LOXHD1 ࡢ᪂つኚ␗యࡢศᏊែࡢ᳨ド ➨ 25 ᅇ᪥ᮏ⪥⛉Ꮫࠊ㛗ᓮ┴ࠊ2015.10.7-10. 㕥ᮌἲ⮧ࠊᯇỌ㐩㞝ࠊᑠᕝ㑳ࠊᏲᮏᏊ ୍㐣ᛶ㔜⠜࡞⚄⤒≧ࢆⓎࡋࡓ Waardenburg ೃ⩌ࡢ 1 ➨ 25 ᅇ᪥ᮏ⪥⛉Ꮫࠊ㛗ᓮ┴ࠊ2015.10.7-10. ᯇᓥྍዉࠊ௰㔝ᩔᏊࠊ᭷ᮏᏘᏊࠊᯇỌ㐩㞝ࠊᕤ⸨௦ m7445A㸼G 㑇ఏᏊኚ␗ࡀྠᐃࡉࢀࡓᗂඣ㐍⾜ᛶឤ㡢㞴⫈ࡢ㸯 ➨ 25 ᅇ᪥ᮏ⪥⛉Ꮫࠊ㛗ᓮ┴ࠊ2015.10.7-10. ༡ಟྖ㑻ࠊົྎⱥᶞࠊబ㔝ᾈ୍㑻ࠊᯇỌ㐩㞝 ୰⪥ᖖᅾ⳦ྀ៏ᛶ୰⪥⅖⣽⳦ྀࡢ 16SrRNA ⳦✀⤌ᡂゎᯒ ᪥ᮏே㢮㑇ఏᏛ➨ 60 ᅇࠊᮾி㒔ࠊ2015.10.14-17. ― 194 ― ቑ⏣బᏊࠊ⮻ᬛᏊࠊ㭯ᒸᘯ⨾ࠊ▼ᕝ௦ࠊᯇỌ㐩㞝ࠊ➉ෆᙪ ᙜ⛉࠾ࡅࡿᑠඣࡢ୧ഃேᕤෆ⪥ࡢ᳨ウ ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. ᑿᜤᏊࠊᏲᮏᏊࠊ௰㔝ᩔᏊࠊ᭷ᮏᏘᏊࠊᮡෆᬛᏊࠊቑ⏣బᏊࠊᒸᮏᗣ⚽ࠊ᳃⏣カᏊࠊ ຍᡃྩᏕࠊᯇỌ㐩㞝 Auditory Neuropathy Spectrum Disorder ࠾ࡅࡿ DPOAE ࡢ⤒㐣⫈ຊ᳨ᰝ⤖ᯝࡢ 㛵ಀ ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. Ᏹబ⨾┿୍ࠊᐑᕝ㯞⾰Ꮚࠊすᑿಙဢࠊụᅬဴ㑻ࠊ▼ᕝᾈኴ㑻ࠊᒾᓮ⪽ࠊᒸᮏ∾ேࠊᑠᕝ㑳ࠊ ຍᡃྩᏕࠊ⇃ᕝᏕ୕ࠊᑠᶫඖࠊᆏ⏣ⱥ᫂ࠊబ⸨ᏹࠊబ㔝⫕ࠊ᭯᰿୕༓ᙪࠊ㧗ᶫᬕ㞝ࠊṊ⏣ ⱥᙪࠊᮾ㔝ဴஓࠊෆ⸨Ὀࠊ୰ᕝᑦᚿࠊす㷂๎ࠊ㔝ཱྀె⿱ࠊ⩚⸨┤ேࠊཎࠊ⚟⏣ㅍࠊᯇỌ 㐩㞝ࠊᒣᒽ㐩ஓ ⱝᖺⓎᆺ୧ഃᛶឤ㡢㞴⫈ࡢ⮫ᗋⓗ≉ᚩࡘ࠸࡚ ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. すᑿಙဢࠊᐑᕝ㯞⾰Ꮚࠊụᅬဴ㑻ࠊ▼ᕝᾈኴ㑻ࠊᒾᓮ⪽ࠊᒸᮏ∾ேࠊᑠᕝ㑳ࠊຍᡃྩᏕࠊ⇃ ᕝᏕ୕ࠊᑠᶫඖࠊᆏ⏣ⱥ᫂ࠊబ⸨ᏹࠊబ㔝⫕ࠊ᭯᰿୕༓ᙪࠊ㧗ᶫᬕ㞝ࠊṊ⏣ⱥᙪࠊᮾ㔝ဴ ஓࠊෆ⸨Ὀࠊ୰ᕝᑦᚿࠊす㷂๎ࠊ㔝ཱྀె⿱ࠊ⩚⸨┤ேࠊཎࠊ⚟⏣ㅍࠊᯇỌ㐩㞝ࠊᒣᒽ㐩 ஓࠊᏱబ⨾┿୍ ≉Ⓨᛶ୧ഃᛶឤ㡢㞴⫈ᝈ⪅ᑐࡍࡿ㑇ఏᏛⓗ᳨ᰝ㹼ḟୡ௦ࢩ࣮ࢣࣥࢧ࣮ࢆ⏝࠸ࡓ᳨ᰝ㹼 ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. 㨣㢌Ⰻ㍜ࠊすᑿಙဢࠊụᅬဴ㑻ࠊ▼ᕝᾈኴ㑻ࠊᒾᓮ⪽ࠊᒸᮏ∾ேࠊᑠᕝ㑳ࠊຍᡃྩᏕࠊ⇃ᕝ Ꮥ୕ࠊᑠᶫඖࠊᆏ⏣ⱥ᫂ࠊబ⸨ᏹࠊబ㔝⫕ࠊ᭯᰿୕༓ᙪࠊ㧗ᶫᬕ㞝ࠊṊ⏣ⱥᙪࠊᮾ㔝ဴஓࠊ ෆ⸨Ὀࠊ୰ᕝᑦᚿࠊす㷂๎ࠊ㔝ཱྀె⿱ࠊ⩚⸨┤ேࠊཎࠊ⚟⏣ㅍࠊᯇỌ㐩㞝ࠊᒣᒽ㐩ஓࠊ Ᏹబ⨾┿୍ ⮫ᗋሗㄪᰝ⚊ࢆ⏝࠸ࡓ✺Ⓨᛶ㞴⫈ࡢᏛㄪᰝ㹼㞴ᛶ⫈ぬ㞀ᐖ㛵ࡍࡿㄪᰝ◊✲⌜ ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. ௰㔝ᩔᏊࠊ᭷ᮏᏘᏊࠊᕤ⸨௦ࠊᯇỌ㐩㞝 㞴⫈ࢆㄆࡵࡓඛኳᛶࢧࢺ࣓࢞ࣟឤᰁ 14 ࡢ᳨ウ ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. ᏲᮏᏊࠊ㕥ᮌἲ⮧ࠊᑠ᳃Ꮫࠊྜྷᆂ♸ࠊᅵᶫዉࠎࠊᰗ⃝▖ࠊబ⸨⿱ᏊࠊᯇỌ㐩㞝 EDNRB 㑇ఏᏊ࣍ࣔ᥋ྜࢆ᭷ࡋࡓ࣮࣡ࣝࢹࣥࣈࣝࢢೃ⩌ 1 ᆺࡢ 1 ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. ― 195 ― ຍ⸨⚽ᩄࠊ༡ಟྖ㑻ࠊ㕥ᮌࠊᯇỌ㐔㞝ࠊຍᡃྩᏕ ᙜ⛉࠾ࡅࡿ⿵⫈ჾእ᮶ࡢྲྀࡾ⤌ࡳㄢ㢟 ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. బ⸨⿱Ꮚࠊᰗ⃝▖ࠊྜྷᆂ♸ࠊᅵᶫዉࠎࠊᑠ᳃ᏛࠊᯇỌ㐩㞝ࠊᏲᮏᏊ OTOF 㑇ఏᏊኚ␗ࢆㄆࡵࡿ Auditory Neuropathy ᑠඣࡢேᕤෆ⪥⾡ᚋ 5 ᖺホ౯ ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.10.21-23. Ọ㑈ᩯࠊᯇỌ㐩㞝ࠊ❶Ꮚࠊ༡ಟྖ㑻ࠊ⸨ṇேࠊຍᡃྩᏕ ᪂ࡓ࡞ཎᅉ㑇ఏᏊࡀྠᐃࡉࢀࡓ Waardenburg ೃ⩌ Type Ϩࡢ 1 ᪥ᮏ⪥㰯ဗႃ⛉Ꮫᮾி㒔ᆅ᪉㒊 ➨ 209 ᅇᏛ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.11.7. ༡ಟྖ㑻ࠊ▮㒊⪽ᏊࠊⱝᯘẎࠊỌ㑈ᩯࠊ❶Ꮚࠊᓥ⏣㈗ಙࠊᓥྐ⾜ࠊᯇỌ㐔㞝ࠊゅ⏣ ୍ ᙜ⛉⿵⫈ჾእ᮶࠾ࡅࡿ⿵⫈ჾᣢࡕ㎸ࡳ㛵ࡍࡿ⪃ᐹ ➨ 15 ᅇ ୡ⏣㇂༊་ᖌ་Ꮫࠊᮾி㒔ࠊ2015.12.5. ༡ ಟྖ㑻, ➉⭜ ⱥᶞ, ຍᡃ ྩᏕ ⼗∵↓ᙧᡂ࠸ᑐࡍࡿேᕤෆ⪥ᡭ⾡㐺ᛂࡘ࠸࡚ࡢ⪃ᐹ ➨ 25 ᅇ᪥ᮏ⪥⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊ㛗ᓮࠊ2015.10.10 ༡ ಟྖ㑻, ົྎ ⱥᶞ, ᇼ ᪂, బ㔝 ᾈ୍㑻, ᱇ ㈨Ὀ, ⏣୰ ⸨ಙ, ℧ཱྀ ဴஓ, ▼ ┤ ᶞ, ᮧ , ❶Ꮚ, Ọ 㑈ᩯ, ᓥ ྐ⾜, ᯇỌ 㐩㞝, ⸨ ṇே, ຍᡃ ྩᏕ ୰⪥ᖖᅾ⳦ྀ៏ᛶ୰⪥⅖⣽⳦ྀࡢ 16SrRNA ⳦✀⤌ᡂゎᯒ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾிࠊ2016.5.23 ༡ ಟྖ㑻, ᴮᮏ ༓ỤᏊ, ቑ⏣ Ẏ, ᑠῲ ༓⤮, ᇛ㛫 ᑗỤ, ຍᡃ ྩᏕ ⼗∵⚄⤒ᗏᙧᡂ 20 ࡢ⾡๓⫈ぬᛂ࣭๓ᗞᶵ⬟ࠊ⾡୰ EABRࠊ࠾ࡼࡧ⾡ᚋ⏝ຠᯝ㛵 ࡍࡿ᳨ウ ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾிࠊ2015.10.22 ༡ ಟྖ㑻, ົྎ ⱥᶞ, ᯇỌ 㐩㞝 ୰⪥ᖖᅾ⳦ྀ៏ᛶ୰⪥⅖⣽⳦ྀࡢ 16SrRNA ⳦✀⤌ᡂゎᯒ ᪥ᮏே㢮㑇ఏᏛ ➨ 60 ᅇࠊᮾிࠊ2015.10.17 㤿ሙ ඃ ࢹࢢ࢚ࣜࣥࡣ㢌㢕㒊⒴ᑐࡋ࡚ EGFR-AKT ࠾ࡼࡧ IGF1R-AKT ࢆᶆⓗࡋ ࣏ࢺ࣮ࢩࢫࢆㄏᑟࡍࡿ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᖹᡂ 27 ᖺ 5 ᭶ 20 ᪥㹼5 ᭶ 23 ᪥ࠊᮾி ― 196 ― ᒣ⃝୍ᶞ ࣓ࢳࣝ␗ᖖ㉳ᅉࡍࡿᑠඣඛኳ␗ᖖೃ⩌࠾࠸࡚ࣄࢻࣟ࢟ࢩ࣓ࢳࣝࡀᯝࡓࡍᙺ ➨ 118 ᅇ᪥ᮏᑠඣ⛉Ꮫ 㜰 2015 ᖺ 4 ᭶ 18 ᪥ ᒣ⃝୍ᶞࠊᯇཎᆂᏊࠊ㙾㞞௦ࠊ῝ぢ┿⣖ࠊ୰ᯘ୍ᙪࠊ⥴᪉ ࣓ࢳࣝ␗ᖖ㉳ᅉࡍࡿ Kagami-Ogata ೃ⩌࠾࠸࡚ࣄࢻࣟ࢟ࢩ࣓ࢳࣝࡢᯝࡓࡍᙺ ࡢゎ᫂ ➨ 38 ᅇᑠඣ㑇ఏᏛ ᶓ 2015 ᖺ 7 ᭶ 25 ᪥ ᒣ⃝୍ᶞࠊᯇཎᆂᏊࠊ㙾㞞௦ࠊ୰ᯘ୍ᙪࠊ῝ぢ┿⣖ࠊ⥴᪉ IG-DMR ࡢ㧗࣓ࢳࣝ㉳ᅉࡍࡿ Kagami-Ogata ೃ⩌࠾ࡅࡿࣄࢻࣟ࢟ࢩ࣓ࢳࣝࡢ᥈ ⣴ ➨ 49 ᅇ᪥ᮏᑠඣෆศἪᏛ ᮾி 2015 ᖺ 10 ᭶ 9 ᪥ Yamazawa K, Matsubara K, Kagami M, Nakabayashi K, Hata K, Fukami M, Ogata T Exploration of hydroxymethylation in Kagami-Ogata syndrome caused by hypermethylation of imprinting control regions ASHG 2015 Annual Meeting, Baltimore, 2015.10.11 ᒣ⃝୍ᶞࠊᯇཎᆂᏊࠊ㙾㞞௦ࠊ୰ᯘ୍ᙪࠊ⛙୍㑻ࠊ῝ぢ┿⣖ࠊ⥴᪉ ࣥࣉࣜࣥࢸࣥࢢㄪ⠇㡿ᇦࡢ㧗࣓ࢳࣝ㉳ᅉࡋࡓ Kagami-Ogata ೃ⩌࠾ࡅࡿࣄࢻ ࣟ࢟ࢩ࣓ࢳࣝࡢ᥈⣴ ᪥ᮏே㢮㑇ఏᏛ➨ 60 ᅇ ᮾி 2015 ᖺ 10 ᭶ 15 ᪥ Pioche M, Rivory J, Aguero G, Guillaud O, O'Brien M, Uraoka T, Yahagi N, Ponchon T. New isolated bovine colon model dedicated to colonic ESD hands-on training: development and first evaluation. Digestive Disease Week 2015, Washington D.C. /USA, May 2015 Fujimoto A, Ochiai Y, Goto O, Nishizawa T, Nakamura R, Maehata T, Kinoshita S, Sagara S, Uraoka T, Yahagi N. Efficacy of a 2% rebamipide solution as a novel submucosal injection agent for gastric endoscopic submucosal dissection. Digestive Disease Week 2015, Washington D.C. /USA, May 2015 Uraoka T, Fujimoto A, Ochiai Y, Goto O, Kawahara Y, Hori K, Masayuki S, Yahagi Y. High pressure carbon dioxide submucosal injection in endoscopic submucosal dissection. Digestive Disease Week 2015, Washington D.C. /USA, May 2015 ― 197 ― Takatori Y, Kato M, Suzuki M, Abe K, Hirata T, Takada Y, Naruse T, Takabayashi K, Kikuchi M, Fujiyama Y, Takahashi M, Uraoka T. History of gastro-duodenal ulcer as an independent predictor for requirement of endoscopic intervention for non-variceral upper gastrointestinal bleeding. Digestive Disease Week 2015, Washington D.C. /USA, May 2015 Sato M, Kato M, Suzuki M, Abe K, Takada Y, Hirata T, Takatori Y, Naruse T, Takabayashi K, Kikuchi M, Fujiyama Y, Takahashi M, Uraoka T. Should all patients with colonic diverticular hemorrhage undergo urgent colonoscopy? Digestive Disease Week 2015, Washington D.C. /USA, May 2015 Uraoka T, Tanaka S, Saito Y, Matsumoto T, Saito S, Oka S, Matsuda T, Moriyama T, Ogata H, Yahagi N, Tajiri H, Ishikawa H. Diagnostic value of extra-wide-angle-view colonoscope in the aAdenoma detection: a multicenter randomized controlled trial. Digestive Disease Week 2015, Washington D.C. /USA, May 2015 Uraoka T, Fujimoto A, Ochiai Y, Goto O, Maehata T, Nishizawa T, Kawahara Y, Hori K, Kato M, Shimoda M, Yahagi N. A novel high-pressure carbon dioxide submucosal injection technique in endoscopic submucosal dissection. United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 Kato M, Sakaguchi E, Abe K, Takada Y, Hirata T, Banno S, Wada M, Takatori T, Kinoshita S, Kikuchi H, Takabayashi K, Kikuchi M, Kikuchi M, Fujiyama Y, Suzuki M, Ohishi T, Uraoka T. Screening colonoscopy for subjects older than 85 years old. United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 Wada M, Kato M, Sakaguchi E, Ishibashi Y, Banno S, Abe K, Takada Y, Hirata T, Takatori Y, Kinoshita S, Takabayashi, Kikuchi M, Kikuchi M, Fujiyama Y, Suzuki M, Uraoka T. The history of colonic diverticular hemorrhage and colonoscopic hemostasis are independent predictors for reccurent hemorrhage. United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 Hirata T, Uraoka T, Kato M, Sakaguchi E, Ishibashi Y, Banno S, Abe K, Takada Y, Takatori Y, Wada M, Kinoshita S, Takabayashi, Kikuchi M, Kikuchi M, Fujiyama Y, Suzuki M, Ohishi T. Endoscopic management for sigmoid volvulus : Should we perform endoscopic detorsion all cases? United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 ― 198 ― Takatori Y, Kato M, Sakaguchi E, Ishibashi Y, Banno S, Abe K, Takada Y, Hirata T, Wada M, Kinoshita S, Takabayashi, Kikuchi M, Kikuchi M, Fujiyama Y, Suzuki M, Uraoka T. History of gastro-duodenal ulcer is an independent predictor for requirement of endoscopic hemostasis for non-variceral upper gastrointestinal bleeding. United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 Maehata T, Uraoka T, Goto O, Akimoto T, Sagara S, Ochiai Y, Fujimoto A, Nishizawa T, Yahagi N. Varidity of endoscopic submucosal dissection for colorectal T1 (submucosal invation) cancer. United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 Ochiai Y, Akimoto T, Sagara S, Maehata T, Fujimoto A, Nakamura R, Nishizawa T, Goto O, Uraoka T, Yahagi N. Clinical outcome of endoscopic submucosal dissection for superficial duodenal neoplasm in 60 lesions. United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 Pioche M, Rivory J, Nishizawa T, Uraoka T, Lienhart I, Ponchon T, Yahagi N. Randomized comparative evaluation of an ESD self-learning software in France and Japan. United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 Fujimoto A, Goto O, Akimoto T, Maehata T, Ochiai Y, Nishizawa T, Nakamura R, Sagara S, Akimoto T, Shimoda M, Uraoka T, Yahagi N. Evaluation of the speed and quality of gastric ulcer healing after ESD using 2% rebamipide solution as a novel submucosal injection material. United Enropean Gastroenterology 2015, Barcelona / Spain, Oct 2015 Kato M, Nishida T, Yamamoto T, Kitamura S, Yamada T, Egawa S, Komori M, Kawai N, Nishihara A, Nakanishi F, Nakahara M, Ogiyama H, Mukai A, Hayashi Y, Tsujii M, Takehara T Severe atrophic gastritis is a significant risk factor of metachronous multiple gastric cancer: A Multicentre Retrospective Cohort Study by the Osaka Gut Forum. United European Gastroenterology Week 2015, Barcelona / Spain, Oct 2015 Masahiro Kikuchi, Rumiko Umeda, Kota Tsuruya, Hirokazu Shiozawa, Miho Kikuchi, Masahiko Takahashi, Yoshinori Horie, Yasuhiro Nishizaki Diagnostic accuracy for non-alcoholic fatty liver disease (NAFLD) with controlled attenuation parameter (CAP) measured by transient elastography The 66th American Association for the Study of the Liver San Francisco(USA), 2015.11.17 ― 199 ― Yasuhiro Nishizaki, Chizumi Yamada, Noriaki Kishimoto, Nobushige Yukumatsu, Hirokazu Shiozawa, Norihito Watanabe, Rumiko Umeda, Masahiro Kikuchi, Takanori Kanai, Naoaki Tshii Ferritin derived oxidative stress is a risk for liver damage even within reference range in male The 10th World Congress for Microcirculation, Kyoto, 2015.9.25 Habu, N., Y. Imanishi, K. Kameyama, M. Shimoda, Y. Tokumaru, K. Sakamoto, R. Fujii, S. Shigetomi, K. Otsuka, Y. Sato, Y. Watanabe, H. Ozawa, T. Tomita, M. Fujii and K. Ogawa (2015). "Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma." BMC Cancer 15: 730. Kunio Mizutari Endoscopic Tympanoplasty, The initial difficulties. 1st World Congress on Endoscopic Ear Surgery, Dubai, UAE, 2015.4.19 㧗ྲྀ♸స, ຍ⸨ඖᙪ, 㕥ᮌ㞞அ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, ᡂ℩ᬛᗣ, 㧗 ᯘ㤾, ⳥ụ┿, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ. ⫶༑ᣦ⭠₽⒆ࡢ᪤ ࡣୖ㒊ᾘ⟶ฟ⾑ᝈ⪅࠾࠸࡚ෆど㙾ⓗṆ⾑⾡ࡢ⊂❧ࡋࡓ༴㝤ᅉᏊ ࡛࠶ࡿ. ➨ 11 ᅇ᪥ᮏᾘ⟶Ꮫ⥲Ꮫ⾡㞟, ᮾி㒔᪂ᐟ༊, 2015.2 ᚋ⸨ ಟ, ๓⏿ᛅ㍤, ⸨ᮏ ឡ, ୗ⏣ᑗஅ, ᯇ⏣ 㐩㞝, బࠎᮌ ᇶ, ⴠྜᗣ, ᇼᇛ୍ᮁ, ᾆ ᒸಇኵ, ᕝஂಖ༤ᩥ, ➉ෆ⿱ஓ, ᕝ㞝ග, ▮స┤ஂ. SM ⫶⒴ᑐࡍࡿෆど㙾ⓗᒙษ㝖⾡࠾ࡅࡿ㐺ษ࡞ษ㞳᩿➃㊥㞳ࡢ᳨ウ. ➨ 11 ᅇ᪥ᮏᾘ ⟶Ꮫ⥲Ꮫ⾡㞟, ᮾி㒔᪂ᐟ༊, 2015.2 ᇼ ᆂ, ᾆᒸಇኵ, ཎ⏣㤾ኴ, ᮾ ⋹, Ἑཎ⚈ᮁ, ᒸ⏣⿱அ, ▮స┤ஂ ᒣᮏ⚽. ࣮ࣛࢽࣥࢢ࣮࢝ࣈᛂࡌࡓ⭠ ESD ᅔ㞴ࡢண ᅉᏊ㛵ࡍࡿ᳨ウ. ➨ 11 ᅇ᪥ᮏᾘ ⟶Ꮫ⥲Ꮫ⾡㞟, ᮾி㒔᪂ᐟ༊, 2015.2 㣬ᮏဴර, ᚋ⸨ ಟ, ᮌୗ ⪽, ┦Ⰻㄔ, ⸨ᮏ ឡ, ⴠྜᗣ, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ᾆᒸ ಇኵ, ⥴᪉ᬕᙪ, ᆏᮏ㛗㐓, ▮స┤ஂ. ᙜ㝔࡛῝㐩ᗘデ᩿ࡀᅔ㞴࡛࠶ࡗࡓ᪩ᮇ⫶⒴ෆど㙾⒪ࡢ᳨ウ. ➨ 11 ᅇ᪥ᮏᾘ⟶Ꮫ ⥲Ꮫ⾡㞟, ᮾி㒔᪂ᐟ༊, 2015.2 ๓⏿ᛅ㍤, ᚋ⸨ ಟ, ➉ෆ⿱ஓ, 㣬ᮏဴර, ᮌୗ ⪽, ┦Ⰻㄔ, す⃝ಇᏹ, ⸨ᮏ ឡ, ⴠྜᗣ , ᾆᒸಇኵ, ➉ෆ⿱ஓ, ᕝ㞝ග, ▮స┤ஂ. NEWS ࢭࣥࢳࢿࣝࣜࣥࣃ⠇ࢼࣅࢤ࣮ࢩࣙࣥᡭ⾡ࡢ⼥ྜࡼࡿ᪂ࡋ࠸⫶⒴⦰ ᑠᡭ⾡. ➨ 87 ᅇ᪥ᮏ⫶⒴ᏛᏛ⾡㞟, 2015 3 ― 200 ― ᾆᒸಇኵ, ຍ⸨ඖᙪ, ▮స┤ஂ㸬 ⭠ ESD ⒪ᅔ㞴ᑐࡍࡿࣉ࣮ࣟࢳ ɆDual knifeɆ ➨ 101 ᅇ᪥ᮏᾘჾᏛᏛ⾡ 㞟, ᐑᇛ┴ྎᕷ, 2015.4 ຍ⸨ඖᙪ, ▼ᓫ, ᾆᒸಇኵ㸬 ↓≧ࡢ 85 ṓ௨ୖࡢ㉸㧗㱋⪅⭠ෆど㙾᳨ᰝࡣᚲせ㸽 ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 ⸨ᮏឡ, ᾆᒸಇኵ, ▮స┤ஂ㸬 Dual Red Imaging ࡢ⌧≧ᒎᮃ㸬➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 ⴠྜᗣ, ᾆᒸಇኵ, ▮స┤ஂ㸬 ┤⭠⫠㛛㒊⭘⒆࠾ࡅࡿෆど㙾⒪ᅔ㞴ኚᑐࡍࡿ ESD㸬➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 ᾆᒸಇኵ, ᚋ⸨ಟ, ▮స┤ஂ㸬 ⫶ ESD ᚋ₽⒆ᑐࡍࡿ᪂つ⮬ᕫ⤌⧊࣌ࣉࢳࢻỈ⁐ᾮࡢ⮫ᗋᛂ⏝ࡢྍ⬟ᛶ㸬➨ 89 ᅇ᪥ᮏ ᾘჾෆど㙾Ꮫ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 ๓⏿ᛅ㍤, ᾆᒸಇኵ, 㣬ᮏဴර, ᮌୗ⪽, ┦Ⰻㄔ, బࠎᮌᇶ, す⃝ಇᏹ, ᚋ⸨ಟ, ⸨ᮏឡ, ⴠྜᗣ, ▮స┤ஂ㸬 ᪩ᮇ⭠⒴ pT1(SM)ᑐࡍࡿ ESD ࡢጇᙜᛶ㸬➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲, ឡ ▱┴ྡྂᒇᕷ, 2015.5 ┦Ⰻㄔ, ᚋ⸨ಟ, 㣬ᮏဴර, ᮌୗ⪽, ⸨ᮏឡ, ⴠྜᗣ, ๓⏿ᛅ㍤, す⃝ಇᏹ, ᾆᒸಇኵ, ⥴᪉ᬕᙪ, ▮స┤ஂ㸬 ᙜ⛉࠾ࡅࡿࢹ࢟ࢧ࣓ࢹࢺ࣑ࢪࣥ㙠㟼ୗ㧗㞴ᗘ ESD ࡢᐇ㝿㸬➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 㧗ྲྀ♸స, ຍ⸨ඖᙪ, 㕥ᮌ㞞அ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ဴ, బ⸨㐨Ꮚ, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ㸬 ⫶༑ᣦ⭠₽⒆ࡢ᪤ ࡣୖ㒊ᾘ⟶ฟ⾑ᝈ⪅࠾ࡅࡿෆど㙾ⓗṆ⾑⾡ࡢせྰᑐࡍࡿ⊂❧ ࡋࡓண ᅉᏊ࡛࠶ࡿ㸬➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 ᮌୗ ⪽, す⃝ಇᏹ, 㣬ᮏဴර, ┦Ⰻㄔ, ᚋ⸨ಟ, ๓⏿ᛅ㍤, ⸨ᮏឡ, ⴠྜᗣ, ୰ᮧ⌮ᜨ Ꮚ, ᾆᒸಇኵ, ▮స┤ஂ㸬 ༑ᣦ⭠⭘⒆ᑐࡍࡿෆど㙾⒪⒪ᡓ␎ࡢ⌧≧㸬➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 ― 201 ― బ⸨㐨Ꮚ, ຍ⸨ඖᙪ, 㕥ᮌ㞞அ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ဴ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ⳥ụ┿, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ㸬 ⭠᠁ᐊฟ⾑ෆど㙾ⓗṆ⾑⾡ࢆ⾜ࡍࡁ㸽㹼ฟ⾑ࣜࢫࢡᅉᏊ㛵ࡍࡿᚋ᪉ど ⓗࢥ࣮࣍ࢺ◊✲㹼㸬➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 㣬ᮏဴර, ᚋ⸨ಟ, ᮌୗ⪽, ┦Ⰻㄔ, ⸨ᮏឡ, ⴠྜᗣ, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ᳜ᮌಙỤ, ᾆᒸಇኵ, ㎮ཱྀ⠜ᚿ, ୕Ꮿ୍ᫀ, ᆏᮏ㛗㐓, ▮స┤ஂ㸬 H.pylori 㝖⳦ᚋ⫶⒴࠾ࡼࡧ⫼ᬒ⢓⭷⏕ࡌࡿ⤌⧊Ꮫⓗኚෆど㙾デ᩿ࡢ᳨ウ㸬 㸬➨ 89 ᅇ ᪥ᮏᾘჾෆど㙾Ꮫ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 ᴿᾈ⾜, ཎ⏣㤾ኴ, ᾆᒸಇኵ, 㧗ᔱᚿಖ, ཱྀಇ༤, ➉, ᮡཎ㞝⟇, ༙᫂᪥㤶, 㧗ཎ ᨻᏹ, ᑠᯘἋ௦, 㧗ᶫ⣴┿, 㰺⸨ಇ, ᇼᇛ୍ᮁ, ᮾ⋹, ᖹᒸబつᏊ, ᒸ⏣⿱அ, ᒣᮏ ⚽㸬 ෆど㙾ⓗ⢓⭷ୗᒙ㞳⾡(ESD)ࡀ⾜ࡉࢀࡓ⭠ T1(SM)⒴ࡢ⒪ᡂ⦼ணᚋࡢ᳨ウ㸬➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲, ឡ▱┴ྡྂᒇᕷ, 2015.5 ᾆᒸಇኵ, ▮స┤ஂ㸬 ⭠⒴ࢫࢡ࣮ࣜࢽࣥࢢ࠾ࡅࡿ㏆ᮍ᮶ࡢ⭠ෆど㙾ࣔࢲࣜࢸ࣮㸬➨ 100 ᅇ᪥ᮏᾘჾෆ ど㙾Ꮫ㛵ᮾᆅ᪉, ᮾி㒔༓௦⏣༊, 2015.6 㧗ᯘ 㤾, 㜿㒊ᆂ୍㑻, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, ຍ⸨ඖᙪ, ⳥ụ ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ㸬 ⭠ ESD ࠾ࡅࡿᡭᢏⓗᅔ㞴ࠊ⾡ᚋ⊃✽ᑐࡍࡿ᳨ウ㸬➨ 100 ᅇ᪥ᮏᾘჾෆど 㙾Ꮫ㛵ᮾᆅ᪉, ᮾி㒔༓௦⏣༊, 2015.6 ⸨ᮏ ឡ,ⴠྜ ᗣ,ᚋ⸨ ಟ, ๓⏿ᛅ㍤, ᇼᇛ୍ᮁ, 㧗ᯘ 㤾, 㣬ᮏဴර, ┦Ⰻㄔ, ᮌୗ ⪽, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ᾆᒸಇኵ, ▮స ┤ஂ. Dual Red Imaging ࡢ⌧≧ᒎᮃ㸬➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉, ᮾி㒔༓௦ ⏣༊, 2015.6 ᖹ⏣ ဴ, ຍ⸨ ඖᙪ, 㜿㒊ᆂ୍ᮁ 㧗⏣♸᫂, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ⳥ ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, 㕥ᮌ㞞அ, 㧗ᶫṇᙪ, ᾆᒸಇኵ㸬 S ≧⤖⭠㌿ᑐࡍࡿෆど㙾ⓗᩚࡢព⩏ࡘ࠸࡚ࡢ᳨ウ㸬➨ 100 ᅇ᪥ᮏᾘჾෆど㙾 Ꮫ㛵ᮾᆅ᪉, ᮾி㒔༓௦⏣༊, 2015.6 ⴠྜᗣ, 㣬ᮏဴර, ᮌୗ ⪽, ┦Ⰻㄔ, ๓⏿ᛅ㍤, ⸨ᮏ ឡ, ᚋ⸨ ಟ, ୰ᮧ⌮ᜨᏊ, す⃝ ಇᏹ, ᾆᒸಇኵ, ▮స┤ஂ㸬 ᙜ㒊㛛࠾ࡅࡿ༑ᣦ⭠ ESD ࡢᏳᛶ࠾ࡼࡧ᭷ຠᛶࡢホ౯㸬➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ 㛵ᮾᆅ᪉, ᮾி㒔༓௦⏣༊, 2015.6 ― 202 ― ❑⃝㝧Ꮚ, 㧗ᯘ 㤾, 㧗ྲྀ♸స, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨ 㐨Ꮚ, ᡂ℩ᬛᗣ, ຍ ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, 㰺⸨ඃᏊ, ᒣᮏ⣪つᏊ, ᮧ⏣᭷ஓ, ๓ᓥ᪂ྐ, 㧗ᶫṇᙪ,బ⸨ 㝯, ᾆᒸಇኵ㸬 ከ⮚ჾ㌿⛣ࢆ᮶ࡋࡓ㣗㐨ཎⓎ↓Ⰽ⣲ᛶᝏᛶ㯮Ⰽ⭘ࡢ 1 㸬➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ 㛵ᮾᆅ᪉, ᮾி㒔༓௦⏣༊, 2015.6 㣬ᮏဴර, ᚋ⸨ ಟ, 㭯⏣ 㞞ኈ, ᮌୗ ⪽, ┦Ⰻㄔ, ⸨ᮏ ឡ, ⴠྜᗣ, ๓⏿ᛅ㍤, す⃝ಇ ᏹ, ୰ᮧ⌮ᜨᏊ, ᾆᒸಇኵ, ⥴᪉ᬕᙪ, டᒣ㤶⧊, ▮స ┤ஂ㸬 ESD ࡛ษ㝖ࡉࢀࡓ SM ῝㒊ᾐ₶⒴ࡀ▷ᮇ㛫࡛ᒁᡤⓎࡋࡓ 1 㸬➨ 100 ᅇ᪥ᮏᾘჾ ෆど㙾Ꮫ㛵ᮾᆅ᪉, ᮾி㒔༓௦⏣༊, 2015.6 ┦Ⰻㄔ, ᚋ⸨ ಟ, 㣬ᮏဴර, ᮌୗ ⪽, ⸨ᮏ ឡ, ⴠྜᗣ, ๓⏿ᛅ㍤, す⃝ಇᏹ, ᾆᒸಇ ኵ, ▮స┤ஂ㸬 ESD ⒪㏵୰ࡼࡾࢹࢡࢫ࣓ࢹࢺ࣑ࢪࣥࢆᑟධࡋⰋዲ࡞㙠㟼ࡀᚓࡽࢀࡓ 2 㸬➨ 100 ᅇ᪥ ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉, ᮾி㒔༓௦⏣༊, 2015.6 㧗⏣♸᫂, ຍ⸨ඖᙪ, 㜿㒊ᆂ୍㑻, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ⳥ụ ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, 㕥ᮌ㞞அ, 㧗ᶫṇᙪ, ᾆᒸಇኵ㸬 ᑠ⭠ࢽࢧ࢟ࢫࡢ⮫ᗋീࡘ࠸࡚ࡢ᳨ウ㸬Japan Digestive Disease Week, රᗜ┴࣭⚄ᡞ ᕷ, 2015. 10 ⳥ụ┿, すᓮὈᘯ, ᡂ℩ᬛᗣ, 㧗ᯘ 㤾, ຍ⸨ඖᙪ, ⳥ụ⨾✑, ⸨ᒣὒ୍, ᾆᒸಇኵ, 㧗ᶫ ṇᙪ, ᒣᓊ⏤ᖾ, ᇼỤ⩏๎, ຍ⸨┾୕, 㔠㝯㸬 CAP(Controlled Attenuation Parameter)┦㛵࣐࣮࣮࢝ࡢ᳨ウ㸪ࣝࢥ࣮ࣝᛶ⫢㞀ᐖ࣭㠀 ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈࡢ㚷ู㸬Japan Digestive Disease Week, රᗜ┴࣭⚄ᡞᕷ, 2015, 10 ⸨ᮏ ឡ, ୗ⏣ᑗஅ, す⃝ಇᏹ, ୰ᮧ⌮ᜨᏊ, ⴠྜᗣ, ๓⏿ᛅ㍤, ᚋ⸨ ಟ, ┦Ⰻㄔ, ᮌୗ ⪽, 㣬ᮏဴර, ᾆᒸಇኵ, ▮స┤ஂ㸬 ᒙษ㝖௦ࡢ᪩ᮇ⫶⒴⠊ᅖデ᩿ - ഃ᪉ఙᒎ㊥㞳㛵ࡍࡿ⌮Ꮫⓗ᳨ウ㸬Japan Digestive Disease Week, රᗜ┴࣭⚄ᡞᕷ, 2015. 10 ຍ⸨ඖᙪ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, 㧗ྲྀ♸స, ᡂ℩ᬛᗣ, ⳥ụᘯே, 㧗 ᯘ 㤾, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, ▼ ᓫ, ᾆᒸಇኵ㸬 ㉸㧗㱋⪅ᑐࡍࡿ⭠ෆど㙾᳨ᰝࡢ㐺ᛂࡘ࠸࡚ࡢ᳨ウ㸬Japan Digestive Disease Week, රᗜ┴࣭⚄ᡞᕷ, 2015. 10 ┦Ⰻㄔ, ᚋ⸨ ಟ, 㣬ᮏဴර, ⸨ᮏ ឡ, ๓⏿ᛅ㍤, ⴠྜᗣ, す⃝ಇᏹ, ᾆᒸಇኵ, ▮స┤ ஂ㸬 ⭠ ESD ᅔ㞴࠾ࡅࡿࣂ࣮ࣝࣥෆど㙾ࡢ᭷⏝ᛶࡢ᳨ウ㸬Japan Digestive Disease Week, රᗜ┴࣭⚄ᡞᕷ, 2015. 10 ― 203 ― 㜿㒊ᆂ୍ᮁ, ⳥ụ┿, ᮌୗ ⪽, 㧗ᯘ 㤾, ຍ⸨ඖᙪ, ⳥ụ⨾✑, ⸨ᒣὒ୍, ᾆᒸಇኵ. ࣝࢥ࣮ࣝᛶ៏ᛶ⮅⅖ࡼࡿ⮅ᛶ⭡Ỉᑐࡋ࡚࢜ࢡࢺࣞ࢜ࢳࢻ㓑㓟ሷࡀዌຌࡋࡓ 1 . ➨ 50 ᅇࣝࢥ࣮࣭ࣝ⸆≀౫Ꮡ㛵㐃ᏛྜྠᏛ⾡⥲. රᗜ┴࣭⚄ᡞᕷ, 2015. 10 㧘ᯘ 㤾ࠊᆏཱྀᜨ⨾ࠊ㜿㒊ᆂ୍ᮁࠊ㧗⏣♸᫂ࠊᖹ⏣ ဴࠊక㔝⦾㞝ࠊ⏣㐨Ꮚࠊ㧗ྲྀ♸సࠊ▼ ᶫᗣ๎ࠊᮌୗ ⪽ࠊ⳥ụ⨾✑ࠊຍ⸨ඖᙪࠊ⳥ụ┿ࠊ⸨ᒣὒ୍ࠊᾆᒸಇኵ㸬 ☜ᐇ࡞ Cold snare polypectomy ࢆᛕ㢌⨨࠸ࡓࢫࢿࡢ㑅ᢥ㸬᪥ᮏ⭠᳨ᰝᏛ㸬ᮾி㒔 ༓௦⏣༊, 2015. 11 ᖹ⏣ ဴ, ⳥ụ┿, ᆏཱྀᐇ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ⏣㐨Ꮚ, క㔝⦾㞝, 㧗ྲྀ♸స, ᮌ ୗ ⪽, 㧘ᯘ 㤾, ⳥ụ⨾✑, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ㸬 ᙜ㝔࠾ࡅࡿ⫢ᛶ⭡Ỉᑐࡍࡿࢺࣝࣂࣉࢱࣥᑟධ㸬➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫ, ᮾி㒔 ୡ⏣㇂༊, 2015. 12 㜿㒊ᆂ୍㑻, ⳥ụ┿, ᆏཱྀᐇ, 㧗⏣♸᫂, ᖹ⏣ ဴ, ⏣㐨Ꮚ, క㔝⦾㞝, 㧗ྲྀ♸స, ᮌ ୗ ⪽, 㧘ᯘ 㤾, ⳥ụ⨾✑, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ㸬 ERCP(ෆど㙾ⓗ㏫⾜ᛶ⮅⫹⟶㐀ᙳ)࠾ࡅࡿ⮅⟶ࢫࢸࣥࢺࡢ᭷⏝ᛶ㸬➨ 15 ᅇୡ⏣㇂༊་ᖌ ་Ꮫ, ᮾி㒔ୡ⏣㇂༊, 2015. 12 క㔝⦾㞝, 㧘ᯘ 㤾, ᆏཱྀᐇ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, ⏣㐨Ꮚ, 㧗ྲྀ♸స, ᮌ ୗ ⪽, ⳥ụ⨾✑, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, ⓑ▼῟୍, ᾆᒸಇኵ㸬 ᙜ㝔࡛ෆど㙾ⓗ⢓⭷ୗᒙ㞳⾡ࢆ⾜ࡋࡓ Barrett ⭢⒴ࡢ᳨ウ㸬➨ 15 ᅇୡ⏣㇂༊་ᖌ་ Ꮫ, ᮾி㒔ୡ⏣㇂༊, 2015. 12 ຍ⸨ඖᙪ, ☾㒊 㝧, ᆏཱྀᐇ, 㧘ᯘ 㤾, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ⏣㐨Ꮚ, క㔝⦾㞝, 㧗 ྲྀ♸స,ᮌୗ ⪽, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ㸬 ୖ㒊ᾘ⟶⭘⒆ᑐࡍࡿ⭡⭍㙾ෆど㙾ྜྠᡭ⾡(LECS)ࡼࡿపく⒪㸬➨ 15 ᅇୡ⏣㇂ ༊་ᖌ་Ꮫ, ᮾி㒔ୡ⏣㇂༊, 2015. 12 㧗ྲྀ♸స, ຍ⸨ඖᙪ, 㕥ᮌ㞞அ, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, బ⸨㐨Ꮚ, ᡂ℩ᬛᗣ, 㧗 ᯘ㤾, ⸨ᒣὒ୍, 㧗ᶫṇᙪ, ᾆᒸಇኵ㸬 ESD ࡢᬑཬࡣෆど㙾ⓗṆ⾑⾡࡞ࢆࡶࡓࡽࡋࡓ㸬➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫ, ᮾி 㒔ୡ⏣㇂༊, 2015. 12 క㔝⦾㞝, 㧘ᯘ 㤾, ᆏཱྀᜨ⨾, 㜿㒊ᆂ୍ᮁ, 㧗⏣♸᫂, ᖹ⏣ ဴ, ⏣㐨Ꮚ, 㧗ྲྀ♸స, ▼ ᶫᗣ๎,ᮌୗ ⪽, ⳥ụ⨾✑, ຍ⸨ඖᙪ, ⳥ụ┿, ⸨ᒣὒ୍, ᾆᒸಇኵ. NBI ే⏝ᣑほᐹ࠾ࡼࡧ㉸㡢Ἴෆど㙾ࡀ῝㐩ᗘデ᩿᭷⏝࡛࠶ࡗࡓ 0-IIc㸩Is ᆺ㣗㐨⒴ࡢ୍ . ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉. ᮾி㒔༓௦⏣༊, 2015.12 ― 204 ― 㧗⏣♸᫂, ຍ⸨ඖᙪ, ᆏཱྀ⨾, 㜿㒊ᆂ୍ᮁ, ᖹ⏣ ဴ, 㧗ྲྀ♸స, క㔝⦾㞝, ⏣㐨Ꮚ, ᮌ ୗ ⪽, 㧗ᯘ 㤾, ⳥ụ⨾✑, ⳥ụ┿, ⸨ᒣὒ୍, 㕥ᮌ㞞அ, ᾆᒸಇኵ. ⭢⒴ᡂศࡀΰᅾࡋࡓ㣗㐨⫶᥋ྜ㒊ཎⓎ⚄⤒ෆศἪ⒴ࡢ 1 ๗᳨. ᪥ᮏᾘჾᏛ➨ 337 ᅇ㛵ᮾᨭ㒊, ᮾி༓௦⏣༊, 2015.12 ఀᮾఙ๛, ┦㤿ᓫᏹ, ጒᑿ⪽⨾, ☾㒊⩏᠇, ᆏཱྀ⨾, ⳥ụ┿ ྤ⾑࡛Ⓨࡋࡓ Budd-Chiari ೃ⩌ࡢ୍ ᮾிࣥࢠ࣭࢜㹇㹔㹐ࠊ ᮾிࠊ2015.12.10 ᪂ᓥ㍜, ᐑཎ᫂㔛, ᶲ ᭸⨾, 㛗㇂㒊ࡺࡾ, 㜿㒊ᆂ୍ᮁ, ⳥ụ⨾✑, ⳥ụ┿ ᙜ㝔࠾ࡅࡿ⫢⮚ᩍᐊࡢྲྀࡾ⤌ࡳ ➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫ, ᮾி㒔ୡ⏣㇂༊, 2015. 12 ᇼỤ⩏๎㸪ᾏ⪁ᾈ㸪୰ᮏఙᏹ㸪⳥ụ┿㸪㔠㝯 ᮏ㑥࠾ࡅࡿࣝࢥ࣮ࣝᛶ⫢⅖ࡢᐇែɆ2013 ᖺᗘࡢࡢゎᯒɆ ➨ 41 ᅇ᪥ᮏ⫢⮚Ꮫす㒊ࠊឡ▱┴ྡྂᒇᕷࠊ2015.12 ᱵ⏣⍠⨾Ꮚ㸪ሷ⃝ᏹ㸪⳥ụ┿㸪すᓮὈᘯ ࣝࢥ࣮ࣝᛶ⫢◳ኚࡢ㞴ᛶ⭡Ỉᑐࡋ⭡Ỉ✸่ CART㸦Cell-free and Concentrated AscitesReinfusion Therapy㸧ࢆే⏝ࡋⰋዲ࡞⤖ᯝࢆᚓࡓ 2 ➨ 41 ᅇ᪥ᮏ⫢⮚Ꮫす㒊ࠊឡ▱┴ྡྂᒇᕷࠊ2015.12 ⳥ụ┿㸪ᇼỤ⩏๎㸪⏣ㅬ࿃㸪ᱵ⏣⍠⨾Ꮚ㸪㭯㇂ᗣኴ㸪ሷ⃝ᏹ㸪すᓮὈᘯ㸪⳥ụ⨾✑㸪 㧗ᶫṇᙪ㸪㔠㝯 ࣝࢥ࣮ࣝᛶ⫢㞀ᐖ㠀ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈ࠾ࡅࡿ⫢◳ᗘ⭁⭘ࡢ㐃㛵ᛶ㛵 ࡍࡿ᳨ウ ➨ 41 ᅇ᪥ᮏ⫢⮚Ꮫす㒊ࠊឡ▱┴ྡྂᒇᕷࠊ2015.12 ᇼỤ⩏๎㸪⳥ụ┿㸪㔠㝯 ෆ⛉་ࡢ❧ሙࡽࡢࣝࢥ࣮ࣝ⒪࠾ࡅࡿ་⒪㐃ᦠᚰ⌮♫ⓗ⒪ ➨ 50 ᅇ᪥ᮏࣝࢥ࣮࣭ࣝ⸆≀་Ꮫ㸪රᗜ௳⚄ᡞᕷ㸪2015.10 ⳥ụ┿ࠊᇼỤ⩏๎ࠊ⏣ㅬ࿃ࠊᱵ⏣⍠⨾Ꮚࠊ㭯㇂ᗣኴࠊሷ⃝ᏹࠊすᓮὈᘯࠊ⳥ụ⨾ ✑ࠊ㧗ᶫṇᙪࠊ㔠㝯 ࣝࢥ࣮ࣝᛶ⫢㞀ᐖ㠀ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈ࠾ࡅࡿ⫢◳ᗘ⭁⭘ࡢ┦㛵ᛶ ➨ 50 ᅇ᪥ᮏࣝࢥ࣮࣭ࣝ⸆≀་Ꮫ㸪රᗜ௳⚄ᡞᕷ㸪2015.10 ― 205 ― ⳥ụ┿ࠊすᓮὈᘯࠊᮌୗ⪽ࠊᡂ℩ᬛᗣࠊ㧗ᯘ㤾ࠊຍ⸨ඖᙪࠊ⳥ụ⨾✑ࠊ⸨ᒣὒ୍ࠊᾆᒸ ಇኵࠊ㧗ᶫṇᙪࠊᒣᓊ⏤ᖾࠊᇼỤ⩏๎ࠊຍ⸨┾୕ࠊ㔠㝯 CAP(Controlled Attenuation Parameter)┦㛵࣐࣮࣮࢝ࡢ᳨ウࣝࢥ࣮ࣝᛶ⫢㞀ᐖ࣭㠀 ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈࡢ㚷ู ➨ 23 ᅇ Japan Digestive Disease Weekࠊᮾிࠊ 2015.10 ⳥ụ┿ࠊᇼỤ⩏๎ࠊ⳥ụ⨾✑ࠊ㧗ᶫṇᙪࠊᱵ⏣⍠⨾Ꮚࠊሷ⃝ᏹࠊすᓮὈᘯࠊᒣᓊ⏤ ᖾࠊຍ⸨┾୕ࠊ㔠㝯 ࣝࢥ࣮ࣝᛶ⫢㞀ᐖ㠀ࣝࢥ࣮ࣝᛶ⬡⫫ᛶ⫢ᝈ࠾ࡅࡿ⫢◳ᗘ⭁⭘ࡢ㛵ಀ ➨ 22 ᅇ᪥ᮏ㛛⬦ᅽஹ㐍Ꮫ せᮃ₇㢟ࠊᶓࠊ 2015.9.11 ⳥ụ┿, 㧗ᯇ༓⧊, 㕥ᮌᰤ㔛Ꮚ, ㏆⸨┿, ᒣ⏣༓✚, ᓊᮏ᠇᫂, ᱵ⏣⍠⨾Ꮚ ,㭯㇂ᗣኴ, ሷ⃝ᏹ, すᓮὈᘯ, ⳥ụ⨾✑, 㧗ᶫṇᙪ, 㔠㝯 ே㛫ࢻࢵࢡ࡛ࡢ⢾ᒀᝈ⪅࠾ࡅࡿ⫢ᶵ⬟␗ᖖ⋡࣭⬡⫫⫢㝧ᛶ⋡ࡢゎᯒࠊFibroscan ࢹ࣮ ࢱࡢ᳨ウ ➨㸰ᅇ⫢⮚⢾ᒀࠊ௦ㅰ◊✲ࠊᒣཱྀ┴ୗ㛵ᕷࠊ 2015.5.23 ᓊᮏ᠇᫂ࠊᒣ⏣༓✚ࠊ➉⏣㯞⨾ࠊᑿᙧ⌔ᜨࠊ㯮⏣ᜨ⨾Ꮚࠊ⳥ụ┿ࠊ㇂㔝㝯୕㑻ࠊஂಖ᫂ࠊ ▼┤᫂ࠊすᓮὈᘯ HDL ࢥࣞࢫࢸ࣮ࣟࣝளศ⏬⬡㉁࣭࣏ࣜ⺮ⓑ௦ㅰࣉࣟࣇࣝࡢ㛵㐃ᛶ ➨ 43 ᅇ ᪥ᮏ⥲ྜデᏛࠊᐩᒣ┴ᐩᒣᕷࠊ 2015.2.20 ⳥ụ┿ࠊᒣ⏣༓✚ࠊᓊᮏ᠇᫂ࠊᱵ⏣⍠⨾Ꮚࠊ㭯㇂ᗣኴࠊሷ⃝ᏹࠊすᓮὈᘯ ⢾ᒀᝈ⪅࠾ࡅࡿ⫢ᶵ⬟␗ᖖ⋡ࠊ⬡⫫⫢㝧ᛶ⋡ࡢኚ㑄 ➨ 43 ᅇ ᪥ᮏ⥲ྜデᏛࠊᐩᒣ┴ᐩᒣᕷࠊ 2015.2.20 ⳥ụ┿ࠊᇼỤ⩏๎ࠊ⳥ụ⨾✑ࠊ㧗ᶫṇᙪࠊᱵ⏣⍠⨾Ꮚࠊሷ⃝ᏹࠊすᓮὈᘯࠊᒣᓊ⏤ ᖾࠊຍ⸨┾୕ࠊ 㔠㝯 ࣝࢥ࣮ࣝᛶ⫢㞀ᐖࡢᛴᛶᮇ࠾ࡅࡿ Fibroscan ⫢◳ᗘࡢព⩏ ➨ 3㸲ᅇ ࣝࢥ࣮ࣝ་Ꮫ⏕≀Ꮫ◊✲ࠊ୕㔜ࠊ2015.1.24 ⳥ụ┿ࠊ㧗ᯇ༓⧊ࠊ㕥ᮌᰤ㔛Ꮚࠊᱵ⏣⍠⨾Ꮚࠊሷ⃝ᏹࠊ⳥ụ⨾✑ࠊ㧗ᶫṇᙪࠊ㏆⸨┿ ࠊᒣ⏣༓✚ࠊ すᓮὈᘯ ே㛫ࢻࢵࢡ࡛ࡢ⢾ᒀᝈ⪅࠾ࡅࡿ⫢ᶵ⬟␗ᖖ⋡࣭⬡⫫⫢㝧ᛶ⋡ࡢゎᯒࠊFibroscan ࢹ ࣮ࢱࡢ᳨ウ ➨ 18 ᅇ᪥ᮏែᰤ㣴Ꮫࠊி㒔ᗓி㒔ᕷࠊ2015.1.10 ― 206 ― ᒣ⏣༓✚ࠊ㏆⸨┿ࠊ⳥ụ┿ࠊᓊᮏ᠇᫂ࠊ㛗㝧Ꮚࠊᰘ⏣㞝ࠊすつࠊ➟ཱྀ㝯㔜ࠊ▼ ┤᫂ࠊすᓮὈᘯ ᖖே࠾ࡅࡿ⫢ᶵ⬟⾑୰࣑ࣀ㓟⃰ᗘࡢ㛵㐃 ➨ 18 ᅇ᪥ᮏែᰤ㣴Ꮫࠊி㒔ᗓி㒔ᕷࠊ2015.1.10 ㏆⸨┿ࠊᒣ⏣༓✚ࠊඖᮧஂಙࠊᓊᮏ᠇᫂ࠊすᓮὈᘯࠊ⳥ụ┿ࠊⓑ▼ග୍ࠊᮌᮧᏲḟࠊ ㇏⏣㞞ኵࠊ῝ᕝ㞞ྐ ప࢚ࢿࣝࢠ࣮㣗 SGLT-2 㜼ᐖ⸆ే⏝ࡼࡾ 1 ᭶࡛ 10 ࡢῶ㔞ᡂຌࡋࡓ 2 ᆺ⢾ᒀ ࡢ1 ➨ 18 ᅇ᪥ᮏែᰤ㣴Ꮫࠊி㒔ᗓி㒔ᕷࠊ2015.1.10 Ozawa H., Imanishi Y., Ito F., Watanabe Y., Kato T., Nameki H., Isobe K., Ogawa K. PICO2 monitoring of transferred jejunum perfusion using an air tonometry technique after hypopharyngeal cancer surgery. 3rd Congress of European ORL-HNS, Czech Republic, Prague, June 2015 ᑠ⃝ᏹஅࠊ⏣ಇᶞࠊΏ㒊ెᘯࠊ㛵Ỉ┿⌮Ꮚࠊఀ⸨ᩥᒎࠊᡞ⏣ṇ༤ࠊᑠᕝ㑳㸬ෆど㙾ୗ㢌 ᗏᡭ⾡࠾ࡅࡿ modified nasal septal flap ࡢ᭷⏝ᛶࡘ࠸࡚㸬➨ 25 ᅇ㢌㢕㒊እ⛉Ꮫ 2015 ᖺ 1 ᭶ 㜰 ᑠ⃝ᏹஅ ఀ⸨ᩥᒎ Ώ㒊ెᘯ 㛵Ỉ┿⌮Ꮚ ⏣ಇᶞ ᑠᕝ㑳㸬㢌㢕㒊⒴࠾ࡅࡿྠᡤ ⛣᳜㌿⛣ࣔࢹࣝࡢ☜❧ HIF㸯ǂ ࡢ㌿⛣ࡢ㛵ࡘ࠸࡚㸬➨ 39 㢌㢕㒊⒴Ꮫ ⚄ᡞᕷ 2015 ᖺ 6 ᭶ ᑠ⃝ᏹஅࠊ⏣ಇᶞࠊΏ㒊ెᘯࠊ㛵Ỉ┿⌮Ꮚࠊఀ⸨ᩥᒎࠊ⊦⊁㞝୍ࠊᡞ⏣ṇ༤ࠊᑠᕝ㑳㸬ෆ ど㙾ୗ㢌ᗏᡭ⾡࠾ࡅࡿ modified nasal septal flap ࡢ᭷⏝ᛶࡘ࠸࡚㸬➨ 27 ᅇ᪥ᮏ㢌 ᗏእ⛉Ꮫ ྡྂᒇᕷ 2015 ᖺ 7 ᭶ ⩚ ⏕ ᪼ ⸨ ṇ ே Expression of stem cell markers Oct3/4 and Nanog and its implications for delayed neck metastasis in tongue carcinoma ➨ 74 ᅇ᪥ᮏ⒴ᏛᏛ⾡ ⥲ ྡྂᒇ 2015.10.10 ⴠྜ༤ᏊࠊᒸឡᏊࠊỈ㇂ேࠊඵᮌ┤Ꮚࠊ᱓ཎඞஅ. ⭝⭷ᛶ║▛ୗᆶ࠾ࡅࡿどᶵ⬟ኚࡢ᳨ウ㸬 ➨30ᅇ᠕⩏ሿᏛᙧᡂእ⛉ྠ㛛Ꮫ⾡㞟ࠊᮾிࠊ2015.1.24. Ỉ㇂ேࠊᒸឡᏊࠊඵᮌ┤Ꮚࠊⴠྜ༤Ꮚ. ᙜ㝔࠾ࡅࡿ㛤㢌⾡ᚋឤᰁᑐࡍࡿ⒪ࡢ᳨ウ㸦࣏ࢫࢱ࣮㸧㸬 ➨58ᅇ᪥ᮏᙧᡂእ⛉Ꮫ⥲࣭Ꮫ⾡㞟ࠊி㒔ࠊ2015.4.9. ― 207 ― ᒸឡᏊࠊỈ㇂ேࠊඵᮌ┤Ꮚࠊⴠྜ༤Ꮚࠊ᱓ཎඞஅ. ⭝⭷ᛶ║▛ୗᆶ࠾ࡅࡿ⮬ぬ≧ࡢ⾡ᚋኚ㸬 ➨58ᅇ᪥ᮏᙧᡂእ⛉Ꮫ⥲࣭Ꮫ⾡㞟ࠊி㒔ࠊ2015.4.9. ⴠྜ༤ᏊࠊᒸឡᏊࠊỈ㇂ேࠊඵᮌ┤Ꮚࠊ᱓ཎඞஅ. ║▛ୗᆶᡭ⾡๓ᚋ࠾ࡅࡿどᶵ⬟᳨ᰝ⤖ᯝࡢ᳨ウ㸬 ➨58ᅇ᪥ᮏᙧᡂእ⛉Ꮫ⥲࣭Ꮫ⾡㞟ࠊி㒔ࠊ2015.4.9. ⴠྜ༤ᏊࠊᆏᮏዲࠊỈ㇂ேࠊຍ⸨㐩ஓࠊ㈗ᚿ⏕㸬 ࣛࢵࢺ㢌㦵࠾ࡅࡿ྾ᛶࣁࢻࣟ࢟ࢩࣃࢱࢺ/ࢥ࣮ࣛࢤࣥ」ྜయࡢ᭷⏝ᛶࡢ᳨ウ㸬 Annual Meeting for Society of Plastics and Regenerative Science(SPRS) ࠊරᗜࠊ20 15.6.27. ⴠྜ༤ᏊࠊᒸឡᏊࠊỈ㇂ேࠊඵᮌ┤Ꮚࠊᖹ⏣ᜨ㔛ࠊ᱓ཎඞஅ. ║▛ୗᆶ⾡ᚋࡢどᶵ⬟ኚࡢ᳨ウ㸬 ➨31ᅇ᠕⩏ሿᏛᙧᡂእ⛉ྠ㛛Ꮫ⾡㞟ࠊᮾிࠊ2015.7.11. ᖹ⏣ᜨ㔛ࠊᒸឡᏊࠊỈ㇂ேࠊඵᮌ┤Ꮚࠊⴠྜ༤Ꮚ. ᙜ⛉࠾ࡅࡿ㒊⭘⒆ࡢ᳨ウ㸬 ➨31ᅇ᠕⩏ሿᏛᙧᡂእ⛉ྠ㛛Ꮫ⾡㞟ࠊᮾிࠊ2015.7.11. Hiroko Ochiai, Takehito Mizutani, Naoko Yagi, Aiko Oka, Eri Hirata, Yoshiaki Kuroshima. Management of cranial bone defect cases caused by infection. The 16th congress of international society of craniofacial surgery (ISCFS),2015. C hiba Japan, 2015.9.18. ᆏᮏዲࠊⴠྜ༤Ꮚࠊ㈗ᚿ⏕㸬 ⮬ᐙ㦵⨨ᆺ྾ᛶேᕤ㦵ࡢຠ⋡ⓗ࡞㦵⏕ࡴࡅ࡚㸬 ➨24ᅇ᪥ᮏᙧᡂእ⛉Ꮫᇶ♏Ꮫ⾡㞟ࠊᒾᡭࠊ2015.10.8. ⴠྜ༤ᏊࠊᒸឡᏊࠊỈ㇂ேࠊඵᮌ┤Ꮚࠊᖹ⏣ᜨ㔛ࠊ᱓ཎඞஅ. ║▛ୗᆶᡭ⾡ᚋ࠾ࡅࡿどᶵ⬟ኚࡢ᳨ウ㸬 ➨33ᅇ᪥ᮏ㢌㢡㢦㠃እ⛉ᏛᏛ⾡㞟ࠊරᗜࠊ2015.11.12. Ỉ㇂ேࠊᒸឡᏊࠊඵᮌ┤Ꮚࠊⴠྜ༤Ꮚ. 㛤㢌⾡ᚋឤᰁ⭣➽⭷⛣᳜ࢆ⾜ࡋࡓࡢ᳨ウ㸬 ➨28ᅇ᠕⩏ሿᏛᙧᡂእ⛉ྠ㛛Ꮫ⾡㞟ࠊᮾிࠊ2014.1.25. ― 208 ― [ ㅮ₇ ] ⸨ṇே Masato Fujii Current and future role of chemoradiation for oropharyhgeal cancer based on HPV status 4th Congress of Asian Society of Head and Neck Oncology ⚄ ᡞ 2015.6.5 ⸨ṇே Masato Fujii Multimodality treatment for oropharyngeal cancer based on HPV status 13th Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery ᮾ ி 2015.12.3-4 ⸨ṇே 㢌㢕㒊ࡀࢇᑐࡍࡿ㞟Ꮫⓗ⒪ࡢ㐍Ṍ㸫Ꮫᨺᑕ⥺⒪ἲࢆ୰ᚰ㸫➨ 25 ᅇ᪥ᮏ㢌㢕㒊እ ⛉Ꮫ 㜰 2015.1.29 ⸨ṇே 㢌㢕㒊ࡀࢇ ࢟ࣂ ࢟ࣕࣥࢧ࣮ࣇ࢛࣮࣒ࣛ㸰㸮㸯㸳 ᮾி 2015.8.8 ⸨ṇே 㢌㢕㒊⒴ࡢ㞟Ꮫⓗ⒪࠾ࡅࡿศᏊᶆⓗ⸆ࡢᙺ ➨ 5 ᅇ༡㜰㢌㢕㒊⭘⒆ࣇ࢛࣮࣒ࣛ 㜰 2015.10.3 ⸨ṇே 㢌㢕㒊⒴⒪ࡢ᭱๓⥺-⸆≀⒪ࡢ᪂ᒎ㛤㸫 ᮾி㒔⪥㰯ဗႃ⛉་Ꮫ⾡ㅮ₇ ᮾி 2016.1.30 ༡ಟྖ㑻 ᮾி་⒪ࢭࣥࢱ࣮ࡢ㞴⫈࣭⪥㬆デ⒪ 㹼⫈⬻ࢺ࣮ࣞࢽࣥࢢ࡛㐺ྜࡉࡏࡿ⿵⫈ჾ㹼 ┠㯮༊⪥㰯ဗႃ⛉㒊Ꮫ⾡ㅮ₇ࠊᮾிࠊ2015.12.3 ༡ಟྖ㑻 ⪥㰯ဗႃ⛉㸸⪥⛉㰯⛉㡿ᇦᝈࡢែ⒪ἲ ᮾி་⒪ಖᏛࠊᮾிࠊ2016.1.6, 2016.1.12 ༡ಟྖ㑻 ⪥㰯ဗႃ⛉㸸ဗႃ㢌㡿ᇦᝈࡢែ⒪ἲ ᮾி་⒪ಖᏛࠊᮾிࠊ2016.1.18, 2016.1.19 ༡ಟྖ㑻 ⪥㰯ဗႃ⛉㸸㢁㒊㡿ᇦᝈࡢែ⒪ἲ ᮾி་⒪ಖᏛࠊᮾிࠊ2016.1.20, 2016.1.25 ― 209 ― ᒣ⃝୍ᶞ 㑇ఏᛶஙࡀࢇ࣭༸ᕢࡀࢇೃ⩌㸦HBOC㸧ࡘ࠸࡚ࡢྲྀࡾ⤌ࡳ ᅜ❧㝔ᶵᵓ ᖹᡂ 27 ᖺᗘ ࢳ࣮࣒་⒪᥎㐍ࡢࡓࡵࡢ◊ಟ㸰㸦ࡀࢇ㸧 ᮾி 2015 ᖺ 10 ᭶ 23 ᪥ ᯇỌ㐩㞝 㞴⫈㑇ఏᏊ᳨ᰝࡢṇࡋ࠸⌮ゎά⏝ ➨ 129 ᅇ㞴⫈ゝㄒ㞀ᐖ◊✲ࠊ⚄ዉᕝ┴ࠊ2015.2.21. ᯇỌ㐩㞝 ᭱ඛ➃ࢩ࣮ࢡ࢚ࣥࢧ࣮ࢆ⏝࠸ࡓ㑇ఏᏊ᳨ᰝ࡛ᗈࡀࡿ㞴⫈デ⒪ ➨ 10 ᅇᕷẸබ㛤ㅮᗙ㸦⫈ぬ㞀ᐖࢩ࣮ࣜࢬ㸧ࠊᮾி㒔ࠊ2015.3.27. ᯇỌ㐩㞝 ᑠඣ㞴⫈ࡢែデ⒪ ➨ 5 ᅇ NICU ࣇ࢛࣮ࣟࢵࣉ᳨ウࠊ୕㔜┴ࠊ2015.11.26. ᯇỌ㐩㞝 㞴⫈ࡢ㑇ఏᏊデ⒪㌟ᝈ ➨ 15 ᅇୡ⏣㇂༊་ᖌ་Ꮫࠊᮾி㒔ࠊ2015.12.5. ⴠྜ༤Ꮚ 〟⒔ࡢヰ ᅜ⬨㧊ᦆയ⪅㐃ྜ≉ูㅮ₇ࠊᮾிࠊ2015.5.24. ⴠྜ༤Ꮚ INFOMࡘ࠸࡚ ᅜ㝿⮬↛࣭᳃ᯘ་ᏛᏛ⾡ㅮ⩦ㅮᖌࠊ㛗㔝ࠊ2015.8.22. [◊ಟ࣭ㅮᖌ] ᯇỌ㐩㞝 㸦ㅮᖌ㸧ᖹᡂ 27 ᖺᗘ⫈ຊ ᐃᢏ⾡ㅮ⩦ ୍⯡ ྜྠᐇ⩦㸦II㸧ㄒ㡢࣭ࣥࣆ࣮ࢲࣥࢫࠊᮾி㒔ࠊ2015.2.11. [ ≉チ ] ≉チฟ㢪㸸Ⓨ᫂ࡢྡ⛠ࠕෆ⪥ᛶ㞴⫈⒪⸆ࠖ≉㢪 2015-007849 ฟ㢪᪥ 2015 ᖺ 1 ᭶ 19 ᪥ Ⓨ᫂⪅㸸⣽㇂ㄔࠊ⸨ᒸṇேࠊᒸ㔝ᰤஅࠊᑠᕝ㑳ࠊᯇỌ㐩㞝 ᅜෆ ― 210 ― [ ࡑࡢ ] ⸨ṇே (ᗙ㛗)➨ 17 ⩌ Ꮫᨺᑕ⥺⒪ἲ㸯➨ 26 ᅇ᪥ᮏ㢌㢕㒊እ⛉Ꮫ⥲ ྡྂᒇ 2016.1.28 ⸨ṇே (ྖ) ᝈ⪅ࡢኌࡽཱྀ⭍ࡀࢇࡢ⒪ࢧ࣏࣮ࢺࡘ࠸࡚⪃࠼ࡿ ➨ 34 ᅇ᪥ᮏ ཱྀ⭍⭘⒆Ꮫ ᶼ 2016.1.22 ⸨ṇே (ᗙ㛗)ࢩ࣏ࣥࢪ࣒࢘ 19 㢌㢕㒊 ࠊヰ㢟ࡢᝈ㸸HPV 㝧ᛶࡢ୰ဗ㢌⒴ ➨ 35 ᅇ ᪥ᮏ⏬ീ་Ꮫ ᮾி 2016.2.26 ⸨ṇே (ྖ) 㐍⾜㢌㢕㒊⒴ᑐࡍࡿ㞟Ꮫⓗ⒪㸫࢚ࣅࢹࣥࢫᐇ⮫ᗋ ➨ 21 ᅇ 㢌 㢕㒊⒴Ꮫ⒪ἲ◊✲ ᮾி 2016.2.26 Masato Fujii (ᗙ㛗)Symposium 5 Personalized Chemoradiotherapy 4th Congress of Asian Society of Head and Neck Oncology ⚄ᡞ 2015.6.5 ⸨ṇே (ྖ)ࣛࣥࢳࣙࣥࢭ࣑ࢼ࣮㸰 ⏥≧⭢㞴ࡀࢇࡢᣮᡓ ➨ 116 ᅇ ᪥ᮏ⪥㰯 ဗႃ⛉Ꮫ ⥲ ᮾி 2016.5.21 ⸨ṇே (ྖ)㢌㢕㒊ࡀࢇᑐࡍࡿᏛ⒪ἲࡢ᪂ᒎ㛤 ➨ 67 ᅇ ᪥ᮏẼ⟶㣗㐨⛉Ꮫ⥲ ⚟ᓥ 2015.11.19 ゅ⏣㐩ᙪࠊ ᐑᶞࠊᯇỌ㐩㞝ࠊົྎⱥᶞ 㸦ࣉࣞࢫ࣮ࣜࣜࢫ㸧࣐࢘ࢫࡢ㞴⫈㐍⾜ᢚไ㛵ࡍࡿ㑇ఏᏊሗࢆ⥙⨶ⓗ㞟㸫㞴⫈㐍 ⾜㛵ࢃࡿ㑇ఏᏊ᥈⣴ࡢᡭࡀࡾ࡞ࡿࢹ࣮ࢱࢆබ㛤㸫 ⌮Ꮫ◊✲ᡤࠊ2015.7.15. ᯇỌ㐩㞝 Ꮚࡶࡢ㞴⫈㸦㸱㸧㑇ఏᏊデ᩿࡛ᡭ⾡Ỵ᩿ ㄞ᪂⪺ᮅห ་⒪ࣝࢿࢧࣥࢫ No.6114 ࠊ2015.7.29. ゅ⏣㐩ᙪࠊ ᐑᶞࠊᯇỌ㐩㞝ࠊົྎⱥᶞ 㞴⫈㐍⾜ᢚไ㛵ࢃࡿ㑇ఏᏊሗ ࣐࢘ࢫ࡛⥙⨶ⓗ㞟ࠊࢹ࣮ࢱࢆබ㛤 ⛉Ꮫ᪂⪺ ➨ 3546 ྕࠊ2015.7.31. ゅ⏣㐩ᙪࠊ ᐑᶞࠊᯇỌ㐩㞝ࠊົྎⱥᶞ 㞴⫈㐍⾜㛵ࡢ㑇ఏᏊሗ ⥙⨶ⓗ㞟ࡋࢹ࣮ࢱබ㛤 ⸆᪥ሗ ᮅห 3 㠃ࠊ2015.7.31. ― 211 ― ᯇỌ㐩㞝 㸦ྖ㸧➨ 10 ᅇឤぬჾࢩ࣏ࣥࢪ࣒࢘㸦ᮾி་⒪ࢭࣥࢱ࣮㸧㹼ᖿ⣽⬊࣭iPS ⣽⬊ࢆ⏝࠸ࡓឤ ぬჾ◊✲ࡢ᭱๓⥺㹼ࠊᮾி㒔ࠊ2015.3.6. ᯇỌ㐩㞝 㸦ྖ㸧᪥ᮏ⪥㰯ဗႃ⛉Ꮫᮾி㒔ᆅ᪉㒊 ➨ 206 ᅇᏛ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.3.14. ᯇỌ㐩㞝 㸦ᗙ㛗㸧୍⯡ㅮ₇ࠕ㞴⫈㑇ఏᏊϨࠖ ➨ 116 ᅇ᪥ᮏ⪥㰯ဗႃ⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾி㒔ࠊ2015.5.20-23. ᯇỌ㐩㞝 㸦ᗙ㛗㸧Free Papers 23: Auditory Neuropathy, Cochlear Nerve Deficiency 30th Politzer Society Meetingࠊ᪂₲┴ࠊ2015.6.30-7.3. ᯇỌ㐩㞝 㸦ᗙ㛗㸧୍⯡ㅮ₇㸦ཱྀ₇㸧 ➨ 61 ⩌ࠕ㑇ఏᏊ 2ࠖ ➨ 25 ᅇ᪥ᮏ⪥⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ 㛗ᓮ┴ࠊ2015.10.7-10. ᯇỌ㐩㞝 㸦ᗙ㛗㸧➨ 23 ⩌㸸⫈ぬ㞀ᐖ 5 ➨ 60 ᅇ᪥ᮏ⫈ぬ་Ꮫ⥲࣭Ꮫ⾡ㅮ₇ ᮾி㒔ࠊ2015.10.21-23. ᾆᒸಇኵ ࠗୖ㒊ᾘ⟶ᝈデ⒪ࡢ᪂ࡓ࡞ࡿࣉ࣮ࣟࢳ࠘₇⪅㸸᠕⩏ሿᏛ་Ꮫ㒊 ෆ⛉Ꮫ㸦ᾘ ჾ㸧ᩍᤵ 㕥ᮌ ⚽ ඛ⏕㸬 ᾘჾᝈࢆ⪃࠼ࡿ㸬ᮾி㒔㇂༊, 2015.4 ᾆᒸಇኵ ୍⯡ཱྀ₇㸦SSA/P㸧㸬 ➨ 89 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ⥲㸬ឡ▱┴ྡྂᒇᕷ, 2015.5 ᾆᒸಇኵ ୍⯡ཱྀ₇㸦⫶ ESD-4㸧㸬 ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉㸬ᮾி㒔᪂ᐟ༊, 2015.6 ― 212 ― ᾆᒸಇኵ㸬 ᳨ウ࣭ㅮ₇㸬➨୍ᅇ࣭ᮾࡀୣᾘჾࢿࢵࢺ࣮࣡ࢡ㸬 ᮾி㒔┠㯮༊, 2015.8 ᾆᒸಇኵ ࠗ⭠ෆど㙾ࢺ࣮ࣞࢽࣥࢢἲ - ⌧≧ㄢ㢟 -࠘₇⪅㸸㡰ኳᇽᏛ་Ꮫ㒊 ᩍᤵ ᆏᮏ ┤ ே ඛ⏕㸬COLONetwork 2015㸬ᮾி㒔࣭༓௦⏣༊, 2015.8 ᾆᒸಇኵ ᳨ウ࣭ㅮ₇㸬 ➨ 11 ᅇ Gut Challenge Meeting㸬ᮾி㒔Ụᮾ༊, 2015.8 ᾆᒸಇኵ ᳨ウࢭࢵࢩࣙࣥࢥ࣓ࣥࢸ࣮ࢱ࣮㸬 ➨ 12 ᅇ᪥ᮏᾘ⟶ᏛᏛ⾡㞟㸬ᮾி㒔᪂ᐟ༊, 2015.2 ᾆᒸಇኵ ᳨ウࢭࢵࢩࣙࣥㄞᙳ⪅㸬 ➨ 100 ᅇ᪥ᮏᾘჾෆど㙾Ꮫ㛵ᮾᆅ᪉㸬ᮾி㒔᪂ᐟ༊, 2015.6 ᾆᒸಇኵ ㌟㏆࡞ẼࠊẼ࡞ࡿ≧ 㹼࠸ࡲࡁࡣࡇ࠺┤ࡍ㸟㹼 ⭠࣏࣮ࣜࣉ㸦๓⦅㸧 ᮾிࢫ࣏࣮ࢶ 2015. 10.20 ᾆᒸಇኵ ㌟㏆࡞ẼࠊẼ࡞ࡿ≧ 㹼࠸ࡲࡁࡣࡇ࠺┤ࡍ㸟㹼 ⭠࣏࣮ࣜࣉ㸦ᚋ⦅㸧 ᮾிࢫ࣏࣮ࢶ 2015. 10.27 Ỉ㊊㑥㞝 㞴⫈ࡼࡿ࠺ࡘࢆண㜵㸸ᢚ࠺ࡘࠊㄆ▱㞀ᐖࢆᨵၿ:᪩ࡵ⿵⫈ჾࢆά⏝ ᒱ㜧᪂⪺ᆅ᪉⣬ ᖹᡂ 27 ᖺ 1 ᭶ 24 ᪥ ― 213 ― 㻌 㻌 㻌 㻌 ேᕤ⮚ჾ䞉ᶵჾ㛤Ⓨ◊✲㒊㻌 㻌 ேᕤ⮚ჾ࣭ᶵჾ㛤Ⓨ◊✲㒊 㹙 ㄽᩥ 㹛 Kobayashi R, Tsunoda K, Ueha R, Fujimaki Y, Saijo H, Itoh K, Yamasoba T. Effect of a nasal clip on inhaling a sufficient cortico steroid powder dose. Ann Allergy Asthma Immunol. 2015Dec;115(6):525-6. impact factor 2.60 Tsunoda K, Fujimaki Y, Nito T, Yamasoba T, Tayama N, Makiyama K, Murofushi T, Tsunoda A, Ohshima K, Nishiyama K, Kano S, Niimi S. Patients' perceptions of vocal problems: results from a survey in the Tokyo area. Acta Otolaryngol. 135(6):532-5, 2015.6 impact factor 1.09 Kikuta S, Sakamoto T, Nagayama S, Kanaya K, Kinoshita M, Kondo K, Tsunoda K, Mori K, Yamasoba T. Sensory deprivation disrupts homeostatic regeneration ofnewly generated olfactory sensory neurons after injury in adult mice. J Neurosci. 11;35(6):2657-73, 2015.2 impact factor 6.34 Nomura T, Ushio M, Kondo K, Yamasoba T Effects of nasal septum perforation repair surgery on three-dimensional airflow: an evaluation using computational fluid dynamics. Eur Arch Otorhinolaryngol. 272(11)㸸3327-33㸪2015.11 impact factor 1.55 Nomura T, Kobayashi T, Shingaki S, Saito C. A case of chondrosarcoma arising in the temporomandibular joint. Case Rep Otolaryngol.2015:832532. 2015.1 impact factor 0 Nomura T, Shingaki S, Kobayashi T , Suzuki I, Saito C Multi-factorial func- tional analysis of the patients with reconstructtion for oral carcinoma. Open Journal of Stomatology. 5:63-71, 2015 impact factor 0 ― 215 ― Sakurai Y, Itoh K, Sai K, Lee S, Abe S, Terao Y, Mannen T Impaired laryngeal voice production in a patient with foreign accent syndrome Neurocase 21㸸289-98㸪2015.4 impact factor 1.336 Atsushi ItoࠊHiroyuki HatanoࠊMasahiro FujiiࠊMie SatoࠊYu Watanabeࠊ Yuko HiramatsuࠊFumihiro Sato and Akira Sasakiࠊ "Performance Evaluation of Ad Hoc Network Protocol Implemented in Server Side Java Script"ࠊ International Workshop on Networking, Computing, Systems, and Software (NCSS) 2015 (2015.12) impact factor 0 㹙 ⥲ㄝ 㹛 ゅ⏣୍ ࠕぬ㞀ᐖࠖ MR ࢸ࢟ࢫࢺϩ ⒪ 2012 ⮫ᗋ 2015 ᖺᨵゞ㸬MR ㄆᐃࢭࣥࢱ࣮,༡ᒣᇽ㸬 2015:180-181 ゅ⏣୍ 㞟ႃ㢌␗ᖖឤࡢၥ⟅࠼ࡿ ࡢࡼ࠺࡞㌟ⓗᝈࡀ㛵ಀࡍࡿࡢ࡛ࡋࡻ࠺ JOHNS 31ᕳ1ྕ㸸81-83㸬2015.1 ゅ⏣୍ ᗣ㛗ᑑ♫ࡢ⪥㰯ဗႃ⛉ࡔࡽ࡛ࡁࡿຍ㱋ࡼࡿᄟୗⓎኌ㞀ᐖࡢண㜵 ᮾி㒔⪥㰯ဗႃ⛉་ሗ 146㸸27-33, 2015.2 ゅ⏣୍ ႍ㬆ࡢ⏕ࡌࡿ࣓࢝ࢽࢬ࣒ࢆᩍ࠼࡚ୗࡉ࠸ ᚰᅉᛶኻኌࡣ࠺ࡋ࡚࠾ࡁࡲࡍ㸽 ࡉࡽ⪺ࡅ࡞࠸㸟 ᑠඣࡢࡳࡳ࣭ࡣ࡞࣭ࡢデ⒪ Q㸤A ϩᕳ, 133ࠊ244ࠊᰴᘧ♫᪥ ᮏ㝔ฟ∧ࠊ2015.4 㹙 ⴭ᭩ 㹛 ゅ⏣୍ ࠕ᪥ࡽ࡛ࡁࡿኌᖏࢺ࣮ࣞࢽࣥࢢ ᗣ㛗ᑑࡣヰࡽࠖ ࣓ࢹ࢝ࣝࢺࣜࣅ࣮ࣗࣥ♫ 2015.4.3 ฟ∧ ― 216 ― 㹙 ᏛⓎ⾲ 㹛 ゅ⏣୍ ⯉ᅽᏊɆయᆺཱྀ⭍ဗ㢌ෆど㙾㸦ࣉࣟࢪ࢙ࢡࢺྡ㸸NTOP2013㸧 ࡇࡢ୍ᖺ㛫ࡢ㐍Ṍ≧ἣࡘ࠸࡚ ➨ 116 ᅇ ᪥ᮏ⪥㰯ဗႃ⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ᮾி ᅜ㝿ࣇ࢛࣮࣒ࣛ 2015.5.23 ゅ⏣୍ Ⓨኌ㞀ᐖᑐࡍࡿ✚ᴟⓗධ ➨ 15 ᅇ ᪥ᮏᢠຍ㱋་Ꮫ⥲ࠊ⚟ᒸᅜ㝿㆟ሙ 2015.5.29-31 ゅ⏣୍ ་⒪ࡢ㉁ྥୖࠊᏳᛶྥୖࡢࡓࡵࡢࠊཱྀ⭍ဗ㢌㙾ࡢ㛤Ⓨࠕ⯉ᅽᏊ୍యᆺཱྀ⭍ဗ㢌ෆ ど㙾ࠖ㸦ࣉࣟࢪ࢙ࢡࢺྡ㸸NTOP2013㸧ࡘ࠸࡚ ➨ 69 ᅇ ᅜ❧㝔⥲ྜ་Ꮫ ࡉࡗࡱࢁⱁ⾡ᩥࡢ㤋 2015.10.3 ゅ⏣୍ࠊᑠᯘ⌮㤶ࠊ▼㇏ኴࠊ୕⃝㐓ே ࠊ㯮⏣ᾈஅࠊୖ⩚⍠⨾ࠊ⸨ᕳⴥᏊࠊ⸨㝯ࠊ ᒣᒽ㐩ஓ ࠕኌࡢ⾨⏕ᩍ⫱ࠖᝈ⪅ၨⓎࡼࡿኌᖏ࣏࣮ࣜࣉࡢಖᏑⓗ⒪ࠊࡑࡢ᭷ຠᛶࡢ᳨ド 㸫ၨⵚࡽၨⓎ㸫 ➨ 60 ᅇ᪥ᮏ㡢ኌゝㄒ་Ꮫ ྡྂᒇ࣭ឡ▱┴⏘ᴗປാࢭࣥࢱ࣮ 2015.10.15-16 ゅ⏣୍ ࠕኌࡢ⾨⏕ᩍ⫱ࠖᝈ⪅ၨⓎࡼࡿኌᖏ࣏࣮ࣜࣉࡢಖᏑⓗ⒪ࠊࡑࡢ᭷ຠᛶࡢ᳨ド ➨ 67 ᅇ ᪥ᮏẼ⟶㣗㐨⛉Ꮫ࡞ࡽࡧᏛ⾡ㅮ₇ ࢨ࣭ࢭࣞࢡࢺࣥ⚟ᓥ࣭࣍ࢸࣝ⚟ᓥࢢ࣮ࣜࣥࣃࣞࢫ 2015.11.19-20 ゅ⏣୍ ᅜ❧㝔ᶵᵓ࠾ࡅࡿࠊኌࡢ⾨⏕ᩍ⫱ࡼࡿಖᏑ⒪ἲࡢ᭷ຠᛶࡢ᳨ド ᖹᡂ 27 ᖺᗘ ⪥㰯ဗႃ⛉ኟᮇ⮫ᗋࣇ࢛࣮࣒ࣛ ᮾிᏛᒣୖ㤋 2015.7.11 㔝ᮧົࠊᓊᮏࡵࡄࡳࠊᒾᇛᘯᑦࠊ㉺ᬛ⠜ࠊᓊᮏㄔྖ ᨺᑕᛶࣚ࢘⣲ෆ⏝⒪ἲࢆ᳨ウࡍࡿ࠶ࡓࡗ࡚ዷᏎᛶ Ꮡࡢ㓄៖ࢆせࡋࡓ⏥≧⭢⒴ࡢ 1 Maxillary Swing Approach for Removal of the Palatal Carcinoma 4th Congress of ASHNO and 39th annual meeting of JSHNC 㜰 2015.6.4 㔝ᮧົࠊ ᮌ 㞞ᩥࠊ⏿ ᩔࠊᓊᮏ ㄔྖ デ᩿⒪ࡢࢥࢶ 㢡ୗ⭢ᡭ⾡ Ᏻ࣭☜ᐇ࡞ᡭᢏ ゎ๗ᇶ࡙ࡃ㢡ୗ⭢ᡭ⾡ ➨ 28 ᅇ᪥ᮏཱྀ⭍࣭ဗ㢌⛉Ꮫ⥲ࠊ㜰ࠊ2015.9.10-11 ― 217 ― 㔝ᮧົࠊ ᓊᮏࡵࡄࡳࠊᒾᇛᘯᑦࠊ ㉺ᬛ⠜ࠊᓊᮏㄔྖ 㢁⚄⤒ྀࢆ⏝࠸ࡓ㢦㠃⚄⤒ᘓࡢ 2 ➨ 38 ᅇ᪥ᮏ㢦㠃⚄⤒Ꮫ⥲ࠊᮾிࠊ2015.6.11-12 㔝ᮧົࠊ㧘ᔱṇࠊᮌ㞞ᩥࠊ⳥ᆅⱱ ᝏᛶ⭘⒆ࡀࢃࢀࡓ㢕㒊㯤Ⰽ⫗ⱆ⭘ᛶ⅖ࡢ୍ ᮇ⮫ᗋࣇ࢛࣮࣒ࣛ㸦㕲㛛グᛕㅮᇽ㸧ࠊᮾிࠊ2015.12.12 ఀ⸨᠇, ᯈᇉᩥᙪ, ⩚┿୍ ᩘ⏕ᡂ㡢ኌ࣭ືస⣔ิࡢ≉ᚩ࣮࣡࢟ࣥࢢ࣓ࣔࣜࡢ㛵㐃 2015 ᖺ㟁Ꮚሗ㏻ಙᏛ⥲ྜ, ⲡὠᕷ, 2015.3.12 ᑠ㔝ဴ, ఀ⸨᠇, 㛵ᮏⲮኴ㑻, ゅ⏣୍ ගࢺ࣏ࢢࣛࣇࡢゝㄒ㛵㐃⬻άືゎᯒཬࡧ BMI ࡢᛂ⏝ 2015 ᖺ㟁Ꮚሗ㏻ಙᏛ⥲ྜ, ⲡὠᕷ, 2015.3.12 ᯈᇉᩥᙪ, ఀ⸨᠇, ᇼ⋞ ࣮࣡࢟ࣥࢢ࣓ࣔࣜ㐀ᛶࡢ᥋Ⅼ—ᩘ⏕ᡂㄢ㢟ࡢศᯒࡽ— ➨ 8 ᅇ 21 ୡ⣖⛉Ꮫே㛫ࢩ࣏ࣥࢪ࣒࢘, ᮾி, 2015.3.6 ᑠ㔝ဴ, ఀ⸨᠇, 㛵ᮏⲮኴ㑻, ゅ⏣୍, ᭷㈡ṇᾈ ගࢺ࣏ࢢࣛࣇࢆ⏝࠸ࡓゝㄒ㛵㐃ࡢ⬻άືゎᯒ ➨ 8 ᅇ 21 ୡ⣖⛉Ꮫே㛫ࢩ࣏ࣥࢪ࣒࢘, ᮾி, 2015.3.6 ྜྷ⸨⿱ెᏊ, ᮏ┿ே, ⊁㔝❶ኴ㑻, ఀ⸨᠇, ᒣᒽ㐩ஓ 㡢ീࡢᖜࡢ⫈ᛶㄏⓎ⬻☢ሙᛂ⟅ࡢᫎ ➨ 20 ᅇㄆ▱⚄⤒⛉ᏛᏛ⾡㞟, ᮾி, 2015.8.8 ᮃ᭶᫂ே, 㡲⸨㊰Ꮚ, ᱒㔝⾨, ఀ⸨᠇ ືㄢ㢟ฎ⌮࠾ࡅࡿ㐠ືࡢ♫ㄆ▱࣭ゝㄒ⬟ຊ࠼ࡿᙳ㡪 ➨ 70 ᅇ᪥ᮏయຊ་Ꮫ, ḷᒣ, 2015.9.18 ⸨ᕳⴥᏊࠊゅ⏣୍ࠊ ᅜ❧㝔ᶵᵓࠕ㡢ኌ⮬ᕫカ⦎ἲࡼࡿ⫵⅖ࡢண㜵ຠᯝࡢ᳨ドࠖ◊✲⌜ 㡢ኌᨾカ⦎ἲࡼࡿ⫵⅖ࡢண㜵ຠᯝࡢ᳨ド㸸Randomuzed Control Trial ➨ 116 ᅇ ᪥ᮏ⪥㰯ဗႃ⛉Ꮫ⥲࣭Ꮫ⾡ㅮ₇ࠊᮾிࠊ2015.5.21 ― 218 ― ⸨ᕳⴥᏊ 㢦㠃⚄⤒ษ᩿ᚋ࠾ࡅࡿ G-CSF ࡼࡿ⚄⤒⏕ಁ㐍ຠᯝࡢ᳨ウ ➨ 38 ᅇ᪥ᮏ㢦㠃⚄⤒Ꮫࠊᮾிࠊ2015.6.11 Yoko Fujimaki, Kenji Kondo, Shotaro Karino, Yayoi Kikkawa, Yu Matsumoto, Chisato Fujimoto, Shu Kikuta, Hironobu Nishijima, Kazuo Yasuhara, Teru Kamogashira, Akinobu Kakigi, Koichi Tsunoda, Tatsuya Yamasoba The effect of G-CSF for promoting regeneration of severed facial nerves in rats 13th Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery, Tokyo, 2015.12.4 㹙 ≉ูㅮ₇ 㹛 ゅ⏣୍ Laryngeal Problems in Advanced Age and Cost-Effective Solutions ➨ 13 ᅇ ᪥ᮏྎ‴⪥㰯ဗႃ⛉࣭㢌㢕㒊እ⛉Ꮫ㆟ ୍ࢶᶫ࣮࣍ࣝ㸦Ꮫ⾡⥲ྜࢭࣥࢱ࣮㸧 2015.12.3-4 ゅ⏣୍ ⪥㰯ဗႃ⛉ࡔࡽ࡛ࡁࡿ་⒪㠃ࡽࡳࡓᗣ㛗ᑑࡢྲྀࡾ⤌ࡳ ᪥⪥㰯ᰣᮌᆅ᪉㒊 ➨ 119 ᅇᏛ⾡ㅮ₇ࠊ㊊ᕷࠊ2015.12.13 㹙 ࡑࡢ 㹛 ࢸࣞࣅฟ₇ 㹌㹆㹉 㹃ࢸࣞࠕࢳࣙࢫ@Ẽ࡞ࡗࡓࡁࠖ ࢸ࣮࣐ࠕẼ࡞ࡿኌࡢࡍࢀࠖ 2015.10.24 ᨺ㏦᪥ 㞧ㄅᥖ㍕ ゅ⏣୍ NHK ࡓࡵࡋ࡚࢞ࢵࢸࣥ ࢫ࣑ࢭ∧ ゅ⏣୍┘ಟࠕኌࡢࡍࢀࢆᨵၿࡍࡿ࣡ࢨࠖ ፬⏕ά♫/㟷♫ 2015.5 ᭶ྕ ゅ⏣୍ ࡅࢇࡱࡔࡼࡾ ࡅࢇࡇ࠺ Q&Aࠕኌᖏⴎ⦰ࡼࡿኌࡢࡍࢀࠖ2015 ᖺ⛅ྕ ― 219 ― 㻌 㻌 㻌 㻌 ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊 ࠙ㄽᩥࠚ Nakanishi A, Ueno S, Kawano K, Ito Y, Kominami T, Yasuda S, Kondo M, Tsunoda K, Iwata T, Terasaki H. Pathologic Changes of Cone Photoreceptors in Eyes With Occult Macular Dystrophy. Invest Ophthalmol Vis Sci. 2015;56:7243-9 Iejima D, Nakayama M, Iwata T. HTRA1 Overexpression Induces the Exudative Form of Age-Related Macular Degeneration. Age-Related Macular Degeneration: Prevalence, Risk Factors and Clinical Management. (Editor: Meanie Carter) Nova Science Publishers, 2015 Katagiri S, Hayashi T, Ohkuma Y, Sekiryu T, Takeuchi T, Gekka T, Kondo M, Iwata T, Tsuneoka H. Mutation analysis of BEST1 in Japanese patients with Best's vitelliform macular dystrophy. Br J Ophthalmol. 2015;99:1577-82 Katagiri S, Hayashi T, Yoshitake K, Sergeev Y, Akahori M, Furuno M, Nishino J, Ikeo K, Tsunoda K, Tsuneoka H, Iwata T. Congenital Achromatopsia and Macular Atrophy Caused by a Novel Recessive PDE6C Mutation (p.E591K). Ophthalmic Genet. 2015;36:137-44 Kato Y, Tsunoda K, Fujinami K, Iwata T, Saga M, Oguchi Y. Association of Retinal Artery and Other Inner Retinal Structures With Distribution of Tapetal-like Reflex in Oguchi's Disease. Invest Ophthalmol Vis Sci. 2015;56:2162-72 Iwata T. Author Response: Postnatal Overexpression of the Human ARMS2 Gene Does Not Induce Abnormalities in Retina and Choroid in Transgenic Mouse Models. Invest Ophthalmol Vis Sci. 2015; 56:1389 Kuniyoshi K, Sakuramoto H, Yoshitake K, Ikeo K, Furuno M, Tsunoda K, Kusaka S, Shimomura Y, Iwata T. Reduced rod electroretinograms in carrier parents of two Japanese siblings with autosomal recessive retinitis pigmentosa associated with PDE6B gene mutations. Doc Ophthalmol. 2015;131:71-9 ― 221 ― Iejima D, Itabashi T, Kawamura Y, Noda T, Yuasa S, Fukuda K, Oka C, Iwata T. HighTemperature Requirement A Serine Peptidase 1 Gene is Transcriptionally Regulated by Insertion/Deletion Nucleotides Located at the 3 Prime End of Age-Related Maculopathy Susceptibility 2 Gene in Patients with Age-Related Macular Degeneration. The Journal of Biological Chemistry 2015;290:2784-97 Impact Factor: 4.573 Kuniyoshi K, Ikeo K, Sakuramoto H, Furuno M, Yoshitake K, Hatsukawa Y, Nakao A, Kusaka S, Shimomura Y, Iwata T. Novel nonsense and splice site mutations in CRB1 gene in two Japanese patients with early-onset retinal dystrophy Documenta Ophthalmologica. Documenta Ophthalmologica 2015;130:49-55 ࠙⥲ㄝࠚ Iejima D, Nakayama M, Iwata T HTRA1 Overexpression Induces the Exudative Form of Age-Related Macular Degeneration. Age-Related Macular Degeneration: Prevalence, Risk Factors and Clinical Management., Nova Science Publishers, 37-51, 2015. ࠙Ꮫࠊ◊✲ࠊᣍᚅㅮ₇࡛ࡢⓎ⾲ࠚ ᒾ⏣ ᓅ Genes and Molecular Mechanisms of Retinal Disease Ἀ⦖⛉Ꮫᢏ⾡Ꮫ㝔Ꮫ ⚄⤒Ⓨ⏕ࣘࢽࢵࢺദࢭ࣑ࢼ࣮ Takeshi Iwata, Subhabrata Chakrabarthy, Sayan Basu, Sushmita Kaushik Audacious goals for Translational Research of Genetic Eye Disease 73th AIOC 2015, New Delhi, 2015.2.6 Gyan Prakash, S. Natarajan, Takeshi Iwata, Subho Chakrabarti, Bishwanath Pal Asian Eye Genetics Consortium (AEGC) 73th AIOC 2015, New Delhi, 2015.2.7 Takeshi Iwata ࣭NISO-NEI collaborative research programs, past and future ࣭Asian Eye Genetics Consortium, Genetic research programs covering the entire Asia Asia-ARVO 2015, Yokohama, 2015.2.16-19 ― 222 ― ᒾ⏣ ᓅ ⥙⭷ᝈࡢᅉែᶵᗎࡢゎ᫂ ᒣཱྀᏛ ➨ 14 ᅇ㧗ḟ⤫ྜឤぬჾ་⒪◊✲ ≉ูㅮ₇ Takeshi Iwata ࣭Japanese Whole Exome Project for Hereditary Retinal Diseaseࠖ ࣭Molecular Mechanism of Normal Tension Glaucoma by Optineurin Mutation APAO2015 ᗈᕞ 2015.4.3 ᒾ⏣ ᓅ Eyeing the Aging Problem ⡿ᅜၟᕤ㆟ᡤ ㅮ₇ ᮾி࣓ࣜ࢝ࣥࢡࣛࣈ 2015.4.7 Takeshi Iwata ࠕOverview of eye genetics in Asia and the way of forwardࠖ ࠕMolecular mechanism of NTG by E50K mutation in optineurin gene ARVO 2015 Annual Meeting, Denver, 2015.5.5 ᒾ⏣ ᓅ 㑇ఏᛶ⥙⭷ᝈࡢཎᅉ㑇ఏᏊࡢ᥈⣴ࠊࢹ࣮ࢱ࣮࣋ࢫࡢᵓ⠏ࡑࡋ࡚ᅜ㝿༠ຊ ᪥ᮏ⥙⭷Ⰽ⣲ኚᛶ༠ ♫ဨ⥲ ་⒪ㅮ₇ 2015.6.27 ᒾ⏣ ᓅ ⥙⭷Ⰽ⣲ኚᛶࢆྵࡴ㑇ఏᛶ⥙⬦⤡⭷ᝈࡢ㑇ఏᏊゎᯒⓎᶵᗎࡢゎ᫂ ᪥ᮏ⥙⭷Ⰽ⣲ኚᛶ༠ ᮾிᨭ㒊⥲ ་⒪ㅮ₇ 2015.7.5 Takeshi Iwata Genes and Molecular Mechanisms of Retinal Disease China –Arab States Expo 2015, Ningxa, China 2015.9.12 Takeshi Iwata Japan Consortium for Hereditary Retinal Diseases / Characterization of HTRA1 Transcription and Development of CNV Mouse Model National Eye Institute, NIH, Bethesda, 2015.10.5 Takeshi Iwata Introduction of the Asian Eye Genetics Consortium and the Japanese Consortium for Hereditary Retinal Disease 2nd Congress of ASEAN Ophthalmology Society, Ha Noi, 2015.10.29 ― 223 ― Daisuke Iejima, Mao Nakayama, Takeshi Itabashi, Yuich Kawamura, Masakazu Akahori, Toru Noda, Takeshi Iwata Characterization of HTRA1 Promoter in Patients with Exudative Age-Related Macular Degeneration. 2015 Asia ARVO, Yokohama, Japan, Feb. 17, 2015. ᐙᓥ㍜㸪୰ᒣ┿ኸ㸪ᕝᮧ㞝୍㸪㔝⏣ᚭ㸪ᒾ⏣ᓅ ࠕⁱฟᆺຍ㱋㯤ᩬኚᛶࡢឤཷᛶ㑇ఏᏊ㡿ᇦ ARMS2/HTRA1 ࡢ㌿ᶵ⬟ゎᯒࠖ ➨ 19 ᅇ║⛉ศᏊ⏕≀Ꮫ◊✲㸪 ᒱ㜧㸪 2015 ᖺ 2 ᭶ 28 ᪥ Daisuke Iejima, Mao Nakayama, Toru Noda, Atsushi Mizota and Takeshi Iwata Human HTEA1 expression is enhanced by indel mutation in the HTRA1 regulatory element region. ARVO 2015, Denver, USA, 2015.5.6 Akiko Suga, Kazuyo Sadamoto, Momo Fujii, Michiko Mandai, Masayo Takahashi, Takeshi Iwata Proliferation potential of Müller glia after retinal damage varies between mouse strains ARVO 2015 Annual Meeting, Denver, USA, 2015.5.7 㡲㈡ ᬗᏊࠊᒾ⏣ ᓅ ࠕ࢚ࢡࢯࣥゎᯒࡼࡿ⥙⭷Ⰽ⣲ኚᛶࡢ᪂つཎᅉ㑇ఏᏊࡢྠᐃኚ␗ࡢᶵ⬟ゎᯒࠖ ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ ⱝᡭ◊✲⪅Ⓨ⾲ࠊᮾி㒔ࠊ2015 ᖺ 11 ᭶ 2 ᪥ ᕝᮧ㞝୍ࠊ⸨ᕳᣅ㑻ࠊྜྷṊᩄࠊゅ⏣⦾ࠊ㡲㈡ᬗᏊࠊᮧୖ ᬗࠊᒾ⏣ ᓅ ON ᆺᴟ⣽⬊␗ᖖࢆక࠺㯤ᩬኚᛶᐙ⣔ࡢཎᅉ㑇ఏᏊゎᯒ ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ⱝᡭ◊✲⪅Ⓨ⾲ࠊᮾி㒔ࠊ2015ࠊ2015 ᖺ 11 ᭶ 2 ᪥ ― 224 ― 㻌 㻌 㻌 㻌 䠘ദ䝅䞁䝫䝆䜴䝮䛺䛹䠚㻌 㻌 ― 225 ― ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ ⱝᡭ◊✲⪅Ⓨ⾲ ࣉࣟࢢ࣒ࣛ ᪥㸸ᖹᡂ ᖺ ᭶ ᪥᭶ 㸸㹼㸸 ሙᡤ㸸Ჷ㆟ᐊ ₇㢟 Ⓨ⾲ ศ ㉁ᛂ⟅ ศ ົྎ ⱥᶞ a ົ㐃⤡ ࢭࢵࢩࣙࣥ㸯 ᗙ㛗 ᒾ⏣ ᓅ㸦ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊㛗㸧 㸸a 21 ᆺᴟ⣽⬊␗ᖖࢆక࠺㯤ᩬኚᛶᐙ⣔ࡢཎᅉ㑇ఏᏊゎᯒ ᕝᮧ 㞝୍ 㸦ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊㸧 㸸a ࢚ࢡࢯࣥゎᯒࡼࡿ⥙⭷Ⰽ⣲ኚᛶࡢ᪂つཎᅉ㑇ఏᏊࡢྠᐃ ኚ␗ࡢᶵ⬟ゎᯒ 㡲㈡ ᬗᏊ 㸦ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊㸧 㸸a ࢤࣀ࣒ࣥࣉࣜࣥࢸࣥࢢඛኳ␗ᖖೃ⩌ ᒣ⃝ ୍ᶞ 㸦ᑠඣ⛉㸧 㸸a ḟୡ௦ࢩ࣮ࢡ࢚ࣥࢫ࡛ぢࡘࡗࡓ /2;+' 㑇ఏᏊࡢ᪂つኚ␗ ࡑࡢศᏊែ 㞴Ἴ ୍ᚨ 㸦⫈ぬᖹ⾮ぬ◊✲㒊㸧 ࢭࢵࢩࣙࣥ㸰 ᗙ㛗 ᑿ⸨ ㄔྖ㸦⮫ᗋᏛ◊✲ᐊ㛗㸧 㸸a ᩚᙧእ⛉≉᭷ࡢ㌿ಽ࣭㌿ⴠῶᑡࡢྲྀࡾ⤌ࡳ 㹼㌿ಽ࣭㌿ⴠせᅉศᯒࡢ⤖ᯝࢆ㏻ࡋ࡚㹼 ᩧ⸨ ᗣ୍ 㸦┳ㆤ࣭% Ჷ㸧 㸸a ከ⫋✀ᑐࡍࡿ᪂᥇⏝⪅ᑐ㇟ឤᰁ㜵Ṇᩍ⫱ࡢᐇ㊶ ̿ࢩ࣑࣮ࣗࣞࢩࣙࣥࢺ࣮ࣞࢽࣥࢢࢆ⏝࠸࡚̿ 㯮⏣ ⨾ᚨ 㸦┳ㆤ࣭་⒪Ᏻ⟶⌮㒊㸧 㸸a 㝔እᚰ⫵Ṇ࠾ࡅࡿ᪤ Ⓚ࠾ࡼࡧ⭈㞀ᐖ⏕Ꮡ㏥㝔ࡢ㛵㐃 ⚟⏣ ṇ 㸦ᚠ⎔ჾෆ⛉㸧 㸸a 6 ≧⤖⭠㌿ᑐࡍࡿෆど㙾ⓗᩚࡢព⩏ࡘ࠸࡚ࡢ᳨ウ ᖹ⏣ ဴ 㸦ᾘჾ⛉㸧 ࢭࢵࢩࣙࣥ㸱 ᗙ㛗 ゅ⏣ ୍㸦ேᕤ⮚ჾ࣭ᶵჾ㛤Ⓨ◊✲㒊㛗㸧 㸸a ேᕤ⫠㛛ࡽࡢ⭠ &7 ᛂ⏝ ┦⃝ ຌ ᨺᑕ⥺⛉ 㸸a ࣟ࣎ࢵࢺᨭ᰿ⓗ๓❧⭢㝖⾡࠾ࡅࡿ⾡୰ࡢ║ᅽୖ᪼ ୕ḟඖ๓║㒊 2&7 ࢆ⏝࠸ࡓ⾡๓ࡢ๓ᡣ῝ᗘ㛵ࡍࡿ᳨ウ Ỉ㔝 㞞 㸦║⛉㸧 㸸a ႃ㢌⫗ⱆ⭘ࡢಖᏑⓗ⒪ᡂ⦼ ᑠᯘ ⌮㤶 㸦ேᕤ⮚ჾ࣭ᶵჾ㛤Ⓨ◊✲㒊㸧 㸸a 㛢ࡢࡈᣵᣜ Ṋ⏣ ⣧୕ 㝔㛗 ࣭࣭࣭࣭ᚋ∦ࡅ㸦 ࡲ࡛㘄㸧࣭࣭࣭࣭ a ᠓ぶ ࡢཔᡣ ― 226 ― 㻌 㻌 㻌 㻌 䊢㻌 ◊✲㈝㻌 㻌 ᖹᡂ27ᖺᗘ◊✲㈝ 1) ᩥ㒊⛉Ꮫ◊✲㈝ 㸺ᇶ┙◊✲㸦㹀㸧㸼 Ỉ㊊ࠉ㑥㞝 ࣄࢺiPS⣽⬊ᑠᆺ㟋㛗㢮ࢥ࣐࣮ࣔࣥࣔࢭࢵࢺࢆ⏝࠸ࡓ⼗∵᭷ẟ⣽⬊ ⏕ࡢ๓⮫ᗋ᳨ウ ᒾ⏣ࠉᓅ 㟋㛗㢮ࣔࢹࣝࢆ⏝࠸ࡓࢻ࣮ࣝࢮࣥ⏕ᡂᶵᗎࡢゎ᫂ண㜵⸆ࡢ㛤Ⓨ 6,240,000 ຊࠉ⿱ ⫈ぬᮎᲈ࠾ࡼࡧ⬻ᖿࡼࡿಙྕᢳฟࡢ⏕⌮ᶵᵓ㸸ࢥ࢘ࣔࣜࢆࣔࢹࣝ ࡋࡓ◊✲ 9,230,000 ᯇᮧࠉ┿ྖ ⬤ᙅ㧗㱋⪅ࡢࢣ⛣⾜࠾ࡅࡿデ⒪ሗఏ㐩ࡢࡓࡵࡢᶆ‽ⓗࣇ࢛࣮ ࣐ࢵࢺ㛤Ⓨ 1,430,000 ᓥࠉྐ⾜ ෆ⪥ᐖཷᐜయ௬ㄝᇶ࡙࠸ࡓ∦㢌③㛵㐃ࡵࡲ࠸ࡢែゎ᫂ࡢࡓࡵࡢ ᇶ♏ⓗ◊✲ 1,950,000 ົྎࠉⱥᶞ ⼗∵⚄⤒పᙧᡂࡢ᪂つཎᅉೃ⿵ZBTB10ࡢෆ⪥Ⓨ⏕࠾ࡅࡿᶵ⬟ゎᯒ 1,560,000 㞴Ἴࠉ୍ᚨ ࣌ࣥࢻࣞࢵࢻೃ⩌ࡢཎᅉ࡞ࡿSLC26A4ࡢ㧗㢖ฟኚ␗ࡼࡿᵓ㐀 㞀ᐖᶵᗎࡢゎ᫂ 1,430,000 ᐙᓥࠉ㍜ ⁱฟᆺຍ㱋㯤ᩬኚᛶ࠾ࡅࡿHTRA1㑇ఏᏊ㉳ᅉࡍࡿ⾑⟶᪂⏕࣓࢝ ࢽࢬ࣒ࡢゎᯒ 1,430,000 㡲㈡ࠉᬗᏊ ᡂయ࣐࢘ࢫ࣑࣮ࣗࣛࢢࣜ⣽⬊ࡢ㑇ఏᏊᑟධࡼࡿin vivo ⥙⭷⚄ ⤒⣽⬊⏕ 1,170,000 ⴠྜࠉ༤Ꮚ MUSE⣽⬊⛣᳜ࡣ⓶യ⒵ࢆಁ㐍ࡋࠊ⓶ᵓ㐀ࢆ⏕ࡍࡿ㸽 1,690,000 195,000 㸺ᇶ┙◊✲㸦C㸧㸼 ⸨ࠉṇே (ศᢸ) 㢌㢕㒊⒴࠾ࡅࡿᶵ⬟ Ꮡࢆ┠ᣦࡋࡓ㞟Ꮫⓗ⒪ᑐࡍࡿࣂ࣐࣮࢜ ࣮࢝ࡢ㛤Ⓨ 650,000 ᑿ⸨ࠉㄔྖ (ศᢸ) ᪥ᮏᆺ⌮ࢥࣥࢧࣝࢸ࣮ࢩࣙࣥయไ⌮ࣉࣟࣇ࢙ࢵࢩࣙࢼࣝ⫱ᡂ 㛵ࡍࡿ◊✲ 260,000 ᯘࠉ⿱ྐ (ศᢸ) ⫈ᖹ⾮ぬ่⃭ᑐࡍࡿ㥆ࢆᣦᶆࡋࡓ๓ᗞᛶ∦㢌③ࡢᐈほⓗデ᩿ἲ ࡢ☜❧ 65,000 ༡ࠉಟྖ㑻 Ᏻ㟼㹤MR1ࢆ⏝࠸ࡓ⫈ぬ␗ᖖឤ⬻ࢿࢵࢺ࣮࣡ࢡࡢゎ᫂ཬࡧࡑࡢ୰ᯡ ไᚚ 1,560,000 ຍᡃ ྩᏕ ேᕤෆ⪥࠾ࡼࡧ⿵⫈ჾ⏝⪅ࡢ㡢※ᐃࠊ୧⪥ศ㞳⬟ࠊ୧⪥ྜᡂ⬟ࡢ ◊✲ 1,040,000 ᮌᮧࠉ⨾Ꮚ 㧗ศᏊ࣑ࢭࣝᆺࢼࣀ࣓ࢹࢩࣥࢆ⏝࠸ࡓ㠉᪂ⓗ࡞㢌㢕㒊⭘⒆⒪ἲࡢ 㛤Ⓨ 910,000 ᚨࠉ⿱ HPV㝧ᛶ㢌㢕㒊⒴࠾ࡅࡿDNA࣓ࢳࣝࢆᣦᶆࡋࡓⓎ⒴࣓࢝ࢽࢬ ࣒ࡢゎ᫂ ఀ⸨ࠉ᠇ (ศᢸ) ⼗∵⚄⤒᰾࠾ࡅࡿ㡢ኌሗฎ⌮ᶵᵓࡢゎ᫂ 1,040,000 130,000 ゅ⏣ࠉ୍ Ⓨኌ⫈ぬࣇ࣮ࢻࣂࢵࢡࡢ୰ᯡㄪ⠇ࡢ⏕⌮ⓗゎ᫂ 1,560,000 ᑿ⸨ࠉㄔྖ ࠕࡶ⪃࠼ࡿࣥࣇ࢛࣮࣒ࢻ࣭ࢥࣥࢭࣥࢺࠖᐇ㊶ࣔࢹࣝࡢᥦ♧᭷ ຠᛶࡢ᳨ド 1,560,000 㧗㱋⪅ࡢࢣෆᐜࢆỴᐃࡍࡿ㝿ࡢ⮫ᗋ᥎ㄽᑐࡍࡿᩍ⫱ࣉࣟࢢ࣒ࣛࡢ ᪉ྥᛶ 520,000 బࠎᮌࠉ┿⌮Ꮚ ㄆ▱Ⓨண ࣂ࣐࣮࣮࢜࢝ࡋ࡚ࡢ⥙⭷ᙧ≧ゎᯒࡢᛂ⏝㸸║⛉ Ꮫࢥ࣮࣍ࢺ◊✲ 1,430,000 Ỉ㊊ࠉ㑥㞝 ⼗∵᭷ẟ⣽⬊࣭ࡽࡏࢇ⚄⤒⠇⣽⬊ࡢ㐜Ⓨᛶ⬺ⴠ࣓࢝ࢽࢬ࣒ࡢゎ᫂ 1,690,000 ➉⭜ࠉⱥᶞ Auditory NeuropathyࡢCHIRP㡢⼗㟁ᅗVEMPࡼࡿ◊✲ 1,040,000 ゅ⏣ࠉ⦾ OPA1㑇ఏᏊኚ␗ࢆ᭷ࡍࡿඃᛶど⚄⤒ጤ⦰࠾ࡅࡿ║⛉ⓗ࠾ࡼࡧ ㌟ⓗ≧ࡢ◊✲ 1,820,000 ᑿ⸨ࠉㄔྖ ᓥࠉྐ⾜ (ศᢸ) (ศᢸ) 㸱ḟඖືⓗࣉࣛࢵࢺࣇ࢛࣮࣒ࢆ⏝࠸ࡓ᪂ࡓ࡞ᖹ⾮ᶵ⬟ࢺ࣮ࣞࢽࣥࢢἲ ࡢ☜❧ ― 227 ― 65,000 㸺ᣮᡓⓗⴌⱆ◊✲㸼 ᒾ⏣ࠉᓅ 㑇ఏᛶ⥙⭷ᝈ࢝ࢽࢡࢨࣝࡢస〇ࡑࡢ⌮Ꮫⓗゎᯒ 3,640,000 ᒣ⃝ࠉ୍ᶞ 㑇ఏᛶஙࡀࢇ࣭༸ᕢࡀࢇ࠾࠸࡚࣓ࢳ࣭ࣝࣄࢻࣟ࢟ࢩ࣓ࢳࣝࡀᯝ ࡓࡍᙺࡢゎ᫂ 2,210,000 Ỉ㊊ࠉ㑥㞝 (ศᢸ) ࣄࢺES/iPS⣽⬊⏤᮶ࡢෆ⪥⣽⬊ࢆ⏝࠸ࡓ⸆ࢫࢡ࣮ࣜࢽࣥࢢ⣔ࡢᵓ⠏ 130,000 ࣓ࢳࣝ␗ᖖ㉳ᅉࡍࡿඛኳ␗ᖖೃ⩌࠾࠸࡚ࣄࢻࣟ࢟ࢩ࣓ࢳࣝ ࡀᯝࡓࡍᙺࡢゎ᫂ 6,500,000 ᯘࠉ⿱ྐ ⼗∵⤌⧊≉␗ⓗ࣐ࢡࣟࣇ࣮ࢪࡢᶵ⬟ゎᯒឤ㡢㞴⫈Ⓨ࣓࢝ࢽࢬ࣒ 㛵ࡍࡿ◊✲ 2,470,000 ⚟ࠉṇᶞ どぬࡽࡢ㧗ḟᶵ⬟ホ౯ἲࡢ᳨ウ 㸺ⱝᡭ◊✲A㸼 ᒣ⃝ࠉ୍ᶞ 㸺ⱝᡭ◊✲㹀㸼 910,000 㸺ᅜ❧◊✲㛤Ⓨἲே⛉Ꮫᢏ⾡⯆ᶵᵓ ጤク◊✲㛤Ⓨ㈝㸼 ᾆᒸࠉಇኵ ෆど㙾⒪࡛⏕ࡌࡓᾘ⟶ቨࡢ✸Ꮝࢆయ ◳ᛶࢤ࡛ࣝ⡆᫆ࡘ☜ᐇ ⿕そࡍࡿ⒪ᢏ⾡ࡢ㛤Ⓨ 3,690,700 㛫᥋⤒㈝ྵࠉࠉࠉࠉᑠィ 61,215,700 2) ཌ⏕ປാ⛉Ꮫ◊✲㈝ 㸺ㄆ▱ᑐ⟇⥲ྜ◊✲ᴗ㸼 Ᏻᮧࠉ㔛⤮ 㯞㓉᪉ἲࡀ⾡ᚋㄆ▱ᶵ⬟࠼ࡿᙳ㡪ࡘ࠸࡚ࡢ◊✲ 2,622,000 㸺㞴ᛶᝈᨻ⟇◊✲ᴗ㸼 ຍᡃࠉྩᏕ (ศᢸ) 㞴ᛶ⫈ぬ㞀ᐖ㛵ࡍࡿㄪᰝ◊✲ 600,000 ᯇỌࠉ㐩㞝 (ศᢸ) 㞴ᛶ⫈ぬ㞀ᐖ㛵ࡍࡿㄪᰝ◊✲ 600,000 ᯇỌࠉ㐩㞝 (ศᢸ) ᅜ㝿ᶆ‽❧⬮ࡋࡓወᙧೃ⩌㡿ᇦࡢデ⒪ᣦ㔪㛵ࡍࡿᏛ㝿ⓗ࣭⥙⨶ ⓗ᳨ウ 700,000 㸺࢚ࢬᑐ⟇ᨻ⟇◊✲ᴗ㸼 ᮏ⏣ ⨾Ꮚ (ศᢸ) HIVឤᰁࡢ་⒪యไࡢᩚഛ㛵ࡍࡿ◊✲ 3,000,000 㸺㞀ᐖ⪅ᨻ⟇⥲ྜ◊✲ᴗ㸼 ᮏ⏣ࠉ⨾Ꮚ (ศᢸ) ⢭⚄㞀ᐖ⪅ࡢᆅᇦ⏕άᨭࡢᅾࡾ᪉ࢩࢫࢸ࣒ᵓ⠏㛵ࡍࡿ◊✲ 㛫᥋⤒㈝ྵࠉࠉࠉࠉᑠィ 2,000,000 9,522,000 3) ᪥ᮏ་⒪◊✲㛤Ⓨᶵᵓጤク◊✲㛤Ⓨ㈝ 㸺㞴ᛶᝈᐇ⏝◊✲ᴗ㸼 ᒾ⏣ࠉᓅ 㑇ఏᛶ⥙⬦⤡⭷ᝈࡢ⏕యヨᩱࡢ㞟࣭⟶⌮࣭ᥦ౪ែゎ᫂ ᯇỌࠉ㐩㞝 Pendredೃ⩌⏤᮶ᝈiPS⣽⬊ࢆ⏝࠸ࡓែ⏕⌮᪂つ⒪ᶆⓗࡢ (ศᢸ) ᥈⣴࠾ࡼࡧiPS⣽⬊ᢏ⾡ࢆ⏝࠸ࡓẖࡢ⸆ឤཷᛶࡢ๓ண 㛵 ࡍࡿ◊✲ ᒣ⃝ࠉ୍ᶞ (ศᢸ) ࣥࣉࣜࣥࢸࣥࢢ␗ᖖⓎ࠾ࡼࡧྜేⓎ࣓࢝ࢽࢬ࣒ࡢゎ᫂㸸 ᝈ⪅⏤᮶iPS⣽⬊ࢆ⏝࠸࡚ࡢ◊✲ ― 228 ― 110,000,000 3,000,000 1,950,000 㸺㞀ᐖ⪅ᑐ⟇⥲ྜ◊✲㛤Ⓨᴗ㸼 ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢ࠾ࡅࡿAuditory Neuropathy Spectrum Disordersࡢ㛗ᮇ㏣㊧◊✲ ຍᡃࠉྩᏕ ᯇỌࠉ㐩㞝 (ศᢸ) ᪂ࡋ࠸㞴⫈㑇ఏᏊデ᩿ࢩࢫࢸ࣒ࡢ㛤Ⓨ࠾ࡼࡧ⮫ᗋᛂ⏝㛵ࡍࡿ◊✲ 9,000,000 650,000 㸺་⒪ᶵჾ㛤Ⓨ᥎㐍◊✲ᴗ㸼 ゅ⏣ࠉ⦾ ᅾᏯ་⒪ᛂ⏝ྍ⬟࡞⡆᫆ᆺ║ᗏほᐹ⨨ࡢ㛤Ⓨ 20,800,000 㸺᪩ᮇ᥈⣴ⓗ࣭ᅜ㝿Ỉ‽⮫ᗋ◊✲ᴗ㸼 Ṋ⏣ࠉ⣧୕ (ศᢸ) ࠕ⮫ᗋ◊✲ရ㉁☜ಖయไᩚഛ㝔ࠖࢆά⏝ࡋࡓᅜ㝿ᶆ‽ࡢ⮫ᗋ◊✲ࡢ ᥎㐍᪂つ་⸆ရ࣭་⒪ᶵჾࡢ㛤Ⓨ㛵ࡍࡿ◊✲ 3,835,000 ゅ⏣ࠉ୍ (ศᢸ) ࠕ⮫ᗋ◊✲ရ㉁☜ಖయไᩚഛ㝔ࠖࢆά⏝ࡋࡓᅜ㝿ᶆ‽ࡢ⮫ᗋ◊✲ࡢ ᥎㐍᪂つ་⸆ရ࣭་⒪ᶵჾࡢ㛤Ⓨ㛵ࡍࡿ◊✲ 6,110,000 㸺㠉᪂ⓗࡀࢇ་⒪ᐇ⏝◊✲ᴗ㸼 ⸨ࠉṇே (ศᢸ) 㐍⾜㢌㢕㒊ࡀࢇᑐࡍࡿ⾡ᚋ⿵ຓ⒪ἲࡢᶆ‽⒪☜❧ࡢࡓࡵࡢከタ ඹྠ◊✲ 1,000,000 ⸨ࠉṇே (ศᢸ) 㐍⾜ୖ㢡Ὕ⒴ᑐࡍࡿ㉸㑅ᢥⓗືὀᏛ⒪ἲࢆే⏝ࡋࡓᨺᑕ⥺⒪ ࡼࡿ᪂つ⒪ἲ㛤Ⓨ㛵ࡍࡿ◊✲ 1,300,000 ⴙࠉ⠜᠇ (ศᢸ) ࢺ࣮ࣞࢧࣅࣜࢸࡢ☜ಖࡉࢀࡓ⥺※⏬ീㄏᑟࢆ⏝ࡋࡓ㧗⥺㔞⋡ᑠ ⥺※⒪ࡢᶆ‽㧗ᗘࡢ◊✲ 400,000 㛫᥋⤒㈝ྵࠉࠉࠉࠉᑠィ 158,045,000 4)ࡑࡢࡢ◊✲㈝ 㸺ࡀࢇ◊✲㛤Ⓨ㈝㸼 ⸨ࠉṇே (ศᢸ) 㢌㢕㒊ࡀࢇᑐࡍࡿᶆ‽⒪☜❧ࡢࡓࡵࡢከタඹྠ◊✲ 800,000 ⸨ࠉṇே (ศᢸ) 㢌㢕㒊⒴ᑐࡍࡿ㞟Ꮫⓗ⒪ࡋ࡚ࡢᏛᨺᑕ⥺⒪ἲࡢ㛤Ⓨ 400,000 㸺ᖹᡂ27ᖺᗘබ┈㈈ᅋἲே⏕Ꮡ⛉Ꮫ◊✲ᡤ◊✲ຓᡂ㔠㸼 ▱ぬ࣭ឤ࣭ゝㄒࡼࡿໟᣓⓗࢣᢏ⾡ࡢᐇ㊶ᛂ⏝ࡑࡢຠᯝ ᮏ⏣ࠉ⨾Ꮚ 800,000 㸺2015ᖺᗘ᪥ᮏᑠඣෆศἪᏛࠉᮍ᮶㛤ᣅ◊✲ຓᡂ㔠㸼 ࣓ࢳࣝ␗ᖖ㉳ᅉࡍࡿᑠඣඛኳ␗ᖖೃ⩌࠾࠸࡚ࣄࢻࣟ࢟ࢩ࣓ࢳ ࣝࡀᯝࡓࡍᙺࡢゎ᫂ ᒣ⃝ࠉ୍ᶞ 1,000,000 㸺ᖹᡂ27ᖺᗘ㕥ᮌㅬ୕グᛕ་⛉Ꮫᛂ⏝◊✲㈈ᅋࠉຓᡂ㔠㸼 ༡ࠉಟྖ㑻 ⪁ேᛶ㞴⫈ᑐࡍࡿࠊᏳ㟼 fMRI ᶵ⬟ⓗ⤖ྜᇶ࡙࠸ࡓ⫈ぬࣜࣁࣅ ࣜࢸ࣮ࢩࣙࣥࡢ㛤Ⓨ 1,000,000 㛫᥋⤒㈝ྵࠉࠉࠉࠉᑠィ 4,000,000 ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤 Ⓨ㛵ࡍࡿ◊✲ 7,070,000 5㸧ᅜ❧㝔ᶵᵓඹྠ⮫ᗋ◊✲ 㸺NHOࢿࢵࢺ࣮࣡ࢡඹྠ◊✲㸼 ༡ࠉಟྖ㑻 ⸨ࠉṇே (ศᢸ) ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤 Ⓨ㛵ࡍࡿ◊✲ 1,000,000 ᯇỌࠉ㐩㞝 (ศᢸ) ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤 Ⓨ㛵ࡍࡿ◊✲ 100,000 ᓥࠉྐ⾜ (ศᢸ) ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤 Ⓨ㛵ࡍࡿ◊✲ 100,000 ົྎࠉⱥᶞ (ศᢸ) ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤 Ⓨ㛵ࡍࡿ◊✲ 1,000,000 ຍᡃࠉྩᏕ (ศᢸ) ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤 Ⓨ㛵ࡍࡿ◊✲ 100,000 ― 229 ― ᵽཱྀࠉᬗᏊ (ศᢸ) ៏ᛶ୰⪥⅖࠾ࡅࡿ㞴ᇵ㣴ᚤ⏕≀ࡢ࣓ࢱࢤࣀ࣒ゎᯒࡼࡿ᪂つ⒪㛤 Ⓨ㛵ࡍࡿ◊✲ 200,000 NHO⾑ᾮ࣭㐀⾑ჾᝈࢿࢵࢺ࣮࣡ࢡཧຍタ᪂ࡓⓎ⏕ࡍࡿከⓎ ᛶ㦵㧊⭘ࡢணᚋ㛵ࡍࡿ⮫ᗋⓗせᅉࢆ᫂ࡽࡍࡿࢥ࣮࣍ࢺ◊✲ Bᆺ⫢⅖࢘ࣝࢫ࠾ࡅࡿ᰾㓟ࢼࣟࢢ⪏ᛶ㑇ఏᏊࡢゎᯒ࠾ࡼࡧ⪏ᛶ (ศᢸ) ᑐࡍࡿrescuetherapyࡢධ 㠀ࣝࢥ࣮ࣝᛶ⫢㞀ᐖ⏤᮶⫢⣽⬊⒴ࡢ᪩ᮇⓎぢ࠾ࡼࡧ༴㝤⩌ࡢᅖ࠸㎸ (ศᢸ) ࡳࡢࡓࡵࡢ⾑୰࣐࣮࣮࢝᥈⣴ 370,000 ⳥ụࠉ┿ (ศᢸ) ᛴᛶ⫢⅖ࡢⓎ⏕≧ἣ࠾ࡼࡧ㔜ࠊ㛵ࡍࡿᅉᏊ㛵ࡍࡿ◊✲ 580,000 ᮧ⏣ࠉ᭷ஓ (ศᢸ) ⣽⬊デ᳨యࢆ⏝࠸ࡓங⒴⸆≀⒪ἲ㐺ᛂỴᐃࡢࡓࡵࡢᇶ♏◊✲ 460,000 ᯇࠉဴ (ศᢸ) ⣽⬊デ᳨యࢆ⏝࠸ࡓங⒴⸆≀⒪ἲ㐺ᛂỴᐃࡢࡓࡵࡢᇶ♏◊✲ 460,000 ⏣ࠉࡲࡍࡳ (ศᢸ) ⣽⬊デ᳨యࢆ⏝࠸ࡓங⒴⸆≀⒪ἲ㐺ᛂỴᐃࡢࡓࡵࡢᇶ♏◊✲ 340,000 ᶓᒣࠉ᫂ᘯ ⳥ụࠉ┿ ⳥ụࠉ┿ (ศᢸ) 110,000 50,000 ຍᡃࠉྩᏕ ᪂⏕ඣ⫈ぬࢫࢡ࣮ࣜࢽࣥࢢࡢ᭷↓ඛኳᛶ㞴⫈ඣࡢணᚋࡢ㛵㐃ࡢゎ ᫂ 4,460,000 ゅ⏣ࠉ୍ ࠕኌࡢ⾨⏕ᩍ⫱ࠖᝈ⪅ၨⓎࡼࡿኌᖏ࣏࣮ࣜࣉࡢಖᏑⓗ⒪ࠊ ࡑࡢ᭷ຠᛶࡢ᳨ドࠉ㸫ၨⵚࡽၨⓎ㸫 7,200,000 Ṋ⏣ࠉ⣧୕ (ศᢸ) ࠕኌࡢ⾨⏕ᩍ⫱ࠖᝈ⪅ၨⓎࡼࡿኌᖏ࣏࣮ࣜࣉࡢಖᏑⓗ⒪ࠊࡑࡢ᭷ ຠᛶࡢ᳨ドࠉ㸫ၨⵚࡽၨⓎ㸫 100,000 ᓥࠉྐ⾜ (ศᢸ) ࠕኌࡢ⾨⏕ᩍ⫱ࠖᝈ⪅ၨⓎࡼࡿኌᖏ࣏࣮ࣜࣉࡢಖᏑⓗ⒪ࠊࡑࡢ᭷ ຠᛶࡢ᳨ドࠉ㸫ၨⵚࡽၨⓎ㸫 50,000 ᓥ⏣ࠉ㈗ಙ (ศᢸ) ࠕኌࡢ⾨⏕ᩍ⫱ࠖᝈ⪅ၨⓎࡼࡿኌᖏ࣏࣮ࣜࣉࡢಖᏑⓗ⒪ࠊࡑࡢ᭷ ຠᛶࡢ᳨ドࠉ㸫ၨⵚࡽၨⓎ㸫 50,000 ᶓᒣࠉ᫂ᘯ (ศᢸ) ከⓎᛶ㦵㧊⭘ࡢ㑇ఏᏊ␗ᖖ⒪ຠᯝ࠾ࡼࡧணᚋ㛵ࡍࡿ◊✲ ୖ㔝ࠉ༤๎ (ศᢸ) Ⓨཪࡣ㞴ᛶࡢ㧗㱋⪅ࡧࡲࢇᛶ⣽⬊ᆺ㹀⣽⬊ࣜࣥࣃ⭘ᑐࡍࡿ㹐 㸫㹅㹂㹎⒪ἲ㛵ࡍࡿ➨㹇㹇┦ヨ㦂 250,000 ⳥ụ ┿ (ศᢸ) Cᆺ⫢⅖࢘ࣝࢫ㥑㝖ᚋࡢ⫢⅖/⥺⥔ᨵၿືែホ౯ࢆ┠ⓗࡋࡓࠊ ⾑ΎmiRNAࣉࣟࣇࣜࣥࢢἲࡢ☜❧ 75,000 ⳥ụ ┿ (ศᢸ) ⏕యヨᩱࣂࣥࢡࢆ⏝ࡋࡓ⮬ᕫචᛶ⫢⅖ࡢศᏊᏛࢥ࣮࣍ࢺ◊✲ ᓥࠉஂ (ศᢸ) 㭯ࠉὒ (ศᢸ) ࡀࢇ࿘⾡ᮇᝈ⪅࠾ࡅࡿཱྀ⭍⟶⌮ධຠᯝཬࡰࡍண ᅉᏊࡢゎ᫂ ᯇỌࠉ㐩㞝 DPC⾜㝔࠾ࡅࡿ⏬ീデ᩿ࢆ୰ᚰࡋࡓ་⒪㈨※⏝ࡢຠ⋡ᛶホ ౯ࡢᣦ㔪సᡂࡢࡓࡵࡢ◊✲ 240,000 280,000 412,000 80,000 ゝㄒ⫈ぬࣜࣁࣅࣜࢸ࣮ࢩࣙࣥࡢྥୖࢆ┠ⓗࡋࡓඛኳᛶ㞴⫈ࡢ㑇ఏⓗ ཎᅉ⏕ᚋ᪩ᮇࡢ⤒㐣ࡢゎ᫂㸫᪂ࡓ࡞◊✲᥎㐍㸫 17,510,000 ຍᡃࠉྩᏕ (ศᢸ) ゝㄒ⫈ぬࣜࣁࣅࣜࢸ࣮ࢩࣙࣥࡢྥୖࢆ┠ⓗࡋࡓඛኳᛶ㞴⫈ࡢ㑇ఏⓗ ཎᅉ⏕ᚋ᪩ᮇࡢ⤒㐣ࡢゎ᫂㸫᪂ࡓ࡞◊✲᥎㐍㸫 100,000 ༡ࠉಟྖ㑻 (ศᢸ) ゝㄒ⫈ぬࣜࣁࣅࣜࢸ࣮ࢩࣙࣥࡢྥୖࢆ┠ⓗࡋࡓඛኳᛶ㞴⫈ࡢ㑇ఏⓗ ཎᅉ⏕ᚋ᪩ᮇࡢ⤒㐣ࡢゎ᫂㸫᪂ࡓ࡞◊✲᥎㐍㸫 100,000 ㎸ᒣ ಟ (ศᢸ) ゝㄒ⫈ぬࣜࣁࣅࣜࢸ࣮ࢩࣙࣥࡢྥୖࢆ┠ⓗࡋࡓඛኳᛶ㞴⫈ࡢ㑇ఏⓗ ཎᅉ⏕ᚋ᪩ᮇࡢ⤒㐣ࡢゎ᫂㸫᪂ࡓ࡞◊✲᥎㐍㸫 200,000 ຍ⸨ࠉⰋ୍ ᶓᒣࠉ᫂ᘯ ᾆᒸࠉಇኵ 75ᡯ௨ୖᚋᮇ㧗㱋⪅㠀ᑠ⣽⬊⫵⒴ࡢᡭ⾡ᡂ⦼㛵ࡍࡿ๓ྥࡁࡢከ タࢥ࣮࣍ࢺ◊✲ ᮍ⒪75ṓ௨ୖ㸦⛣᳜㠀㐺ᛂ㸧ࡢከⓎᛶ㦵㧊⭘ᝈ⪅ࢆᑐ㇟ࡍࡿ Bd/Ld᭰ᑟධ⒪ἲࡢᏳᛶ࣭᭷ຠᛶ㛵ࡍࡿ⮫ᗋ◊✲ 㠀ࢫࢸࣟࢻᛶᢠ⅖⥅⥆ᢞᝈ⪅࠾ࡅࡿ⫶༑ᣦ⭠₽⒆Ⓨᢚ (ศᢸ) ไຠᯝᑐࡍࡿ࢚ࢯ࣓ࣉࣛࢰ࣮ࣝࠊࣛࣥࢯࣉࣛࢰ࣮ࣝࡢࣛࣥࢲ࣒ẚ ㍑ヨ㦂 (ศᢸ) 40,000 1,027,000 100,000 ᮧ⏣ࠉ᭷ஓ (ศᢸ) ᅜ❧㝔ᶵᵓ࠾ࡅࡿ㐲㝸ங⭢⌮デ᩿ࢿࢵࢺ࣮࣡ࢡᵓ⠏ 500,000 ᯇࠉဴ (ศᢸ) ᅜ❧㝔ᶵᵓ࠾ࡅࡿ㐲㝸ங⭢⌮デ᩿ࢿࢵࢺ࣮࣡ࢡᵓ⠏ 100,000 ― 230 ― ᒾ⏣ࠉᓅ 14,500,000 㑇ఏᛶ⥙⭷ᝈ⏝㑇ఏᏊデ᩿࢟ࢵࢺࡢᐇ⏝◊✲ ᯇỌࠉ㐩㞝 (ศᢸ) NICUඹ㏻ࢹ࣮ࢱ࣮࣋ࢫࡽぢࡓᡂ⫱་⒪࠾ࡅࡿ࿘⏘ᮇ་⒪ࡢホ౯ ␗ᖖᑐࡍࡿ᪩ᮇⓎぢࠊධࡢ☜❧㛵ࡍࡿ◊✲ 800,000 ㎸ᒣࠉಟ (ศᢸ) NICUඹ㏻ࢹ࣮ࢱ࣮࣋ࢫࡽぢࡓᡂ⫱་⒪࠾ࡅࡿ࿘⏘ᮇ་⒪ࡢホ౯ ␗ᖖᑐࡍࡿ᪩ᮇⓎぢࠊධࡢ☜❧㛵ࡍࡿ◊✲ 1,000,000 ᒣ⃝ࠉ୍ᶞ (ศᢸ) NICUඹ㏻ࢹ࣮ࢱ࣮࣋ࢫࡽぢࡓᡂ⫱་⒪࠾ࡅࡿ࿘⏘ᮇ་⒪ࡢホ౯ ␗ᖖᑐࡍࡿ᪩ᮇⓎぢࠊධࡢ☜❧㛵ࡍࡿ◊✲ 300,000 ▮㔝ࠉᑛၨ (ศᢸ) ຍ㱋ᛶEpstein-Barr virus㛵㐃ࣜࣥࣃቑṪᛶᝈ࠾ࡅࡿPD-1/PD-L1 ࢩࢢࢼࣝࡢែࡢ㛵ணᚋண 㛵ࡍࡿゎᯒ 20,000 ᾆᒸࠉಇኵ (ศᢸ) ⭠ෆど㙾⒪࠾ࡅࡿ᪂つ⤒ཱྀᢠจᅛ⨨ࡢ᭷⏝ᛶᏳᛶ㛵 ࡍࡿከタඹྠ◊✲ 200,000 ࠉࠉࠉࠉᑠィ 61,634,000 6㸧EBM᥎㐍◊✲㈝ 㒯ࠉᮾᏕ 2ᆺ⢾ᒀࢆేࡏᣢࡘ㧗⾑ᅽᝈ⪅࠾ࡅࡿ࣓ࢺ࣑࣍ࣝࣥࡢᚰ⫧࣭ᚰ ᶵ⬟ᑐࡍࡿຠᯝࡢ᳨ウ ຍ⸨ࠉⰋ୍ ႚ↮⪅ࠊ㠀ႚ↮⪅ࡢ⫵⒴ᅉ㛵ࡍࡿศᏊᏛⓗ◊✲ ᓥࠉஂ ⫵⅖ࣜࢫࢡࢆ᭷ࡍࡿ㛵⠇࣐ࣜ࢘ࢳᝈ⪅ࢆᑐ㇟ࡋࡓ23౯⫵⅖⌫⳦࣡ࢡ ࢳࣥ㸦PPV)ࡢ᭷⏝ᛶ᳨ドࡢࡓࡵࡢRCT 240,000 ᵻᒣࠉᖾᙪ 㓟⣲ᢞࡼࡿᚰ⮚࢝ࢸ࣮ࢸࣝᚋ㐀ᙳ⭈ࡢண㜵ຠᯝ㛵ࡍࡿ◊✲ 660,000 ᯇࠉဴ 㑇ఏᛶஙࡀࢇ࣭༸ᕢࡀࢇࡢ㑇ఏᏊゎᯒࡼࡿ࣮࢜ࢲ࣮࣓ࢻ་⒪ࡢᐇ ⌧ 3,000,000 ᑠィ 4,240,000 ― 231 ― 250,000 90,000 㻌 㻌 㻌 㻌 䊣㻌 ⤌⧊⾲㻌 㻌 ― 233 ― ᒾ⏣ࠉᓅ ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊㛗 ゅ⏣ࠉ୍ ேᕤ⮚ჾ࣭ᶵჾ㛤Ⓨ◊✲㒊㛗 ⸨ࠉṇே ⫈ぬ࣭ᖹ⾮ぬ◊✲㒊㛗 どぬ◊✲㒊㛗 ゅ⏣ࠉ⦾ 㸦ࢭࣥࢱ࣮㛗ే௵㸧 ᨻ⟇་⒪⏬◊✲㒊㛗 㒊㛗 ྡࢭࣥࢱ࣮㛗ࠉࠉࠉࠉࠉࠉࠉຍᡃࠉྩᏕ Ṋ⏣⣧୕ ົྲྀᢅ ࢭࣥࢱ࣮㛗 ᵻᒣࠉᖾᙪ ゅ⏣ࠉ⦾ ⮫ᗋ◊✲࣭㦂᥎㐍ᐊ どぬ⏕⌮Ꮫ◊✲ᐊ ᒾ⏣ࠉᓅ㸧 どぬ⏕≀Ꮫ◊✲ᐊ ⮫ᗋ◊✲ࢭࣥࢱ࣮ົᐊ ᒾ⏣ࠉᓅ㸧 㸦ゅ⏣ࠉ୍㸧 Ⓨ⏕་Ꮫ◊✲ᐊ ⚄⤒⏕≀Ꮫ◊✲ᐊ 㸦ゅ⏣ࠉ୍㸧 㸦ゅ⏣ࠉ୍㸧 ⴠྜࠉ༤Ꮚ ࠉᓥࠉྐ⾜ࠉ ᯇỌࠉ㐩㞝 㡢ኌ࣭ゝㄒࢥ࣑ࣗࢽࢣ࣮ ࢩࣙࣥ◊✲ᐊ ௦⏝⮚ჾ㛤Ⓨ◊✲ᐊ ⏕་⒪◊✲ᐊ ᖹ⾮ぬ㞀ᐖ◊✲ᐊ ⫈ぬ㞀ᐖ◊✲ᐊ ࣮ࣟࣅࢪࣙࣥ◊✲ᐊ 㔝⏣ࠉᚭ ᩧ⸨ྐ㑻 ᡭ⾡ᨭࣟ࣎ࢵࢺᢏ⾡ ᛂ⏝◊✲ᐊ ║⛉Ꮫ◊✲ᐊ ᮏ⏣ࠉ⨾Ꮚ ᑿ⸨ࠉㄔྖ ᐊ㛗 ་⒪⤒Ⴀሗ࣭㧗㱋⪅ࢣ ◊✲ᐊ ⮫ᗋᏛ◊✲ᐊ ◊✲ᐊ ࣭ᱵ⏣⛱Ꮚ ࣭ᐙᓥ㍜ ࣭ᒸᮏᬗᏊ ࣭%ULDQ35RVVPLOOHU ࣭ົྎⱥᶞ ࣭㞴Ἴ୍ᚨ ὶື◊✲ဨ ࣭బࠎᮌᚭ ࣭㛵ᮏⲮኴ㑻 ࣭ෆ⸨⌮ᜨ ࣭すᒣ⪔୍㑻 ࣭㔝ᮧົ ࣭⸨ᕳⴥᏊ ࣭ᒸࠉឡᏊ ࣭㤿ሙඃ ࣭⩚⏕᪼ ࣭Ọ㑈ᩯ ࣭ᑠᯈᶫ⨾㤶 ࣭㈏㔝ᙬᏊ ࣭ᮌᮧዉὠᏊ ࣭ቑ⏣ṇḟ ࣭ྜྷᆂ♸ ࣭ᑿ௰❶⏨ ࣭ᑠᯘ⌮㤶 ࣭ᒾᮧᆒ ࣭ᡞ㇂Ⓩ㈗Ꮚ ࣭ఀ⸨⠜ ࣭ᆏᮏᖾኈ ࣭ᓥ⏣㈗ಙ ࣭❶Ꮚ ࣭ᑠ⃝ᏹஅ ࣭ᮌཎᙬᏊ ࣭Ώ㒊㧗ஂ ࣭బ㔝ᾈ୍㑻 ࣭ᑿᜤᏊ ࣭ᒣᮏಟᏊ ࣭ᚋ⸨ࠉ⪽ ࣭⚟ṇᶞ ࣭ᖹᙧᑑᙯ ࣭⛙ᮍ⛥ ࣭Ỉ㔝ಙ ࣭▼㔛 ࣭㇂ᆅࠉ㇏ ࣭▮ᮌᗣே ࣭▮㔝ᑛၨ ࣭᳃ࠉ᭸᭷ ࣭ᒣୗࠉ༤ ࣭⯞ὠὒᖹ ࣭᳃ࠉఙ ࣭ᯇဴ࣭ 㣤ᒸ⥴⨾ ࣭ᯘࠉᣅ㑻 ࣭ᘪሙᚭ ࣭▼ᶫᗣᏊ ࣭⃝ⱱⰋ ࣭5RVHWWH0HUHVFRWWL ࣭<YHV*LQHVWH ࣭༓ཎᗣ⿱ ࣭ᯇᮏ⣧ኵ ࣭⣽㇂ࠉㄔ ࣭ᾆᒸಇኵ ࣭ᒣ⃝୍ᶞ ࣭ᮧࠉ ࣭ᯘ┿⌮Ꮚ ࣭Ṋ⏣⣧୕ ࣭⸨⏣㈗ஓ ࣭㏕ⱱⓏᙪ ࣭ᾆᒸಇኵ ࣭ຍ⸨ඖᙪ ࣭ෆᐊᬛஓ ࣭㧗ᯘࠉ㤾 ࣭㛵ᒇఙᏊ ࣭ᮌᮧඃ ࣭ຊࠉ⿱ ࣭ఀཎ⣲Ꮚ ࣭ᏳᝋᏊ ࣭ධỤ㤶⤮-3236ⅆ㹼㔠࣭㛛㤿ࡢࡾᏊ㸦75,3᭶࣭ⅆ࣭ᮌ࣭㔠 ࣭ྜྷᕝளᕼ᭶㹼㔠 ࣭ቑ⏣▱ᐇ㸦᭶㹼㔠㸧 ࣭ᮌᮧ⮳ ࣭୰ᕝ㐍 ࣭⸨ᒸṇே ࣭Ỉ㊊㑥㞝 ࣭༡ಟྖ㑻 ࣭ᮤ㜶 ࣭ᚨ⿱ ࣭Ⲩ⨾ᕼ ࣭⚄ᓮᬗ ࣭ዉ㡲ᜨ⨾Ꮚ ࣭୕ᾆṇ⛱ ࣭ᆏᮏዲ ࣭Ỉ㇂ே ࣭▼ᮏ୍ ࣭ఀ⸨᠇ ࣭ୖ⩚⍠⨾ ࣭ຍ⣡ ࣭⳥⏣࿘ ࣭⇃⏣ᨻಙ ࣭⠛⏣ၨ ࣭㕥ᮌ⯟ ࣭ⰼᅬඖ ࣭⸨Ἴⰾ ࣭ᕝᓥ⣲Ꮚ ࣭㇂ၨ୍ ࣭⛅ᒣ㑥ᙪ ࣭ᓥஂ ࣭ఫᖾྖ ࣭ᑠᒣ⏣Ꮥ ࣭㛛ᯇࠉ㈼ ࣭ᩧ⸨ྐ㑻 ࣭᪂᳃ຍዉᏊ ࣭㧗ᶫṇᙪ ࣭㟷ᮌၨ ࣭ᩧ⸨ྐ㑻 ࣭ຍᡃྩᏕ ࣭ෆᒣຮ ࣭ᴮᮏ༓ỤᏊ ࣭ᮌᮧ⨾Ꮚ ࣭ቑ⏣Ẏ ࣭ᐑᓮ᪥ฟᾏ ࣭☾㒊㝧 ࣭ᒣ⏣ᩄஅ ࣭すཎభ୍ ࣭㏆⸨┤ᶞ ࣭㧗ᮌᜨ⨾ ◊✲ဨ ࣭ྡ㒓┤ᶞ ࣭୰ᮧࠉ᠇ ࣭すᒣࠉᚭ ࣭ᯇᓮ୍㑻 ࣭ᯇᮧ┿ྖ ࣭㟷ᮌὈᏊ ࣭㛗㇂ᕝᨻᚨ ࣭ᒾ㷂ᫀᶞ ࣭ᵽཱྀ㡰ஓ ࣭ᆏ⏣ⱥ᫂ ࣭᪂ṇ⏤⣖Ꮚ ࣭㐍⸨⨾ὠᏊ ࣭➉⭜ⱥᶞ ࣭୰ᮧ㞞Ꮚ ࣭ᯘ⿱ྐ ࣭ᮡᮏ┿ᶞ ࣭ᑠὠ୍㑻 ࣭ụୖᖾ᠇ ࣭➉ୗᬛᜨ ࣭✄ྜྷ⨾⏤⣖ ࣭⸨ᕝᏊ ࣭బࠎᮌ┿⌮Ꮚ ࣭୰ᮧዉὠᏊ ࣭ຍ⸨ᝆ ࣭⏣୰ᏹᶞ ࣭ᒣ⏣ᫀ ࣭㔜Ᏻ༓ⰼ ⮫ᗋ◊✲ࢭࣥࢱ࣮⤌⧊ᅗ◊✲ဨ㸧 ࠉ ࣭㧗ᮧᬗᏊ㸦᭶ⅆᮌ㔠㸧 ࣭ྜྷ⏣⨾Ụ㸦᭶࣭Ỉ㸧 ࣭୕⎼ⱥᏊ㸦ⅆ࣭ᮌ㸧 ࣭ୖⷵ┤Ꮚ㸦ⅆ࣭㔠㸧 ࣭㛵ཱྀ㤶௦Ꮚ ྡࢭࣥࢱ࣮㛗┤ᒓ ୍ぴ㸼 ⛎᭩ ࣭ᯘඵ༓ᜨ㸦᭶࣭Ỉ࣭㔠㸧 ࣭Ώ㎶㝧Ꮚ ࣭ྜྷ⏣ᬛ⨾㸦Ỉᮌ㔠㸧 ࣭ᕝᮧ㞝୍ ࣭୰ᒣ┿ኸ 㛵ཱྀ㤶௦Ꮚ᭶㹼㔠 ࣭↷ᒣ㐟᭶ⅆᮌ㔠 ࣭ᡞᮧᖾ௦ࠉ㸦᭶࣭ⅆ㸧 ࣭⇃⏣ࡲࡾ㸦᭶࣭Ỉ㹼㔠㸧 ࣭㧗⃝⨾⿱㸦᭶࣭ⅆ࣭Ỉ㸧 ࣭㕥ᮌ᭸Ꮚࠉࠉ࣭∦ᒸᯞ㔛Ꮚ ࣭⊁ሙ㈗Ꮚ᭶㺃Ỉ㹼㔠 ࣭ఀ㐩ዉ⨾࣭ᯘ┿ᕫᏊ ࣭ᗈᏳᩥᏊ࣭ᓥ㔝῟Ꮚ ࣭୰ᕝ⏤⨾ࠉࠉ࣭㔠ග❶Ụ ࣭ᮏஂ⨾Ꮚ ◊✲ຓᡭ ࣭⸨ᒸ⳯✑Ꮚ࣭Ⲩ∾⨾ᶞ 㻌 㻌 㻌 㻌 䊤㻌 ⥘㡿䚸つ⛬䛺䛹㻌 㻌 ᖹᡂ㸯㸴ᖺ㸲᭶㸯᪥つ⛬➨㸰㸷ྕ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ ⮫ᗋ◊✲ࢭࣥࢱ࣮㸦ឤぬჾࢭࣥࢱ࣮㸧タ⨨㐠Ⴀ⥘㡿 㸦タ⨨㸧 ➨㸯᮲ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮㸦௨ୗࠕᙜ㝔ࠖ࠸࠺ࠋ㸧⮫ᗋ◊ ✲ࢭࣥࢱ࣮㸦ឤぬჾࢭࣥࢱ࣮㸧㸦௨ୗࠕឤぬჾࢭࣥࢱ࣮ࠖ࠸࠺ࠋ㸧ࢆ⨨ࡃࠋ 㸦┠ⓗ㸧 ➨㸰᮲ ឤぬჾࢭࣥࢱ࣮ࡣࠊ⮫ᗋ㒊㛛ᐦ᥋㐃ᦠࢆࡾ࡞ࡀࡽࠊឤぬჾᝈ㸦║⛉ࠊ⪥ 㰯⛉㸧ࡢ⮫ᗋ◊✲యࢆ࠾ࡁࠊཎᅉ᫂ࡢᝈࠊ࠶ࡿ࠸ࡣ⒪ࡢᅔ㞴࡞ᝈࡢᅉࡢ ゎ᫂ࠊ⒪ἲࡢ㛤Ⓨ࡞ࢆ⾜࠺ࡓࡵࠊෆእࡢ◊✲⪅ᗈࡃ◊✲ࡢሙࢆ࠼ࠊ◊✲タࡢ ຠᯝⓗ࡞㐠⏝ࢆᅗࡾࡘࡘࠊࡉࡽࠊᮏ㝔ࡢᢸ࠺ᨻ⟇་⒪ศ㔝㸦ࡀࢇࠊᚠ⎔ჾᝈࠊ⭈ ᝈࠊෆศἪ࣭௦ㅰᝈࠊච␗ᖖᝈࠊ⾑ᾮ㐀⾑ჾᝈࠊᡂ⫱་⒪ࠊ⢭⚄ᝈ➼㸧ࢆྵ ࡵࡓᖜᗈ࠸⮫ᗋ◊✲ࢆ᥎㐍ࡍࡿࠋ 㸦⤌⧊㸧 ➨㸱᮲ ឤぬჾࢭࣥࢱ࣮ࡣࠊ⮫ᗋ◊✲ࢭࣥࢱ࣮㛗㸦௨ୗࠕࢭࣥࢱ࣮㛗ࠖ࠸࠺ࠋ㸧ࠊ㒊㛗ࠊ ᐊ㛗ࠊᐊဨཬࡧὶື◊✲ဨ࡛ᵓᡂࡍࡿࠋ 㸰 ࢭࣥࢱ࣮㛗ࡣࠊ㝔㛗ࡢᣦ┘╩ࡢࡶࠊᡤᒓ⫋ဨࢆᣦࡋࠊឤぬჾࢭࣥࢱ࣮ࡢᴗົ ࢆ⤫ᣓࡍࡿࠋ 㸱 㒊㛗ࡣࠊࢭࣥࢱ࣮㛗ࡢᣦࡢࡶࠊᐊ㛗ࢆ┘╩ࡋ◊✲ࡘ࠸࡚ຓゝᣦᑟࢆ⾜࠺ࠋ 㸲 ᐊ㛗ࡣࠊᐊဨཬࡧ◊✲ဨࢆᣦᑟ┘╩ࡋࠊᙜヱ◊✲ᐊࡢᴗົࢆ㐙⾜ࡍࡿࠋ 㸳 ឤぬჾࢭࣥࢱ࣮ḟࡢ◊✲㒊ཬࡧᐊࢆ⨨ࡁࠊ㒊㛗ࠊᐊ㛗ࢆᐃࡵࡿࠋ ୍ ᨻ⟇་⒪⏬◊✲㒊 ⮫ᗋᏛ◊✲ᐊ ࣟ ་⒪⤒Ⴀሗ◊✲ᐊ ࣁ ᡭ⾡ᨭࣟ࣎ࢵࢺᢏ⾡ᛂ⏝◊✲ᐊ ࢽ ⮫ᗋ◊✲࣭㦂᥎㐍ᐊ どぬ◊✲㒊 どぬ⏕⌮Ꮫ◊✲ᐊ ࣟ ║ගᏛ◊✲ᐊ ࣁ ࣮ࣟࣅࢪࣙࣥ◊✲ᐊ ୕ ⫈ぬ࣭ᖹ⾮ぬ◊✲㒊 ⫈ぬ㞀ᐖ◊✲ᐊ ࣟ ᖹ⾮ぬ㞀ᐖ◊✲ᐊ ࣁ ⏕་⒪◊✲ᐊ ᅄ ேᕤ⮚ჾ࣭ᶵჾ㛤Ⓨ◊✲㒊 ௦⏝⮚ჾ㛤Ⓨ◊✲ᐊ ࣟ 㡢ኌ࣭ゝㄒࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ◊✲ᐊ ࣁ Ⓨ⏕་Ꮫ◊✲ᐊ ศᏊ⣽⬊⏕≀Ꮫ◊✲㒊 どぬ⏕≀Ꮫ◊✲ᐊ ࣟ ⚄⤒⏕≀Ꮫ◊✲ᐊ ― 235 ― 㸦㐠Ⴀጤဨ㸧 ➨㸲᮲ ឤぬჾࢭࣥࢱ࣮ࡢ࡞㐠Ⴀࢆᅗࡿࡓࡵࠊ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭ ࣥࢱ࣮⮫ᗋ◊✲ࢭࣥࢱ࣮㸦ឤぬჾࢭࣥࢱ࣮㸧㐠Ⴀጤဨ㸦௨ୗࠕጤဨࠖ࠸࠺ࠋ㸧ࢆ ⨨ࡃࠋ 㸰 ጤဨࡢጤဨ㛗ࡣ㝔㛗ࡋࠊጤဨࡣ㝔㛗ࠊࢭࣥࢱ࣮㛗ࠊྛࢭࣥࢱ࣮㒊㛗ࠊົ㒊 㛗ࠊ⟶⌮ㄢ㛗ࠊ⏬ㄢ㛗ཬࡧᴗົ⌜㛗ࡍࡿࠋ 㸱 ጤဨ㛗ࡣᚲせㄆࡵࡓࡁࡣࠊ๓㡯ᐃࡵࡿ⫋ဨࡢ㛵ಀ⫋ဨࢆጤဨฟᖍࡉࡏ ពぢࢆồࡵࡿࡇࡀ࡛ࡁࡿࠋ 㸲 㐠Ⴀጤဨࡣᖺ㸰ᅇ㛤ദࡋࠊጤဨ㛗ࡀᚲせㄆࡵࡓࡁࡣࠊ⮫ጤဨࢆ㛤ദࡍࡿ ࡇࡀ࡛ࡁࡿࠋ 㸳 ጤဨ࠾࠸࡚ḟࡢ㡯ࡘ࠸࡚ᑂ㆟ࢆ⾜࠺ࠋ ୍ ឤぬჾࢭࣥࢱ࣮ࡢ⟶⌮㐠Ⴀ㛵ࡍࡿࡇ ឤぬჾࢭࣥࢱ࣮ࡢே⤒⌮㛵ࡍࡿࡇ ୕ ࡑࡢ 㸴 ጤဨ㆟ࡣࠊ࡚㆟㘓ࡋ࡚ಖᏑࡍࡿࡶࡢࡋࠊグ㘓ࡣᴗົ⌜㛗ࡀࡇࢀ࠶ࡓࡿࠋ 㸦ឤぬჾࢭࣥࢱ࣮ᇶᮏᴗົ㸧 ➨㸳᮲ ឤぬჾࢭࣥࢱ࣮ࡣࠊ㝔㛗ࡢᣦ┘╩ࡢࡶࠊḟࡢᴗົࢆ㐙⾜ࡍࡿࡶࡢࡍࡿࠋ ୍ ᙜ㝔ࡢ≉Ⰽࢆ⏕ࡋࡓ⮫ᗋ◊✲ࢆᐇࡍࡿࡇࠋ ᨻ⟇་⒪ࢿࢵࢺ࣮࣡ࢡࢆ⏕ࡋࡓ⮫ᗋ◊✲ࢆᐇࡍࡿࡇࠋ ୕ ◊✲㈝ࡢᇳ⾜ࡘ࠸࡚ࡣࠊࢭࣥࢱ࣮㛗ࡀྛ㒊㛗༠㆟ࡢ࠺࠼ᇳ⾜ィ⏬ࢆ⟇ᐃࡋࠊ 㝔㛗ࡢᢎㄆࢆᚓ࡚ᇳ⾜ࡋࠊᖺᗘᮎࡑࡢィሗ࿌ࢆ⾜࠺ࡇࠋ ᅄ ࢭࣥࢱ࣮௨እࡢ◊✲⪅ࡶඹྠࡋ࡚⮫ᗋ◊✲ࢆ⾜࠸ࠊ◊✲ᡂᯝࢆᙜ㝔ࡢ⮫ᗋᫎ ࡉࡏࡿࡼ࠺ດࡵࡿࡇࠋ ᆅᇦ་⒪㐃ᦠࢆᅗࡿ࠺࠼ࡽࡶࠊᆅᇦ་⒪ᢏ⾡ࡢྥୖ㈨ࡍࡿࡇࠋ භ ᐃᮇⓗ⮫ᗋ◊✲᳨ウࠊⓎ⾲ࢆ㛤ദࡋࠊࡇࢀࢆබ㛤ࡍࡿࡇࠋ ◊✲ᡂᯝࡣᏛࠊᏛ⾡㞧ㄅ࡞ࢆ㏻ࡌ࡚ࠊᗈࡃබ⾲ࡍࡿࡇࠋ ඵ ឤぬჾ㛵㐃ࡢ᪂⸆㛤Ⓨࠊᶵჾ㛤Ⓨ㛵ࢃࡿᇶ♏ⓗࠊ⮫ᗋⓗ㦂ࢆ✚ᴟⓗ᥎㐍ࡍࡿ ࡇࠋ ࢭࣥࢱ࣮㛗ࡣࠊᙜヱᖺᗘ࠾ࡅࡿ◊✲ィ⏬ࢆ㸲᭶ᮎ᪥ࡲ࡛ࠊ◊✲ሗ࿌ࢆ⩣ᖺࡢ㸳᭶ ᮎ᪥ࡲ࡛సᡂࡍࡿࡇࠋ ༑ ឤぬჾࢭࣥࢱ࣮ࢆ⏝ࡋ࡚⾜ࢃࢀࡓ࡚ࡢᴗ⦼ࡣࠊྛ㒊㛗ࡢ㈐௵࠾࠸࡚ࠊᙜヱᖺ ᗘᮎࡲ࡛ࢭࣥࢱ࣮㛗ሗ࿌ࡍࡿࡇࠋ ༑୍ ➇தⓗ◊✲㈝㸦ᩥ㒊⛉Ꮫ┬◊✲㈝⿵ຓ㔠ࠊཌ⏕⛉Ꮫ◊✲㈝⿵ຓ㔠࡞㸧➼ࡢ⤒⌮ ົࡣࠊ㝔㛗ົጤ௵ࡍࡿࡇࠋ 㸦ឤぬჾࢭࣥࢱ࣮㆟㸧 ➨㸴᮲ ឤぬჾࢭࣥࢱ࣮◊✲ࡢຠ⋡ࢆࡣࡿࡓࡵཬࡧឤぬჾࢭࣥࢱ࣮ෆࡢ㐃⤡ㄪᩚ ࢆ⾜࠺ࡓࡵឤぬჾࢭࣥࢱ࣮㆟ࢆࡶ࠺ࡅࡿࠋ 㸰 ࢭࣥࢱ࣮㆟ࡣࢭࣥࢱ࣮㛗ࡀྊ㞟ࡋࠊྛ㒊㛗ࠊᐊ㛗ࠊ◊✲ဨ࡞ᐇ㝿◊✲ࢆ⾜ࡗ࡚ ࠸ࡿ⪅ࡣཧຍࡍࡿࡇࡀฟ᮶ࡿࠋ 㸱 ࢭࣥࢱ࣮㆟ࡣẖ᭶➨ᮌ᭙᪥㛤ദࡍࡿࠋ 㸦ேホ౯㸧 ➨㸵᮲ ࢭࣥࢱ࣮◊✲⫋ဨࡣࠊࢭࣥࢱ࣮㛗ࢆྵࡵࠊ௵ᮇࢆ㸱ᖺࡋࠊ㸱ᖺ㛫ࡢᴗ⦼ࢆホ౯ࠊ ― 236 ― ຺ࡋࠊࡑࡢ⫋ࢆ⥅⥆ࡍࡿࡇࡀฟ᮶ࡿࠋ 㸰 ホ౯ࡢࡓࡵࡢឤぬჾࢭࣥࢱ࣮ホ౯ጤဨࢆタࡅࡿࠋ 㸦ホ౯ጤဨ㸧 ➨㸶᮲ ホ౯ጤဨࡣ㝔㛗ࡀྊ㞟ࡋࠊᵓᡂጤဨࡣ㝔㛗ࠊ㝔㛗ࠊࢭࣥࢱ࣮㛗ࡋࠊཎ ๎ࡋ࡚ࠊ㝔እࡽⱝᖸྡࡢ᭷㆑⪅㸦እ㒊ጤဨ㸧ࡢཧຍࢆせㄳࡍࡿࠋ 㸰 ホ౯ጤဨࡣࠊឤぬჾࢭࣥࢱ࣮ࡢάືཬࡧ◊✲ဨࡢᴗ⦼ࢆ㸯ᖺࡈホ౯ࡋࠊ㐠Ⴀጤ ဨሗ࿌ࡍࡿࠋ ➨㸷᮲ ࡇࡢ⥘㡿ᐃࡵࡿࡶࡢࡢࠊឤぬჾࢭࣥࢱ࣮㛵ࡋ࡚ᚲせ࡞㡯ࡘ࠸࡚ࡣࠊ㐠 Ⴀጤဨ࠾࠸࡚ᑂ㆟Ỵᐃࡍࡿࠋ 㝃 ๎ 㸦⾜ᮇ᪥㸧 ࡇࡢ⥘㡿ࡣࠊᖹᡂ㸯㸴ᖺ㸲᭶㸯᪥ࡽ⾜ࡍࡿࠋ࡞࠾ࠊᖹᡂ㸯㸳ᖺ㸯㸮᭶㸯᪥ࡽ⾜ ࡋ࡚࠸ࡿ⥘㡿ࡣᗫṆࡍࡿࠋ 㝃 ๎ 㸦⾜ᮇ᪥㸧 ࡇࡢ⥘㡿ࡣࠊᖹᡂ㸰㸲ᖺ㸶᭶㸯᪥ࡽ୍㒊ᨵᐃࡋ࡚⾜ࡍࡿࠋ 㝃 ๎㸦➨㸱᮲➨㸳㡯➨㸯ྕ㛵ಀ㸧 㸦⾜ᮇ᪥㸧 ࡇࡢ⥘㡿ࡣࠊᖹᡂ㸰㸳ᖺ㸲᭶㸯᪥ࡽ⾜ࡍࡿࠋ ― 237 ― ᖹᡂ㸯㸴ᖺ㸲᭶㸯᪥つ⛬➨㸶㸵ྕ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ ⮫ᗋ◊✲ࢭࣥࢱ࣮⛉Ꮫ◊✲㈝⿵ຓ㔠ࡼࡿ◊✲ᐇつ⛬ 㸦タ⨨㸧 ➨㸯᮲ ࡇࡢつ⛬ࡣࠊ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮㸦௨ୗࠕᙜ㝔ࠖ࠸࠺ࠋ 㸧 ⮫ᗋ◊✲ࢭࣥࢱ࣮ࡢ◊✲⪅ࡀ⾜࠺◊✲ࡢ࠺ࡕࠊ⛉Ꮫ◊✲⿵ຓ㔠ࡼࡿ◊✲ࡢᡂᯝࢆ࠶ࡆ ࡿࡶ◊✲ᡂᯝࡢᬑཬࢆᅗࡿࡇࢆ┠ⓗࡍࡿࠋ 㸦◊✲ィ⏬ࡢ⟇ᐃ㸧 ➨㸰᮲ ◊✲⪅ࡣࠊ⛉Ꮫ◊✲㈝⿵ຓ㔠ࡼࡿ◊✲ࢆ⾜࠺ሙྜࡣࠊࡢᴗົᨭ㞀ࢆཬࡰࡉ ࡞࠸⠊ᅖ࠾࠸࡚⮬Ⓨⓗ◊✲ィ⏬ࢆ❧ࡋࠊᐇࡍࡿࡶࡢࡍࡿࠋ 㸰 ◊✲⪅ࡣࠊ࠶ࡽࡌࡵᵝᘧᚑࡗࡓ◊✲ィ⏬᭩ࢆసᡂࡋࠊᙜヱㄪ᭩ࡢࡋࢆᙜ㝔㝔 㛗ᐄᥦฟࡍࡿࡶࡢࡍࡿࠋ 㸦◊✲ᡂᯝࡢྲྀᢅ㸧 ➨㸱᮲ ◊✲⪅ࡣࠊ๓᮲ࡼࡾ⛉Ꮫ◊✲㈝⿵ຓ㔠ࡼࡾ⾜ࡗࡓ◊✲ࡘ࠸࡚ࡣࠊࡢつ⛬ ಀࢃࡽࡎࠊᙜヱ◊✲ࡢ◊✲ᡂᯝࡘ࠸࡚⮬ࡽࡢุ᩿࡛බ⾲ࡍࡿࡇࡀฟ᮶ࡿࠋࡲࡓࠊ බ⾲࠶ࡓࡗ࡚ࡣࠊ⫋ົࡋ࡚⮬ⓎⓗᏛ➼ཧຍ࡛ࡁࡿࡶࡢࡍࡿࠋ 㸦◊✲ሗ࿌ࡢ⩏ົ㸧 ➨㸲᮲ ◊✲⪅ࡣࠊᙜヱไᗘಀࢃࡿつ⛬㢮ᚑ࠸ሗ࿌᭩ࢆసᡂࡋࠊᙜヱሗ࿌᭩➼ࡢࡋ ࢆᙜ㝔㝔㛗ᐄᥦฟࡍࡿࡶࡢࡍࡿࠋ 㸦⟶⌮➼ࡢົ㸧 ➨㸳᮲ ⛉Ꮫ◊✲㈝⿵ຓ㔠ࡢ⟶⌮➼ࡢົࡣࠊ⏬ㄢࡀᡤᤸࡍࡿࠋ 㝃 ๎ 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸯㸴ᖺ㸲᭶㸯᪥ࡽ⾜ࡍࡿࠋ࡞࠾ࠊᖹᡂ㸯㸳ᖺ㸯㸮᭶㸯᪥ࡽ⾜ ࡋ࡚࠸ࡿ᪤Ꮡࡢつ⛬ࡣᗫṆࡍࡿࠋ 㝃 ๎ 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸰㸲ᖺ㸶᭶㸯᪥ࡽ୍㒊ᨵᐃࡋ࡚⾜ࡍࡿࠋ ― 238 ― ᖹᡂ㸰㸲ᖺ㸲᭶㸯᪥つ⛬➨㸴㸮ྕ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮㑇ఏᏊ⤌࠼ᐇ㦂Ᏻ⟶⌮つ⛬ ➨㸯᮲ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲ࢭࣥࢱ࣮ 㸦ឤぬჾࢭࣥࢱ࣮㸧 㸦௨ୗࠕᮏࢭࣥࢱ࣮ࠖ࠸࠺ࠋ 㸧࠾ࡅࡿ㑇ఏᏊ⤌࠼ᐇ㦂ࡢ㐺ṇ࡞ᐇ㛵ࡋ࡚ࡣࠊ⏕ ≀ࡢከᵝᛶ㛵ࡍࡿ᮲⣙ࡢࣂ࢜ࢭ࣮ࣇࢸ㛵ࡍࡿ࢝ࣝࢱ࣊ࢼ㆟ᐃ᭩ࠊ㑇ఏᏊ⤌⤌ ࠼⏕≀➼ࡢ⏝➼ࡢつไࡼࡿ⏕≀ࡢከᵝᛶࡢ☜ಖ㛵ࡍࡿἲᚊ㸦ᖹᡂ㸯㸳ᖺἲᚊ➨㸷 㸵ྕ㸧 ࠊ ◊✲㛤Ⓨ➼ಀࡿ㑇ఏᏊ⤌࠼⏕≀➼ࡢ➨✀⏝➼ᙜࡓࡗ࡚ᇳࡿࡁᣑᩓ㜵 Ṇᥐ⨨➼ࢆᐃࡵࡿ┬௧㸦ᖹᡂ㸯㸴ᖺᩥ㒊⛉Ꮫ┬࣭⎔ቃ┬௧➨㸯ྕ㸧 ࠊ◊✲㛤Ⓨẁ㝵࠾ࡅ ࡿ㑇ఏᏊ⤌࠼⏕≀➼ࡢ➨✀⏝➼ࡢᡭᘬࡁ㸦ᖹᡂ㸰㸱ᖺ㸳᭶ᩥ㒊⛉Ꮫ┬◊✲⯆ᒁ ࣛࣇࢧ࢚ࣥࢫㄢ ⏕⌮࣭Ᏻᑐ⟇ᐊ㸧 ࠊᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲ࢭࣥࢱ࣮㑇ఏ Ꮚ⤌࠼⏕≀➼ᐇ㦂ᣦ㔪ᇶ࡙ࡁᐃࡵࡽࢀࡿࡶࡢࢆ㑂Ᏺࡍࡿࠋ ➨㸰᮲ ᮏࢭࣥࢱ࣮࠾ࡅࡿ㑇ఏᏊ⤌࠼ᐇ㦂ࡢ㐺ṇ࡞ᐇ㛵ࡋ࡚ࡣࠊ⮫ᗋ◊✲ࢭࣥࢱ ࣮㛗㸦௨ୗࠕࢭࣥࢱ࣮㛗ࠖ࠸࠺ࠋ㸧ࡀ⥲ᣓ⟶⌮ࡍࡿࠋ ➨㸱᮲ 㑇ఏᏊ⤌࠼ᐇ㦂ࢆ㐺ṇᐇࡍࡿࡓࡵࠊᮏࢭࣥࢱ࣮㑇ఏᏊ⤌࠼ᐇ㦂Ᏻጤ ဨ㸦௨ୗࠕጤဨࠖ࠸࠺ࠋ㸧ࢆ⨨ࡃࠋ ➨㸲᮲ ጤဨࡣࠊูᐃࡵࡿ㑇ఏᏊ⤌࠼ᐇ㦂ィ⏬᭩ࢆࠊᐇ㦂⪅ࡽ⏦ㄳࡀ࠶ࡗࡓࡁ ᑂᰝࡋࠊᢎㄆཪࡣᢎㄆࢆỴᐃࡍࡿࠋ 㸰 ጤဨࡣࠊᢎㄆࡋࡓ㑇ఏᏊ⤌࠼ᐇ㦂ࡢ◊✲ィ⏬ࡀἲ௧㐪ࡋ࡚࠸ࡿࡳࡵࡽࢀ ࡿࡁཪࡣᙜヱ◊✲ࡀィ⏬ᚑࡗ࡚㐺ṇᐇࡉࢀ࡚࠸࡞࠸ㄆࡵࡽࢀࡿࡁࡣࠊᚲせ ࡞ᥐ⨨ࡘ࠸࡚ᣦᑟࠊຓゝࡋࠊሙྜࡼࡗ࡚ࡣࡇࢀࢆ୰Ṇࡉࡏࡿࡇࡀ࡛ࡁࡿࠋ ➨㸳᮲ ጤဨࡣࠊḟࡢྛྕᥖࡆࡿጤဨ࡛⤌⧊ࡍࡿࠋ ୍ ᐇ㦂ື≀ࢆྲྀࡾᢅ࠺◊✲㒊㒊㛗࠶ࡿ࠸ࡣ◊✲ᐊᐊ㛗 㸰ྡ ࡑࡢࢭࣥࢱ࣮㛗ࡀᚲせㄆࡵࡿ⪅ ⱝᖸྡ 㸰 ጤဨࡢጤဨ㛗ࡣࢭࣥࢱ࣮㛗ࢆ௨࡚࡚ࠊጤဨࡣࢭࣥࢱ࣮㛗ࡀጤკࡍࡿࠋ ࡞࠾ࠊࢭࣥࢱ࣮㛗ᅾࡢሙྜࡣ㝔㛗ࡀጤဨ㛗ࢆᣦྡࡍࡿࡶࡢࡍࡿࠋ ➨㸴᮲ ◊✲ィ⏬ࡢ㐺ṇ࡞ᐇ㝿ࡋ࡚ࡣࠊࡑࡢ㈐௵ࡣ◊✲㒊㒊㛗ࡲࡓࡣ◊✲ᐊᐊ㛗㸦௨ ୗࠕᐇ㦂⟶⌮⪅ࠖ࠸࠺ࠋ㸧ࡀ㈇࠺ࡶࡢࡍࡿࠋ ➨㸵᮲ 㑇ఏᏊ⤌࠼ᐇ㦂ࢆᐇࡋࡼ࠺ࡍࡿ⪅ࡣࠊᮏࢭࣥࢱ࣮ࡢ◊✲ᐊᡤᒓࡋ࡞ࡅࢀ ࡤ࡞ࡽ࡞࠸ࠋ 㸰 ᐇ㦂⟶⌮⪅ࡣࠊ◊✲ィ⏬ࡢ❧ཬࡧᐇ㝿ࡋ࡚ࡣࠊἲ௧ཬࡧࡇࡢつ⛬ࢆ㑂Ᏺࡋࠊ㑇 ఏᏊ⤌࠼ᐇ㦂ࡢ㐺ṇ࡞⟶⌮࠶ࡓࡿࡶࡢࡍࡿࠋ ➨㸶᮲ 㑇ఏᏊ⤌࠼ᐇ㦂ࢆᐇࡋࡼ࠺ࡍࡿሙྜࡣࠊᐇ㦂⟶⌮⪅ࡣᡤᐃࡢᐇ㦂ィ⏬᭩ ࢆጤဨᥦฟࡋ࡚ࠊᢎㄆࢆཷࡅ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋᢎㄆࢆཷࡅࡓ◊✲ィ⏬ࢆኚ᭦ࡋࡼ ࠺ࡍࡿሙྜࡶྠᵝࡍࡿࠋ 㸰 ᐇ㦂⟶⌮⪅ࡣࠊ◊✲ࡢᐇᙜࡓࡗ࡚ணࡉࢀࡿ༴㝤ᛶࡑࡢᑐᛂ᪉ἲࡘ࠸࡚ᐇ㦂 ィ⏬᭩᫂☜グ㍕ࡍࡿࠋ ― 239 ― 㸱 ᐇ㦂ィ⏬᭩ࡀᥦฟࡉࢀࡓሙྜࠊጤဨࡣ᳨ウ㆟ࢆ㛤࠸࡚ᐇ㦂ࡢᢎㄆࡢ᭷↓ࢆỴᐃࡍ ࡿࠋ 㸲 ጤဨࡣࠊᢎㄆࡋࡓ◊✲ィ⏬ࢆࢭࣥࢱ࣮㛗ሗ࿌ࡋࠊᐇ㦂⟶⌮⪅㏻▱ࡍࡿࠋ ➨㸷᮲ ᐇ㦂⟶⌮⪅ࡣࠊ㑇ఏᏊ⤌࠼ᐇ㦂ࡢᐇ≧ἣࡘ࠸࡚ࠊᐇ㦂ィ⏬᭩࠾ࡅࡿ◊✲ ⤊ཬࡧጤဨ࡞ࡢồࡵᛂࡌ࡚ࠊጤဨᩥ᭩࡛ሗ࿌ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸯㸮᮲ ࢭࣥࢱ࣮㛗ࡣࠊᢎㄆࡋࡓ◊✲ィ⏬㐪ࡋ࡚⾜࡞ࢃࢀ࡚࠸ࡿㄆࡵࡓሙྜࡲࡓ ࡣጤဨࡀ◊✲ࡢኚ᭦ⱝࡋࡃࡣ୰Ṇࡢ່࿌ࢆ⾜࡞ࡗࡓሙྜࡣࠊᐇ㦂⟶⌮⪅ኚ᭦ཪࡣ ୰Ṇࢆࡌ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸯㸯᮲ ᐇ㦂⟶⌮⪅ࡣࠊᐇ㦂ࡢᐇᙜࡓࡾᐇ⪅࠾ࡼࡧ࿘㎶タᑐࡍࡿᏳ☜ಖࠊ බ⾗⾨⏕ࠊ࠾ࡼࡧ⏕ែ⣔ಖୖࡢᨭ㞀ࢆ㜵Ṇࡍࡿࡓࡵᚲせ࡞ᥐ⨨ࢆㅮࡌ࡞ࡅࢀࡤ࡞ࡽ ࡞࠸ࠋ 㸰 ᐇ㦂⟶⌮⪅ࡣࠊ㑇ఏᏊ⤌࠼⏕≀➼ࢆ⟶⌮༊ᇦᑒࡌ㎸ࡵࡿࡼ࠺ࠊᚲせ࡞ᣑᩓ㜵Ṇ ⨨ࢆᇳࡽ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸱 ⅏ᐖࡑࡢࡢᨾࡼࡾࠊ⤌࠼㑇ఏᏊࡼࡿởᰁࡶࡋࡃࡣ༊ᇦእࡢ㐓㉮ࡀⓎ⏕ࡋࠊ ࡲࡓࡣⓎ⏕ࡍࡿᜍࢀࡢ࠶ࡿែࢆⓎぢࡋࡓ⪅ࡣࠊ┤ࡕ㐺ษ࡞ᥐ⨨ࢆࡿࡶࠊ㏿ ࡸᙜヱᐇ㦂⟶⌮⪅࠾ࡼࡧࢭࣥࢱ࣮㛗㏻ሗࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸲 ᐇ㦂⟶⌮⪅ཬࡧࢭࣥࢱ࣮㛗ࡣࠊ┦㐃⤡ࡋࠊᛂᛴࡢᥐ⨨ࢆㅮࡎࡿඹࠊ㝔㛗ࠊᅜ ❧㝔ᶵᵓᮏ㒊ࠊ ᩥ㒊⛉Ꮫ┬◊✲⯆ᒁࣛࣇࢧ࢚ࣥࢫㄢሗ࿌ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸯㸰᮲ ᐇ㦂ᐇ⪅ࡣࠊ ᙜヱᐇ㦂ಀࡿෆᐜࢆグ㘓ࡋࠊ ࡇࢀࢆಖᏑࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰 ᐇ㦂ᐇ⪅ࡣࠊ㑇ఏᏊ⤌࠼ື≀ࡢ㣫⫱ᙜࡓࡗ࡚ࡣࠊ㣫⫱ື≀ࡢᩘࢆయࡶྵࡵ ࡚ẖ㐌ィ ࡋࠊ㣫⫱ᩘ⟶⌮⡙グ㘓ࡋ࡚ࠊᐇ㦂⟶⌮⪅ሗ࿌ࡍࡿࠋ 㸱 ᐇ㦂ᐇ⪅ࡣࠊ㑇ఏᏊ⤌࠼⏕≀➼ࡢ⟶⌮༊ᇦ࠾࠸࡚ࡣධ㏥ฟ⟶⌮⡙グ㍕ࡍ ࡿࠋ 㸲 㣫⫱ᩘ⟶⌮⡙ཬࡧධ㏥ฟ⟶⌮⡙ࡣࠊື≀ᐇ㦂ጤဨ୪ࡧጤဨᐃᮇⓗᥦฟࡋࠊ ᑂᰝ࣭ᢎㄆࢆ࠺ࡅࡿࠋ ➨㸯㸱᮲ 㝔㛗ࡣࠊᖺ㸯ᅇ⛬ᗘࠊᐇ㦂ᐇ⪅୪ࡧᐇ㦂⟶⌮⪅ᑐࡋ࡚ࠊ㑇ఏᏊ⤌࠼ ᐇ㦂㛵ࡍࡿἲ௧ࠊసᴗ⟶⌮ࠊ⤌࠼㑇ఏᏊᣑᩓ㜵Ṇᥐ⨨ࠊ⥭ᛴࡢᑐᛂ࡞ࡘ࠸࡚ ᩍ⫱カ⦎ࢆ⾜࠺ࠋ 㸰 ጤဨࡣࠊ⏝タࡘ࠸࡚ᖺ㸯ᅇ⤌࠼㑇ఏᏊᣑᩓ㜵Ṇᥐ⨨ࢳ࢙ࢵࢡࣜࢫࢺࡼࡿ ⮬ᕫⅬ᳨ࢆᐇࡋࠊࡇࢀࢆᅜ❧㝔ᶵᵓᮏ㒊⥲ྜ◊✲ࢭࣥࢱ࣮ᥦฟࡍࡿࠋ ➨㸯㸲᮲ ࡇࡢつ⛬ᐃࡵࡿࡶࡢࡢࠊࡑࡢᚲせ࡞㡯ࡣࠊጤဨࡀᐃࡵࡿࠋ 㝃 ๎ 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸰㸲ᖺ㸲᭶㸯᪥ࡽ⾜ࡍࡿࠋ 㝃 ๎㸦➨㸳᮲➨㸰㡯㛵ಀ㸧 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸰㸳ᖺ㸷᭶㸷᪥ࡽ⾜ࡍࡿࠋ ― 240 ― 㝃 ๎㸦➨㸳᮲➨㸰㡯㛵ಀ㸧 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸰㸵ᖺ㸴᭶㸯㸳᪥ࡽ⾜ࡍࡿࠋ ― 241 ― ᖹᡂ㸰㸲ᖺ㸲᭶㸯᪥つ⛬➨㸴㸯ྕ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ື≀ᐇ㦂⟶⌮つ⛬ ┠ḟ ➨㸯❶ ⥲๎㸦➨㸯᮲㸫➨㸲᮲㸧 ➨㸰❶ ື≀ᐇ㦂ጤဨ㸦➨㸳᮲㸫➨㸯㸱᮲㸧 ➨㸱❶ ື≀ᐇ㦂➼ࡢᐇ㸦➨㸯㸲᮲㸫➨㸯㸵᮲㸧 ➨㸲❶ タ➼㸦➨㸯㸶᮲㸫➨㸰㸱᮲㸧 ➨㸳❶ ᐇ㦂ື≀ࡢ㣫㣴ཬࡧಖ⟶㸦➨㸰㸲᮲㸫➨㸱㸰᮲㸧 ➨㸴❶ Ᏻ⟶⌮㸦➨㸱㸱᮲㸫➨㸱㸲᮲㸧 ➨㸵❶ ᩍ⫱カ⦎㸦➨㸱㸳᮲㸧 ➨㸶❶ ⮬ᕫⅬ᳨࣭ホ౯ཬࡧ᳨ド㸦➨㸱㸴᮲㸧 ➨㸷❶ ሗබ⾲㸦➨㸱㸵᮲㸧 ➨㸯㸮❶ 㞧๎㸦➨㸱㸶᮲㸫➨㸱㸷᮲㸧 㝃 ๎ ➨㸯❶ ⥲๎ 㸦㊃᪨㸧 ➨㸯᮲ ࡇࡢつ⛬ࡣࠊ◊✲ᶵ㛵➼࠾ࡅࡿື≀ᐇ㦂➼ࡢᐇ㛵ࡍࡿᇶᮏᣦ㔪㸦ᖹᡂ㸯㸶 ᖺᩥ㒊⛉Ꮫ┬࿌♧➨㸵㸯ྕࠋ௨ୗࠕᩥ⛉┬ᇶᮏᣦ㔪ࠖ࠸࠺ࠋ㸧➨㸰᮲ࡢồࡵࡿᶵ㛵ෆ つ⛬ࡋ࡚ࠊ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮㸦௨ୗࠕࢭࣥࢱ࣮ࠖ࠸࠺ࠋ㸧 ࠾ࡅࡿື≀ᐇ㦂➼㛵ࡋࠊᚲせ࡞㡯ࢆᐃࡵࡿࡶࡢࡍࡿࠋ 㸦ᇶᮏཎ๎㸧 ➨㸰᮲ ᙜࢭࣥࢱ࣮࠾ࡅࡿື≀ᐇ㦂➼ࡘ࠸࡚ࡣࠊື≀ࡢឡㆤཬࡧ⟶⌮㛵ࡍࡿἲᚊ㸦 㸲㸶ᖺἲᚊ➨㸯㸮㸳ྕࠋ௨ୗࠕἲࠖ࠸࠺ࠋ㸧ࠊᐇ㦂ື≀ࡢ㣫㣴ཬࡧಖ⟶୪ࡧⱞ③ ࡢ㍍ῶ㛵ࡍࡿᇶ‽㸦ᖹᡂ㸯㸶ᖺ⎔ቃ┬࿌♧➨㸶㸶ྕࠋ௨ୗࠕ㣫㣴ಖ⟶ᇶ‽ࠖ࠸࠺ࠋ㸧ࠊ ᩥ⛉┬ᇶᮏᣦ㔪ࠊື≀ᐇ㦂ࡢ㐺ṇ࡞ᐇྥࡅࡓ࢞ࢻࣛࣥ㸦᪥ᮏᏛ⾡㆟ᖹᡂ㸯㸶 ᖺ㸴᭶㸯᪥ࠋ௨ୗࠕ࢞ࢻࣛࣥࠖ࠸࠺ࠋ㸧ࠊື≀ࡢฎศ᪉ἲ㛵ࡍࡿᣦ㔪㸦ᖹᡂ㸵 ᖺ⥲⌮ᗓ࿌♧➨㸲㸮ྕ㸧ࡑࡢࡢἲ௧➼ᐃࡵࡀ࠶ࡿࡶࡢࡢࠊࡇࡢつ⛬ࡢᐃࡵࡿ ࡇࢁࡼࡿࠋ 㸰 Ꮫ➼࠾ࡅࡿື≀ᐇ㦂➼ࢆక࠺⏕⛉Ꮫ◊✲ࡣࠊேࡢᗣ࣭⚟♴࣭ඛ➃་⒪ࡢ㛤Ⓨ ᒎ㛤ࡢࡳ࡞ࡽࡎື≀ࡢᗣቑ㐍➼࠾ࡅࡿ◊✲ศ㔝ࡢ㐍ᒎ࠾࠸࡚ࡶᚲせ࡞ᡭẁ࡛࠶ࡿ ࡇࡽࠊື≀ᐇ㦂➼ࡢᐇᙜࡓࡗ࡚ࡣࠊἲཬࡧ㣫㣴ಖ⟶ᇶ‽༶ࡋࠊື≀ᐇ㦂➼ࡢ ཎ๎࡛࠶ࡿ௦᭰ἲࡢ⏝㸦⛉Ꮫୖࡢ⏝ࡢ┠ⓗࢆ㐩ࡍࡿࡇࡀ࡛ࡁࡿ⠊ᅖ࠾࠸࡚ࠊ࡛ ࡁࡿ㝈ࡾື≀ࢆ౪ࡍࡿ᪉ἲ௦ࢃࡾᚓࡿࡶࡢࢆ⏝ࡍࡿࡇࢆ࠸࠺ࠋ㸧ࠊ⏝ᩘࡢ๐ῶ 㸦⛉Ꮫୖࡢ⏝ࡢ┠ⓗࢆ㐩ࡍࡿࡇࡀ࡛ࡁࡿ⠊ᅖ࠾࠸࡚ࠊ࡛ࡁࡿ㝈ࡾࡑࡢ⏝౪ࡉ ࢀࡿື≀ࡢᩘࢆᑡ࡞ࡃࡍࡿࡇ➼ࡼࡾᐇ㦂ື≀ࢆ㐺ษ⏝ࡍࡿࡇ㓄៖ࡍࡿࡇ ࢆ࠸࠺ࠋ㸧ཬࡧⱞ③ࡢ㍍ῶ㸦⛉Ꮫୖࡢ⏝ᚲせ࡞㝈ᗘ࠾࠸࡚ࠊ࡛ࡁࡿ㝈ࡾື≀ⱞ ③ࢆ࠼࡞࠸᪉ἲࡼࡗ࡚ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࡇࢆ࠸࠺ࠋ㸧ࡢ㸱㹐㸦5HSODFHPHQW㸦௦ ᭰ἲࡢ⏝㸧ࠊ5HGXFWLRQ㸦ື≀⏝ᩘࡢ๐ῶ㸧ࠊ5HILQHPHQW㸦ⱞ③ࡢ㍍ῶ㸧㸧ᇶ࡙ࡁࠊ 㐺ṇᐇࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ― 242 ― 㸦ᐃ⩏㸧 ➨㸱᮲ ࡇࡢつ⛬࠾࠸࡚ࠊḟࡢྛྕᥖࡆࡿ⏝ㄒࡢព⩏ࡣࠊࡑࢀࡒࢀᙜヱྛྕᐃࡵࡿ ࡇࢁࡼࡿࠋ ୍ ື≀ᐇ㦂➼ ᐇ㦂ື≀ࢆᩍ⫱ࠊヨ㦂◊✲ཪࡣ⏕≀Ꮫⓗ〇ࡢ〇㐀ࡢ⏝ࡑࡢࡢ⛉Ꮫୖࡢ⏝౪ ࡍࡿࡇࢆ࠸࠺ࠋ 㣫㣴ಖ⟶タ ᐇ㦂ື≀ࢆᜏᖖⓗ㣫㣴ⱝࡋࡃࡣಖ⟶ཪࡣື≀ᐇ㦂➼ࢆ⾜࠺タ࣭タഛࢆ࠸࠺ࠋ ୕ ᐇ㦂ᐊ ᐇ㦂ື≀ᐇ㦂᧯స㸦㸲㸶㛫௨ෆࡢ୍ⓗ࡞ಖ⟶ࢆྵࡴࠋ㸧ࢆ⾜࠺ື≀ᐇ㦂ᐊࢆ ࠸࠺ࠋ ᅄ タ➼ 㣫㣴ಖ⟶タཬࡧᐇ㦂ᐊࢆ࠸࠺ࠋ ᐇ㦂ື≀ ື≀ᐇ㦂➼ࡢ⏝౪ࡍࡿࡓࡵࠊタ➼࡛㣫㣴ཪࡣಖ⟶ࡋ࡚࠸ࡿ့ங㢮ࠊ㫽㢮ཪࡣ ∐㢮➼ᒓࡍࡿື≀㸦タ➼ᑟධࡍࡿࡓࡵ㍺㏦୰ࡢࡶࡢࢆྵࡴࠋ㸧ࢆ࠸࠺ࠋ භ ື≀ᐇ㦂ィ⏬ ື≀ᐇ㦂➼ࡢᐇ㛵ࡍࡿィ⏬ࢆ࠸࠺ࠋ ື≀ᐇ㦂ᐇ⪅ ື≀ᐇ㦂➼ࢆᐇࡍࡿ⪅ࢆ࠸࠺ࠋ ඵ ື≀ᐇ㦂㈐௵⪅ ື≀ᐇ㦂➼ࡢᐇ㛵ࡍࡿᴗົࢆ⤫ᣓࡍࡿ⪅ࢆ࠸࠺ࠋ㸦⮫ᗋ◊✲ࢭࣥࢱ࣮㛗㸧 ⟶⌮⪅ 㝔㛗ࢆ࠸࠺ࠋ ༑ ᐇ㦂ື≀⟶⌮⪅ ᐇ㦂ື≀㛵ࡍࡿ▱㆑ཬࡧ⤒㦂ࢆ᭷ࡍࡿ⪅࡛ࠊ⟶⌮⪅ࢆ⿵బࡋࠊᐇ㦂ື≀ࡢ⟶⌮ࢆ ᢸᙜࡍࡿ⪅ࢆ࠸࠺ࠋ㸦◊✲㒊㛗࠶ࡿ࠸ࡣ◊✲ᐊ㛗࠾ࡼࡧጤဨࡀㄆࡵࡓ⪅㸧 ༑୍ 㣫㣴⪅ ᐇ㦂ື≀⟶⌮⪅ཪࡣື≀ᐇ㦂ᐇ⪅ࡢୗ࡛ᐇ㦂ື≀ࡢ㣫㣴ཪࡣಖ⟶ᚑࡍࡿ⪅ࢆ ࠸࠺ࠋ ༑ ⟶⌮⪅➼ ⟶⌮⪅ࠊື≀ᐇ㦂㈐௵⪅ࠊᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ཬࡧ㣫㣴⪅ࢆ࠸࠺ࠋ ༑୕ ᣦ㔪➼ ື≀ᐇ㦂➼㛵ࡋ࡚ྛ⾜ᨻᶵ㛵ࡢᐃࡵࡿᇶᮏᣦ㔪ཬࡧ࢞ࢻࣛࣥࢆ࠸࠺ࠋ 㸰 ๓㡯➨㸶ྕ࡛つᐃࡍࡿື≀ᐇ㦂㈐௵⪅ࡣࠊ⮫ᗋ◊✲ࢭࣥࢱ࣮㛗ࢆ௨࡚࡚ࡿࡀࠊ⮫ᗋ ◊✲ࢭࣥࢱ࣮㛗ᅾࡼࡾࢭࣥࢱ࣮㝔㛗ࡀົྲྀᢅ࡞ࡗ࡚࠸ࡿሙྜ㝈ࡾࠊ⟶⌮⪅ࡣ ⮫ᗋ◊✲ࢭࣥࢱ࣮ᡤᒓࡍࡿ㒊㛗⫋ࡢ୰ࡽື≀ᐇ㦂㈐௵⪅ࢆᣦྡࡍࡿࡇࡀ࡛ࡁࡿࠋ 㸦㐺⏝⠊ᅖ㸧 ➨㸲᮲ ࡇࡢつ⛬ࡣࠊᙜࢭࣥࢱ࣮࠾࠸࡚ᐇࡉࢀࡿ့ங㢮ࠊ㫽㢮ཪࡣ∐㢮➼ࡢ⏕యࢆ ⏝࠸ࡿ࡚ࡢື≀ᐇ㦂㐺⏝ࡍࡿࠋ 㸰 ື≀ᐇ㦂㈐௵⪅ࡣࠊື≀ᐇ㦂➼ࡢᐇࢆᙜࢭࣥࢱ࣮௨እࡢᶵ㛵ጤクࡍࡿሙྜࡣࠊጤ クඛ࠾࠸࡚ࡶື≀ᐇ㦂➼㛵ࡋ࡚ྛ⾜ᨻᶵ㛵ࡢᐃࡵࡿᇶᮏᣦ㔪ᇶ࡙ࡁື≀ᐇ㦂➼ࡀ ᐇࡉࢀࡿࡇࢆ☜ㄆࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸰❶ ື≀ᐇ㦂ጤဨ㸦,QVWLWXWLRQDO$QLPDO&DUH8VH&RPPLWWHH,$&8&㸧 ― 243 ― 㸦ጤဨࡢタ⨨㸧 ➨㸳᮲ ⟶⌮⪅ࡣࠊື≀ᐇ㦂ィ⏬ࡢᢎㄆࠊᐇ≧ἣཬࡧ⤖ᯝࡢᢕᥱࠊ㣫㣴ಖ⟶タཬࡧᐇ 㦂ᐊࡢᢎㄆࠊᩍ⫱カ⦎ࠊ⮬ᕫⅬ᳨࣭ホ౯ࠊሗබ㛤ࡑࡢື≀ᐇ㦂➼ࡢ㐺ṇ࡞ᐇ㛵 ࡋ࡚ሗ࿌ཪࡣຓゝࢆ⾜࠺⤌⧊ࡋ࡚ࠊᙜࢭࣥࢱ࣮ື≀ᐇ㦂ጤဨ㸦௨ୗࠕጤဨࠖ ࠸࠺ࠋ㸧ࢆ⨨ࡃࠋ 㸦ጤဨࡢ௵ົ㸧 ➨㸴᮲ ጤဨࡣࠊḟࡢ㡯ࢆᑂ㆟ཪࡣㄪᰝࡋࠊࡑࡢ⤖ᯝࢆ㝔㛗ሗ࿌ࡍࡿࡶࠊᚲ せࡀ࠶ࢀࡤᨵၿࡢࡓࡵពぢࢆ㏙ࡿࠋ ୍ ື≀ᐇ㦂ィ⏬ࡢᑂᰝ㛵ࡍࡿࡇ ື≀ᐇ㦂ィ⏬ࡢᐇ≧ἣཬࡧ⤖ᯝ㛵ࡍࡿࡇ ୕ タ➼ࡢ⟶⌮≧ἣཬࡧᐇ㦂ື≀ࡢ㣫㣴ಖ⟶≧ἣ㛵ࡍࡿࡇ ᅄ ື≀ᐇ㦂➼ཬࡧᐇ㦂ື≀ࡢ㐺ṇ࡞ྲྀᢅ࠸୪ࡧ㛵ಀἲ௧➼㛵ࡍࡿᩍ⫱カ⦎ࡢෆᐜ ཪࡣయไ㛵ࡍࡿࡇ ື≀ᐇ㦂➼ಀࡿ⮬ᕫⅬ᳨࣭ホ౯㛵ࡍࡿࡇ භ ࡑࡢື≀ᐇ㦂➼ࡢ㐺ṇ࡞ᐇࡢࡓࡵᚲせ࡞㡯㛵ࡍࡿࡇ 㸦ጤဨࡢᵓᡂ㸧 ➨㸵᮲ ጤဨࡣࠊḟᥖࡆࡿጤဨ࡛⤌⧊ࡍࡿࠋ ୍ 㝔㛗㸯ྡࠊ⮫ᗋ◊✲ࢭࣥࢱ࣮㛗 ┳ㆤ㒊ࠊົ㒊ࠊ⮫ᗋ᳨ᰝ⛉ࠊ⸆㒊ࡢ⫋ဨࡢ࠺ࡕࡽᙜヱᡤᒓ㛗ࡀ᥎⸀ࡍࡿࡶࡢ ྛ㸯ྡ ୕ ⮫ᗋ◊✲ࢭࣥࢱ࣮࠾࠸࡚ື≀ᐇ㦂ᦠࢃࡿ◊✲ဨࡢ࠺ࡕ⮫ᗋ◊✲ࢭࣥࢱ࣮㛗ࡀ᥎ ⸀ࡍࡿࡶࡢ㸰ྡ ᅄ ᐇ㦂ື≀ࡢᑓ㛛ᐙ㸯ྡ ື≀ᐇ㦂㛵ࢃࡽ࡞࠸Ꮫ㆑⤒㦂ࢆ᭷ࡍࡿ⪅㸯ྡ භ ࡑࡢࠊጤဨ㛗ࡀᚲせㄆࡵࡓ⪅ⱝᖸྡ 㸰 ጤဨࡣࠊ㝔㛗ࡀ௵ࡍࡿࠋ 㸦௵ᮇ㸧 ➨㸶᮲ ๓᮲➨㸯㡯➨㸰ྕࡽ➨㸴ྕࡲ࡛ࡢጤဨࡢ௵ᮇࡣࠊ㸰ᖺࡍࡿࠋࡓࡔࡋࠊ௵ࢆ ጉࡆ࡞࠸ࠋ 㸰 ๓᮲➨㸯㡯➨㸰ྕࡽ➨㸴ྕࡲ࡛ࡢጤဨḞဨࡀ⏕ࡌࡓሙྜࡢ⿵Ḟጤဨࡢ௵ᮇࡣࠊ๓ ௵⪅ࡢṧ௵ᮇ㛫ࡍࡿࠋ 㸦ጤဨ㛗ཬࡧጤဨ㛗㸧 ➨㸷᮲ ጤဨጤဨ㛗ࢆ⨨ࡁࠊ㝔㛗ࢆࡶࡗ࡚࡚ࡿࠋ 㸰 ጤဨ㛗ࡣࠊ㆟ࢆᣍ㞟ࡋࠊࡑࡢ㆟㛗࡞ࡿࠋ 㸱 ጤဨጤဨ㛗ࢆ⨨ࡁࠊጤဨ㛗ࡢᣦྡࡍࡿጤဨࢆࡶࡗ࡚࡚ࡿࠋ 㸲 ጤဨ㛗ࡣࠊጤဨ㛗ࢆຓࡅࠊጤဨ㛗ᨾ➼ࡀ࠶ࡿࡁࡣࠊࡑࡢ⫋ົࢆ௦⾜ࡍࡿࠋ 㸦㆟㸧 ➨㸯㸮᮲ ጤဨࡣࠊጤဨࡢ㐣༙ᩘࡀฟᖍࡋ࡞ࡅࢀࡤࠊ㆟ࢆ㛤ࡃࡇࡀ࡛ࡁ࡞࠸ࠋ 㸰 ጤဨࡢ㆟ࡣࠊฟᖍࡋࡓጤဨࡢ㸱ศࡢ㸰௨ୖࡢከᩘ࡛Ỵࡍࡿࡶࡢࡍࡿࠋ 㸱 ጤဨࡣࠊ⮬ࡽࡀື≀ᐇ㦂㈐௵⪅࡞ࡿື≀ᐇ㦂ィ⏬ࡢᑂ㆟ຍࢃࡿࡇࡀ࡛ࡁ࡞࠸ࠋ ― 244 ― 㸦ពぢࡢ⫈ྲྀ㸧 ➨㸯㸯᮲ ጤဨ㛗ࡀᚲせㄆࡵࡓࡁࡣࠊጤဨጤဨ௨እࡢ⪅ࢆฟᖍࡉࡏࠊពぢࢆ⫈ྲྀ ࡍࡿࡇࡀ࡛ࡁࡿࠋ 㸦㛵ಀ⫋ဨࡢฟᖍ㸧 ➨㸯㸰᮲ ጤဨ㛗ࡣࠊᚲせᛂࡌࠊጤဨ㛵ಀ⫋ဨࢆฟᖍࡉࡏࡿࡇࡀ࡛ࡁࡿࠋ 㸦ົ㸧 ➨㸯㸱᮲ ጤဨࡢົࡣࠊ⮫ᗋ◊✲ࢭࣥࢱ࣮ົ࠾࠸࡚ฎ⌮ࡋࠊጤဨ㆟㘓➼ࡢస ᡂཬࡧಖᏑ➼ࢆ⾜࠺ࡶࡢࡍࡿࠋ ➨㸱❶ ື≀ᐇ㦂➼ࡢᐇ 㸦ື≀ᐇ㦂ィ⏬ࡢ❧ࠊ⏦ㄳࠊᑂᰝ➼㸧 ➨㸯㸲᮲ ື≀ᐇ㦂㈐௵⪅ࡣࠊື≀ᐇ㦂➼ࢆ⾜࠺ሙྜࡣࠊ࠶ࡽࡌࡵḟᥖࡆࡿ㡯 ࡘ࠸᳨࡚ウࡋࡓୖ࡛ື≀ᐇ㦂ィ⏬ࢆ❧ࡋࠊูᐃࡵࡿື≀ᐇ㦂ィ⏬᭩࡞ࢆ⟶⌮⪅ ᥦฟࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ୍ ◊✲ࡢ┠ⓗࠊព⩏ཬࡧᐇ㦂ࡢᚲせᛶࢆ᫂☜ࡍࡿࡇࠋ ௦᭰ἲࢆ⪃៖ࡋࡓື≀ᐇ㦂ࡢ᪉ἲ ୕ ᐇ㦂ື≀ࡢ⏝๐ῶࡢࡓࡵࠊᐇ㦂┠ⓗ㐺ࡋࡓᐇ㦂ື≀ࡢ✀ࠊᩘࠊ㑇ఏᏛⓗཬࡧᚤ ⏕≀Ꮫⓗရ㉁୪ࡧ㣫㣴᮲௳ࢆ⪃៖ࡍࡿࡇࠋ ᅄ ᐇ㦂ື≀ࡢⱞ③ࡢ㍍ῶ ⱞ③ࡢ⛬ᗘࡢ㧗࠸ᐇ㦂㸦⮴Ṛⓗ࡞ẘᛶヨ㦂ࠊឤᰁᐇ㦂ࠊⓎ⒴ᐇ㦂ࠊᨺᑕ⥺↷ᑕᐇ㦂 ➼㸧࠾ࡅࡿே㐨ⓗ࢚ࣥࢻ࣏ࣥࢺ㸦ᐇ㦂ື≀ࢆ⃭ࡋ࠸ⱞ③ࡽゎᨺࡍࡿࡓࡵࡢᐇ㦂 ࢆᡴࡕษࡿࢱ࣑ࣥࢢࢆ࠸࠺ࠋ㸧ࡢタᐃࢆ⪃៖ࡍࡿࡇࠋ 㸰 ⟶⌮⪅ࡣࠊື≀ᐇ㦂㈐௵⪅ࡽື≀ᐇ㦂ィ⏬᭩ࡢᥦฟࢆཷࡅࡓࡁࡣࠊጤဨᑂᰝ ࢆ㆟ࡋࠊࡑࡢ⤖ᯝࢆᙜヱື≀ᐇ㦂㈐௵⪅㏻▱ࡍࡿࡶࡢࡍࡿࠋ 㸱 ື≀ᐇ㦂㈐௵⪅ࡣࠊື≀ᐇ㦂ィ⏬ࡘ࠸࡚⟶⌮⪅ࡢᢎㄆࢆᚓࡓᚋ࡛࡞ࡅࢀࡤࠊື≀ᐇ 㦂➼ࢆ⾜࠺ࡇࡀ࡛ࡁ࡞࠸ࠋ 㸲 ⟶⌮⪅ࡣࠊ➨㸰㡯ࡢつ⛬ࡼࡾᢎㄆࢆ࠼ࡓື≀ᐇ㦂ィ⏬ࡘ࠸࡚ࠊᐇ㦂ࡢᐇ≧ἣ ᇶ࡙ࡃጤဨࡢຓゝࢆཷࡅ࡚ࠊᐇ㦂ࡢ⚗Ṇཪࡣ୰Ṇࢆ່࿌ࡍࡿࡇࡀ࡛ࡁࡿࠋ 㸦ື≀ᐇ㦂ィ⏬ࡢ᭦᪂࣭ኚ᭦㸧 ➨㸯㸳᮲ ື≀ᐇ㦂㈐௵⪅ࡣࠊᢎㄆࡉࢀࡓື≀ᐇ㦂ィ⏬ࢆ᭦᪂ཪࡣኚ᭦ࡋࡼ࠺ࡍࡿࡁ ࡣࠊูᐃࡵࡿື≀ᐇ㦂ィ⏬᭩㸦᭦᪂࣭ኚ᭦㸧ࡼࡾ⟶⌮⪅⏦ㄳࡍࡿࡶࡢࡍࡿࠋ 㸦ᐇ㦂᧯స㸧 ➨㸯㸴᮲ ື≀ᐇ㦂ᐇ⪅ࡣࠊື≀ᐇ㦂➼ࡢᐇ࠶ࡓࡗ࡚ࡣࠊἲࠊ㣫㣴ಖ⟶ᇶ‽ཬࡧᣦ 㔪➼༶ࡍࡿࡶࠊ≉௨ୗࡢ㡯ࢆ㑂Ᏺࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ୍ 㐺ษ⥔ᣢ⟶⌮ࡉࢀࡓタ➼࠾࠸࡚ື≀ᐇ㦂➼ࢆ⾜࠺ࡇࠋ ື≀ᐇ㦂ィ⏬᭩グ㍕ࡉࢀࡓ㡯ཬࡧḟᥖࡆࡿ㡯ࢆ㑂Ᏺࡍࡿࡇࠋ 㯞㓉⸆ࠊ㙠③⸆ཪࡣ㙠㟼⸆➼ࢆ㐺ษ⏝ࡋࠊᐇ㦂ື≀ⱞ③ࢆ࠼࡞࠸ࡼ࠺ດ ࡵࡿࡇࠋ ᐇ㦂ࡢ⤊ࡢᮇ㸦ே㐨ⓗ࢚ࣥࢻ࣏ࣥࢺࢆྵࡴࠋ㸧ࢆ㓄៖ࡍࡿࡇࠋ ࢘ ື≀ᐇ㦂➼ࡢᐇ࠾࠸࡚ࡣࠊ㐺ษ࡞⾡ᚋ⟶⌮ࢆ⾜࠺ࡇࠋ ― 245 ― ࢚ ື≀ᐇ㦂➼ࡢ⤊ཪࡣᐇ㦂ື≀ࡀᅇࡢぢ㎸ࡀ࡞࠸ุ᩿ࡋࡓࡁࡣࠊฟ᮶ࡿ 㝈ࡾⱞ③ࢆకࢃ࡞࠸᪉ἲࡼࡾࠊᐇ㦂ື≀ࢆᏳᴦṚࡉࡏࡿࡇࠋ ୕ Ᏻ⟶⌮ὀពࢆᡶ࠺ࡁᐇ㦂㸦≀⌮ⓗࠊᏛⓗ༴㝤࡞ᮦᩱࠊཎయࠊ㑇ఏᏊ⤌ ࠼ື≀➼ࢆ⏝࠸ࡿᐇ㦂ࢆ࠸࠺ࠋ㸧ࡘ࠸࡚ࡣࠊ㛵ಀἲ௧➼ཬࡧᙜ㝔࠾ࡅࡿ㛵㐃ࡍ ࡿつ⛬➼ᚑ࠺ࡇࠋ ᅄ ๓㡯ࡢື≀ᐇ㦂➼ࡣࠊᏳࢆ☜ಖࡍࡿࡓࡵᚲせ࡞タഛࢆ᭷ࡍࡿタ➼࡛ᐇࡍࡿ ࡇࠋ ᐇ㦂ᐇඛ❧ࡕᚲせ࡞ᐇ㦂ᡭᢏ➼ࡢ⩦ᚓດࡵࡿࡇࠋ භ くᛶࡢ㧗࠸つᶍ࡞Ꮡᡭ⾡࠶ࡓࡗ࡚ࡣࠊ⤒㦂➼ࢆ᭷ࡍࡿ⪅ࡢᣦᑟୗ࡛⾜࠺ࡇ ࠋ 㸦ື≀ᐇ㦂ィ⏬ࡢሗ࿌㸧 ➨㸯㸵᮲ ື≀ᐇ㦂㈐௵⪅ࡣࠊᐇ㦂ࢆ⤊ཪࡣ୰Ṇࡋࡓࡁࡣࠊูᐃࡵࡿື≀ᐇ㦂➼ 㛵ࡍࡿሗ࿌᭩ࡼࡾࠊ⟶⌮⪅ሗ࿌ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰 ື≀ᐇ㦂㈐௵⪅ࡣࠊẖᖺᗘ⤊ᚋࠊูᐃࡵࡿື≀ᐇ㦂ሗ࿌᭩ࡼࡾࠊᙜヱᖺᗘࡢ ᐇ㦂≧ἣࢆ⟶⌮⪅ሗ࿌ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸲❶ タ➼ 㸦㣫㣴ಖ⟶タࡢᢎㄆ㸧 ➨㸯㸶᮲ ᐇ㦂ື≀⟶⌮⪅ࡣࠊ㣫㣴ಖ⟶タࢆタ⨨ཪࡣኚ᭦㸦௨ୗࠕタ⨨➼ࠖ࠸࠺ࠋ㸧 ࢆࡍࡿሙྜࡣࠊື≀ᐇ㦂㈐௵⪅ࢆ⤒⏤ࡋู࡚ᐃࡵࡿ㣫㣴ಖ⟶タタ⨨ᢎㄆ⏦ㄳ᭩ࢆ⟶ ⌮⪅ᥦฟࡋࠊᢎㄆࢆᚓࡿࡶࡢࡍࡿࠋ 㸰 ⟶⌮⪅ࡣࠊ⏦ㄳࡉࢀࡓ㣫㣴ಖ⟶タࢆື≀ᐇ㦂ጤဨㄪᰝࡉࡏࠊጤဨࡢㄪᰝ⤖ᯝ ཬࡧຓゝࡼࡾࠊᢎㄆࢆ⾜࠺ྰࡢỴᐃࢆ⾜࠸ࠊື≀ᐇ㦂㈐௵⪅ࢆ⤒⏤ࡋ࡚ࠊࡑࡢ⤖ ᯝࢆᐇ㦂ື≀⟶⌮⪅㏻▱ࡍࡿࠋ 㸱 ᐇ㦂ື≀ࡢ㣫㣴ⱝࡋࡃࡣಖ⟶ཪࡣື≀ᐇ㦂➼ࡣࠊ⟶⌮⪅ࡢᢎㄆࢆᚓࡓ㣫㣴ಖ⟶タ࡛ ࡞ࡅࢀࡤ⾜࠺ࡇࡀ࡛ࡁ࡞࠸ࠋ 㸦㣫㣴ಖ⟶タࡢせ௳㸧 ➨㸯㸷᮲ 㣫㣴ಖ⟶タࡢタ⨨➼ಀࡿせ௳ࡣ௨ୗࡢ࠾ࡾࡍࡿࠋ ୍ 㐺ษ࡞ ᗘࠊ‵ᗘࠊẼࠊ᫂ࡿࡉ➼ࢆಖࡘࡇࡀ࡛ࡁࡿᵓ㐀➼࡛࠶ࡿࡇࠋ ື≀✀ࠊ㣫㣴ಖ⟶ᩘ➼ᛂࡌࡓ㣫⫱タഛࢆ᭷ࡍࡿࡇࠋ ୕ ᗋࠊෆቨ➼ࡢΎᤲࠊᾘẘ➼ࡀᐜ᫆࡞ᵓ㐀࡛ࠊჾᮦࡢὙίࠊᾘẘ➼ࢆ⾜࠺⾨⏕タഛࢆ ᭷ࡍࡿࡇࠋ ᅄ ᐇ㦂ື≀ࡀ㐓㉮ࡋ࡞࠸ᵓ㐀ཬࡧᙉᗘࢆ᭷ࡍࡿࡇࠋ ⮯Ẽࠊ㦁㡢ࠊᗫᲠ≀➼ࡼࡿ࿘㎶⎔ቃࡢᝏᙳ㡪ࢆ㜵Ṇࡍࡿᥐ⨨ࡀࡽࢀ࡚࠸ࡿࡇ ࠋ භ ᐇ㦂ື≀⟶⌮⪅㸦◊✲ᐊ㒊㛗ࡲࡓࡣ◊✲ᐊ㛗㸧ࡀ࠾ࢀ࡚࠸ࡿࡇࠋ 㸦ᐇ㦂ᐊࡢタ⨨㸧 ➨㸰㸮᮲ ᐇ㦂ື≀⟶⌮⪅ࡣࠊ㣫㣴ಖ⟶タ௨እ࠾࠸࡚ࠊᐇ㦂ᐊࢆタ⨨➼ࡍࡿሙྜࡣࠊ ື≀ᐇ㦂㈐௵⪅ࢆ⤒⏤ࡋู࡚ᐃࡵࡿࠕᐇ㦂ᐊタ⨨ᢎㄆ⏦ㄳ᭩ࠖࢆᥦฟࡋࠊ⟶⌮⪅ࡢᢎ ㄆࢆᚓ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰 ⟶⌮⪅ࡣࠊ⏦ㄳࡉࢀࡓᐇ㦂ᐊࢆጤဨㄪᰝࡉࡏࠊጤဨࡢㄪᰝ⤖ᯝཬࡧຓゝࡼࡾࠊ ᢎㄆࢆ⾜࠺ྰࡢỴᐃࢆ⾜࠸ࠊື≀ᐇ㦂㈐௵⪅ࢆ⤒⏤ࡋ࡚ᐇ㦂ື≀⟶⌮⪅㏻▱ࡍࡿࠋ ― 246 ― 㸱 ື≀ᐇ㦂➼ࡣࠊ⟶⌮⪅ࡢᢎㄆࢆᚓࡓᐇ㦂ᐊ࡛࡞ࡅࢀࡤ⾜࠺ࡇࡀ࡛ࡁ࡞࠸ࠋࡲࡓࠊ㸲 㸶㛫௨ෆࡢ୍ⓗಖ⟶ࡢሙྜ࠶ࡗ࡚ࡶࠊྠᵝࡍࡿࠋ 㸦ᐇ㦂ᐊࡢせ௳㸧 ➨㸰㸯᮲ ᐇ㦂ᐊࡢタ⨨➼ಀࡿせ௳ࡣ௨ୗࡢ࠾ࡾࡍࡿࠋ ୍ ᐇ㦂ື≀ࡀ㐓㉮ࡋ࡞࠸ᵓ㐀ཬࡧᙉᗘࢆ᭷ࡋࠊᐇ㦂ື≀ࡀᐊෆ࡛㐓㉮ࡋ࡚ࡶᤕ⋓ࡋࡸ ࡍ࠸⎔ቃࡀ⥔ᣢࡉࢀ࡚࠸ࡿࡇࠋ ἥ≀ࠊ⾑ᾮ➼ࡼࡿởᰁᑐࡋ࡚ࠊΎᤲཬࡧᾘẘࡀᐜ᫆࡞ᵓ㐀࡛࠶ࡿࡇࠋ ୕ ᖖΎ₩࡞≧ែࢆಖࡕࠊ⮯Ẽࠊ㦁㡢ࠊᗫᲠ≀➼ࡼࡿ࿘㎶⎔ቃࡢᝏᙳ㡪ࢆ㜵Ṇࡍ ࡿᥐ⨨ࡀࡽࢀ࡚࠸ࡿࡇࠋ 㸦タ➼ࡢ⥔ᣢ⟶⌮ཬࡧᨵၿ㸧 ➨㸰㸰᮲ ⟶⌮⪅ࡣࠊᐇ㦂ື≀ࡢ㐺ษ࡞⟶⌮୪ࡧື≀ᐇ㦂➼ࡢ㐙⾜ᚲせ࡞タ➼ࡢ⥔ ᣢ⟶⌮ཬࡧᨵၿດࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦タࡢᗫṆ㸧 ➨㸰㸱᮲ ᐇ㦂ື≀⟶⌮⪅ࡣࠊタ➼ࢆᗫṆࡍࡿሙྜࡣࠊື≀ᐇ㦂㈐௵⪅ࢆ⤒⏤ࡋ࡚ࠊู ᐃࡵࡿタ➼ᗫṆᒆࡼࡾࠊ㏿ࡸ⟶⌮⪅ᒆࡅฟ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰 ⟶⌮⪅ࡣࠊタ➼ࢆᗫṆࡍࡿሙྜࡣࠊᚲせᛂࡌ࡚ࠊᐇ㦂ື≀⟶⌮⪅༠ຊࡋࠊ㣫㣴 ಖ⟶୰ࡢᐇ㦂ື≀ࢆࠊࡢ㣫㣴ಖ⟶タㆡࡾΏࡍࡼ࠺ດࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸳❶ ᐇ㦂ື≀ࡢ㣫㣴ཬࡧಖ⟶ 㸦࣐ࢽࣗࣝࡢసᡂ࿘▱㸧 ➨㸰㸲᮲ ⟶⌮⪅ཬࡧື≀ᐇ㦂㈐௵⪅ࡣࠊ㣫㣴ཬࡧಖ⟶ࡢ࣐ࢽࣗࣝࢆᐃࡵࠊື≀ᐇ㦂ᐇ ⪅ཬࡧ㣫㣴⪅࿘▱ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦ᐇ㦂ື≀ࡢᗣཬࡧᏳࡢಖᣢ㸧 ➨㸰㸳᮲ ᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ཬࡧ㣫㣴⪅ࡣࠊ㣫㣴ಖ⟶ᇶ‽ࢆ㑂Ᏺࡋࠊᐇ㦂 ື≀ࡢᗣཬࡧᏳࡢಖᣢດࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦ᐇ㦂ື≀ࡢᑟධ㸧 ➨㸰㸴᮲ ⟶⌮⪅➼ࡣࠊᐇ㦂ື≀ࡢᑟධ࠶ࡓࡗ࡚ࠊ㛵ಀἲ௧ཬࡧᣦ㔪➼ᇶ࡙ࡁ㐺ṇ ⟶⌮ࡋ࡚࠸ࡿᶵ㛵ࡼࡾᑟධࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰 ᐇ㦂ື≀⟶⌮⪅ࡣࠊᐇ㦂ື≀ࡢᑟධ࠶ࡓࡗ࡚ࠊ㐺ษ࡞᳨ࠊ㝸㞳㣫⫱➼ࢆ⾜ࢃ࡞ࡅ ࢀࡤ࡞ࡽ࡞࠸ࠋ 㸱 ᐇ㦂ື≀⟶⌮⪅ࡣࠊᐇ㦂ື≀ࡢ㣫㣴⎔ቃࡢ㡰࣭㡰ᛂࢆᅗࡿࡓࡵࡢᚲせ࡞ᥐ⨨ࢆㅮ ࡌ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦⤥㣵࣭⤥Ỉ㸧 ➨㸰㸵᮲ ᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ཬࡧ㣫㣴⪅ࡣࠊᐇ㦂ື≀ࡢ⏕⌮ࠊ⏕ែࠊ⩦ᛶ ➼ᛂࡌ࡚ࠊ㐺ษ⤥㣵࣭⤥Ỉࢆ⾜ࢃ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦ᗣ⟶⌮㸧 ➨㸰㸶᮲ ᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ཬࡧ㣫㣴⪅ࡣࠊᐇ㦂┠ⓗ௨እࡢയᐖཬࡧ ࢆண㜵ࡍࡿࡓࡵࠊᐇ㦂ື≀ᚲせ࡞ᗣ⟶⌮ࢆ⾜ࢃ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ― 247 ― 㸰 ᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ཬࡧ㣫㣴⪅ࡣࠊᐇ㦂ື≀ࡀᐇ㦂┠ⓗ௨እࡢയᐖཪࡣ ࡗࡓሙྜࡣࠊ㐺ษ࡞⒪➼ࢆ⾜ࢃ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦␗✀ཪࡣ」ᩘࡢᐇ㦂ື≀ࡢ㣫⫱㸧 ➨㸰㸷᮲ ᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ཬࡧ㣫㣴⪅ࡣࠊ␗✀ཪࡣ」ᩘࡢᐇ㦂ື≀ࢆྠ ୍タෆ࡛㣫㣴ཬࡧಖ⟶ࡍࡿሙྜࡣࠊࡑࡢ⤌ࡳྜࢃࡏࢆ⪃៖ࡋࡓᐜࢆ⾜ࢃ࡞ࡅࢀࡤ࡞ ࡽ࡞࠸ࠋ 㸦グ㘓ࡢಖᏑཬࡧሗ࿌㸧 ➨㸱㸮᮲ ᐇ㦂ື≀⟶⌮⪅ཬࡧື≀ᐇ㦂㈐௵⪅ࡣࠊᐇ㦂ື≀ࡢධᡭඛࠊ㣫⫱ᒚṔࠊṔ➼ 㛵ࡍࡿグ㘓ࢆᩚഛࡋࠊಖᏑࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰 ᐇ㦂ᐇ⪅ࡣࠊᐇ㦂ື≀ࡢ㣫⫱ᙜࡓࡗ࡚ࡣࠊ㣫⫱ື≀ࡢᩘࢆయࡶྵࡵ࡚ẖ㐌ィ ࡋࠊ㣫⫱ᩘ⟶⌮⡙グ㘓ࡋ࡚ࠊᐇ㦂ື≀⟶⌮⪅ሗ࿌ࡍࡿࡇࠋ 㸱 ᐇ㦂ᐇ⪅ࡣࠊసᴗ๓ᚋసᴗࡋࡓࢣ࣮ࢪࡈື≀ᩘኚㄗࡾࡢ࡞࠸ࡇࢆィ ࣭グ㘓ࡍࡿࡇࠋ 㸲 ᐇ㦂ᐇ⪅ࡣࠊᐇ㦂ື≀ᐊࡢධ㏥ฟࢆ⟶⌮⡙グ㘓ࡍࡿࡇࠋ 㸳 ື≀ᐇ㦂㈐௵⪅ࡣࠊ㣫㣴ಖ⟶ࡋࡓᐇ㦂ື≀ࡢ✀㢮ᩘ➼ࡘ࠸࡚ࠊᐃᮇⓗጤဨ࡛ ᑂᰝᚋࠊ⟶⌮⪅ሗ࿌ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦ㆡΏࡢ㝿ࡢሗᥦ౪㸧 ➨㸱㸯᮲ ⟶⌮⪅➼ࡣࠊᐇ㦂ື≀ࡢㆡΏ࠶ࡓࡗ࡚ࡣࠊࡑࡢ≉ᛶࠊ㣫㣴ಖ⟶ࡢ᪉ἲࠊឤᰁ ᛶ➼㛵ࡍࡿሗࢆᥦ౪ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦㍺㏦㸧 ➨㸱㸰᮲ ⟶⌮⪅➼ࡣࠊᐇ㦂ື≀ࡢ㍺㏦࠶ࡓࡗ࡚ࠊ㣫㣴ಖ⟶ᇶ‽ࢆ㑂Ᏺࡋࠊᐇ㦂ື≀ࡢ ᗣཬࡧᏳࡢ☜ಖ୪ࡧேࡢ༴ᐖ㜵Ṇດࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸴❶ Ᏻ⟶⌮ 㸦༴ᐖ㜵Ṇ㸧 ➨㸱㸱᮲ ື≀ᐇ㦂㈐௵⪅ࡣࠊ㐓㉮ࡋࡓᐇ㦂ື≀ࡢᤕ⋓ࡢ᪉ἲ➼ࢆ࠶ࡽࡌࡵᐃࡵ࡞ࡅࢀ ࡤ࡞ࡽ࡞࠸ࠋ 㸰 ື≀ᐇ㦂㈐௵⪅ࡣࠊே༴ᐖࢆຍ࠼ࡿ➼ࡢ࠾ࡑࢀࡢ࠶ࡿᐇ㦂ື≀ࡀタ➼እ㐓㉮ࡋ ࡓሙྜࡣࠊ⟶⌮⪅ሗ࿌ࡍࡿࡶࠊ㏿ࡸ㛵ಀᶵ㛵㐃⤡ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸱 ື≀ᐇ㦂㈐௵⪅ࡣࠊᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ཬࡧ㣫㣴⪅ࡢᐇ㦂ື≀⏤᮶ࡢ ឤᰁࠊᐇ㦂ື≀ࡼࡿညയ➼ᑐࡍࡿண㜵ᥐ⨨ࢆㅮࡌࡿࡶࠊឤᰁ➼ࡢⓎ⏕ ࡣᚲせ࡞ᥐ⨨ࢆㅮࡌ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸲 ື≀ᐇ㦂㈐௵⪅ࡣࠊẘࡧ➼ࡢ᭷ẘື≀ࡢ㣫㣴ཪࡣಖ⟶ࢆࡍࡿሙྜࡣࠊேࡢ༴ᐖࡢ Ⓨ⏕ࡢ㜵Ṇࡢࡓࡵࠊ㣫㣴ಖ⟶ᇶ‽ᇶ࡙ࡁᚲせ࡞㡯ࢆูᐃࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸳 ື≀ᐇ㦂㈐௵⪅ࡣࠊᐇ㦂ື≀ࡢ㣫㣴ཬࡧື≀ᐇ㦂➼ࡢᐇ㛵ಀࡢ࡞࠸⪅ࡀᐇ㦂ື≀ ➼᥋ゐࡋ࡞࠸ࡼ࠺ࠊᚲせ࡞ᥐ⨨ࢆㅮࡌ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸦⥭ᛴࡢᑐᛂ㸧 ➨㸱㸲᮲ ື≀ᐇ㦂㈐௵⪅ࡣࠊᆅ㟈ࠊⅆ⅏➼ࡢ⥭ᛴࡿࡁᥐ⨨ࡢィ⏬ࢆ࠶ࡽࡌࡵ సᡂࡋࠊ㛵ಀ⪅ᑐࡋ࡚࿘▱ࢆᅗࡽ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰 ື≀ᐇ㦂㈐௵⪅ࡣࠊ⥭ᛴែⓎ⏕࠾࠸࡚ࠊᐇ㦂ື≀ࡢಖㆤཬࡧᐇ㦂ື≀ࡢ㐓㉮ ― 248 ― ࡼࡿ༴ᐖ㜵Ṇດࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸵❶ ᩍ⫱カ⦎ 㸦ᩍ⫱カ⦎㸧 ➨㸱㸳᮲ ᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ཬࡧ㣫㣴⪅ࡣࠊጤဨࡀᖺ୍ᅇ⛬ᗘദࡍ ࡿ௨ୗࡢ㡯㛵ࡍࡿᡤᐃࡢᩍ⫱カ⦎ࢆཷࡅ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ୍ 㛵ಀἲ௧ࠊᣦ㔪➼ࠊᙜ㝔ࡢᐃࡵࡿつ๎➼ ື≀ᐇ㦂➼ࡢ᪉ἲ㛵ࡍࡿᇶᮏⓗ㡯 ୕ ᐇ㦂ື≀ࡢ㣫㣴ಖ⟶㛵ࡍࡿᇶᮏⓗ㡯 ᅄ Ᏻ☜ಖཬࡧᏳ⟶⌮㛵ࡍࡿ㡯 ࡑࡢ㐺ษ࡞ື≀ᐇ㦂➼ࡢᐇ㛵ࡍࡿ㡯 㸰 ጤဨࡣࠊᩍ⫱カ⦎ࡢᐇ᪥ࠊᩍ⫱ෆᐜࠊㅮᖌཬࡧཷㅮ⪅ྡ㛵ࡍࡿグ㘓ࢆᩚഛࡋࠊ ಖᏑࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ➨㸶❶ ⮬ᕫⅬ᳨࣭ホ౯ཬࡧ᳨ド 㸦⮬ᕫⅬ᳨࣭ホ౯ཬࡧ᳨ド㸧 ➨㸱㸴᮲ ⟶⌮⪅ࡣࠊጤဨࠊᩥ⛉┬ᇶᮏᣦ㔪ᑐࡍࡿ㐺ྜᛶ㛵ࡋ⮬ᕫⅬ᳨࣭ホ౯ࢆ ⾜ࢃࡏ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰 ጤဨࡣࠊື≀ᐇ㦂➼ࡢᐇ≧ἣ➼㛵ࡍࡿ⮬ᕫⅬ᳨࣭ホ౯ࢆᖺ㸯ᅇ⾜࠸ࠊࡑࡢ⤖ᯝ ࢆ⟶⌮⪅࠾ࡼࡧᅜ❧㝔ᶵᵓᮏ㒊⥲ྜ◊✲ࢭࣥࢱ࣮ሗ࿌ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸱 ጤဨࡣࠊ⟶⌮⪅ࠊື≀ᐇ㦂㈐௵⪅ࠊᐇ㦂ື≀⟶⌮⪅ࠊື≀ᐇ㦂ᐇ⪅ࠊ㣫㣴⪅➼ࠊ ⮬ᕫⅬ᳨࣭ホ౯ࡢࡓࡵࡢ㈨ᩱࢆᥦฟࡉࡏࡿࡇࡀ࡛ࡁࡿࠋ ➨㸷❶ ሗࡢබ⾲ 㸦ሗࡢබ⾲㸧 ➨㸱㸵᮲ ᙜࢭࣥࢱ࣮࠾ࡅࡿື≀ᐇ㦂➼㛵ࡍࡿつ⛬➼ࠊᐇ㦂ື≀ࡢ㣫㣴ಖ⟶≧ἣࠊ⮬ ᕫⅬ᳨࣭ホ౯ཬࡧ᳨ドࡢ⤖ᯝ➼㛵ࡍࡿሗࡘ࠸࡚ࠊẖᖺ㸯ᅇ⛬ᗘබ⾲ࡍࡿࡶࡢࡍ ࡿࠋ ➨㸯㸮❶ 㞧๎ 㸦ᐇ㦂ື≀௨እࡢື≀ࡢ⏝㸧 ➨㸱㸶᮲ ᐇ㦂ື≀௨እࡢື≀ࢆ⏝ࡍࡿື≀ᐇ㦂➼ࡘ࠸࡚ࡣࠊ㣫㣴ಖ⟶ᇶ‽ࡢ㊃᪨ ἢࡗ࡚⾜࠺ࡼ࠺ດࡵࡿࡶࡢࡍࡿࠋ 㸦⿵๎㸧 ➨㸱㸷᮲ ࡇࡢつ⛬ᐃࡵࡿࡶࡢࡢࠊື≀ᐇ㦂㛵ࡋᚲせ࡞㡯ࡣࠊูᐃࡵࡿࡇ ࡀ࡛ࡁࡿࠋ 㝃 ๎ 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸰㸲ᖺ㸲᭶㸯᪥ࡽ⾜ࡍࡿࠋ ― 249 ― 㸦つ⛬ࡢᗫṆ㸧 ࡇࡢつ⛬ࡢ⾜ేࡏ࡚ࠊḟᥖࡆࡿᚑ๓ࡢつ⛬ࡣᗫṆࡍࡿࠋ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ື≀ᐇ㦂ጤဨつ⛬ 㝃 ๎㸦➨㸵᮲➨㸯㡯ཬࡧ➨㸷᮲➨㸯㡯㛵ಀ㸧 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸰㸲ᖺ㸯㸯᭶㸯᪥ࡽ⾜ࡍࡿࠋ 㝃 ๎㸦➨㸱᮲➨㸰㡯㛵ಀ㸧 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸰㸳ᖺ㸷᭶㸳᪥ࡽ⾜ࡍࡿࠋ 㝃 ๎㸦➨㸯᮲ࠊ➨㸴᮲ཬࡧ➨㸯㸲᮲㛵ಀ㸧 㸦⾜ᮇ᪥㸧 ࡇࡢつ⛬ࡣࠊᖹᡂ㸰㸵ᖺ㸴᭶㸯᪥ࡽ⾜ࡍࡿࠋ ― 250 ― ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ື≀ᐇ㦂ᣦ㔪 Ϩ ┠ⓗ ࡇࡢᣦ㔪ࡣ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲ࢭࣥࢱ࣮㸦௨ୗ ࠕ◊✲ࢭࣥࢱ࣮ࠖ࠸࠺ࠋ㸧࠾࠸࡚ື≀ᐇ㦂ࢆィ⏬ࡋࠊᐇࡍࡿ㝿㑂Ᏺࡍࡁ 㡯ࢆ♧ࡍࡇࡼࡾࠊ⛉ᏛⓗほⅬࡽࡣࡶࡼࡾࠊື≀⚟♴ࡢほⅬࡽࡶ㐺ṇ࡞ ື≀ᐇ㦂ࡢᐇࢆಁࡍࡇࢆ┠ⓗࡍࡿࠋ ϩ ᐃ⩏ ࡇࡢᣦ㔪࠾࠸࡚ࠊḟࡢྛྕᥖࡆࡿ⏝ㄒࡢព⩏ࡣࠊᙜヱྛྕᐃࡵࡿࡇࢁ ࡼࡿࠋ 㸯㸬⟶⌮⪅ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮㝔㛗 㸰㸬ື≀ᐇ㦂㈐௵⪅ ື≀ᐇ㦂➼ࡢᐇ㛵ࡍࡿᴗົࢆ⤫ᣓࡍࡿ⪅ࢆ࠸࠺ࠋ㸦⮫ᗋ◊✲ࢭࣥࢱ࣮㛗㸧 㸱㸬ᐇ㦂ື≀⟶⌮⪅ ᐇ㦂ື≀㛵ࡍࡿ▱㆑ཬࡧ⤒㦂ࢆ᭷ࡍࡿ⪅࡛ࠊ⟶⌮⪅ࢆ⿵బࡋࠊᐇ㦂ື≀ࡢ⟶ ⌮ࢆᢸᙜࡍࡿ⪅ࢆ࠸࠺ࠋ㸦◊✲㒊㛗࠶ࡿ࠸ࡣ◊✲ᐊ㛗㸧 㸲㸬ື≀ᐇ㦂ᐇ⪅ ື≀ᐇ㦂➼ࢆ⾜࠺⪅௨ୗᐇ⪅ 㸳㸬㣫㣴⪅ ᐇ㦂ື≀⟶⌮⪅ཪࡣື≀ᐇ㦂ᐇ⪅ࡢୗ࡛ᐇ㦂ື≀ࡢ㣫㣴ཪࡣಖ⟶ᚑࡍ ࡿ⪅ࢆ࠸࠺ࠋ 㸴㸬ᐇ㦂ື≀ࡢᑓ㛛ᐙ ᐇ㦂ື≀Ꮫࢆ⩦ᚓࡋࡓ⪅ཪࡣᐇ㦂ື≀ཬࡧື≀ᐇ㦂ࡘ࠸࡚༑ศ࡞▱㆑࣭⤒㦂 ࢆ᭷ࡍࡿ⪅ 㸵㸬タ࣭タഛ ᐇ㦂ື≀ࡢ㣫⫱ࡶࡋࡃࡣಖ⟶ࡲࡓࡣᐇ㦂➼ࢆ⾜࠺ࡓࡵࡢタ࣭タഛ 㸶㸬ᐇ㦂ື≀ ᐇ㦂ື≀ࡢ⏝౪ࡍࡿࡓࡵ㣫⫱ࡋࠊࡲࡓࡣಖ⟶ࡋ࡚࠸ࡿ့ங㢮ᒓࡍࡿື ≀㸦タᑟධࡍࡿࡓࡵ㍺㏦୰ࡢࡶࡢࢆྵࡴ㸧 Ϫ 㐺⏝⠊ᅖ 㸯㸬ࡇࡢᣦ㔪ࡣࠊ◊✲ࢭࣥࢱ࣮࡛⾜ࢃࢀࡿࡍ࡚ࡢື≀ᐇ㦂㐺⏝ࡉࢀࡿࠋ 㸰㸬့ங㢮ᒓࡍࡿື≀௨እࡢື≀ࢆ⏝࠸ࡓᐇ㦂ࡘ࠸࡚ࡶࡇࡢᣦ㔪ࡢ㊃᪨ἢࡗ ࡚ᐇࡍࡿࡼ࠺ດࡵࡿࡶࡢࡍࡿࠋ ϫ ື≀ᐇ㦂ጤဨ 㸯㸬⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ࡇࡢᣦ㔪ࡢ㐺ṇ࡞㐠⏝ࢆᅗࡿࡓ ― 251 ― ࡵࠊ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ື≀ᐇ㦂ጤဨ㸦௨ୗࠕጤဨࠖ ࠸࠺ࠋ㸧ࢆ⨨ࡃࠋ 㸰㸬ጤဨ㛵ࡍࡿ㡯ࡣࠊูᐃࡵࡿࠋ Ϭ ᐇ㦂ィ⏬ࡢ❧ 㸯㸬ᐇ⪅ࡣࠊື≀ᐇ㦂ࡢ⠊ᅖࢆ◊✲ࡢ┠ⓗᚲせ࡞᭱ᑠᗘࡵࡿࡓࡵࠊ㐺ṇ ࡞ᐇ㦂ື≀ࡢ㑅ᢥཬࡧᐇ㦂᪉ἲࡢ᳨ウࢆ⾜࠺ࡶࠊ㐺ṇ࡞ື≀ᐇ㦂ᚲせ࡞ 㣫⫱⎔ቃࡑࡢࡢ᮲௳ࢆ☜ಖࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰㸬ᐇ⪅ࡣࠊᐇ㦂ື≀ࡢ㑅ᢥᙜࡓࡗ࡚ࠊᐇ㦂┠ⓗ㐺ࡋࡓື≀✀ࡢ㑅ᐃࠊᐇ㦂 ᡂ⦼ࡢ⢭ᗘࡸ⌧ᛶࢆᕥྑࡍࡿᐇ㦂ື≀ࡢᩘࠊ㑇ఏᏛⓗ࣭ᚤ⏕≀Ꮫⓗရ㉁ཬࡧ㣫 ⫱᮲௳➼ࢆ⪃៖ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋᚤ⏕≀Ꮫⓗရ㉁㛵ࡋ࡚ࡣࠊ⟶⌮⪅ࡢᣦ♧ ᚑࢃ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸱㸬ᐇ⪅ࡣࠊᐇ㦂ィ⏬ࡢ❧ᙜࡓࡗ࡚ࠊᚲせᛂࡌ࡚ࠊື≀ᐇ㦂⟶⌮⪅ⱝࡋࡃ ࡣᐇ㦂ື≀ࡢᑓ㛛ᐙཪࡣጤဨຓゝཬࡧᣦᑟࢆồࡵࠊ᭷ຠࡘ㐺ṇ࡞ᐇ㦂ດ ࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸲㸬ᐇ⪅ࡣࠊ๓㡯ࡢ❧ࡋࡓᐇ㦂ィ⏬ࡘ࠸࡚ࠊጤဨࡢᑂᰝࢆཷࡅ࡞ࡅࢀࡤ࡞ ࡽ࡞࠸ࠋ ϭ ᐇ㦂ື≀ࡢ᳨ཬࡧ᳨ 㸯㸬ᐇ⪅ࡣࠊᐇ㦂ື≀ࡢⓎὀ᮲௳ࠊ␗ᖖཬࡧṚஸࡢ᭷↓ࢆ☜ㄆࡍࡿࡶࠊᐇ 㦂ື≀ࡢ㍺㏦ࡢ᪉ἲཬࡧ㛫➼ࢆᢕᥱࡋ࡚࠾࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰㸬ᐇ㦂⪅ࡣࠊᑟධࡉࢀࡓᐇ㦂ື≀ࡘ࠸࡚ࠊఏᰁࡑࡢࡢ᳨ࢆ⾜ࢃ࡞ࡅ ࢀࡤ࡞ࡽ࡞࠸ࠋ Ϯ ᐇ㦂ື≀ࡢ㣫⫱⟶⌮ 㸯㸬ື≀㣫⫱ࡢタ࣭タഛཬࡧ㣫⫱᮲௳ࡣࠊᐇ㦂ື≀Ꮫⓗࡣࡶࡼࡾࠊື≀⚟♴ ࡢ㠃ࡽࡶ㐺ษ࡞ࡶࡢ࡛࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰㸬ᐇ⪅ཬࡧᐇ㦂ື≀⟶⌮⪅ࡣࠊ༠ຊࡋ࡚㐺ษ࡞タ࣭タഛࡢ⥔ᣢ⟶⌮ດࡵࡿ ࡶࠊᐇ㦂ື≀ࡢ㐺ษ࡞⤥㣵ཬࡧ⤥Ỉ➼ࡢ㣫⫱⟶⌮ࢆ⾜ࢃ࡞ࡅࢀࡤ࡞ࡽ࡞ ࠸ࠋ 㸱㸬ᐇ⪅ཬࡧᐇ㦂ື≀⟶⌮⪅ࡣࠊ༠ຊࡋ࡚ᐇ㦂ື≀ࡢᑟධࡽᐇ㦂⤊࠸ ࡓࡿࡍ࡚ࡢᮇ㛫ࢃࡓࡗ࡚ࠊᐇ㦂ື≀ࡢ≧ែࢆ⣽ほᐹࡋࠊ㐺ษ࡞ฎ⨨ࢆ ࡉ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ϯ ᐇ㦂᧯స 㸯㸬ື≀ᐇ㦂ࡣࠊᩚഛࡢ⾜ࡁᒆ࠸ࡓᑓ⏝༊ᇦෆ࡛⾜ࢃ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰㸬ᐇ⪅ࡣࠊື≀⚟♴ࡢほⅬࡽࠊ㯞㓉➼ࡢᡭẁࡼࡗ࡚ᐇ㦂ື≀↓⏝࡞ⱞ③ ࢆ࠼࡞࠸ࡼ࠺㓄៖ࡋࠊేࡏ࡚㐺ษ࡞ಖᐃࢆ⾜࠺ࡶࡢࡍࡿࠋ 㸱㸬ᐇ⪅ࡣࠊᚲせᛂࡌ࡚ࠊᐇ㦂ື≀⟶⌮⪅ⱝࡋࡃࡣᐇ㦂ື≀ࡢᑓ㛛ᐙཪࡣጤဨ ― 252 ― ᣦᑟཬࡧุ᩿ࢆồࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ ϰ ᐇ㦂⤊ᚋࡢฎ⨨ 㸯㸬ᐇ⪅ࡣࠊᐇ㦂ࢆ⤊ࡋࡓື≀ࡢฎ⨨ᙜࡓࡾࠊ⮴Ṛ㔞௨ୖࡢ㯞㓉⸆ࡢᢞࡑ ࡢ㐺ษ࡞᪉ἲࡼࡗ࡚ࠊ㏿ࡸᐇ㦂ື≀ࢆⱞ③ࡽ㛤ᨺࡉࡏࡿࡼ࠺ດࡵ࡞ࡅ ࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰㸬ᐇ⪅ࡣࠊᐇ㦂ື≀ࡢṚయࠊᝏ⮯ཬࡧ⣅ᒀ➼ࡼࡗ࡚ࠊேࡢᗣཬࡧ⏕ά⎔ቃ ࡀᦆ࡞ࢃࢀ࡞࠸ࡼ࠺ດࡵ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ ϱ Ᏻ⟶⌮➼≉ὀពࢆᡶ࠺ᚲせࡢ࠶ࡿᐇ㦂 㸯㸬ື≀ᐇ㦂㈐௵⪅ࡣࠊ≀⌮ⓗⱝࡋࡃࡣᏛⓗ༴㝤࡞≀㉁ཪࡣཎయ➼ࢆᢅ࠺ື ≀ᐇ㦂ࡢᐇᙜࡓࡾࠊேࡢᏳࢆ☜ಖࡍࡿࡇࡣࡶࡼࡾࠊ㣫⫱⎔ቃࡢởᰁ ࡼࡾᐇ㦂ື≀ࡀ㞀ᐖࢆཷࡅࠊཪࡣᐇ㦂ᡂ⦼ࡢಙ㢗ᛶࡀᦆ࡞ࢃࢀࡿࡇࡢ࡞࠸ࡼ࠺ࠊ ༑ศ㓄៖ࡋ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋࡲࡓࠊタࡢ࿘ᅖࡢởᰁ㜵Ṇࡘ࠸࡚ࡣࠊ≉ ὀពࢆᡶࢃ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸰㸬ᐇ㦂ᐇ⪅ཬࡧື≀ᐇ㦂㈐௵⪅ࡣࠊࡇࡢᣦ㔪ࢆ㑂Ᏺࡍࡿࡶࠊ㛵㐃ࡍࡿㅖ ἲ௧ཬࡧ㝔ෆつ⛬➼ᚑࢃ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸱㸬ᐇ⪅ཬࡧື≀ᐇ㦂㈐௵⪅ࡣࠊᐇ㦂ື≀ࡀ⟶⌮༊ᇦࡽ㐓㉮ࡋ࡞࠸ࡼ࠺ࠊ㐺ษ ࡞㏨ஸ㜵Ṇᥐ⨨ࢆㅮࡌ࡞ࡅࢀࡤ࡞ࡽ࡞࠸ࠋ 㸲㸬ᐇ⪅ཬࡧື≀ᐇ㦂㈐௵⪅ࡣࠊᐇ㦂ື≀ࡀ⟶⌮༊ᇦࡽ㐓㉮ࡋࡓሙྜࡣ┤ࡕ ᛂᛴᥐ⨨ࢆࡾࠊ㛵㐃ᶵ㛵㏿ࡸ㐃⤡ࡍࡿࡇࠋ 㸳㸬ᆅ㟈࣭ⅆ⅏࡞ࡢ⥭ᛴࡿࡁᥐ⨨㛵ࡍࡿィ⏬ࢆ࠶ࡽࡌࡵィ⏬ࡋ࡚࠾ ࡃࡇࠋ ϱϨ ᐇ㦂ࡢグ㘓࣭ಖᏑ➼ 㸯㸬ᐇ㦂ᐇ⪅ࡣࠊᐇ㦂ື≀ࡢ㣫⫱ᙜࡓࡗ࡚ࡣࠊ㣫⫱ື≀ࡢᩘࢆయࡶྵࡵ࡚ ẖ㐌ィ ࡋࠊ㣫⫱ᩘ⟶⌮⡙グ㘓ࡋ࡚ࠊᐇ㦂ື≀⟶⌮⪅ሗ࿌ࡍࡿࡇࠋ 㸰㸬ᐇ㦂ᐇ⪅ࡣࠊసᴗ๓ᚋసᴗࡋࡓࢣ࣮ࢪࡈື≀ᩘኚㄗࡾࡢ࡞࠸ࡇ ࢆィ ࣭グ㘓ࡍࡿࡇࠋ 㸱㸬ᐇ㦂ᐇ⪅ࡣࠊᐇ㦂ື≀ᐊࡢධ㏥ฟࢆ⟶⌮⡙グ㘓ࡍࡿࡇࠋ 㸲㸬㣫⫱ᩘ⟶⌮⡙ཬࡧධ㏥ฟ⟶⌮⡙ࡣࠊື≀ᐇ㦂ጤဨ୪ࡧ㑇ఏᏊ⤌࠼ᐇ㦂Ᏻ ጤဨᐃᮇⓗᥦฟࡋࠊᑂᰝࢆཷࡅࡿࡇࠋ ϱϩ ᩍ⫱࣭⮬ᕫⅬ᳨ 㸯㸬⟶⌮⪅ࡣࠊᐇ㦂ື≀ࡢ⏝➼ᚲせ࡞ἲ௧࣭సᴗᡭ㡰㛵ࡍࡿᩍ⫱࣭カ⦎ࢆᖺ 㸯ᅇ⛬ᗘ㛤ദࡋࠊ◊✲ᐊ㛗ࠊᐇ㦂ᐇ⪅ཬࡧື≀ᐇ㦂㈐௵⪅ࡣࡇࢀཧຍࡍࡿࡇ ࠋ 㸰㸬ື≀ᐇ㦂ጤဨࡣࠊᐇ㦂ື≀ࡢ⏝タᑐࡋᣑᩓ㜵Ṇᥐ⨨ࢳ࢙ࢵࢡࣜࢫࢺ ࡼࡿᖺ ᅇࡢ⮬ᕫⅬ᳨ࢆᐇࡋࠊᅜ❧㝔ᶵᵓᮏ㒊⥲ྜ◊✲ࢭࣥࢱ࣮ࢳ࢙ࢵࢡ ― 253 ― ࣜࢫࢺࢆᥦฟࡍࡿࡇࠋ 㸱㸬⮬ᕫⅬ᳨࣭ホ౯ཬࡧ᳨ドࡢ⤖ᯝ➼㛵ࡍࡿሗࡣࠊẖᖺ㸯ᅇ⛬ᗘබ⾲ࡍࡿࡶࡢ ࡍࡿࠋ ϱϪ ⿵๎ ࡇࡢᣦ㔪ᐃࡵࡿࡶࡢࡢࠊື≀ᐇ㦂ࡢᐇ㛵ࡋᚲせ࡞㡯ࡣࠊጤဨࡢ㆟ ࢆ⤒࡚㝔㛗ࡀᐃࡵࡿࠋ 㝃 ๎㸦ᖹᡂ㸰㸲ᖺ㸲᭶㸯᪥ᨵṇ㸧 㸦⾜ᮇ᪥㸧 ࡇࡢᣦ㔪ࡣࠊᖹᡂ㸰㸲ᖺ㸲᭶㸯᪥ࡽ⾜ࡍࡿࠋ 㸦つᐃࡢᗫṆ㸧 ࡇࡢᣦ㔪ࡢ⾜ేࡏ࡚ࠊḟᥭࡆࡿᚑ๓ࡢᣦ㔪ࡣᗫṆࡍࡿࠋ ᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ື≀ᐇ㦂ᣦ㔪㸦ᖹᡂ㸯㸴ᖺ㸲᭶⾜㸧 ― 254 ― 㻌 㻌 㻌 㻌 䊥㻌 ⮫ᗋ◊✲䝉䞁䝍䞊ධ㒊䞉㏥㒊ᡭ⥆᭩㢮㻌 㻌 ὀ㻌 㻌 ᮾி་⒪䝉䞁䝍䞊ෆ䛚䜘䜃እ㒊䛾◊✲⪅䛜䝉䞁䝍䞊◊✲ဨ䛸䛧䛶 Ⓩ㘓䛩䜛䛯䜑䛾ᡭ⥆᭩㢮㻌 ᖹᡂ㸰㸳ᖺ㸯㸰᭶㸯㸯᪥つ⛬➨㸯㸮㸶ྕ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲ࢭࣥࢱ࣮◊✲ဨධ㒊⥘㡿 㸦┠ⓗ㸧 ➨㸯᮲ ࡇࡢ⥘㡿ࡣࠊᮾி་⒪ࢭࣥࢱ࣮⮫ᗋ◊✲ࢭࣥࢱ࣮㸦௨ୗࠕឤぬჾࢭࣥࢱ࣮ࠖ࠸ ࠺ࠋ 㸧᥇⏝ࡉࢀࡓ◊✲ဨࢆ㐺ṇ⟶⌮ࡋࠊ࡞ឤぬჾࢭࣥࢱ࣮ࡢ㐠Ⴀࢆᅗࡿࡓࡵࠊ ◊✲ဨࡢ◊✲┠ⓗࠊ◊✲ᮇ㛫ཬࡧᮏேᒚṔ➼⟶⌮ᚲせ࡞㡯ࢆᐃࡵࡿࡶࡢࡍࡿࠋ 㸦ᚲせ᭩㢮㸧 ➨㸰᮲ ධ㒊ཬࡧ㏥㒊ᚲせ࡞᭩㢮ࡣࠊḟࡢྛྕࡢ࠾ࡾࡍࡿࠋࡲࡓࠊ᭩㢮ࡣ㐜࡞ࡃ ᚲࡎᥦฟࡍࡿࡶࡢࡍࡿࠋ ୍ ⮫ᗋ◊✲ࢭࣥࢱ࣮ධ㒊⏦㎸᭩㸦ᵝᘧ㸯㸧 ㄋ⣙᭩㸦ᵝᘧ㸰㸧 ୕ ᒚṔ᭩㸦ᵝᘧ㸱㸧 ᅄ ⮫ᗋ◊✲ࢭࣥࢱ࣮ධ㒊⏦㎸᭩㸦⸆ᖌࠊ┳ㆤᖌࠊົࠊࡑࡢ㸧㸦ᵝᘧ㸲㸧 ㏥㒊㢪㸦ᵝᘧ㸳㸧 㸦ྡ⡙ཬࡧ㓄⨨ᅗ㸧 ➨㸱᮲ ⮫ᗋ◊✲ࢭࣥࢱ࣮ົᐊࡣࠊ᪂ࡓ◊✲ဨࢆධ㒊ࡉࡏࡓሙྜࠊឤぬჾࢭࣥࢱ࣮ྡ ⡙ཬࡧ㓄⨨ᅗグ㍕ࡋࠊ㸯ࣨ᭶ẖసᡂࡍࡿࠋ 㸦ಖ⟶㸧 ➨㸲᮲ ➨㸰᮲つᐃࡍࡿ᭩㢮ࡘ࠸࡚ࡣࠊ⮫ᗋ◊✲ࢭࣥࢱ࣮ົᐊ࡛ಖ⟶ࡍࡿࠋ࡞࠾ࠊ ಖ⟶ᮇ㛫ࡣ◊✲ဨࡈ㏥㒊ᚋ㸳ᖺ㛫ࡍࡿࠋ 㸦◊✲ᮇ㛫㸧 ➨㸳᮲ ཎ๎ࡋ࡚ධ㒊Ⅼ࠾࠸࡚◊✲ᮇ㛫ࢆᐃࡵࡿࡇࡍࡿࠋ 㸰 ◊✲ᮇ㛫ࡀᐃࡵࡽࢀ࡞࠸ሙྜ࠾࠸࡚ࡶධ㒊ࢆチྍ࡛ࡁࡿࡀࠊࡑࡢሙྜ࡛ࡶ㸱ᖺ㛫ࢆ 㝈ᗘࡍࡿࠋ 㸱 ◊✲ࢆ⥅⥆ࡍࡿሙྜࡣࠊධ㒊⏦㎸᭩㸦⥅⥆㸧ࢆᥦฟࡍࡿࠋ࡞࠾ࠊࡑࡢሙྜࡣ➨㸰᮲ ➨㸱ྕᐃࡵࡿᒚṔ᭩ࢆ┬␎ࡍࡿࡇࡀ࡛ࡁࡿࠋ 㸲 ᭶ࡢ㏵୰ධ㒊ࡋࡓሙྜࡣࠊᙜヱ᭶ࡢึ᪥ࢆ㉳⟬᪥ࡍࡿࠋࡑࡢࡓࡵࠊ➨㸰㡯ࡢつᐃ ࡼࡾ◊✲ᮇ㛫ࡀ㸱ᖺ㛫࡞ࡗࡓሙྜࡣࠊධ㒊ࡋࡓ᪥ࡢ㸱ᖺᚋࡢ๓᭶ᮎ᪥ࢆࡶࡗ࡚ᮇ 㛫‶ࡍࡿࠋ 㸳 ᮾி་⒪ࢭࣥࢱ࣮ࢆ㏥⫋ࡋࡓሙྜࡣࠊ㏥㒊ࡋࡓࡇࡍࡿࠋࡑࡢሙྜࡣࠊ➨㸰᮲ ➨㸳ྕᐃࡵࡿ㏥㒊㢪ࡣ┬␎ࡍࡿࡇࡀฟ᮶ࡿࠋ 㸦⫋ဨࡢධ㒊㸧 ➨㸴᮲ ᮾி་⒪ࢭࣥࢱ࣮ࡢ⫋ဨࡀධ㒊ࡍࡿ㝿ࡣࠊ➨㸰᮲➨㸯ྕࡲࡓࡣ➨㸲ྕᐃࡵࡿධ 㒊⏦㎸᭩ཬࡧ➨㸰ྕᐃࡵࡿㄋ⣙᭩ࡢࡳࡍࡿࠋ 㸦ࡑࡢ㸧 ➨㸵᮲ ࡇࡢ⥘㡿ᐃࡵࡿࡶࡢࡢࠊࡇࡢ⥘㡿ࡢᐇᙜࡓࡾᚲせ࡞㡯ࡣ⮫ᗋ◊✲ࢭ ࣥࢱ࣮㛗ࡀูᐃࡵࡿࡇࡀ࡛ࡁࡿࠋ ― 255 ― 㝃 ๎ 㸦⾜ᮇ᪥㸧 ࡇࡢ⥘㡿ࡣࠊᖹᡂ㸰㸳ᖺ㸯㸰᭶㸯㸯᪥ࡽ⾜ࡍࡿࠋ ― 256 ― ⮫ᗋ◊✲ ࢭࣥࢱ࣮ ົྲྀᢅ ෆ ⏦ ᭩ ูῧࠊධ㒊⏦㎸᭩ࡢ ࡣࠊ⮫ᗋ◊✲ࢭࣥࢱ࣮ဨࡋ࡚㐺௵⪅ㄆ ࡵࠊ᥇⏝᪉ෆ⏦⮴ࡋࡲࡍࠋ ᖹᡂ ᖺ ᭶ ᪥ 㒊 㛗 ༳ ― 257 ― 㸦ᵝᘧ㸯㸧 ⮫ᗋ◊✲ࢭࣥࢱ࣮ධ㒊⏦㎸᭩ 㸦 ᪂つ ࣭ ⥅⥆ 㸧 ͤࢆۑࡅ࡚ࡃࡔࡉ࠸ ⏦ㄳ᪥㸸ᖹᡂ ᖺ ᭶ ᪥ 㸯㸬⏦ㄳ⪅ 㸰㸬⏕ᖺ᭶᪥ 㸱㸬ᡤᒓタ 㸲㸬ᚑ⫋ྡ 㸳㸬Ꮫ Ṕ 㸴㸬་ᖌචチ 㸵㸬◊✲ㄢ㢟ྡ 㸶㸬◊✲ᮇ㛫 Ặྡ ༳ 㸦 ⏨ ࣭ ዪ 㸧 ఫᡤ 㸯㸷 ᖺ ᭶ ᪥ 㸦‶ ṓ㸧 タྡ ᡤᅾᆅ ᭱⤊༞ᴗᏛᰯྡ ༞ᴗᖺ᭶᪥ ᖺ Ⓩ㘓ᖺ᭶᪥ ᖺ Ⓩ㘓␒ྕ ⮬ ᖹᡂ ᖺ ⮳ ᖹᡂ ᖺ ᭶ ᪥ ᭶ ᪥ ᭶ ᪥ ᭶ ᪥ 㸷 㸬 ධ 㒊 ᕼ ᮃ 㒊 ᐊ ◊✲㒊 㸯㸮 ⫋ ✀ ✲◊ ڧဨ ✲◊ ڧຓᡭཬࡧᢏ⾡ဨ ⮫ ڧᗋ་ᖌ ڧእ㒊◊✲ဨ㸦ᖖࡢタ࣭⫋✀㸧 ࡢࡑ ڧ 㸦 㸧 㸯㸯㸬ῧ㈨ᩱ 㸦㸯㸧ㄋ⣙᭩ 㸦㸰㸧ᒚṔ᭩ 㸦㸱㸧◊✲ィ⏬᭩ ― 258 ― 㸦ᵝᘧ㸰㸧 ㄋ ⣙ ᭩ ᖹᡂ ᖺ ᭶ ᪥ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓ ᮾி་⒪ࢭࣥࢱ࣮㝔㛗 Ẋ ◊✲⪅Ặྡ ༳ ⚾ࡣࠊᅇࠊ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮࠾ࡅࡿ◊✲ࡘ࠸࡚ࡣࠊୗグ ᮇ㛫୰ࠊἲ௧ཬࡧㅖつ๎ࢆ㑂Ᏺࡋ࡚◊✲ࡍࡿࡇࢆㄋ⣙࠸ࡓࡋࡲࡍࠋṇࢆ⾜ࡗࡓሙྜࡣࠊ ᶵ㛵ࡸ㓄ศᶵ㛵ࡢฎศཬࡧἲⓗ࡞㈐௵ࢆ㈇࠺ࢆేࡏ࡚ㄋ⣙࠸ࡓࡋࡲࡍࠋ グ ◊✲ᮇ㛫 㸸 ⮬ ᖹᡂ ᖺ ᭶ ᪥ ⮳ ᖹᡂ ᖺ ᭶ ᪥ ― 259 ― ― 260 ― 㸦ᵝᘧ 㸧 ⮫ᗋ◊✲ࢭࣥࢱ࣮ධ㒊⏦㎸᭩ 㸦 ⸆ᖌ ࣭ ┳ㆤᖌ ࣭ ົ ࣭ ࡑࡢ 㸧 ͤ࠸ࡉࡔࡃ࡚ࡅࡘࢆۑ ⏦ㄳ᪥㸸ᖹᡂ ᖺ ᭶ ᪥ 㸯 Ặ ྡ ༳ 㸦 ⏨ ࣭ ዪ 㸧 㸰 ⏕ᖺ᭶᪥ 㸯㸷 ᖺ ᭶ ᪥ 㸦‶ ṓ㸧 㸱 ᡤᒓ◊✲㒊 㒊 㸲 ᡤᒓ◊✲ᐊ ᐊ 㸳 ෆ⥺␒ྕ 㸴(PDLO 㸵㸬༊ ศ ڧ㠀ᖖ ڧὴ㐵 ࡢࡑ ڧ㸦 㸧 㸶㸬᥇⏝᪥ ᖹᡂ ᖺ ᭶ ᪥ 㸷 ົ㛫 ᭶᭙᪥ ⅆ᭙᪥ Ỉ᭙᪥ ᮌ᭙᪥ 㔠᭙᪥ 㹼 㹼 㹼 㹼 㹼 ͤ㏥⫋ࡢ㝿ࡣᚲࡎࠕ㏥㒊ᒆࠖࢆࡈᥦฟࡃࡔࡉ࠸ࠋ ͤົ㛫࣭᭙᪥ࡢኚ᭦ࡢ㝿ࡣົᐊࡲ࡛࠾ᒆࡅࡃࡔࡉ࠸ࠋ ― 261 ― 㸦ᵝᘧ 㸧 ㏥ 㒊 㢪 ࡇࡢࡓࡧ ࡼࡾ ᖹᡂ ᖺ ᭶ ᪥㏥㒊࠸ࡓࡋࡓ࠸ࡢ࡛ࡈᢎㄆ㢪࠸ࡲࡍࠋ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓ ᮾி་⒪ࢭࣥࢱ࣮ ⮫ᗋ◊✲ࢭࣥࢱ࣮㛗 Ẋ ᖹᡂ ᖺ ᭶ ᪥ ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪ࢭࣥࢱ࣮ ⮫ᗋ◊✲ࢭࣥࢱ࣮ ᡤᒓ㒊ྡ ᡤᒓᐊྡ Ặ ྡ ༳ 㸦ົ⏝ḍ㸧 㘽 ㏉༷ ㌟ศド᫂᭩㏉༷ ― 262 ― ࢭࣥࢱ࣮ㅮᖌᐟἩタ⏝ᡭ㡰 ᇶᮏ㸸ᐟἩ⪅㛵ಀࡍࡿྛ◊✲㒊ࡀ㈐௵ࢆᣢࡗ࡚ ୗグࡢ࣮ࣝࣝᚑࡗ࡚ᑐᛂࡍࡿࡇࢆཎ๎ࡍࡿࠋ 㸯㸬⏝チྍ⏦ㄳ᭩ࢆ 㝵ົᐊᥦฟ㸦Ѝ 㝵ົᐊಖ⟶㸧ࠋ 㸰㸬⏦ㄳ᭩ᥦฟ 㝵ົᐊ࡚ㅮᖌᐊᐟἩグ㘓ࣀ࣮ࢺᚲせ㡯グධࠋ 㸱㸬⏦ㄳ⪅࠶ࡿ࠸ࡣ⏝⪅ࡀࣜࢿࣥᐊࣇࣛࣥࢫ࣋ࢵࢺෆ⥺㸱㸮㸱㸮㟁ヰࡋࠊ ࠕ⮫ᗋ◊✲ࢭࣥࢱ࣮ࡢㅮᖌᐟἩᐊ࠺ࡢ࡛ᕸᅋࢆ୍ᘧ㈚ࡋ࡚ୗࡉ࠸ࠖఏ࠼ࠊ ⏝᪥ࠊ㏉༷᪥ࢆᡴࡕྜࢃࡏࠊྲྀࡾ⾜ࡃࠋ 㸲㸬ㅮᖌᐊࡢ㘽ࢆ 㝵ົᐊࡽࡾࡿࠋ 㸳㸬ᐟἩᚋࠊᕸᅋ㏉༷࣭Ύᤲࠋ 㸴㸬 㝵ົᐊ㘽ࢆ㏉ࡍࠋ 㸨Ὑ㠃⏝ල➼ᾘ⪖ရࡣྛ⮬࡛ࡈ⏝ពࡃࡔࡉ࠸ࠋ㸦㒊ᒇ⨨ࡁࡗࡥ࡞ࡋྍ㸧 㸨Ύᤲ≧ἣ᭹ࡢሙྜࡣᐟἩグ㘓ࣀ࣮ࢺࢆぢ࡚ྛ⮬㐃⤡ࢆྲྀࡾྜࡗ࡚ୗࡉ࠸ࠋ 㸨ᅵ᪥ࡣ 㝵ົᐊࡣఇࡳࡢⅭࠊ㘽ࡢ㏉༷ࡀᅵ᪥ࡢሙྜࠊ㛵ಀࡍࡿ◊✲㒊ࡀ㈐௵ࢆ ᣢࡗ࡚ཷࡅྲྀࡾࠊ㐌᫂ࡅ 㝵ົᐊ㏉༷ࡢࡇ ࡇࡢ⏝ᡭ㡰ࡣࠊᖹᡂ ᖺ ᭶ ᪥ࡼࡾ⾜ࡍࡿࠋ ᮾி་⒪ࢭࣥࢱ࣮ ⮫ᗋ◊✲ࢭࣥࢱ࣮ ࢭࣥࢱ࣮㛗 ຍᡃ ྩᏕ ― 263 ― ⦅㞟ᚋグ ᖹᡂ ᖺᗘࡣయࡢάືࡘࡢࡁ࡞ฟ᮶ࡀ࠶ࡾࡲࡋࡓࠋ୍ࡘࡣ ᖺ ᭶ ᪥㛤ദࡉࢀࡓ ➨ ᅇឤぬჾࢩ࣏ࣥࢪ࣒࡛࢘ࠊᕷẸබ㛤ㅮᗙࢆවࡡࡓᅇࡢ≉㞟ࡢࢸ࣮࣐ࡣࠕ㧗㱋⪅་⒪ ࢧࢡࢭࢫ ࣇ࣭࢚ࣝࢪࣥࢢࡢᣮᡓ࡛ࠖ ྡࡢࢩ࣏ࣥࢪࢫࢺࡼࡿㅮ₇ࡣࡁ࡞㡪ࡀ࠶ࡾࡲࡋࡓࠋ࣏ࢫࢱ࣮ࡢ ࢹࢨࣥࡣ *UDSKLF'HVLJQ5RRP ͆)͇౫㢗ࡋࣥࣃࢡࢺࡢ࠶ࡿࡶࡢ࡞ࡾࡲࡋࡓࠋࡶ࠺୍ࡘࡣᮾி ་⒪ࢭࣥࢱ࣮❧ ࿘ᖺグᛕᘧ⚃㈡࡛ᖹᡂ ᖺ ᭶ ᪥㛤ദࡉࢀࡲࡋࡓࠋᮾி་⒪ࢭࣥࢱ ࣮ࡢ๓㌟ࡣᅜ❧➨㝔࡛ࠊྂ࠸ᮌ㐀ࡢ㝔࡛࠶ࡗࡓ௦ࠊ་ᖌᅜᐙヨ㦂ࡢ㠃᥋ࢆཷࡅ᮶ࡲࡋࡓࡀࠊྂ ࡃᬯ࠸༳㇟࡛ࠊࡓࡃࡉࢇࡢᶞᮌᅖࡲࢀ࡚࠸ࡲࡋࡓࠋ⌧ᅾࡢᮾி་⒪ࢭࣥࢱ࣮ࡣྛᆅࡽゼࢀࡿᝈ⪅ࡢ ⓙᵝࡀ࣍ࢵࡍࡿࡼ࠺࡞ⓑளࡢ㝔࡛ࡍࠋ㥖ἑ࢜ࣜࣥࣆࢵࢡබᅬࡢ୍㒊࠶ࡿࡼ࠺࡞༳㇟ࢆ࠼࡚ࡃࢀ ࡲࡍࠋ ᖺࡢᅄᏘࢆࡾ㏉ࡾࡲࡍࠊࢭࣥࢱ࣮ࡢ࿘ᅖࡣ ᭶ࡢ⨾ࡋ࠸⣚ᱵࠊ ᭶ࡢᱜࠊ ᭶ࡢࢶࢶࢪࠊኟ ࡢ㖟ᮥࡢᮌࡢ⥳ࠊࡦࡲࢃࡾࠊ⛅ࡢ⣚ⴥࡢᏘ⠇ࡶᮾி࡛࠶ࡾ࡞ࡀࡽ⮬↛ࡢኚࢆᴦࡋࡲࡏ࡚ࡃࢀࡲ ࡍࠋ᪂ࡋࡃࣄ࣏ࢡࣛࢸࢫࡢᮌ㸦㕥ᠱࡢᮌ㸧ࡀ ᖺࡼࡾຍࢃࡾࡲࡋࡓࠋ๓㝔㛗ࡢᯇᮏ⣧ኵඛ⏕ࡢ㏥ ௵グᛕ᳜ᶞࡉࢀࡓࡶࡢ࡛ࡍࠋ ⮫ᗋ◊✲ࢭࣥࢱ࣮㸦ឤぬჾࢭࣥࢱ࣮㸧ࡢྡ⛠ࡀࢭࣥࢱ࣮㆟࡛㆟ㄽࡉࢀࡲࡋࡓࠋᮾி་⒪ࢭࣥࢱ࣮ࡢ⮫ ᗋ◊✲ࢭࣥࢱ࣮ࡣᖺᛴ㏽ࡉࢀࡓᒸᮏඛ⏕ࡀ㝔㛗ࡢ㡭ࠊࡈᮏேࡀᜍࡽࡃᚚ㧗ྡ࡞⫈ぬ◊✲⪅࡛࠶ࡗ ࡓࡇࡶ࠶ࡾឤぬჾ◊✲ࡀ㔜どࡉࢀࡲࡋࡓࠋ⌧ᅾࡢ⮫ᗋ◊✲ࢭࣥࢱ࣮ࡀㄌ⏕ࡋࡓࡣࠊᑗ᮶ࡢᅜ❧ឤぬ ჾ◊✲ࢭࣥࢱ࣮Ⓨᒎࡉࡏࡿࡇࢆ┠ᣦࡋࠊ⌧ᅾ࡛ࡶࡑࡢ⪃࠼ࡀᗏὶ࠶ࡾࠊ᪥ᮏ║⛉Ꮫ᪥ᮏ⪥㰯 ဗႃ⛉Ꮫࡀࡁ࡞ᨭࢆࡋ࡚ࡁࡲࡋࡓࠋᾏእⓎಙࡍࡿ◊✲ㄽᩥࡣ 1DWLRQDO ,QVWLWXWH RI 6HQVRU\ 2UJDQVࠊ␎⛠ 1,62 ࡣࡇࡢࡼ࠺࡞Ṕྐⓗ⫼ᬒࡀ࠶ࡾࡲࡍࠋ ᭱㏆࡛ࡣ◊✲άືྲྀࡾ⤌ࡴࡣከࡃࡢ㛵ᡤࢆ⤒࡞ࡅࢀࡤ㐍ࡵࡽࢀ࡞࠸ࡼ࠺࡞ࢤ࣮ࢺࡀ⏝ពࡉࢀ࡚࠸ࡲ ࡍࠋඹྠ◊✲⪅࡛◊✲ဨ࡛ࡣ࠶ࡾࡲࡍࡀࡢタ࡛ࢆࡋ࡚࠾ࡽࢀ࡚ࡶࠊᮾி་⒪ࢭࣥࢱ࣮ࡢࢤ࣮ࢺࢆ ✺◚ࡍࡿᚲせࡀ࠶ࡾࠊྛ◊✲⌜ࡢඛ⏕ࡀఏ࠼ࡿᚲせࡀ࠶ࡾࡲࡍࠋ ⮫ᗋ◊✲ࢭࣥࢱ࣮ࡣ◊✲άືࢆᨭ࠼ࡿ⣙ ྡࡢ⛎᭩ࡢⓙࡉࢇࡀᅾ⫋ࡋᨭ࠼࡚ࡃࢀ࡚࠸ࡲࡍࠋᏛࡢ ᩍᐊ୪ࡢⓙࡉࢇࡀά㌍ࡋ࡚࠸ࡲࡍࠋ ⟶⌮Ჷ 㝵ࡢ⮫ᗋ◊✲ࢭࣥࢱ࣮ࡢົᐊࡢྜྷᕝளᕼࡉࢇቑ⏣▱ᐇࡉࢇࡣ࣋ࢸࣛࣥࡢ⛎᭩ࡢⓙࡉࢇࡢ ୰࡛ࡍࡗࡾᯈࡘ࠸࡚ࢫ࣒࣮ࢬ㐠Ⴀࡉࢀ࡚࠸ࡿࡇᚚ♩ࢆ⏦ࡋୖࡆࡲࡍࠋ ྡ⮫ᗋ◊✲ࢭࣥࢱ࣮㛗 ຍᡃ ྩᏕ ― 265 ― 㻌 㻌 㻌 㻌 㻌 㻌 㻌 㻌 ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓᮾி་⒪䝉䞁䝍䞊⮫ᗋ◊✲䝉䞁䝍䞊㻌 ᖹᡂ 㻞㻣 ᖺ◊✲ᖺሗ㻌 㻌 㻞㻜㻝㻢 ᖺ 㻤 ᭶Ⓨ⾜㻌 㻌 Ⓨ⾜㻌 㻌 㻌 ⊂❧⾜ᨻἲேᅜ❧㝔ᶵᵓ㻌 ᮾி་⒪䝉䞁䝍䞊㻌 ⮫ᗋ◊✲䝉䞁䝍䞊㻌 䛈㻝㻡㻞㻙㻤㻥㻜㻞㻌 ᮾி㒔┠㯮༊ᮾ䛜ୣ䠎䠉䠑䠉䠍㻌 㻌 ༳ๅ㻌 㻌 㻌 ᰴᘧ♫㻌 ♽㇂༳ๅᡤ㻌